Citrus Sinensis ID: 015202
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 411 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.900 | 0.366 | 0.387 | 1e-60 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.892 | 0.355 | 0.349 | 3e-53 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.841 | 0.353 | 0.363 | 1e-47 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.885 | 0.355 | 0.374 | 8e-46 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.890 | 0.378 | 0.327 | 2e-45 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.897 | 0.353 | 0.320 | 2e-45 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.892 | 0.333 | 0.324 | 3e-44 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.897 | 0.329 | 0.326 | 4e-44 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.866 | 0.364 | 0.332 | 1e-43 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.854 | 0.312 | 0.326 | 8e-43 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 234 bits (596), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 148/382 (38%), Positives = 221/382 (57%), Gaps = 12/382 (3%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL 65
ISGSIP +I NL NL + L N L+G + +LGKL L+ L L N+L G IP + +
Sbjct: 373 ISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNM 432
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
L LDL +N G VP+ GN ++L +L++G N+L IPL + ++ +L L++S NS
Sbjct: 433 TMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNS 492
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
LP +IG L+ L + L N SG +P T+G ++ LFLE N G IPD + GL
Sbjct: 493 LIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGL 551
Query: 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244
+ +K +DLSNN+LSG+IP L+++N+SFN LEG++P +G F N + S GN
Sbjct: 552 VGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNND 611
Query: 245 LC-GMPNLHVPPCRTGI-----HHTSRKNDLLIGIVLPLS---TIFMMVVILLILRYRKR 295
LC G+ + PC + H+SR ++IG+ + ++ +FM V L+ LR RK+
Sbjct: 612 LCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKK 671
Query: 296 GKPLLNDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKA-RIQDGMEVAVK 354
K N + +Y +L +ATNGFS++N++G G G++YKA + + VAVK
Sbjct: 672 NKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVK 731
Query: 355 VFDLQYREAFKSFDNEFMTVVD 376
V ++Q R A KSF E ++ D
Sbjct: 732 VLNMQRRGAMKSFMAECESLKD 753
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (532), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 142/406 (34%), Positives = 215/406 (52%), Gaps = 39/406 (9%)
Query: 6 ISGSIPEEINNL-TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR 64
+ G +P I NL T L +++LG N ++G+I +G L LQ L LE N L G +P +
Sbjct: 356 LGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGK 415
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYIL------- 116
L L +DL N +SG +PS FGN+T L+KL+L SN IP +L +Y+L
Sbjct: 416 LLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTN 475
Query: 117 -----------------YLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGG 159
Y++LS+N T P E+G LE+LV + S N SG +P IGG
Sbjct: 476 RLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGG 535
Query: 160 LKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
+++LF++ N G+IPD I L++LK++D SNNNLSG IP L L L+++N+S N
Sbjct: 536 CLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMN 594
Query: 220 KLEGEIPREGPFRNFSIESFKGNELLC-GMPNLHVPPCRTGIHHTSRK-----NDLLIGI 273
K EG +P G FRN + S GN +C G+ + + PC RK ++ GI
Sbjct: 595 KFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGI 654
Query: 274 VLPLSTIFMMVVILLILRYRKRGKPLLNDANMPPLAN-----QRRFTYLELFHATNGFSA 328
+ ++++ +++++ + + KR K P + + +Y EL AT+ FS+
Sbjct: 655 CIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSS 714
Query: 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMT 373
N+IG G G+++K + + VAVKV +L A KSF E T
Sbjct: 715 TNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECET 760
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (484), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 139/382 (36%), Positives = 197/382 (51%), Gaps = 36/382 (9%)
Query: 8 GSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAA 67
G IP E+ L+ L +YL N L G I + LG + +L LL + N L GSIP L+
Sbjct: 335 GPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQ 394
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPL----TLWNLKYILYLNLSS 122
L +L L N LSG VP G NL L L N LT IP+ L NLK LYLNLSS
Sbjct: 395 LRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLK--LYLNLSS 452
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N + P+P E+ +++++ +DLS N SG IP +G L++L L N ++P +G
Sbjct: 453 NHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLG 512
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGN 242
L LK LD+S N L+GAIP S ++ L+H+N SFN L G + +G F +IESF G+
Sbjct: 513 QLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGD 572
Query: 243 ELLCGMPNLHVPPCRTGIHHTSRKNDLLIGIVLPLSTIFMMVVILLILRYRKRGKPLL-- 300
LLCG + + + LL I P+ +F ++ + + GK L
Sbjct: 573 SLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLV----QRSRFGKNLTVY 628
Query: 301 -------------NDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQD 347
ND P R +Y +L AT GF+A+++IG G G +YK +++
Sbjct: 629 AKEEVEDEEKQNQNDPKYP------RISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRN 682
Query: 348 GMEVAVKVFD----LQYREAFK 365
+VAVKV D L++ +FK
Sbjct: 683 NTKVAVKVLDPKTALEFSGSFK 704
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (468), Expect = 8e-46, Method: Compositional matrix adjust.
Identities = 141/377 (37%), Positives = 208/377 (55%), Gaps = 13/377 (3%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL 65
ISGSIP I NL +L + LG N L G + +LG+L +L+ + L N L G IP L +
Sbjct: 389 ISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNI 448
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
+ L L L +N G +PS G+ + L L LG+N+L IP L L ++ LN+S N
Sbjct: 449 SGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNL 508
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
PL +IG L+ L+ +D+S N SG IP T+ L++L L+ N G IPD I GL
Sbjct: 509 LVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGL 567
Query: 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244
L+ LDLS NNLSG IP + LQ++N+S N +G +P EG FRN S S GN
Sbjct: 568 TGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNIN 627
Query: 245 LC-GMPNLHVPPCRTGI--HHTSRKNDLLIGIVLPLSTIFMMVVILLILRYRK------R 295
LC G+P+L + PC + H+S + + I + ++ + ++ + ++ L + K R
Sbjct: 628 LCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVR 687
Query: 296 GKPLLNDANMPPLAN-QRRFTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAV 353
ND + P+ + + +Y EL+ T GFS++N+IG G G+++K + VA+
Sbjct: 688 ANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAI 747
Query: 354 KVFDLQYREAFKSFDNE 370
KV +L R A KSF E
Sbjct: 748 KVLNLCKRGAAKSFIAE 764
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 183 bits (465), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 132/403 (32%), Positives = 200/403 (49%), Gaps = 37/403 (9%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL 65
++G IP + NL+ +YL GNKL G I LG + +L L L DN+L G IP +L +L
Sbjct: 300 LTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKL 359
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
LF+L+L +N L G +PS + L + + N L+ +PL NL + YLNLSSNS
Sbjct: 360 EQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNS 419
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
F +P+E+G++ L +DLS NNFSG+IP T+G L+ L L L N L G++P G L
Sbjct: 420 FKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNL 479
Query: 185 INLKSLDLSNNNLSGAIPISLEKL------------------------LDLQHINVSFNK 220
+++ +D+S N L+G IP L +L L ++N+SFN
Sbjct: 480 RSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNN 539
Query: 221 LEGEIPREGPFRNFSIESFKGNELLCGMPNLHVPPCRTGIHHTSRKNDLLIGIVLPLSTI 280
L G IP F FS SF GN LCG N C + + + + I + L I
Sbjct: 540 LSGIIPPMKNFTRFSPASFFGNPFLCG--NWVGSICGPSLPKSQVFTRVAV-ICMVLGFI 596
Query: 281 FMMVVILLILRYRKRGKPLLNDANMPPLANQRRF---------TYLELFHATNGFSANNI 331
++ +I + + K+ KP+L ++ P + + T+ ++ T I
Sbjct: 597 TLICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLVILHMDMAIHTFDDIMRVTENLDEKYI 656
Query: 332 IGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTV 374
IG G ++YK + +A+K QY F+ F+ E T+
Sbjct: 657 IGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREFETELETI 699
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 183 bits (464), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 131/409 (32%), Positives = 204/409 (49%), Gaps = 40/409 (9%)
Query: 8 GSIPEEINNLTNLIAIYLGGNKLNGSISIALG------------------------KLQK 43
G +P+ + + +LI + GN +G IS A G + QK
Sbjct: 420 GPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQK 479
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
L L +N + G+IP ++ + L QLDL N+++G +P N+ + KL L N+L+
Sbjct: 480 LVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLS 539
Query: 104 -YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD 162
IP + L + YL+LSSN F+ +P + NL L ++LS N+ IP + L
Sbjct: 540 GKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQ 599
Query: 163 LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
LQ L L YN+L G I L NL+ LDLS+NNLSG IP S + +L L H++VS N L+
Sbjct: 600 LQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQ 659
Query: 223 GEIPREGPFRNFSIESFKGNELLCGMPNLH--VPPCRTGIHHTSRKN-DLLIGIVLPL-- 277
G IP FRN ++F+GN+ LCG N + PC S K+ +L+I I++P+
Sbjct: 660 GPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIG 719
Query: 278 STIFMMVVILLILRYRKRGKPLLNDAN-------MPPLANQRRFTYLELFHATNGFSANN 330
+ I + V + + +RKR K + + + + + Y E+ AT F
Sbjct: 720 AIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKY 779
Query: 331 IIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFK--SFDNEFMTVVDA 377
+IG GG G +YKA++ + + +AVK + + S EF+ + A
Sbjct: 780 LIGTGGHGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLNEIRA 827
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (455), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 127/391 (32%), Positives = 198/391 (50%), Gaps = 24/391 (6%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL 65
++GS+P E+ NL NL A+ L N L+G+IS LGKL+ L+ L L +N G IP ++ L
Sbjct: 463 LTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNL 522
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
+ ++ N+L+G +P G+ +++L L N+ + YI L L Y+ L LS N
Sbjct: 523 TKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNR 582
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQY-LFLEYNRLQGSIPDFIGG 183
T +P G+L L+++ L N S IP +G L LQ L + +N L G+IPD +G
Sbjct: 583 LTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGN 642
Query: 184 LINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNE 243
L L+ L L++N LSG IP S+ L+ L N+S N L G +P F+ +F GN
Sbjct: 643 LQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNH 702
Query: 244 LLCGMPNLHVPPCRTGIHHT----------SRKNDLLIGIVLPLSTIFMMVVILLILRYR 293
LC H C+ + H+ S++ +L + + ++F++ + L +
Sbjct: 703 GLCNSQRSH---CQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIK 759
Query: 294 KRGKPL--LNDANMPPLAN-----QRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQ 346
+R L D P + + ++ FTY L AT FS + ++GRG G++YKA +
Sbjct: 760 RREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMS 819
Query: 347 DGMEVAVKVFDLQYREAFKSFDNEFMTVVDA 377
G +AVK L R S DN F +
Sbjct: 820 GGEVIAVK--KLNSRGEGASSDNSFRAEIST 848
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 4e-44, Method: Compositional matrix adjust.
Identities = 125/383 (32%), Positives = 196/383 (51%), Gaps = 14/383 (3%)
Query: 7 SGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLA 66
+G I E +L I NK +G IS K KL L + +N + G+IP ++ +
Sbjct: 523 TGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMT 582
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNSF 125
L +LDL N L G +P GNLTNL +L L NQL+ +P L L + L+LSSN+F
Sbjct: 583 QLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNF 642
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLI 185
+ +P + L ++LS N F G+IP + L L L L +N+L G IP + L
Sbjct: 643 SSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSKLTQLTQLDLSHNQLDGEIPSQLSSLQ 701
Query: 186 NLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELL 245
+L LDLS+NNLSG IP + E ++ L ++++S NKLEG +P FR + ++ + N L
Sbjct: 702 SLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGL 761
Query: 246 CG-MPNLHVPPCRTGIHHTSRKNDLLIGIVLPLSTIFMMVVILL-ILRYRKRGKPLLNDA 303
C +P + PCR + + +L++ I++P+ + +++ I Y R + L N
Sbjct: 762 CSNIPKQRLKPCRE-LKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGR 820
Query: 304 NMPPLANQR--------RFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKV 355
N P + +F Y ++ +TN F ++IG GG +Y+A +QD + ++
Sbjct: 821 NTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTIIAVKRL 880
Query: 356 FDLQYREAFKS-FDNEFMTVVDA 377
D E K EF+ V A
Sbjct: 881 HDTIDEEISKPVVKQEFLNEVKA 903
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 136/409 (33%), Positives = 194/409 (47%), Gaps = 53/409 (12%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL 65
+SGSIP + NLT +YL NKL GSI LG + KL L L DN L G IP +L +L
Sbjct: 295 LSGSIPPILGNLTFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKL 354
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
LF L++ +N L G +P + TNL L + N+ + IP L+ + YLNLSSN+
Sbjct: 355 TDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNN 414
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
P+P E+ + L +DLS N +G IP+++G L+ L + L N + G +P G L
Sbjct: 415 IKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNL 474
Query: 185 INLKSLDLSNNNLSGAIPISLEKL-----------------------LDLQHINVSFNKL 221
++ +DLSNN++SG IP L +L L L +NVS N L
Sbjct: 475 RSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNL 534
Query: 222 EGEIPREGPFRNFSIESFKGNELLCGMPNLHVPPCRTGIHHTSRKN-------DLLIGIV 274
G+IP+ F FS +SF GN LCG + PC H SR+ ++GI
Sbjct: 535 VGDIPKNNNFSRFSPDSFIGNPGLCG--SWLNSPC-----HDSRRTVRVSISRAAILGIA 587
Query: 275 LPLSTIFMMVVILLILRYRKRGKPLLNDANM--------PPLA----NQRRFTYLELFHA 322
+ I +MV LI R P D ++ P L N Y ++
Sbjct: 588 IGGLVILLMV---LIAACRPHNPPPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRM 644
Query: 323 TNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEF 371
T S IIG G ++YK +++ VA+K ++ K F+ E
Sbjct: 645 TENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMKQFETEL 693
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 8e-43, Method: Compositional matrix adjust.
Identities = 121/371 (32%), Positives = 189/371 (50%), Gaps = 20/371 (5%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL 65
++G P E+ L NL AI L N+ +G + +G QKLQ L L NQ ++P ++ +L
Sbjct: 481 LTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKL 540
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQ-LTYIPLTLWNLKYILYLNLSSNS 124
+ L ++ N L+G +PS N L++L L N + +P L +L + L LS N
Sbjct: 541 SNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENR 600
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLF-LEYNRLQGSIPDFIGG 183
F+ +P IGNL L ++ + N FSG+IP +G L LQ L YN G IP IG
Sbjct: 601 FSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGN 660
Query: 184 LINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNE 243
L L L L+NN+LSG IP + E L L N S+N L G++P F+N ++ SF GN+
Sbjct: 661 LHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNK 720
Query: 244 LLCGMPNLHVPPCRTGIHHTSR---------KNDLLIGIVLPLSTIFMMVVILLILR--- 291
LCG P + H S + +++ V+ ++ ++ +++ LR
Sbjct: 721 GLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPV 780
Query: 292 -----YRKRGKPLLNDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQ 346
Y +P ++++ + RFT ++ AT GF + I+GRG G++YKA +
Sbjct: 781 EPTAPYVHDKEPFFQESDI-YFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMP 839
Query: 347 DGMEVAVKVFD 357
G +AVK +
Sbjct: 840 SGKTIAVKKLE 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 411 | ||||||
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.892 | 0.337 | 0.510 | 6e-89 | |
| 255585401 | 843 | serine-threonine protein kinase, plant-t | 0.895 | 0.436 | 0.493 | 3e-87 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.897 | 0.347 | 0.465 | 2e-85 | |
| 449500845 | 982 | PREDICTED: probable LRR receptor-like se | 0.900 | 0.376 | 0.502 | 7e-85 | |
| 449465016 | 1092 | PREDICTED: probable LRR receptor-like se | 0.897 | 0.337 | 0.493 | 2e-84 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.890 | 0.359 | 0.477 | 2e-84 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.888 | 0.335 | 0.472 | 1e-83 | |
| 359483688 | 1197 | PREDICTED: LRR receptor-like serine/thre | 0.895 | 0.307 | 0.477 | 2e-83 | |
| 359497186 | 1140 | PREDICTED: LRR receptor-like serine/thre | 0.888 | 0.320 | 0.481 | 1e-82 | |
| 359483675 | 1250 | PREDICTED: LRR receptor-like serine/thre | 0.888 | 0.292 | 0.475 | 2e-82 |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 334 bits (856), Expect = 6e-89, Method: Compositional matrix adjust.
Identities = 189/370 (51%), Positives = 251/370 (67%), Gaps = 3/370 (0%)
Query: 4 CNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC 63
C + G+IP EI NL+NL + L N L G+I ++G+LQKLQ L L N+L+GSIP D+C
Sbjct: 479 CKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDIC 538
Query: 64 RLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQL-TYIPLTLWNLKYILYLNLSS 122
+L L +L L +N+LSG +P+C G LT LR LYLGSN+L + IP TLW+L +IL L++SS
Sbjct: 539 QLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSS 598
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N LPS++GNL+VLV+IDLS N SG IP+ IGGL+DL L L +NR +G I
Sbjct: 599 NFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFS 658
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGN 242
L +L+ +DLS+N L G IP SLE L+ L++++VSFN L GEIP EGPF NFS ESF N
Sbjct: 659 NLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMN 718
Query: 243 ELLCGMPNLHVPPCRTGIHHTSRKNDLLIGIVLP--LSTIFMMVVILLILRYRKRGKPLL 300
+ LCG P L +PPCRTG ++ + LL+ +LP LST+ + +I + R RKR L
Sbjct: 719 KALCGSPRLKLPPCRTGTRWSTTISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLP 778
Query: 301 NDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY 360
+ A RR +Y E+F ATNGFSA N++GRG +GS+Y+ + DG A+KVF+LQ
Sbjct: 779 TQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQE 838
Query: 361 REAFKSFDNE 370
AFKSFD E
Sbjct: 839 EAAFKSFDAE 848
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 328 bits (841), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 182/369 (49%), Positives = 247/369 (66%), Gaps = 1/369 (0%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+CNI G+IP EI L+NLI ++L N+L GSI + +G LQKLQ L L N L GSIP D+
Sbjct: 231 SCNIKGNIPSEIGVLSNLITLHLQNNELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDI 290
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKYILYLNLS 121
C L+ L +L L +N L G +P+CFG+L +LR L+L SN T IP +LW+LK +L LNLS
Sbjct: 291 CHLSNLGELFLSNNSLFGPLPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLS 350
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
SNS + +P IGNL+VL Q+D S N+ SG IP IG L++L L L +NR +G IP+
Sbjct: 351 SNSLSGHIPLSIGNLKVLTQVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPF 410
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKG 241
G LI+L+SLDLS+NNLSG IP SLE+L L+++NVSFN L+GE+P +G F NFS SF G
Sbjct: 411 GELISLESLDLSSNNLSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLG 470
Query: 242 NELLCGMPNLHVPPCRTGIHHTSRKNDLLIGIVLPLSTIFMMVVILLILRYRKRGKPLLN 301
N LCG L + PC+ H S+ + L+ I + ++I + IL+ LR +K L N
Sbjct: 471 NLALCGSRLLPLMPCKNNTHGGSKTSTKLLLIYVLPASILTIAFILVFLRCQKVKLELEN 530
Query: 302 DANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYR 361
++ + RR ++ EL AT+GF A+N++G GG GS+YK R++DG VA+KVF+L
Sbjct: 531 VMDIITVGTWRRISFQELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVE 590
Query: 362 EAFKSFDNE 370
AFK FD E
Sbjct: 591 GAFKIFDTE 599
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 322 bits (825), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 173/372 (46%), Positives = 238/372 (63%), Gaps = 3/372 (0%)
Query: 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
F+C I G+IP I NL+NLI + L N+L G+I +G+L+ LQ L N+L+G IP +
Sbjct: 444 FDCRIIGNIPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNE 503
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLS 121
+C L L L L +N SG +P+C N+T+LR+LYLGSN+ T IP T W+LK +L +NLS
Sbjct: 504 ICHLERLSYLYLLENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLS 563
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
NS T LP EIGNL+V+ ID S N SG IPT+I L++L + L NR+QG IP
Sbjct: 564 FNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSF 623
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKG 241
G L++L+ LDLS N+LSGAIP SLEKL+ L+ NVSFN+L+GEI GPF NFS SF
Sbjct: 624 GDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMD 683
Query: 242 NELLCGMPNLHVPPCRTGIHH--TSRKNDLLIGIVLPLSTIFMMVVILLILRYRKRGKPL 299
NE LCG + VPPC++ H + R + +I ++P ++V+ L ++ +R+ K
Sbjct: 684 NEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRK 743
Query: 300 LNDANMP-PLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDL 358
L+ P P A R+ +Y EL+ AT GF+ N++G G GS+YK + DG+ +AVKVF L
Sbjct: 744 LSTQEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHL 803
Query: 359 QYREAFKSFDNE 370
Q FD+E
Sbjct: 804 QLEGELMRFDSE 815
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449500845|ref|XP_004161209.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 320 bits (820), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 189/376 (50%), Positives = 251/376 (66%), Gaps = 6/376 (1%)
Query: 1 MFNCNISGSIPEEINN-LTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP 59
M N I G IP++I N L +L + + N++ G+I ++GKL++LQ L L +N LEG+IP
Sbjct: 498 MVNTGIKGMIPKDIGNFLRSLTVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIP 557
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQL-TYIPLTLWNLKYILYL 118
++C+L L +L L +NKLSG +P CF NL+ LR L LGSN L + +P +LW+L YIL+L
Sbjct: 558 AEICQLENLDELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHL 617
Query: 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178
NLSSNS LP EIGNLEV++ ID+S N SG IP++IGGL +L L L +N L+GSIP
Sbjct: 618 NLSSNSLRGSLPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIP 677
Query: 179 DFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIES 238
D G L+NLK LDLS+NNL+G IP SLEKL L+ NVSFN+LEGEIP GPF NFS +S
Sbjct: 678 DSFGNLVNLKILDLSSNNLTGVIPKSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQS 737
Query: 239 FKGNELLCGMPN-LHVPPCRTGIHHTS-RKNDLLIGIVLPL-STIFMMVVILLILRYRKR 295
F N LC + V PC T S RK + L+ I+ P+ + ++++LL + YR R
Sbjct: 738 FISNIGLCSASSRFQVAPCTTKTSQGSGRKTNKLVYILPPILLAMLSLILLLLFMTYRHR 797
Query: 296 GKP-LLNDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVK 354
K + D +P RR TY EL AT+GFS +N+IGRG GS+YKA + DG AVK
Sbjct: 798 KKEQVREDTPLPYQPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGTIAAVK 857
Query: 355 VFDLQYREAFKSFDNE 370
+FDL ++A KSF+ E
Sbjct: 858 IFDLLTQDANKSFELE 873
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 319 bits (817), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 186/377 (49%), Positives = 251/377 (66%), Gaps = 8/377 (2%)
Query: 1 MFNCNISGSIPEEINN-LTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP 59
M N I G IP++I N L +LI + + N++ G+I ++GKL++LQ L L +N LEG+IP
Sbjct: 476 MVNTGIKGMIPKDIGNFLRSLIVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIP 535
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQL-TYIPLTLWNLKYILYL 118
++C+L L +L L +NKLSG +P CF NL+ LR L LGSN L + +P +LW+L YIL+L
Sbjct: 536 AEICQLENLDELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHL 595
Query: 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178
NLSSNS LP EIGNLEV++ ID+S N SG IP++IGGL +L L L +N L+GSIP
Sbjct: 596 NLSSNSLRGSLPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIP 655
Query: 179 DFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIES 238
D G L+NL+ LDLS+NNL+G IP SLEKL L+ NVSFN+LEGEIP GPF NFS +S
Sbjct: 656 DSFGNLVNLEILDLSSNNLTGVIPRSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQS 715
Query: 239 FKGNELLCGMPN-LHVPPCRTGIHHTS-RKNDLLIGI---VLPLSTIFMMVVILLILRYR 293
F N LC + V PC T S RK + L+ I +L +++++ + R+R
Sbjct: 716 FISNIGLCSASSRFQVAPCTTKTSQGSGRKTNKLVYILPSILLAMLSLILLLLFMTYRHR 775
Query: 294 KRGKPLLNDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAV 353
K+ + + D +P RR TY EL AT+GFS +N+IGRG GS+YKA + DG AV
Sbjct: 776 KK-EQVREDTPLPYQPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGTIAAV 834
Query: 354 KVFDLQYREAFKSFDNE 370
K+FDL ++A KSF+ E
Sbjct: 835 KIFDLLTQDANKSFELE 851
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 318 bits (816), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 180/377 (47%), Positives = 234/377 (62%), Gaps = 11/377 (2%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
++ + G+IP EI NL+NLI + L N L G I +G L+K+Q+L L N L GSIP
Sbjct: 403 VYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPS 462
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLN 119
D+C L + L +N LSG +PSC GNLT+LR LYL N L+ IP+ LW+LK +L LN
Sbjct: 463 DICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILN 522
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
L SN LPS++G +E + I LS N SG IP+TIG L++L L N QGSIP+
Sbjct: 523 LHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPE 582
Query: 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESF 239
GGL++L+ LDLS NNLSG IP SLE L L+ +VSFN L+GEIPR GPF NF+ SF
Sbjct: 583 AFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSF 642
Query: 240 KGNELLCGMPNLHVPPCRTGIHHTSRKNDLLIGIVLPLSTIFMMVVILLIL------RYR 293
N+ LCG L VPPC S+ L+ LP ++VV + L RYR
Sbjct: 643 IMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYR 702
Query: 294 KRGKPLLNDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAV 353
K P +P A QRR +YLEL HATN F +N++G G GS+Y+ R++DG+ VAV
Sbjct: 703 KDPIP----EALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAV 758
Query: 354 KVFDLQYREAFKSFDNE 370
K+F+LQ + AF+SFD E
Sbjct: 759 KIFNLQLQRAFRSFDTE 775
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 316 bits (809), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 175/370 (47%), Positives = 235/370 (63%), Gaps = 5/370 (1%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL 65
I GS+ E I NL++L + LG N L G I +G L+ LQ L L N L+GSIP +LC L
Sbjct: 477 IKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDL 536
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQ-LTYIPLTLWNLKYILYLNLSSNS 124
L+ L+L NKLSG +P+CF NLT+LR L+L SN+ ++ I TLW LK IL +NL+SN
Sbjct: 537 RTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNY 596
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
T LPSEI NL + I++S N SG IP +IGGL+DL L+L N+LQG IP +G +
Sbjct: 597 LTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDI 656
Query: 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244
+L+ LDLS+NNLSG IP SL+ LL L++ NVSFN L+GEIP G F NFS +SF GNE
Sbjct: 657 KSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEA 716
Query: 245 LCGMPNLHVPPCRTGIHHTSRK--NDLLIGIVLP--LSTIFMMVVILLILRYRKRGKPLL 300
LCG L V PC+ + + +++ VLP + +F++ ++++ RY +R
Sbjct: 717 LCGSARLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFS 776
Query: 301 NDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY 360
+ + L RR +Y EL ATNGF +N +G G GS+YK + DG +A KVF+LQ
Sbjct: 777 IEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQL 836
Query: 361 REAFKSFDNE 370
AFKSFD E
Sbjct: 837 ERAFKSFDTE 846
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483688|ref|XP_003633002.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 315 bits (807), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 178/373 (47%), Positives = 244/373 (65%), Gaps = 5/373 (1%)
Query: 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
+ C G+IP I NLTNLI ++LG N L GSI LG+LQKLQ L + N++ GSIP D
Sbjct: 590 YACQFRGTIPTGIGNLTNLIMLHLGANDLTGSIPTTLGQLQKLQALSIAGNRIRGSIPND 649
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKYILYLNL 120
LC L L L L NKLSG PSCFG+L LR+L+L SN L + IP +LW+L+ +L LNL
Sbjct: 650 LCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNL 709
Query: 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
SSN T LP E+GN++ ++ +DLS N SG IP+ +G L++L L L N+LQG IP
Sbjct: 710 SSNFLTGNLPPEVGNMKYIITLDLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVE 769
Query: 181 IGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFK 240
G L++L+SLDLS NNLS IP SLE L+ L+++NVSFNKL+GEIP GPF NF+ ESF
Sbjct: 770 CGDLVSLESLDLSQNNLSRIIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVNFNAESFM 829
Query: 241 GNELLCGMPNLHVPPCRTGIHHTSRKND--LLIGIVLPL-STIFMMVVILLILRYRKRGK 297
NE LCG P+ V C S K +L I+LP+ ST+ ++V I+L +R R +
Sbjct: 830 FNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNME 889
Query: 298 PLLNDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFD 357
A+ P + ++ +L +ATN F +N+IG+G G +YK + +G+ VA+KVF+
Sbjct: 890 IPTPIASWLP-GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFN 948
Query: 358 LQYREAFKSFDNE 370
L+++ A +SFD+E
Sbjct: 949 LEFQRALRSFDSE 961
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 313 bits (801), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 179/372 (48%), Positives = 242/372 (65%), Gaps = 7/372 (1%)
Query: 4 CNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC 63
C G+IP I NLTNLI + LG N L GSI LG+LQKLQ L + N++ GSIP DLC
Sbjct: 535 CQFRGTIPTGIGNLTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLC 594
Query: 64 RLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKYILYLNLSS 122
L L L L NKLSG +PSCFG+L L++L+L SN L + IP +LW+L+ +L LNLSS
Sbjct: 595 HLKDLGYLFLSSNKLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSS 654
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N T LP E+GN++ + +DLS N SG IP+ +G L+ L L L NRLQG IP G
Sbjct: 655 NFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFG 714
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGN 242
L++L+SLDLS NNLSG IP SLE L+ L+++NVS NKL+GEIP GPF NF+ ESF N
Sbjct: 715 DLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFN 774
Query: 243 ELLCGMPNLHVPPCRTGIHHTSRKND--LLIGIVLPLSTIFMMVV-ILLILRYRKRGK-P 298
E LCG P+ V C S K +L I+LP+ +I +VV I+L +R R + P
Sbjct: 775 EALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIP 834
Query: 299 LLNDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDL 358
D+ +P + ++ +L +ATN F +N+IG+G G +YK + +G+ VA+KVF+L
Sbjct: 835 TPIDSWLP--GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNL 892
Query: 359 QYREAFKSFDNE 370
+++ A +SFD+E
Sbjct: 893 EFQGALRSFDSE 904
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 312 bits (800), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 177/372 (47%), Positives = 242/372 (65%), Gaps = 7/372 (1%)
Query: 4 CNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC 63
C+ G+IP I NLTNLI + LG N L GSI LG+LQKLQ L + N+++GSIP DL
Sbjct: 623 CHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQRLYIAGNRIQGSIPNDLF 682
Query: 64 RLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKYILYLNLSS 122
L L L L NKLSG +PSCFG+L LR+L L SN L + IP++ W+L+ +L L+LSS
Sbjct: 683 HLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLSLSS 742
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N T LP E+GN++ + +DLS N SG IP +G L++L L L N+LQGSIP G
Sbjct: 743 NFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFG 802
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGN 242
L++L+S+DLS NNLSG IP SLE L+ L+H+NVSFNKL+GEIP GPF NF+ ESF N
Sbjct: 803 DLLSLESMDLSQNNLSGTIPKSLEALIYLKHLNVSFNKLQGEIPDGGPFVNFTAESFIFN 862
Query: 243 ELLCGMPNLHVPPCRTGIHHTSRKND--LLIGIVLPLSTIFMMV--VILLILRYRKRGKP 298
E LCG P+ V C H S K +L I+LP+ +I +V ++L I R P
Sbjct: 863 EALCGAPHFQVIACDKNNHTQSWKTKSFILKYILLPVGSIVTLVAFIVLWIRRQDNTEIP 922
Query: 299 LLNDANMPPLANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDL 358
D+ +P + + +L +ATN F +N+IG+G +G +YK + +G+ VA+KVF+L
Sbjct: 923 APIDSWLP--GAHEKISQQQLLYATNDFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNL 980
Query: 359 QYREAFKSFDNE 370
+++ A +SFD+E
Sbjct: 981 EFQGALRSFDSE 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 411 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.900 | 0.366 | 0.342 | 2.7e-48 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.875 | 0.351 | 0.351 | 1.3e-46 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.892 | 0.451 | 0.328 | 1e-43 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.878 | 0.352 | 0.328 | 6.2e-43 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.900 | 0.366 | 0.307 | 9.3e-43 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.895 | 0.363 | 0.302 | 1.7e-40 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.863 | 0.362 | 0.331 | 1.1e-38 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.892 | 0.355 | 0.299 | 3.2e-38 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.905 | 0.317 | 0.293 | 3e-37 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.880 | 0.328 | 0.304 | 2e-34 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 2.7e-48, Sum P(2) = 2.7e-48
Identities = 131/382 (34%), Positives = 194/382 (50%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPYDLCRL 65
ISGSIP +I NL NL + L N L+G + + N+L G IP + +
Sbjct: 373 ISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNM 432
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
L LDL +N G VP+ GN ++L +L++G N+L IPL + ++ +L L++S NS
Sbjct: 433 TMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNS 492
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
LP +IG L+ L + L N SG +P T+G ++ LFLE N G IPD + GL
Sbjct: 493 LIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGL 551
Query: 185 IXXXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244
+ G+IP L+++N+SFN LEG++P +G F N + S GN
Sbjct: 552 VGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNND 611
Query: 245 LCG-MPNLHVPPCRTGI-----HHTSRKNDLLIGI---VLPLSTIFMMVVILLILRYRKR 295
LCG + + PC + H+SR ++IG+ + L +FM V L+ LR RK+
Sbjct: 612 LCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKK 671
Query: 296 GKPLLNDANMPPLANQRRFTYLELFHATNGFSANNXXXXXXXXXXYKARI-QDGMEVAVK 354
K N + +Y +L +ATNGFS++N YKA + + VAVK
Sbjct: 672 NKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVK 731
Query: 355 VFDLQYREAFKSFDNEFMTVVD 376
V ++Q R A KSF E ++ D
Sbjct: 732 VLNMQRRGAMKSFMAECESLKD 753
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.3e-46, P = 1.3e-46
Identities = 130/370 (35%), Positives = 185/370 (50%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPYDLCRL 65
I+GSIP++I NL L +YL N GS+ + +N L GSIP + L
Sbjct: 388 ITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNL 447
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKYI-LYLNLSSN 123
L L LG NK SG++P NLTNL L L +N L+ IP L+N++ + + +N+S N
Sbjct: 448 TELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKN 507
Query: 124 SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGG 183
+ +P EIG+L+ LV+ N SG IP T+G + L+YL+L+ N L GSIP +G
Sbjct: 508 NLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQ 567
Query: 184 LIXXXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNE 243
L G IP SL + L +N+SFN GE+P G F S S +GN
Sbjct: 568 LKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNA 627
Query: 244 LLCG-MPNLHVPPCRTGIHHTSRKNDLLIGIVLPLSTIFMMVVILLILRYR--KRGKPLL 300
LCG +P+LH+P C + + L I + L + + + LLI ++ K+G P
Sbjct: 628 KLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSR 687
Query: 301 NDANMPPLANQRRFTYLELFHATNGFSANNXXXXXXXXXXYKARIQDGMEVAVKVFDLQY 360
PL + Y +L AT+GF+ N YK ++ VAVKV L+
Sbjct: 688 TSMKGHPLVS-----YSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLEN 742
Query: 361 REAFKSFDNE 370
+A KSF E
Sbjct: 743 PKALKSFTAE 752
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 1.0e-43, P = 1.0e-43
Identities = 124/378 (32%), Positives = 189/378 (50%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPYDLCRL 65
ISGS+P +I NL NL + L N L GS+ + ++N+L GS+P + L
Sbjct: 362 ISGSLPRDIGNLVNLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNL 421
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQ-LTYIPLTLWNLKYIL-YLNLSSN 123
L +++ N G +PS GNLT L ++ LG N + IP+ ++++ + L++S N
Sbjct: 422 TQLTNMEVQFNAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHN 481
Query: 124 SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGG 183
+ +P EIG L+ +V+ N SG P+TIG + LQ+LFL+ N L GSIP +
Sbjct: 482 NLEGSIPKEIGKLKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQ 541
Query: 184 LIXXXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNE 243
L G IP+SL + L +N+SFN GE+P G F N S +GN
Sbjct: 542 LKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNA 601
Query: 244 LLCG-MPNLHVPPCRTGIHHTSRKNDLLIGIVLPL-STIFMMVVILLILRYRKRGKPLLN 301
+CG +P LH+P C + LL+ +V+ L ST+ + ++ ++L KR K +
Sbjct: 602 HICGGIPELHLPTCSLKSRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVP 661
Query: 302 DANMPPLANQRRFTYLELFHATNGFSANNXXXXXXXXXXYKARI--QDG---MEVAVKVF 356
+ TY +L AT+GFS+++ YK QDG VAV+V
Sbjct: 662 ATTS--MQGHPMITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVL 719
Query: 357 DLQYREAFKSFDNEFMTV 374
L+ +A KSF E T+
Sbjct: 720 KLETPKALKSFTAECETL 737
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 450 (163.5 bits), Expect = 6.2e-43, Sum P(2) = 6.2e-43
Identities = 123/374 (32%), Positives = 183/374 (48%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPYDLCRL 65
ISGSIP I NL +L + LG N L G + + N L G IP L +
Sbjct: 389 ISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNI 448
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
+ L L L +N G +PS G+ + L L LG+N+L IP L L ++ LN+S N
Sbjct: 449 SGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNL 508
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
PL +IG L+ L+ +D+S N SG IP T+ L++L L+ N G IPD I GL
Sbjct: 509 LVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGL 567
Query: 185 IXXXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244
G IP + LQ++N+S N +G +P EG FRN S S GN
Sbjct: 568 TGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNIN 627
Query: 245 LCG-MPNLHVPPCRTGI--HHTSRKNDLLIGIVLPLSTIFMMVVILLILR-YRKRGKPLL 300
LCG +P+L + PC + H+S + + I + ++ + ++ + ++ L Y+ R K +
Sbjct: 628 LCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVR 687
Query: 301 -----NDANMPPLAN-QRRFTYLELFHATNGFSANNXXXXXXXXXXYKARI-QDGMEVAV 353
ND + P+ + + +Y EL+ T GFS++N +K + VA+
Sbjct: 688 ANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAI 747
Query: 354 KVFDLQYREAFKSF 367
KV +L R A KSF
Sbjct: 748 KVLNLCKRGAAKSF 761
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 9.3e-43, P = 9.3e-43
Identities = 117/380 (30%), Positives = 192/380 (50%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPYDLCRL 65
I GSIP +I NL L ++ L N L G + + N+ G IP + L
Sbjct: 374 IYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNL 433
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
L +L L +N G VP G+ +++ L +G N+L IP + + +++LN+ SNS
Sbjct: 434 TQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNS 493
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
+ LP++IG L+ LV++ L NN SG +P T+G ++ ++L+ N G+IPD I GL
Sbjct: 494 LSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPD-IKGL 552
Query: 185 IXXXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244
+ G+I E L+++N+S N EG +P EG F+N ++ S GN+
Sbjct: 553 MGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKN 612
Query: 245 LCG-MPNLHVPPC-----RTGIHHTSRKNDLLIGIVLPLSTIFMMVVILLI-LRYRKRGK 297
LCG + L + PC H S + IG+ + ++ + ++ ++ L + RK +
Sbjct: 613 LCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQ 672
Query: 298 PLLNDANMPPLANQRRFTYLELFHATNGFSANNXXXXXXXXXXYKARIQ-DGMEVAVKVF 356
+ N A + +Y +L +AT+GFS++N +KA +Q + VAVKV
Sbjct: 673 KINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVL 732
Query: 357 DLQYREAFKSFDNEFMTVVD 376
++Q R A KSF E ++ D
Sbjct: 733 NMQRRGAMKSFMAECESLKD 752
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 1.7e-40, P = 1.7e-40
Identities = 115/380 (30%), Positives = 192/380 (50%)
Query: 8 GSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPYDLCRLAA 67
GSIP++I NL L + LG N L G + + N++ G IP + L
Sbjct: 376 GSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQ 435
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNSFT 126
L L L +N G VP G +++ L +G N+L IP + + ++ L++ NS +
Sbjct: 436 LEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLS 495
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLIX 186
LP++IG+L+ LV++ L N FSG +P T+G ++ LFL+ N G+IP+ I GL+
Sbjct: 496 GSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPN-IRGLMG 554
Query: 187 XXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLC 246
G+IP L+++N+S N G++P +G F+N +I GN+ LC
Sbjct: 555 VRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLC 614
Query: 247 G-MPNLHVPPCRTG-----IHHTSRKNDLLIGIVLPLSTIFMMVVILLILR-YRKRGKPL 299
G + +L + PC H+S + I + + ++ + ++V+ ++L +RKR K
Sbjct: 615 GGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQ 674
Query: 300 LNDANMPPLAN--QRRFTYLELFHATNGFSANNXXXXXXXXXXYKARIQ-DGMEVAVKVF 356
+ +P + +Y +L +ATNGFS++N +KA + + VAVKV
Sbjct: 675 QTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVL 734
Query: 357 DLQYREAFKSFDNEFMTVVD 376
++Q R A KSF E ++ D
Sbjct: 735 NMQRRGAMKSFMAECESLKD 754
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 424 (154.3 bits), Expect = 1.1e-38, P = 1.1e-38
Identities = 125/377 (33%), Positives = 181/377 (48%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPYDLCRL 65
+SG IP E+ L+ L +YL N L G I + N L GSIP L
Sbjct: 333 LSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNL 392
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPL-TLWNLKYI-LYLNLSS 122
+ L +L L N LSG VP G NL L L N LT IP+ + NL+ + LYLNLSS
Sbjct: 393 SQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSS 452
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N + P+P E+ +++++ +DLS N SG IP +G L++L L N ++P +G
Sbjct: 453 NHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLG 512
Query: 183 GLIXXXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGN 242
L GAIP S ++ L+H+N SFN L G + +G F +IESF G+
Sbjct: 513 QLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGD 572
Query: 243 ELLCGMPNLHVPPCRTGIHHTSRKNDLLIGIVLPLSTIFMMVVILLILRYRKR-GKPLL- 300
LLCG + C+ + S +L+ ++L L ++ V L R R GK L
Sbjct: 573 SLLCGSIK-GMQACKKKHKYPS----VLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTV 627
Query: 301 ---NDANMPPLANQR-----RFTYLELFHATNGFSANNXXXXXXXXXXYKARIQDGMEVA 352
+ NQ R +Y +L AT GF+A++ YK +++ +VA
Sbjct: 628 YAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVA 687
Query: 353 VKVFD----LQYREAFK 365
VKV D L++ +FK
Sbjct: 688 VKVLDPKTALEFSGSFK 704
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 3.2e-38, P = 3.2e-38
Identities = 114/381 (29%), Positives = 179/381 (46%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPYDLCRL 65
ISG+IP +I NL +L + L N L+G + ++ N + G IP +
Sbjct: 381 ISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNM 440
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
L +L L N G +P G L L++ +N+L IP + + + Y++LS+N
Sbjct: 441 TRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNF 500
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
T P E+G LE+LV + S N SG +P IGG +++LF++ N G+IPD I L
Sbjct: 501 LTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRL 559
Query: 185 IXXXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244
+ G IP L L L+++N+S NK EG +P G FRN + S GN
Sbjct: 560 VSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTN 619
Query: 245 LCG-MPNLHVPPCRTGIHHTSRK-----NDLLIGIVLPLSTIFMMVVILLILRYRKRGKP 298
+CG + + + PC RK ++ GI + ++++ +++++ + + KR K
Sbjct: 620 ICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKK 679
Query: 299 L-LNDANMPPLANQRRF----TYLELFHATNGFSANNXXXXXXXXXXYKARI-QDGMEVA 352
+D N F +Y EL AT+ FS+ N +K + + VA
Sbjct: 680 NNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVA 739
Query: 353 VKVFDLQYREAFKSFDNEFMT 373
VKV +L A KSF E T
Sbjct: 740 VKVLNLLKHGATKSFMAECET 760
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 412 (150.1 bits), Expect = 3.0e-37, P = 3.0e-37
Identities = 114/389 (29%), Positives = 192/389 (49%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPY 60
M++ ++ G IPEE+ ++ L + L NK +G I + N+ GSIP
Sbjct: 534 MYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPA 593
Query: 61 DLCRLAALFQLDLGDNKLSGFVPS-CFGNLTNLRKLYLG--SNQLT-YIPLTLWNLKYIL 116
L L+ L D+ DN L+G +P +L N++ LYL +N LT IP L L+ +
Sbjct: 594 SLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQ-LYLNFSNNLLTGTIPKELGKLEMVQ 652
Query: 117 YLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNRLQG 175
++LS+N F+ +P + + + +D S NN SG IP + G+ + L L N G
Sbjct: 653 EIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSG 712
Query: 176 SIPDFIGGLIXXXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
IP G + G IP SL L L+H+ ++ N L+G +P G F+N +
Sbjct: 713 EIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNIN 772
Query: 236 IESFKGNELLCGMPNLHVPPC--RTGIHHTSRKNDLLIGIVLPLSTIFMMVVILLILRY- 292
GN LCG + PC + H S++ +++ I+ + + ++++++LIL
Sbjct: 773 ASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCC 831
Query: 293 RKRGKPLLN--DANMPPLANQ---RRFTYLELFHATNGFSANNXXXXXXXXXXYKARIQD 347
+K+ K + N ++++P L + +RF EL AT+ F++ N YK +++D
Sbjct: 832 KKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLED 891
Query: 348 GMEVAVKVFDLQY--REAFKSFDNEFMTV 374
G +AVKV +L+ E+ K F E T+
Sbjct: 892 GTVIAVKVLNLKEFSAESDKWFYTEAKTL 920
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 371 (135.7 bits), Expect = 2.0e-34, Sum P(2) = 2.0e-34
Identities = 117/384 (30%), Positives = 172/384 (44%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIAXXXXXXXXXXXXEDNQLEGSIPYDLCRL 65
++GS+P E+ NL NL A+ L N L+G+IS +N G IP ++ L
Sbjct: 463 LTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNL 522
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
+ ++ N+L+G +P G+ +++L L N+ + YI L L Y+ L LS N
Sbjct: 523 TKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNR 582
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQY-LFLEYNRLQGSIPDFIGG 183
T +P G+L L+++ L N S IP +G L LQ L + +N L G+IPD +G
Sbjct: 583 LTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGN 642
Query: 184 LIXXXXXXXXXXXXXGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNE 243
L G IP S+ L+ L N+S N L G +P F+ +F GN
Sbjct: 643 LQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNH 702
Query: 244 LLCGMPNLHVPPCRTGIHHTSRKNDLLIGI----VLPLSTIFMMVVILLI---LRYR-KR 295
LC H P H S+ N L+ G +L ++ I + V L+ L + KR
Sbjct: 703 GLCNSQRSHCQPLVP--HSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKR 760
Query: 296 GKPL---LNDANMPPLAN-----QRRFTYLELFHATNGFSANNXXXXXXXXXXYKARIQD 347
+P L D P + + ++ FTY L AT FS + YKA +
Sbjct: 761 REPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSG 820
Query: 348 GMEVAVKVFDLQYREAFKSFDNEF 371
G +AVK L R S DN F
Sbjct: 821 GEVIAVK--KLNSRGEGASSDNSF 842
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00025215001 | SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (691 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 411 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-17 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-40
Identities = 94/227 (41%), Positives = 133/227 (58%), Gaps = 4/227 (1%)
Query: 3 NCNISGSIPEEINNLT-NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
N +SG IP++I + +L + L N GSI G + L+ L L +N L G IP D
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP--RGSIPNLETLDLSNNMLSGEIPND 159
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNL 120
+ ++L LDLG N L G +P+ NLT+L L L SNQL IP L +K + ++ L
Sbjct: 160 IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219
Query: 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
N+ + +P EIG L L +DL NN +G IP+++G LK+LQYLFL N+L G IP
Sbjct: 220 GYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
Query: 181 IGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR 227
I L L SLDLS+N+LSG IP + +L +L+ +++ N G+IP
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-39
Identities = 93/225 (41%), Positives = 129/225 (57%), Gaps = 1/225 (0%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
N +SG IP +I + ++L + LGGN L G I +L L L+ L L NQL G IP +L
Sbjct: 149 NNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPREL 208
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLS 121
++ +L + LG N LSG +P G LT+L L L N LT IP +L NLK + YL L
Sbjct: 209 GQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLY 268
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
N + P+P I +L+ L+ +DLS N+ SG IP + L++L+ L L N G IP +
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
L L+ L L +N SG IP +L K +L +++S N L GEIP
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-38
Identities = 90/223 (40%), Positives = 131/223 (58%), Gaps = 1/223 (0%)
Query: 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL 65
+ G IP + NLT+L + L N+L G I LG+++ L+ + L N L G IPY++ L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNS 124
+L LDL N L+G +PS GNL NL+ L+L N+L+ IP ++++L+ ++ L+LS NS
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
+ +P + L+ L + L NNF+G IP + L LQ L L N+ G IP +G
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR 227
NL LDLS NNL+G IP L +L + + N LEGEIP+
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-35
Identities = 91/236 (38%), Positives = 127/236 (53%), Gaps = 24/236 (10%)
Query: 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAA------- 67
NN + +++I L G ++G IS A+ +L +Q + L +NQL G IP D+ ++
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 68 ----------------LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLW 110
L LDL +N LSG +P+ G+ ++L+ L LG N L IP +L
Sbjct: 126 SNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185
Query: 111 NLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEY 170
NL + +L L+SN +P E+G ++ L I L NN SG IP IGGL L +L L Y
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245
Query: 171 NRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
N L G IP +G L NL+ L L N LSG IP S+ L L +++S N L GEIP
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-35
Identities = 87/254 (34%), Positives = 133/254 (52%), Gaps = 1/254 (0%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR 64
N++G IPE + + NL + L N L G I +LG + L+ + L+DN G +P + +
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNS 124
L ++ LD+ +N L G + S ++ +L+ L L N+ + K + L+LS N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
F+ +P ++G+L L+Q+ LS N SG IP + K L L L +N+L G IP +
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244
L LDLS N LSG IP +L + L +N+S N L G +P G F + + GN
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID 606
Query: 245 LCGMPNLH-VPPCR 257
LCG +PPC+
Sbjct: 607 LCGGDTTSGLPPCK 620
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 88/222 (39%), Positives = 120/222 (54%), Gaps = 1/222 (0%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR 64
N+SG IP EI LT+L + L N L G I +LG L+ LQ L L N+L G IP +
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSN 123
L L LDL DN LSG +P L NL L+L SN T IP+ L +L + L L SN
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 124 SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGG 183
F+ +P +G L +DLS NN +G IP + +L L L N L+G IP +G
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 184 LINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225
+L+ + L +N+ SG +P KL + +++S N L+G I
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-31
Identities = 78/227 (34%), Positives = 116/227 (51%), Gaps = 2/227 (0%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+F+ N +G IP + +L L + L NK +G I LGK L +L L N L G IP
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLN 119
LC LF+L L N L G +P G +LR++ L N + +P L + +L+
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
+S+N+ + S ++ L + L+ N F G +P + G K L+ L L N+ G++P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPR 493
Query: 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
+G L L L LS N LSG IP L L +++S N+L G+IP
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 60/160 (37%), Positives = 89/160 (55%), Gaps = 4/160 (2%)
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKY-ILYLNLSSNSFTIP 128
+DL +SG + S L ++ + L +NQL+ IP ++ + YLNLS+N+FT
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLK 188
+P G++ L +DLS N SG IP IG L+ L L N L G IP+ + L +L+
Sbjct: 134 IPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLE 191
Query: 189 SLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
L L++N L G IP L ++ L+ I + +N L GEIP E
Sbjct: 192 FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 29/178 (16%)
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI 177
L L + +P++I L L I+LS N+ G IP ++G + L+ L L YN GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 178 PDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIE 237
P+ +G L +L+ L+L+ N+LSG +P +L G NF+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASFNFT-- 523
Query: 238 SFKGNELLCGMPNLHVPPCRTGIHHTSRKNDLLIGIVLPLSTIFMMVVILLILRYRKR 295
N LCG+P L C G H + IGI +S F+ +VI + +++R
Sbjct: 524 ---DNAGLCGIPGLR--AC--GPHLSVGAK---IGIAFGVSVAFLFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 85/239 (35%), Positives = 122/239 (51%), Gaps = 9/239 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKL-QKLQLLGLEDNQLEGSIPYD 61
N N S E+ LTNL ++ L N + I +G L L+ L L DN++E S+P
Sbjct: 101 NLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLS 121
L L L LDL N LS NL+NL L L N+++ +P + L + L+LS
Sbjct: 159 LRNLPNLKNLDLSFNDLSDLPKL-LSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLS 217
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
+NS I L S + NL+ L ++LS NN +P +IG L +L+ L L N++ S +
Sbjct: 218 NNS-IIELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNNQI--SSISSL 273
Query: 182 GGLINLKSLDLSNNNLSGAIP-ISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESF 239
G L NL+ LDLS N+LS A+P I+L LL +N+ E+ N +I S
Sbjct: 274 GSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 35/85 (41%), Positives = 50/85 (58%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
N + G IP +I+ L +L +I L GN + G+I +LG + L++L L N GSIP L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFG 87
+L +L L+L N LSG VP+ G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 29/74 (39%), Positives = 40/74 (54%)
Query: 30 LNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNL 89
L G I + KL+ LQ + L N + G+IP L + +L LDL N +G +P G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 90 TNLRKLYLGSNQLT 103
T+LR L L N L+
Sbjct: 490 TSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 71/242 (29%), Positives = 107/242 (44%), Gaps = 7/242 (2%)
Query: 4 CNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC 63
N +P ++ L +L + G L L L L N+L +I L
Sbjct: 56 SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLD-LNLNRLRSNISELL- 113
Query: 64 RLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSN 123
L L LDL +N ++ P +NL++L L N++ +P L NL + L+LS N
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFN 173
Query: 124 SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGG 183
+ LP + NL L +DLS N S +P I L L+ L L N + + +
Sbjct: 174 DLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSN 230
Query: 184 LINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNE 243
L NL L+LSNN L +P S+ L +L+ +++S N++ I G N GN
Sbjct: 231 LKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNS 288
Query: 244 LL 245
L
Sbjct: 289 LS 290
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 12/210 (5%)
Query: 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
+ N S+P + NL NL + L N L+ + L L L L L N++ +P +
Sbjct: 147 LSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPE 204
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLS 121
+ L+AL +LDL +N + S NL NL L L +N+L +P ++ NL + L+LS
Sbjct: 205 IELLSALEELDLSNNSIIEL-LSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLS 263
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
+N + S +G+L L ++DLS N+ S A+P L L L +
Sbjct: 264 NNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIA-------LLLLLLELLLNLLLTLK 314
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDL 211
+ L S+ L+NN LS S E L L
Sbjct: 315 ALELKLNSILLNNNILSNGETSSPEALSIL 344
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 1e-06
Identities = 24/59 (40%), Positives = 31/59 (52%)
Query: 163 LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L+ L L NRL GL NLK LDLS NNL+ P + L L+ +++S N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 4e-05
Identities = 26/63 (41%), Positives = 33/63 (52%), Gaps = 3/63 (4%)
Query: 135 NLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSN 194
NL+ L DLS N + GL +L+ L L N L P+ GL +L+SLDLS
Sbjct: 1 NLKSL---DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57
Query: 195 NNL 197
NNL
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 4e-05
Identities = 20/56 (35%), Positives = 27/56 (48%), Gaps = 1/56 (1%)
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSF 125
LDL +N+L+ F L NL+ L L N LT I L + L+LS N+
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 1e-04
Identities = 20/78 (25%), Positives = 32/78 (41%), Gaps = 12/78 (15%)
Query: 332 IGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-ANLLTREDKHF--- 387
I I +++A ++DG EVAVKV Q K ++ + A +L + F
Sbjct: 19 IAAASIAQVHRAVLKDGEEVAVKV---QRPGVKKRIRSDLKLLKFLAKILKKFFPGFDLD 75
Query: 388 -MTKEQRVSFVFNLAMEC 404
+ E F +L E
Sbjct: 76 WLVDE----FRKSLPQEL 89
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 4e-04
Identities = 21/60 (35%), Positives = 26/60 (43%)
Query: 43 KLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQL 102
L+ L L +N+L L L LDL N L+ P F L +LR L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.001
Identities = 25/83 (30%), Positives = 32/83 (38%), Gaps = 23/83 (27%)
Query: 91 NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS 150
NL+ L L +N+LT IP +F L L +DLS NN +
Sbjct: 1 NLKSLDLSNNRLTVIP---------------DGAF--------KGLPNLKVLDLSGNNLT 37
Query: 151 GAIPTTIGGLKDLQYLFLEYNRL 173
P GL L+ L L N L
Sbjct: 38 SISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 411 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.88 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.85 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.85 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.75 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.75 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.74 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.73 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.62 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.58 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.37 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.33 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.3 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.28 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.27 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.21 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.14 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.12 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.12 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.1 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.08 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.05 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 98.98 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 98.97 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.96 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 98.93 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.89 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 98.78 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.77 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 98.76 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 98.75 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.71 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 98.71 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.66 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 98.64 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 98.59 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 98.59 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 98.58 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 98.58 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 98.57 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.56 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 98.56 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.56 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 98.56 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 98.54 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 98.54 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 98.53 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.53 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 98.53 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.51 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 98.51 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 98.51 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 98.5 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 98.5 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 98.5 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 98.49 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 98.49 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.48 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 98.48 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 98.48 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 98.47 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 98.46 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 98.46 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 98.46 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 98.46 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 98.46 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 98.45 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 98.45 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 98.45 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 98.44 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 98.44 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 98.44 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 98.44 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 98.44 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 98.43 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 98.43 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 98.43 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 98.42 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 98.42 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 98.4 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 98.4 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 98.4 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 98.4 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 98.39 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 98.39 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 98.39 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 98.39 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 98.39 | |
| PTZ00284 | 467 | protein kinase; Provisional | 98.38 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 98.38 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 98.38 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 98.38 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 98.38 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 98.38 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 98.38 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 98.38 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 98.38 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 98.38 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 98.38 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 98.37 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 98.37 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 98.37 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 98.37 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 98.37 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 98.37 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 98.37 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 98.36 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 98.36 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 98.36 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 98.36 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 98.35 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 98.35 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 98.35 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 98.34 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 98.34 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 98.34 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 98.34 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 98.34 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 98.34 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 98.34 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 98.33 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 98.33 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 98.33 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 98.33 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 98.33 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 98.33 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 98.33 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 98.33 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 98.33 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 98.33 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 98.33 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 98.32 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 98.32 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 98.32 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 98.32 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 98.32 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 98.32 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 98.32 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 98.31 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 98.31 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 98.31 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 98.31 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 98.31 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 98.31 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 98.3 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 98.3 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 98.3 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 98.3 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 98.3 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 98.3 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 98.3 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 98.3 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 98.3 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 98.3 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 98.29 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 98.29 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 98.29 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 98.29 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 98.29 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 98.29 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 98.28 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 98.28 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 98.28 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 98.28 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 98.28 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 98.28 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 98.28 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 98.27 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 98.27 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 98.27 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 98.27 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 98.27 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 98.27 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 98.27 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 98.27 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 98.27 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 98.27 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 98.26 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 98.26 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 98.26 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 98.26 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 98.26 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 98.26 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 98.26 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 98.25 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 98.25 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 98.25 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 98.25 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 98.25 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 98.25 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 98.25 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 98.25 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 98.25 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 98.25 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 98.25 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 98.24 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 98.24 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 98.24 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 98.24 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 98.24 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 98.24 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.24 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 98.24 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 98.24 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 98.24 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 98.24 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 98.24 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 98.23 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 98.23 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.23 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 98.23 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 98.23 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 98.23 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 98.23 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 98.23 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 98.23 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 98.23 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 98.22 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 98.22 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 98.22 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 98.22 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 98.22 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 98.22 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 98.22 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 98.22 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 98.21 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 98.21 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 98.21 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 98.21 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 98.21 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 98.21 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 98.21 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 98.21 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 98.21 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 98.21 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 98.21 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 98.21 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 98.2 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 98.2 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 98.2 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 98.2 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 98.19 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.19 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 98.19 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 98.19 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 98.19 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 98.19 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 98.19 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 98.19 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 98.19 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 98.19 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 98.19 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 98.19 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 98.18 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 98.18 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 98.18 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 98.18 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 98.18 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 98.18 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 98.17 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 98.17 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 98.17 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 98.17 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 98.17 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 98.17 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 98.17 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 98.17 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 98.16 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 98.16 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 98.16 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 98.16 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 98.16 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 98.16 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.15 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 98.15 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 98.15 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 98.15 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 98.15 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 98.14 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 98.14 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 98.14 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 98.14 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 98.14 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 98.14 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 98.14 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.14 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 98.14 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 98.14 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 98.13 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 98.13 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 98.13 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 98.13 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 98.13 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 98.13 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 98.13 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 98.12 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 98.12 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 98.12 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 98.12 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 98.12 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 98.11 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 98.11 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 98.11 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.1 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 98.1 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.1 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 98.09 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 98.09 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 98.09 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 98.09 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 98.09 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 98.09 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 98.09 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 98.08 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 98.08 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 98.07 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 98.07 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.07 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 98.07 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 98.07 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 98.07 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 98.07 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 98.06 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 98.06 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 98.06 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 98.05 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 98.05 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 98.04 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 98.04 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 98.04 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 98.04 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 98.04 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 98.04 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 98.03 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.03 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 98.03 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 98.02 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 98.02 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 98.02 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.01 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 98.01 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 98.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 97.99 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 97.99 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 97.99 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 97.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 97.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 97.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 97.98 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 97.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 97.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 97.96 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 97.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 97.94 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 97.93 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 97.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 97.93 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 97.93 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 97.92 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 97.92 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 97.91 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 97.89 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 97.88 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 97.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 97.87 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 97.87 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 97.87 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 97.86 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 97.84 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 97.84 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 97.84 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 97.84 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 97.82 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 97.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 97.77 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 97.77 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 97.77 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 97.75 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 97.75 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 97.73 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 97.73 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 97.7 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 97.68 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 97.68 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 97.68 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 97.68 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 97.67 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 97.65 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 97.65 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 97.64 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 97.64 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 97.63 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 97.59 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 97.58 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 97.57 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 97.57 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 97.56 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 97.55 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 97.51 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 97.5 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 97.47 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 97.45 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 97.43 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 97.42 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 97.39 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 97.32 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 97.32 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 97.29 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 97.27 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 97.2 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 97.17 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 97.17 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 97.14 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 97.13 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 97.1 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 97.05 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 96.95 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 96.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 96.9 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 96.88 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 96.79 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 96.78 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 96.78 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 96.76 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 96.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 96.69 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 96.57 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 96.49 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 96.45 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 96.4 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 96.26 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 96.11 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 96.09 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.06 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 96.05 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 96.04 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 96.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 95.99 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.97 | |
| PF00560 | 22 | LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le | 95.87 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 95.87 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 95.85 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 95.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 95.83 | |
| KOG1947 | 482 | consensus Leucine rich repeat proteins, some prote | 95.77 | |
| KOG0473 | 326 | consensus Leucine-rich repeat protein [Function un | 95.71 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 95.42 | |
| PF13504 | 17 | LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO | 95.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.35 | |
| KOG4308 | 478 | consensus LRR-containing protein [Function unknown | 95.25 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 95.19 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 95.03 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 94.98 | |
| KOG0473 | 326 | consensus Leucine-rich repeat protein [Function un | 94.96 | |
| KOG4308 | 478 | consensus LRR-containing protein [Function unknown | 94.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 94.77 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 94.59 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 94.41 | |
| KOG1947 | 482 | consensus Leucine rich repeat proteins, some prote | 94.07 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 94.06 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 94.04 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 93.9 | |
| smart00369 | 26 | LRR_TYP Leucine-rich repeats, typical (most popula | 93.86 | |
| smart00370 | 26 | LRR Leucine-rich repeats, outliers. | 93.86 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 93.64 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 93.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 92.83 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 92.68 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 92.46 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 92.08 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 92.04 | |
| smart00370 | 26 | LRR Leucine-rich repeats, outliers. | 91.87 | |
| smart00369 | 26 | LRR_TYP Leucine-rich repeats, typical (most popula | 91.87 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 91.39 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=383.00 Aligned_cols=398 Identities=26% Similarity=0.411 Sum_probs=261.5
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCC------------------------CCCeeecccCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQ------------------------KLQLLGLEDNQLEGS 57 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~------------------------~L~~L~l~~n~l~~~ 57 (411)
++|.+.+.+|..++.+++|+.|++++|++++..|..+..++ +|+.|++++|.+++.
T Consensus 340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~ 419 (968)
T PLN00113 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419 (968)
T ss_pred cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence 45566666666666666666666666655555555554444 444555555444444
Q ss_pred CchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCC-ccCccccCCCCCcEEEcCCCeeeecCCCCccCc
Q 015202 58 IPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNL 136 (411)
Q Consensus 58 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 136 (411)
.|..|..+++|+.|++++|.+.+..+..+..+++|+.|++++|++. .+|. ....++|+.|++++|.+++..|..+.++
T Consensus 420 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~-~~~~~~L~~L~ls~n~l~~~~~~~~~~l 498 (968)
T PLN00113 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD-SFGSKRLENLDLSRNQFSGAVPRKLGSL 498 (968)
T ss_pred CChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCc-ccccccceEEECcCCccCCccChhhhhh
Confidence 4444455555555555555555444444445555555555555554 2332 2345677778888888887888888889
Q ss_pred cCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEc
Q 015202 137 EVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINV 216 (411)
Q Consensus 137 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l 216 (411)
++|+.|++++|.+.+.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|.+++.+|..+..+++|+.+++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCccccccCCCCcccCCCC-CCCCCCCCCCccCcccccceEeehhHHHHHHHHHHHHhhhhhhcC
Q 015202 217 SFNKLEGEIPREGPFRNFSIESFKGNELLCGMPN-LHVPPCRTGIHHTSRKNDLLIGIVLPLSTIFMMVVILLILRYRKR 295 (411)
Q Consensus 217 ~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~-~~~~~c~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 295 (411)
++|++.+.+|....+..+....+.+|+.+|+..+ ...++|.... ......+++++++++++++++++++++++++++
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR--KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRN 656 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc--ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhh
Confidence 9999999999888888888888999999998653 3456675321 111112222222223222223333333333222
Q ss_pred CC--CCCCC---CCCCCc---cccccccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHh
Q 015202 296 GK--PLLND---ANMPPL---ANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKS 366 (411)
Q Consensus 296 ~~--~~~~~---~~~~~~---~~~~~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~ 366 (411)
.. +..+. .+.... .....++++++. ..+...++||+|+||.||+|+. .+|..||||+++.....
T Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---- 729 (968)
T PLN00113 657 NLELKRVENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---- 729 (968)
T ss_pred cccccccccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----
Confidence 11 11000 010000 011234555544 4567789999999999999987 57889999998543221
Q ss_pred HHHHHHHHHH-----------------------cccCCCC-C--CCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 367 FDNEFMTVVD-----------------------ANLLTRE-D--KHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 367 f~~e~~~~~~-----------------------~~l~~~~-~--~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
...|++.+.+ +|+.+.. . -+.++|.+|.+||.|||+||+|||.
T Consensus 730 ~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~ 798 (968)
T PLN00113 730 PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHC 798 (968)
T ss_pred cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhcc
Confidence 2234555554 3332221 0 0238999999999999999999993
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=260.43 Aligned_cols=248 Identities=37% Similarity=0.591 Sum_probs=193.1
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+.+.+|..+.++++|+.|++++|.+++.+|..+..+++|+.|++++|.+.+..|+.+..+++|+.|++++|.+.+
T Consensus 315 l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~ 394 (968)
T PLN00113 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394 (968)
T ss_pred CCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecc
Confidence 57899999999999999999999999999999999999999999999999999988777777666666666666666665
Q ss_pred cCCccccCCccCCeeecccccCC-ccCcccc------------------------CCCCCcEEEcCCCeeeecCCCCccC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLT-YIPLTLW------------------------NLKYILYLNLSSNSFTIPLPSEIGN 135 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~-~~p~~~~------------------------~~~~L~~L~l~~n~l~~~~~~~~~~ 135 (411)
..|..+..+++|+.|++++|+++ .+|..+. .+++|+.|++++|.+.+.+|..+ .
T Consensus 395 ~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~ 473 (968)
T PLN00113 395 EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-G 473 (968)
T ss_pred cCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-c
Confidence 55555555555555555555554 3444444 44555555555555554444433 3
Q ss_pred ccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEE
Q 015202 136 LEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHIN 215 (411)
Q Consensus 136 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ 215 (411)
.++|+.|++++|.+++..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|+
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 45677777777777777788888888899999999999888888888999999999999999999999999999999999
Q ss_pred cccCcccccCCCC-CCCCCccccccCCCCcccCCC
Q 015202 216 VSFNKLEGEIPRE-GPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 216 l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 249 (411)
+++|.+++.+|.. ..+..+..+++.+|+..+..|
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 9999999888764 456678888888887665443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-27 Score=219.29 Aligned_cols=249 Identities=22% Similarity=0.254 Sum_probs=157.7
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|+|+..--..|.++.+|.+|.|++|+++...+.+|.++++|+.|+|..|+|.-...-.|.++++|+.|.|..|.|..
T Consensus 180 La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k 259 (873)
T KOG4194|consen 180 LASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK 259 (873)
T ss_pred eccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc
Confidence 56788888777788888888888888888887777778778888888888887764434456666666666666666655
Q ss_pred cCCccccCCccCCeeecccccCCccC-------------------------ccccCCCCCcEEEcCCCeeeecCCCCccC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIP-------------------------LTLWNLKYILYLNLSSNSFTIPLPSEIGN 135 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p-------------------------~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 135 (411)
.....|-.|.++++|+|..|++..+. +++..+.+|++|+|++|.++...+..|..
T Consensus 260 L~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~ 339 (873)
T KOG4194|consen 260 LDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRV 339 (873)
T ss_pred ccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHH
Confidence 44455555555555555555555332 33334445555555555555444445555
Q ss_pred ccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCC---ccccCCCCCCEEeCCCCccccccchhhhcCCCCC
Q 015202 136 LEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP---DFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQ 212 (411)
Q Consensus 136 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~---~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 212 (411)
+..|+.|.|+.|.++......|..+++|+.|||.+|.+.+.+. ..|.++++|+.|++.+|++..+...+|.+++.|+
T Consensus 340 L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE 419 (873)
T KOG4194|consen 340 LSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALE 419 (873)
T ss_pred HHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccc
Confidence 5555555555555554445555556666666666666655433 2356677777777777777766666777777777
Q ss_pred EEEcccCcccccCCCCCCCCCccccccCCCCcccCCC
Q 015202 213 HINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 213 ~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 249 (411)
.|||.+|.+...-|....-..+..+.+.....+|+|.
T Consensus 420 ~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 420 HLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ 456 (873)
T ss_pred eecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence 7777777776666655433355556666666777764
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-27 Score=215.75 Aligned_cols=243 Identities=22% Similarity=0.199 Sum_probs=201.3
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
||.|.|+..--+.|..-.+++.|+|++|.|+....+.|.++.+|..|.|+.|+++...+..|.++++|+.|+|..|+|.-
T Consensus 156 LSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iri 235 (873)
T KOG4194|consen 156 LSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRI 235 (873)
T ss_pred hhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceee
Confidence 56788877666778777889999999999998888899999999999999999997777889999999999999999986
Q ss_pred cCCccccCCccCCeeecccccCCccCcccc-CCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGG 159 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~-~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 159 (411)
...-.|.++++|+.|.+..|.+..+.++.+ .+.++++|+|..|+++..-...+.+++.|+.|++++|.|..+.++.+.-
T Consensus 236 ve~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf 315 (873)
T KOG4194|consen 236 VEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF 315 (873)
T ss_pred ehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh
Confidence 667789999999999999999998877654 7999999999999999777788899999999999999999999999998
Q ss_pred CCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC----CCCCCcc
Q 015202 160 LKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE----GPFRNFS 235 (411)
Q Consensus 160 ~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~----~~~~~~~ 235 (411)
+++|+.|+|+.|+++...+..|..+..|++|+|+.|.+...-...|..+.+|++|||+.|.+++.+... ..++.++
T Consensus 316 tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr 395 (873)
T KOG4194|consen 316 TQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR 395 (873)
T ss_pred cccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh
Confidence 999999999999999888888877777777777777777666666777777777777777776655432 1234444
Q ss_pred ccccCCCC
Q 015202 236 IESFKGNE 243 (411)
Q Consensus 236 ~~~~~~n~ 243 (411)
.+.+.||.
T Consensus 396 kL~l~gNq 403 (873)
T KOG4194|consen 396 KLRLTGNQ 403 (873)
T ss_pred heeecCce
Confidence 45555553
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-24 Score=202.15 Aligned_cols=240 Identities=28% Similarity=0.433 Sum_probs=174.7
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccc--
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLS-- 79 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-- 79 (411)
|.|++. +.|..+.+-+++-.|+|++|+|..++-..|.+++.|-.||||+|++. .+|+....+.+|++|+|++|.+.
T Consensus 111 ShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hf 188 (1255)
T KOG0444|consen 111 SHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHF 188 (1255)
T ss_pred chhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHH
Confidence 344443 34555555566666666666666555556667777777777777776 44455666777777777777532
Q ss_pred -----------------------ccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCc
Q 015202 80 -----------------------GFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNL 136 (411)
Q Consensus 80 -----------------------~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 136 (411)
..+|.++..+.||..+|+|.|++..+|..+.++++|+.|+|++|.++ .+....+.+
T Consensus 189 QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W 267 (1255)
T KOG0444|consen 189 QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEW 267 (1255)
T ss_pred HHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCcee-eeeccHHHH
Confidence 12556666677777778888888888888888888888888888877 555556667
Q ss_pred cCCCeEEccCCeecccCCCCccCCCccCeeeccccccc-ccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEE
Q 015202 137 EVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ-GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHIN 215 (411)
Q Consensus 137 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ 215 (411)
.+|++|++|.|+++ .+|+.+..+++|+.|.+.+|+++ .-+|+.++.+..|+.+..++|.+. ..|+.++.|.+|+.|.
T Consensus 268 ~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~ 345 (1255)
T KOG0444|consen 268 ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLK 345 (1255)
T ss_pred hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhc
Confidence 77888888888887 77888888888888888888765 235777888888888888888887 7889999999999999
Q ss_pred cccCcccccCCCCCCCCCccccccCCCCccc
Q 015202 216 VSFNKLEGEIPREGPFRNFSIESFKGNELLC 246 (411)
Q Consensus 216 l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c 246 (411)
|+.|.+.......--++.+..+++..||.+.
T Consensus 346 L~~NrLiTLPeaIHlL~~l~vLDlreNpnLV 376 (1255)
T KOG0444|consen 346 LDHNRLITLPEAIHLLPDLKVLDLRENPNLV 376 (1255)
T ss_pred ccccceeechhhhhhcCCcceeeccCCcCcc
Confidence 9999887554444556778888888887654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-24 Score=187.65 Aligned_cols=228 Identities=29% Similarity=0.405 Sum_probs=182.0
Q ss_pred cCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccC
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGN 88 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 88 (411)
.+|++++.+.+++.|+.++|+++ .+|..+..+.+|..++.++|.+. .+|+++..+..|..++..+|++. ..|..+..
T Consensus 82 ~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~ 158 (565)
T KOG0472|consen 82 QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVN 158 (565)
T ss_pred hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHH
Confidence 34555666666666777777665 56666677777777777777776 45556677777777777777777 56677777
Q ss_pred CccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeec
Q 015202 89 LTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFL 168 (411)
Q Consensus 89 l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l 168 (411)
+.+|..+++.+|+++++|...-+++.|++|+...|.+. .+|..++.+.+|..|++..|++. ..| .|.+++.|..+++
T Consensus 159 ~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~ 235 (565)
T KOG0472|consen 159 LSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHV 235 (565)
T ss_pred HHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHh
Confidence 77788888888888877777667888888888888776 78888999999999999999997 666 7888999999999
Q ss_pred ccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCc
Q 015202 169 EYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244 (411)
Q Consensus 169 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~ 244 (411)
+.|.+.........+++++..||+..|+++ ..|+.+.-+++|..||+++|.+++-.++.+.+ .+..+.+.|||.
T Consensus 236 g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 236 GENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred cccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence 999998333344558999999999999999 78899999999999999999999988888777 888888899984
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-23 Score=192.70 Aligned_cols=208 Identities=34% Similarity=0.493 Sum_probs=86.7
Q ss_pred ChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCccc-ccCchhhhccccCCeeeecCCcccccCCccccCC
Q 015202 11 PEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLE-GSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNL 89 (411)
Q Consensus 11 p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 89 (411)
|+.++.+.+|+.|+++.|++. .+-..++.++.|+.+++..|++. .-+|+++-.+.-|..||||+|+++ ..|..+...
T Consensus 48 PeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~A 125 (1255)
T KOG0444|consen 48 PEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYA 125 (1255)
T ss_pred hHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhh
Confidence 333334444444444444433 22223333333444444443332 122333344444555555555554 344444444
Q ss_pred ccCCeeecccccCCccCcccc-CCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeec
Q 015202 90 TNLRKLYLGSNQLTYIPLTLW-NLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFL 168 (411)
Q Consensus 90 ~~L~~L~l~~n~l~~~p~~~~-~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l 168 (411)
+++..|+||+|+|.+||..++ +++.|-.|+|++|.+. .+|+.+..+..|++|+|++|.+.......+..+++|+.|++
T Consensus 126 Kn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 126 KNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred cCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 555555555555555554433 4444445555555544 34444444444555555554443211111112222222222
Q ss_pred cccccc-ccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCccc
Q 015202 169 EYNRLQ-GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 169 ~~n~l~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~ 222 (411)
++.+-+ ..+|..+.++.+|..++++.|.+. ..|+.+..+++|+.|+||+|.++
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 222111 122333334444444445444444 34444444555555555554443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-21 Score=176.24 Aligned_cols=100 Identities=31% Similarity=0.437 Sum_probs=86.8
Q ss_pred ccccccHHHHHHHhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------
Q 015202 310 NQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 310 ~~~~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------- 376 (411)
..+.|++.++..||++|+++++||+|+||.||+|.+++|..||||++...+.+..++|.+|++++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 5668999999999999999999999999999999999999999999966544325679999999997
Q ss_pred --------------------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++||..... +++|.+|++||+|+|+||+|||+.
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~ 193 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEG 193 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccC
Confidence 455554433 899999999999999999999984
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-22 Score=178.43 Aligned_cols=239 Identities=23% Similarity=0.307 Sum_probs=181.3
Q ss_pred cCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecC-CcccccCCcccc
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGD-NKLSGFVPSCFG 87 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~ 87 (411)
++|..+. +.-..+.|+.|.|+.+++.+|..+++|++|||++|.|+.+-|++|.++++|.+|.+-+ |+|+....+.|.
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~ 137 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG 137 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence 4555443 4567888889999888888899999999999999999888888899988887776555 888877667788
Q ss_pred CCccCCeeecccccCCccCc-cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeec----------------
Q 015202 88 NLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS---------------- 150 (411)
Q Consensus 88 ~l~~L~~L~l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~---------------- 150 (411)
++..|+.|.+.-|++..++. .+..+++|..|.+.+|.+....-..|..+..++++.+..|.+-
T Consensus 138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ 217 (498)
T KOG4237|consen 138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNP 217 (498)
T ss_pred hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhch
Confidence 88888888888888875543 4557788888888777776333335666666655555555411
Q ss_pred ---------------------------------------------ccCC-CCccCCCccCeeecccccccccCCccccCC
Q 015202 151 ---------------------------------------------GAIP-TTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184 (411)
Q Consensus 151 ---------------------------------------------~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~ 184 (411)
++-| ..|..+++|+.|+|++|.++++.+.+|.+.
T Consensus 218 ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~ 297 (498)
T KOG4237|consen 218 IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGA 297 (498)
T ss_pred hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcch
Confidence 0011 235667889999999999998888899999
Q ss_pred CCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCC-CCCCccccccCCCCcccCCC
Q 015202 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREG-PFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 185 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~-~~~~~~~~~~~~n~~~c~~~ 249 (411)
..++.|.|..|++...-...|..+..|+.|+|.+|+|++..|... ....+..+.+.+||+.|.+-
T Consensus 298 a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 298 AELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCR 363 (498)
T ss_pred hhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccc
Confidence 999999999999886667778888899999999999988877653 34556777888899888764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-22 Score=176.63 Aligned_cols=225 Identities=25% Similarity=0.277 Sum_probs=189.2
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeeccc-CcccccCchhhhccccCCeeeecCCccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLED-NQLEGSIPYDLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 79 (411)
|..|+|+..=|.+|+.+++|+.|+|++|+|+.+-|++|.++.+|..|.+-+ |+|+....+.|.+|..|+.|.+.-|++.
T Consensus 74 LdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~ 153 (498)
T KOG4237|consen 74 LDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHIN 153 (498)
T ss_pred eccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhc
Confidence 346888877778999999999999999999999999999999998887766 8999887788999999999999888888
Q ss_pred ccCCccccCCccCCeeecccccCCccCc-cccCCCCCcEEEcCCCee---------------------------------
Q 015202 80 GFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSF--------------------------------- 125 (411)
Q Consensus 80 ~~~~~~~~~l~~L~~L~l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l--------------------------------- 125 (411)
....+.|..+++|..|.+.+|.+..++. .+..+.+++++.+..|.+
T Consensus 154 Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~ 233 (498)
T KOG4237|consen 154 CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYY 233 (498)
T ss_pred chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHH
Confidence 7777788888888888888887776665 344555555554444331
Q ss_pred ----------------------------eecCC-CCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccccccc
Q 015202 126 ----------------------------TIPLP-SEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176 (411)
Q Consensus 126 ----------------------------~~~~~-~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 176 (411)
.+..| ..|.++++|+.|+|++|.++++-+.+|.+...++.|.|.+|++..+
T Consensus 234 ~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v 313 (498)
T KOG4237|consen 234 KRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFV 313 (498)
T ss_pred HHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHH
Confidence 00111 2367789999999999999999999999999999999999999877
Q ss_pred CCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccC
Q 015202 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225 (411)
Q Consensus 177 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 225 (411)
....|.++..|++|+|.+|+|+..-|..|..+.+|.++++-.|++.|.+
T Consensus 314 ~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 314 SSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred HHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence 7788999999999999999999999999999999999999999997654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.9e-22 Score=155.27 Aligned_cols=165 Identities=30% Similarity=0.488 Sum_probs=124.9
Q ss_pred hhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcE
Q 015202 38 LGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILY 117 (411)
Q Consensus 38 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~ 117 (411)
+.++.+++.|.|++|+++ .+|+.+..+.+|+.|++++|++. .+|..+.+++.|+.|++.-|++..+|.+++.++.|+.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~lev 106 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEV 106 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhh
Confidence 446677777778888777 45556777777888888888777 5677777778888888887777777888888888888
Q ss_pred EEcCCCeeee-cCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCc
Q 015202 118 LNLSSNSFTI-PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNN 196 (411)
Q Consensus 118 L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~ 196 (411)
||+..|++.. .+|..|..++.|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+- ..|..++.+..|+.|++.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 8887777653 56777777888888888888876 67777788888888888888876 667777888888888888888
Q ss_pred cccccchhhhc
Q 015202 197 LSGAIPISLEK 207 (411)
Q Consensus 197 l~~~~~~~~~~ 207 (411)
++ .+|..+..
T Consensus 185 l~-vlppel~~ 194 (264)
T KOG0617|consen 185 LT-VLPPELAN 194 (264)
T ss_pred ee-ecChhhhh
Confidence 87 45545443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-22 Score=175.56 Aligned_cols=234 Identities=25% Similarity=0.394 Sum_probs=201.1
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
+.|.+....|+ +.++..|.+|.+..|+++ ..|.+++.+.+++.++.++|++. .+|+....+.+|..++.+.|.+. .
T Consensus 53 s~N~l~~l~~d-l~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-e 128 (565)
T KOG0472|consen 53 SHNDLEVLRED-LKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-E 128 (565)
T ss_pred ccCchhhccHh-hhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-e
Confidence 55666655555 788999999999999987 67778899999999999999988 67888888999999999999998 5
Q ss_pred CCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCC
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLK 161 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~ 161 (411)
.|+.++.+-.|+.++..+|+++++|.+++++.+|..+++.+|.+....|..+ +++.|++||...|-+. .+|..++.+.
T Consensus 129 l~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~ 206 (565)
T KOG0472|consen 129 LPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLE 206 (565)
T ss_pred cCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchh
Confidence 6777888889999999999999999999999999999999999985555444 4999999999999886 7888899999
Q ss_pred ccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCC
Q 015202 162 DLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKG 241 (411)
Q Consensus 162 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~ 241 (411)
+|..|++.+|++. ..| .|.++..|..++++.|++.....+....++++..||+.+|+++........++++..+++++
T Consensus 207 ~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSN 284 (565)
T KOG0472|consen 207 SLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSN 284 (565)
T ss_pred hhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccC
Confidence 9999999999998 777 68999999999999999984444445589999999999999987666666677888888888
Q ss_pred CC
Q 015202 242 NE 243 (411)
Q Consensus 242 n~ 243 (411)
|.
T Consensus 285 N~ 286 (565)
T KOG0472|consen 285 ND 286 (565)
T ss_pred Cc
Confidence 75
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-21 Score=152.00 Aligned_cols=154 Identities=32% Similarity=0.551 Sum_probs=85.5
Q ss_pred cCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCee
Q 015202 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKL 95 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 95 (411)
++.+++.|.|+.|.++ .+|+.++.+.+|+.|++++|++. .+|..+..+++|+.|++.-|++. .+|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4455555555555555 44445555555555555555555 34445555555555555555555 455555555555555
Q ss_pred ecccccCC--ccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccc
Q 015202 96 YLGSNQLT--YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173 (411)
Q Consensus 96 ~l~~n~l~--~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l 173 (411)
|+.+|++. .+|..++.+..|+.|++++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|+.|++.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 55555554 45555555555555555555555 45555555555555555555554 4455555555555555555555
Q ss_pred c
Q 015202 174 Q 174 (411)
Q Consensus 174 ~ 174 (411)
+
T Consensus 186 ~ 186 (264)
T KOG0617|consen 186 T 186 (264)
T ss_pred e
Confidence 5
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.9e-18 Score=172.59 Aligned_cols=194 Identities=25% Similarity=0.407 Sum_probs=101.1
Q ss_pred CCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccC
Q 015202 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFV 82 (411)
Q Consensus 3 ~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 82 (411)
++.++ .+|..+. ++|+.|+|++|+++. +|..+. .+|++|++++|.++ .+|..+. ++|+.|+|++|.+. .+
T Consensus 187 ~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~L 256 (754)
T PRK15370 187 ILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-EL 256 (754)
T ss_pred CCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cC
Confidence 34444 3555443 467777777777763 443332 46777777777776 3444332 35677777777766 44
Q ss_pred CccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCc
Q 015202 83 PSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD 162 (411)
Q Consensus 83 ~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~ 162 (411)
|..+. .+|+.|++++|+++.+|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|.++. +|..+ .++
T Consensus 257 P~~l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~s 326 (754)
T PRK15370 257 PERLP--SALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETL--PPG 326 (754)
T ss_pred ChhHh--CCCCEEECcCCccCccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCccc--ccc
Confidence 55443 366777777777776665543 46677777777666 3343322 244555555555542 22222 134
Q ss_pred cCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCccc
Q 015202 163 LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 163 L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~ 222 (411)
|+.|++++|.+++ +|..+. ++|+.|++++|.++ .+|..+ .++|+.|++++|.++
T Consensus 327 L~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt 380 (754)
T PRK15370 327 LKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALT 380 (754)
T ss_pred ceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCC
Confidence 5555555555442 232221 34445555555444 223222 134444444444444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.6e-17 Score=174.99 Aligned_cols=226 Identities=25% Similarity=0.290 Sum_probs=123.6
Q ss_pred CChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCC
Q 015202 10 IPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNL 89 (411)
Q Consensus 10 ~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 89 (411)
+|..+..+++|+.|+|+++.....+| .+..+++|++|+|++|.....+|..+..+++|+.|++++|.....+|..+ .+
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l 703 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL 703 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence 44445555555555555544333333 24455555555555554333445555555555555555543222333322 23
Q ss_pred ---------------------ccCCeeecccccCCccCcccc------------------------------CCCCCcEE
Q 015202 90 ---------------------TNLRKLYLGSNQLTYIPLTLW------------------------------NLKYILYL 118 (411)
Q Consensus 90 ---------------------~~L~~L~l~~n~l~~~p~~~~------------------------------~~~~L~~L 118 (411)
.+|+.|++++|.+..+|..+. ..++|+.|
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L 783 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRL 783 (1153)
T ss_pred CCCCEEeCCCCCCccccccccCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchhe
Confidence 345555555565555554320 12355666
Q ss_pred EcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccc
Q 015202 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLS 198 (411)
Q Consensus 119 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 198 (411)
++++|.....+|..++++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.. ..+|+.|++++|.++
T Consensus 784 ~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~ 859 (1153)
T PLN03210 784 FLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE 859 (1153)
T ss_pred eCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc
Confidence 666665555666667777777777777654333555444 4666777777666443334432 246778888888777
Q ss_pred cccchhhhcCCCCCEEEcccC-cccccCCCCCCCCCccccccCCC
Q 015202 199 GAIPISLEKLLDLQHINVSFN-KLEGEIPREGPFRNFSIESFKGN 242 (411)
Q Consensus 199 ~~~~~~~~~l~~L~~l~l~~n-~l~~~~~~~~~~~~~~~~~~~~n 242 (411)
.+|..+..+++|+.|++++| .+.+..+....+..+..+++.++
T Consensus 860 -~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 860 -EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred -cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence 56777888888888888874 44443333334444444444443
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=165.38 Aligned_cols=204 Identities=23% Similarity=0.290 Sum_probs=102.5
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhc----------------
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR---------------- 64 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~---------------- 64 (411)
+++|.|+ .+|+.+. ++|+.|++.+|+++. +|. ..++|++|++++|+++.. |.....
T Consensus 208 Ls~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~lp~sL~~L~Ls~N~L~~Lp~ 279 (788)
T PRK15387 208 VGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVLPPGLLELSIFSNPLTHLPA 279 (788)
T ss_pred cCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCcccccceeeccCCchhhhhh
Confidence 3556666 5777654 356666666666653 332 235566666666655532 211100
Q ss_pred -cccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCcccc-----------------CCCCCcEEEcCCCeee
Q 015202 65 -LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-----------------NLKYILYLNLSSNSFT 126 (411)
Q Consensus 65 -l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~-----------------~~~~L~~L~l~~n~l~ 126 (411)
..+|+.|++++|.++. +|. ..++|+.|++++|+++.+|.... -..+|+.|++++|.++
T Consensus 280 lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls 355 (788)
T PRK15387 280 LPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA 355 (788)
T ss_pred chhhcCEEECcCCcccc-ccc---cccccceeECCCCccccCCCCcccccccccccCccccccccccccceEecCCCccC
Confidence 0122333333333331 121 12345555555555554432100 0125666666666666
Q ss_pred ecCCCCccC-----------------ccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCE
Q 015202 127 IPLPSEIGN-----------------LEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKS 189 (411)
Q Consensus 127 ~~~~~~~~~-----------------l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 189 (411)
.+|....+ ..+|+.|++++|.+++ +|.. .++|+.|++++|.++. +|.. +.+|+.
T Consensus 356 -~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~ 426 (788)
T PRK15387 356 -SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLS 426 (788)
T ss_pred -CCCCCCcccceehhhccccccCcccccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhh
Confidence 23322111 1234555555555552 2321 2356666666666653 3432 235666
Q ss_pred EeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 190 LDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 190 L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
|++++|.++ .+|..+..+++|+.+++++|++++..+
T Consensus 427 L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~ 462 (788)
T PRK15387 427 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 462 (788)
T ss_pred hhhccCccc-ccChHHhhccCCCeEECCCCCCCchHH
Confidence 677777766 456667777777777777777776544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=166.26 Aligned_cols=218 Identities=29% Similarity=0.405 Sum_probs=165.0
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|.|+ .+|..+. ++|+.|++++|+++ .+|..+. .+|+.|+|++|.+. .+|..+. .+|++|++++|.++
T Consensus 206 Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~- 275 (754)
T PRK15370 206 LDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS- 275 (754)
T ss_pred ecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-
Confidence 4678888 5777654 58999999999998 4555443 47999999999988 5566554 47999999999998
Q ss_pred cCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 160 (411)
.+|..+. ++|+.|++++|+++.+|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|.+++ +|..+.
T Consensus 276 ~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~-- 345 (754)
T PRK15370 276 CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP-- 345 (754)
T ss_pred ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--
Confidence 4676664 589999999999999887653 57899999999988 4555443 689999999999985 565543
Q ss_pred CccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC-----CCCCCcc
Q 015202 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE-----GPFRNFS 235 (411)
Q Consensus 161 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-----~~~~~~~ 235 (411)
++|+.|++++|+++ .+|..+ .++|+.|++++|.++. +|..+. ..|+.|++++|.++. +|.. ...+.+.
T Consensus 346 ~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~ 418 (754)
T PRK15370 346 PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPT 418 (754)
T ss_pred CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCcc
Confidence 68999999999998 466554 3689999999999984 555543 368899999999974 3321 1234456
Q ss_pred ccccCCCCcc
Q 015202 236 IESFKGNELL 245 (411)
Q Consensus 236 ~~~~~~n~~~ 245 (411)
.+.+.+|+..
T Consensus 419 ~L~L~~Npls 428 (754)
T PRK15370 419 RIIVEYNPFS 428 (754)
T ss_pred EEEeeCCCcc
Confidence 6777888753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-19 Score=172.08 Aligned_cols=221 Identities=27% Similarity=0.401 Sum_probs=150.2
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeec
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 97 (411)
.+|++++++.|+++ .+|..+..+.+|+.++..+|.+. .+|.......+|+.|.+.+|.+. .+|....+++.|++|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 46777777777777 34477777788888887777775 55666666667777777777776 45566666777777777
Q ss_pred ccccCCccCcccc--------------------------CCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecc
Q 015202 98 GSNQLTYIPLTLW--------------------------NLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSG 151 (411)
Q Consensus 98 ~~n~l~~~p~~~~--------------------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~ 151 (411)
..|++..+|+.+. ..+.|+.|++.+|.++...-..+-+..+|+.|+|++|++..
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 7777766664211 13445666677777765555556677777778888887765
Q ss_pred cCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCccccc-CCCCCC
Q 015202 152 AIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGE-IPREGP 230 (411)
Q Consensus 152 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~-~~~~~~ 230 (411)
.....+.+++.|+.|+|++|.++ .+|..+..++.|++|...+|++. ..| .+..++.|+.+|++.|.++.. +|...+
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC
Confidence 55556677777778888888777 56677777777777777777776 344 566777777777777777543 333334
Q ss_pred CCCccccccCCCCc
Q 015202 231 FRNFSIESFKGNEL 244 (411)
Q Consensus 231 ~~~~~~~~~~~n~~ 244 (411)
.++++-+++.||++
T Consensus 475 ~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 475 SPNLKYLDLSGNTR 488 (1081)
T ss_pred CcccceeeccCCcc
Confidence 46677777777763
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-18 Score=160.64 Aligned_cols=243 Identities=23% Similarity=0.254 Sum_probs=160.0
Q ss_pred CCCCccc-ccCChhcccCCcCCceeecCccccc----ccchhhhCCCCCCeeecccCcccc------cCchhhhccccCC
Q 015202 1 MFNCNIS-GSIPEEINNLTNLIAIYLGGNKLNG----SISIALGKLQKLQLLGLEDNQLEG------SIPYDLCRLAALF 69 (411)
Q Consensus 1 l~~n~~~-~~~p~~~~~~~~L~~L~l~~n~~~~----~~~~~~~~l~~L~~L~l~~n~l~~------~~~~~~~~l~~L~ 69 (411)
|..+.++ +..+..|..+.+|+.|+++++.++. .++..+...++|++|+++++.+.+ .++..+..+++|+
T Consensus 5 L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~ 84 (319)
T cd00116 5 LKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQ 84 (319)
T ss_pred cccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCcee
Confidence 3456666 4555666777788888888888753 245556677788888888877652 2344566778888
Q ss_pred eeeecCCcccccCCccccCCcc---CCeeecccccCC-----ccCccccCC-CCCcEEEcCCCeeeec----CCCCccCc
Q 015202 70 QLDLGDNKLSGFVPSCFGNLTN---LRKLYLGSNQLT-----YIPLTLWNL-KYILYLNLSSNSFTIP----LPSEIGNL 136 (411)
Q Consensus 70 ~L~l~~n~l~~~~~~~~~~l~~---L~~L~l~~n~l~-----~~p~~~~~~-~~L~~L~l~~n~l~~~----~~~~~~~l 136 (411)
+|++++|.+....+..+..+.+ |+.|++++|+++ .+...+..+ ++|+.|++++|.+++. ++..+..+
T Consensus 85 ~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~ 164 (319)
T cd00116 85 ELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRAN 164 (319)
T ss_pred EEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhC
Confidence 8888888887555555555544 888888888876 233344556 7888888888887732 33345666
Q ss_pred cCCCeEEccCCeeccc----CCCCccCCCccCeeeccccccccc----CCccccCCCCCCEEeCCCCccccccchhhh-c
Q 015202 137 EVLVQIDLSMNNFSGA----IPTTIGGLKDLQYLFLEYNRLQGS----IPDFIGGLINLKSLDLSNNNLSGAIPISLE-K 207 (411)
Q Consensus 137 ~~L~~L~l~~n~~~~~----~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-~ 207 (411)
++|+.|++++|.+++. ++..+..+++|+.|++++|.+++. +...+..+++|++|++++|.+++.....+. .
T Consensus 165 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~ 244 (319)
T cd00116 165 RDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA 244 (319)
T ss_pred CCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHH
Confidence 7888888888887742 233344556888888888887642 233456678888888888888753332222 2
Q ss_pred ----CCCCCEEEcccCcccc--cC---CCCCCCCCccccccCCCC
Q 015202 208 ----LLDLQHINVSFNKLEG--EI---PREGPFRNFSIESFKGNE 243 (411)
Q Consensus 208 ----l~~L~~l~l~~n~l~~--~~---~~~~~~~~~~~~~~~~n~ 243 (411)
.+.|+.+++++|.++. .. .....+..+..+++.+|.
T Consensus 245 ~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~ 289 (319)
T cd00116 245 LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNK 289 (319)
T ss_pred HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCC
Confidence 3678888888888752 10 111223455666666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=168.72 Aligned_cols=127 Identities=27% Similarity=0.323 Sum_probs=56.6
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeec
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 97 (411)
.+|+.|+|.+|.+. .++..+..+++|+.|+|+++.....+| .+..+++|++|+|++|.....+|..+..+++|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 34444444444443 233344445555555554443222333 2444455555555554433344445555555555555
Q ss_pred ccc-cCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeec
Q 015202 98 GSN-QLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS 150 (411)
Q Consensus 98 ~~n-~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~ 150 (411)
++| .+..+|..+ ++++|+.|++++|.....+|.. ..+|+.|++++|.+.
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE 738 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence 543 344444433 4445555555544333233321 234445555555543
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-18 Score=159.41 Aligned_cols=223 Identities=26% Similarity=0.264 Sum_probs=168.4
Q ss_pred CCCcccc----cCChhcccCCcCCceeecCcccc------cccchhhhCCCCCCeeecccCcccccCchhhhcccc---C
Q 015202 2 FNCNISG----SIPEEINNLTNLIAIYLGGNKLN------GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAA---L 68 (411)
Q Consensus 2 ~~n~~~~----~~p~~~~~~~~L~~L~l~~n~~~------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~---L 68 (411)
++|.+++ .++..+...++|+.|+++.+.+. ..++..+.++++|+.|++++|.+.+..+..+..+.+ |
T Consensus 31 ~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L 110 (319)
T cd00116 31 EGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110 (319)
T ss_pred cCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcc
Confidence 4556544 35666778888999999998876 234557788999999999999998666667766666 9
Q ss_pred CeeeecCCcccc----cCCccccCC-ccCCeeecccccCC-----ccCccccCCCCCcEEEcCCCeeeec----CCCCcc
Q 015202 69 FQLDLGDNKLSG----FVPSCFGNL-TNLRKLYLGSNQLT-----YIPLTLWNLKYILYLNLSSNSFTIP----LPSEIG 134 (411)
Q Consensus 69 ~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~l~~n~l~-----~~p~~~~~~~~L~~L~l~~n~l~~~----~~~~~~ 134 (411)
++|++++|++.. .+...+..+ ++|+.|++++|.++ .++..+..++.|++|++++|.+.+. ++..+.
T Consensus 111 ~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~ 190 (319)
T cd00116 111 QELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLK 190 (319)
T ss_pred cEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHH
Confidence 999999999873 233455666 89999999999988 3444566778999999999998742 233455
Q ss_pred CccCCCeEEccCCeeccc----CCCCccCCCccCeeecccccccccCCcccc-----CCCCCCEEeCCCCcccc----cc
Q 015202 135 NLEVLVQIDLSMNNFSGA----IPTTIGGLKDLQYLFLEYNRLQGSIPDFIG-----GLINLKSLDLSNNNLSG----AI 201 (411)
Q Consensus 135 ~l~~L~~L~l~~n~~~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-----~~~~L~~L~l~~n~l~~----~~ 201 (411)
..++|+.|++++|.+++. ....+..+++|+.|++++|.+++.....+. ..+.|+.|++++|.++. .+
T Consensus 191 ~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l 270 (319)
T cd00116 191 ANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDL 270 (319)
T ss_pred hCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHH
Confidence 567999999999988643 334566788999999999998752222221 24789999999999972 23
Q ss_pred chhhhcCCCCCEEEcccCccccc
Q 015202 202 PISLEKLLDLQHINVSFNKLEGE 224 (411)
Q Consensus 202 ~~~~~~l~~L~~l~l~~n~l~~~ 224 (411)
...+..+++|+.+++++|.++..
T Consensus 271 ~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 271 AEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHhcCCCccEEECCCCCCcHH
Confidence 44566678999999999999743
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-17 Score=162.05 Aligned_cols=212 Identities=35% Similarity=0.426 Sum_probs=163.1
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
+.|++++ +|+.++.+.+|+.+...+|+++ .+|..+..+++|+.|.+.+|.+. .+|+...++++|++|+|..|.+..
T Consensus 249 s~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~- 324 (1081)
T KOG0618|consen 249 SHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPS- 324 (1081)
T ss_pred chhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccc-
Confidence 3444443 5677788888888888888885 66777778888888888888887 455566678888888888887763
Q ss_pred CCcccc--------------------------CCccCCeeecccccCC-ccCccccCCCCCcEEEcCCCeeeecCCCCcc
Q 015202 82 VPSCFG--------------------------NLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNSFTIPLPSEIG 134 (411)
Q Consensus 82 ~~~~~~--------------------------~l~~L~~L~l~~n~l~-~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 134 (411)
+|+.+- .++.|+.|++.+|.++ ..-..+.+.+.|+.|+|++|.+.......+.
T Consensus 325 lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~ 404 (1081)
T KOG0618|consen 325 LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLR 404 (1081)
T ss_pred cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHh
Confidence 333221 1234666777777776 3334677889999999999999855556688
Q ss_pred CccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccc-cchhhhcCCCCCE
Q 015202 135 NLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA-IPISLEKLLDLQH 213 (411)
Q Consensus 135 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~ 213 (411)
+++.|+.|+||+|.++ .+|..+..++.|++|...+|++. ..| .+..++.|+.+|++.|.++.. +|... ..++|+.
T Consensus 405 kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~-p~p~Lky 480 (1081)
T KOG0618|consen 405 KLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL-PSPNLKY 480 (1081)
T ss_pred chHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC-CCcccce
Confidence 9999999999999998 67788899999999999999998 677 688999999999999999744 33333 3389999
Q ss_pred EEcccCcc
Q 015202 214 INVSFNKL 221 (411)
Q Consensus 214 l~l~~n~l 221 (411)
||+++|..
T Consensus 481 LdlSGN~~ 488 (1081)
T KOG0618|consen 481 LDLSGNTR 488 (1081)
T ss_pred eeccCCcc
Confidence 99999974
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.6e-15 Score=147.18 Aligned_cols=169 Identities=28% Similarity=0.359 Sum_probs=113.7
Q ss_pred cCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhh----------------cc-ccCCeeeecCCccccc
Q 015202 19 NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC----------------RL-AALFQLDLGDNKLSGF 81 (411)
Q Consensus 19 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----------------~l-~~L~~L~l~~n~l~~~ 81 (411)
+|+.|++++|+++. +|. ..++|+.|++++|.+++. |.... .+ .+|++|+|++|+++.
T Consensus 283 ~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~- 356 (788)
T PRK15387 283 GLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS- 356 (788)
T ss_pred hcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CCCcccccccccccCccccccccccccceEecCCCccCC-
Confidence 34455555555552 222 235677777777776642 22110 01 246666666666663
Q ss_pred CCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCC
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLK 161 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~ 161 (411)
+|.. ..+|+.|++++|.++.+|.. ..+|+.|++++|.+. .+|.. .++|+.|++++|.++. +|.. ..
T Consensus 357 LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l---~~ 422 (788)
T PRK15387 357 LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPML---PS 422 (788)
T ss_pred CCCC---CcccceehhhccccccCccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcc---hh
Confidence 3332 13556666666666666643 256889999999988 45543 3579999999999985 5643 35
Q ss_pred ccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcC
Q 015202 162 DLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKL 208 (411)
Q Consensus 162 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 208 (411)
+|+.|++++|+++ .+|..+..+++|+.|++++|.+++..+..+..+
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 7899999999998 678889999999999999999998877766443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.6e-16 Score=145.44 Aligned_cols=174 Identities=33% Similarity=0.498 Sum_probs=125.9
Q ss_pred CCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEc
Q 015202 41 LQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNL 120 (411)
Q Consensus 41 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l 120 (411)
+.--...||+.|++. .+|..++.+..|+.+.|..|.+. .+|..++.+..|+.|||+.|+++.+|..++.++ |+.|.+
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIV 150 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEE
Confidence 334455677777777 66777777777777777777777 567777777777777777777777777777665 677777
Q ss_pred CCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccc
Q 015202 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 121 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
++|+++ .+|..++.+.+|..||.+.|.+. .+|..++.+.+|+.|.+.+|++. .+|..+..+ .|..||+++|++. .
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~ 225 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y 225 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence 777776 66777777777777777777776 56666777777777777777776 445555544 4677777777777 5
Q ss_pred cchhhhcCCCCCEEEcccCccc
Q 015202 201 IPISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 201 ~~~~~~~l~~L~~l~l~~n~l~ 222 (411)
+|..|..+..|+.|-|.+|+++
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC
Confidence 6777777777777777777775
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.9e-14 Score=139.34 Aligned_cols=119 Identities=33% Similarity=0.557 Sum_probs=103.4
Q ss_pred CCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcc
Q 015202 138 VLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVS 217 (411)
Q Consensus 138 ~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~ 217 (411)
.++.|+|++|.+.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|+++
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCC--CCCccccccCCCCcccCCCCCCCCCCCC
Q 015202 218 FNKLEGEIPREGP--FRNFSIESFKGNELLCGMPNLHVPPCRT 258 (411)
Q Consensus 218 ~n~l~~~~~~~~~--~~~~~~~~~~~n~~~c~~~~~~~~~c~~ 258 (411)
+|.++|.+|.... ...+..+++.+|+.+|+.+. .++|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~ 539 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGP 539 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCcc
Confidence 9999999986522 23445677899999998653 456753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5e-15 Score=137.13 Aligned_cols=178 Identities=28% Similarity=0.414 Sum_probs=127.1
Q ss_pred cCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecc
Q 015202 19 NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLG 98 (411)
Q Consensus 19 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 98 (411)
.-...+|+.|++. .+|..+..+..|+.+.|..|.+. .+|+.++++..|.+|||+.|++. .+|..++.| -|+.|.++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEEe
Confidence 3456677777776 66777777777777777777776 56667777777777777777777 566666654 46777777
Q ss_pred cccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCC
Q 015202 99 SNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178 (411)
Q Consensus 99 ~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 178 (411)
+|+++.+|..++....|..|+.+.|.+. .+|..++.+.+|+.|.+..|++. .+|..+. .-.|..||++.|++. .+|
T Consensus 152 NNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 152 NNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLP 227 (722)
T ss_pred cCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecc
Confidence 7777777777777777777777777776 66777777777777777777776 4455554 345677777777777 667
Q ss_pred ccccCCCCCCEEeCCCCccccccchhh
Q 015202 179 DFIGGLINLKSLDLSNNNLSGAIPISL 205 (411)
Q Consensus 179 ~~~~~~~~L~~L~l~~n~l~~~~~~~~ 205 (411)
..|..+..|++|-|.+|.+. ..|..+
T Consensus 228 v~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred hhhhhhhhheeeeeccCCCC-CChHHH
Confidence 77777777777777777776 344443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=130.46 Aligned_cols=198 Identities=37% Similarity=0.506 Sum_probs=154.2
Q ss_pred ceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccc-cCCeeeecCCcccccCCccccCCccCCeeecccc
Q 015202 22 AIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLA-ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSN 100 (411)
Q Consensus 22 ~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 100 (411)
.+.+..+.+. .....+..++.++.|++.+|.++.+ ++....+. +|++|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i-~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDI-PPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccccC-ccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4666777664 2233455668899999999988844 44555553 8999999999988 45667888899999999999
Q ss_pred cCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCcc
Q 015202 101 QLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180 (411)
Q Consensus 101 ~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 180 (411)
+++.+|......+.|+.|++++|.+. .+|.....+..|++|.+++|.+. ..+..+..+.++..+.+.+|++. ..+..
T Consensus 174 ~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~ 250 (394)
T COG4886 174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250 (394)
T ss_pred hhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence 99999887778889999999999988 66766556667889999999543 45666778888888888888887 44677
Q ss_pred ccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCC
Q 015202 181 IGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 181 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 227 (411)
++.+++++.|++++|.++.... +..+.+++.+++++|.+....+.
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 7888889999999999985444 77888999999999988765554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.6e-13 Score=129.17 Aligned_cols=186 Identities=38% Similarity=0.536 Sum_probs=156.0
Q ss_pred cccCCcCCceeecCcccccccchhhhCCC-CCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQ-KLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNL 92 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 92 (411)
+..++.++.|++.+|+++ .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|++. .+|.....+++|
T Consensus 112 ~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L 188 (394)
T COG4886 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188 (394)
T ss_pred hhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhh
Confidence 456688999999999998 5555566664 9999999999998 45566889999999999999999 456655578999
Q ss_pred CeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccc
Q 015202 93 RKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNR 172 (411)
Q Consensus 93 ~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~ 172 (411)
+.|++++|++..+|..+.....|++|.+++|.+. ..+..+.++..+..+.+.+|++. ..+..++.++++++|++++|.
T Consensus 189 ~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~ 266 (394)
T COG4886 189 NNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ 266 (394)
T ss_pred hheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccc
Confidence 9999999999999987767777999999999644 46777888999999999999986 336778888999999999999
Q ss_pred ccccCCccccCCCCCCEEeCCCCccccccchhhh
Q 015202 173 LQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLE 206 (411)
Q Consensus 173 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 206 (411)
++...+ +....+++.|++++|.+....+....
T Consensus 267 i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 267 ISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred cccccc--ccccCccCEEeccCccccccchhhhc
Confidence 985444 78899999999999999877665543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.4e-12 Score=118.68 Aligned_cols=78 Identities=24% Similarity=0.311 Sum_probs=61.8
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cc-----cCC
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------AN-----LLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~-----l~~ 381 (411)
.++|+|+||.||||.+ +++.||||++.. +..+.|.+|-++++. +| +|.
T Consensus 216 eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 6899999999999999 559999999943 446679999888875 00 111
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPNL 411 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~~ 411 (411)
+. ..+..+|..-.+||.-+||||+|||+.+
T Consensus 292 kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~ 327 (534)
T KOG3653|consen 292 KGSLCDYLKANTISWNSLCRIAESMARGLAHLHEEL 327 (534)
T ss_pred CCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccC
Confidence 11 2345999999999999999999999864
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.6e-13 Score=122.11 Aligned_cols=184 Identities=26% Similarity=0.275 Sum_probs=103.0
Q ss_pred ccCCcCCceeecCcccccccc-hhhhCCCCCCeeecccCcccccC--chhhhccccCCeeeecCCcccccCCcc-ccCCc
Q 015202 15 NNLTNLIAIYLGGNKLNGSIS-IALGKLQKLQLLGLEDNQLEGSI--PYDLCRLAALFQLDLGDNKLSGFVPSC-FGNLT 90 (411)
Q Consensus 15 ~~~~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~ 90 (411)
.++++|+.+.|+++.+..... .-...|++++.|||++|-+..-. ......+|+|+.|+|+.|.+....... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 566777777777777652221 24567777777777777655322 223455777777777777765332222 12456
Q ss_pred cCCeeecccccCC--ccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccC-CCCccCCCccCeee
Q 015202 91 NLRKLYLGSNQLT--YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAI-PTTIGGLKDLQYLF 167 (411)
Q Consensus 91 ~L~~L~l~~n~l~--~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~-~~~~~~~~~L~~L~ 167 (411)
+|+.|.|+.|+++ .+...+..+|+|..|++..|............+..|++|+|++|.+-... -...+.++.|..|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 6777777777776 33334445677777777776422222233344556666777776654221 12334566666666
Q ss_pred cccccccccC-Ccc-----ccCCCCCCEEeCCCCccc
Q 015202 168 LEYNRLQGSI-PDF-----IGGLINLKSLDLSNNNLS 198 (411)
Q Consensus 168 l~~n~l~~~~-~~~-----~~~~~~L~~L~l~~n~l~ 198 (411)
++.+.+..+. |+. ...+++|+.|++..|++.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 6666655321 221 123445555555555553
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.7e-12 Score=124.75 Aligned_cols=112 Identities=36% Similarity=0.537 Sum_probs=103.4
Q ss_pred CcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCC
Q 015202 115 ILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSN 194 (411)
Q Consensus 115 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 194 (411)
++.|+|++|.+.+.+|..++.+++|+.|+|++|.+.|.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccchhhhcC-CCCCEEEcccCcccccCC
Q 015202 195 NNLSGAIPISLEKL-LDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 195 n~l~~~~~~~~~~l-~~L~~l~l~~n~l~~~~~ 226 (411)
|.+++.+|..+... .++..+++.+|...|..|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999988764 467789999998766554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=8e-12 Score=115.34 Aligned_cols=79 Identities=22% Similarity=0.358 Sum_probs=63.6
Q ss_pred CeeeccCCceEEEEEecCCCE-EEEEEEecccchh--hHhHHHHHHHHHH------------------------------
Q 015202 330 NIIGRGGIGSIYKARIQDGME-VAVKVFDLQYREA--FKSFDNEFMTVVD------------------------------ 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~-vavk~l~~~~~~~--~~~f~~e~~~~~~------------------------------ 376 (411)
..+|+|+||.||+|.|. |+. ||||++....... .++|.+|+.++.+
T Consensus 47 ~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 55999999999999994 455 9999995543222 5689999999997
Q ss_pred ---cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++|+.. ....++|..|++||+|||+||.|||++
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~ 161 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE 161 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 334332 145699999999999999999999986
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.6e-13 Score=115.08 Aligned_cols=132 Identities=24% Similarity=0.225 Sum_probs=100.4
Q ss_pred CccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeec
Q 015202 89 LTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFL 168 (411)
Q Consensus 89 l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l 168 (411)
.+.|+.+||+.|.|+.+..++.-.|.++.|+++.|.+. .+. .+..+++|+.|||++|.++. ....=..+.+.++|.|
T Consensus 283 Wq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKL 359 (490)
T ss_pred HhhhhhccccccchhhhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHh-hhhhHhhhcCEeeeeh
Confidence 35688889999998888888877888899999999887 333 37788889999999998873 3333346778889999
Q ss_pred ccccccccCCccccCCCCCCEEeCCCCcccccc-chhhhcCCCCCEEEcccCcccccC
Q 015202 169 EYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI-PISLEKLLDLQHINVSFNKLEGEI 225 (411)
Q Consensus 169 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~l~~n~l~~~~ 225 (411)
++|.+... +.+..+-+|..||+++|+|.... ...++.+|-|+.+.+.+|++.+.+
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 99988632 34566778889999999886322 235778888999999999987554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.6e-12 Score=103.59 Aligned_cols=125 Identities=27% Similarity=0.240 Sum_probs=34.6
Q ss_pred CCCCCCeeecccCcccccCchhhh-ccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCcccc-CCCCCcE
Q 015202 40 KLQKLQLLGLEDNQLEGSIPYDLC-RLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILY 117 (411)
Q Consensus 40 ~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~-~~~~L~~ 117 (411)
+..++++|+|++|.|+.+ +.+. .+.+|+.|++++|.|+.. +.+..++.|+.|++++|.++.++..+. .+++|++
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE 92 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence 444455555555555532 1233 345555555555555532 234555555555555555555544332 3555666
Q ss_pred EEcCCCeeeec-CCCCccCccCCCeEEccCCeecccCC---CCccCCCccCeeec
Q 015202 118 LNLSSNSFTIP-LPSEIGNLEVLVQIDLSMNNFSGAIP---TTIGGLKDLQYLFL 168 (411)
Q Consensus 118 L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~~~~~~~---~~~~~~~~L~~L~l 168 (411)
|++++|.+... .-..+..+++|+.|++.+|.++...- ..+..+|+|+.||-
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 66665555421 11234455666666666666653211 22345677777763
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-12 Score=115.56 Aligned_cols=184 Identities=23% Similarity=0.202 Sum_probs=137.5
Q ss_pred hCCCCCCeeecccCcccccCc-hhhhccccCCeeeecCCcccccC--CccccCCccCCeeecccccCCccCccc--cCCC
Q 015202 39 GKLQKLQLLGLEDNQLEGSIP-YDLCRLAALFQLDLGDNKLSGFV--PSCFGNLTNLRKLYLGSNQLTYIPLTL--WNLK 113 (411)
Q Consensus 39 ~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~p~~~--~~~~ 113 (411)
.++.+|+.+.|.++......- .....|++++.|||+.|-+.... ......+|+|+.|+++.|.+...-++. ..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 578889999999988763221 24677999999999999887432 234567999999999999987443322 2578
Q ss_pred CCcEEEcCCCeeee-cCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccC-CccccCCCCCCEEe
Q 015202 114 YILYLNLSSNSFTI-PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI-PDFIGGLINLKSLD 191 (411)
Q Consensus 114 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~L~ 191 (411)
.|+.|.+++|.++. .+......+++|+.|+|..|...........-+..|+.|+|++|++-... -.....++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 89999999999873 23334556789999999999633343344455678999999999987433 13456789999999
Q ss_pred CCCCcccccc-chh-----hhcCCCCCEEEcccCccc
Q 015202 192 LSNNNLSGAI-PIS-----LEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 192 l~~n~l~~~~-~~~-----~~~l~~L~~l~l~~n~l~ 222 (411)
++.+.+.+.- |+. ...+++|+.|++..|++.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 9999987542 222 356789999999999985
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.6e-11 Score=99.71 Aligned_cols=126 Identities=28% Similarity=0.313 Sum_probs=34.3
Q ss_pred ccccCCeeeecCCcccccCCcccc-CCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeE
Q 015202 64 RLAALFQLDLGDNKLSGFVPSCFG-NLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQI 142 (411)
Q Consensus 64 ~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 142 (411)
+..++++|+|++|.|+.+ +.+. .+.+|+.|++++|.++.++ ++.. ++.|++|
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~-~l~~------------------------L~~L~~L 69 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE-GLPG------------------------LPRLKTL 69 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S--T-T----------------------------TT--EE
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc-CccC------------------------hhhhhhc
Confidence 333455555555555532 1232 3445555555555555443 2333 4444444
Q ss_pred EccCCeecccCCCCccCCCccCeeecccccccccC-CccccCCCCCCEEeCCCCcccccc---chhhhcCCCCCEEEc
Q 015202 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI-PDFIGGLINLKSLDLSNNNLSGAI---PISLEKLLDLQHINV 216 (411)
Q Consensus 143 ~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~L~l~~n~l~~~~---~~~~~~l~~L~~l~l 216 (411)
++++|.++...+.....+++|+.|++++|++.... -..+..+++|+.|++.+|+++... ...+..+|+|+.||-
T Consensus 70 ~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 70 DLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred ccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 44444444221111123455555555555554311 133455667777777777765332 234566777777764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=8.7e-11 Score=113.75 Aligned_cols=80 Identities=16% Similarity=0.285 Sum_probs=63.3
Q ss_pred CCeeeccCCceEEEEEe-cCCC----EEEEEEEecc-cchhhHhHHHHHHHHHH--------------------------
Q 015202 329 NNIIGRGGIGSIYKARI-QDGM----EVAVKVFDLQ-YREAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~----~vavk~l~~~-~~~~~~~f~~e~~~~~~-------------------------- 376 (411)
+.+||+|+||+||||.| ++|. +||+|++... +.+...+|..|+-+|++
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP 780 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMP 780 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcc
Confidence 48999999999999987 6654 6899998543 45567899999999997
Q ss_pred -----cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|++..+ ..+.-...+.++.|||+||.|||++
T Consensus 781 ~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q 817 (1177)
T KOG1025|consen 781 LGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ 817 (1177)
T ss_pred cchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc
Confidence 5555432 3466677888899999999999974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.3e-11 Score=115.24 Aligned_cols=98 Identities=21% Similarity=0.277 Sum_probs=80.6
Q ss_pred ccccccHHHHHHHhcCCCc---------CCeeeccCCceEEEEEec----CCCEEEEEEEecccc-hhhHhHHHHHHHHH
Q 015202 310 NQRRFTYLELFHATNGFSA---------NNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQYR-EAFKSFDNEFMTVV 375 (411)
Q Consensus 310 ~~~~~~~~~l~~at~~f~~---------~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~~~-~~~~~f~~e~~~~~ 375 (411)
-.+.++|+|=-.|...|.. +++||.|.||.||+|.+. ....||||.++.... +.+++|..|..+|+
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG 685 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence 4567899998888888864 479999999999999982 235799999987764 45789999999999
Q ss_pred H--------------------------------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 376 D--------------------------------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 376 ~--------------------------------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+ .+|+..++ .++|-|.+.|-.|||.||.||.+
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsd 749 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSD 749 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhh
Confidence 8 55665542 39999999999999999999854
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.1e-11 Score=110.45 Aligned_cols=85 Identities=21% Similarity=0.375 Sum_probs=66.9
Q ss_pred ccHHHHHHHhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH---------------
Q 015202 314 FTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD--------------- 376 (411)
Q Consensus 314 ~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~--------------- 376 (411)
+.++|++.+ ..||+|.||+||+|.|.+ .||||.++... ....+.|-+|+.++.+
T Consensus 389 Ip~~ev~l~-------~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 389 IPPEEVLLG-------ERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cCHHHhhcc-------ceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 345555554 789999999999999954 79999995433 3456889999999997
Q ss_pred ----------------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ----------------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ----------------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.++|... ..++-.+-+.||.|||+||.|||.
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHA 506 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHA 506 (678)
T ss_pred CceeeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhh
Confidence 4444432 348888999999999999999995
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.8e-10 Score=102.30 Aligned_cols=77 Identities=23% Similarity=0.363 Sum_probs=59.7
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------------------
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------------- 376 (411)
.+.||+|.||.||+|.| .|..||||.+. ..+.+.|.+|.+++..
T Consensus 216 ~e~IGkGRyGEVwrG~w-rGe~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRW-RGEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeeccc-cCCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 47899999999999999 67999999994 3335678888887776
Q ss_pred --cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 --ANLLTREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 --~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
..|++......++-...+++|+.+|.||++||-
T Consensus 292 e~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~ 326 (513)
T KOG2052|consen 292 EHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHM 326 (513)
T ss_pred cCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHH
Confidence 111121123458888999999999999999994
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.8e-12 Score=107.28 Aligned_cols=139 Identities=29% Similarity=0.273 Sum_probs=111.5
Q ss_pred cccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccC
Q 015202 32 GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWN 111 (411)
Q Consensus 32 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~ 111 (411)
|..-..+...+.|+++||++|.|+ .+.+++.-.|.++.|++++|.+... +.++.+++|+.|||++|.++++...=..
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gwh~K 350 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGWHLK 350 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhhHhh
Confidence 444444556678999999999988 5667788889999999999999844 4488899999999999999988755557
Q ss_pred CCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccC-CCCccCCCccCeeecccccccc
Q 015202 112 LKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAI-PTTIGGLKDLQYLFLEYNRLQG 175 (411)
Q Consensus 112 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~-~~~~~~~~~L~~L~l~~n~l~~ 175 (411)
+-+.++|.+.+|.+. . -..++++-+|..||+++|+|.... -..++++|-|+.+.|.+|.+.+
T Consensus 351 LGNIKtL~La~N~iE-~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 351 LGNIKTLKLAQNKIE-T-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hcCEeeeehhhhhHh-h-hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 888999999999876 2 235677888999999999986432 3567889999999999999974
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.3e-11 Score=79.37 Aligned_cols=59 Identities=32% Similarity=0.408 Sum_probs=34.0
Q ss_pred cCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCc
Q 015202 19 NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNK 77 (411)
Q Consensus 19 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 77 (411)
+|++|++++|+++...+..|.++++|++|++++|.++...++.|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45556666665555545555556666666666555555555555555556666555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-10 Score=78.04 Aligned_cols=61 Identities=39% Similarity=0.573 Sum_probs=51.9
Q ss_pred CCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccC
Q 015202 42 QKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQL 102 (411)
Q Consensus 42 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 102 (411)
++|++|++++|+++...++.|.++++|++|++++|.++...+..|.++++|+.|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5788889998888877777888888999999998888888888888888888888888865
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.3e-11 Score=105.15 Aligned_cols=231 Identities=20% Similarity=0.237 Sum_probs=156.8
Q ss_pred cccCCcCCceeecCccccc----ccchhhhCCCCCCeeecccC---cccccCchh-------hhccccCCeeeecCCccc
Q 015202 14 INNLTNLIAIYLGGNKLNG----SISIALGKLQKLQLLGLEDN---QLEGSIPYD-------LCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~----~~~~~~~~l~~L~~L~l~~n---~l~~~~~~~-------~~~l~~L~~L~l~~n~l~ 79 (411)
...+..++.|+|++|.+.. .+...+.+.++|+..++++- +....+|+. +..+++|++||||+|-+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 4566788999999999863 24456778889999999874 233344444 346789999999999987
Q ss_pred ccCCcc----ccCCccCCeeecccccCCccCc--------------cccCCCCCcEEEcCCCeeeec----CCCCccCcc
Q 015202 80 GFVPSC----FGNLTNLRKLYLGSNQLTYIPL--------------TLWNLKYILYLNLSSNSFTIP----LPSEIGNLE 137 (411)
Q Consensus 80 ~~~~~~----~~~l~~L~~L~l~~n~l~~~p~--------------~~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~ 137 (411)
..-++. +.++.+|+.|+|.+|.+..... -...-+.|+++..+.|.+... +...|...+
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~ 185 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHP 185 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcc
Confidence 554443 4567899999999999873321 234567889999988887522 223466678
Q ss_pred CCCeEEccCCeeccc----CCCCccCCCccCeeecccccccc----cCCccccCCCCCCEEeCCCCccccccchhh----
Q 015202 138 VLVQIDLSMNNFSGA----IPTTIGGLKDLQYLFLEYNRLQG----SIPDFIGGLINLKSLDLSNNNLSGAIPISL---- 205 (411)
Q Consensus 138 ~L~~L~l~~n~~~~~----~~~~~~~~~~L~~L~l~~n~l~~----~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~---- 205 (411)
.|+.+.++.|.|... ....|..++.|+.|||.+|-++. .....++.+++|+.|++++|.+...-...+
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 888889988877422 22445678889999999988763 223456777888899998888864433322
Q ss_pred -hcCCCCCEEEcccCcccccCC-----CCCCCCCccccccCCCCc
Q 015202 206 -EKLLDLQHINVSFNKLEGEIP-----REGPFRNFSIESFKGNEL 244 (411)
Q Consensus 206 -~~l~~L~~l~l~~n~l~~~~~-----~~~~~~~~~~~~~~~n~~ 244 (411)
...|+|+.+.+.+|.++-.-- ....-+.+..+.+++|..
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 246788888888888763210 011234455555666643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.9e-10 Score=102.33 Aligned_cols=89 Identities=19% Similarity=0.205 Sum_probs=71.5
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------- 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------- 376 (411)
.+..+++... +.||+|.||.||.|.|.....||||.++... ...++|.+|+.+|.+
T Consensus 202 ei~r~~l~l~-------~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 202 EIPREELKLI-------RELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred eecHHHHHHH-------HHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 4555666555 7899999999999999666699999997653 335789999999998
Q ss_pred ----------------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+||+.. .+..++-.+-+.+|.|||+||+||+++
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~ 322 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK 322 (468)
T ss_pred CceEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC
Confidence 556552 245689999999999999999999763
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.97 E-value=8e-10 Score=108.00 Aligned_cols=80 Identities=23% Similarity=0.263 Sum_probs=63.1
Q ss_pred CeeeccCCceEEEEEe------cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH--------------------------
Q 015202 330 NIIGRGGIGSIYKARI------QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-------------------------- 376 (411)
+.||+|.||.||+|+. ++.+.||||.++.... +..++|.+|+++++.
T Consensus 492 ~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm 571 (774)
T KOG1026|consen 492 EELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYM 571 (774)
T ss_pred hhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEec
Confidence 7899999999999986 3346799999966554 478999999999998
Q ss_pred ------cccCCCC-------C----CCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ------ANLLTRE-------D----KHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ------~~l~~~~-------~----~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
++|+... . ..+|+-.+.+.||.|||.||+||-+
T Consensus 572 ~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 572 DHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred ccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3333111 1 2238999999999999999999854
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.2e-10 Score=111.26 Aligned_cols=197 Identities=31% Similarity=0.340 Sum_probs=129.0
Q ss_pred cCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCee
Q 015202 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKL 95 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 95 (411)
.+..++.+++..|.+.. .-..+..+++|+.|++.+|.+..+.. .+..+++|++|++++|.|+.. ..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccc--cchhhccchhhh
Confidence 45666777777777763 23346777888888888888874432 256778888888888888755 345666778888
Q ss_pred ecccccCCccCccccCCCCCcEEEcCCCeeeecCCCC-ccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccccc
Q 015202 96 YLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSE-IGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ 174 (411)
Q Consensus 96 ~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~ 174 (411)
++++|.++.+. .+..++.|+.+++++|.+....+ . ...+..++.+++.+|.+... ..+..+..+..+++..|.++
T Consensus 146 ~l~~N~i~~~~-~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 146 NLSGNLISDIS-GLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eeccCcchhcc-CCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence 88888888766 34457888888888888773333 1 46677778888888877533 22333445555577777776
Q ss_pred ccCCccccCCCC--CCEEeCCCCccccccchhhhcCCCCCEEEcccCcccc
Q 015202 175 GSIPDFIGGLIN--LKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 175 ~~~~~~~~~~~~--L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
...+. ..+.. |+.+++++|.+.. .+..+..+..+..+++..|.+..
T Consensus 222 ~~~~l--~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 222 KLEGL--NELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred eccCc--ccchhHHHHHHhcccCcccc-ccccccccccccccchhhccccc
Confidence 43322 22222 6777777777763 22445566667777777776643
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.7e-11 Score=113.43 Aligned_cols=175 Identities=31% Similarity=0.321 Sum_probs=78.7
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
+..+.+|+.|++.+|.|..+. ..+..+++|++|++++|.|+.+.+ +..++.|+.|++++|.|... ..+..+++|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhhcc-cchhhhhcchheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhh
Confidence 344455555555555554222 114455555555555555553322 33444455555555555432 2334455555
Q ss_pred eeecccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCc--cCeeeccc
Q 015202 94 KLYLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD--LQYLFLEY 170 (411)
Q Consensus 94 ~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~--L~~L~l~~ 170 (411)
.+++++|.+..+... ...+.+++.+++.+|.+. ....+..+..+..+++..|.++...+. ..+.. |+.+++++
T Consensus 166 ~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~l--~~~~~~~L~~l~l~~ 241 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEGL--NELVMLHLRELYLSG 241 (414)
T ss_pred cccCCcchhhhhhhhhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccCc--ccchhHHHHHHhccc
Confidence 555555555544432 234455555555555444 111222223333334555554422111 11112 45555555
Q ss_pred ccccccCCccccCCCCCCEEeCCCCccc
Q 015202 171 NRLQGSIPDFIGGLINLKSLDLSNNNLS 198 (411)
Q Consensus 171 n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 198 (411)
|.+. ..+..+..+..+..+++.+|.+.
T Consensus 242 n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 242 NRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred Cccc-cccccccccccccccchhhcccc
Confidence 5554 22233344445555555555544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.7e-09 Score=101.92 Aligned_cols=79 Identities=20% Similarity=0.327 Sum_probs=63.6
Q ss_pred CeeeccCCceEEEEEecC--C--CE-EEEEEEec---ccchhhHhHHHHHHHHHH-------------------------
Q 015202 330 NIIGRGGIGSIYKARIQD--G--ME-VAVKVFDL---QYREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~--~--~~-vavk~l~~---~~~~~~~~f~~e~~~~~~------------------------- 376 (411)
++||+|.||.||+|++.. + .. ||||.... .......+|.+|.++|.+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 899999999999999843 2 23 89998864 334557899999999998
Q ss_pred -------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+||.... ..+++.+|++++.|+|+||+|||+.
T Consensus 243 ~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k 281 (474)
T KOG0194|consen 243 CNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK 281 (474)
T ss_pred cCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC
Confidence 4444332 2599999999999999999999974
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.3e-11 Score=103.12 Aligned_cols=222 Identities=20% Similarity=0.179 Sum_probs=154.6
Q ss_pred CCCCcccccCC----hhcccCCcCCceeecCcc---cccccc-------hhhhCCCCCCeeecccCcccccCchhh----
Q 015202 1 MFNCNISGSIP----EEINNLTNLIAIYLGGNK---LNGSIS-------IALGKLQKLQLLGLEDNQLEGSIPYDL---- 62 (411)
Q Consensus 1 l~~n~~~~~~p----~~~~~~~~L~~L~l~~n~---~~~~~~-------~~~~~l~~L~~L~l~~n~l~~~~~~~~---- 62 (411)
|++|.|...-. ..+.+.++|+..++++-- ....+| .++..+++|++|+||.|-+....+..|
T Consensus 37 lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll 116 (382)
T KOG1909|consen 37 LSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELL 116 (382)
T ss_pred ccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHH
Confidence 45666655433 445667778887777532 222333 345688899999999998765444443
Q ss_pred hccccCCeeeecCCcccccC-------------CccccCCccCCeeecccccCCccC-----ccccCCCCCcEEEcCCCe
Q 015202 63 CRLAALFQLDLGDNKLSGFV-------------PSCFGNLTNLRKLYLGSNQLTYIP-----LTLWNLKYILYLNLSSNS 124 (411)
Q Consensus 63 ~~l~~L~~L~l~~n~l~~~~-------------~~~~~~l~~L~~L~l~~n~l~~~p-----~~~~~~~~L~~L~l~~n~ 124 (411)
..+..|++|.|.+|.+...- ..-.+.-+.|+++...+|++..-+ ..+...+.|+.+.+..|.
T Consensus 117 ~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~ 196 (382)
T KOG1909|consen 117 SSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNG 196 (382)
T ss_pred HhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEeccc
Confidence 45788999999999876321 122344578999999999887444 345567899999999988
Q ss_pred eeec----CCCCccCccCCCeEEccCCeeccc----CCCCccCCCccCeeecccccccccCCc----cc-cCCCCCCEEe
Q 015202 125 FTIP----LPSEIGNLEVLVQIDLSMNNFSGA----IPTTIGGLKDLQYLFLEYNRLQGSIPD----FI-GGLINLKSLD 191 (411)
Q Consensus 125 l~~~----~~~~~~~l~~L~~L~l~~n~~~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~----~~-~~~~~L~~L~ 191 (411)
+... +...+..+++|+.|||.+|-++.. +...+..++.|+.|++++|.+...-.. .+ ...|+|+.|.
T Consensus 197 I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~ 276 (382)
T KOG1909|consen 197 IRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLE 276 (382)
T ss_pred ccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceec
Confidence 7521 223567789999999999988743 334566778999999999988642111 11 3478999999
Q ss_pred CCCCccccc----cchhhhcCCCCCEEEcccCccc
Q 015202 192 LSNNNLSGA----IPISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 192 l~~n~l~~~----~~~~~~~l~~L~~l~l~~n~l~ 222 (411)
+.+|.++.. +...+...+.|..|++++|.+.
T Consensus 277 l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 277 LAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 999999732 2334556789999999999984
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.9e-09 Score=93.31 Aligned_cols=80 Identities=26% Similarity=0.402 Sum_probs=63.6
Q ss_pred CeeeccCCceEEEEEec-----CCCEEEEEEEecccc-hhhHhHHHHHHHHHH---------------------------
Q 015202 330 NIIGRGGIGSIYKARIQ-----DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-----~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~--------------------------- 376 (411)
+.||+|.||.||+|++. .+..|+||.++.... ...++|.+|++.+.+
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 68999999999999996 256799999955333 346889999999987
Q ss_pred -----cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++|+.. ....++|.++.+|+.|||+||+|||+.
T Consensus 85 ~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~ 122 (259)
T PF07714_consen 85 GGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN 122 (259)
T ss_dssp TEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccc-ccccccccccccccccccccccccccc
Confidence 233332 134699999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.4e-09 Score=107.06 Aligned_cols=158 Identities=26% Similarity=0.320 Sum_probs=89.2
Q ss_pred CCcCCceeecCcc--cccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCe
Q 015202 17 LTNLIAIYLGGNK--LNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRK 94 (411)
Q Consensus 17 ~~~L~~L~l~~n~--~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 94 (411)
+++|++|-+..|. +.......|..++.|++|||++|.-.+.+|..++.|-+|++|+++++.+. .+|..+..++.|.+
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 3466677666665 44333444666777777777766544566767777777777777777766 56677777777777
Q ss_pred eecccccCC-ccCccccCCCCCcEEEcCCCee--eecCCCCccCccCCCeEEccCCee----------------------
Q 015202 95 LYLGSNQLT-YIPLTLWNLKYILYLNLSSNSF--TIPLPSEIGNLEVLVQIDLSMNNF---------------------- 149 (411)
Q Consensus 95 L~l~~n~l~-~~p~~~~~~~~L~~L~l~~n~l--~~~~~~~~~~l~~L~~L~l~~n~~---------------------- 149 (411)
|++..+... .+|.....+.+|++|.+..... +...-..+.++.+|+.+.......
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~ 702 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSIE 702 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhhc
Confidence 777666533 3333334466666666544321 111112223333333222211111
Q ss_pred ---cccCCCCccCCCccCeeecccccccc
Q 015202 150 ---SGAIPTTIGGLKDLQYLFLEYNRLQG 175 (411)
Q Consensus 150 ---~~~~~~~~~~~~~L~~L~l~~n~l~~ 175 (411)
....+..+..+.+|+.|.+.++.+..
T Consensus 703 ~~~~~~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 703 GCSKRTLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred ccccceeecccccccCcceEEEEcCCCch
Confidence 11334556678888888888887753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1e-08 Score=104.00 Aligned_cols=82 Identities=17% Similarity=0.331 Sum_probs=64.2
Q ss_pred CCeeeccCCceEEEEEecC--CC----EEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cc
Q 015202 329 NNIIGRGGIGSIYKARIQD--GM----EVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~--~~----~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
.+.||+|.||.||.|++.+ |. .||||.+.... .+...+|..|..+|++ +|
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 3789999999999999843 32 48999996554 5567899999999998 44
Q ss_pred cCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.+ +...++-..-+.||+|||+||.|||++
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~ 821 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK 821 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC
Confidence 43222 123488888999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.4e-08 Score=91.46 Aligned_cols=84 Identities=20% Similarity=0.309 Sum_probs=64.8
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------------ 376 (411)
.+|.....||+|+||+||+|.+ .++..||||.+... .++..+-...||+++..
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 4455557799999999999998 45789999999544 33445568999999997
Q ss_pred --------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|++.+ ..++-.+-.....|+|.||+|||++
T Consensus 90 yC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~ 128 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHEN 128 (429)
T ss_pred eCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 334332 2477777888899999999999985
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.2e-09 Score=106.63 Aligned_cols=207 Identities=25% Similarity=0.308 Sum_probs=140.1
Q ss_pred CChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCc--ccccCchhhhccccCCeeeecCCcccccCCcccc
Q 015202 10 IPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQ--LEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFG 87 (411)
Q Consensus 10 ~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 87 (411)
+|. ..+....+...+-+|.+. .++.. ..+++|+.|-+.+|. +....++.|..++.|++|||++|.--+.+|+.++
T Consensus 516 ~~~-~~~~~~~rr~s~~~~~~~-~~~~~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~ 592 (889)
T KOG4658|consen 516 IPQ-VKSWNSVRRMSLMNNKIE-HIAGS-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG 592 (889)
T ss_pred ccc-ccchhheeEEEEeccchh-hccCC-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh
Confidence 344 345577888888888876 33333 355689999999996 5655566688899999999999887778999999
Q ss_pred CCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeec--ccCCCCccCCCccCe
Q 015202 88 NLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS--GAIPTTIGGLKDLQY 165 (411)
Q Consensus 88 ~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~--~~~~~~~~~~~~L~~ 165 (411)
.+-+|+.|+++++.+..+|.++.++..|.+|++..+.....+|.....+.+|++|.+...... ...-..+..+.+|+.
T Consensus 593 ~Li~LryL~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ 672 (889)
T KOG4658|consen 593 ELVHLRYLDLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLEN 672 (889)
T ss_pred hhhhhhcccccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhh
Confidence 999999999999999999999999999999999988765556777777999999988776522 111222233444444
Q ss_pred eecccccccccCCccccCCCCCC----EEeCCCCccccccchhhhcCCCCCEEEcccCccc
Q 015202 166 LFLEYNRLQGSIPDFIGGLINLK----SLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 166 L~l~~n~l~~~~~~~~~~~~~L~----~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~ 222 (411)
+........ .. ..+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++...
T Consensus 673 ls~~~~s~~-~~-e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 673 LSITISSVL-LL-EDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred heeecchhH-hH-hhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCc
Confidence 443222220 00 1111222222 2333332222 33445667778888888777664
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.5e-08 Score=89.70 Aligned_cols=93 Identities=12% Similarity=0.109 Sum_probs=71.2
Q ss_pred HHHHHhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------
Q 015202 318 ELFHATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 318 ~l~~at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------- 376 (411)
|++.+++++.....||+|+||.||+|... ++..||+|.+........+.|.+|++++.+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45567888888899999999999999864 567899999866555566789999998886
Q ss_pred ---cccCCCC-------CCCCC--CHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE-------DKHFM--TKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~-------~~~~l--~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ...++ ++.+...++.++++||+|||+.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 127 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence 2222111 11234 7778889999999999999974
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.9e-09 Score=89.60 Aligned_cols=205 Identities=21% Similarity=0.155 Sum_probs=96.2
Q ss_pred CcCCceeecCccccc--ccchhhhCCCCCCeeecccCcccc--cCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 18 TNLIAIYLGGNKLNG--SISIALGKLQKLQLLGLEDNQLEG--SIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~--~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
..++.|.+.++.|.. .....-..++.++.+||.+|.++. .+...+.++|.|++|+|+.|++...+...-..+.+|+
T Consensus 45 ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~ 124 (418)
T KOG2982|consen 45 RALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLR 124 (418)
T ss_pred cchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceE
Confidence 334445555555431 111112355666667777766552 2222345566777777777666533322113445666
Q ss_pred eeecccccCC--ccCccccCCCCCcEEEcCCCeeeecC--CCCccCc-cCCCeEEccCCeeccc--CCCCccCCCccCee
Q 015202 94 KLYLGSNQLT--YIPLTLWNLKYILYLNLSSNSFTIPL--PSEIGNL-EVLVQIDLSMNNFSGA--IPTTIGGLKDLQYL 166 (411)
Q Consensus 94 ~L~l~~n~l~--~~p~~~~~~~~L~~L~l~~n~l~~~~--~~~~~~l-~~L~~L~l~~n~~~~~--~~~~~~~~~~L~~L 166 (411)
.|.|.+..+. .....+..+|.+++|.++.|++.... ....... +.+.+|.+..|...-- .-..-..++++..+
T Consensus 125 ~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv 204 (418)
T KOG2982|consen 125 VLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSV 204 (418)
T ss_pred EEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchhe
Confidence 6666666554 33334445666666666666332110 0111111 2333333333322100 00001123455556
Q ss_pred ecccccccccC-CccccCCCCCCEEeCCCCcccccc-chhhhcCCCCCEEEcccCccc
Q 015202 167 FLEYNRLQGSI-PDFIGGLINLKSLDLSNNNLSGAI-PISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 167 ~l~~n~l~~~~-~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~l~~n~l~ 222 (411)
.+..|.+.... ...+..++.+.-|+|+.|++.+.- -+.+..++.|..|.+++|++.
T Consensus 205 ~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 205 FVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred eeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 66666554321 222334455556666666665332 234556666666666666654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=98.64 E-value=5e-08 Score=90.07 Aligned_cols=86 Identities=17% Similarity=0.225 Sum_probs=63.3
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCC----EEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGM----EVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~----~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
+|...+.||+|+||.||+|++. +|. .||||.+.... ....++|..|+.++..
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~ 87 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT 87 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeee
Confidence 4667789999999999999863 343 38999986443 3345789999998886
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....++|...++++.+||+||+|||+.
T Consensus 88 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 128 (316)
T cd05108 88 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128 (316)
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc
Confidence 1111110 123488999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=98.59 E-value=9.9e-08 Score=85.72 Aligned_cols=85 Identities=15% Similarity=0.215 Sum_probs=63.5
Q ss_pred CCcCCeeeccCCceEEEEEec----CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~ 377 (411)
|.-.+.||+|+||.||+|++. .+..||+|.++.... .....|.+|+.++.+ +
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence 334478999999999999863 356899999865432 334679999999886 2
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....++|.+.++++.++++||+|||+.
T Consensus 87 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~ 126 (266)
T cd05064 87 YMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126 (266)
T ss_pred eCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.6e-07 Score=85.28 Aligned_cols=85 Identities=14% Similarity=0.202 Sum_probs=64.1
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||++.. .+|+.||||.+.... ......|.+|+.++.+ ++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 45568899999999999986 568899999985432 2234568899999887 22
Q ss_pred cCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.+.. ....++|.+...++.++++||+|||+.
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 22211 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.7e-07 Score=85.00 Aligned_cols=85 Identities=16% Similarity=0.248 Sum_probs=65.1
Q ss_pred CCcCCeeeccCCceEEEEEec-----CCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-----DGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-----~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------ 376 (411)
|.-.+.||+|+||.||++.+. ++..||||++........+.|.+|++++.+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 444578999999999999862 477899999976555556789999998887
Q ss_pred -cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++|.++..++.++++||+|||+.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~ 127 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1121111 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.7e-08 Score=91.61 Aligned_cols=79 Identities=16% Similarity=0.275 Sum_probs=61.7
Q ss_pred CeeeccCCceEEEEEe--cCCC--EEEEEEEecccch-hhHhHHHHHHHHHH----------------------------
Q 015202 330 NIIGRGGIGSIYKARI--QDGM--EVAVKVFDLQYRE-AFKSFDNEFMTVVD---------------------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l--~~~~--~vavk~l~~~~~~-~~~~f~~e~~~~~~---------------------------- 376 (411)
++||+|.||+|++|.| ++|. .||||.+...... ...+|.+|+.+|-+
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELaplG 195 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPLG 195 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcccc
Confidence 7899999999999999 3454 4799999766543 56899999999987
Q ss_pred ---cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ---ANLLTREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ---~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+.||. .....+-...-+..|.|||+||.||..
T Consensus 196 SLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes 230 (1039)
T KOG0199|consen 196 SLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES 230 (1039)
T ss_pred hHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh
Confidence 33444 123346677789999999999999964
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.4e-07 Score=84.03 Aligned_cols=94 Identities=11% Similarity=0.093 Sum_probs=69.2
Q ss_pred ccccccHHHHHHHhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchh---hHhHHHHHHHHHH----------
Q 015202 310 NQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREA---FKSFDNEFMTVVD---------- 376 (411)
Q Consensus 310 ~~~~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~---~~~f~~e~~~~~~---------- 376 (411)
....++.+++... ....+|+|++|.||+|.+ +|..||||++....... .+.|.+|+.++.+
T Consensus 11 ~~~~i~~~~i~~~-----~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDKY-----TSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCCC-----CCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 4445666666332 347899999999999999 78999999985433222 4678899999998
Q ss_pred -----------------cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 -----------------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 -----------------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|..+.. ....++|.++.+++.++|+||.|||+
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~ 140 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK 140 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHh
Confidence 1111111 12358999999999999999999996
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1e-09 Score=94.64 Aligned_cols=85 Identities=20% Similarity=0.221 Sum_probs=45.8
Q ss_pred cCCceeecCccccc-ccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCc-cccc-CCccccCCccCCee
Q 015202 19 NLIAIYLGGNKLNG-SISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNK-LSGF-VPSCFGNLTNLRKL 95 (411)
Q Consensus 19 ~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~-~~~~~~~l~~L~~L 95 (411)
.|+.|+|++..++. .....+..|.+|+.|.|.++.+.+.+...+..-.+|+.|+|+.+. ++.. ..-.+.+++.|..|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 35666666666552 223345566666666666666665555555566666666666543 2211 11124455566666
Q ss_pred ecccccCC
Q 015202 96 YLGSNQLT 103 (411)
Q Consensus 96 ~l~~n~l~ 103 (411)
+++.+.+.
T Consensus 266 NlsWc~l~ 273 (419)
T KOG2120|consen 266 NLSWCFLF 273 (419)
T ss_pred CchHhhcc
Confidence 66655543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.4e-07 Score=84.75 Aligned_cols=87 Identities=17% Similarity=0.193 Sum_probs=64.8
Q ss_pred cCCCcCCeeeccCCceEEEEEecC----CCEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQD----GMEVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~----~~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
++|.-.+.||+|+||.||+|++.. ...||||.+.... .....+|.+|+.++.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 356666899999999999999842 3579999985443 3345689999998876
Q ss_pred -cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....++|.++.+++.++|.||+|||+.
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~ 125 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222111 122589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.3e-09 Score=80.43 Aligned_cols=131 Identities=21% Similarity=0.191 Sum_probs=92.3
Q ss_pred cCCceeecCcccccccch---hhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCee
Q 015202 19 NLIAIYLGGNKLNGSISI---ALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKL 95 (411)
Q Consensus 19 ~L~~L~l~~n~~~~~~~~---~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 95 (411)
.+..++|++|.+- .+++ .+....+|...+|++|.+....+......+.++.|+|++|.|. .+|..++.++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 4667888888764 3333 3456667777899999988444433344568899999999998 578889999999999
Q ss_pred ecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeeccc
Q 015202 96 YLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGA 152 (411)
Q Consensus 96 ~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 152 (411)
+++.|.+...|..+..+.++-.|+..+|... .+|..+.--......++.++.+.+.
T Consensus 106 Nl~~N~l~~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~ 161 (177)
T KOG4579|consen 106 NLRFNPLNAEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDE 161 (177)
T ss_pred ccccCccccchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCccccc
Confidence 9999999988888888888888888888766 4554432222222334455555433
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.6e-07 Score=83.98 Aligned_cols=84 Identities=12% Similarity=0.131 Sum_probs=64.9
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTRE 383 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~~ 383 (411)
|.-.++||+|+||.||+|...+++.||+|.+.... ....+|.+|+.++.+ ++..+..
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~ 86 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGS 86 (260)
T ss_pred ceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCCC
Confidence 33457899999999999999888999999985433 234679999998887 2222111
Q ss_pred --------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 --------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 --------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+..++|.++..++.+++.||+|||+.
T Consensus 87 L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 121 (260)
T cd05067 87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.4e-07 Score=85.25 Aligned_cols=80 Identities=18% Similarity=0.210 Sum_probs=58.8
Q ss_pred eeeccCCceEEEEEecC-------------------------CCEEEEEEEecccchhhHhHHHHHHHHHH---------
Q 015202 331 IIGRGGIGSIYKARIQD-------------------------GMEVAVKVFDLQYREAFKSFDNEFMTVVD--------- 376 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~~-------------------------~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------- 376 (411)
.||+|+||.||+|++.. ...|+||.++........+|..|+.+++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998621 13588998865544445778889888875
Q ss_pred --------------cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....++|..+++|+.|+|+||+|||+.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 136 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK 136 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC
Confidence 2222111 123488999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.1e-07 Score=85.39 Aligned_cols=85 Identities=14% Similarity=0.161 Sum_probs=61.6
Q ss_pred CCcCCeeeccCCceEEEEEecC-----------------CCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------
Q 015202 326 FSANNIIGRGGIGSIYKARIQD-----------------GMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~-----------------~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------- 376 (411)
|.-.+.||+|+||.||++.+.+ +..||||.+.... .....+|.+|++++.+
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 3345789999999999998632 2369999986543 3345679999998886
Q ss_pred ------------cccCCCC-------------------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------------ANLLTRE-------------------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------------~~l~~~~-------------------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++|.+..+|+.|+|+||+|||+.
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 2221100 012478999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.3e-07 Score=84.69 Aligned_cols=85 Identities=13% Similarity=0.157 Sum_probs=65.0
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
+|.-.+.||+|++|.||+|...++..||+|.+.... ...+.|..|+.++.+ +++.+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 344458899999999999998888899999985432 235689999999887 22221
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. .+..++|.+++.++.++|+||+|||+.
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~ 122 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 123488999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.3e-07 Score=85.48 Aligned_cols=87 Identities=15% Similarity=0.135 Sum_probs=64.7
Q ss_pred cCCCcCCeeeccCCceEEEEEecC-----CCEEEEEEEeccc-chhhHhHHHHHHHHHH---------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQD-----GMEVAVKVFDLQY-REAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~-----~~~vavk~l~~~~-~~~~~~f~~e~~~~~~--------------------- 376 (411)
++|.-.++||+|+||.||+|...+ +..|++|++.... ......+.+|+.++.+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 345555899999999999999855 6789999985432 3335778999988876
Q ss_pred ------------cccCCCCC-----CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------------ANLLTRED-----KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------------~~l~~~~~-----~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++..... +..++|.+++.|+.++++||+|||+.
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 136 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 12211111 13589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.3e-09 Score=79.94 Aligned_cols=132 Identities=23% Similarity=0.208 Sum_probs=93.2
Q ss_pred CCCeeecccCcccccCchh---hhccccCCeeeecCCcccccCCcccc-CCccCCeeecccccCCccCccccCCCCCcEE
Q 015202 43 KLQLLGLEDNQLEGSIPYD---LCRLAALFQLDLGDNKLSGFVPSCFG-NLTNLRKLYLGSNQLTYIPLTLWNLKYILYL 118 (411)
Q Consensus 43 ~L~~L~l~~n~l~~~~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L 118 (411)
.+..++|+.|.+. .+++. +.....|+..+|++|.+. ..|..|. ..+.++.|++++|.++.+|.++..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhc
Confidence 4667888888776 34444 344556777799999988 4555554 4468899999999999999998899999999
Q ss_pred EcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCC
Q 015202 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178 (411)
Q Consensus 119 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 178 (411)
+++.|.+. ..|..+..+.+|..|+..+|.+..+.-+.| .-+.+-..++.++.+.+..+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~-~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLF-YSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHh-ccccHHHHHhcCCcccccCc
Confidence 99999988 566677778888999999998864433322 22233333445555554433
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.1e-08 Score=86.27 Aligned_cols=86 Identities=13% Similarity=0.232 Sum_probs=67.0
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cc--
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------AN-- 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~-- 378 (411)
.+|.-.+.||+|+||.||+|...++..||+|.+.........++..|+.++.. +|
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 34444588999999999999998888999999865555456789999988876 22
Q ss_pred -------cCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 -------LLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 -------l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.. .+..++|.++..++.++++||.|||+.
T Consensus 86 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~ 123 (261)
T cd05148 86 KGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ 123 (261)
T ss_pred cCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2211 123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=6.5e-10 Score=106.54 Aligned_cols=126 Identities=27% Similarity=0.238 Sum_probs=56.4
Q ss_pred cCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccC
Q 015202 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSM 146 (411)
Q Consensus 67 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 146 (411)
.|.+.+.++|.+. ....++.-++.|+.|+|++|+++... .+..++.|++||++.|.+. .+|..-..-..|+.|.+.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrn 241 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRN 241 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhhheeeeecc
Confidence 3444444555554 33344444555555555555555444 4445555555555555554 2222111111255555555
Q ss_pred CeecccCCCCccCCCccCeeecccccccccC-CccccCCCCCCEEeCCCCcc
Q 015202 147 NNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI-PDFIGGLINLKSLDLSNNNL 197 (411)
Q Consensus 147 n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~L~l~~n~l 197 (411)
|.++.. ..+.++.+|+.||++.|-+.+.- -..+..+..|+.|.|.||.+
T Consensus 242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 554421 12334455555555555443211 01123334445555555554
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=98.51 E-value=2e-07 Score=83.32 Aligned_cols=81 Identities=15% Similarity=0.145 Sum_probs=63.0
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCCC---
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTRE--- 383 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~~--- 383 (411)
.+.||+|++|.||+|...++..||+|.+..... ...+|.+|+.++.+ ++.....
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLD 89 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHH
Confidence 378999999999999988888899999864332 34679999998887 2221111
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.++.+|+.+++.||+|||+.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05070 90 FLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121 (260)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.3e-07 Score=82.96 Aligned_cols=86 Identities=14% Similarity=0.116 Sum_probs=66.0
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
++|.-.+.||+|++|.||+|...++..||||.++... ...++|.+|++++.+ ++..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4455568999999999999998777889999985433 235679999998887 2221
Q ss_pred CCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .+..++|.++.+++.+++.||.|||+.
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.9e-07 Score=82.15 Aligned_cols=84 Identities=13% Similarity=0.147 Sum_probs=63.8
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
|.-.+.||+|+||.||++.+.++..+|+|.+.... ....+|.+|+.++.+ +|..+.
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 44447899999999999999877889999885332 234679999999887 222211
Q ss_pred C-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....++|..+.+++.++++||+|||+.
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 119 (256)
T cd05114 85 CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1 112489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.7e-07 Score=86.56 Aligned_cols=81 Identities=17% Similarity=0.129 Sum_probs=60.9
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
+.||+|+||.||+|.. .+|+.||||.+.... ......|.+|++++.+ +|+.+..
T Consensus 80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 159 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL 159 (353)
T ss_pred hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcc
Confidence 7899999999999987 468899999985432 2335679999999886 2332221
Q ss_pred -CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.....++.....|+.+|++||+|||++
T Consensus 160 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 187 (353)
T PLN00034 160 EGTHIADEQFLADVARQILSGIAYLHRR 187 (353)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 112356777889999999999999974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.3e-07 Score=88.22 Aligned_cols=53 Identities=19% Similarity=0.347 Sum_probs=38.7
Q ss_pred cCCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH
Q 015202 324 NGFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~ 376 (411)
++|.-.+.||+|+||.||+|.. ..+..||||++.... ......|.+|++++.+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 66 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIH 66 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHH
Confidence 3444458899999999999974 234679999986433 2334679999988865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.8e-07 Score=84.45 Aligned_cols=85 Identities=12% Similarity=0.113 Sum_probs=62.6
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~ 377 (411)
|.-.+.||+|+||.||++.. .+|..||+|.+.... ....+.+..|.+++.. +
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 44558999999999999986 467899999985432 2233567788877764 3
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|+.+.. ....+++.+...|+.++++||+|||+.
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~ 120 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 332221 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.1e-07 Score=82.09 Aligned_cols=86 Identities=14% Similarity=0.158 Sum_probs=65.7
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
++|.-.+.||+|+||.||+|...++..||||.+.... ....+|.+|+.++.+ ++..
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 3455558899999999999998878889999986432 234679999998887 2221
Q ss_pred CCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .+..++|.++..++.+++.||.|||++
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~ 122 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 123589999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1e-09 Score=105.24 Aligned_cols=127 Identities=32% Similarity=0.271 Sum_probs=75.0
Q ss_pred cCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCC-CccCCCccCeeecc
Q 015202 91 NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPT-TIGGLKDLQYLFLE 169 (411)
Q Consensus 91 ~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~-~~~~~~~L~~L~l~ 169 (411)
.|...+.++|.+..+..++.-++.|+.|+|+.|+++... .+..++.|.+|||++|.+. .+|. ....+ .|+.|.+.
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 355556666666666666666667777777777766332 5566667777777777765 3332 22223 37777777
Q ss_pred cccccccCCccccCCCCCCEEeCCCCccccccc-hhhhcCCCCCEEEcccCcccc
Q 015202 170 YNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIP-ISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 170 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~l~l~~n~l~~ 223 (411)
+|.++.. ..+.++.+|..||++.|-+.+.-. ..+..+..|..|.|.+|++-+
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 7766532 234566667777777776653311 123445566666777776643
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.7e-07 Score=83.43 Aligned_cols=86 Identities=19% Similarity=0.256 Sum_probs=62.4
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCC----EEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGM----EVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~----~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
+|...+.||+|+||.||+|.+ ++|. .||||.+.... ....++|.+|+.++..
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~ 87 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVT 87 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEE
Confidence 455558999999999999986 4444 47999985433 3345678899888876
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....+++...++++.++++||+|||++
T Consensus 88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 128 (279)
T cd05109 88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128 (279)
T ss_pred EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111111 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.1e-07 Score=83.45 Aligned_cols=85 Identities=13% Similarity=0.169 Sum_probs=63.2
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||+|.. .+++.||+|.+..... .....+..|++++.+ +|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 44558899999999999987 4678999999854321 223457889998876 22
Q ss_pred cCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. +...++|.....++.|+++||.|||+.
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~ 121 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 22111 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.3e-07 Score=78.19 Aligned_cols=82 Identities=18% Similarity=0.247 Sum_probs=61.4
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEecccchh--hHhHHHHHHHHHH-----------------------cccCC-
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREA--FKSFDNEFMTVVD-----------------------ANLLT- 381 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~--~~~f~~e~~~~~~-----------------------~~l~~- 381 (411)
.+.+|+|.||.||+|.- ..|+.||||+++.....+ ...-.+||+.+.. +|+..
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~td 86 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPTD 86 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecccc
Confidence 36899999999999974 578999999996654221 4557889988886 22221
Q ss_pred -----CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 -----REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 -----~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++....++=.+...+++.+-+|++|+|++
T Consensus 87 Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~ 120 (318)
T KOG0659|consen 87 LEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK 120 (318)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh
Confidence 11234577778899999999999999975
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.1e-07 Score=80.88 Aligned_cols=80 Identities=18% Similarity=0.170 Sum_probs=58.9
Q ss_pred eeeccCCceEEEEEecC-------------CCEEEEEEEecccchhhHhHHHHHHHHHH---------------------
Q 015202 331 IIGRGGIGSIYKARIQD-------------GMEVAVKVFDLQYREAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~~-------------~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------------- 376 (411)
.||+|+||.||+|.+.+ ...|++|.+..........|..|+.++..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998632 22588888865544445678888888876
Q ss_pred --cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ...+++|..+.+||.|||+||+|||+.
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 124 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK 124 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC
Confidence 2221111 123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=98.46 E-value=6e-07 Score=79.69 Aligned_cols=81 Identities=21% Similarity=0.302 Sum_probs=62.4
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------cccCCCC--
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------ANLLTRE-- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~~l~~~~-- 383 (411)
++||+|+||.||+|...++..+|+|.+..... .....|.+|++++.+ ++..+..
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999855433 234579999998886 2222111
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.++++++.+++.||.|||+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 112 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123489999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.5e-07 Score=82.06 Aligned_cols=86 Identities=12% Similarity=0.124 Sum_probs=64.1
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+ +
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 4555689999999999999874 57899999985432 2234668899988886 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.++++||+|||+.
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 120 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123578888999999999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.4e-07 Score=82.30 Aligned_cols=86 Identities=14% Similarity=0.158 Sum_probs=64.1
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+|...+.||+|+||.||+|... .++.||+|++.... ....+.|.+|++++.+ +|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 3455689999999999999985 47899999874322 2234678899988876 33
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.+.. ....++|.+...++.++|+||+|||+.
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 119 (286)
T cd07846 82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119 (286)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 32211 122489999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.2e-07 Score=83.58 Aligned_cols=85 Identities=12% Similarity=0.132 Sum_probs=62.3
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~ 377 (411)
|.-.+.||+|+||.||+|... .++.||||.+.... ....+.+..|++++.. +
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 444578999999999999874 46789999985432 2334568888887765 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.+...++.++++||+|||+.
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123478999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.9e-07 Score=79.88 Aligned_cols=81 Identities=20% Similarity=0.242 Sum_probs=61.3
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
+.||+|+||.||+|.. .+|+.||+|.+.... ......|.+|++++.+ +|+.+..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999987 468899999875332 3335679999998887 2322211
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+..++|.+...++.++++||+|||+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 113 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK 113 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.9e-07 Score=87.10 Aligned_cols=51 Identities=22% Similarity=0.309 Sum_probs=37.8
Q ss_pred CCcCCeeeccCCceEEEEEe------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH
Q 015202 326 FSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~ 376 (411)
|.-.+.||+|+||.||+|.. ..+..||||+++... ....+.|.+|+.++..
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~ 94 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHH
Confidence 44458999999999999974 235589999985432 3345678999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.3e-07 Score=87.33 Aligned_cols=81 Identities=19% Similarity=0.228 Sum_probs=63.0
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------cccCCCC--
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------ANLLTRE-- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~~l~~~~-- 383 (411)
+.||+|.||.|...+...+..||||.+++.... ...+|.+||++|++ +|.+..+
T Consensus 544 ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLn 623 (807)
T KOG1094|consen 544 EKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLN 623 (807)
T ss_pred hhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHH
Confidence 789999999999999977799999999766544 46899999999998 5555433
Q ss_pred ---CCC--C-CCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ---DKH--F-MTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ---~~~--~-l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+ + ..=..-++||.|||.||+||.++
T Consensus 624 qFl~aheapt~~t~~~vsi~tqiasgmaYLes~ 656 (807)
T KOG1094|consen 624 QFLSAHELPTAETAPGVSICTQIASGMAYLESL 656 (807)
T ss_pred HHHHhccCcccccchhHHHHHHHHHHHHHHHhh
Confidence 111 1 23344588999999999999753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.1e-07 Score=88.92 Aligned_cols=47 Identities=17% Similarity=0.343 Sum_probs=34.5
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe-----------------cCCCEEEEEEEecccchhhHhHH
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI-----------------QDGMEVAVKVFDLQYREAFKSFD 368 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l-----------------~~~~~vavk~l~~~~~~~~~~f~ 368 (411)
.+++|...++||+|+||.||+|.+ .+++.||||++........++|.
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl 206 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFL 206 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHH
Confidence 367888889999999999999974 24567999998654333333444
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.7e-07 Score=85.32 Aligned_cols=86 Identities=17% Similarity=0.223 Sum_probs=64.4
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|...+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.++.. +
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 566678999999999999987 457899999995432 2234568889998887 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....|+.++++||+|||+.
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 120 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222111 123488888999999999999999974
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.3e-07 Score=81.90 Aligned_cols=87 Identities=18% Similarity=0.250 Sum_probs=64.7
Q ss_pred cCCCcCCeeeccCCceEEEEEec------CCCEEEEEEEecccch-hhHhHHHHHHHHHH--------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-------------------- 376 (411)
.+|.....||+|+||.||+|... +...|++|.+...... ..++|.+|++++.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 35666688999999999999863 2457899988554433 35679999999887
Q ss_pred ------------cccCCCCC------CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------------ANLLTRED------KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------------~~l~~~~~------~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++.... ...++|..++.++.++++||+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~ 136 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA 136 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 22221111 11589999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.44 E-value=5e-07 Score=80.54 Aligned_cols=84 Identities=18% Similarity=0.269 Sum_probs=64.3
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
+|.-.+.+|+|++|.||+|.. .|+.||||.+..... ..+.|.+|+.++.+ ++...
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 344458999999999999997 578999999965433 46789999998887 22211
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++|.....++.++++||.|||+.
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~ 121 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 112589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=98.44 E-value=4e-07 Score=81.39 Aligned_cols=85 Identities=14% Similarity=0.170 Sum_probs=64.5
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTR 382 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~ 382 (411)
.+.-.+.||+|+||.||+|...++..+|+|.+.... .....|.+|++++.+ ++....
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~ 85 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKG 85 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCCC
Confidence 344558999999999999998777889999885432 234679999998887 222211
Q ss_pred C--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. .+..++|.+++.++.+++.||.|||+.
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 121 (260)
T cd05073 86 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121 (260)
T ss_pred cHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 123478999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.6e-07 Score=81.26 Aligned_cols=85 Identities=14% Similarity=0.179 Sum_probs=63.2
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||++.. .++..||||.+..... .....|.+|+.++.+ +|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 44558899999999999986 4678999999954321 223568889998876 22
Q ss_pred cCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.+.. ....+++.....++.++++||.|||+.
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22211 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.6e-07 Score=82.43 Aligned_cols=81 Identities=11% Similarity=0.163 Sum_probs=61.0
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
++||+|+||.||++.. .+|+.||||.+.... ......+.+|++++.+ +|..+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 468899999996432 2234568889998876 232222
Q ss_pred C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++.+...|+.+|++||+|||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 114 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 123588999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.9e-07 Score=81.35 Aligned_cols=86 Identities=13% Similarity=0.118 Sum_probs=61.9
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH------------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------~~ 378 (411)
+|.....||+|+||.||+|... +|..||+|+++... .....++..|+..+.+ +|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 5566688999999999999874 58899999986432 2234556667765443 12
Q ss_pred c--------CCC-CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 L--------LTR-EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l--------~~~-~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ ... .....++|....+++.|+|.||+|||+.
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (283)
T cd06617 82 MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122 (283)
T ss_pred hcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 1 111 1123589999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=98.42 E-value=8.6e-07 Score=82.25 Aligned_cols=81 Identities=11% Similarity=0.191 Sum_probs=61.2
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
++||+|+||.||++.- .+|..||||.+.... ......+.+|++++.. +|..+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 468899999995432 2334678899988876 333221
Q ss_pred C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++.+...++.++++||+|||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 114 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 123588999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=98.42 E-value=8.1e-07 Score=82.24 Aligned_cols=81 Identities=14% Similarity=0.183 Sum_probs=61.1
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
++||+|+||.||++.- .+|..||+|.+.... ......+..|++++.+ +|..+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 468899999995432 2334567889988876 333222
Q ss_pred C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++.....++.++++||+|||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 114 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 114 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1 123588999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.6e-07 Score=82.25 Aligned_cols=89 Identities=16% Similarity=0.188 Sum_probs=64.7
Q ss_pred HHhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------
Q 015202 321 HATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------- 376 (411)
.+++.|...+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35566666788999999999999874 57789999985432 334578888887765
Q ss_pred -------cccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------ANLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------~~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++|.....++.+++.||+|||+.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 130 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111100 123488999999999999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=98.40 E-value=6.9e-07 Score=80.10 Aligned_cols=87 Identities=18% Similarity=0.218 Sum_probs=65.5
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecc---cchhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQ---YREAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~---~~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|++|.||+|... +|+.||+|.+... .....+.+.+|++++.+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 45556689999999999999985 7889999988532 22335679999998887
Q ss_pred cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.++.+++.++++||+|||+.
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 125 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 2221111 123488999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.1e-07 Score=83.02 Aligned_cols=89 Identities=16% Similarity=0.156 Sum_probs=64.7
Q ss_pred HhcCCCcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------ 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------ 376 (411)
++++|.-.+.||+|+||.||+|... .+..||||++.... .....+|.+|+.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4556777799999999999999752 24579999985432 3345679999998886
Q ss_pred -----cc---------cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----AN---------LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~---------l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++ ++... ....++|.++++++.++|+||+|||+.
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 138 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN 138 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22 21111 012378999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.2e-06 Score=78.71 Aligned_cols=86 Identities=19% Similarity=0.201 Sum_probs=64.2
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
+|.-.+.||+|+||.||+|.. .+|..||+|++..........+.+|+.++.+ +|+.
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 344558899999999999986 5678899999865444445668889988886 2221
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ...++++.+...++.++++||.|||+.
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 125 (267)
T cd06646 90 GGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111 123578889999999999999999973
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.6e-07 Score=84.63 Aligned_cols=52 Identities=19% Similarity=0.336 Sum_probs=38.7
Q ss_pred CCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH
Q 015202 325 GFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~ 376 (411)
+|.-.+.||+|+||.||+|.. ..++.||||+++... ......+.+|+.++.+
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 66 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 66 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHh
Confidence 344458899999999999973 346789999996433 2334678889988876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.3e-07 Score=82.04 Aligned_cols=88 Identities=17% Similarity=0.245 Sum_probs=65.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEecC------CCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQD------GMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~------~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------- 376 (411)
+++|.-.+.||+|++|.||+|...+ +..||+|.+.... .....+|..|+.++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4556666899999999999998843 4578899885433 3335679999998886
Q ss_pred ----c---------ccCCCC----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----A---------NLLTRE----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~---------~l~~~~----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ +++... ....++|.++++|+.+|++||+|||+.
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 135 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2 221111 112489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=98.39 E-value=8.8e-07 Score=81.92 Aligned_cols=81 Identities=10% Similarity=0.159 Sum_probs=59.5
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
++||+|+||.||+|+.. .|+.||||.+.... ......+..|.+++.. +|..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999874 47899999985432 2234567788887764 22222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.....++.++++||+|||+.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 115 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 123488889999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=98.39 E-value=9.6e-07 Score=83.48 Aligned_cols=86 Identities=14% Similarity=0.173 Sum_probs=63.8
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------------- 376 (411)
+|+..+.||+|+||.||++.- .+|..||||++... .....+.+.+|++++..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 366678999999999999986 47889999998432 22334678899998876
Q ss_pred ---cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.... ....+++.....++.++++||.|||+.
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 122 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA 122 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111100 123488999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.6e-07 Score=79.85 Aligned_cols=81 Identities=11% Similarity=0.111 Sum_probs=62.4
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC--
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE-- 383 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~-- 383 (411)
...||+|+||.||.|...++..+|||.+.... ....+|.+|+.++.+ ++..+..
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 36899999999999998777789999986432 234679999998887 2222211
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.++++|+.+|++||+|||+.
T Consensus 88 ~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 119 (256)
T cd05113 88 NYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119 (256)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.8e-07 Score=88.92 Aligned_cols=91 Identities=12% Similarity=0.104 Sum_probs=62.9
Q ss_pred HHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------cccC
Q 015202 318 ELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------ANLL 380 (411)
Q Consensus 318 ~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------~~l~ 380 (411)
++...+++|...++||+|+||.||+|.. ..++.||||+++... ...+++..|+.++.. ++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3444567787788999999999999986 457789999985432 223345556555543 0000
Q ss_pred -------------CCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 381 -------------TRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 381 -------------~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+.. ....++|.....|+.+|++||+|||+
T Consensus 202 ~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~ 249 (467)
T PTZ00284 202 NETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT 249 (467)
T ss_pred cCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 000 12348888899999999999999996
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.1e-06 Score=81.45 Aligned_cols=85 Identities=12% Similarity=0.133 Sum_probs=60.9
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~ 377 (411)
|.-.+.||+|+||.||+|... ++..||||.+.... ......+..|.+++.. +
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 445688999999999999874 56789999985432 1223456777777654 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.+...++.++++||+|||+.
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 120 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 332211 123488899999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.1e-06 Score=80.01 Aligned_cols=86 Identities=17% Similarity=0.166 Sum_probs=63.3
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++.+ +++
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3455689999999999999874 57899999985432 2234568899998887 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. .+..+++.....++.++++||+|||+.
T Consensus 86 ~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 122 (288)
T cd07871 86 DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122 (288)
T ss_pred CcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2100 123478888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.5e-06 Score=77.49 Aligned_cols=85 Identities=18% Similarity=0.221 Sum_probs=63.6
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-----chhhHhHHHHHHHHHH-----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-----REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-----~~~~~~f~~e~~~~~~----------------------- 376 (411)
|...+.||+|++|.||+|+.. ++..|++|.+.... ....+.|.+|+.++.+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 344578999999999999985 68899999884332 2235679999998876
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ...+++|.....++.++++||+|||+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 122488999999999999999999974
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.8e-07 Score=81.50 Aligned_cols=85 Identities=16% Similarity=0.206 Sum_probs=61.9
Q ss_pred CCcCCeeeccCCceEEEEEe-----cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-----QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-----~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------- 376 (411)
|.-.+.||+|+||.||+|.. .++..||+|.+.... .+...+|.+|++++.+
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 33347899999999999985 345789999996433 3334679999998887
Q ss_pred cccCCC---------C--------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTR---------E--------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~---------~--------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|.... . ....++|.+.+.++.++++||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 143 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc
Confidence 222110 0 012378889999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.9e-07 Score=80.47 Aligned_cols=84 Identities=13% Similarity=0.150 Sum_probs=62.7
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTRE 383 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~~ 383 (411)
|.-.+.||+|+||.||+|...+...||+|.+.... ....+|..|+.++.+ +++....
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~ 86 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGS 86 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCCc
Confidence 33447899999999999998776789999985422 234579999998876 2221111
Q ss_pred --------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 --------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 --------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+..++|.++..++.++++||+|||+.
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 121 (262)
T cd05071 87 LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121 (262)
T ss_pred HHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123478999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.1e-06 Score=79.49 Aligned_cols=82 Identities=17% Similarity=0.229 Sum_probs=61.8
Q ss_pred CCeeeccCCceEEEEEec-----CCCEEEEEEEecccch-hhHhHHHHHHHHHH-------------------------c
Q 015202 329 NNIIGRGGIGSIYKARIQ-----DGMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-------------------------A 377 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~-----~~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-------------------------~ 377 (411)
.+.||+|+||.||+|++. .+..||||.+...... ..++|.+|++++.+ +
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 378999999999999974 2578999999654432 46789999988876 1
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....++|.+++.++.++++||+|||+.
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 89 YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred cCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 111111 112389999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=98.38 E-value=8.7e-07 Score=79.51 Aligned_cols=87 Identities=17% Similarity=0.221 Sum_probs=63.9
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc---cchhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ---YREAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~---~~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||+|.. .++..||||.+... .......|.+|++++.+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 3455668899999999999986 46789999987432 22334679999999887
Q ss_pred cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....++......++.++++||.|||+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 1211111 123377888899999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.1e-06 Score=82.91 Aligned_cols=86 Identities=19% Similarity=0.261 Sum_probs=64.3
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|...+.||+|+||.||++.. ..++.||||.+.... ......+..|+.++.+ +
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 566678999999999999976 457899999995432 2234567888888876 3
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.+++.||+|||+.
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 120 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 332211 123588899999999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.8e-07 Score=84.61 Aligned_cols=98 Identities=13% Similarity=0.171 Sum_probs=72.8
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------ccc
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------ANL 379 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~~l 379 (411)
+....++...+++|.....||+|+||.||+|.. .+|..||||++.... ....+.+.+|+.++.+ +..
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 345567778889998889999999999999975 568899999985432 2234568889988876 000
Q ss_pred ------------------CCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 ------------------LTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ------------------~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|..+..|+.++++||+|||+.
T Consensus 86 ~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 139 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139 (345)
T ss_pred eecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0000 113488999999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=98.38 E-value=8.7e-07 Score=79.57 Aligned_cols=87 Identities=17% Similarity=0.269 Sum_probs=64.8
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CC---CEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DG---MEVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~---~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
++|...+.||+|+||.||+|... ++ ..+|+|++.... ....++|.+|++++.+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 45666789999999999999874 23 368999986543 3345779999998876
Q ss_pred -cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....++|.++.+++.+++.||+|||+.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 126 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.4e-07 Score=80.24 Aligned_cols=84 Identities=12% Similarity=0.179 Sum_probs=63.4
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
|.-.+.||+|++|.||+|... .+..||+|.+... .....+|.+|++++.+ +|..+
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 445588999999999999974 4778999998543 2335679999998876 22211
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++|.+++.++.++++||+|||+.
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 123 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=98.37 E-value=1e-06 Score=80.12 Aligned_cols=85 Identities=20% Similarity=0.184 Sum_probs=58.6
Q ss_pred CCcCCeeeccCCceEEEEEe--cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI--QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l--~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------- 376 (411)
|.-.+.||+|+||.||+|.. .+|..||||++.... ......+.+|+.++..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 44457899999999999986 346789999985432 2223456677776653
Q ss_pred ------cccCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+. .....++|.++..|+.++++||+|||+.
T Consensus 83 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~ 129 (290)
T cd07862 83 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 129 (290)
T ss_pred cEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111100 0112478899999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=98.37 E-value=8.6e-07 Score=80.34 Aligned_cols=86 Identities=22% Similarity=0.224 Sum_probs=64.7
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+|...+.||+|++|.||+|... +|+.||||++.... ......|.+|++++.+ +|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3566688999999999999874 67899999885332 2233578999999887 33
Q ss_pred cCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+... .....++|.....++.++++||+|||+.
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 119 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3211 0123589999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.6e-07 Score=79.63 Aligned_cols=82 Identities=15% Similarity=0.151 Sum_probs=62.4
Q ss_pred cCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCCC--
Q 015202 328 ANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTRE-- 383 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~~-- 383 (411)
-...||+|++|.||+|...++..||+|++.... ...+.|.+|++++.+ ++.....
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHH
Confidence 347899999999999998777789999885432 234679999998886 2222111
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|..+..++.+++.||+|||+.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05069 89 DFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121 (260)
T ss_pred HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.1e-06 Score=79.66 Aligned_cols=85 Identities=20% Similarity=0.275 Sum_probs=63.2
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|...+.||+|++|.||+|+.. +|..||||++.... ......+.+|+.++.+ +|.
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 444578999999999999874 68899999985332 2224678889988876 222
Q ss_pred C--------CCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 L--------TREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~--------~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. .......+++.+...++.++++||+|||+.
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 120 (285)
T cd07861 82 SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120 (285)
T ss_pred CCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 111124589999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=98.37 E-value=8.1e-07 Score=79.10 Aligned_cols=85 Identities=19% Similarity=0.236 Sum_probs=64.4
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecc--cchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|.-.+.||+|++|.||+|+.. +|..|++|.+... ......+|.+|++++.+ +|.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 445588999999999999874 6789999998532 33446789999998887 222
Q ss_pred CCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|.+..+|+.++++||.|||+.
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~ 120 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111 124588999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.3e-06 Score=80.58 Aligned_cols=81 Identities=11% Similarity=0.158 Sum_probs=58.8
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
+.||+|+||.||+|... ++..||||.+.... ......+..|.+++.. +|..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999974 46789999996432 2233456677777653 22222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.+...++.++++||.|||+.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~ 115 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 123588999999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.1e-06 Score=81.80 Aligned_cols=86 Identities=13% Similarity=0.194 Sum_probs=64.4
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.....||+|+||.||+|+.. .|+.||||++.... ....+.+..|++++.. +
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 4555689999999999999985 57899999995432 2234678899998886 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.+...++.++++||.|||+.
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 120 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 332221 123478888899999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.2e-06 Score=78.16 Aligned_cols=80 Identities=16% Similarity=0.186 Sum_probs=59.6
Q ss_pred eeeccCCceEEEEEec---CCCEEEEEEEecccc-hhhHhHHHHHHHHHH----------------------cccCCCC-
Q 015202 331 IIGRGGIGSIYKARIQ---DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD----------------------ANLLTRE- 383 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~----------------------~~l~~~~- 383 (411)
.||+|+||.||+|++. ++..||||.+..... ...++|.+|+.++.+ +|..+..
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999873 345699999855433 334679999999887 2222111
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.++++++.++++||+|||++
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 114 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.3e-06 Score=79.36 Aligned_cols=86 Identities=19% Similarity=0.199 Sum_probs=63.7
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+|.-.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+ +|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 3455578999999999999984 57789999985432 2234678889988876 33
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++.....++.++++||+|||+.
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 119 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 32211 123488888999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.3e-07 Score=80.40 Aligned_cols=86 Identities=19% Similarity=0.251 Sum_probs=63.7
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|++|.||+|.. .+|..+|||.+.... .....+|.+|+.++.. +
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 344457899999999999986 578899999885322 2334689999998886 1
Q ss_pred ccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....++|.+..+++.++++||+|||+.
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111111 123489999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=98.35 E-value=8e-07 Score=80.47 Aligned_cols=79 Identities=11% Similarity=0.187 Sum_probs=58.9
Q ss_pred eeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 332 IGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 332 lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
||+|+||.||++.. .+|+.+|||.+.... ......|..|++++.. +|..+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999986 467899999985332 1233567889988886 2222111
Q ss_pred ---------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ---------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ---------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.....++.++++||+|||+.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 116 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123489999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=98.35 E-value=2e-06 Score=77.10 Aligned_cols=86 Identities=13% Similarity=0.229 Sum_probs=63.6
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-----chhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-----REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-----~~~~~~f~~e~~~~~~---------------------- 376 (411)
+|...+.+|+|+||.||+|.. ..|..||+|++.... .+....+.+|+.++.+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 567779999999999999986 457899999884321 2234568899998887
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++..+.+++.++|+||+|||++
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 125 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 123478888999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.3e-06 Score=82.88 Aligned_cols=86 Identities=12% Similarity=0.104 Sum_probs=63.5
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.|...+.||+|+||.||+|.. .++..||||++.... ......|..|++++.+ +
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 355568899999999999986 457899999995432 2334678999998887 3
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|+.+.. ....+++.....++.+++.||+|||+.
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~ 120 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 332221 123477788888899999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.9e-07 Score=79.29 Aligned_cols=81 Identities=15% Similarity=0.178 Sum_probs=60.9
Q ss_pred CeeeccCCceEEEEEecC--CC--EEEEEEEecccc-hhhHhHHHHHHHHHH----------------------cccCCC
Q 015202 330 NIIGRGGIGSIYKARIQD--GM--EVAVKVFDLQYR-EAFKSFDNEFMTVVD----------------------ANLLTR 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~--~~--~vavk~l~~~~~-~~~~~f~~e~~~~~~----------------------~~l~~~ 382 (411)
+.||+|++|.||+|.+.+ +. .||||.+..... ...++|..|+.++.+ ++....
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 368999999999998733 33 689999965544 556789999999887 111111
Q ss_pred C-------CC-CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-------DK-HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-------~~-~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. .. ..++|.....++.++++||+|||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 116 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence 1 01 3589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.3e-06 Score=78.53 Aligned_cols=85 Identities=16% Similarity=0.194 Sum_probs=62.8
Q ss_pred CCcCCeeeccCCceEEEEEecCC----CEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQDG----MEVAVKVFDLQY-REAFKSFDNEFMTVVD----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~----~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------~~ 378 (411)
|.-.+.||+|+||.||+|...+. ..||||...... ....+.|.+|+.++.+ ++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~e~ 87 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMEL 87 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEEEc
Confidence 44458999999999999987432 468999885443 3445789999998886 12
Q ss_pred cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..... ....++|.++..++.++++||+|||+.
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 126 (270)
T cd05056 88 APLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126 (270)
T ss_pred CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11111 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=98.34 E-value=2e-06 Score=78.55 Aligned_cols=84 Identities=21% Similarity=0.248 Sum_probs=62.6
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccch-----hhHhHHHHHHHHHH-----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYRE-----AFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~-----~~~~f~~e~~~~~~----------------------- 376 (411)
|...+.||+|++|.||+|... +|+.||||++...... ....+..|++++.+
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 344578999999999999874 5789999998544322 23557788888876
Q ss_pred cccCCCC------CC-CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DK-HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~-~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|. ... .. ..++|....+++.+|++||+|||+.
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 121 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 333 111 11 2599999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.5e-06 Score=80.13 Aligned_cols=79 Identities=15% Similarity=0.098 Sum_probs=59.5
Q ss_pred eeccCCceEEEEEec-CCCEEEEEEEecc---cchhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 332 IGRGGIGSIYKARIQ-DGMEVAVKVFDLQ---YREAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 332 lg~g~~g~vy~g~l~-~~~~vavk~l~~~---~~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
||+|+||.||++... ++..||+|.+... .......+..|++++.+ +|..+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999874 5778999998543 22334678899998886 2222211
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.....++.++++||.|||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 112 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKF 112 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123488999999999999999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.8e-07 Score=79.34 Aligned_cols=84 Identities=13% Similarity=0.139 Sum_probs=62.6
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
|.-.+.||+|+||.||+|...++..+|+|.+.... ....+|..|++++.+ ++..+.
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 33447899999999999998777789999885332 234578899998887 222111
Q ss_pred C-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....++|.....|+.++++||+|||+.
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 119 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1 122489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.2e-06 Score=79.33 Aligned_cols=85 Identities=21% Similarity=0.252 Sum_probs=63.4
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|...+.||+|++|.||+|+.. +|..||||++...... ....+..|+.++.+ ++..
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 555689999999999999984 5788999998544322 24567789988887 1111
Q ss_pred --------CCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 --------TREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 --------~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.......++|.+..+++.++++||+|||+.
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (284)
T cd07836 82 KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119 (284)
T ss_pred ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 111123489999999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.7e-06 Score=79.90 Aligned_cols=81 Identities=11% Similarity=0.153 Sum_probs=59.5
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
++||+|+||.||++... ++..||||.+.... ......+..|++++.. +|..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 47789999996432 2234567788887764 22222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++|.+...++.++++||.|||+.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 115 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-06 Score=81.75 Aligned_cols=86 Identities=20% Similarity=0.292 Sum_probs=64.2
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|...+.||+|+||.||+|... +|..||||++.... ......|..|++++.. +
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4555689999999999999874 68899999985432 2334678889988886 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....|+.++++||+|||+.
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 120 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123588888999999999999999973
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.1e-06 Score=78.98 Aligned_cols=83 Identities=19% Similarity=0.224 Sum_probs=62.1
Q ss_pred cCCeeeccCCceEEEEEecC-C---CEEEEEEEecc-cchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 328 ANNIIGRGGIGSIYKARIQD-G---MEVAVKVFDLQ-YREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~~-~---~~vavk~l~~~-~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
-.+.||+|+||.||+|+... | ..||||.+... .....++|..|+.++.+ ++.
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 44889999999999999742 2 36999998543 23345789999998876 222
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|.++.+++.++++||.|||+.
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~ 125 (269)
T cd05065 88 ENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125 (269)
T ss_pred CCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2211 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.9e-07 Score=80.47 Aligned_cols=88 Identities=19% Similarity=0.229 Sum_probs=64.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------- 376 (411)
.++|...+.||+|+||.||++... ++..||+|.+.... ....++|.+|+.++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 355667789999999999999863 35689999985432 3345679999998886
Q ss_pred ----c---------ccCCCC-------------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----A---------NLLTRE-------------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~---------~l~~~~-------------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ +++... ....++|.++++++.++++||+|||+.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~ 149 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER 149 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 111100 112478899999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.4e-06 Score=77.78 Aligned_cols=80 Identities=15% Similarity=0.159 Sum_probs=59.8
Q ss_pred eeeccCCceEEEEEe---cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------------------cccCCCC
Q 015202 331 IIGRGGIGSIYKARI---QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------------------ANLLTRE 383 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l---~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------------------~~l~~~~ 383 (411)
.||+|+||.||+|++ .++..+|+|+++... ....++|..|+.++.+ ++.....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999976 346789999985332 2335789999998887 1111111
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++....+|+.+++.||+|||+.
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~ 114 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123488999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.6e-07 Score=84.37 Aligned_cols=53 Identities=21% Similarity=0.357 Sum_probs=38.8
Q ss_pred cCCCcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~ 376 (411)
+.|.-.+.||+|+||.||+|+.. .+..||||++.... ....+.|.+|++++.+
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~ 96 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTH 96 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHh
Confidence 34444589999999999999852 13469999995433 2335679999998886
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.2e-06 Score=78.05 Aligned_cols=85 Identities=16% Similarity=0.270 Sum_probs=63.0
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|...+.+|+|+||.||+|... +|..||+|.+.... ....+.+.+|+.++.+ +|.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 445578999999999999884 57889999985432 2334678899988886 222
Q ss_pred CCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. .+..++|..+.+++.++++||+|||++
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111 123479999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.9e-06 Score=76.51 Aligned_cols=81 Identities=20% Similarity=0.251 Sum_probs=62.3
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------cccCCCC--
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------ANLLTRE-- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~~l~~~~-- 383 (411)
++||+|++|.||++...+++.||+|.+...... ....|.+|++++.+ ++..+..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877899999998544332 45789999998886 2221111
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++...+.++.++++||+|||++
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~ 112 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123478889999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.7e-06 Score=78.49 Aligned_cols=85 Identities=15% Similarity=0.124 Sum_probs=63.3
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|.....||+|++|.||+|... +|+.||+|++.... ....+.|.+|+.++.+ +|.
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 444578999999999999985 57899999985332 2234568899998887 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... ....++|..+.+++.++++||+|||+.
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~ 119 (286)
T cd07847 83 DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119 (286)
T ss_pred CccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2111 123489999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=98.33 E-value=2e-06 Score=79.80 Aligned_cols=81 Identities=12% Similarity=0.171 Sum_probs=60.2
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
++||+|+||.||++... ++..||||.+.... ......+..|+.++.+ +|..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999874 57899999996432 2234567888888764 33322
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.....++.++++||+|||+.
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 115 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.6e-06 Score=76.25 Aligned_cols=90 Identities=16% Similarity=0.117 Sum_probs=68.5
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH--------------
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-------------- 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-------------- 376 (411)
.++..|++.. +.||+|..|+|||+.. +.+...|.|.+..... .-.++..+|++++.+
T Consensus 75 ~i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 4677787776 8999999999999988 4577889999954433 346889999999987
Q ss_pred ----------cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ----------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ----------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|+.+.+ ....++...--+||.+|.+||.|||+
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~ 196 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE 196 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3333322 11236667778999999999999996
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.5e-06 Score=73.55 Aligned_cols=80 Identities=13% Similarity=0.177 Sum_probs=57.2
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccch--h-------hHhH-----------------HHHHHHHHH-------
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYRE--A-------FKSF-----------------DNEFMTVVD------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~--~-------~~~f-----------------~~e~~~~~~------- 376 (411)
..||+|++|.||+|..++|+.||||+++..... . ...| ..|++.+.+
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999999654211 1 1122 237776665
Q ss_pred --------------cccCCCC------CCCCCCHHHHHHHHHHHhhhhccc-CC
Q 015202 377 --------------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVE-SP 409 (411)
Q Consensus 377 --------------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~yl-h~ 409 (411)
+|+.+.. ...++++.+-.+++.++++||.|+ |+
T Consensus 83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~ 136 (190)
T cd05147 83 CPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD 136 (190)
T ss_pred CCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3343211 123578888899999999999999 65
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-06 Score=79.09 Aligned_cols=85 Identities=12% Similarity=0.218 Sum_probs=59.7
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCC----EEEEEEEecccc-hhhHhHHHHHHHHHH----------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGM----EVAVKVFDLQYR-EAFKSFDNEFMTVVD----------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~----~vavk~l~~~~~-~~~~~f~~e~~~~~~----------------------~ 377 (411)
|...+.||+|+||.||+|.+ ++|. .|++|.+..... ...++|..|+..+++ +
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~e 88 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQ 88 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEEE
Confidence 34448899999999999987 3444 377787754332 334678888877765 1
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..... ....++|....+|+.+||+||+|||+.
T Consensus 89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (279)
T cd05111 89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128 (279)
T ss_pred eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111111 123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.8e-06 Score=80.04 Aligned_cols=81 Identities=14% Similarity=0.209 Sum_probs=60.3
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
+.||+|+||.||++.. .+++.||||++.... ....+.+..|+.++.+ +|..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 456889999996432 2234568888887765 33322
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++..+..|+.++++||+|||+.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~ 115 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.8e-06 Score=79.71 Aligned_cols=81 Identities=10% Similarity=0.125 Sum_probs=57.2
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
+.||+|+||.||+|... .+..||||.+.... ......+..|.+++.. +|..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 57789999985432 2233456666666653 33322
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++..+...++.++++||+|||+.
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 115 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21 123478888889999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.6e-06 Score=82.21 Aligned_cols=86 Identities=12% Similarity=0.173 Sum_probs=63.0
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|...+.||+|+||.||++.. .+|..||||++.... ....+.+.+|++++.+ +
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 455668999999999999976 467899999985322 2234668889998876 3
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.+++.||+|||+.
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~ 120 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 332211 123477777788999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.4e-06 Score=81.21 Aligned_cols=83 Identities=17% Similarity=0.188 Sum_probs=61.4
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------------------------
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD---------------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~---------------------------- 376 (411)
-.+.||+|+||.||+|.- .+|..||||++.... ......+.+|++++.+
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 347899999999999986 468899999985322 2334578899998886
Q ss_pred cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..... ....++|.....|+.++++||+|||+.
T Consensus 84 e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 122 (338)
T cd07859 84 ELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA 122 (338)
T ss_pred ecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111000 122488999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-06 Score=83.64 Aligned_cols=50 Identities=20% Similarity=0.323 Sum_probs=37.7
Q ss_pred CcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH
Q 015202 327 SANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~ 376 (411)
.-.+.||+|+||.||+|.+. .+..||||++.... ....+.|.+|++++.+
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~ 96 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSH 96 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHh
Confidence 33489999999999999863 23579999996432 2234579999998885
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.1e-06 Score=77.96 Aligned_cols=85 Identities=13% Similarity=0.178 Sum_probs=62.6
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||++... .++.+|||.+..... .....+..|+.++.+ +|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 445588999999999999874 578999999854321 223567889998876 22
Q ss_pred cCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.+.. ....+++.++..++.+++.||.|||+.
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 22111 123488889999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-06 Score=80.05 Aligned_cols=86 Identities=21% Similarity=0.210 Sum_probs=62.9
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~------------------------- 376 (411)
+|...+.||+|+||.||+|... +|..||||.+..... .....+.+|+.++..
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 4566689999999999999874 688999998754322 224578889888865
Q ss_pred ----cccCC--------CC-C-CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLT--------RE-D-KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~--------~~-~-~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+ .. . ...++|.+...++.+|++||.|||+.
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 129 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH 129 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11111 00 0 23478999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.1e-06 Score=76.54 Aligned_cols=81 Identities=21% Similarity=0.172 Sum_probs=59.5
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------c-----c
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------A-----N 378 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~-----~ 378 (411)
-++|+|+||+|||..- +.|+.||||++-... ..-.+--.+||+++.+ + .
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 4689999999999987 458999999994332 2224557899998887 1 1
Q ss_pred cCCCC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
||+-. ..+.++-....++..|+++|+.|.|++
T Consensus 88 L~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~ 120 (396)
T KOG0593|consen 88 LHELERYPNGVPSELVKKYLYQLLKAIHFCHKN 120 (396)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc
Confidence 22111 233477777899999999999999975
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=98.31 E-value=2e-06 Score=78.54 Aligned_cols=86 Identities=21% Similarity=0.268 Sum_probs=65.4
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|...+.+|+|++|.||+|.. .++..||+|.+..........|..|++++.. +|+.
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 344457899999999999985 4678999999865544556778999998876 3332
Q ss_pred CCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....++|.+...++.++|+||+|||+.
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~ 135 (296)
T cd06654 101 GGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135 (296)
T ss_pred CCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222 123478999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.4e-06 Score=80.93 Aligned_cols=86 Identities=13% Similarity=0.195 Sum_probs=63.3
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.++.+ +
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 3445588999999999999884 57899999985432 2234678999998887 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.++++||+|||+.
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 137 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123477888888999999999999974
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.3e-06 Score=79.30 Aligned_cols=80 Identities=10% Similarity=0.166 Sum_probs=60.0
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
+.||+|+||.||++.- .+|..||+|.+.... ......+..|++++.. +|..+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999975 467899999995432 2234567888888875 333222
Q ss_pred C------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 383 E------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 383 ~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
. ....++|.+...|+.++++||+|||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~ 113 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 113 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1 12358999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.31 E-value=1e-06 Score=82.29 Aligned_cols=89 Identities=13% Similarity=0.128 Sum_probs=64.2
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------cccC--------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------ANLL-------- 380 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~~l~-------- 380 (411)
..+.|.....||+|+||.||+|.. .++..||||++.... ....+.+.+|++++.+ +...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 345566668999999999999986 467889999985422 2234567889988886 1000
Q ss_pred ----------CCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 ----------TRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ----------~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.....|+.++++||+|||+.
T Consensus 93 ~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 137 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA 137 (343)
T ss_pred CcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 000 113488889999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.4e-06 Score=79.33 Aligned_cols=81 Identities=14% Similarity=0.187 Sum_probs=59.4
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
++||+|+||.||++... +++.||+|.+.... ......+..|+.++.+ +|+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999874 57889999985432 2234567788887754 33322
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.....|+.++++||+|||+.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~ 115 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21 123588889999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-06 Score=79.16 Aligned_cols=82 Identities=16% Similarity=0.220 Sum_probs=61.8
Q ss_pred CCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccCCCC
Q 015202 329 NNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLLTRE 383 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~~~~ 383 (411)
.+.||+|+||.||+|... ++..||+|.+.... ....+.|.+|++++.+ +|+.+..
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 367999999999999864 56789999885332 3345679999998886 2222211
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.....++.++++||.|||+.
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 120 (277)
T cd06642 89 ALDLLKPGPLEETYIATILREILKGLDYLHSE 120 (277)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 123588999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.6e-06 Score=77.32 Aligned_cols=80 Identities=16% Similarity=0.177 Sum_probs=58.4
Q ss_pred CeeeccCCceEEEEEecCCC-----------EEEEEEEecccchhhHhHHHHHHHHHH----------------------
Q 015202 330 NIIGRGGIGSIYKARIQDGM-----------EVAVKVFDLQYREAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~-----------~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------- 376 (411)
+.||+|+||.||+|+..+.. .|++|.+...... ...|.+|+.++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 36899999999999985432 4778877544332 6789999988876
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.... ....++|..++.++.+++.||+|||+.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 120 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 1221111 122589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.9e-07 Score=83.40 Aligned_cols=52 Identities=17% Similarity=0.333 Sum_probs=37.8
Q ss_pred CCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH
Q 015202 325 GFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~ 376 (411)
+|.-.+.||+|+||.||+|.. .++..||||++.... ......+.+|++++..
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~ 97 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHh
Confidence 444558999999999999874 233579999995433 2334568899988864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.7e-06 Score=79.58 Aligned_cols=86 Identities=16% Similarity=0.142 Sum_probs=63.0
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|...+.||+|+||.||+|+.. .+..||+|+++.... .....+.+|++++.+ +|+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3445578999999999999874 567899999864332 234568889998886 232
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... .+..+++.....++.++++||+|||+.
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~ 123 (309)
T cd07872 87 DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123 (309)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2100 123478888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=98.30 E-value=2e-06 Score=77.86 Aligned_cols=81 Identities=20% Similarity=0.201 Sum_probs=62.9
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC--
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE-- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~-- 383 (411)
..||+|+||.||+|... .+..+++|.+..........|.+|++++.. +|+.+..
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~ 90 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 90 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHH
Confidence 57999999999999885 466789998865555556789999998886 2222111
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
...+++|..+..++.++++||.|||+.
T Consensus 91 ~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~ 122 (282)
T cd06643 91 AVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122 (282)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 124589999999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=98.30 E-value=2e-06 Score=79.48 Aligned_cols=81 Identities=14% Similarity=0.184 Sum_probs=59.4
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
++||+|+||.||+|... +++.||||.+.... ......+..|++++.. +|..+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 57899999985432 2234567788887764 22222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.....++.++++||+|||+.
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~ 115 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 123588888999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.8e-06 Score=78.83 Aligned_cols=81 Identities=23% Similarity=0.250 Sum_probs=62.5
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC--
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE-- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~-- 383 (411)
..||+|+||.||++.. .+++.||+|.++.......+.+.+|+.++.. +|+.+..
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 5799999999999986 4688999999865444455678899888775 3332211
Q ss_pred ---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.+...++.+++.||+|||+.
T Consensus 107 ~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 136 (297)
T cd06659 107 DIVSQTRLNEEQIATVCESVLQALCYLHSQ 136 (297)
T ss_pred HHHhhcCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123488999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.5e-07 Score=84.10 Aligned_cols=88 Identities=14% Similarity=0.143 Sum_probs=63.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~---------------------- 376 (411)
.++|...+.||+|+||.||++... ++..||+|.+.... ......|..|++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 445666689999999999999874 57899999985322 2234558889998887
Q ss_pred -cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++......++.++++||+|||+.
T Consensus 122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~ 161 (370)
T cd05596 122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM 161 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 112366667788899999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.30 E-value=2e-06 Score=80.29 Aligned_cols=87 Identities=16% Similarity=0.203 Sum_probs=63.7
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------c-------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------A------------- 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~------------- 377 (411)
++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++.. +
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6677778999999999999986 468899999985321 2224568889988876 0
Q ss_pred ------ccCCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 ------NLLTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ------~l~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... .+..+++.....++.++++||+|||+.
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 136 (342)
T cd07879 95 FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136 (342)
T ss_pred EEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 000000 122578888999999999999999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.4e-06 Score=78.08 Aligned_cols=87 Identities=22% Similarity=0.267 Sum_probs=66.2
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
++|...+.||+|++|.||+|.- .++..||+|.+........+.+.+|+.++.. +|.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 3455568899999999999985 5788999999965544455678899988876 222
Q ss_pred CCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++.++.+++.++++||.|||+.
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~ 134 (297)
T cd06656 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN 134 (297)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2211 123478899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.5e-06 Score=79.01 Aligned_cols=86 Identities=20% Similarity=0.242 Sum_probs=64.2
Q ss_pred CCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------- 376 (411)
+|.-.+.+|+|+||.||++.. .++..+|+|.+........+.|.+|+.++.+
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 444558899999999999974 2345689999866555556789999999986
Q ss_pred -ccc---------CCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANL---------LTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l---------~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|. +... ....++|.+++.++.+++.||+|||+.
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~ 139 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ 139 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 221 1110 112489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=98.29 E-value=2e-06 Score=78.85 Aligned_cols=87 Identities=20% Similarity=0.208 Sum_probs=64.0
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------cc
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
++|.-.+.||+|+||.||+|... +|..||||.+..... .....+.+|++++.+ +|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 45556689999999999999874 678999999854332 223467889998887 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..... ....+++.....++.++++||+|||+.
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 122 (303)
T cd07869 85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122 (303)
T ss_pred CCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22110 123478888899999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.2e-06 Score=79.11 Aligned_cols=81 Identities=15% Similarity=0.174 Sum_probs=58.8
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
++||+|+||.||+|+.. +|..||||.++... ......+..|.+++.. +|+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999874 57899999996432 2233456777777653 33322
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.+...++.++++||+|||+.
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 115 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21 123478888999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.3e-06 Score=79.26 Aligned_cols=82 Identities=16% Similarity=0.195 Sum_probs=59.5
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH--------------------------cc
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD--------------------------AN 378 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~--------------------------~~ 378 (411)
.+.||+|+||.||+|.. .+|+.||||.+.... ....+.+..|++++.. +|
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 47899999999999987 457899999996432 2233567777765532 22
Q ss_pred cCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....++|.+...++.++++||.|||+.
T Consensus 84 ~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05589 84 AAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN 120 (324)
T ss_pred CCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 22211 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.7e-06 Score=77.13 Aligned_cols=82 Identities=16% Similarity=0.242 Sum_probs=61.8
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
|.-.+.||+|+||.||+|.. .|..||+|.++... ..+.|.+|+.++.+ ++..+
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred CeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 44458899999999999987 57889999885332 24579999998887 22211
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++|...++++.+++.||+|||++
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 122388999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.5e-06 Score=78.62 Aligned_cols=83 Identities=17% Similarity=0.192 Sum_probs=64.3
Q ss_pred cCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC
Q 015202 328 ANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE 383 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~ 383 (411)
-...||+|++|.||+|... ++..||+|.+..........|..|++++.+ +|..+..
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 3367999999999999884 578899999866555556789999998887 2222211
Q ss_pred -------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.++++.....++.++|.||.|||+.
T Consensus 89 L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~ 122 (280)
T cd06611 89 LDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122 (280)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123588999999999999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.9e-06 Score=78.73 Aligned_cols=85 Identities=21% Similarity=0.270 Sum_probs=65.8
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
|...+.||.|++|.||+|.- .+|+.||+|.+........+.+.+|++++.. +|+.+
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 55557899999999999975 5788999999865544456778999998876 33322
Q ss_pred CC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++|.++..++.++++||+|||+.
T Consensus 101 ~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~ 134 (296)
T cd06655 101 GSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN 134 (296)
T ss_pred CcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22 123489999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.4e-06 Score=78.38 Aligned_cols=81 Identities=14% Similarity=0.079 Sum_probs=57.8
Q ss_pred CeeeccCCceEEEEEecC---CCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccC--
Q 015202 330 NIIGRGGIGSIYKARIQD---GMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLL-- 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~---~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~-- 380 (411)
+.||+|+||.||+|...+ +..+|+|+++... ......|.+|+.++.+ +|..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998743 3468999885433 2334579999998887 2221
Q ss_pred -------CCC--CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 -------TRE--DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 -------~~~--~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ....++|....+++.++|+||+|||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 119 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 111 112367778889999999999999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.7e-06 Score=76.92 Aligned_cols=85 Identities=19% Similarity=0.114 Sum_probs=62.8
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|.-...||+|+||.||+|.. .+++.||+|.+.... ....++|.+|++++.+ +|..
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 33447899999999999985 567889999985432 3335679999998876 2222
Q ss_pred CCC--CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.....++.+++.||+|||+.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 114 (279)
T cd06619 83 GGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSL 114 (279)
T ss_pred CCChHHhhcCCHHHHHHHHHHHHHHHHHHHHC
Confidence 221 012367888899999999999999974
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.2e-06 Score=79.07 Aligned_cols=85 Identities=18% Similarity=0.202 Sum_probs=63.7
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||+|.. .+|..||+|.+.... .....+|.+|++++.+ +|
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 44557899999999999986 467899999985332 2234578899998886 33
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ...+++|.++..++.++|+||.|||+.
T Consensus 107 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~ 144 (317)
T cd06635 107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144 (317)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 32210 134589999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.1e-06 Score=80.56 Aligned_cols=87 Identities=21% Similarity=0.304 Sum_probs=63.0
Q ss_pred cCCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH--------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-------------------- 376 (411)
++|.-.+.||+|+||.||+|.. ..+..||||.+.... ......|.+|+.++.+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3466668999999999999974 124479999885432 2334679999998876
Q ss_pred ----cccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..... ....++|.++..|+.+++.||+|||+.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~ 160 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2221111 112389999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.7e-06 Score=79.00 Aligned_cols=86 Identities=13% Similarity=0.164 Sum_probs=64.6
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------cc
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
++|...+.||+|+||.||++... .|..+|+|.+..... .....|.+|++++.+ +|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 45666688999999999999874 577899998864422 335679999999987 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
..+.. ....+++....+++.++++||.|||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~ 121 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 22211 12347888889999999999999996
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.8e-06 Score=75.88 Aligned_cols=84 Identities=15% Similarity=0.242 Sum_probs=63.2
Q ss_pred CcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 327 SANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
...+.||+|+||.||+|.. .++..||||.+.... ......|.+|+.++.+ +|..+
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 3447899999999999986 467899999885433 2334678999998877 23222
Q ss_pred CC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++|.....++.+++.||.|||+.
T Consensus 87 ~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (277)
T cd06641 87 GSALDLLEPGPLDETQIATILREILKGLDYLHSE 120 (277)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC
Confidence 11 123589999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.5e-06 Score=75.48 Aligned_cols=84 Identities=13% Similarity=0.217 Sum_probs=62.6
Q ss_pred CcCCeeeccCCceEEEEEecCCCEEEEEEEecccc------hhhHhHHHHHHHHHH-----------------------c
Q 015202 327 SANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYR------EAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~------~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.-.+.||+|+||.||+|...+|..+|||.++.... .....|.+|++++.+ +
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 34578999999999999988889999998854321 123568889988876 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ...++++.....++.++++||+|||+.
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (265)
T cd06631 83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121 (265)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 322211 123478888899999999999999974
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.3e-06 Score=75.72 Aligned_cols=86 Identities=16% Similarity=0.191 Sum_probs=63.7
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc------chhhHhHHHHHHHHHH---------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY------REAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~------~~~~~~f~~e~~~~~~--------------------- 376 (411)
+|...+.||+|++|.||+|.- .++..||+|.+.... ....+.|..|++++.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 355668999999999999975 567899999885322 1124678999999886
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ...++++....+++.++++||.|||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~ 122 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN 122 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222111 123588899999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.7e-06 Score=77.84 Aligned_cols=80 Identities=15% Similarity=0.116 Sum_probs=56.3
Q ss_pred eeeccCCceEEEEEecCC---CEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc----
Q 015202 331 IIGRGGIGSIYKARIQDG---MEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL---- 379 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~~~---~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l---- 379 (411)
.||+|+||.||+|+..++ ..+|+|.+.... ......|.+|++++.. ++.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999986433 467888875433 2334678999988875 222
Q ss_pred -----CCCCC--CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 -----LTRED--KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 -----~~~~~--~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..... ....+|....+++.++++||+|||+.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc
Confidence 11110 12256778899999999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.5e-06 Score=75.31 Aligned_cols=84 Identities=18% Similarity=0.201 Sum_probs=63.7
Q ss_pred CcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------cccC
Q 015202 327 SANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
...+.||+|+||.||+|... ++..|++|.+..... ...+.|.+|+.++.+ +|..
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 34578999999999999874 678999999854433 246789999998887 2222
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++..+..|+.++++||.|||+.
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 118 (264)
T cd06626 83 GGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118 (264)
T ss_pred CCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC
Confidence 111 123488899999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.27 E-value=3e-06 Score=78.75 Aligned_cols=86 Identities=15% Similarity=0.260 Sum_probs=61.9
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||++... +++.||||.+.... ....+.|..|+.++.. +
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 3445588999999999999874 57899999985321 2234568888887765 3
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|+.+.. ....+++.....++.+|+.||+|||+.
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 332211 123477788889999999999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.8e-06 Score=78.07 Aligned_cols=85 Identities=13% Similarity=0.109 Sum_probs=63.0
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|...+.||+|+||.||++... +|..+|+|.+.... .....++.+|++++.+ +|.
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 4666689999999999999874 57788999885432 2234668999998886 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.+.. ....+++.....++.++++||+|||+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~ 117 (308)
T cd06615 82 DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117 (308)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 2111 12347888889999999999999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.2e-06 Score=77.95 Aligned_cols=89 Identities=17% Similarity=0.136 Sum_probs=64.8
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~----------------------- 376 (411)
++.+|...+.||+|+||.||+|.. .+|..||+|++..... .....+.+|+.++.+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 356677778999999999999986 4688999999854332 223467889888876
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.... ....+.+.+...++.++++||.|||+.
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 122 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222110 112477888889999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.9e-06 Score=76.48 Aligned_cols=85 Identities=18% Similarity=0.221 Sum_probs=64.3
Q ss_pred CCcCCeeeccCCceEEEEEecC-CCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------~~l 379 (411)
+...+.||+|+||.||.+...+ |...|||.+........+...+|++++.+ +|.
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 3445899999999999999844 88999999865533336779999999998 222
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. .+..++-..-.+.+.+|.+||+|||+.
T Consensus 99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~ 136 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK 136 (313)
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2211 011578888899999999999999964
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.7e-06 Score=79.05 Aligned_cols=86 Identities=16% Similarity=0.214 Sum_probs=63.5
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||++.. .+|..||||++.... ....+.|..|+.++.. +
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 455668999999999999986 468899999996432 2234568888888876 2
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.++++||.|||+.
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 121 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222111 113588888889999999999999974
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.3e-06 Score=78.97 Aligned_cols=81 Identities=17% Similarity=0.204 Sum_probs=60.2
Q ss_pred CeeeccCCceEEEEEe----cCCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------cccC
Q 015202 330 NIIGRGGIGSIYKARI----QDGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l----~~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
+.||+|+||.||++.- ..|+.+|||++..... .....+..|++++.+ +|..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998864 3578999999964322 234567889988876 3332
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.....++.++++||+|||+.
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 117 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 117 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 211 123488999999999999999999974
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=7e-07 Score=84.34 Aligned_cols=85 Identities=18% Similarity=0.222 Sum_probs=60.4
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccch---hhHhHHHHHHHHHH-----------cccCCCC-------
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYRE---AFKSFDNEFMTVVD-----------ANLLTRE------- 383 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~---~~~~f~~e~~~~~~-----------~~l~~~~------- 383 (411)
|++.+.||.|+||.||.+.- .+...||||++.-..++ ..++...||+.+.+ =||++..
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44557899999999999974 46678999999654443 35788999999987 1122111
Q ss_pred -----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
...|+---....|+.|+..||+|||+.
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~ 145 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 145 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh
Confidence 112344445677888999999999974
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.1e-06 Score=77.22 Aligned_cols=82 Identities=20% Similarity=0.316 Sum_probs=59.6
Q ss_pred CCeeeccCCceEEEEEecC----CCEEEEEEEeccc--chhhHhHHHHHHHHHH--------------------------
Q 015202 329 NNIIGRGGIGSIYKARIQD----GMEVAVKVFDLQY--REAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~----~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-------------------------- 376 (411)
.+.||+|+||.||+|...+ +..||||++.... ......|.+|++.+..
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4789999999999998742 3579999986432 2334679999998876
Q ss_pred ---cccC---------CCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLL---------TRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~---------~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|.. ... ....++|.+...++.+++.||+|||+.
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~ 132 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR 132 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0100 000 112488899999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.4e-06 Score=78.82 Aligned_cols=82 Identities=18% Similarity=0.208 Sum_probs=61.7
Q ss_pred CCeeeccCCceEEEEEecC------CCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------cc
Q 015202 329 NNIIGRGGIGSIYKARIQD------GMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~------~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~~ 378 (411)
.+.||+|+||.||+|...+ +..||||.+...... ..+.|.+|++++.+ +|
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 89 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY 89 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence 3789999999999998733 468999998654433 45789999998886 11
Q ss_pred ---------cCCC-----------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 ---------LLTR-----------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 ---------l~~~-----------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.. .....++|.+...++.+++.|+.|||+.
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 1111 0123488999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-06 Score=80.01 Aligned_cols=88 Identities=19% Similarity=0.282 Sum_probs=62.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEecC------CCEEEEEEEecc-cchhhHhHHHHHHHHHH-------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQD------GMEVAVKVFDLQ-YREAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~------~~~vavk~l~~~-~~~~~~~f~~e~~~~~~------------------- 376 (411)
.++|.-.+.||+|+||.||+|...+ ...+|+|.+... ..+...++.+|+.++.+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3445556889999999999998732 257899988543 23344678899987764
Q ss_pred -----cc---------cCCC-------------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----AN---------LLTR-------------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~---------l~~~-------------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+| ++.. .....++|..+++|+.++|.||+|||+.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 151 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK 151 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 1110 1123589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.5e-06 Score=77.30 Aligned_cols=83 Identities=20% Similarity=0.167 Sum_probs=61.9
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
..+.||+|++|.||+|.. .+|..||||++.... ......|.+|++++.+ ++...
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~~ 82 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL 82 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccCc
Confidence 347899999999999987 478999999985432 2224578899998886 22211
Q ss_pred C-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 R-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. .....++|.++.+++.++++||+|||+.
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~ 118 (283)
T cd07835 83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118 (283)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0 0112589999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-06 Score=86.12 Aligned_cols=89 Identities=13% Similarity=0.228 Sum_probs=64.0
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~---------------------- 376 (411)
..+.|.-.+.||+|+||.||+|.. .+|+.||||.+... .......+.+|+.++..
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 345666668999999999999975 57899999998543 23345678889887764
Q ss_pred ---------cccCCC---------C-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------ANLLTR---------E-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------~~l~~~---------~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|.... . ...++++.....|+.++++||.|||+.
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~ 162 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK 162 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111110 0 123477778888999999999999974
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.1e-06 Score=78.32 Aligned_cols=81 Identities=19% Similarity=0.213 Sum_probs=56.9
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
+.||+|+||.||+|.. .+|+.||||.+.... .....++..|...+.+ +|..+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999987 468899999985432 2223456666654432 22222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.....++.+|++||.|||+.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 115 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 123478888899999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.7e-06 Score=76.60 Aligned_cols=82 Identities=17% Similarity=0.164 Sum_probs=64.1
Q ss_pred CCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 329 NNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
.+.||+|+||.||+|... ++..|++|.+........++|..|+.++.. +|..+..
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 96 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV 96 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence 368999999999999874 478899999866555556789999988887 2222111
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.+...++.++|+||+|||+.
T Consensus 97 ~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 129 (292)
T cd06644 97 DAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129 (292)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 123589999999999999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.7e-06 Score=74.49 Aligned_cols=85 Identities=15% Similarity=0.147 Sum_probs=65.6
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|.-.+.||+|++|.||+++.. .|..|+||++..... ...++|.+|++.+.+ ++.
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 4555689999999999999985 488999999855433 446789999998876 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.+.. ...++++..+.+++.++++||+|||+
T Consensus 82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~ 117 (264)
T cd06623 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 2111 12458889999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.4e-06 Score=77.15 Aligned_cols=89 Identities=20% Similarity=0.190 Sum_probs=65.1
Q ss_pred HhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------ccc---------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------ANL--------- 379 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~~l--------- 379 (411)
+.++|.-.+.+|+|+||.||+|... +|+.||||+++... ......+.+|++++.+ ++.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4556767789999999999999984 57899999985432 2223567888888876 000
Q ss_pred ----------CCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 ----------LTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ----------~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|.+...|+.++++||+|||+.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 135 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK 135 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0000 112489999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-06 Score=84.69 Aligned_cols=83 Identities=17% Similarity=0.256 Sum_probs=59.3
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------c---------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------A--------------- 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------~--------------- 377 (411)
.+|...++||+|+||.||+|.. ..+..||||++.... ....+|+.++.+ +
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 4566668999999999999987 467899999884322 234467777776 1
Q ss_pred ------ccCCC---------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 ------NLLTR---------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ------~l~~~---------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|+.+. .....+++.....++.++++||+|||+.
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~ 189 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 10000 0123477888899999999999999974
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=98.25 E-value=2e-06 Score=78.42 Aligned_cols=86 Identities=14% Similarity=0.112 Sum_probs=62.6
Q ss_pred CCCcCCeeeccCCceEEEEEecC-----------------CCEEEEEEEeccc-chhhHhHHHHHHHHHH----------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD-----------------GMEVAVKVFDLQY-REAFKSFDNEFMTVVD---------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~-----------------~~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------- 376 (411)
+|.-.+.||+|+||.||++...+ +..||+|.+.... .....+|.+|++++.+
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34455889999999999988642 2458999985433 3346789999999887
Q ss_pred -------------cccCCC---------C--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------------ANLLTR---------E--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------------~~l~~~---------~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.+. . ....++|.+...++.++++||+|||+.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~ 149 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL 149 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 122111 0 012589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-06 Score=79.71 Aligned_cols=97 Identities=16% Similarity=0.186 Sum_probs=71.6
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH---------------
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD--------------- 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------- 376 (411)
.+++.++..++++|.-...||+|+||.||++.. .+++.+|+|.+.... ....++..|+.++.+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 356677778889998889999999999999987 467889999985432 223556777776654
Q ss_pred --------------cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. .+..++|.....++.++++||.|||+.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 147 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111100 123588999999999999999999974
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.1e-06 Score=77.34 Aligned_cols=82 Identities=18% Similarity=0.298 Sum_probs=59.3
Q ss_pred CCeeeccCCceEEEEEec----CCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------c---------------
Q 015202 329 NNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------A--------------- 377 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------~--------------- 377 (411)
.+.||+|+||.||+|.+. .++.||||++... .....++|.+|+.++.+ +
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 478999999999999863 3578999998543 23345678999998887 1
Q ss_pred ----ccCCCC----------C--CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 ----NLLTRE----------D--KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ----~l~~~~----------~--~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..... . ...+++....+++.+++.||+|||+.
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 132 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK 132 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 000000 0 11367888899999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.8e-06 Score=75.73 Aligned_cols=81 Identities=22% Similarity=0.332 Sum_probs=61.9
Q ss_pred CeeeccCCceEEEEEecC----CCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------ccc--
Q 015202 330 NIIGRGGIGSIYKARIQD----GMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------ANL-- 379 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~----~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~~l-- 379 (411)
+.||+|+||.||+|+..+ +..||||.+...... ..+.+..|++++.. ++.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999854 778999998654333 36788999988886 222
Q ss_pred -------CCCCC------CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 -------LTRED------KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 -------~~~~~------~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..... ...++|.++.+++.++++||+|||+.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 124 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK 124 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC
Confidence 22100 24589999999999999999999974
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=98.25 E-value=2e-06 Score=78.06 Aligned_cols=88 Identities=20% Similarity=0.212 Sum_probs=66.9
Q ss_pred HhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------c
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.+++|...+.+|+|++|.||+|... ++..|++|++..... ....|..|++++.+ +
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4445555678999999999999985 578999999965443 45678999998876 2
Q ss_pred ccCCCC-----CC--CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-----DK--HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-----~~--~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. .. ..++|..+..|+.++++||+|||+.
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~ 135 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 222111 11 2699999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.4e-06 Score=78.14 Aligned_cols=81 Identities=20% Similarity=0.219 Sum_probs=57.5
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
+.||+|+||.||+|.. .+|+.+|||.+.... ......+..|..++.+ +|..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999986 468899999985432 2234556667654432 23222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.+...++.+|++||+|||+.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~ 115 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 123588888999999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.6e-06 Score=79.46 Aligned_cols=86 Identities=19% Similarity=0.242 Sum_probs=61.2
Q ss_pred CCCcCCeeeccCCceEEEEEe--------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI--------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l--------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------- 376 (411)
+|.....||+|+||.||+|.. .++..||+|.+.... ....+++.+|+.++..
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 344458999999999999974 124579999885432 3445678899887764
Q ss_pred --------------cccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------ANLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------~~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ....++|.++++++.||++||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 156 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ 156 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC
Confidence 1222111 012488999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.6e-06 Score=75.09 Aligned_cols=81 Identities=19% Similarity=0.171 Sum_probs=59.8
Q ss_pred CeeeccCCceEEEEEecC----CCEEEEEEEecccc-hhhHhHHHHHHHHHH----------------------cccCCC
Q 015202 330 NIIGRGGIGSIYKARIQD----GMEVAVKVFDLQYR-EAFKSFDNEFMTVVD----------------------ANLLTR 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~----~~~vavk~l~~~~~-~~~~~f~~e~~~~~~----------------------~~l~~~ 382 (411)
++||+|+||.||+|.+.. +..+|+|.+..... ...++|.+|+.++.+ ++....
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 469999999999998622 25799999864443 345689999998886 121111
Q ss_pred C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....++|..+..++.++++||+|||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~ 114 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 1 112488999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.9e-06 Score=77.98 Aligned_cols=84 Identities=18% Similarity=0.245 Sum_probs=61.6
Q ss_pred CcCCeeeccCCceEEEEEec-CCC----EEEEEEEeccc-chhhHhHHHHHHHHHH----------------------cc
Q 015202 327 SANNIIGRGGIGSIYKARIQ-DGM----EVAVKVFDLQY-REAFKSFDNEFMTVVD----------------------AN 378 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l~-~~~----~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------~~ 378 (411)
.-.+.||+|+||.||+|... +|. .||+|.+.... .....+|.+|+.++.+ ++
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 89 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQL 89 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEEEec
Confidence 34478999999999999873 232 58999885443 3345789999999887 11
Q ss_pred cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..... ....++|...++++.|+|+||+|||++
T Consensus 90 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 128 (279)
T cd05057 90 MPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128 (279)
T ss_pred CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11111 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.7e-06 Score=76.38 Aligned_cols=86 Identities=19% Similarity=0.239 Sum_probs=62.7
Q ss_pred CCCcCCeeeccCCceEEEEEec----CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------- 376 (411)
+|.-.+.||+|+||.||+|+.. .+..+|+|.++... ....+.|..|+.++.+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3444589999999999999862 23378999885433 2335689999998876
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....++|.+.++|+.+++.||.|||+.
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 125 (267)
T cd05066 85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125 (267)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-06 Score=81.60 Aligned_cols=51 Identities=22% Similarity=0.365 Sum_probs=36.4
Q ss_pred CCcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH
Q 015202 326 FSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~ 376 (411)
|.-.+.||+|+||.||+|... .+..||+|++.... ....+.+..|+.++.+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~ 66 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIH 66 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHh
Confidence 334489999999999999742 24689999985432 2234567888887765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.1e-06 Score=76.70 Aligned_cols=83 Identities=16% Similarity=0.184 Sum_probs=61.2
Q ss_pred cCCeeeccCCceEEEEEe-----cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------------
Q 015202 328 ANNIIGRGGIGSIYKARI-----QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-----~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------- 376 (411)
..+.||+|+||.||.+.+ .++..||+|.+.... ......|.+|++++.+
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 347899999999988654 356789999985443 2345679999998886
Q ss_pred cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....++|.++..|+.++++||.|||+.
T Consensus 88 e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~ 126 (283)
T cd05080 88 EYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ 126 (283)
T ss_pred cCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111111 122489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.2e-06 Score=75.21 Aligned_cols=84 Identities=20% Similarity=0.277 Sum_probs=64.3
Q ss_pred CCCcCCeeeccCCceEEEEEecC-CCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
+|.-.+.||+|++|.||+|...+ +..+++|.+..... .++|.+|++++.+ ++..
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 45555789999999999999854 78999999854322 6789999998887 1111
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .+..++|.....++.++++||.|||+.
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~ 118 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111 134589999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.7e-07 Score=81.25 Aligned_cols=213 Identities=18% Similarity=0.157 Sum_probs=137.8
Q ss_pred cccchhhhCCCCCCeeecccCcccccCc-hhhh-ccccCCeeeecCCcccc--cCCccccCCccCCeeecccccCCccCc
Q 015202 32 GSISIALGKLQKLQLLGLEDNQLEGSIP-YDLC-RLAALFQLDLGDNKLSG--FVPSCFGNLTNLRKLYLGSNQLTYIPL 107 (411)
Q Consensus 32 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~-~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~p~ 107 (411)
|..+-.++....++.|.+.++.|...-. +.|+ .+..++++||..|.|+. .+...+.+||.|+.|+++.|++..--.
T Consensus 35 g~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~ 114 (418)
T KOG2982|consen 35 GLSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIK 114 (418)
T ss_pred ccceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccc
Confidence 3344444455566678888887763321 2233 36789999999999873 344557889999999999999884433
Q ss_pred cc-cCCCCCcEEEcCCCeeee-cCCCCccCccCCCeEEccCCeeccc--CCCCccC-CCccCeeecccccccc--cCCcc
Q 015202 108 TL-WNLKYILYLNLSSNSFTI-PLPSEIGNLEVLVQIDLSMNNFSGA--IPTTIGG-LKDLQYLFLEYNRLQG--SIPDF 180 (411)
Q Consensus 108 ~~-~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~~~~~--~~~~~~~-~~~L~~L~l~~n~l~~--~~~~~ 180 (411)
.+ ....+|+.|.|.+..+.- .....+..++.++.|.++.|.+... ....... .+.+.++++.+|...- .....
T Consensus 115 ~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l 194 (418)
T KOG2982|consen 115 SLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKL 194 (418)
T ss_pred cCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhH
Confidence 33 367889999999887653 2344567788899999999955422 1122222 2367777777765431 01111
Q ss_pred ccCCCCCCEEeCCCCcccccc-chhhhcCCCCCEEEcccCcccccC--CCCCCCCCccccccCCCCc
Q 015202 181 IGGLINLKSLDLSNNNLSGAI-PISLEKLLDLQHINVSFNKLEGEI--PREGPFRNFSIESFKGNEL 244 (411)
Q Consensus 181 ~~~~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~l~l~~n~l~~~~--~~~~~~~~~~~~~~~~n~~ 244 (411)
-.-+|++..+-+..|.+.+.- ......+|.+-.|+++.|++.... .....++++..+.+..+|.
T Consensus 195 ~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl 261 (418)
T KOG2982|consen 195 SRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPL 261 (418)
T ss_pred HhhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcc
Confidence 123567888888888886442 335667778888899988886432 2334566677777776654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.3e-06 Score=82.17 Aligned_cols=83 Identities=23% Similarity=0.308 Sum_probs=61.1
Q ss_pred cCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc---
Q 015202 328 ANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN--- 378 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~--- 378 (411)
-...||+|+||+||||+-. +.+.||+|.+.... .++.+...+|++++.+ +|
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 3467999999999999853 46789999984432 3345779999999997 11
Q ss_pred -cCCCC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 -LLTRE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 -l~~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|+... ....++..+...||.++..||.|||++
T Consensus 86 ~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~ 119 (808)
T KOG0597|consen 86 DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN 119 (808)
T ss_pred hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 11000 122477788899999999999999985
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.6e-06 Score=77.11 Aligned_cols=85 Identities=18% Similarity=0.240 Sum_probs=61.0
Q ss_pred CCcCCeeeccCCceEEEEEecCC------CEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQDG------MEVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~------~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
|.-.+.||+|+||.||+|..... ..||+|.+.... .....+|.+|++++.+
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 33347899999999999987332 468999985433 2335679999998886
Q ss_pred -cc---------cCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -AN---------LLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~---------l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+| +.... ....+++.+...++.++++||+|||+.
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~ 143 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH 143 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 11110 013478889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.8e-06 Score=76.61 Aligned_cols=86 Identities=22% Similarity=0.267 Sum_probs=64.8
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|...+.||+|+||.||+|.- .++..||+|.+........+.|.+|+.++.+ +|+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 444557899999999999975 4678899999865444456778999988876 2222
Q ss_pred CCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....++|..+..|+.++++||.|||+.
T Consensus 100 ~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~ 134 (293)
T cd06647 100 GGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 134 (293)
T ss_pred CCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 211 123478999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.7e-06 Score=78.47 Aligned_cols=86 Identities=16% Similarity=0.225 Sum_probs=64.4
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|...+.||+|++|.||++... ++..+|+|.+..... ...+.|..|++++.. +
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4556688999999999999875 478999999854322 245678999988876 2
Q ss_pred ccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. .+..+++..+..++.++++||+|||+.
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 122 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC
Confidence 222111 124589999999999999999999964
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.3e-06 Score=77.57 Aligned_cols=85 Identities=18% Similarity=0.194 Sum_probs=63.9
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||+|... +|+.||+|.+.... ....+++.+|++++.. +|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 555588999999999999874 68899999885332 2334678999998886 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ...+++|..+..++.|++.||.|||++
T Consensus 97 ~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~ 134 (307)
T cd06607 97 CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134 (307)
T ss_pred hCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21110 123589999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=98.23 E-value=4e-06 Score=77.98 Aligned_cols=86 Identities=13% Similarity=0.171 Sum_probs=64.3
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------cc
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
++|...+.||+|+||.||++... +|..+|+|.+..... .....|.+|++++.+ +|
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 45666689999999999999874 577899998864422 334679999999887 33
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
..+.. ....+++.....++.++++||.|||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~ 121 (333)
T cd06650 85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121 (333)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 32211 12347888889999999999999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=98.23 E-value=2e-06 Score=81.18 Aligned_cols=89 Identities=12% Similarity=0.113 Sum_probs=64.1
Q ss_pred HhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH---------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~--------------------- 376 (411)
..++|...+.||+|+||.||++... ++..+|+|.+.... ......|..|+.++..
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3455666689999999999999874 57789999985321 2234568888888876
Q ss_pred --cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++......++.+++.||+|||+.
T Consensus 121 v~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~ 161 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 122467778889999999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.5e-06 Score=77.37 Aligned_cols=133 Identities=19% Similarity=0.239 Sum_probs=61.9
Q ss_pred hCCCCCCeeecccCcccccCchhhhccc-cCCeeeecCCcccccCCccccCCccCCeeecccc-cCCccCccccCCCCCc
Q 015202 39 GKLQKLQLLGLEDNQLEGSIPYDLCRLA-ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSN-QLTYIPLTLWNLKYIL 116 (411)
Q Consensus 39 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~p~~~~~~~~L~ 116 (411)
..+.+++.|++++|.++ .+| .+| +|++|++++|.--..+|..+. ++|+.|++++| .+..+|.. |+
T Consensus 49 ~~~~~l~~L~Is~c~L~-sLP----~LP~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~sLP~s------Le 115 (426)
T PRK15386 49 EEARASGRLYIKDCDIE-SLP----VLPNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEISGLPES------VR 115 (426)
T ss_pred HHhcCCCEEEeCCCCCc-ccC----CCCCCCcEEEccCCCCcccCCchhh--hhhhheEccCcccccccccc------cc
Confidence 34566666666666555 223 122 466666665433234444442 45666666665 45555532 44
Q ss_pred EEEcCCCeee--ecCCCCccCccCCCeEEccCCeec--ccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeC
Q 015202 117 YLNLSSNSFT--IPLPSEIGNLEVLVQIDLSMNNFS--GAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDL 192 (411)
Q Consensus 117 ~L~l~~n~l~--~~~~~~~~~l~~L~~L~l~~n~~~--~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l 192 (411)
.|++..+... +.+|. +|+.|.+.+++.. ...|..+ .++|+.|++++|... ..|..+. .+|+.|++
T Consensus 116 ~L~L~~n~~~~L~~LPs------sLk~L~I~~~n~~~~~~lp~~L--PsSLk~L~Is~c~~i-~LP~~LP--~SLk~L~l 184 (426)
T PRK15386 116 SLEIKGSATDSIKNVPN------GLTSLSINSYNPENQARIDNLI--SPSLKTLSLTGCSNI-ILPEKLP--ESLQSITL 184 (426)
T ss_pred eEEeCCCCCcccccCcc------hHhheecccccccccccccccc--CCcccEEEecCCCcc-cCccccc--ccCcEEEe
Confidence 5555444322 11222 3444554332210 0111111 145666776666544 3333232 36666666
Q ss_pred CCC
Q 015202 193 SNN 195 (411)
Q Consensus 193 ~~n 195 (411)
+.+
T Consensus 185 s~n 187 (426)
T PRK15386 185 HIE 187 (426)
T ss_pred ccc
Confidence 654
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=98.23 E-value=4e-06 Score=76.81 Aligned_cols=86 Identities=16% Similarity=0.263 Sum_probs=60.6
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCC----EEEEEEEecccc-hhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGM----EVAVKVFDLQYR-EAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~----~vavk~l~~~~~-~~~~~f~~e~~~~~~---------------------- 376 (411)
+|...+.||+|+||.||+|.. ++|. .||+|.+..... ....+|.+|+.++..
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v~ 87 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVT 87 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceeee
Confidence 344457899999999999986 3444 468888754332 334578899988876
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....++|....+++.++++||+|||++
T Consensus 88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 128 (303)
T cd05110 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128 (303)
T ss_pred hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 1111110 122478899999999999999999974
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.5e-06 Score=75.79 Aligned_cols=82 Identities=18% Similarity=0.349 Sum_probs=59.3
Q ss_pred CCeeeccCCceEEEEEecCC-C--EEEEEEEecc--cchhhHhHHHHHHHHHH---------------------------
Q 015202 329 NNIIGRGGIGSIYKARIQDG-M--EVAVKVFDLQ--YREAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~-~--~vavk~l~~~--~~~~~~~f~~e~~~~~~--------------------------- 376 (411)
...||+|+||.||+|+..+. . .||||.++.. +......|..|++++..
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 47899999999999998543 2 5899988543 23345778999988876
Q ss_pred --cccCCCC------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..... ....++|.+...++.++++||+|||+.
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 131 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK 131 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0110000 112378999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.6e-06 Score=79.46 Aligned_cols=86 Identities=13% Similarity=0.135 Sum_probs=62.9
Q ss_pred CCCcCCeeeccCCceEEEEEecC--CCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD--GMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~--~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
+|.-.+.||+|+||.||+|...+ +..||||++.... ......|.+|++++..
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 34455899999999999998643 3579999985332 2234678899998886
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.+++.||+|||+.
T Consensus 111 Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 150 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150 (340)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332221 123588888999999999999999974
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.9e-06 Score=77.01 Aligned_cols=81 Identities=15% Similarity=0.219 Sum_probs=61.5
Q ss_pred CCeeeccCCceEEEEEec-CCCEEEEEEEecc-cchhhHhHHHHHHHHHH-----------------------cccCCCC
Q 015202 329 NNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQ-YREAFKSFDNEFMTVVD-----------------------ANLLTRE 383 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~-~~~~~~~f~~e~~~~~~-----------------------~~l~~~~ 383 (411)
.+.||+|+||.||++... .|..||+|.+... .......|.+|+.++.+ +|..+..
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence 378999999999999884 6889999988543 22334679999988876 2222211
Q ss_pred ---------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 384 ---------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 384 ---------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
....++|....+++.++++||.|||+
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 120 (286)
T cd06622 86 LDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120 (286)
T ss_pred HHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 11258999999999999999999995
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.3e-06 Score=83.00 Aligned_cols=81 Identities=19% Similarity=0.293 Sum_probs=63.5
Q ss_pred cCCeeeccCCceEEEEEec---CCC--EEEEEEEecccc-hhhHhHHHHHHHHHH-------------------------
Q 015202 328 ANNIIGRGGIGSIYKARIQ---DGM--EVAVKVFDLQYR-EAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~---~~~--~vavk~l~~~~~-~~~~~f~~e~~~~~~------------------------- 376 (411)
..++||+|-||.||+|++. .|. .||||..+..+. ...+.|.+|..+|.+
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~ 472 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELA 472 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecc
Confidence 3479999999999999983 333 588999876554 346779999999997
Q ss_pred ------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+||... ...++..+-...|.|+..||+|||+.
T Consensus 473 ~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk 510 (974)
T KOG4257|consen 473 PLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK 510 (974)
T ss_pred cchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh
Confidence 444443 24588888999999999999999873
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=98.23 E-value=4e-06 Score=77.91 Aligned_cols=85 Identities=13% Similarity=0.177 Sum_probs=61.0
Q ss_pred CCcCCeeeccCCceEEEEEe----cCCCEEEEEEEeccc----chhhHhHHHHHHHHHH---------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI----QDGMEVAVKVFDLQY----REAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l----~~~~~vavk~l~~~~----~~~~~~f~~e~~~~~~--------------------- 376 (411)
|.-.+.||+|+||.||++.. ..|..||+|.+.... ....+.+..|+.++..
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 44457899999999999875 357899999985422 1223567888887775
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.++++||+|||+.
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 124 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 123488888899999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.5e-06 Score=80.02 Aligned_cols=86 Identities=13% Similarity=0.136 Sum_probs=62.5
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++.+ +
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 355668999999999999986 457889999985432 2234678899998886 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....++......++.+++.||+|||+.
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~ 120 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 222211 112466777778889999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.3e-06 Score=75.63 Aligned_cols=86 Identities=15% Similarity=0.207 Sum_probs=64.4
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|.-.+.+|.|++|.||+|.. .++..+|+|++.... ....+.+.+|++++.. +++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 455568899999999999986 467789999985432 2345789999998876 222
Q ss_pred CCCC---------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE---------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~---------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|.....++.+++.||+|||++
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2211 113478999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.1e-06 Score=75.32 Aligned_cols=85 Identities=13% Similarity=0.198 Sum_probs=63.5
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|...+.||+|++|.||++.. .+++.+|||++... .....+.|.+|++++.+ ++.
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 34457899999999999886 46788999998543 23345779999998886 222
Q ss_pred CCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. .+..+++....+++.++++||.|||++
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 120 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111 123488999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.4e-06 Score=79.88 Aligned_cols=86 Identities=13% Similarity=0.114 Sum_probs=62.0
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||++.- ..|+.||||.+.... ......+.+|++++.+ +
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 455568899999999999986 357899999985332 2234568899998886 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....++......++.+|++||+|||+.
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~ 120 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 322211 122467777778899999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.9e-06 Score=77.96 Aligned_cols=86 Identities=14% Similarity=0.230 Sum_probs=61.8
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||++... .+..||+|.+.... ......|..|+.++.. +
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4555688999999999999874 56789999985421 2234557888887765 3
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.+++.||+|||+.
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~ 121 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 322211 123478888889999999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.4e-06 Score=77.04 Aligned_cols=79 Identities=19% Similarity=0.184 Sum_probs=57.7
Q ss_pred CeeeccCCceEEEEEecC---CCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQD---GMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~---~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------~~l~~ 381 (411)
..||+|+||.||+|...+ +..||+|.+.... ....+.+|++++.+ ++...
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 689999999999998743 4679999985432 23467889988886 11100
Q ss_pred ----------C----CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 ----------R----EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ----------~----~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. .....++|....+|+.|+|+||.|||+.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~ 127 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0 0112478888999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.5e-06 Score=76.31 Aligned_cols=81 Identities=20% Similarity=0.315 Sum_probs=57.6
Q ss_pred CeeeccCCceEEEEEec----CCCEEEEEEEecc-cchhhHhHHHHHHHHHH------------------------cccC
Q 015202 330 NIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQ-YREAFKSFDNEFMTVVD------------------------ANLL 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~-~~~~~~~f~~e~~~~~~------------------------~~l~ 380 (411)
++||+|+||.||+|... ++..||+|++... .....+.|..|+.++.. ++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 2346899998533 23345688899888776 1111
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ....++|..++.++.++|+||.|||+.
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 117 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 012367888899999999999999974
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.5e-06 Score=77.58 Aligned_cols=88 Identities=16% Similarity=0.155 Sum_probs=61.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------- 376 (411)
+++|.-.+.||+|+||.||+|... .+..||||.+.... ......|.+|+.++.+
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 345555689999999999999753 24579999885332 2334578889988876
Q ss_pred ----cc---------cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----AN---------LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~---------l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+| ++... .....+|....+++.++++||.|||+.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 138 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK 138 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 22 21110 112367788899999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.3e-06 Score=76.55 Aligned_cols=85 Identities=15% Similarity=0.240 Sum_probs=62.7
Q ss_pred CCcCCeeeccCCceEEEEEe-----cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-----QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-----~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------- 376 (411)
|...+.||+|+||.||.+.+ ..+..||+|.+.... ......|.+|+.++.+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 34457899999999999985 246789999986443 3335679999998887
Q ss_pred --cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++|..+..++.+++.||+|||++
T Consensus 86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~ 128 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128 (284)
T ss_pred EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111111 112489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.5e-06 Score=77.84 Aligned_cols=85 Identities=14% Similarity=0.195 Sum_probs=60.7
Q ss_pred CCcCCeeeccCCceEEEEEecC-------------C--CEEEEEEEeccc-chhhHhHHHHHHHHHH-------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQD-------------G--MEVAVKVFDLQY-REAFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~-------------~--~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------- 376 (411)
|.-.+.||+|+||.||+++..+ + ..||||.+.... ......|.+|++++.+
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 86 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 3344789999999999987532 1 248999986442 3335679999999988
Q ss_pred ----------cccCCCC------------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTRE------------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~~------------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....++|.++++|+.++|+||+|||+.
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 148 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL 148 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc
Confidence 2222110 012378999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.7e-06 Score=80.35 Aligned_cols=83 Identities=19% Similarity=0.149 Sum_probs=61.3
Q ss_pred cCCeeeccCCceEEEEE-ecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------ccc
Q 015202 328 ANNIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-------------------------ANL 379 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~-l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-------------------------~~l 379 (411)
...+||+|.||.||+|. +..|..||+|++.-.. .....--.+||.++.+ +|+
T Consensus 121 ki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 121 KIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence 33679999999999996 4678999999985433 2223345899999998 222
Q ss_pred C-CCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 L-TRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~-~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. +-. .+-.++-.+..-+..|+.+||+|+|..
T Consensus 201 dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~ 237 (560)
T KOG0600|consen 201 DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR 237 (560)
T ss_pred cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc
Confidence 1 111 123488899999999999999999974
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=98.21 E-value=5e-06 Score=74.53 Aligned_cols=86 Identities=14% Similarity=0.266 Sum_probs=62.0
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--c---chhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--Y---REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~---~~~~~~f~~e~~~~~~---------------------- 376 (411)
+|.-.+.||+|+||.||+|.. .+|..||||.+... . ....+.|.+|+.++.+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 556668999999999999987 45789999987422 1 1224578889998886
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++....+++.+++.||+|||+.
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 112367778899999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.8e-06 Score=78.17 Aligned_cols=84 Identities=19% Similarity=0.183 Sum_probs=63.0
Q ss_pred CcCCeeeccCCceEEEEEec------CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------c
Q 015202 327 SANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.-...+|+|+||.||++... ++..+|+|.+.........+|.+|++++.+ +
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 33478999999999999642 355789999876655666789999998887 2
Q ss_pred cc---------CCCC------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NL---------LTRE------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l---------~~~~------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+. +... ....++|.+++.++.+++.||+|||+.
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 141 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL 141 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 22 1110 012489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.1e-06 Score=73.86 Aligned_cols=85 Identities=18% Similarity=0.253 Sum_probs=64.8
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-------------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-------------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-------------------------~ 377 (411)
|...+.||+|++|.||+|... ++..|++|++..... ...+.+.+|+.++.+ +
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 455688999999999999985 688999999854432 345789999998887 1
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....++|.++..++.++++||+|||+.
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (260)
T cd06606 82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120 (260)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111111 112589999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=98.21 E-value=1e-06 Score=78.74 Aligned_cols=80 Identities=19% Similarity=0.220 Sum_probs=59.2
Q ss_pred eeeccCCceEEEEEecC--------CCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 331 IIGRGGIGSIYKARIQD--------GMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~~--------~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
.||+|+||.||+|.... ...||+|.+........++|..|+.++.. +|.
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 68999999999998632 23488888865444455788889988876 232
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... .+..++|..+++++.|||+||+|||+.
T Consensus 82 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (258)
T cd05078 82 KFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119 (258)
T ss_pred CCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2211 123489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.8e-06 Score=79.05 Aligned_cols=86 Identities=17% Similarity=0.256 Sum_probs=63.5
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|...+.||+|+||.||++... .|..||||.+.... ......+..|+.++.+ +
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4666689999999999999874 57899999995432 2234567888888776 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.+++.||.|||+.
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~ 120 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 322211 123578888889999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.8e-06 Score=76.92 Aligned_cols=82 Identities=18% Similarity=0.299 Sum_probs=61.9
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTRE 383 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~~ 383 (411)
|.-.+.||+|+||.||+|.. .+..||+|.+.... ....|.+|+.++.+ ++..+..
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~ 84 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGN 84 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCC
Confidence 33448899999999999986 67889999985432 24679999998876 2222111
Q ss_pred --------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 --------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 --------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.++.+++.++++||.|||++
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 119 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123488999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.6e-06 Score=74.93 Aligned_cols=85 Identities=11% Similarity=0.208 Sum_probs=63.4
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|...+.||+|+||.||++.. .+|+.||+|++... ......++.+|++++.+ +++
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 44558999999999999876 46789999998543 23345689999998886 222
Q ss_pred CCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... ....+++.+..+++.++|+||+|||++
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2111 122478899999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.9e-06 Score=76.47 Aligned_cols=81 Identities=23% Similarity=0.235 Sum_probs=62.3
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC--
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE-- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~-- 383 (411)
..||+|+||.||++.. .++..||||.+..........|.+|+.++.. ++..+..
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5699999999999986 4578999999865555556779999988776 2222211
Q ss_pred ---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.+..+++.++++||+|||+.
T Consensus 108 ~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 137 (292)
T cd06658 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQ 137 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 122478999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.9e-06 Score=76.93 Aligned_cols=80 Identities=16% Similarity=0.082 Sum_probs=61.2
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
+.||+|+||.||++.. ++|+.||+|.+.... ......|.+|++++.. +|..+..
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL 90 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCH
Confidence 7899999999999987 457889999875432 3345789999998876 3332221
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
...+++|....+++.++++||.|||+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 121 (284)
T cd06620 91 DRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121 (284)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 12357899999999999999999995
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.2e-06 Score=77.27 Aligned_cols=86 Identities=20% Similarity=0.343 Sum_probs=61.2
Q ss_pred CCCcCCeeeccCCceEEEEEecC-CC--EEEEEEEecc-cchhhHhHHHHHHHHHH------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD-GM--EVAVKVFDLQ-YREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~-~~--~vavk~l~~~-~~~~~~~f~~e~~~~~~------------------------ 376 (411)
+|.-...||+|+||.||+|...+ +. .+++|.+... .....+.|..|+.++.+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 44455789999999999998843 33 4788888643 23345679999988865
Q ss_pred ---------cccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------ANLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------~~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ....++|.+..+|+.++++||+|||+.
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~ 138 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK 138 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1121110 012488899999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=98.20 E-value=4.6e-06 Score=76.17 Aligned_cols=84 Identities=18% Similarity=0.157 Sum_probs=60.9
Q ss_pred CCcCCeeeccCCceEEEEEecC-CCEEEEEEEeccc-chhhHhHHHHHHHHHH------------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------~~l 379 (411)
|.-.+.||+|++|.||+|...+ ++.||||++.... .....++..|+.++.+ +++
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 3344899999999999999854 8899999985432 2334567777776654 122
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.... ...+++|..+.+|+.++++||+|||+
T Consensus 97 ~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 132 (296)
T cd06618 97 STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132 (296)
T ss_pred CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1100 12358999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2e-06 Score=84.91 Aligned_cols=81 Identities=16% Similarity=0.246 Sum_probs=65.0
Q ss_pred CCeeeccCCceEEEEEecCC-CEEEEEEEecccchhhHhHHHHHHHHHH-------------------------------
Q 015202 329 NNIIGRGGIGSIYKARIQDG-MEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~-~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------------- 376 (411)
++.|++|||+.||.+....+ ..+|+||+-.......+...+||.+|..
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 48999999999999998666 8999999855566778899999999998
Q ss_pred ---------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++..+. ...|+-...++|.-|+++|+++||.+
T Consensus 122 EyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~~ 163 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHYL 163 (738)
T ss_pred hhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhcC
Confidence 2222111 12377788999999999999999974
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.7e-06 Score=78.93 Aligned_cols=81 Identities=16% Similarity=0.115 Sum_probs=59.1
Q ss_pred Ceeecc--CCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 330 NIIGRG--GIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g--~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
.+||+| +||.||++.. ++|..||||+++... ....+.+..|++++.. +|...
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 679999 6789999987 568899999995432 2223557778887775 22211
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++|....+|+.|+++||+|||+.
T Consensus 84 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 120 (327)
T cd08227 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120 (327)
T ss_pred CcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 123489999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.5e-06 Score=79.68 Aligned_cols=89 Identities=12% Similarity=0.149 Sum_probs=65.1
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------cccC--------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------ANLL-------- 380 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------~~l~-------- 380 (411)
..++|...+.||+|+||.||+|.. .+|..||||++... .......+.+|+.++.+ +...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 455676778999999999999985 46889999998432 22234568899998886 0000
Q ss_pred ----------CCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 ----------TRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ----------~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....++|.....|+.++++||+|||+.
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 137 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA 137 (343)
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 000 123588999999999999999999974
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.6e-06 Score=75.34 Aligned_cols=79 Identities=14% Similarity=0.165 Sum_probs=57.7
Q ss_pred eeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 332 IGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 332 lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
||+|+||.||++.. .+|+.+|+|++.... ......+..|++++.+ +|..+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999987 458899999985322 1223456678888887 2222111
Q ss_pred -------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.+...++.+++.||+|||+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 114 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM 114 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123488999999999999999999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.19 E-value=8.4e-08 Score=83.06 Aligned_cols=136 Identities=18% Similarity=0.121 Sum_probs=87.5
Q ss_pred hcccCCcCCceeecCcccccccchhhhCCCCCCeeecccC-cccccCc-hhhhccccCCeeeecCCcccccCCcc-ccC-
Q 015202 13 EINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDN-QLEGSIP-YDLCRLAALFQLDLGDNKLSGFVPSC-FGN- 88 (411)
Q Consensus 13 ~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~- 88 (411)
-+..|.+|+.|+|.++++...+...+++-.+|+.|+|+.+ .++..-. --+..|..|.+|+|+.|.+....-.. +.+
T Consensus 205 iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V~hi 284 (419)
T KOG2120|consen 205 ILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVAVAHI 284 (419)
T ss_pred HHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHHHhhh
Confidence 3567889999999999999888888999999999999986 3542211 23577999999999999876432111 222
Q ss_pred CccCCeeecccccCC----ccCccccCCCCCcEEEcCCCe-eeecCCCCccCccCCCeEEccCCe
Q 015202 89 LTNLRKLYLGSNQLT----YIPLTLWNLKYILYLNLSSNS-FTIPLPSEIGNLEVLVQIDLSMNN 148 (411)
Q Consensus 89 l~~L~~L~l~~n~l~----~~p~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~ 148 (411)
-++|+.|+++++.-. .+..-...+++|.+|||++|. ++...-..|.+++.|++|.++.|.
T Consensus 285 se~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY 349 (419)
T KOG2120|consen 285 SETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCY 349 (419)
T ss_pred chhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhc
Confidence 257888888876321 222222357777777777653 221122233444555555555443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.2e-06 Score=75.19 Aligned_cols=81 Identities=21% Similarity=0.251 Sum_probs=58.8
Q ss_pred CeeeccCCceEEEEEecC------CCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------c--
Q 015202 330 NIIGRGGIGSIYKARIQD------GMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------A-- 377 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~------~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~-- 377 (411)
+.||+|+||.||+|...+ +..||||++...... ....|..|+.++.. +
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcC
Confidence 689999999999998632 467999999644332 34678899988775 1
Q ss_pred -------ccCCC-------------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 -------NLLTR-------------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 -------~l~~~-------------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++... .....++|..+.+++.++++||+|||+.
T Consensus 91 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~ 143 (283)
T cd05091 91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH 143 (283)
T ss_pred CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 11100 0112488899999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.6e-06 Score=80.41 Aligned_cols=95 Identities=13% Similarity=0.100 Sum_probs=67.2
Q ss_pred HHHHHHHhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH---------------
Q 015202 316 YLELFHATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD--------------- 376 (411)
Q Consensus 316 ~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~--------------- 376 (411)
..++....++|...+.||+|+||.||++... +++.+|+|.+.... ......|..|+.++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3444555677777899999999999999874 57789999985321 2234568888888876
Q ss_pred --------cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++......++.++++||+|||+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 161 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222111 112366777788999999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.6e-06 Score=76.37 Aligned_cols=80 Identities=18% Similarity=0.176 Sum_probs=57.7
Q ss_pred CCeeeccCCceEEEEEec---CCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------cccC
Q 015202 329 NNIIGRGGIGSIYKARIQ---DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------ANLL 380 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------~~l~ 380 (411)
...||+|+||.||+|... ++..+|+|.+.... ....+.+|++++.+ ++..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999863 45789999985332 23467889988887 1100
Q ss_pred ----------CC----CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 ----------TR----EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ----------~~----~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. .....+++.....|+.|+++||.|||+.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 127 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 00 0112477888899999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.1e-06 Score=80.33 Aligned_cols=82 Identities=22% Similarity=0.248 Sum_probs=64.4
Q ss_pred CcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc---cchhhHhHHHHHHHHHH--------------------------
Q 015202 327 SANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ---YREAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~---~~~~~~~f~~e~~~~~~-------------------------- 376 (411)
...+.||+|||+.||.++- ..|..||+|++... .....+...+||++-.+
T Consensus 21 ~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 21 KRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence 3458999999999999986 88999999999542 23346779999998887
Q ss_pred -----cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..|+. ...+++.+.-..+..||..||.|||+.
T Consensus 101 ~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 101 HRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred CCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 11222 234688888888999999999999974
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.1e-06 Score=74.88 Aligned_cols=85 Identities=18% Similarity=0.230 Sum_probs=64.1
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|...+.+|.|++|.||+|... +++.||+|.+.... .....+|.+|+.++.. ++..
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 444578999999999999874 57889999985433 3345678999988876 2222
Q ss_pred CCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ...+++|.....++.+++.||.|||+.
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~ 117 (274)
T cd06609 83 GGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117 (274)
T ss_pred CCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 211 123689999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.1e-06 Score=74.72 Aligned_cols=83 Identities=19% Similarity=0.204 Sum_probs=60.2
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---h-------hhHhHHHHHHHHHH--------------------
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---E-------AFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~-------~~~~f~~e~~~~~~-------------------- 376 (411)
..+.||+|++|.||+|.. .+|+.||||.++.... . ..+.|.+|+.++..
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 457899999999999976 4688999998743211 0 12467888888776
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ...++++..+..|+.++++||.|||+.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 127 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127 (272)
T ss_pred EEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 2221111 113588999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=98.19 E-value=4e-06 Score=76.31 Aligned_cols=85 Identities=19% Similarity=0.253 Sum_probs=60.7
Q ss_pred CCcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
|.-.+.||+|+||.||+|+.. ....||+|.+.... ....++|.+|+.++..
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 334578999999999999852 22468888875433 3345679999998886
Q ss_pred ----------cccCCC---------------------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTR---------------------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~---------------------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++... ....+++|.+.+.++.++++||+|||+.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 146 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM 146 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 111110 0113488999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.4e-06 Score=77.78 Aligned_cols=85 Identities=20% Similarity=0.205 Sum_probs=63.1
Q ss_pred CCcCCeeeccCCceEEEEEec------CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------- 376 (411)
|.-.+.||+|+||.||+|... ++..+++|.+........+.|.+|++++.+
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 344478999999999999742 345689999866555556789999998887
Q ss_pred ccc---------CCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANL---------LTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l---------~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|. +... ....++|.++++|+.+++.||+|||+.
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 142 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ 142 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 222 1110 012389999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.6e-06 Score=74.27 Aligned_cols=84 Identities=12% Similarity=0.142 Sum_probs=62.7
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
|.-.+.||+|+||.||+|...++..+|+|.+.... ....+|..|++++.+ ++..+.
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 33347899999999999998767899999885332 234579999998886 222111
Q ss_pred C-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....++|.....++.++++||+|||+.
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 119 (256)
T cd05112 85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1 123478999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-06 Score=82.50 Aligned_cols=81 Identities=14% Similarity=0.055 Sum_probs=60.5
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
.+|.-...||+|+||.||+++.. .++.||||... ...+.+|++++.+ ++.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 34666688999999999999985 46789999642 2346789988887 111
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... ....++|.++.+|+.++++||+|||+.
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 279 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE 279 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1100 123599999999999999999999974
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.7e-06 Score=74.63 Aligned_cols=85 Identities=14% Similarity=0.251 Sum_probs=62.8
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH--------------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD--------------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~--------------------------~ 377 (411)
|...+.||+|+||.||+|.. .+|..||||.+.... .....++.+|+.++.+ +
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 34457899999999999997 567899999985432 3334678888887665 2
Q ss_pred ccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ...+++|.....++.++++||.|||+.
T Consensus 83 ~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~ 120 (277)
T cd06917 83 YAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV 120 (277)
T ss_pred cCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 222211 123589999999999999999999974
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.2e-06 Score=77.93 Aligned_cols=88 Identities=14% Similarity=0.167 Sum_probs=64.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH------------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------ 376 (411)
+++|.-.+.||+|+||.||+|.. .+|+.||||++.... ......+..|+.++.+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 35566678999999999999986 468899999985432 2334668889888886
Q ss_pred ----cccCCCC----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTRE----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.+.. ....+++.....++.++++||+|||+.
T Consensus 84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~ 125 (336)
T cd07849 84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA 125 (336)
T ss_pred EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111000 123488888999999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.2e-06 Score=74.72 Aligned_cols=81 Identities=20% Similarity=0.220 Sum_probs=62.4
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
.+.||+|++|.||+|.. .+|..||||++.... ......|.+|+.++.+ ++. +.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 47899999999999987 468899999985443 2234679999998876 222 11
Q ss_pred C-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ...++++.++.+++.+|++||+|||+.
T Consensus 84 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 118 (286)
T cd07832 84 DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118 (286)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1 124589999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.8e-06 Score=87.06 Aligned_cols=86 Identities=17% Similarity=0.157 Sum_probs=63.3
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|...++||+|+||.||+|+.. .|+.||||++.... ....+.|.+|++++++ +
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 4555689999999999999864 57899999985432 2234679999999887 1
Q ss_pred ccCCCC-----------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-----------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-----------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. .....+|.+.++|+.+|++||+|||+.
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~ 132 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK 132 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC
Confidence 211110 012367788899999999999999974
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.8e-06 Score=77.04 Aligned_cols=86 Identities=22% Similarity=0.399 Sum_probs=60.7
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCC--EEEEEEEeccc-chhhHhHHHHHHHHHH------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGM--EVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~--~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------ 376 (411)
+|.-.+.||+|+||.||+|... +|. .+|+|++.... ......|.+|++++.+
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 3444588999999999999974 444 45788775432 3345678999988766
Q ss_pred cc---------cCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 AN---------LLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~---------l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+| ++... ....+++.+.+.++.++++||+|||+.
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 143 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 143 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 12 11110 012478999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.5e-06 Score=74.72 Aligned_cols=85 Identities=22% Similarity=0.220 Sum_probs=63.9
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
+...+.||+|++|.||+|.. .++..+++|++........+.+.+|+.++.. ++..+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 33447999999999999986 4678999999865544455678899988876 12211
Q ss_pred CC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.....++.+++.||+|||+.
T Consensus 101 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~ 134 (285)
T cd06648 101 GALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134 (285)
T ss_pred CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 113478889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=98.17 E-value=1e-05 Score=71.54 Aligned_cols=85 Identities=28% Similarity=0.350 Sum_probs=65.8
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
|...+.||+|++|.||++... ++..+++|++..........+.+|++++.+ ++..+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 445588999999999999985 678999999965544456789999998887 22221
Q ss_pred CC------C-CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------D-KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~-~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. . ...++|..+..++.++++||.|||+.
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 117 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC
Confidence 11 1 13589999999999999999999973
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.3e-06 Score=78.67 Aligned_cols=88 Identities=15% Similarity=0.088 Sum_probs=63.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------c------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------A------------ 377 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------~------------ 377 (411)
.++|...+.||+|+||.||++.- ..|..||||++... .......+.+|+.++.. +
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 35566678999999999999986 45789999998532 22335678899988876 1
Q ss_pred -------ccCCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 -------NLLTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 -------~l~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|+.... ....+++.+...++.++++||+|||+.
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 142 (359)
T cd07876 100 DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA 142 (359)
T ss_pred eeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111000 011367788889999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.4e-06 Score=75.69 Aligned_cols=84 Identities=20% Similarity=0.142 Sum_probs=61.7
Q ss_pred CcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cccC
Q 015202 327 SANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
...+.||+|+||.||+|.. .+|..||+|++.... ......+.+|+.++.+ +|..
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 3447899999999999987 468899999985432 1223567889988876 2221
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.....++.+|++||.|||+.
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 118 (284)
T cd07839 83 QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118 (284)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 100 123489999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.8e-06 Score=76.56 Aligned_cols=81 Identities=15% Similarity=0.267 Sum_probs=58.2
Q ss_pred CeeeccCCceEEEEEe----cCCCEEEEEEEeccc----chhhHhHHHHHHHHHH-----------------------cc
Q 015202 330 NIIGRGGIGSIYKARI----QDGMEVAVKVFDLQY----REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l----~~~~~vavk~l~~~~----~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+.||+|+||.||++.. ..++.||||.+.... ......+..|++++.. +|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357889999985432 1223567889988887 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+.+.....++.++++||+|||+.
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22211 122367777888999999999999974
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.9e-06 Score=77.96 Aligned_cols=85 Identities=16% Similarity=0.194 Sum_probs=61.1
Q ss_pred CCcCCeeeccCCceEEEEEec--------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH--------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ--------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~--------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-------------------- 376 (411)
|.-.+.||+|+||.||++... ++..+|+|.+.... .....++..|++++.+
T Consensus 20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 444589999999999999752 23469999986432 3345678889987775
Q ss_pred -------------cccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------------ANLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------------~~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ....++|.++++|+.+++.||+|||++
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 159 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK 159 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1222111 012489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.3e-06 Score=75.77 Aligned_cols=83 Identities=22% Similarity=0.187 Sum_probs=62.0
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE 383 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~ 383 (411)
..+.||+|+||.||+|.. .++..||+|.++.........+.+|+.++.. +|..+..
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS 92 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence 337899999999999986 4578899999865544445668888888775 2221111
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.+...++.+++.||.|||+.
T Consensus 93 L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 125 (267)
T cd06645 93 LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123488899999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.6e-06 Score=75.47 Aligned_cols=81 Identities=25% Similarity=0.257 Sum_probs=62.3
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC--
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE-- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~-- 383 (411)
..||+|+||.||+|.. .+|..||||++..........|.+|+.++.. +|..+..
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999987 4688999999865444456679999988876 2222211
Q ss_pred ---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.....++.+++.||+|||+.
T Consensus 106 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~ 135 (292)
T cd06657 106 DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123478999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=98.17 E-value=5e-06 Score=75.46 Aligned_cols=85 Identities=20% Similarity=0.158 Sum_probs=58.1
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH--------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-------------------------- 376 (411)
|...+.||+|+||.||+|... +|+.||+|.+..... .....+..|+.++.+
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 334578999999999999874 578999998854321 123456667665543
Q ss_pred -----cccCC-------CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLT-------REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~-------~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.. ......+++.....++.+++.||.|||+.
T Consensus 82 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 127 (288)
T cd07863 82 VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127 (288)
T ss_pred EEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11110 00112378889999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.9e-06 Score=76.12 Aligned_cols=86 Identities=16% Similarity=0.215 Sum_probs=64.0
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+|.-.+.||+|++|.||+|... +++.||||+++... ......|.+|++++.+ +|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 3445578999999999999885 57889999885432 2335679999998886 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..... ....+++.+...++.+|++||.|||+.
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 119 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22111 123488999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.2e-06 Score=77.18 Aligned_cols=86 Identities=14% Similarity=0.237 Sum_probs=61.5
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||++... .+..+|+|.+.... ......|..|+.++.. +
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 4555689999999999999985 46789999985321 2223458888887765 2
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.+++.||.|||+.
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~ 121 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222111 123478888889999999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=98.16 E-value=7.9e-06 Score=72.71 Aligned_cols=82 Identities=20% Similarity=0.318 Sum_probs=62.2
Q ss_pred CCeeeccCCceEEEEEecC-----CCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------ccc
Q 015202 329 NNIIGRGGIGSIYKARIQD-----GMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~-----~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~~l 379 (411)
.+.||+|+||.||++...+ +..||+|.+...... ..+.|..|++++.+ ++.
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 3789999999999999843 378999999655433 56789999998876 222
Q ss_pred CCCC------C-CCC-CCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------D-KHF-MTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~-~~~-l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. . ... ++|.++..++.+++.||+|||+.
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~ 122 (258)
T smart00219 84 EGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122 (258)
T ss_pred CCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC
Confidence 2211 1 112 89999999999999999999974
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.3e-06 Score=76.91 Aligned_cols=86 Identities=17% Similarity=0.170 Sum_probs=62.6
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~------------------------- 376 (411)
+|...+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++.+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4455588999999999999985 578899999854332 223457788888876
Q ss_pred cccCCC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+... .....+++.....|+.++++||+|||++
T Consensus 86 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 125 (293)
T cd07843 86 EYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125 (293)
T ss_pred hhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 122110 0122489999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.3e-06 Score=73.73 Aligned_cols=85 Identities=19% Similarity=0.258 Sum_probs=64.2
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|...+.||+|++|.||++... ++..+++|++..... ....++..|++++.. ++.
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 444578999999999999984 578999999854432 445678899988776 222
Q ss_pred CCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. .+..+++.+..+|+.++++||.|||+.
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 122 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111 124589999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.2e-06 Score=73.69 Aligned_cols=79 Identities=14% Similarity=0.184 Sum_probs=59.4
Q ss_pred eeccCCceEEEEEecC-CCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 332 IGRGGIGSIYKARIQD-GMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 332 lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
||+|+||.||+++..+ |..+++|.+..... .....+.+|++++.+ ++..+..
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999999864 88999999854332 335678888887775 2332211
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++..+.+|+.++++||+|||++
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~ 112 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN 112 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 113589999999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.8e-06 Score=69.73 Aligned_cols=105 Identities=23% Similarity=0.165 Sum_probs=60.8
Q ss_pred ccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCcccc-CCCCCcEEEcCCCeeeecC-CCCccCccCCCeEE
Q 015202 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILYLNLSSNSFTIPL-PSEIGNLEVLVQID 143 (411)
Q Consensus 66 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~-~~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~ 143 (411)
.+...+||++|.+... +.|..++.|.+|.+.+|+|+.+...+. .+++|+.|.+.+|++.... -..+..++.|++|.
T Consensus 42 d~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Lt 119 (233)
T KOG1644|consen 42 DQFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLT 119 (233)
T ss_pred cccceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceee
Confidence 3455666666666522 445666666666666666666655555 3455666666666655211 11244556677777
Q ss_pred ccCCeecccCC---CCccCCCccCeeeccccc
Q 015202 144 LSMNNFSGAIP---TTIGGLKDLQYLFLEYNR 172 (411)
Q Consensus 144 l~~n~~~~~~~---~~~~~~~~L~~L~l~~n~ 172 (411)
+-+|..+..-- ..+..+++|+.||+..-.
T Consensus 120 ll~Npv~~k~~YR~yvl~klp~l~~LDF~kVt 151 (233)
T KOG1644|consen 120 LLGNPVEHKKNYRLYVLYKLPSLRTLDFQKVT 151 (233)
T ss_pred ecCCchhcccCceeEEEEecCcceEeehhhhh
Confidence 77776653211 234567888888876543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.15 E-value=8.2e-06 Score=73.08 Aligned_cols=86 Identities=15% Similarity=0.263 Sum_probs=62.7
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc-----cchhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ-----YREAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~-----~~~~~~~f~~e~~~~~~---------------------- 376 (411)
+|.-.+.||+|+||.||+|.. .+|..||+|.+... ..+....|.+|++++.+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 455668999999999999986 45889999987421 12334678999998887
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ...++++....+++.+++.||.|||++
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~ 125 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 112477888899999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.4e-06 Score=83.95 Aligned_cols=85 Identities=19% Similarity=0.295 Sum_probs=66.0
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc-cchhhHhHHHHHHHHHH---------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ-YREAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~-~~~~~~~f~~e~~~~~~--------------------------- 376 (411)
|-..+.+|+|+||.||+|+- ..|..||||.++.. .......+..|++++.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 33457899999999999984 56899999999553 34456779999999998
Q ss_pred -----------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..|.+......|+-..-+.+..+++.||.|||||
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn 139 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN 139 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 2222222233488888999999999999999986
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.8e-06 Score=75.46 Aligned_cols=83 Identities=20% Similarity=0.148 Sum_probs=59.1
Q ss_pred cCCeeeccCCceEEEEEecC-CCEEEEEEEeccc--chhhHhHHHHHHHHHH----------------------------
Q 015202 328 ANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQY--REAFKSFDNEFMTVVD---------------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~--~~~~~~f~~e~~~~~~---------------------------- 376 (411)
..+.||+|+||.||+|.... +..+|+|++.... ......+.+|+.++.+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 34789999999999999854 8899999985322 2223457778766543
Q ss_pred ---cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....++|.+..+++.++|+||.|||+.
T Consensus 83 l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~ 126 (287)
T cd07838 83 LVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH 126 (287)
T ss_pred EEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111100 112489999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.1e-06 Score=79.52 Aligned_cols=83 Identities=12% Similarity=0.096 Sum_probs=59.8
Q ss_pred HhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------c
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
...+|...+.||+|+||.||+|... .+..||+|..... ....|+.++.+ +
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3456777789999999999999974 4568899875322 23457777765 1
Q ss_pred ccCCC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.... ....+++|..+.+|+.+||+||.|||+.
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 176 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11110 0134589999999999999999999974
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.5e-06 Score=79.33 Aligned_cols=81 Identities=14% Similarity=0.025 Sum_probs=61.1
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
.+|...+.||+|+||.||++.- ..++.||+|... ...+.+|++++.+ +++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 4566678999999999999976 457889999753 2357889999887 111
Q ss_pred CCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... ....++|...+.|+.++++||+|||+.
T Consensus 166 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~ 201 (391)
T PHA03212 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN 201 (391)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1100 123588999999999999999999974
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.8e-06 Score=74.34 Aligned_cols=81 Identities=22% Similarity=0.408 Sum_probs=58.1
Q ss_pred CeeeccCCceEEEEEecC-CC--EEEEEEEeccc-chhhHhHHHHHHHHHH------------------------cc---
Q 015202 330 NIIGRGGIGSIYKARIQD-GM--EVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------AN--- 378 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~-~~--~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------~~--- 378 (411)
++||+|+||.||+|...+ |. .+|+|.+.... ....+.|.+|++++.+ +|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999843 33 46888885432 3345679999988875 11
Q ss_pred ------cCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 ------LLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 ------l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++... ....++|.++.+++.+++.||+|||+.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~ 131 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 131 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11110 012378999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=98.14 E-value=6.4e-06 Score=75.38 Aligned_cols=85 Identities=19% Similarity=0.152 Sum_probs=62.4
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++.+ +|..
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 445578999999999999874 57889999985433 2234567889988886 2221
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ....+++.....++.++++||+|||+.
T Consensus 88 ~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~ 123 (301)
T cd07873 88 KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123 (301)
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 100 123478888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.7e-06 Score=76.81 Aligned_cols=85 Identities=8% Similarity=-0.049 Sum_probs=59.0
Q ss_pred HhcCCCcCCeeeccCCceEEEEEec--CCCEEEEEEEecc-----cchhhHhHHHHHHHHHH------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQ--DGMEVAVKVFDLQ-----YREAFKSFDNEFMTVVD------------------ 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~--~~~~vavk~l~~~-----~~~~~~~f~~e~~~~~~------------------ 376 (411)
.-++|...+.||+|+||.||+|... +++.||||++... .....+.|.+|++++.+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~L 95 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGL 95 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEE
Confidence 3456777799999999999999874 5777899987432 11234569999999987
Q ss_pred --cccCCCCCCCCCCHH---HHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTREDKHFMTKE---QRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~~~~~l~w~---~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+. +..|... ....++.++++||+|||+.
T Consensus 96 VmE~~~----G~~L~~~~~~~~~~~~~~i~~aL~~lH~~ 130 (365)
T PRK09188 96 VRGWTE----GVPLHLARPHGDPAWFRSAHRALRDLHRA 130 (365)
T ss_pred EEEccC----CCCHHHhCccchHHHHHHHHHHHHHHHHC
Confidence 2221 1112111 1256788999999999974
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.4e-06 Score=75.09 Aligned_cols=81 Identities=15% Similarity=0.074 Sum_probs=54.7
Q ss_pred CeeeccCCceEEEEEecCCC---EEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cc----
Q 015202 330 NIIGRGGIGSIYKARIQDGM---EVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------AN---- 378 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~---~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~---- 378 (411)
++||+|+||.||+|...++. .+++|.+.... ....+.|.+|+.++.. +|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36899999999999864433 45677765433 3345789999887775 22
Q ss_pred -----cCCCC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 -----LLTRE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 -----l~~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++... .....++....+++.+||+||+|||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~ 118 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 21111 112355566788999999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=98.14 E-value=6.9e-06 Score=73.14 Aligned_cols=85 Identities=14% Similarity=0.183 Sum_probs=63.4
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|...++||+|+||.||.+.- .++..+++|.+... .....++|.+|+.++.+ +|.
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 44458999999998888765 46788999998543 23445779999999987 222
Q ss_pred CCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++.++..++.++++||+|||++
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2111 123588999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=98.14 E-value=7.4e-06 Score=73.04 Aligned_cols=85 Identities=18% Similarity=0.252 Sum_probs=63.8
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|.-.+.||+|+||.||++... .+..||+|.+.... ....+.+.+|++++.+ ++
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 444578999999999999874 47899999985322 2345789999988876 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ...++++.+...|+.++++||.|||++
T Consensus 82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 119 (258)
T cd05578 82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119 (258)
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 22211 123588889999999999999999974
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.6e-06 Score=53.73 Aligned_cols=36 Identities=36% Similarity=0.584 Sum_probs=15.9
Q ss_pred CCCeeecccCcccccCchhhhccccCCeeeecCCccc
Q 015202 43 KLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 43 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 79 (411)
+|++|++++|+++. +|+.+.+|++|++|++++|+++
T Consensus 2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCC
Confidence 44555555555442 2333444555555555555444
|
... |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.9e-06 Score=77.45 Aligned_cols=81 Identities=21% Similarity=0.341 Sum_probs=59.1
Q ss_pred CeeeccCCceEEEEEecC-------CCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------------
Q 015202 330 NIIGRGGIGSIYKARIQD-------GMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~-------~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------- 376 (411)
+.||+|+||.||+|...+ +..+|||.+.... .....+|.+|+.++.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998732 2478999874432 2345689999998887
Q ss_pred -------cccCCCC----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------ANLLTRE----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------~~l~~~~----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ....++|.+++.++.++++||.|||+.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM 125 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC
Confidence 2222111 112378999999999999999999974
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=98.14 E-value=7.5e-06 Score=75.72 Aligned_cols=81 Identities=17% Similarity=0.206 Sum_probs=55.5
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
++||+|+||.||+|+. .+|..||+|.+.... ......+..|...+.+ +|..+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 467899999985432 2223456666654332 22222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++..+...++.+|++||+|||+.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 115 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 122366777788999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=98.13 E-value=8e-06 Score=74.90 Aligned_cols=86 Identities=13% Similarity=0.131 Sum_probs=64.1
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|...+.||+|+||.||++... .+..||+|.+.... ......+.+|++++.. +
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 4556689999999999999873 56789999985443 2234678899988876 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....++|.....++.++++||.|||+.
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 120 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123588898999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=98.13 E-value=5e-06 Score=78.07 Aligned_cols=88 Identities=13% Similarity=0.079 Sum_probs=62.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------c------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------A------------ 377 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~------------ 377 (411)
.++|...+.||+|+||.||++.- ..+..||||++.... ......+.+|+.++.. +
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 45676778999999999999975 357889999985432 2334678888888775 0
Q ss_pred -------ccCCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 -------NLLTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 -------~l~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... ....+++.+...++.++++||+|||+.
T Consensus 96 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 138 (355)
T cd07874 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138 (355)
T ss_pred eeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 000000 011367888889999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.2e-06 Score=78.06 Aligned_cols=35 Identities=31% Similarity=0.562 Sum_probs=28.4
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY 360 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~ 360 (411)
+...+++|.|+||.||+|.+. .+..||||+.....
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~ 61 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK 61 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC
Confidence 345589999999999999984 46889999985443
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=98.13 E-value=7.5e-06 Score=73.95 Aligned_cols=84 Identities=15% Similarity=0.210 Sum_probs=63.3
Q ss_pred CcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 327 SANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
...+.||+|+||.||+|... .+..||+|.+.... ......|.+|+.++.+ +|..+
T Consensus 7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 34478999999999999874 57889999986433 3445789999998886 23322
Q ss_pred CC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ...++++.+...++.++++||+|||++
T Consensus 87 ~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~ 120 (277)
T cd06640 87 GSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120 (277)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 123478888999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=98.13 E-value=6e-06 Score=77.81 Aligned_cols=88 Identities=13% Similarity=0.050 Sum_probs=62.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------------------- 376 (411)
.++|...+.||+|+||.||++.- ..+..||||++... .....+.+.+|+.++..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 35666678999999999999985 35788999998542 22334678889888776
Q ss_pred ------cccCCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.... -...+++.+...++.++++||+|||+.
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 145 (364)
T cd07875 103 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145 (364)
T ss_pred eEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC
Confidence 0000000 011367888899999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.8e-06 Score=77.01 Aligned_cols=96 Identities=15% Similarity=0.179 Sum_probs=68.5
Q ss_pred ccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------
Q 015202 314 FTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------- 376 (411)
Q Consensus 314 ~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------- 376 (411)
+.++.+..++++|.-...||+|+||.||++.. ..+..+|+|.+.... ....++.+|+.++.+
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 45566677888888889999999999999987 457889999875422 223567778776654
Q ss_pred -------------cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------------ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------------~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.++++||.|||+.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 143 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC
Confidence 1111100 112467777888999999999999963
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.13 E-value=4e-06 Score=75.64 Aligned_cols=86 Identities=16% Similarity=0.163 Sum_probs=62.2
Q ss_pred CCCcCCeeeccCCceEEEEEecC------CCEEEEEEEeccc-chhhHhHHHHHHHHHH---------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD------GMEVAVKVFDLQY-REAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~------~~~vavk~l~~~~-~~~~~~f~~e~~~~~~--------------------- 376 (411)
+|.-.+.||+|+||.||+|...+ +..||+|.+.... .....+|.+|+.++..
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 34445889999999999998732 3579999985443 2345679999998876
Q ss_pred --cc---------cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --AN---------LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~---------l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++ +.... ....++|.+.+.|+.+++.||.|||+.
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 138 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK 138 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 12 11111 112378999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.1e-06 Score=76.34 Aligned_cols=88 Identities=20% Similarity=0.184 Sum_probs=63.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~----------------------- 376 (411)
.++|...+.||+|+||.||+|.. .+|..||+|++..... .....+.+|+.++.+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 34566678999999999999987 4588999999854322 123456788888876
Q ss_pred --cccCCC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... .....++|.+...++.++++||+|||+.
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 127 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111100 0123489999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.4e-06 Score=73.57 Aligned_cols=83 Identities=16% Similarity=0.231 Sum_probs=61.4
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-------------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD-------------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~-------------------------~ 377 (411)
|.-.+.+|.|+||.||++.. .+|..||+|.+... .....+.+..|+.++.+ +
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 33447899999999999986 46788999988532 23345678899988876 1
Q ss_pred ccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccC
Q 015202 378 NLLTRE----------DKHFMTKEQRVSFVFNLAMECTVES 408 (411)
Q Consensus 378 ~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh 408 (411)
|..+.. ...+++|.....++.++++||+|||
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 122 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 111110 1245889999999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.12 E-value=1e-05 Score=72.31 Aligned_cols=87 Identities=14% Similarity=0.245 Sum_probs=63.9
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-----chhhHhHHHHHHHHHH---------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-----REAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-----~~~~~~f~~e~~~~~~--------------------- 376 (411)
++|...+.||+|++|.||++.. .++..||+|.+.... ....+.+.+|++++.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4677779999999999999986 467899999884322 1224578899998876
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++....+++.++++||+|||++
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 123 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222111 122477788899999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=98.12 E-value=9.7e-06 Score=73.38 Aligned_cols=96 Identities=15% Similarity=0.171 Sum_probs=68.8
Q ss_pred ccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------
Q 015202 314 FTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------- 376 (411)
Q Consensus 314 ~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------- 376 (411)
.++.++..+.+.|.-...+|+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.+
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 35566666777787778999999999999987 457889999885432 234567788777665
Q ss_pred --------------cccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------ANLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------~~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..... ....+++.....++.++++||.|||+.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 140 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111100 112367777889999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.3e-05 Score=71.11 Aligned_cols=85 Identities=21% Similarity=0.266 Sum_probs=64.1
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|.-...||+|++|.||+|... ++..+++|.+..... .....|.+|++++.+ ++.
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 334578999999999999874 578899999855433 345789999998886 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|..+..++.+++.||.|||+.
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 118 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 1111 113589999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=98.11 E-value=8.2e-06 Score=74.11 Aligned_cols=80 Identities=18% Similarity=0.120 Sum_probs=59.4
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH------------------------cccCCC-
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------ANLLTR- 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------~~l~~~- 382 (411)
..||+|+||.||++.. .+|+.||+|++.... ......|..|+.++.+ ++....
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l 89 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISL 89 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCH
Confidence 6899999999999987 357899999985433 2345678999988876 111000
Q ss_pred ---------CCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 383 ---------EDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 383 ---------~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.....+++....+++.++++||+|||+
T Consensus 90 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~ 125 (288)
T cd06616 90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125 (288)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 012347888889999999999999996
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.6e-06 Score=82.38 Aligned_cols=84 Identities=13% Similarity=0.180 Sum_probs=64.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEecC-CCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------- 376 (411)
.-++...+++|-|-||.||.|+|.. .-.||||.++.... ...+|..|..+|..
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3344455899999999999999943 56799999966543 35799999999997
Q ss_pred -------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccC
Q 015202 377 -------ANLLTREDKHFMTKEQRVSFVFNLAMECTVES 408 (411)
Q Consensus 377 -------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh 408 (411)
+||++.. ...++---.+.||-||+.||+||.
T Consensus 345 M~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLE 382 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLE 382 (1157)
T ss_pred ccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHH
Confidence 6666554 223554557899999999999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.3e-05 Score=71.93 Aligned_cols=84 Identities=14% Similarity=0.257 Sum_probs=60.2
Q ss_pred CCcCCeeeccCCceEEEEEecC--CCEEEEEEEeccc----------chhhHhHHHHHHHHHH-----------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQD--GMEVAVKVFDLQY----------REAFKSFDNEFMTVVD----------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~--~~~vavk~l~~~~----------~~~~~~f~~e~~~~~~----------------- 376 (411)
|.-.+.||+|+||.||+|...+ +..+|||.+.... .....++.+|+.++.+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4445789999999999999854 6789999874221 1223567888887764
Q ss_pred -------cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 -------ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 -------~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|+.+.. ....+++..+.+++.++++||.|||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 131 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK 131 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc
Confidence 2222111 12348888999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.9e-06 Score=67.85 Aligned_cols=103 Identities=21% Similarity=0.160 Sum_probs=54.2
Q ss_pred CcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccC-CccccCCCCCCEEeCC
Q 015202 115 ILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI-PDFIGGLINLKSLDLS 193 (411)
Q Consensus 115 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~L~l~ 193 (411)
...+||++|.+. .-..|..++.|.+|.+.+|+|+.+.|.--.-+++|+.|.|.+|++...- -+-+..+|.|++|.+-
T Consensus 44 ~d~iDLtdNdl~--~l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltll 121 (233)
T KOG1644|consen 44 FDAIDLTDNDLR--KLDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTLL 121 (233)
T ss_pred cceecccccchh--hcccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeeec
Confidence 344455555443 1123444555555556666555554443334455666666666655311 1224566677777777
Q ss_pred CCccccc---cchhhhcCCCCCEEEcccC
Q 015202 194 NNNLSGA---IPISLEKLLDLQHINVSFN 219 (411)
Q Consensus 194 ~n~l~~~---~~~~~~~l~~L~~l~l~~n 219 (411)
+|.++.. --..+..+|+|+.||++.-
T Consensus 122 ~Npv~~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 122 GNPVEHKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred CCchhcccCceeEEEEecCcceEeehhhh
Confidence 7766522 1224556677777776543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.8e-06 Score=74.77 Aligned_cols=86 Identities=21% Similarity=0.174 Sum_probs=63.1
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|.....||+|++|.||+|... +++.||||.+..... .....+.+|++++.+ +|+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4555678999999999999874 678999999854322 223457889998886 232
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... ....+++.....++.++++||.|||+.
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~ 122 (291)
T cd07844 86 DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122 (291)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2100 123578888899999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.10 E-value=7.6e-06 Score=83.17 Aligned_cols=87 Identities=18% Similarity=0.248 Sum_probs=63.8
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||+|... ++..||||++.... ......|..|+.++..
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 34555688999999999999984 57899999985432 2224678888888775
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....+++....+|+.+|++||+|||++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~ 123 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3332211 122478888899999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.8e-06 Score=76.02 Aligned_cols=86 Identities=17% Similarity=0.172 Sum_probs=61.2
Q ss_pred CCCcCCeeeccCCceEEEEEec-----------------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH----------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-----------------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD---------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-----------------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------- 376 (411)
+|.-.+.||+|+||.||++... ++..||||++.... .....+|..|+.++.+
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3444578999999999987532 23468999986443 3345789999998887
Q ss_pred ----------------------cccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------------------ANLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------------------~~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ....++|.+...++.+++.||+|||+.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~ 149 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL 149 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 1121111 012378889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.1e-06 Score=77.61 Aligned_cols=87 Identities=17% Similarity=0.162 Sum_probs=64.8
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------cccC------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------ANLL------------ 380 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------~~l~------------ 380 (411)
++|...+.||+|+||.||+|.- ..|..||+|.+........+.+.+|++++.+ +...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 3455668999999999999987 4578999999865555556778899988876 1000
Q ss_pred -----------C---CC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 -----------T---RE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 -----------~---~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ .. ....+++.....++.++++||.|||+.
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 133 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA 133 (342)
T ss_pred ccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0 00 112478888999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=98.09 E-value=9.6e-06 Score=73.78 Aligned_cols=86 Identities=13% Similarity=0.123 Sum_probs=63.8
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-...||+|++|.||++... +++.||+|.+.... ......+.+|++++.+ +
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 3445578999999999999874 57899999985322 2234678999998887 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++..+..++.++++||.|||+.
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~ 120 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123488889999999999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.2e-05 Score=74.19 Aligned_cols=83 Identities=17% Similarity=0.178 Sum_probs=61.8
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------cccC
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
..+.||+|+||.||+|.. .+|..|++|++..... ...+.+.+|++++.+ +|..
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 346799999999999986 4678899999854322 234578889988887 2221
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ...+++|.++..++.+++.||.|||+.
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 140 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 110 134589999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.9e-06 Score=76.89 Aligned_cols=83 Identities=18% Similarity=0.205 Sum_probs=59.4
Q ss_pred cCCeeeccCCceEEEEEec--------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 328 ANNIIGRGGIGSIYKARIQ--------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~--------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
-.+.||+|+||.||++... .+..||+|.+.... ....++|.+|+.++.+
T Consensus 16 i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (334)
T cd05100 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 95 (334)
T ss_pred ecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEE
Confidence 3478999999999999741 12368999885432 3345789999988865
Q ss_pred -----------cccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----------ANLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----------~~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.... ....++|.++++++.++++||+|||++
T Consensus 96 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~ 153 (334)
T cd05100 96 LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ 153 (334)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1121110 112489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.8e-06 Score=73.97 Aligned_cols=82 Identities=16% Similarity=0.138 Sum_probs=57.9
Q ss_pred CCeeeccCCceEEEEEec-CCCEEEEEEEecccc-hhhHhHHHHHHHHHH------------------------cccCCC
Q 015202 329 NNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD------------------------ANLLTR 382 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~------------------------~~l~~~ 382 (411)
.+.||+|++|.||+|... .+..|+||++..... .....+.+|+..+.+ ++..+.
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGN 83 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCCC
Confidence 478999999999999985 467899999854322 222334556665554 233111
Q ss_pred C-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. .+..++|.+.+.++.++++||.|||++
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~ 118 (283)
T cd07830 84 LYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118 (283)
T ss_pred HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1 123589999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.3e-05 Score=72.99 Aligned_cols=84 Identities=12% Similarity=0.142 Sum_probs=60.5
Q ss_pred CcCCeeeccCCceEEEEEe----cCCCEEEEEEEecccc----hhhHhHHHHHHHHHH----------------------
Q 015202 327 SANNIIGRGGIGSIYKARI----QDGMEVAVKVFDLQYR----EAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l----~~~~~vavk~l~~~~~----~~~~~f~~e~~~~~~---------------------- 376 (411)
.-.+.||+|+||.||.+.. .+|..||+|++..... ...+.+.+|+.++.+
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 3447899999999999875 4688999999854321 224668888888775
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ...++++.+...++.++|+||.|||+.
T Consensus 83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~ 124 (290)
T cd05613 83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124 (290)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222211 123477888888888999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.08 E-value=8.9e-06 Score=75.53 Aligned_cols=79 Identities=16% Similarity=0.222 Sum_probs=54.2
Q ss_pred eeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH--------------------------cccCC
Q 015202 332 IGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD--------------------------ANLLT 381 (411)
Q Consensus 332 lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~--------------------------~~l~~ 381 (411)
||+|+||.||+|.. .+|..||||++.... ......+..|..++.+ +|+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999986 458899999985322 1122345556555542 22222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.....|+.+|++||+|||+.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~ 115 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 123478888899999999999999974
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.5e-05 Score=71.50 Aligned_cols=83 Identities=17% Similarity=0.208 Sum_probs=60.2
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEecccch---------hhHhHHHHHHHHHH---------------------
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYRE---------AFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~---------~~~~f~~e~~~~~~--------------------- 376 (411)
-...||+|++|.||+|.. .++..+|+|.+...... ..+.|..|+.++.+
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 347899999999999986 45788999988433211 12568889888876
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.+++.||+|||++
T Consensus 84 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~ 125 (267)
T cd06628 84 FLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125 (267)
T ss_pred EEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc
Confidence 2222211 123478888999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.8e-06 Score=75.09 Aligned_cols=86 Identities=14% Similarity=0.070 Sum_probs=63.2
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-------------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-------------------------~ 377 (411)
+|...+.||.|++|.||++... .++.+|+|.+.... .....+|.+|++++.+ +
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 4666689999999999999984 57889999985432 2345779999998886 1
Q ss_pred ccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++....+|+.++++||+|||+.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~ 124 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111100 122367777889999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.8e-06 Score=75.70 Aligned_cols=87 Identities=17% Similarity=0.200 Sum_probs=64.2
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------ 376 (411)
++|...+.||+|++|.||+|.. .+|..||+|++.... ....+.+.+|+.++.+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5666678999999999999986 458899999985432 2234667889888875
Q ss_pred ---cccCCC-----CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTR-----EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~-----~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+. .....+++.....++.++++||.|||+.
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 126 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126 (334)
T ss_pred EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111000 0123489999999999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.2e-06 Score=51.82 Aligned_cols=39 Identities=26% Similarity=0.425 Sum_probs=32.4
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCccccc
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGS 57 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 57 (411)
++|++|++++|+|+ .+|+.+.+|++|++|++++|.++..
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i 39 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDI 39 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBE
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCC
Confidence 57999999999999 5566799999999999999998843
|
... |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=98.07 E-value=9.6e-06 Score=72.21 Aligned_cols=83 Identities=18% Similarity=0.294 Sum_probs=61.0
Q ss_pred cCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH------------------------cccC
Q 015202 328 ANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------ANLL 380 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------~~l~ 380 (411)
-.+.||+|++|.||++... +++.||+|++.... ....+.+..|++++.+ ++..
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence 3478999999999999863 56789999985432 2345678889888776 1111
Q ss_pred CCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ...++++.+..+++.+++.|++|||+.
T Consensus 84 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~ 121 (257)
T cd08223 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121 (257)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 123488999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.3e-06 Score=74.34 Aligned_cols=86 Identities=15% Similarity=0.184 Sum_probs=61.7
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+|.....||+|++|.||+|... +|+.||+|++..... .....|.+|++++.+ +|
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 4555688999999999999874 678999998843322 234578899998886 22
Q ss_pred cCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... ......++.....++.++++||+|||+.
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 121 (294)
T PLN00009 83 LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121 (294)
T ss_pred ccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 2110 0112256777788999999999999974
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=98.07 E-value=9.7e-06 Score=72.56 Aligned_cols=84 Identities=14% Similarity=0.069 Sum_probs=62.8
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|.-.+.||+|++|.||++... +++.||+|++.... .....+|.+|++++.+ ++..
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 334478999999999999884 57899999986543 3345679999988876 2222
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+.. ...+++.....+++.++++||+|||+
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 118 (265)
T cd06605 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118 (265)
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC
Confidence 111 11457888889999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.4e-06 Score=72.83 Aligned_cols=85 Identities=18% Similarity=0.241 Sum_probs=62.7
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|.-.+.||+|++|.||++.. .++..+|+|++.... .....++..|++++++ ++.
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 44457899999999999975 467889999985432 3345678899988876 222
Q ss_pred CCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|.....++.++++||.|||+.
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~ 122 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 1111 124588889999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.4e-05 Score=72.17 Aligned_cols=86 Identities=15% Similarity=0.181 Sum_probs=62.9
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecc---cchhhHhHHHHHHHHHH------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQ---YREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~---~~~~~~~f~~e~~~~~~------------------------ 376 (411)
+|.-.+.||+|++|.||+|... +|+.||+|.+... .......+..|.+++.+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 3445578999999999999874 6889999988542 12234667888877765
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....++|.....|+.+++.||.|||+.
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~ 121 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2221111 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.2e-05 Score=72.85 Aligned_cols=82 Identities=21% Similarity=0.200 Sum_probs=61.0
Q ss_pred CCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------cccCCC-------------
Q 015202 329 NNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------ANLLTR------------- 382 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~~l~~~------------- 382 (411)
.+.||+|++|.||+|... +|..+|||++.... ......|.+|++++.+ ++....
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 368999999999999875 47899999996542 2334678899988876 111110
Q ss_pred -C-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 -E-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 -~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++.+...++.++++||+|||+.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 119 (287)
T cd07840 84 HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119 (287)
T ss_pred ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0 113589999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.5e-05 Score=72.00 Aligned_cols=80 Identities=19% Similarity=0.258 Sum_probs=54.2
Q ss_pred eeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH--------------------------cccC
Q 015202 331 IIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD--------------------------ANLL 380 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~--------------------------~~l~ 380 (411)
+||+|+||.||++.. ..|+.||+|.+.... ......+..|..++.. +|..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 457899999885432 1222335555433221 2222
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....++|..+..|+.++++||.|||+.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 116 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.5e-05 Score=73.90 Aligned_cols=81 Identities=17% Similarity=0.189 Sum_probs=53.9
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHH-HH-----------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTV-VD-----------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~-~~-----------------------~~l~~ 381 (411)
+.||+|+||.||++... ++..||+|.+.... ......+..|...+ .. +|+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999874 56789999985432 22234555555443 22 22222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+...+...++.++++||+|||+.
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 115 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 122366667778999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.8e-06 Score=75.73 Aligned_cols=86 Identities=16% Similarity=0.190 Sum_probs=60.7
Q ss_pred CCCcCCeeeccCCceEEEEEec--------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ--------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~--------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------- 376 (411)
+|.-.+.||+|+||.||++... .+..+|+|.+.... .....+|..|++++.+
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 3444589999999999999741 23568999885432 3335678899988864
Q ss_pred -----c---------ccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----A---------NLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~---------~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ ++.... ....++|.+.++|+.+++.||.|||+.
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 153 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR 153 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 1 111110 113489999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.7e-05 Score=71.78 Aligned_cols=80 Identities=19% Similarity=0.263 Sum_probs=54.0
Q ss_pred eeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH--------------------------cccC
Q 015202 331 IIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD--------------------------ANLL 380 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~--------------------------~~l~ 380 (411)
+||+|+||.||++.. .+|+.+|||.+.... ......+..|..++.. +|..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 457899999885432 1222334455433221 2222
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....++|.+...|+.|+++||.|||+.
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~ 116 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111 123489999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.4e-06 Score=73.78 Aligned_cols=84 Identities=18% Similarity=0.171 Sum_probs=59.6
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccch-h-hHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYRE-A-FKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~-~-~~~f~~e~~~~~~------------------------- 376 (411)
+|...|.|++|.||.||+|.- +.+..||.|+++..... + .---.+||.++.+
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 344558999999999999975 45789999999543311 1 1234889998887
Q ss_pred cc--------cCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 AN--------LLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~--------l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+| ++.- +.++.-.+..-+..|+.+|++|||.+
T Consensus 157 e~~EhDLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~ 196 (419)
T KOG0663|consen 157 EYVEHDLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDN 196 (419)
T ss_pred HHHHhhHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhc
Confidence 11 1111 23466666777889999999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.5e-06 Score=71.85 Aligned_cols=87 Identities=16% Similarity=0.213 Sum_probs=58.5
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH----------cccCCCC------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------ANLLTRE------ 383 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------~~l~~~~------ 383 (411)
++|.-.+.+|+|.||.||.|... ++..||+|++.... .+-.+++.+||++=+. .|.|+..
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 34555599999999999999984 46689999984322 2335778888887665 1111111
Q ss_pred ---------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ---------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ---------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++-..--.+..++|.||.|+|..
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k 143 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK 143 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC
Confidence 011244444456788999999999974
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.8e-05 Score=70.64 Aligned_cols=87 Identities=20% Similarity=0.206 Sum_probs=65.6
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
++|.....+|+|++|.||+|... ++..+|+|.+........+.+.+|+.++.+ ++.
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 34555578999999999999874 567899999865544456789999998887 222
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++..+...++.+++.||+|||++
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~ 120 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111 124588889999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=98.04 E-value=9.8e-06 Score=74.38 Aligned_cols=86 Identities=16% Similarity=0.032 Sum_probs=61.8
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------c--------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------A-------------- 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~-------------- 377 (411)
+|.....||+|+||.||+|... +++.||||.+.... ......+.+|++++.+ +
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4556689999999999999874 57899999885332 2223456788888876 1
Q ss_pred -------ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 -------NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 -------~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..... ....+++.+...++.++++||.|||+.
T Consensus 93 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 138 (310)
T cd07865 93 SFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN 138 (310)
T ss_pred eEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 000000 012478999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.5e-05 Score=70.96 Aligned_cols=84 Identities=10% Similarity=0.168 Sum_probs=62.0
Q ss_pred CcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc-cchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 327 SANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ-YREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~-~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
.-.+.||+|+||.||++.. .++..+|+|.+... .....+.+..|+.++.+ +|+.+
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 3447899999999999986 35788999988543 23345678889888876 22221
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. .+..++.....+++.++++||.|||++
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~ 119 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 11 123478888999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.2e-05 Score=75.90 Aligned_cols=85 Identities=25% Similarity=0.312 Sum_probs=66.9
Q ss_pred CCcCCeeeccCCceEEEEE-ecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~-l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
|..-..||+|+.|.||.+. ...++.||||+++......++-..+|+.+|.. +|+.+
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 3445789999999999985 46788999999977665556678999999997 55544
Q ss_pred CC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....++..+...|+.++.+||+|||.+
T Consensus 355 gsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~ 388 (550)
T KOG0578|consen 355 GSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR 388 (550)
T ss_pred CchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc
Confidence 33 122377889999999999999999974
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.1e-06 Score=73.57 Aligned_cols=192 Identities=18% Similarity=0.194 Sum_probs=87.4
Q ss_pred cCCcCCceeecCcccccccc----hhhhCCCCCCeeecccCc---ccccCch-------hhhccccCCeeeecCCccccc
Q 015202 16 NLTNLIAIYLGGNKLNGSIS----IALGKLQKLQLLGLEDNQ---LEGSIPY-------DLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~----~~~~~l~~L~~L~l~~n~---l~~~~~~-------~~~~l~~L~~L~l~~n~l~~~ 81 (411)
.+..+..++|++|.|...-. ..+.+-.+|+..+++.-. ....+++ .+-+||+|+..+||+|.+...
T Consensus 28 ~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~ 107 (388)
T COG5238 28 MMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSE 107 (388)
T ss_pred hhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcc
Confidence 34556666666666653222 233444556665555421 1112221 233456666666666655544
Q ss_pred CCcc----ccCCccCCeeecccccCCccCc-----cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeeccc
Q 015202 82 VPSC----FGNLTNLRKLYLGSNQLTYIPL-----TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGA 152 (411)
Q Consensus 82 ~~~~----~~~l~~L~~L~l~~n~l~~~p~-----~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 152 (411)
.|.. +.+.+.|..|.+++|.+..+.. .++++. ......+-+.|+.+....|++..-
T Consensus 108 ~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la---------------~nKKaa~kp~Le~vicgrNRleng 172 (388)
T COG5238 108 FPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLA---------------YNKKAADKPKLEVVICGRNRLENG 172 (388)
T ss_pred cchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHH---------------HHhhhccCCCceEEEeccchhccC
Confidence 3332 2334556666666665543321 111000 001122334455555555554311
Q ss_pred C----CCCccCCCccCeeecccccccccCC-----ccccCCCCCCEEeCCCCccccc----cchhhhcCCCCCEEEcccC
Q 015202 153 I----PTTIGGLKDLQYLFLEYNRLQGSIP-----DFIGGLINLKSLDLSNNNLSGA----IPISLEKLLDLQHINVSFN 219 (411)
Q Consensus 153 ~----~~~~~~~~~L~~L~l~~n~l~~~~~-----~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~l~l~~n 219 (411)
. ...+....+|+.+.+..|.|...-- ..+..+.+|+.|++..|.++-. +...+..++.|+.|++.+|
T Consensus 173 s~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDC 252 (388)
T COG5238 173 SKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDC 252 (388)
T ss_pred cHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccch
Confidence 0 0112222455666666665542100 0112345666666666666522 2334555666666666666
Q ss_pred ccc
Q 015202 220 KLE 222 (411)
Q Consensus 220 ~l~ 222 (411)
-++
T Consensus 253 lls 255 (388)
T COG5238 253 LLS 255 (388)
T ss_pred hhc
Confidence 554
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=98.03 E-value=8e-06 Score=76.09 Aligned_cols=87 Identities=14% Similarity=0.128 Sum_probs=61.3
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecc--cchhhHhHHHHHHHHHH-----------c------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD-----------A------------ 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~-----------~------------ 377 (411)
++|...+.||+|+||.||+|... +|..+|||++... .......+..|+.++.+ +
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 34445578999999999999874 5788999988432 22334567788877765 1
Q ss_pred ---ccCCC----CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 ---NLLTR----EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ---~l~~~----~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++... .....++|..+..++.++|+||+|||+.
T Consensus 87 v~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 126 (337)
T cd07852 87 VFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG 126 (337)
T ss_pred EecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11100 0012579999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.8e-06 Score=73.22 Aligned_cols=83 Identities=18% Similarity=0.144 Sum_probs=61.1
Q ss_pred cCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 328 ANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
....||+|++|.||+|... +++.+|+|.+.... ....+.+..|+.++.+ ++...
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM 82 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc
Confidence 3467999999999999985 48899999985443 2234678888887775 11110
Q ss_pred CC-----C-CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-----D-KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-----~-~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.- . ...+++.++.+++.++++||.|||++
T Consensus 83 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 117 (282)
T cd07829 83 DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117 (282)
T ss_pred CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 00 0 13589999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.6e-06 Score=75.65 Aligned_cols=85 Identities=16% Similarity=0.265 Sum_probs=59.9
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|.....||+|.||.||||.- ..++.||+|.++... .....+..+|+.++++ +|..
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 44557899999999999986 346789999996544 3345788899988887 3333
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .+..++.....-|..++-.||.|||..
T Consensus 95 gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~ 130 (467)
T KOG0201|consen 95 GGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE 130 (467)
T ss_pred CcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc
Confidence 222 112234444556677999999999963
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.3e-06 Score=74.55 Aligned_cols=82 Identities=20% Similarity=0.281 Sum_probs=59.3
Q ss_pred CCeeeccCCceEEEEEecC-CCEEEEEEEecccchh--hHhHHHHHHHHHH-----------------------cccCCC
Q 015202 329 NNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYREA--FKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~~--~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
.+.||+|+||.||++...+ ++.+|+|.+....... ......|+.++.+ ++....
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 3689999999999999854 5589999996554322 2234558887776 222111
Q ss_pred C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++..+..++.++++||+|||+.
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~ 117 (260)
T PF00069_consen 84 SLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK 117 (260)
T ss_dssp BHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccc
Confidence 1 134589999999999999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.5e-05 Score=74.01 Aligned_cols=155 Identities=17% Similarity=0.199 Sum_probs=96.8
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCC-cccccCCccccCCccC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDN-KLSGFVPSCFGNLTNL 92 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L 92 (411)
+..+.+++.|++++|.++ .+|. --.+|+.|.+++|.--..+|+.+. ++|++|++++| .+. .+|. +|
T Consensus 48 ~~~~~~l~~L~Is~c~L~-sLP~---LP~sLtsL~Lsnc~nLtsLP~~LP--~nLe~L~Ls~Cs~L~-sLP~------sL 114 (426)
T PRK15386 48 IEEARASGRLYIKDCDIE-SLPV---LPNELTEITIENCNNLTTLPGSIP--EGLEKLTVCHCPEIS-GLPE------SV 114 (426)
T ss_pred HHHhcCCCEEEeCCCCCc-ccCC---CCCCCcEEEccCCCCcccCCchhh--hhhhheEccCccccc-cccc------cc
Confidence 456789999999999887 4452 223699999998643335665543 58999999998 454 3443 57
Q ss_pred CeeecccccCC---ccCccccCCCCCcEEEcCCCeee--ecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeee
Q 015202 93 RKLYLGSNQLT---YIPLTLWNLKYILYLNLSSNSFT--IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLF 167 (411)
Q Consensus 93 ~~L~l~~n~l~---~~p~~~~~~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~ 167 (411)
+.|++..+... .+|. +|+.|.+.++... ...|..+ .++|+.|++++|... ..|..+. .+|+.|.
T Consensus 115 e~L~L~~n~~~~L~~LPs------sLk~L~I~~~n~~~~~~lp~~L--PsSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ 183 (426)
T PRK15386 115 RSLEIKGSATDSIKNVPN------GLTSLSINSYNPENQARIDNLI--SPSLKTLSLTGCSNI-ILPEKLP--ESLQSIT 183 (426)
T ss_pred ceEEeCCCCCcccccCcc------hHhheecccccccccccccccc--CCcccEEEecCCCcc-cCccccc--ccCcEEE
Confidence 77778776643 5554 4667776543211 0112111 258999999998765 4454443 5899999
Q ss_pred cccccccc--cCCccccCCCCCCEEeCCCC
Q 015202 168 LEYNRLQG--SIPDFIGGLINLKSLDLSNN 195 (411)
Q Consensus 168 l~~n~l~~--~~~~~~~~~~~L~~L~l~~n 195 (411)
++.+.... .....+. +++ .|++.++
T Consensus 184 ls~n~~~sLeI~~~sLP--~nl-~L~f~n~ 210 (426)
T PRK15386 184 LHIEQKTTWNISFEGFP--DGL-DIDLQNS 210 (426)
T ss_pred ecccccccccCcccccc--ccc-Eechhhh
Confidence 98764321 1222222 345 6777654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=98.01 E-value=9e-06 Score=75.45 Aligned_cols=92 Identities=20% Similarity=0.165 Sum_probs=66.8
Q ss_pred HHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-------------------
Q 015202 319 LFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 319 l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------- 376 (411)
+...+++|...+.||+|+||.||++.- .+|..||||++... .....+.+..|++++.+
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345677788889999999999999975 47889999988432 22335678889998886
Q ss_pred -----cccCCC----CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTR----EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~----~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... ....++++.....++.++++||.|||+.
T Consensus 85 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~ 127 (328)
T cd07856 85 IYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127 (328)
T ss_pred EEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111000 0123467777788999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.1e-06 Score=85.11 Aligned_cols=88 Identities=10% Similarity=0.040 Sum_probs=64.6
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~---------------------- 376 (411)
..++|.-...||+|+||.||++.. ..+..||+|.+... .......|..|+.++.+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 344565668999999999999987 34668899988543 22345679999999987
Q ss_pred ---cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ---ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ---~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|..... ....++|.....|+.+|+.||+|||+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs 136 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1111110 11348889999999999999999997
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.9e-05 Score=73.31 Aligned_cols=84 Identities=17% Similarity=0.164 Sum_probs=62.0
Q ss_pred CcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH---------------------------
Q 015202 327 SANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~--------------------------- 376 (411)
.-.+.||+|++|.||+|... .|..||||++.... ....+.|..|++++..
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 34478999999999999975 48899999985433 3335678889887776
Q ss_pred -cccCCC-----CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTR-----EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~-----~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... ....+++|..+..++.++++||+|||+.
T Consensus 83 ~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~ 122 (330)
T cd07834 83 TELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA 122 (330)
T ss_pred ecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 011100 0123588999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.4e-05 Score=72.22 Aligned_cols=79 Identities=14% Similarity=0.187 Sum_probs=58.9
Q ss_pred eeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 332 IGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 332 lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
||+|+||.||++.. .+|..+|+|.+.... ......|..|++++.+ +|+.+..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 467899999985432 2234567889998887 3332211
Q ss_pred -------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++..+..++.++++||.|||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~ 114 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.1e-05 Score=62.06 Aligned_cols=60 Identities=13% Similarity=0.223 Sum_probs=20.5
Q ss_pred hhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecc
Q 015202 37 ALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLG 98 (411)
Q Consensus 37 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 98 (411)
.|.++++|+.+.+.. .+..+....|.++++|+.+++.++ +.......|..+++|+.+.+.
T Consensus 7 ~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~ 66 (129)
T PF13306_consen 7 AFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFP 66 (129)
T ss_dssp TTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEET
T ss_pred HHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeeccccccccccc
Confidence 344444444444442 233333334444444444444432 333333334444444444443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.8e-05 Score=69.46 Aligned_cols=79 Identities=13% Similarity=0.177 Sum_probs=59.1
Q ss_pred eeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 332 IGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 332 lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
||+|++|.||++... .++.||+|.+.... ....+.|.+|+.++.+ +|..+..
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999984 37899999985432 2234679999998876 2222111
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++..+..++.++++||.|||++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 112 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 123478899999999999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.9e-05 Score=72.57 Aligned_cols=85 Identities=19% Similarity=0.220 Sum_probs=62.0
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc---cchhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ---YREAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~---~~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.+|+|++|.||+|.. .++..||+|.+... .....++|..|++++.. +|
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 33347899999999999986 45778999988532 22334678899988876 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ...++++.++..++.+++.||.|||+.
T Consensus 97 ~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~ 134 (308)
T cd06634 97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134 (308)
T ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 21110 123588999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.9e-05 Score=72.55 Aligned_cols=88 Identities=18% Similarity=0.185 Sum_probs=63.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH----------cccC---------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD----------ANLL--------- 380 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~----------~~l~--------- 380 (411)
+++|.-.+.||+|++|.||+|+.. +++.+|||++..... .....+.+|++++.. +...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 456666789999999999999874 578899999844322 223467788888776 1000
Q ss_pred -----------CC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 -----------TR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 -----------~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. .....+++.+...++.++++||.|||+.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~ 134 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 00 0123489999999999999999999974
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.9e-05 Score=71.41 Aligned_cols=82 Identities=16% Similarity=0.161 Sum_probs=58.0
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH--------------------------cccC
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD--------------------------ANLL 380 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~--------------------------~~l~ 380 (411)
.+.+|+|+||.||+|.. .++..||+|++.... .........|+.++.+ +|..
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 36799999999999986 467899999985432 2222345577777664 1111
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ....++|.+...++.++++||.|||+.
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 119 (282)
T cd07831 84 MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119 (282)
T ss_pred ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 100 123589999999999999999999974
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.4e-06 Score=74.66 Aligned_cols=175 Identities=18% Similarity=0.226 Sum_probs=96.0
Q ss_pred hhCCCCCCeeecccCcccccCchhhhc----cccCCeeeecCCccc---cc-------CCccccCCccCCeeecccccCC
Q 015202 38 LGKLQKLQLLGLEDNQLEGSIPYDLCR----LAALFQLDLGDNKLS---GF-------VPSCFGNLTNLRKLYLGSNQLT 103 (411)
Q Consensus 38 ~~~l~~L~~L~l~~n~l~~~~~~~~~~----l~~L~~L~l~~n~l~---~~-------~~~~~~~l~~L~~L~l~~n~l~ 103 (411)
+.-+..+..++||+|-|...-..++++ -.+|+..++++-... .. +...+.++|.|++.+||.|-+.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg 105 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG 105 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence 345677788888888776555545443 345666555543211 01 1123444566666666666554
Q ss_pred -ccCc----cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCC
Q 015202 104 -YIPL----TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178 (411)
Q Consensus 104 -~~p~----~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 178 (411)
+.|. -+.+-+.|.+|.+++|.+--..-..++. .|. .|..|+ ....-|.|+.....+|++..-..
T Consensus 106 ~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigk--al~--~la~nK-------Kaa~kp~Le~vicgrNRlengs~ 174 (388)
T COG5238 106 SEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGK--ALF--HLAYNK-------KAADKPKLEVVICGRNRLENGSK 174 (388)
T ss_pred cccchHHHHHHhcCCCceeEEeecCCCCccchhHHHH--HHH--HHHHHh-------hhccCCCceEEEeccchhccCcH
Confidence 3332 2334455555555555443111111110 011 112221 12345789999999998863211
Q ss_pred ----ccccCCCCCCEEeCCCCccccc-----cchhhhcCCCCCEEEcccCcccc
Q 015202 179 ----DFIGGLINLKSLDLSNNNLSGA-----IPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 179 ----~~~~~~~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
..+.+-..|+.+.+..|.|... .-..+..+.+|+.||+.+|-++-
T Consensus 175 ~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~ 228 (388)
T COG5238 175 ELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTL 228 (388)
T ss_pred HHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhh
Confidence 1233335789999999988622 12245678899999999998863
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.7e-05 Score=70.33 Aligned_cols=82 Identities=22% Similarity=0.254 Sum_probs=61.4
Q ss_pred CCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 329 NNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
.+.||+|++|.||+|... +|+.+++|++..... .....+..|+.++.+ ++....
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 83 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTD 83 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCCC
Confidence 367999999999999874 678899999854332 234678888888776 222211
Q ss_pred C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ...+++|.++..++.++++||.|||+.
T Consensus 84 l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 117 (283)
T cd05118 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117 (283)
T ss_pred HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0 123689999999999999999999974
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.6e-05 Score=77.50 Aligned_cols=37 Identities=22% Similarity=0.391 Sum_probs=31.0
Q ss_pred HhcCCCcCCeeeccCCceEEEEEecC-----CCEEEEEEEec
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQD-----GMEVAVKVFDL 358 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~~-----~~~vavk~l~~ 358 (411)
..++|...+.||+|+||.||+|+..+ +..||||++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~ 171 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE 171 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecc
Confidence 45677778999999999999999843 67899999843
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.6e-05 Score=71.55 Aligned_cols=88 Identities=20% Similarity=0.225 Sum_probs=65.0
Q ss_pred HhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------c------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------A------------ 377 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------~------------ 377 (411)
++++|.-.+.||+|++|.||+|... +++.+++|.+..... ...+|.+|+.++.+ +
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4667777789999999999999984 567899998854432 34678999988775 0
Q ss_pred -------ccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 -------NLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 -------~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++.....++.++++||.|||+.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~ 132 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN 132 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 001000 023578888899999999999999974
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.2e-05 Score=65.53 Aligned_cols=80 Identities=19% Similarity=0.223 Sum_probs=55.7
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccch--h------------------------hHhHHHHHHHHHH-------
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYRE--A------------------------FKSFDNEFMTVVD------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~--~------------------------~~~f~~e~~~~~~------- 376 (411)
..||+|++|.||+|...+|+.||||.+...... . ...+..|.+.+.+
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999878999999998654211 0 0113456666654
Q ss_pred --------------cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 --------------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 --------------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|+.+.. ...+++.....+|+.++++|+.|+|+
T Consensus 83 ~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~ 135 (190)
T cd05145 83 VPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQ 135 (190)
T ss_pred CceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHH
Confidence 3333321 11235666789999999999999996
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=97.94 E-value=2.5e-05 Score=70.89 Aligned_cols=84 Identities=13% Similarity=0.183 Sum_probs=60.2
Q ss_pred CcCCeeeccCCceEEEEEe----cCCCEEEEEEEeccc----chhhHhHHHHHHHHHH----------------------
Q 015202 327 SANNIIGRGGIGSIYKARI----QDGMEVAVKVFDLQY----REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l----~~~~~vavk~l~~~~----~~~~~~f~~e~~~~~~---------------------- 376 (411)
.-.+.||+|++|.||++.. .++..||||.+.... ....+.|.+|+.++.+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 3447899999999999875 356789999985322 1224568889988776
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.++++||.|||+.
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~ 124 (288)
T cd05583 83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124 (288)
T ss_pred EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222111 123478888999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3e-05 Score=74.83 Aligned_cols=88 Identities=15% Similarity=0.198 Sum_probs=64.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~---------------------- 376 (411)
-++|.-..++|+|+||.|+.+++ .+++..|||.++... ..+.+....|.+++..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 45666678999999999999998 456788999995443 2334556777777664
Q ss_pred --cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.+ ....++.++-.=+|+.|+-||+|||++
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~ 487 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN 487 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc
Confidence 4444433 224577777777899999999999986
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=1.4e-05 Score=76.13 Aligned_cols=81 Identities=12% Similarity=0.092 Sum_probs=59.0
Q ss_pred CCCcCCeeeccCCceEEEEEec---CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ---DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
.|.-...||+|+||.||++... .+..||||.+... +.+.+|++++.+ ++
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 4556688999999999999763 3467899987432 245678888876 11
Q ss_pred cCCC-----CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTR-----EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~-----~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... .....++|..++.|+.++++||.|||+.
T Consensus 168 ~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~ 204 (392)
T PHA03207 168 YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR 204 (392)
T ss_pred cCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1100 0134589999999999999999999974
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.8e-05 Score=72.23 Aligned_cols=85 Identities=16% Similarity=0.209 Sum_probs=60.2
Q ss_pred CCcCCeeeccCCceEEEEEec-C--CCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------c------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-D--GMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------A------------ 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~--~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------~------------ 377 (411)
|.-.+.||+|+||.||++... . +..||+|++.... ....+.+.+|++++.+ +
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 334478999999999999974 3 6789999985322 2234568888887764 0
Q ss_pred cc----CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NL----LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l----~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++ .+.. ....+++.....++.++++||.|||+.
T Consensus 82 ~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 124 (332)
T cd07857 82 YLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA 124 (332)
T ss_pred EEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 00 0000 123578899999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.6e-05 Score=72.55 Aligned_cols=81 Identities=17% Similarity=0.102 Sum_probs=58.4
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccchh--------------hHhHHHHHHHHHH------------------
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREA--------------FKSFDNEFMTVVD------------------ 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~--------------~~~f~~e~~~~~~------------------ 376 (411)
+.||+|+||.||+|.. .+|+.||||.+....... ...+.+|++++.+
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 94 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence 6799999999999986 468899999884332111 1257889998886
Q ss_pred -----cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.....++.++++||.|||+.
T Consensus 95 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~ 138 (335)
T PTZ00024 95 INLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW 138 (335)
T ss_pred EEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2221100 122478888999999999999999974
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=97.92 E-value=3.1e-05 Score=72.13 Aligned_cols=86 Identities=17% Similarity=0.173 Sum_probs=62.0
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------------- 376 (411)
.|.-...||+|+||.||+|.- ..|..||||++... .......+..|+.++..
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 455567899999999999986 46889999998542 22234567788888775
Q ss_pred ---cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.... ....+++.....|+.++++||.|||+.
T Consensus 86 lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 127 (337)
T cd07858 86 IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127 (337)
T ss_pred EEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111000 123478889999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=7e-06 Score=75.76 Aligned_cols=81 Identities=14% Similarity=0.195 Sum_probs=57.7
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH-------------------------cccCC-
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-------------------------ANLLT- 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-------------------------~~l~~- 381 (411)
+.+|.|.||.||+|+- +.|..||||+++.... .+.-.=.+|+.-+.+ +++..
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~N 95 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCN 95 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhh
Confidence 6799999999999975 6788999999843321 111223567766665 12110
Q ss_pred -----CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 -----REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 -----~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+...++++......|+.||-+||+|+|++
T Consensus 96 LYqLmK~R~r~fse~~irnim~QilqGL~hiHk~ 129 (538)
T KOG0661|consen 96 LYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH 129 (538)
T ss_pred HHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc
Confidence 01246799999999999999999999975
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.5e-05 Score=71.94 Aligned_cols=85 Identities=21% Similarity=0.274 Sum_probs=60.3
Q ss_pred CCcCCeeeccCCceEEEEEec---CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ---DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
|.-...||+|++|.||+|... .+..||+|.+.... ......+.+|+.++.+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 334478999999999999974 47899999986532 2234667888888886
Q ss_pred --cccCC--------CC--CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLT--------RE--DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~--------~~--~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++... .. ....++......|+.++++||.|||+.
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 127 (316)
T cd07842 82 LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127 (316)
T ss_pred EEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 11110 00 112467777889999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=97.89 E-value=2.9e-05 Score=61.22 Aligned_cols=123 Identities=20% Similarity=0.202 Sum_probs=69.0
Q ss_pred hhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCcc
Q 015202 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTN 91 (411)
Q Consensus 12 ~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 91 (411)
.+|.++.+|+.+.+.. .+..+...+|.++++|+.+.+.++ +.......|.++++|+.+.+.+ .+.......|..+++
T Consensus 6 ~~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~ 82 (129)
T PF13306_consen 6 NAFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTN 82 (129)
T ss_dssp TTTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TT
T ss_pred HHHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-ccccccccccccccc
Confidence 4688999999999985 566677788999999999999886 6656566789998999999976 555455667888889
Q ss_pred CCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCC
Q 015202 92 LRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVL 139 (411)
Q Consensus 92 L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 139 (411)
|+.+++..+ +..++.....-.+|+.+.+.. .+.......|.++++|
T Consensus 83 l~~i~~~~~-~~~i~~~~f~~~~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 83 LKNIDIPSN-ITEIGSSSFSNCNLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp ECEEEETTT--BEEHTTTTTT-T--EEE-TT-B-SS----GGG-----
T ss_pred ccccccCcc-ccEEchhhhcCCCceEEEECC-CccEECCccccccccC
Confidence 998888765 665555444323777776654 2332333444444433
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=3.9e-06 Score=72.97 Aligned_cols=78 Identities=13% Similarity=0.190 Sum_probs=58.7
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------cccCCCC--------------
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------ANLLTRE-------------- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------~~l~~~~-------------- 383 (411)
.++|+|+||.|||+.. ..|+.||+|++-.. .+.++...||.+|.+ .|....+
T Consensus 39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiS 116 (502)
T KOG0574|consen 39 GKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSIS 116 (502)
T ss_pred HHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHH
Confidence 5799999999999977 46899999998433 346789999999998 1111000
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
...+++-...-.|..+..+||+|||.
T Consensus 117 DI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~ 147 (502)
T KOG0574|consen 117 DIMRARRKPLSEQEISAVLRDTLKGLQYLHD 147 (502)
T ss_pred HHHHHhcCCccHHHHHHHHHHHHhHHHHHHH
Confidence 12347777777788899999999995
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=2.4e-05 Score=76.52 Aligned_cols=85 Identities=9% Similarity=0.091 Sum_probs=62.3
Q ss_pred CCcCCeeeccCCceEEEEEec-C-CCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-D-GMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~-~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|.-.+.+|+|++|.||+|.-. + +..||+|.+..........+..|+.+++. +|..
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 334589999999999999753 3 56788887754444445678889999887 3332
Q ss_pred CCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ...++++.....++.+|++||.|||+.
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~ 188 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 211 123588888899999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=97.87 E-value=6.5e-05 Score=65.14 Aligned_cols=83 Identities=20% Similarity=0.221 Sum_probs=62.8
Q ss_pred cCCeeeccCCceEEEEEecC-CCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 328 ANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
..+.||+|++|.||++...+ +..+|+|.+...... ..+.+.+|++.+.+ ++....
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 34789999999999999865 789999999654443 56788999988776 111111
Q ss_pred C------CCCC-CCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E------DKHF-MTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~------~~~~-l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. .... ++|.+...++.++++|+.|||+.
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 117 (225)
T smart00221 83 DLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL 117 (225)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 1123 78999999999999999999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=1.4e-05 Score=67.85 Aligned_cols=82 Identities=12% Similarity=0.170 Sum_probs=63.3
Q ss_pred CCeeeccCCceEEEEE-ecCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------------
Q 015202 329 NNIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~-l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------------- 376 (411)
.+.+|+|||..||.++ +.++...|+|++.-.+.++.+.-.+|++...+
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy 105 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY 105 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence 3789999999999887 56778899999965555666778888887766
Q ss_pred ------cccCCCC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTRE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++...+ ++..++-.+-++|..||.+||+|||+.
T Consensus 106 ~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~ 146 (302)
T KOG2345|consen 106 KRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK 146 (302)
T ss_pred ccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc
Confidence 1111111 344588899999999999999999985
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=1.8e-05 Score=70.58 Aligned_cols=81 Identities=23% Similarity=0.254 Sum_probs=55.2
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccch-h-hHhHHHHHHHHHH-----------cccCC--------------
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYRE-A-FKSFDNEFMTVVD-----------ANLLT-------------- 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~-~-~~~f~~e~~~~~~-----------~~l~~-------------- 381 (411)
+++|+|.||.||+|+- ..|+.||+|++...... + -.--.+|+.++.+ +..|.
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 6799999999999986 57899999999654432 1 2334677777776 11111
Q ss_pred -------------CCCC-CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 -------------REDK-HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 -------------~~~~-~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.... ..++-.....+..|+.+||+|+|++
T Consensus 97 e~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~ 139 (323)
T KOG0594|consen 97 EFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH 139 (323)
T ss_pred EeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1000 1233345788899999999999985
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=97.86 E-value=3.3e-05 Score=72.42 Aligned_cols=88 Identities=14% Similarity=0.081 Sum_probs=62.7
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------cc-----------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------AN----------- 378 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------~~----------- 378 (411)
.+.|...+.||+|+||.||+|.- .+|..||||.+... .......+.+|+.++.+ +.
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 35577778999999999999986 46889999998432 22334567889988886 00
Q ss_pred --------cCCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 --------LLTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 --------l~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.... -...+++.+...++.++++||+|||+.
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~ 137 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA 137 (353)
T ss_pred cEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 00000 011267778888999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=97.84 E-value=5.9e-05 Score=66.78 Aligned_cols=79 Identities=14% Similarity=0.149 Sum_probs=58.8
Q ss_pred eeccCCceEEEEEec-CCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 332 IGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 332 lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
||+|+||.||++... +++.+|+|.+..... .....+..|+.++.+ ++..+..
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999874 478999999854322 234578888888776 2222111
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.....++.++++||.|||+.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~ 112 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 122589999999999999999999974
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=97.84 E-value=3.3e-05 Score=71.61 Aligned_cols=81 Identities=25% Similarity=0.254 Sum_probs=57.6
Q ss_pred Ceeecc--CCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 330 NIIGRG--GIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g--~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
..||+| +||.||++.. ..|+.||||.+.... ....+.|.+|+.++.. +++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 8899999986 478999999985432 2234678888887775 12211
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.....++.+++.||+|||++
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~ 120 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 123478888889999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=97.84 E-value=3.4e-05 Score=72.02 Aligned_cols=88 Identities=13% Similarity=0.130 Sum_probs=63.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------cccC---------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------ANLL--------- 380 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------~~l~--------- 380 (411)
.++|.....||+|++|.||+|... ++..||||++... .....+.+.+|+.++.+ +...
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 455666689999999999999884 5788999998532 22234567788887775 1000
Q ss_pred ---------CCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 ---------TRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ---------~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....++|....+++.++++||+|||+.
T Consensus 94 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~ 137 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA 137 (343)
T ss_pred cEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 000 112589999999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=97.84 E-value=5.6e-05 Score=67.44 Aligned_cols=81 Identities=15% Similarity=0.194 Sum_probs=55.3
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
..||+|++|.||+|.. .+|+.||||.+.... ......+..|..++.. +|..+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4589999999999987 457899999985432 1222345555544432 22222
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ...++++....+|+.++++||.|||+.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~ 116 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 113478888999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=4.9e-05 Score=69.84 Aligned_cols=83 Identities=16% Similarity=0.187 Sum_probs=61.9
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchh-hHhHHHHHHHHHH-----------------------cccCCC
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREA-FKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~-~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
-..+||.|..++||+|.. +.+..||||+++...... ..+..+|+..|.. -++...
T Consensus 30 L~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 30 LQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCC
Confidence 347899999999999975 778999999997554433 4778999998886 111111
Q ss_pred C--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ ....++......|..++.+||.|||.+
T Consensus 110 S~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~ 145 (516)
T KOG0582|consen 110 SLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN 145 (516)
T ss_pred cHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc
Confidence 1 122367777888889999999999975
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=9.6e-06 Score=69.46 Aligned_cols=124 Identities=23% Similarity=0.236 Sum_probs=68.1
Q ss_pred CCceeecCcccc-cccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCC--cccccCCccccCCccCCeee
Q 015202 20 LIAIYLGGNKLN-GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDN--KLSGFVPSCFGNLTNLRKLY 96 (411)
Q Consensus 20 L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n--~l~~~~~~~~~~l~~L~~L~ 96 (411)
.+.+.++++.-. +.+......+.+|+.|.+.+..++.. ..|..|++|+.|.++.| ++.+.++-....+++|++|+
T Consensus 20 v~~l~lD~~~s~~g~~~gl~d~~~~le~ls~~n~gltt~--~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ 97 (260)
T KOG2739|consen 20 VDELFLDNARSGAGKLGGLTDEFVELELLSVINVGLTTL--TNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLN 97 (260)
T ss_pred hhhhhcchhhhcCCCcccccccccchhhhhhhccceeec--ccCCCcchhhhhcccCCcccccccceehhhhCCceeEEe
Confidence 334455543321 23444455666666666666665522 23555667777777777 55544444445557777777
Q ss_pred cccccCCccC--ccccCCCCCcEEEcCCCeeeecCC---CCccCccCCCeEEcc
Q 015202 97 LGSNQLTYIP--LTLWNLKYILYLNLSSNSFTIPLP---SEIGNLEVLVQIDLS 145 (411)
Q Consensus 97 l~~n~l~~~p--~~~~~~~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l~ 145 (411)
++.|+++-+. ..+..+.+|..|++.+|..+..-. ..|.-+++|++|+-.
T Consensus 98 ls~Nki~~lstl~pl~~l~nL~~Ldl~n~~~~~l~dyre~vf~ll~~L~~LD~~ 151 (260)
T KOG2739|consen 98 LSGNKIKDLSTLRPLKELENLKSLDLFNCSVTNLDDYREKVFLLLPSLKYLDGC 151 (260)
T ss_pred ecCCccccccccchhhhhcchhhhhcccCCccccccHHHHHHHHhhhhcccccc
Confidence 7777766321 123456667777777766543111 124445666655543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00011 Score=64.48 Aligned_cols=85 Identities=16% Similarity=0.094 Sum_probs=56.5
Q ss_pred CCcCCeeeccCCceEEEEE--ecCCCEEEEEEEecccch------------------------hhHhHHHHHHHHHH---
Q 015202 326 FSANNIIGRGGIGSIYKAR--IQDGMEVAVKVFDLQYRE------------------------AFKSFDNEFMTVVD--- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~--l~~~~~vavk~l~~~~~~------------------------~~~~f~~e~~~~~~--- 376 (411)
|.-...||+|++|.||+|+ ..+|+.||||.+...... ....+..|++.+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3344789999999999998 578999999988543210 01235577777665
Q ss_pred ------------------cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------------------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------------------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.+.. ...++...+...|+.++++|+.|||+.
T Consensus 110 ~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 167 (237)
T smart00090 110 AGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE 167 (237)
T ss_pred cCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc
Confidence 2222211 111234445678999999999999964
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=6.3e-05 Score=72.33 Aligned_cols=80 Identities=15% Similarity=0.125 Sum_probs=61.7
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------------
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------------- 376 (411)
.++||+|.||.|.|+.- ..++.||||.++... .-.++=..|++++..
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfEL 269 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFEL 269 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehh
Confidence 47899999999999975 458899999996442 224555678887776
Q ss_pred ------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.... ..+++...-..|+.+|..||.+||+.
T Consensus 270 L~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l 308 (586)
T KOG0667|consen 270 LSTNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHEL 308 (586)
T ss_pred hhhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4444432 44588888999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=1.7e-05 Score=68.08 Aligned_cols=83 Identities=17% Similarity=0.210 Sum_probs=56.8
Q ss_pred CcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH---------------------------
Q 015202 327 SANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~--------------------------- 376 (411)
..++-||-|.||+||..+- ++|+.||.|++-.- +-...+.|.+|+++++.
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3558899999999998776 57999999998321 12234567777877764
Q ss_pred -----cccCCCC-CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 -----ANLLTRE-DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 -----~~l~~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.-||.-. ...+++-....-+..+|.|||.|||+
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs 174 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT 174 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhh
Confidence 2233222 12335555555666799999999996
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=4.5e-05 Score=69.53 Aligned_cols=23 Identities=4% Similarity=-0.052 Sum_probs=20.1
Q ss_pred CCHHHHHHHHHHHhhhhcccCCC
Q 015202 388 MTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 388 l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.++.....|+.++|+||+|||+.
T Consensus 123 ~~~~~~~~i~~qi~~~l~~lH~~ 145 (294)
T PHA02882 123 KNKKLIKNIMKDMLTTLEYIHEH 145 (294)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC
Confidence 56777889999999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=5.1e-05 Score=71.13 Aligned_cols=81 Identities=20% Similarity=0.289 Sum_probs=58.8
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
++++|.|-||+||-|.. ..|+.||||.++... .+......+|+.++.+ +-||+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 48999999999999987 468999999996543 4445789999999987 333321
Q ss_pred C-------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 383 E-------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 383 ~-------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
- ....|+-+.-.=+..||..||.|||-
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~ 682 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF 682 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh
Confidence 1 11125544444456799999999995
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.73 E-value=3.1e-05 Score=66.99 Aligned_cols=81 Identities=20% Similarity=0.298 Sum_probs=61.5
Q ss_pred CeeeccCCceEEEEE-ecCCCEEEEEEEe--cccchhhHhHHHHHHHHHH-------cccC-------------------
Q 015202 330 NIIGRGGIGSIYKAR-IQDGMEVAVKVFD--LQYREAFKSFDNEFMTVVD-------ANLL------------------- 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~-l~~~~~vavk~l~--~~~~~~~~~f~~e~~~~~~-------~~l~------------------- 380 (411)
.+||+|.||.|||+. +.+|..||.|.++ ....+..++...||.++.+ .|.+
T Consensus 25 ~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~ 104 (375)
T KOG0591|consen 25 KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDA 104 (375)
T ss_pred HHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcc
Confidence 689999999999996 5789999999884 3445667889999999998 1100
Q ss_pred ---------CCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 ---------TREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ---------~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
-+...+.++-...-++-+|+++||...|..
T Consensus 105 GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~ 143 (375)
T KOG0591|consen 105 GDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK 143 (375)
T ss_pred cCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc
Confidence 000123366677788999999999999973
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=2.3e-05 Score=78.77 Aligned_cols=103 Identities=22% Similarity=0.296 Sum_probs=47.5
Q ss_pred cCCceeecCccccccc--chhhhCCCCCCeeecccCcccc-cCchhhhccccCCeeeecCCcccccCCccccCCccCCee
Q 015202 19 NLIAIYLGGNKLNGSI--SIALGKLQKLQLLGLEDNQLEG-SIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKL 95 (411)
Q Consensus 19 ~L~~L~l~~n~~~~~~--~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 95 (411)
+|+.|++++......- ...-.-+|.|+.|.+++-.+.. .+-.-..++|+|..||+|+++++.. ..+..+++|+.|
T Consensus 123 nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L 200 (699)
T KOG3665|consen 123 NLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVL 200 (699)
T ss_pred hhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHH
Confidence 4555555554332111 1122345555555555543321 1112233455555555555555533 445555555555
Q ss_pred ecccccCCccC--ccccCCCCCcEEEcCCC
Q 015202 96 YLGSNQLTYIP--LTLWNLKYILYLNLSSN 123 (411)
Q Consensus 96 ~l~~n~l~~~p--~~~~~~~~L~~L~l~~n 123 (411)
.+.+-.+.... ..++++++|+.||+|..
T Consensus 201 ~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~ 230 (699)
T KOG3665|consen 201 SMRNLEFESYQDLIDLFNLKKLRVLDISRD 230 (699)
T ss_pred hccCCCCCchhhHHHHhcccCCCeeecccc
Confidence 55554444322 23445555555555543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00014 Score=61.99 Aligned_cols=79 Identities=16% Similarity=0.299 Sum_probs=59.9
Q ss_pred eeccCCceEEEEEecC-CCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------cccCCCC---
Q 015202 332 IGRGGIGSIYKARIQD-GMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------ANLLTRE--- 383 (411)
Q Consensus 332 lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~~l~~~~--- 383 (411)
||+|.+|.||++...+ |..++||++...... ....|.+|+..+.. ++..+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999854 889999999654432 34678999988886 2222111
Q ss_pred --CC--CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 --DK--HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 --~~--~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ..+++..+..++.++++|+.|||+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 111 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN 111 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 2588999999999999999999974
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00013 Score=67.64 Aligned_cols=86 Identities=15% Similarity=0.182 Sum_probs=61.4
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc--h------------hhHhHHHHHHHHHH-------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR--E------------AFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~--~------------~~~~f~~e~~~~~~------------- 376 (411)
.|.-...||+|.||.|-+|.- .+++.||||.+..... + ..+...+||.+|.+
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 344447899999999999874 4788999999833211 1 12468999999998
Q ss_pred ------------cccCCCC-----CCCC-CCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------------ANLLTRE-----DKHF-MTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------------~~l~~~~-----~~~~-l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..... ...+ ++..+-.++..|+..||+|||.+
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q 229 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ 229 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc
Confidence 3333211 1123 77778889999999999999964
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=8.5e-06 Score=69.94 Aligned_cols=78 Identities=15% Similarity=0.264 Sum_probs=55.1
Q ss_pred eeeccCCceEEEEEecCCCEEEEEEE--ecccchhhHhHHHHHHHH---HH-----------------------------
Q 015202 331 IIGRGGIGSIYKARIQDGMEVAVKVF--DLQYREAFKSFDNEFMTV---VD----------------------------- 376 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~~~~~vavk~l--~~~~~~~~~~f~~e~~~~---~~----------------------------- 376 (411)
+|.+...|..|+|.|++ .-+++|.+ +.....-.++|..|+..+ +.
T Consensus 197 kl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 57788899999999955 55555665 333344467888887433 22
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..||+.. +-..+-.|-+++|+||||||+|||+.
T Consensus 276 nvlhe~t-~vvvd~sqav~faldiargmaflhsl 308 (448)
T KOG0195|consen 276 NVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL 308 (448)
T ss_pred HHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc
Confidence 4455543 33477788999999999999999973
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=1.8e-05 Score=71.39 Aligned_cols=93 Identities=20% Similarity=0.138 Sum_probs=60.9
Q ss_pred HHHHHHhcCCCcCCeeeccCCceEEEEEecC------CCEEEEEEEec-ccchhhHhHHHHHHHHHH-------------
Q 015202 317 LELFHATNGFSANNIIGRGGIGSIYKARIQD------GMEVAVKVFDL-QYREAFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 317 ~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~------~~~vavk~l~~-~~~~~~~~f~~e~~~~~~------------- 376 (411)
.|+......|.-..++-+|.||.||+|.|++ -+.|-||.++. ++.-....|.+|...+-.
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444455556666788999999999997643 23466776633 333334557777665543
Q ss_pred --------------------cccCC-----CCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 --------------------ANLLT-----REDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 --------------------~~l~~-----~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.+|.. ..+.+.++-.+-+.+|.|+|.||+|||.
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~ 414 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN 414 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 33331 1122346767889999999999999996
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=9.3e-05 Score=74.28 Aligned_cols=80 Identities=20% Similarity=0.281 Sum_probs=61.1
Q ss_pred CeeeccCCceEEEEEec----C----CCEEEEEEEecc-cchhhHhHHHHHHHHHH------------------------
Q 015202 330 NIIGRGGIGSIYKARIQ----D----GMEVAVKVFDLQ-YREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~----~----~~~vavk~l~~~-~~~~~~~f~~e~~~~~~------------------------ 376 (411)
+.+|+|.||.|++|.+. . ...||||.+... ...+.++|..|+++|..
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~ 381 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV 381 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence 59999999999999862 1 346999998543 33556889999999997
Q ss_pred ---------cccCCCC-------CC------CCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ---------ANLLTRE-------DK------HFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ---------~~l~~~~-------~~------~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+||+... .+ ..++-...+.+|.|||+||+||++
T Consensus 382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~ 436 (609)
T KOG0200|consen 382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS 436 (609)
T ss_pred EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh
Confidence 3343322 00 238888899999999999999976
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=97.67 E-value=8e-05 Score=66.43 Aligned_cols=82 Identities=13% Similarity=0.197 Sum_probs=54.6
Q ss_pred CCeeeccCCceEEEEEecC-CCEEEEEEEecc-----cchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 329 NNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQ-----YREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~-----~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++.+ +|.
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 3789999999999998633 334555554321 12234456677776665 222
Q ss_pred CCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. .+..++|.++..++.++|+||.|||+.
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 85 EGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred CCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 2111 124589999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.65 E-value=8.9e-05 Score=65.34 Aligned_cols=91 Identities=19% Similarity=0.237 Sum_probs=66.6
Q ss_pred ccHHHHHHHhcCCCcCCeeeccCCceEEEEE-ecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------cc---
Q 015202 314 FTYLELFHATNGFSANNIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------AN--- 378 (411)
Q Consensus 314 ~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~-l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------~~--- 378 (411)
-+|+|+-+.|+ .++|+|+++.|-..+ +..|...|||.++......+....+|++++.+ +|
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 35777777776 789999999998775 46789999999976655556678899999887 22
Q ss_pred ----------cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 379 ----------LLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 379 ----------l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+++.. ...-++-..--++..+||.||.|||.
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~ 194 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHT 194 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh
Confidence 11111 01125555667889999999999996
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=1.2e-05 Score=68.90 Aligned_cols=99 Identities=25% Similarity=0.216 Sum_probs=49.2
Q ss_pred cccCCeeeecCCcccccCCccccCCccCCeeecccccC--C-ccCccccCCCCCcEEEcCCCeeeecCCCC---ccCccC
Q 015202 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQL--T-YIPLTLWNLKYILYLNLSSNSFTIPLPSE---IGNLEV 138 (411)
Q Consensus 65 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l--~-~~p~~~~~~~~L~~L~l~~n~l~~~~~~~---~~~l~~ 138 (411)
+..|+.|++.+..++.. ..|..|++|++|.++.|.. . .++.-.-.+++|++|++++|.+.. +.. +..+.+
T Consensus 42 ~~~le~ls~~n~gltt~--~~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~--lstl~pl~~l~n 117 (260)
T KOG2739|consen 42 FVELELLSVINVGLTTL--TNFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKD--LSTLRPLKELEN 117 (260)
T ss_pred ccchhhhhhhccceeec--ccCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCcccc--ccccchhhhhcc
Confidence 44555555555555422 3455566666666666632 2 333333344666666666666551 222 333445
Q ss_pred CCeEEccCCeecccC---CCCccCCCccCeee
Q 015202 139 LVQIDLSMNNFSGAI---PTTIGGLKDLQYLF 167 (411)
Q Consensus 139 L~~L~l~~n~~~~~~---~~~~~~~~~L~~L~ 167 (411)
|..|++.+|..+... -..|.-+++|++|+
T Consensus 118 L~~Ldl~n~~~~~l~dyre~vf~ll~~L~~LD 149 (260)
T KOG2739|consen 118 LKSLDLFNCSVTNLDDYREKVFLLLPSLKYLD 149 (260)
T ss_pred hhhhhcccCCccccccHHHHHHHHhhhhcccc
Confidence 556666666544311 02233345555554
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00013 Score=58.94 Aligned_cols=81 Identities=22% Similarity=0.201 Sum_probs=55.8
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccc--hhhHhHHHHHHHHHH----------cccCCCCC------------
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD----------ANLLTRED------------ 384 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~----------~~l~~~~~------------ 384 (411)
++||+|.+|+||||.- +.++.||.|+++.... ..-..-.+||-++.. +.+|...+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdl 87 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHH
Confidence 6799999999999975 4567899999854332 223456778877775 33332210
Q ss_pred -------CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 385 -------KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 385 -------~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
...++-..-....+|+.+||.|.|+.
T Consensus 88 kkyfdslng~~d~~~~rsfmlqllrgl~fchsh 120 (292)
T KOG0662|consen 88 KKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH 120 (292)
T ss_pred HHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh
Confidence 11255556677889999999999973
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=1.4e-05 Score=80.35 Aligned_cols=148 Identities=22% Similarity=0.226 Sum_probs=70.3
Q ss_pred ccCCeeeecCCccc-ccCCcccc-CCccCCeeecccccCC--ccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCe
Q 015202 66 AALFQLDLGDNKLS-GFVPSCFG-NLTNLRKLYLGSNQLT--YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQ 141 (411)
Q Consensus 66 ~~L~~L~l~~n~l~-~~~~~~~~-~l~~L~~L~l~~n~l~--~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 141 (411)
.+|++|++++...- ...|..++ -+|+|+.|.+++-.+. .+..-..++|+|..||+++++++. + ..++.+++|+.
T Consensus 122 ~nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~n-l-~GIS~LknLq~ 199 (699)
T KOG3665|consen 122 QNLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISN-L-SGISRLKNLQV 199 (699)
T ss_pred HhhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccC-c-HHHhccccHHH
Confidence 35666666554321 11122222 2456666666554443 223333355666666666655552 2 34555555555
Q ss_pred EEccCCeecc-cCCCCccCCCccCeeecccccccccC------CccccCCCCCCEEeCCCCccccccc-hhhhcCCCCCE
Q 015202 142 IDLSMNNFSG-AIPTTIGGLKDLQYLFLEYNRLQGSI------PDFIGGLINLKSLDLSNNNLSGAIP-ISLEKLLDLQH 213 (411)
Q Consensus 142 L~l~~n~~~~-~~~~~~~~~~~L~~L~l~~n~l~~~~------~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~ 213 (411)
|.+.+=.+.. ..-..+-.+++|+.||+|........ -+.-..+|.|+.||.+++.+....- ..+..-|+|+.
T Consensus 200 L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~~le~ll~sH~~L~~ 279 (699)
T KOG3665|consen 200 LSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEEILEELLNSHPNLQQ 279 (699)
T ss_pred HhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhHHHHHHHHHhCccHhh
Confidence 5555443331 11122335666666666655433111 1122346777777777777654332 22333444444
Q ss_pred EE
Q 015202 214 IN 215 (411)
Q Consensus 214 l~ 215 (411)
+.
T Consensus 280 i~ 281 (699)
T KOG3665|consen 280 IA 281 (699)
T ss_pred hh
Confidence 33
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0001 Score=67.07 Aligned_cols=82 Identities=15% Similarity=0.225 Sum_probs=56.0
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-ch------hhHhHHHHHHHHHH-----------------------c
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-RE------AFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~------~~~~f~~e~~~~~~-----------------------~ 377 (411)
.+.+|+|+||.|-+|.- ..|+.||||.+.... .. ......+|+++|.+ +
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE 256 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE 256 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence 37899999999999965 578999999984321 11 12335799999998 3
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+.-..-.-++.|+..|+.|||++
T Consensus 257 ~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~ 295 (475)
T KOG0615|consen 257 YVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ 295 (475)
T ss_pred EecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc
Confidence 333222 011133334466778999999999985
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=5.9e-05 Score=71.43 Aligned_cols=80 Identities=16% Similarity=0.179 Sum_probs=54.4
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------- 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------- 376 (411)
.+.|+++-.. +-+|.|+-|.||.|.+ .+..||||+++.... .+|+-+.+
T Consensus 120 eiPFe~IsEL-------eWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 120 EIPFEEISEL-------EWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred cCCHHHhhhh-------hhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCC
Confidence 3455655444 6799999999999999 569999999854332 33333333
Q ss_pred ----------------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.|+ .+++++=..-+++..|||.||.|||.+
T Consensus 185 PcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~h 231 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLH 231 (904)
T ss_pred ceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHh
Confidence 2222 233455455577789999999999964
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=97.58 E-value=5.3e-05 Score=66.50 Aligned_cols=84 Identities=19% Similarity=0.188 Sum_probs=57.3
Q ss_pred CcCCeeeccCCceEEEEEecC---C--CEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------
Q 015202 327 SANNIIGRGGIGSIYKARIQD---G--MEVAVKVFDLQYR--EAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l~~---~--~~vavk~l~~~~~--~~~~~f~~e~~~~~~----------------------- 376 (411)
.....||+|.+|.||+|+-.+ . ...|+|+++..+. .-...-.+||.++..
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 344679999999999996522 1 2579999965432 224556677766665
Q ss_pred ------cc-----cCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------AN-----LLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~-----l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+. .|.....+.++=.....|..+|..|+.|||+|
T Consensus 107 fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N 151 (438)
T KOG0666|consen 107 FDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN 151 (438)
T ss_pred ehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh
Confidence 11 12333334577677789999999999999987
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00028 Score=63.29 Aligned_cols=88 Identities=7% Similarity=0.029 Sum_probs=55.6
Q ss_pred HHHhcCCCcCCe--eeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHH-HHH-------------------
Q 015202 320 FHATNGFSANNI--IGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMT-VVD------------------- 376 (411)
Q Consensus 320 ~~at~~f~~~~~--lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~-~~~------------------- 376 (411)
..-.+++.-.+. +|+|+||.||++.- .++..+|+|.+....... ...++.. +..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 333344443344 59999999999986 456788999885432111 1111221 211
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ...+++|.+...++.++++||.|||+.
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 128 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH 128 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3333222 123689999999999999999999974
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00011 Score=66.00 Aligned_cols=88 Identities=15% Similarity=0.275 Sum_probs=60.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~---------------------- 376 (411)
-++|.-.++||+|+||.||...- +.++..|+|.++... ..+.+.-.+|-.++.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 34566779999999999999876 457788999985432 2234567778888877
Q ss_pred -cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....++-.+-.=.+..|+.||.|||+.
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~ 144 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK 144 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC
Confidence 4444422 112255443344567999999999974
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00013 Score=67.09 Aligned_cols=78 Identities=14% Similarity=0.036 Sum_probs=54.5
Q ss_pred eeccCCceEEEEEecCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-----------------------cccCCCC---
Q 015202 332 IGRGGIGSIYKARIQDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD-----------------------ANLLTRE--- 383 (411)
Q Consensus 332 lg~g~~g~vy~g~l~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~-----------------------~~l~~~~--- 383 (411)
+|.|+++.||++.. +|..||||++... .......+..|++++.+ +|.....
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44556666667665 7899999998543 33345679999998887 2221111
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.....++.++++||+|||+.
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~ 120 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123477888899999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00034 Score=69.40 Aligned_cols=87 Identities=11% Similarity=0.033 Sum_probs=53.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEecCCCEEEEEE-Eecc-cc------hhhHhHHHHHHHHHH---ccc--------C---
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQDGMEVAVKV-FDLQ-YR------EAFKSFDNEFMTVVD---ANL--------L--- 380 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~-l~~~-~~------~~~~~f~~e~~~~~~---~~l--------~--- 380 (411)
...+...+.||+|+||.||+|.+.+. .+++|+ +... .. .....|.+|++++.. ..+ .
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 33445568999999999999998554 444443 2111 11 123568899988886 000 0
Q ss_pred -----CCCCCCCCC--HHHHHHHHHHHhhhhcccCCC
Q 015202 381 -----TREDKHFMT--KEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 -----~~~~~~~l~--w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.-.+..+. +..+.+++.++|++|.|||+.
T Consensus 411 ~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~ 447 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKA 447 (535)
T ss_pred CEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhC
Confidence 000111222 124678999999999999974
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0002 Score=66.61 Aligned_cols=81 Identities=12% Similarity=0.016 Sum_probs=59.5
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------------
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------------- 376 (411)
.++||=|.|.+||.+.- ++.+.||+|+.+.+.. -.+.-+.||+++.+
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV 161 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV 161 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence 47899999999999974 5667899999864421 13456789998887
Q ss_pred ----cccC-------CCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLL-------TREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~-------~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++|- .+..-+.++.....+||.+|..||.|||+.
T Consensus 162 CMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e 206 (590)
T KOG1290|consen 162 CMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE 206 (590)
T ss_pred EEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh
Confidence 1111 011123477788999999999999999974
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0002 Score=67.18 Aligned_cols=81 Identities=17% Similarity=0.181 Sum_probs=59.9
Q ss_pred CeeeccCCceEEEEEecC-CCEEEEEEEecccch---hhHhHHHHHHHHHH------------------------cccCC
Q 015202 330 NIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYRE---AFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~---~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
++||+|.||.||+++-.. |..+|+|.+...... ....+.+|+.+|.+ ++..+
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 789999999999998855 899999999544332 34689999999997 11111
Q ss_pred CC----CCC-CCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE----DKH-FMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~----~~~-~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. -.. .++-.....++.+|+.|+.|||+.
T Consensus 121 GeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~ 154 (382)
T KOG0032|consen 121 GELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL 154 (382)
T ss_pred chHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 000 166667789999999999999974
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=7.7e-05 Score=73.34 Aligned_cols=87 Identities=13% Similarity=0.091 Sum_probs=52.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEecCC--CEEEEE------------------EEecccchhhHhHHHHHHHHHH------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQDG--MEVAVK------------------VFDLQYREAFKSFDNEFMTVVD------ 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~~--~~vavk------------------~l~~~~~~~~~~f~~e~~~~~~------ 376 (411)
.++|.-.+.||+|+||.||++.+... ...++| ++. ........|.+|++++.+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 35676778999999999999876321 112222 111 111224568899999887
Q ss_pred ----c---------------------ccCCCC--CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----A---------------------NLLTRE--DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~---------------------~l~~~~--~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ ++.... ......+.+..+|+.|+++||+|||+.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~ 286 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK 286 (501)
T ss_pred CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 0 111100 001122344567999999999999974
|
|
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.45 E-value=9.1e-06 Score=70.07 Aligned_cols=100 Identities=26% Similarity=0.301 Sum_probs=71.9
Q ss_pred ccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCc--cccCCccC
Q 015202 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPS--CFGNLTNL 92 (411)
Q Consensus 15 ~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--~~~~l~~L 92 (411)
..+.+.+.|+..+|.++.+ ....+|+.|++|.|+-|.|+..-| |..|++|++|+|..|.|... .. -+.++++|
T Consensus 16 sdl~~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sl-dEL~YLknlpsL 90 (388)
T KOG2123|consen 16 SDLENVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESL-DELEYLKNLPSL 90 (388)
T ss_pred hHHHHhhhhcccCCCccHH--HHHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccH-HHHHHHhcCchh
Confidence 3456778899999988743 245688999999999999885544 78889999999999988743 22 25677888
Q ss_pred CeeecccccCC-ccCc-----cccCCCCCcEEE
Q 015202 93 RKLYLGSNQLT-YIPL-----TLWNLKYILYLN 119 (411)
Q Consensus 93 ~~L~l~~n~l~-~~p~-----~~~~~~~L~~L~ 119 (411)
+.|.|..|.-. +-+. .+.-+|+|+.||
T Consensus 91 r~LWL~ENPCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 91 RTLWLDENPCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred hhHhhccCCcccccchhHHHHHHHHcccchhcc
Confidence 88888888765 2222 244567777665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00051 Score=60.09 Aligned_cols=75 Identities=15% Similarity=0.153 Sum_probs=56.1
Q ss_pred CCceEEEEEecC-CCEEEEEEEecccchh-hHhHHHHHHHHHH-----------------------cccCCCC------C
Q 015202 336 GIGSIYKARIQD-GMEVAVKVFDLQYREA-FKSFDNEFMTVVD-----------------------ANLLTRE------D 384 (411)
Q Consensus 336 ~~g~vy~g~l~~-~~~vavk~l~~~~~~~-~~~f~~e~~~~~~-----------------------~~l~~~~------~ 384 (411)
+||.||+|+..+ |..+|+|++....... .+.|.+|++.+.+ ++..... .
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999854 8899999996554433 6789999998876 2222211 1
Q ss_pred CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 385 KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 385 ~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
...+++.++.+++.++++|+.|||+.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~ 106 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSN 106 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 12278999999999999999999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00028 Score=60.26 Aligned_cols=75 Identities=11% Similarity=0.028 Sum_probs=49.5
Q ss_pred eeeccCCceEEEEEecCCCEEEEEEEecccc--------hhhHhHHHHHHHHHH-----------------------ccc
Q 015202 331 IIGRGGIGSIYKARIQDGMEVAVKVFDLQYR--------EAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~--------~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
.||+|++|.||+|.+ +|..|+||+...... .....+.+|++++.. +++
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999997 678899998633211 113557788888775 111
Q ss_pred CCCCCCCCCC-HHHH-H-HHHHHHhhhhcccCCC
Q 015202 380 LTREDKHFMT-KEQR-V-SFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~~~~~l~-w~~r-~-~ia~~ia~gl~ylh~~ 410 (411)
. +..+. +... . .++.+++++|.|||+.
T Consensus 80 ~----g~~l~~~~~~~~~~~~~~i~~~l~~lH~~ 109 (199)
T TIGR03724 80 E----GKPLKDVIEEGNDELLREIGRLVGKLHKA 109 (199)
T ss_pred C----CccHHHHHhhcHHHHHHHHHHHHHHHHHC
Confidence 1 11111 1111 1 7899999999999973
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0003 Score=60.64 Aligned_cols=79 Identities=11% Similarity=0.032 Sum_probs=52.5
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccch--------hhHhHHHHHHHHHH-----------------------cc
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYRE--------AFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~--------~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+.||+|++|.||+|.. +|..|+||+....... ....+.+|++++.. +|
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999998 6788999976432211 12457888888765 12
Q ss_pred cCCCCCC---CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTREDK---HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~~~---~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.+..-. ....+ .+.+++.+++++|.|+|+.
T Consensus 81 ~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~ 114 (211)
T PRK14879 81 IEGEPLKDLINSNGM-EELELSREIGRLVGKLHSA 114 (211)
T ss_pred eCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhC
Confidence 2111100 00112 5679999999999999963
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00042 Score=67.45 Aligned_cols=81 Identities=15% Similarity=0.173 Sum_probs=52.9
Q ss_pred CeeeccCCceEEEEEecC-CCEEEEEEEecccchhhHhHHHHHHHHHH-------cccC-------------CCCCC---
Q 015202 330 NIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYREAFKSFDNEFMTVVD-------ANLL-------------TREDK--- 385 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------~~l~-------------~~~~~--- 385 (411)
-++|+|.+|+||.|.-.+ ...+|||-+.....+..+-...||.+=++ .||- +..++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999998544 34689999965555556667778765554 1211 11111
Q ss_pred -------CCC--CHHHHHHHHHHHhhhhcccCCC
Q 015202 386 -------HFM--TKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 386 -------~~l--~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.|+ +-.+.-=...||.+||.|||++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen 694 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN 694 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc
Confidence 112 2334444567999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00027 Score=63.30 Aligned_cols=82 Identities=18% Similarity=0.152 Sum_probs=55.2
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEec-c-cchhhHhHHHHHHHHHH----------------------------
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDL-Q-YREAFKSFDNEFMTVVD---------------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~-~-~~~~~~~f~~e~~~~~~---------------------------- 376 (411)
..+.||+|++|.|..++- ++|..||||++.. - ..-..+.-.+|++++.+
T Consensus 26 ~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 26 LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred ccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 347799999999999986 5789999999842 2 22234667889988887
Q ss_pred cc----cCCCCC-CCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 AN----LLTRED-KHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ~~----l~~~~~-~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
++ ||+--+ +..++-.+--=+..|+.+||.|+|+
T Consensus 106 elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHS 143 (359)
T KOG0660|consen 106 ELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHS 143 (359)
T ss_pred hHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhc
Confidence 11 111111 1124444444455799999999997
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0008 Score=57.41 Aligned_cols=33 Identities=39% Similarity=0.403 Sum_probs=28.3
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEec
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDL 358 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~ 358 (411)
+...+.||+|+||.||+|..++|+.||||++..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~ 49 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRL 49 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEec
Confidence 344588999999999999988899999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00079 Score=63.12 Aligned_cols=87 Identities=14% Similarity=0.208 Sum_probs=59.8
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc----cc-hhhHhHHHHHHHHHH---------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ----YR-EAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~----~~-~~~~~f~~e~~~~~~--------------------- 376 (411)
+.+.-.+.||+|+||.||.|.. ..|..||||.++.. .. ...+...+|+.++.+
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 4445568999999999999976 46799999976443 11 123345578888876
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ...++.-..-..+..|++.|++|+|+.
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~ 139 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR 139 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC
Confidence 3332211 112355566677889999999999985
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00013 Score=70.15 Aligned_cols=80 Identities=18% Similarity=0.274 Sum_probs=62.3
Q ss_pred eeeccCCceEEEEEecCC-CEEEEEEEecccchhhHhHHHHHHHHHH-----------cccCCCC---------------
Q 015202 331 IIGRGGIGSIYKARIQDG-MEVAVKVFDLQYREAFKSFDNEFMTVVD-----------ANLLTRE--------------- 383 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~~~-~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------~~l~~~~--------------- 383 (411)
.+|.|+||.||+|+-.+- ...|.|+++..+.....+|+-||++++. .|.++..
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 578999999999987543 3457888887777778999999999997 2222211
Q ss_pred ----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
-+++|+-.+.--||.++..||.|||++
T Consensus 119 imlEL~r~LtE~QIqvvc~q~ldALn~LHs~ 149 (1187)
T KOG0579|consen 119 IMLELGRVLTEDQIQVVCYQVLDALNWLHSQ 149 (1187)
T ss_pred HHHHhccccchHHHHHHHHHHHHHHHHHhhc
Confidence 134688888888999999999999985
|
|
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.17 E-value=2e-05 Score=68.05 Aligned_cols=84 Identities=25% Similarity=0.210 Sum_probs=56.6
Q ss_pred CCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCc--cccCCCCCcEE
Q 015202 41 LQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL--TLWNLKYILYL 118 (411)
Q Consensus 41 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~--~~~~~~~L~~L 118 (411)
+.+.+.|+.++|+++++ .....++.|+.|.|+-|.|+.. ..+..+++|+.|+|..|.|..+.. .+.++++|+.|
T Consensus 18 l~~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL--~pl~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~L 93 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSL--APLQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTL 93 (388)
T ss_pred HHHhhhhcccCCCccHH--HHHHhcccceeEEeeccccccc--hhHHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhH
Confidence 45667788888877744 2235677888888888888744 346677788888888887776543 23466777777
Q ss_pred EcCCCeeeec
Q 015202 119 NLSSNSFTIP 128 (411)
Q Consensus 119 ~l~~n~l~~~ 128 (411)
.|..|...+.
T Consensus 94 WL~ENPCc~~ 103 (388)
T KOG2123|consen 94 WLDENPCCGE 103 (388)
T ss_pred hhccCCcccc
Confidence 7766655543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00046 Score=60.36 Aligned_cols=80 Identities=16% Similarity=0.158 Sum_probs=56.7
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH---------------------------
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~--------------------------- 376 (411)
-...+|.|+||.|..... ..|...|.|.++... .+..+...+|.+++..
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 337899999999999877 457778999995433 2234557888888887
Q ss_pred -----cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.||+. .+.++-+.-.=+|.+|.-||+|||++
T Consensus 128 GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~ 163 (355)
T KOG0616|consen 128 GGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSL 163 (355)
T ss_pred CccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhc
Confidence 22222 12345555556899999999999974
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0014 Score=59.92 Aligned_cols=90 Identities=14% Similarity=0.175 Sum_probs=59.1
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEecC-CCEEEEEEEeccc---chhhHhHHHHHHHHHH------------
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------ 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------ 376 (411)
.+.+..++.. +.||.|..|+||.+++.+ +...|+|+++..+ .+.......|-++++.
T Consensus 73 ~l~l~~f~ll-------k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~ 145 (459)
T KOG0610|consen 73 SLGLRHFRLL-------KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS 145 (459)
T ss_pred ccCHHHHHHH-------HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe
Confidence 4555665555 789999999999999954 3678999995443 2233455666666665
Q ss_pred -----------cc--------cCCCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 -----------AN--------LLTREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 -----------~~--------l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+| |+++..++.++-..-.=.|..|.-||+|||-
T Consensus 146 fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm 197 (459)
T KOG0610|consen 146 FETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM 197 (459)
T ss_pred eeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh
Confidence 11 1222223335555444567899999999993
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0011 Score=55.91 Aligned_cols=29 Identities=38% Similarity=0.507 Sum_probs=26.2
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEec
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDL 358 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~ 358 (411)
+.||+|+||.||+|...+|+.||||++..
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~ 31 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRT 31 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEec
Confidence 67999999999999988899999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00073 Score=56.09 Aligned_cols=82 Identities=16% Similarity=0.211 Sum_probs=54.9
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------------------
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------------- 376 (411)
..||+|++|.|-+-++ ++|+..|||++...- .+.-+....|+.+..+
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSl 131 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSL 131 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhH
Confidence 6799999998876655 688999999995432 3334556677766665
Q ss_pred cccCCC--CCCCCCCHHHHHHHHHHHhhhhcccCCCC
Q 015202 377 ANLLTR--EDKHFMTKEQRVSFVFNLAMECTVESPNL 411 (411)
Q Consensus 377 ~~l~~~--~~~~~l~w~~r~~ia~~ia~gl~ylh~~~ 411 (411)
+-++.+ ..+...+..-.=+||..|.+||.|||+.|
T Consensus 132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL 168 (282)
T KOG0984|consen 132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL 168 (282)
T ss_pred HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh
Confidence 000000 01222444556689999999999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.003 Score=50.73 Aligned_cols=77 Identities=10% Similarity=0.032 Sum_probs=55.0
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------cccCCCC
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------ANLLTRE 383 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------~~l~~~~ 383 (411)
.+.+|+|.++.||++...+ ..++||....... ...|..|+..+.. +|+.+..
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 3679999999999999844 7899998854332 4567788877765 1111111
Q ss_pred CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 384 DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 384 ~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
...+++..+..++.+++++|+++|.
T Consensus 80 -~~~~~~~~~~~~~~~~~~~l~~lh~ 104 (155)
T cd05120 80 -LDEVSEEEKEDIAEQLAELLAKLHQ 104 (155)
T ss_pred -cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 0113567889999999999999997
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.00019 Score=61.81 Aligned_cols=58 Identities=28% Similarity=0.248 Sum_probs=43.1
Q ss_pred ccccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH
Q 015202 312 RRFTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD 376 (411)
Q Consensus 312 ~~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~ 376 (411)
..|+-++|+.. ..||.|.||+|+|=.. +.|+..|||++..... .+-+.|..|.++..+
T Consensus 59 ~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mk 118 (361)
T KOG1006|consen 59 HTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMK 118 (361)
T ss_pred cccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHh
Confidence 35665666655 6799999999999776 5789999999965443 444678888876665
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0012 Score=61.72 Aligned_cols=82 Identities=16% Similarity=0.186 Sum_probs=58.1
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH------------------------cccCC
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------------ANLLT 381 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------------~~l~~ 381 (411)
.+.+|+|+||.++.... .++..+++|.+... +....+.-.+|+.++++ +|..+
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 36899999999886554 35678999988443 34445678899999997 23222
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+ ++.-++-.+.+++.+|+..|+.|||++
T Consensus 89 g~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~ 125 (426)
T KOG0589|consen 89 GDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN 125 (426)
T ss_pred CCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh
Confidence 22 112255556688999999999999964
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.00032 Score=67.25 Aligned_cols=81 Identities=20% Similarity=0.260 Sum_probs=54.5
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEE--EE-ec-ccchhhHhHHHHHHHHHH-----------cc---------------
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVK--VF-DL-QYREAFKSFDNEFMTVVD-----------AN--------------- 378 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk--~l-~~-~~~~~~~~f~~e~~~~~~-----------~~--------------- 378 (411)
.+||+|.|-+||||.-+ +|..||=- ++ +. .+....+.|..|++++.. .|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 68999999999999752 45666521 22 11 223445789999999997 11
Q ss_pred ----cCCCC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 ----LLTRE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 ----l~~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|+.+. .-+.++-....++|.+|.+||.|||++
T Consensus 126 TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~ 162 (632)
T KOG0584|consen 126 TSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ 162 (632)
T ss_pred cCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC
Confidence 11111 112366667788999999999999974
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.00096 Score=60.89 Aligned_cols=81 Identities=15% Similarity=0.196 Sum_probs=59.6
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccC--
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLL-- 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~-- 380 (411)
+.+|+|.||.|-+|.- ..|+.||||.++... .++.-...+||++|+. +|-.
T Consensus 59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~G 138 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGG 138 (668)
T ss_pred HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCc
Confidence 5699999999999965 578999999985443 3334457899999997 2211
Q ss_pred ---CCC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 ---TRE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ---~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. ....|+-+.-..+..||..|..|.|.+
T Consensus 139 eLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn 172 (668)
T KOG0611|consen 139 ELYDYISERGSLSEREARHFFRQIVSAVHYCHKN 172 (668)
T ss_pred cHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc
Confidence 111 123477777788889999999999975
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.00073 Score=62.54 Aligned_cols=87 Identities=15% Similarity=0.200 Sum_probs=62.6
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
+.|+.-++||+||||.||-.+.. .|...|.|+++... +++...-.+|-.++.+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45788899999999999988774 57788998884322 3344556777777776
Q ss_pred cccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.+.+ +.+.++-.+..=.|.+|+-||++||+.
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~ 306 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR 306 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc
Confidence 1111111 234588887788899999999999973
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.00061 Score=67.57 Aligned_cols=47 Identities=30% Similarity=0.524 Sum_probs=34.7
Q ss_pred CCcCCeeeccCCc-eEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH
Q 015202 326 FSANNIIGRGGIG-SIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD 376 (411)
Q Consensus 326 f~~~~~lg~g~~g-~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~ 376 (411)
|+..+++|.|+.| .||+|++ +|+.||||++-... ..--.+||..+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~e 558 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQE 558 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHh
Confidence 4566789999987 6799999 77999999983222 2233678887776
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0023 Score=59.16 Aligned_cols=86 Identities=14% Similarity=0.147 Sum_probs=54.8
Q ss_pred CCCcCCeeeccCCceEEEEEecCC--CEEEEEEEecccchhhHhHHHHHHHHHH-c----------------------c-
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDG--MEVAVKVFDLQYREAFKSFDNEFMTVVD-A----------------------N- 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~--~~vavk~l~~~~~~~~~~f~~e~~~~~~-~----------------------~- 378 (411)
.|.-...||+|+||.||.+.-.+. ..+|+|.-..........+..|+.++.. . |
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566668999999999999986442 3677776533222211145555554443 0 0
Q ss_pred -----------cCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 -----------LLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 -----------l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|........++-.+.++||.++..||.|||+.
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~ 141 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK 141 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc
Confidence 00000123488889999999999999988863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0037 Score=54.87 Aligned_cols=71 Identities=8% Similarity=0.052 Sum_probs=48.1
Q ss_pred cCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC------C
Q 015202 335 GGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE------D 384 (411)
Q Consensus 335 g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~------~ 384 (411)
|.+|.||++.- .+|+.+|+|++...+ ++..|...+.. +|+.+.. .
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 78999999976 467899999985432 22233322221 3333221 1
Q ss_pred CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 385 KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 385 ~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
...++|....+++.++++||+|||+.
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~ 104 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHRE 104 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 12488999999999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0016 Score=59.71 Aligned_cols=88 Identities=19% Similarity=0.159 Sum_probs=61.4
Q ss_pred HHhcCCCcCCeeeccCCceEEEEEec----CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------cccCCCC--
Q 015202 321 HATNGFSANNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------ANLLTRE-- 383 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------~~l~~~~-- 383 (411)
...+.|...++||+|.|++||+++.. ....||+|.+...+.. ....+|++++.. ..++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 33445667799999999999999873 3567999999655443 348888888876 1111111
Q ss_pred --------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 --------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 --------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
--..++.+.........-+||.|+|.+
T Consensus 111 ~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~ 151 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN 151 (418)
T ss_pred EEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc
Confidence 011266777777788999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0059 Score=52.35 Aligned_cols=48 Identities=15% Similarity=0.158 Sum_probs=35.3
Q ss_pred CcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH
Q 015202 327 SANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~ 376 (411)
++...||+|+||.||. .++....+||++........+++.+|+..+..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~ 52 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAH 52 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHH
Confidence 3558999999999996 43333347998865444456789999998885
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0057 Score=57.91 Aligned_cols=55 Identities=20% Similarity=0.296 Sum_probs=41.1
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccch---hhHhHHHHHHHHHH
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYRE---AFKSFDNEFMTVVD 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~---~~~~f~~e~~~~~~ 376 (411)
..++|.-..+||+|+||.||.+.- ..|...|.|++...... ......+|=.+|+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~ 197 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE 197 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh
Confidence 456777779999999999999976 45889999999554332 23446667677765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0019 Score=61.11 Aligned_cols=84 Identities=21% Similarity=0.264 Sum_probs=55.9
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chh-hHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REA-FKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~-~~~f~~e~~~~~~----------------------- 376 (411)
++|.=.++||+|+|.+||+|+- ..+...|||+++..- ++. .+-...|-.+|.+
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 3444448999999999999975 567899999984321 111 2335556666665
Q ss_pred ----------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++. -..++-..-.-.|.+|..||+|||++
T Consensus 153 Le~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~ 193 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSN 193 (604)
T ss_pred EEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhc
Confidence 12221 12366666666889999999999975
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0026 Score=59.95 Aligned_cols=78 Identities=17% Similarity=0.164 Sum_probs=55.3
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccc--hhhHhHHHHHHHHHH------------------------------
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD------------------------------ 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~------------------------------ 376 (411)
+-||+|.|++|-.|.. =.|..||||+++.... .......+|+++|.-
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD 103 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD 103 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence 5699999999987753 2689999999965432 235678899999986
Q ss_pred --cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 --ANLLTREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 --~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|+-.+ ...+...--.+...||.+|+.|.|+
T Consensus 104 l~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHq 136 (864)
T KOG4717|consen 104 LFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQ 136 (864)
T ss_pred HHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhh
Confidence 121111 1225555556778899999999996
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0028 Score=57.50 Aligned_cols=86 Identities=13% Similarity=0.094 Sum_probs=59.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------- 376 (411)
++.|.....+|+|.||.|.+..-. .+..||||.++.-.+- ...=..|++++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 344445578999999999887643 3678999998543322 2345567777766
Q ss_pred ------------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++|.... ..+++-.+...|+.|+.++++|||++
T Consensus 167 CivfellG~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~ 211 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL 211 (415)
T ss_pred EEEEeccChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc
Confidence 3333221 23567778899999999999999985
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.0096 Score=51.79 Aligned_cols=89 Identities=19% Similarity=0.189 Sum_probs=56.7
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH--------------
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-------------- 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-------------- 376 (411)
..+..|++.. ..+|.|.+|.||+.++. .|..+|||.+.... +.+.+.....+.++..
T Consensus 88 ~~dindl~~l-------~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 88 QADINDLENL-------GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ccChHHhhhH-------HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 3455666655 56999999999999985 47889999995433 3334555555555554
Q ss_pred -----------------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 -----------------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 -----------------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+-|..+. ..+++..--=+|.+.+.+||.||.+
T Consensus 161 i~n~dV~IcMelMs~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe 209 (391)
T KOG0983|consen 161 ITNTDVFICMELMSTCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE 209 (391)
T ss_pred eeCchHHHHHHHHHHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH
Confidence 2221111 1234433345677889999999854
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.007 Score=54.09 Aligned_cols=84 Identities=10% Similarity=0.092 Sum_probs=52.2
Q ss_pred CCcCCeeeccCCceEEEEE-ecCCCEEEEEEE--ecccchhhHhHHHHHHHHHH---------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKAR-IQDGMEVAVKVF--DLQYREAFKSFDNEFMTVVD---------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~-l~~~~~vavk~l--~~~~~~~~~~f~~e~~~~~~---------------------~~l~~ 381 (411)
|.-.++||+|.||+.+.|+ +=+++.||||-= +....+-..++..- ++++. +.|-.
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~Y-KlL~g~~GIP~vYYFGqeG~~NiLVidLLGP 108 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTY-KLLGGTEGIPQVYYFGQEGKYNILVIDLLGP 108 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHH-HHHcCCCCCCceeeeccccchhhhhhhhhCc
Confidence 4455899999999999996 347899999853 22222323333221 12222 11111
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. -++.++..+.+.||.++..-++|+|+.
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k 143 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK 143 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc
Confidence 00 133466667899999999999999974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.0084 Score=60.17 Aligned_cols=93 Identities=17% Similarity=0.220 Sum_probs=67.1
Q ss_pred HHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------
Q 015202 316 YLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------ 376 (411)
Q Consensus 316 ~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------ 376 (411)
++.+...++-|.-..+||+|.+|.||++.- .+|+.+|||.+.... ....+...|.+++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 333444455566668999999999999974 678899999886543 334567777777775
Q ss_pred --------------------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+...+- .+..+.|....=|+..+.+||.+||.+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~-~g~rl~E~~IaYI~re~lrgl~HLH~n 142 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNT-KGNRLKEEWIAYILREILRGLAHLHNN 142 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhh-cccchhhHHHHHHHHHHHHHHHHHhhc
Confidence 222222 245588998999999999999999986
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.0025 Score=65.97 Aligned_cols=55 Identities=29% Similarity=0.514 Sum_probs=43.3
Q ss_pred HHhcCCCcCCeeeccCCceEEEEE--ecCCCEEEEEEEecc-cchhhHhHHHHHHHHHH
Q 015202 321 HATNGFSANNIIGRGGIGSIYKAR--IQDGMEVAVKVFDLQ-YREAFKSFDNEFMTVVD 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~--l~~~~~vavk~l~~~-~~~~~~~f~~e~~~~~~ 376 (411)
+...+|.+..+||+||||.||++. + ||+..|||++... +........+|++++++
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl-DGr~YAIKKIpl~~s~~~~skI~rEVk~LAr 533 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL-DGREYAIKKIPLKASDKLYSKILREVKLLAR 533 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc-cchhhhhhhccCchHHHHHHHHHHHHHHHhh
Confidence 344567777899999999999986 5 8899999999443 33344667889999997
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.0039 Score=57.72 Aligned_cols=30 Identities=40% Similarity=0.748 Sum_probs=24.7
Q ss_pred CeeeccCCceEEEEE-ecCCCEEEEEEEecc
Q 015202 330 NIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQ 359 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~-l~~~~~vavk~l~~~ 359 (411)
+++|+|||..|||+. +.+.+.||||.-...
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlN 499 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLN 499 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhc
Confidence 689999999999996 456678999987443
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.0039 Score=65.17 Aligned_cols=90 Identities=18% Similarity=0.194 Sum_probs=59.7
Q ss_pred HHhcCCCcCCeeeccCCceEEEEE-ecCCCEEEEEEE--ecccchhhHhHHHHHHHHHH---------------------
Q 015202 321 HATNGFSANNIIGRGGIGSIYKAR-IQDGMEVAVKVF--DLQYREAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~-l~~~~~vavk~l--~~~~~~~~~~f~~e~~~~~~--------------------- 376 (411)
..+-+|...+.||.|.||.||.|+ ++.|...|||-+ +..........-+|+.++..
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345556677999999999999997 467888999976 33333445667777777765
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. .++..+...--....+++.|++|||+.
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~ 1353 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH 1353 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc
Confidence 3333222 111233333344567999999999974
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.0045 Score=47.80 Aligned_cols=45 Identities=24% Similarity=0.372 Sum_probs=34.7
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~ 376 (411)
.+-+|.|+.|.||+|++.+|+.||||...+.-. +.+...+++|..
T Consensus 16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~---~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLKDGEEVAVKVQRPGIE---EQIEADLRILRR 60 (119)
T ss_pred cchhhheehhhheeeeecccchhhhhhcchHHH---HHHHHHHHHHHH
Confidence 377999999999999999999999999866543 345555555543
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.00064 Score=58.10 Aligned_cols=79 Identities=23% Similarity=0.172 Sum_probs=50.6
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEE-ecccchh-hHhHHHHHHHHHH------------------------------
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVF-DLQYREA-FKSFDNEFMTVVD------------------------------ 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l-~~~~~~~-~~~f~~e~~~~~~------------------------------ 376 (411)
.+||+|.||.||+|+-. .|+.||+|++ -...+.+ -..-.+|++++..
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 68999999999999874 4667898865 1111111 1223445554443
Q ss_pred ---------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..|.+. ...++..+..++..++-.||.|+|++
T Consensus 103 f~~cehDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~ 143 (376)
T KOG0669|consen 103 FDFCEHDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN 143 (376)
T ss_pred HHHhhhhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh
Confidence 111111 12377778888999999999999974
|
|
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.0031 Score=32.34 Aligned_cols=11 Identities=36% Similarity=0.561 Sum_probs=4.4
Q ss_pred CeeecccCccc
Q 015202 45 QLLGLEDNQLE 55 (411)
Q Consensus 45 ~~L~l~~n~l~ 55 (411)
++|+|++|+++
T Consensus 3 ~~Ldls~n~l~ 13 (22)
T PF00560_consen 3 EYLDLSGNNLT 13 (22)
T ss_dssp SEEEETSSEES
T ss_pred cEEECCCCcCE
Confidence 33444444333
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.0029 Score=32.46 Aligned_cols=12 Identities=50% Similarity=0.603 Sum_probs=5.2
Q ss_pred CCeeeecCCccc
Q 015202 68 LFQLDLGDNKLS 79 (411)
Q Consensus 68 L~~L~l~~n~l~ 79 (411)
|++|||++|+++
T Consensus 2 L~~Ldls~n~l~ 13 (22)
T PF00560_consen 2 LEYLDLSGNNLT 13 (22)
T ss_dssp ESEEEETSSEES
T ss_pred ccEEECCCCcCE
Confidence 344444444444
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A .... |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.016 Score=55.85 Aligned_cols=86 Identities=15% Similarity=0.186 Sum_probs=59.3
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~---------------------- 376 (411)
.+.+|.-...||+|.|+.|..|.. ..|..||+|.++... ....+.+.+|+.+|..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345566668899999999999986 358899999985543 2234569999999987
Q ss_pred ----------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.... +--+ ..--.+-.++.+|++|+|+.
T Consensus 134 ~eya~~ge~~~yl~~~g--r~~e-~~ar~~F~q~vsaveYcH~k 174 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG--RMKE-KEARAKFRQIVSAVEYCHSK 174 (596)
T ss_pred EEeccCchhHHHHHhcc--cchh-hhhhhhhHHHHHHHHHHhhc
Confidence 3333221 1122 33334446899999999975
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.027 Score=48.61 Aligned_cols=81 Identities=11% Similarity=0.047 Sum_probs=56.8
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccc-hhhHhHHHHHHHHHH----------------------------cccC
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD----------------------------ANLL 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~----------------------------~~l~ 380 (411)
..++.|..+.||+.+..+|..++||....... ....++..|++++.. +++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46889999999999987778899998743322 134567888877775 1121
Q ss_pred CCCCC-----CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TREDK-----HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~~~-----~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..-. ..++..++.+++.++|++|.+||+.
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 118 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSV 118 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCC
Confidence 11100 1256678899999999999999974
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.017 Score=55.45 Aligned_cols=85 Identities=13% Similarity=0.122 Sum_probs=56.4
Q ss_pred CCcCCeeeccCCceEEEEEecC-CCEEEEEEEecc-----cch---hhHhHHHHHHHHHH-------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQ-----YRE---AFKSFDNEFMTVVD-------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~-----~~~---~~~~f~~e~~~~~~-------------------~ 377 (411)
|.--..+|+|+||.|+.+.... ...|+||.+... +.- ...-.-.||.+|++ +
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 4445789999999999999844 456888876321 111 12346789999987 1
Q ss_pred c--cCCCCCC------------CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 N--LLTREDK------------HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~--l~~~~~~------------~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
| |.-...+ ..++...-.-|-.||+.|.++||++
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~ 689 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ 689 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc
Confidence 1 1111111 1255566677889999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.012 Score=51.06 Aligned_cols=53 Identities=13% Similarity=0.096 Sum_probs=38.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhh---Hh------HHHHHHHHHH
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAF---KS------FDNEFMTVVD 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~---~~------f~~e~~~~~~ 376 (411)
.++|...+++|.|+||.||.... ++..+|||.+.+...... .. |.+|+..+.+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~r 91 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDR 91 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHH
Confidence 45677779999999999999766 567899999954332211 12 6888877776
|
|
| >KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.00095 Score=65.32 Aligned_cols=15 Identities=27% Similarity=0.193 Sum_probs=8.7
Q ss_pred cCCCCCCEEeCCCCc
Q 015202 182 GGLINLKSLDLSNNN 196 (411)
Q Consensus 182 ~~~~~L~~L~l~~n~ 196 (411)
..++.++.+.+..+.
T Consensus 359 ~~~~~l~~~~l~~~~ 373 (482)
T KOG1947|consen 359 RSCPKLTDLSLSYCG 373 (482)
T ss_pred hcCCCcchhhhhhhh
Confidence 455566666665555
|
|
| >KOG0473 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.00055 Score=57.80 Aligned_cols=88 Identities=17% Similarity=0.214 Sum_probs=53.9
Q ss_pred hhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCc
Q 015202 37 ALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYIL 116 (411)
Q Consensus 37 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~ 116 (411)
.+..+...+.||++.|++. .....|.-+..|..|+++.|++. ..|..+..+..++.+++.+|..+..|.+....+.++
T Consensus 37 ei~~~kr~tvld~~s~r~v-n~~~n~s~~t~~~rl~~sknq~~-~~~~d~~q~~e~~~~~~~~n~~~~~p~s~~k~~~~k 114 (326)
T KOG0473|consen 37 EIASFKRVTVLDLSSNRLV-NLGKNFSILTRLVRLDLSKNQIK-FLPKDAKQQRETVNAASHKNNHSQQPKSQKKEPHPK 114 (326)
T ss_pred hhhccceeeeehhhhhHHH-hhccchHHHHHHHHHhccHhhHh-hChhhHHHHHHHHHHHhhccchhhCCccccccCCcc
Confidence 3455556666666666654 22334555666666666666666 556666666666666666666666666666666666
Q ss_pred EEEcCCCeee
Q 015202 117 YLNLSSNSFT 126 (411)
Q Consensus 117 ~L~l~~n~l~ 126 (411)
.+++-.|.+.
T Consensus 115 ~~e~k~~~~~ 124 (326)
T KOG0473|consen 115 KNEQKKTEFF 124 (326)
T ss_pred hhhhccCcch
Confidence 6666666543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.028 Score=54.18 Aligned_cols=44 Identities=27% Similarity=0.380 Sum_probs=33.5
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHH
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVV 375 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~ 375 (411)
.+-+|.|++|.||+|++.+|+.||||+..+.. .+.+..+++++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i---~~~i~~Dl~~l~ 165 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGI---EKTIAADIALLY 165 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCc---HHHHHHHHHHHH
Confidence 36799999999999999999999999986554 233444444433
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.009 Score=28.40 Aligned_cols=15 Identities=53% Similarity=0.707 Sum_probs=5.3
Q ss_pred cCCeeecccccCCcc
Q 015202 91 NLRKLYLGSNQLTYI 105 (411)
Q Consensus 91 ~L~~L~l~~n~l~~~ 105 (411)
+|+.|++++|+++++
T Consensus 2 ~L~~L~l~~n~L~~l 16 (17)
T PF13504_consen 2 NLRTLDLSNNRLTSL 16 (17)
T ss_dssp T-SEEEETSS--SSE
T ss_pred ccCEEECCCCCCCCC
Confidence 344444444444443
|
... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.005 Score=59.89 Aligned_cols=86 Identities=21% Similarity=0.230 Sum_probs=59.1
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------cccCCCC---------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------ANLLTRE--------- 383 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------~~l~~~~--------- 383 (411)
+|.-...+|.|.+|.|||++- +.+...|||.++...........+||-++.. .|++...
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 344447899999999999974 5678899999866554445556666665554 3333111
Q ss_pred ---------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ---------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ---------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
...+++-.|.--++...-+||+|||+.
T Consensus 96 ggslQdiy~~TgplselqiayvcRetl~gl~ylhs~ 131 (829)
T KOG0576|consen 96 GGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ 131 (829)
T ss_pred CCcccceeeecccchhHHHHHHHhhhhccchhhhcC
Confidence 112466666667778999999999974
|
|
| >KOG4308 consensus LRR-containing protein [Function unknown] | Back alignment and domain information |
|---|
Probab=95.25 E-value=6.4e-05 Score=72.38 Aligned_cols=87 Identities=24% Similarity=0.268 Sum_probs=50.2
Q ss_pred ccCCCeEEccCCeeccc----CCCCccCCCc-cCeeeccccccccc----CCccccCC-CCCCEEeCCCCcccccc----
Q 015202 136 LEVLVQIDLSMNNFSGA----IPTTIGGLKD-LQYLFLEYNRLQGS----IPDFIGGL-INLKSLDLSNNNLSGAI---- 201 (411)
Q Consensus 136 l~~L~~L~l~~n~~~~~----~~~~~~~~~~-L~~L~l~~n~l~~~----~~~~~~~~-~~L~~L~l~~n~l~~~~---- 201 (411)
..++++|.+.+|.++.. ....+...+. +..+++..|.+.+. ....+..+ +.++.++++.|.++..-
T Consensus 203 ~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~d~g~~~L~~~l~~~~~~l~~l~l~~nsi~~~~~~~L 282 (478)
T KOG4308|consen 203 LSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLGDVGVEKLLPCLSVLSETLRVLDLSRNSITEKGVRDL 282 (478)
T ss_pred cccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcchHHHHHHHHHhcccchhhhhhhhhcCCccccchHHH
Confidence 55666667766665421 1122233333 55577777776532 11223334 56778888888886443
Q ss_pred chhhhcCCCCCEEEcccCccc
Q 015202 202 PISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 202 ~~~~~~l~~L~~l~l~~n~l~ 222 (411)
...+..++.++.+.+++|++.
T Consensus 283 ~~~l~~~~~l~~l~l~~n~l~ 303 (478)
T KOG4308|consen 283 AEVLVSCRQLEELSLSNNPLT 303 (478)
T ss_pred HHHHhhhHHHHHhhcccCccc
Confidence 334445667788888888775
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.041 Score=47.98 Aligned_cols=82 Identities=15% Similarity=0.169 Sum_probs=54.2
Q ss_pred cCCeeeccCCceEEEEEecC-CCEEEEEEEecccchhhHhHHHHHH----------HHHH---------------cc---
Q 015202 328 ANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYREAFKSFDNEFM----------TVVD---------------AN--- 378 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~~~~~f~~e~~----------~~~~---------------~~--- 378 (411)
-.+.+|+|.||.+..++.+. .+.+++|-+... ..-.++|.+|.. ++.. +|
T Consensus 28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~ 106 (378)
T KOG1345|consen 28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPR 106 (378)
T ss_pred HHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCcc
Confidence 34789999999999999854 567888877321 122467888874 2221 11
Q ss_pred --cCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 --LLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 --l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|...-....+.-..-.+|+.+++.|+.|+|+.
T Consensus 107 gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk 140 (378)
T KOG1345|consen 107 GDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK 140 (378)
T ss_pred chhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc
Confidence 11111222366667788999999999999973
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.014 Score=55.66 Aligned_cols=79 Identities=14% Similarity=0.077 Sum_probs=56.9
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEE--ecccchhhHhHHHHHHHHHH-----------------c------------
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVF--DLQYREAFKSFDNEFMTVVD-----------------A------------ 377 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l--~~~~~~~~~~f~~e~~~~~~-----------------~------------ 377 (411)
...||+||...||+..-.+.+.+|+|++ .....+....|.+||+.+.+ +
T Consensus 366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~D 445 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDID 445 (677)
T ss_pred HHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccccc
Confidence 3689999999999999888888898876 33444556889999999998 2
Q ss_pred ---ccCCCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 378 ---NLLTREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 378 ---~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|..+ .+...+|. +..+-.++..|..|+|+
T Consensus 446 L~kiL~k~-~~~~~~~~-lk~ywkqML~aV~~IH~ 478 (677)
T KOG0596|consen 446 LNKILKKK-KSIDPDWF-LKFYWKQMLLAVKTIHQ 478 (677)
T ss_pred HHHHHHhc-cCCCchHH-HHHHHHHHHHHHHHHHH
Confidence 22222 23345663 44455688888888875
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.051 Score=46.33 Aligned_cols=81 Identities=7% Similarity=-0.074 Sum_probs=51.9
Q ss_pred cCCeeeccCCceEEEEEecCCCEEEEEEEecccchh----hHhHHHHHHHHHH--------------------cccCCCC
Q 015202 328 ANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREA----FKSFDNEFMTVVD--------------------ANLLTRE 383 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~----~~~f~~e~~~~~~--------------------~~l~~~~ 383 (411)
.+..+++|+||+||.+.- ++..++.+.+....... ...|.+|++++.+ +|+.+..
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~ 84 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAA 84 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCcc
Confidence 457899999999996664 66788888875544311 2358899999987 2222211
Q ss_pred CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
-..... .....+..+++++|+|+|+.
T Consensus 85 L~~~~~-~~~~~~~~qi~~~L~~lH~~ 110 (218)
T PRK12274 85 MYQRPP-RGDLAYFRAARRLLQQLHRC 110 (218)
T ss_pred HHhhhh-hhhHHHHHHHHHHHHHHHHC
Confidence 000000 12245778899999999974
|
|
| >KOG0473 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.0013 Score=55.71 Aligned_cols=87 Identities=20% Similarity=0.234 Sum_probs=51.3
Q ss_pred hhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCe
Q 015202 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQ 141 (411)
Q Consensus 62 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 141 (411)
+......+.||++.|++. .+-..|.-++.|..|+++.|.+..+|..+.....++.+++..|..+ ..|.+++..+.++.
T Consensus 38 i~~~kr~tvld~~s~r~v-n~~~n~s~~t~~~rl~~sknq~~~~~~d~~q~~e~~~~~~~~n~~~-~~p~s~~k~~~~k~ 115 (326)
T KOG0473|consen 38 IASFKRVTVLDLSSNRLV-NLGKNFSILTRLVRLDLSKNQIKFLPKDAKQQRETVNAASHKNNHS-QQPKSQKKEPHPKK 115 (326)
T ss_pred hhccceeeeehhhhhHHH-hhccchHHHHHHHHHhccHhhHhhChhhHHHHHHHHHHHhhccchh-hCCccccccCCcch
Confidence 334455666666666655 2334455556666666666666666666655555566666655555 55666666666666
Q ss_pred EEccCCeec
Q 015202 142 IDLSMNNFS 150 (411)
Q Consensus 142 L~l~~n~~~ 150 (411)
+++..|.+.
T Consensus 116 ~e~k~~~~~ 124 (326)
T KOG0473|consen 116 NEQKKTEFF 124 (326)
T ss_pred hhhccCcch
Confidence 666666544
|
|
| >KOG4308 consensus LRR-containing protein [Function unknown] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.0001 Score=70.93 Aligned_cols=65 Identities=25% Similarity=0.293 Sum_probs=30.7
Q ss_pred CCCccCeeecccccccccC----CccccCCCC-CCEEeCCCCccccc----cchhhhcC-CCCCEEEcccCcccc
Q 015202 159 GLKDLQYLFLEYNRLQGSI----PDFIGGLIN-LKSLDLSNNNLSGA----IPISLEKL-LDLQHINVSFNKLEG 223 (411)
Q Consensus 159 ~~~~L~~L~l~~n~l~~~~----~~~~~~~~~-L~~L~l~~n~l~~~----~~~~~~~l-~~L~~l~l~~n~l~~ 223 (411)
...++++|++.+|.++... ...+...+. +..+++.+|.+.+. ....+... ..++.++++.|.++.
T Consensus 202 ~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~d~g~~~L~~~l~~~~~~l~~l~l~~nsi~~ 276 (478)
T KOG4308|consen 202 PLSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLGDVGVEKLLPCLSVLSETLRVLDLSRNSITE 276 (478)
T ss_pred ccccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcchHHHHHHHHHhcccchhhhhhhhhcCCccc
Confidence 3455666666666554211 112223333 44566666665432 11222223 345666666666653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.067 Score=45.88 Aligned_cols=83 Identities=17% Similarity=0.095 Sum_probs=52.9
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------cccCCC-----------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------ANLLTR----------- 382 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------~~l~~~----------- 382 (411)
.+.-.+.||.|+||.+|.|.. .+|..||||.=.... ..-...-|.++... .|.+..
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 344558899999999999974 789999999753221 12245556655543 111100
Q ss_pred --C-------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 383 --E-------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 383 --~-------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+ -.+.++-.+.+-.|-|+..-++|+|.
T Consensus 94 GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~ 129 (341)
T KOG1163|consen 94 GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL 129 (341)
T ss_pred CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh
Confidence 0 01225555667778899999999885
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.018 Score=48.87 Aligned_cols=45 Identities=16% Similarity=0.313 Sum_probs=36.7
Q ss_pred CCeeeccCCceEEEEE-ecCCCEEEEEEEecccchhhHhHHHHHHHHHH
Q 015202 329 NNIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~-l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~ 376 (411)
.+.+|+|.++.|+.|. ..+.+.++||.+++-. .+...+|+.++..
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~n 88 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQN 88 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHh
Confidence 3789999999999997 4577889999997544 4568899999886
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.038 Score=49.33 Aligned_cols=87 Identities=11% Similarity=0.180 Sum_probs=50.5
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+++|+|.||.|-...- ..|...|+|.++..- +.....-..|-+++..
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 3444458999999999987654 457788999874321 1112223455555554
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ..+.++-.+-.=.-..|..||.|||+.
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~ 287 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR 287 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC
Confidence 2222111 112344333233457899999999974
|
|
| >KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.0084 Score=58.63 Aligned_cols=110 Identities=22% Similarity=0.096 Sum_probs=66.9
Q ss_pred cCCcCCceeecCcccccc--cchhhhCCCCCCeeecccC-cccccCc----hhhhccccCCeeeecCCc-ccccCCcccc
Q 015202 16 NLTNLIAIYLGGNKLNGS--ISIALGKLQKLQLLGLEDN-QLEGSIP----YDLCRLAALFQLDLGDNK-LSGFVPSCFG 87 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~--~~~~~~~l~~L~~L~l~~n-~l~~~~~----~~~~~l~~L~~L~l~~n~-l~~~~~~~~~ 87 (411)
.+++|+.|.+..+.-... .-.....+++|+.|+++++ ......+ .....+++|+.|+++.+. ++...-..+.
T Consensus 186 ~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~L~~l~l~~~~~isd~~l~~l~ 265 (482)
T KOG1947|consen 186 SCPLLKRLSLSGCSKITDDSLDALALKCPNLEELDLSGCCLLITLSPLLLLLLLSICRKLKSLDLSGCGLVTDIGLSALA 265 (482)
T ss_pred hCchhhHhhhcccccCChhhHHHHHhhCchhheecccCcccccccchhHhhhhhhhcCCcCccchhhhhccCchhHHHHH
Confidence 467888888887743322 3345678888888888863 2111111 233456788888888877 4422212222
Q ss_pred -CCccCCeeeccccc-CC--ccCccccCCCCCcEEEcCCCee
Q 015202 88 -NLTNLRKLYLGSNQ-LT--YIPLTLWNLKYILYLNLSSNSF 125 (411)
Q Consensus 88 -~l~~L~~L~l~~n~-l~--~~p~~~~~~~~L~~L~l~~n~l 125 (411)
.+++|+.|.+.++. ++ .+-.....++.|++|+++.+..
T Consensus 266 ~~c~~L~~L~l~~c~~lt~~gl~~i~~~~~~L~~L~l~~c~~ 307 (482)
T KOG1947|consen 266 SRCPNLETLSLSNCSNLTDEGLVSIAERCPSLRELDLSGCHG 307 (482)
T ss_pred hhCCCcceEccCCCCccchhHHHHHHHhcCcccEEeeecCcc
Confidence 26788888877665 44 2333334677788888887654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.056 Score=52.96 Aligned_cols=81 Identities=14% Similarity=0.192 Sum_probs=57.0
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
..-||+|+.|.|-.|.. ..|+.+|||.+.... ...-....+||.+|.- +|.-+
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 36799999999999976 579999999984332 2223568889988886 11111
Q ss_pred CC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 382 RE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 382 ~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.. ...++.-+.-.+.-.||..|+.|.|.
T Consensus 97 GELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~ 130 (786)
T KOG0588|consen 97 GELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA 130 (786)
T ss_pred chhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh
Confidence 11 12246666677888899999999985
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.04 E-value=0.057 Score=56.14 Aligned_cols=82 Identities=18% Similarity=0.135 Sum_probs=54.1
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchh---hHhHHHHHH---------HHHH-----------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREA---FKSFDNEFM---------TVVD----------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~---~~~f~~e~~---------~~~~----------------- 376 (411)
|.-...+|+|+||.||+|+-.+|+.||+|.=.+.+..+ ..+...-++ ++.-
T Consensus 700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 33447999999999999999889999999876554322 011111111 1110
Q ss_pred ---cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++. ....++|.--+-++.++++=++.||.+
T Consensus 780 tlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~ 813 (974)
T KOG1166|consen 780 TLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM 813 (974)
T ss_pred cHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc
Confidence 1111 223588988899999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.0012 Score=56.36 Aligned_cols=47 Identities=17% Similarity=0.371 Sum_probs=36.2
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~ 376 (411)
.+||+|.|..||+... +.|+..|+|.++.. +..+.++..+|++++..
T Consensus 17 e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~ 66 (355)
T KOG0033|consen 17 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 66 (355)
T ss_pred HHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHh
Confidence 5799999999998765 56788888877432 23356788999998886
|
|
| >smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.044 Score=29.27 Aligned_cols=20 Identities=45% Similarity=0.604 Sum_probs=12.5
Q ss_pred ccCCeeecccccCCccCccc
Q 015202 90 TNLRKLYLGSNQLTYIPLTL 109 (411)
Q Consensus 90 ~~L~~L~l~~n~l~~~p~~~ 109 (411)
++|+.|+|++|+++.+|...
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~ 21 (26)
T smart00369 2 PNLRELDLSNNQLSSLPPGA 21 (26)
T ss_pred CCCCEEECCCCcCCcCCHHH
Confidence 45666666666666666543
|
|
| >smart00370 LRR Leucine-rich repeats, outliers | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.044 Score=29.27 Aligned_cols=20 Identities=45% Similarity=0.604 Sum_probs=12.5
Q ss_pred ccCCeeecccccCCccCccc
Q 015202 90 TNLRKLYLGSNQLTYIPLTL 109 (411)
Q Consensus 90 ~~L~~L~l~~n~l~~~p~~~ 109 (411)
++|+.|+|++|+++.+|...
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~ 21 (26)
T smart00370 2 PNLRELDLSNNQLSSLPPGA 21 (26)
T ss_pred CCCCEEECCCCcCCcCCHHH
Confidence 45666666666666666543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.047 Score=56.70 Aligned_cols=95 Identities=17% Similarity=0.191 Sum_probs=63.4
Q ss_pred HHHHHHhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecc--c-chhhHhHHHHHHHHHH----------------
Q 015202 317 LELFHATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQ--Y-REAFKSFDNEFMTVVD---------------- 376 (411)
Q Consensus 317 ~~l~~at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~--~-~~~~~~f~~e~~~~~~---------------- 376 (411)
.+++...++|.-..+||+|+||.|....+. .++..|.|++... . .....-|..|=.+|+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 344445566766789999999999998874 4567799998542 2 2223447777777775
Q ss_pred -------cccCCCC--------CCCCCCHHH----HHHHHHHHhhhhcccCCCC
Q 015202 377 -------ANLLTRE--------DKHFMTKEQ----RVSFVFNLAMECTVESPNL 411 (411)
Q Consensus 377 -------~~l~~~~--------~~~~l~w~~----r~~ia~~ia~gl~ylh~~~ 411 (411)
+|+-+.+ ..-|=+|++ =+-+|++...-|-|.|+++
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDi 201 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDI 201 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccC
Confidence 4433333 112356764 3567788889999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=93.59 E-value=0.17 Score=49.89 Aligned_cols=36 Identities=31% Similarity=0.475 Sum_probs=30.4
Q ss_pred cCCCcCCeeeccCCceEEEEEecC-CCEEEEEEEeccc
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQY 360 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~ 360 (411)
.+|+. .-+|.|++|.||+|++.+ |+.||||++.+..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i 156 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDI 156 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcch
Confidence 34655 679999999999999987 9999999997654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.25 Score=40.55 Aligned_cols=75 Identities=8% Similarity=-0.052 Sum_probs=48.4
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCCCCCCC
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTREDKHF 387 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~~~~~~ 387 (411)
+.++.|.++.||+.+. .|..+++|....... ...++..|++++.. +|+.+. .
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~----~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGS----E 77 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCC----c
Confidence 4678899999999997 467899998743321 22356777776665 233222 2
Q ss_pred CCH--HHHHHHHHHHhhhhcccCCC
Q 015202 388 MTK--EQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 388 l~w--~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .....++.+++++|+.||+.
T Consensus 78 l~~~~~~~~~~~~~l~~~l~~LH~~ 102 (170)
T cd05151 78 LLTEDFSDPENLEKIAKLLKKLHSS 102 (170)
T ss_pred cccccccCHHHHHHHHHHHHHHhCC
Confidence 221 11234567899999999974
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.68 E-value=0.1 Score=45.60 Aligned_cols=80 Identities=16% Similarity=0.214 Sum_probs=55.9
Q ss_pred CcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccch--------hhHhHHHHHHHHHH---------------------
Q 015202 327 SANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYRE--------AFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~--------~~~~f~~e~~~~~~--------------------- 376 (411)
.+.+++|+|..++|-+... ..|...|||+++..... -..+-.+|+.++.+
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 4457899999998888766 45778999988543321 13456788888887
Q ss_pred ------------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ------------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ------------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+||... -.++-..-.+|..++-+|.+|||.
T Consensus 100 lVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa 141 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHA 141 (411)
T ss_pred hhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHH
Confidence 222211 125556668899999999999995
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=92.46 E-value=0.16 Score=30.12 Aligned_cols=28 Identities=25% Similarity=0.670 Sum_probs=15.7
Q ss_pred ccceEeehhHHHHHHHHHHHHhhhhhhc
Q 015202 267 NDLLIGIVLPLSTIFMMVVILLILRYRK 294 (411)
Q Consensus 267 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 294 (411)
..+..++++++.+++++++++++.+||+
T Consensus 11 vaIa~~VvVPV~vI~~vl~~~l~~~~rR 38 (40)
T PF08693_consen 11 VAIAVGVVVPVGVIIIVLGAFLFFWYRR 38 (40)
T ss_pred EEEEEEEEechHHHHHHHHHHhheEEec
Confidence 3455666666666666555555544443
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.08 E-value=0.058 Score=49.81 Aligned_cols=86 Identities=12% Similarity=0.092 Sum_probs=49.5
Q ss_pred CCCcCCeeeccCCceEEEEEecC-CCEEEEEEEeccc-chh-h-HhHHHHHHHHHH------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQY-REA-F-KSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~-~~~-~-~~f~~e~~~~~~------------------------ 376 (411)
+|.=..+||+|+||.|..|+-.+ ....|||.++..- -|. + +--+.|-++++-
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 45545899999999999998632 2457888774321 111 0 111233333332
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.+ .-..+.-+.-+=.|+.||-||-|||+.
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k 469 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK 469 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC
Confidence 3333322 001233444566789999999999974
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.04 E-value=0.095 Score=47.01 Aligned_cols=87 Identities=13% Similarity=0.169 Sum_probs=53.1
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhh-HhHHHHHHHHHH----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAF-KSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~-~~f~~e~~~~~~---------------------- 376 (411)
..+|.-.++||+|+++.|..+++. ..+..|+|+++..- ...+ .=...|-.++.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 456777799999999999999884 34667888873221 1111 223444444443
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|..+.+ ..+.++-..-.=....|.-||.|||+
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~ 369 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE 369 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh
Confidence 3333322 12345554433455688899999997
|
|
| >smart00370 LRR Leucine-rich repeats, outliers | Back alignment and domain information |
|---|
Probab=91.87 E-value=0.14 Score=27.30 Aligned_cols=14 Identities=43% Similarity=0.584 Sum_probs=7.0
Q ss_pred CCCCeeecccCccc
Q 015202 42 QKLQLLGLEDNQLE 55 (411)
Q Consensus 42 ~~L~~L~l~~n~l~ 55 (411)
++|++|+|++|.++
T Consensus 2 ~~L~~L~L~~N~l~ 15 (26)
T smart00370 2 PNLRELDLSNNQLS 15 (26)
T ss_pred CCCCEEECCCCcCC
Confidence 34455555555544
|
|
| >smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily | Back alignment and domain information |
|---|
Probab=91.87 E-value=0.14 Score=27.30 Aligned_cols=14 Identities=43% Similarity=0.584 Sum_probs=7.0
Q ss_pred CCCCeeecccCccc
Q 015202 42 QKLQLLGLEDNQLE 55 (411)
Q Consensus 42 ~~L~~L~l~~n~l~ 55 (411)
++|++|+|++|.++
T Consensus 2 ~~L~~L~L~~N~l~ 15 (26)
T smart00369 2 PNLRELDLSNNQLS 15 (26)
T ss_pred CCCCEEECCCCcCC
Confidence 34455555555544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.39 E-value=0.35 Score=39.78 Aligned_cols=44 Identities=20% Similarity=0.234 Sum_probs=34.1
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~ 376 (411)
..||+|.+|.||.|.+ .|..||+|+-...+. ...+..|++++..
T Consensus 28 ~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLei 71 (201)
T COG2112 28 KELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEI 71 (201)
T ss_pred hhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHH
Confidence 7899999999999999 456889988755443 4567788876654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 411 | ||||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-16 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-14 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 4e-07 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 4e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-06 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 3e-05 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 1e-04 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 1e-04 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 3e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-04 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 4e-04 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 4e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 4e-04 | ||
| 2a0z_A | 705 | The Molecular Structure Of Toll-like Receptor 3 Lig | 5e-04 | ||
| 3ulu_A | 694 | Structure Of Quaternary Complex Of Human Tlr3ecd Wi | 5e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 7e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 7e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 8e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 9e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 9e-04 |
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 | Back alignment and structure |
|
| >pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 411 | |||
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-89 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-48 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-43 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-65 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-65 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-60 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-57 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-51 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-47 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-33 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-50 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-46 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-46 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-41 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-40 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-40 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-39 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-36 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-14 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-12 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-12 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 8e-46 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-44 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-43 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-39 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-38 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-36 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-27 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-25 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-44 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-41 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-40 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-34 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-32 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 9e-10 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-43 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-41 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-38 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-37 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-29 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-24 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-14 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-42 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-36 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-35 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-29 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-04 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-40 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 8e-33 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-32 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-37 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-34 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-33 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-33 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-32 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-31 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-37 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-37 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-37 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-35 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-34 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-33 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-31 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-23 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-36 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-31 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-25 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-23 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-18 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-34 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-34 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-28 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 8e-19 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-31 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-30 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-22 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-05 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-28 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-26 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-17 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-30 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-30 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-28 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-25 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-20 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-05 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-30 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-26 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-10 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-30 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-29 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-27 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 9e-22 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 9e-20 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-14 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-30 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-23 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-13 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-30 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-13 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-25 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-20 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-13 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-12 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-08 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-28 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-27 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-26 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-26 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 8e-23 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 9e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-12 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-04 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-15 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-04 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-27 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-26 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 9e-25 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-24 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-26 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-26 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-25 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-25 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-22 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-10 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-26 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-19 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-10 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-24 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-24 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-18 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-16 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-12 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-24 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-24 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-23 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-16 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-24 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-23 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-23 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-11 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-04 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-23 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-19 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-15 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-11 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 8e-11 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-23 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-21 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-20 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-18 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-12 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-11 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-04 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-19 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 7e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-21 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-14 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-09 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 8e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 7e-18 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-20 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-18 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-20 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-08 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 7e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-19 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 7e-18 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 7e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-08 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 9e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-15 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-15 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-15 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-14 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-13 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 6e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 8e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-12 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 6e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 8e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-07 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-04 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 3e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 6e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 6e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 6e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 6e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-05 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-05 |
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 4e-89
Identities = 86/261 (32%), Positives = 126/261 (48%), Gaps = 10/261 (3%)
Query: 1 MFNCNISGS--IPEEINNLTNLIAIYLGG-NKLNGSISIALGKLQKLQLLGLEDNQLEGS 57
+ N+ IP + NL L +Y+GG N L G I A+ KL +L L + + G+
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 58 IPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYIL 116
IP L ++ L LD N LSG +P +L NL + N+++ IP + + +
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 117 -YLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG 175
+ +S N T +P NL L +DLS N G G K+ Q + L N L
Sbjct: 177 TSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 176 SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
+ +G NL LDL NN + G +P L +L L +NVSFN L GEIP+ G + F
Sbjct: 236 DLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD 294
Query: 236 IESFKGNELLCGMPNLHVPPC 256
+ ++ N+ LCG P +P C
Sbjct: 295 VSAYANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 1e-48
Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 6/183 (3%)
Query: 51 DNQLEGSIPYDLCRLAALFQLDLGDNKLSG--FVPSCFGNLTNLRKLYL-GSNQLT-YIP 106
+ G + + + LDL L +PS NL L LY+ G N L IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 107 LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYL 166
+ L + YL ++ + + +P + ++ LV +D S N SG +P +I L +L +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 167 FLEYNRLQGSIPDFIGGLINL-KSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225
+ NR+ G+IPD G L S+ +S N L+G IP + L+L +++S N LEG+
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-LNLAFVDLSRNMLEGDA 213
Query: 226 PRE 228
Sbjct: 214 SVL 216
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 6e-43
Identities = 50/163 (30%), Positives = 72/163 (44%), Gaps = 5/163 (3%)
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT---YIPLTLWNLKYILYLNLSS-NSFT 126
D + G + + L L L IP +L NL Y+ +L + N+
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLIN 186
P+P I L L + ++ N SGAIP + +K L L YN L G++P I L N
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 187 LKSLDLSNNNLSGAIPISLEKLLDL-QHINVSFNKLEGEIPRE 228
L + N +SGAIP S L + +S N+L G+IP
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 4e-78
Identities = 88/285 (30%), Positives = 126/285 (44%), Gaps = 26/285 (9%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+++G IP ++N TNL I L N+L G I +G+L+ L +L L +N G+IP +L
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
Query: 63 CRLAALFQLDLGDNKLSGFVPSC--------------------FGNLTNLRKLYLGSNQL 102
+L LDL N +G +P+ N ++ + N L
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
Query: 103 TY---IPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGG 159
+ L L N++S + N ++ +D+S N SG IP IG
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654
Query: 160 LKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
+ L L L +N + GSIPD +G L L LDLS+N L G IP ++ L L I++S N
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714
Query: 220 KLEGEIPREGPFRNFSIESFKGNELLCGMPNLHVPPCRTGIHHTS 264
L G IP G F F F N LCG P +P C
Sbjct: 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGY 756
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 4e-65
Identities = 76/231 (32%), Positives = 119/231 (51%), Gaps = 5/231 (2%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISI-ALGKLQKLQLLGLEDNQLEGSIPYD 61
+ G++P + + L ++ L N +G + + L K++ L++L L N+ G +P
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
Query: 62 LCRLAA-LFQLDLGDNKLSGFVPSCFGN--LTNLRKLYLGSNQLT-YIPLTLWNLKYILY 117
L L+A L LDL N SG + L++LYL +N T IP TL N ++
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI 177
L+LS N + +PS +G+L L + L +N G IP + +K L+ L L++N L G I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 178 PDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
P + NL + LSNN L+G IP + +L +L + +S N G IP E
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 4e-65
Identities = 73/233 (31%), Positives = 114/233 (48%), Gaps = 5/233 (2%)
Query: 1 MFNCNISGSIPEE-INNLTNLIAIYLGGNKLNGSISIALGKL-QKLQLLGLEDNQLEGSI 58
+ + N SG +P + + + L + L N+ +G + +L L L L L N G I
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384
Query: 59 PYDLCR--LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYI 115
+LC+ L +L L +N +G +P N + L L+L N L+ IP +L +L +
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL 444
Query: 116 LYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG 175
L L N +P E+ ++ L + L N+ +G IP+ + +L ++ L NRL G
Sbjct: 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG 504
Query: 176 SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
IP +IG L NL L LSNN+ SG IP L L ++++ N G IP
Sbjct: 505 EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-60
Identities = 76/235 (32%), Positives = 110/235 (46%), Gaps = 12/235 (5%)
Query: 1 MFNCNISGSIPEEI---NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGS 57
+ +ISG+ + L + + GNK++G + + + L+ L + N
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTG 215
Query: 58 IPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYIL 116
IP L +AL LD+ NKLSG T L+ L + SNQ IP LK +
Sbjct: 216 IP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQ 272
Query: 117 YLNLSSNSFTIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG 175
YL+L+ N FT +P + G + L +DLS N+F GA+P G L+ L L N G
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332
Query: 176 SIP-DFIGGLINLKSLDLSNNNLSGAIPISLEKLL-DLQHINVSFNKLEGEIPRE 228
+P D + + LK LDLS N SG +P SL L L +++S N G I
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-57
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 12/233 (5%)
Query: 3 NCNISGSIP-EEINNLTNLIAIYLGGNKLNGSISIAL---GKLQKLQLLGLEDNQLEGSI 58
+ + L +L + L N ++G+ + +L+ L + N++ G +
Sbjct: 135 SNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV 194
Query: 59 PYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILY 117
+ R L LD+ N S +P G+ + L+ L + N+L+ + +
Sbjct: 195 D--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKL 251
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGG-LKDLQYLFLEYNRLQGS 176
LN+SSN F P+P L+ L + L+ N F+G IP + G L L L N G+
Sbjct: 252 LNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 177 IPDFIGGLINLKSLDLSNNNLSGAIPI-SLEKLLDLQHINVSFNKLEGEIPRE 228
+P F G L+SL LS+NN SG +P+ +L K+ L+ +++SFN+ GE+P
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-51
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 13/229 (5%)
Query: 7 SGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP--YDLCR 64
++ + +LT L +++L + +NGS+S L L L N L G + L
Sbjct: 66 FSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGS 124
Query: 65 LAALFQLDLGDNKLSGFVP-SCFGNLTNLRKLYLGSNQLT-YIPLTLW---NLKYILYLN 119
+ L L++ N L S L +L L L +N ++ + + +L
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLA 184
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
+S N + + + L +D+S NNFS IP +G LQ+L + N+L G
Sbjct: 185 ISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR 241
Query: 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
I LK L++S+N G IP L LQ+++++ NK GEIP
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDF 288
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-47
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 14/223 (6%)
Query: 16 NLTNLIAIYLGGNKLN---GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLD 72
+ +I L LN ++S +L L L+ L L ++ + GS+ A+L LD
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 73 LGDNKLSGFVPS--CFGNLTNLRKLYLGSNQLTY-IPLTLW-NLKYILYLNLSSNSFTIP 128
L N LSG V + G+ + L+ L + SN L + ++ L + L+LS+NS +
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 129 LPSEI---GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLI 185
L + +S N SG + + +L++L + N IP F+G
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCS 223
Query: 186 NLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
L+ LD+S N LSG ++ +L+ +N+S N+ G IP
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL 266
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 11/173 (6%)
Query: 63 CRLAALFQLDLGDNKLSGF---VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLN 119
CR + +DL L+ V S +LT L L+L ++ + + L+
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLD 106
Query: 120 LSSNSFT--IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG-GLKDLQYLFLEYNRLQGS 176
LS NS + + + +G+ L +++S N + G L L+ L L N + G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 177 IPDFI---GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
G LK L +S N +SG + +S + ++L+ ++VS N IP
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIP 217
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-50
Identities = 50/260 (19%), Positives = 96/260 (36%), Gaps = 27/260 (10%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKL--------NGSISIALGKLQKLQLLGLEDN 52
++NC +P + L + I + N+ + +K+Q++ + N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 53 QL-EGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW- 110
L + L ++ L L+ N+L G +P+ FG+ L L L NQ+T IP
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCG 374
Query: 111 NLKYILYLNLSSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSG-------AIPTTIGGLKD 162
+ + L+ + N IP + ++ V+ ID S N + T +
Sbjct: 375 FTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
Query: 163 LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG-------AIPISLEKLLDLQHIN 215
+ + L N++ + L S++L N L+ + + L I+
Sbjct: 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSID 494
Query: 216 VSFNKLEGEIPREGPFRNFS 235
+ FNKL + +
Sbjct: 495 LRFNKLTK-LSDDFRATTLP 513
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-46
Identities = 42/249 (16%), Positives = 81/249 (32%), Gaps = 27/249 (10%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNG-SISIALGKLQKLQLLGLEDNQLEG--- 56
+ I+ + + NKL + + + N++
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 57 ----SIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP------ 106
+ + + ++L +N++S F F + L + L N LT IP
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 107 --LTLWNLKYILYLNLSSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDL 163
N + ++L N T + L LV IDLS N+FS PT L
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 164 QYLFLE------YNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVS 217
+ + NR P+ I +L L + +N++ + + ++ +++
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIK 595
Query: 218 FNKLEGEIP 226
N
Sbjct: 596 DNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-46
Identities = 43/239 (17%), Positives = 79/239 (33%), Gaps = 19/239 (7%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQL-------- 54
+ + +NL +L + + + L L ++QL+ + N+
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293
Query: 55 EGSIPYDLCRLAALFQLDLGDNKL-SGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLK 113
+ D + + +G N L + V + + L L NQL +
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEI 353
Query: 114 YILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTT--IGGLKDLQYLFLEYN 171
+ LNL+ N T + G E + + + N IP + + + YN
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYN 412
Query: 172 RLQG-------SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223
+ + IN+ S++LSNN +S L IN+ N L
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 41/252 (16%), Positives = 80/252 (31%), Gaps = 28/252 (11%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEG-SIP 59
+ G +P + L ++ L N++ + G ++++ L N+L+
Sbjct: 337 CLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNI 395
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCF-------GNLTNLRKLYLGSNQLTYIPL-TLWN 111
+D ++ + +D N++ F N+ + L +NQ++ P
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455
Query: 112 LKYILYLNLSSNSFT-------IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI--GGLKD 162
+ +NL N T N +L IDL N + + L
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPY 514
Query: 163 LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSN------NNLSGAIPISLEKLLDLQHINV 216
L + L YN P LK + N N P + L + +
Sbjct: 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQI 573
Query: 217 SFNKLEGEIPRE 228
N + + +
Sbjct: 574 GSNDIRK-VNEK 584
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 38/237 (16%), Positives = 78/237 (32%), Gaps = 18/237 (7%)
Query: 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQL--LGLEDNQLEGSIP 59
N P+ I+ + + + L + + + SI
Sbjct: 117 EKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYL 118
Q+ N ++ V LT LR+ Y+G++ W + Y
Sbjct: 177 KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235
Query: 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL----- 173
+ NL+ L +++ +PT + L ++Q + + NR
Sbjct: 236 QQYKT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 174 ---QGSIPDFIGGLINLKSLDLSNNNL-SGAIPISLEKLLDLQHINVSFNKLEGEIP 226
++ + + NNL + + SL+K+ L + +N+LEG++P
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 30/241 (12%), Positives = 67/241 (27%), Gaps = 20/241 (8%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNG----SISIALGKLQKLQLLGLEDNQLEGSI 58
SG +P+ I LT L + LG + + + + +
Sbjct: 90 GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149
Query: 59 PYDLCRLA--ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYIL 116
R L + + + + ++ SN +T++ + L +
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLR 209
Query: 117 YLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
+ ++ F E E + LKDL + +
Sbjct: 210 QFYMGNSPFVAENICEAWENE-----NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 177 IPDFIGGLINLKSLDLSNNNL--------SGAIPISLEKLLDLQHINVSFNKL-EGEIPR 227
+P F+ L ++ ++++ N +Q I + +N L +
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324
Query: 228 E 228
Sbjct: 325 S 325
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 33/229 (14%), Positives = 64/229 (27%), Gaps = 29/229 (12%)
Query: 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEG----- 56
+ + N+ +I L N+++ L + L N L
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476
Query: 57 --SIPYDLCRLAALFQLDLGDNKLSGFVPS-CFGNLTNLRKLYLGSNQLTYIPLTLWNLK 113
+ L +DL NKL+ L L + L N + P N
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSS 536
Query: 114 YILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173
+ + + D N P I L L + N +
Sbjct: 537 TLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 174 QGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
+ + + I N+ LD+ +N + ++ + ++K +
Sbjct: 579 R-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 36/227 (15%), Positives = 77/227 (33%), Gaps = 13/227 (5%)
Query: 4 CNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEG----SIP 59
+N+ + + L G +G + A+G+L +L++L L + + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFG--NLTNLRKLYLGSNQLT-YIPLTLWNLKYIL 116
+ + Q + ++L K + S+ I +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 117 YLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
+ SN+ T + + L L Q + + F ++ EY + +
Sbjct: 187 QIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQQYKT 240
Query: 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223
L +L +++ N +P L+ L ++Q INV+ N+
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 26/185 (14%), Positives = 50/185 (27%), Gaps = 27/185 (14%)
Query: 70 QLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-----YIPLTLWNLKYILYLNLSSNS 124
L L SG VP G LT L L LGS+ + P +
Sbjct: 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144
Query: 125 FTIPLPSEIGNLEV--LVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
+ + L++ ++ + +I + + N + + +
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVM 203
Query: 183 GLINLKSLDLSNNNLSG-------------------AIPISLEKLLDLQHINVSFNKLEG 223
L L+ + N+ + + L DL + V
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263
Query: 224 EIPRE 228
++P
Sbjct: 264 KLPTF 268
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 20/135 (14%), Positives = 40/135 (29%), Gaps = 12/135 (8%)
Query: 100 NQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGG 159
P WN N + + + + + + L SG +P IG
Sbjct: 50 QGFGTQPGANWNF------NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 160 LKDLQYLFLEYNRLQG----SIPDFIGGLINLKSLDLSNNNLSGAIP--ISLEKLLDLQH 213
L +L+ L L + + P I ++ + + E DL
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 214 INVSFNKLEGEIPRE 228
++ + + I +
Sbjct: 164 DCINSDPQQKSIKKS 178
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 16/110 (14%), Positives = 30/110 (27%), Gaps = 10/110 (9%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLG------GNKLNGSISIALGKLQKLQLLGLEDNQLEG 56
+ S P + N + L + GN+ + L L + N +
Sbjct: 522 YNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR- 579
Query: 57 SIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP 106
+ + + LD+ DN S L ++ I
Sbjct: 580 KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIR 627
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 16/116 (13%), Positives = 35/116 (30%), Gaps = 7/116 (6%)
Query: 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG--- 199
+ ++ + ++ + L LE G +PD IG L L+ L L ++
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 200 -AIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS---IESFKGNELLCGMPNL 251
P + + + + P +FS + + +
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-46
Identities = 54/265 (20%), Positives = 93/265 (35%), Gaps = 18/265 (6%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISI-ALGKLQKLQLLGLEDNQLEGSIPYD 61
IS + + L +L + LG N++ ++ L+ + + L N+
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
Query: 62 LCRLAALFQLDLGDNKLSGF--VPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYL 118
+ +L +L L L PS F L NL L L +N + I L L+ + L
Sbjct: 450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEIL 509
Query: 119 NLSSNSFTI--------PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEY 170
+L N+ + L L ++L N F L +L+ + L
Sbjct: 510 DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569
Query: 171 NRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD-LQHINVSFNKLEGEIPREG 229
N L ++LKSL+L N ++ L +++ FN +
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA 629
Query: 230 PFRNFSIESFK-----GNELLCGMP 249
F N+ E+ + LC P
Sbjct: 630 WFVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-44
Identities = 51/234 (21%), Positives = 90/234 (38%), Gaps = 8/234 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + + L ++ +G N ++ KL L++L L+ N+L
Sbjct: 34 HNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLS 121
L +L L N + + F NL L L N L+ L T L+ + L LS
Sbjct: 94 AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLS 153
Query: 122 SNSFTIPLPSEIGNLE--VLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
+N E+ L +++LS N P + L LFL +L S+ +
Sbjct: 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213
Query: 180 FIG---GLINLKSLDLSNNNLSGAIPISLE--KLLDLQHINVSFNKLEGEIPRE 228
+ ++++L LSN+ LS + K +L +++S+N L
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 17/241 (7%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ +I NLI + L N L+ + +L+ LQ L L +N+++ +L
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 63 --CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP----LTLWNLKYIL 116
++L +L+L N++ F P CF + L L+L + QL I
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 117 YLNLSSNSFTIPLPSEIGNLEV--LVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ 174
L+LS++ + + L+ L +DLS NN + + L L+Y FLEYN +Q
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 175 GSIPDFIGGLINLKSLDLSNN---------NLSGAIPISLEKLLDLQHINVSFNKLEGEI 225
+ GL N++ L+L + +L S + L L+H+N+ N + G
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 226 P 226
Sbjct: 346 S 346
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-39
Identities = 50/230 (21%), Positives = 95/230 (41%), Gaps = 9/230 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ ++ +P+++ TN+ + L N+L + + +L L + N + P
Sbjct: 13 HLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC 69
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLS 121
+L L L+L N+LS F TNL +L+L SN + I K ++ L+LS
Sbjct: 70 QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS 129
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD--LQYLFLEYNRLQGSIPD 179
N + LE L ++ LS N + + L+ L L N+++ P
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189
Query: 180 FIGGLINLKSLDLSNNNLSGAIPISL---EKLLDLQHINVSFNKLEGEIP 226
+ L L L+N L ++ L ++++++S ++L
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 54/242 (22%), Positives = 93/242 (38%), Gaps = 16/242 (6%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNG----SISIALGKLQKLQLLGLEDNQLEG 56
M + +I G L NL + L + + + + L +L L N++
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 57 SIPYDLCRLAALFQLDLGDNKLSGFVP-SCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKY 114
L L LDLG N++ + + L N+ ++YL N+ + + +
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455
Query: 115 ILYLNLSSNSFT--IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNR 172
+ L L + PS L L +DLS NN + + GL+ L+ L L++N
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515
Query: 173 LQ--------GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGE 224
L G F+ GL +L L+L +N + L +L+ I++ N L
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575
Query: 225 IP 226
Sbjct: 576 PA 577
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 57/247 (23%), Positives = 97/247 (39%), Gaps = 21/247 (8%)
Query: 1 MFNCNISGSIPEEIN--NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSI 58
+ N I EE++ ++L + L N++ + +L L L + QL S+
Sbjct: 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSL 211
Query: 59 PYDLC---RLAALFQLDLGDNKLSGFVPSCFGNL--TNLRKLYLGSNQLTYI-PLTLWNL 112
LC ++ L L +++LS + F L TNL L L N L + + L
Sbjct: 212 TEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWL 271
Query: 113 KYILYLNLSSNSFTIPLPSEIGNLEVLVQIDL---------SMNNFSGAIPTTIGGLKDL 163
+ Y L N+ + L + ++L S+ + + LK L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 164 QYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLE----KLLDLQHINVSFN 219
++L +E N + G + GLINLK L LSN+ S + L +N++ N
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391
Query: 220 KLEGEIP 226
K+
Sbjct: 392 KISKIES 398
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 4/159 (2%)
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTIPL 129
D KL+ VP TN+ L L NQL + + L++ N+ +
Sbjct: 9 ADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 130 PSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKS 189
P L +L ++L N S T +L L L N +Q + NL +
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 190 LDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
LDLS+N LS + +L +LQ + +S NK++ E
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 30/138 (21%), Positives = 47/138 (34%), Gaps = 2/138 (1%)
Query: 90 TNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNF 149
+ +LT +P L I LNL+ N + L +D+ N
Sbjct: 4 VSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 150 SGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLL 209
S P L L+ L L++N L NL L L +N++ K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 210 DLQHINVSFNKLEGEIPR 227
+L +++S N L
Sbjct: 122 NLITLDLSHNGLSSTKLG 139
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 4e-44
Identities = 50/259 (19%), Positives = 89/259 (34%), Gaps = 27/259 (10%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNG---------SISIALGKLQKLQLLGLED 51
++NC +P+ + +L L ++ + N+ ++ K+Q+ +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 52 NQLEG-SIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW 110
N LE L ++ L LD NK+ FG L L L NQ+ IP
Sbjct: 558 NNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIPEDFC 615
Query: 111 -NLKYILYLNLSSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD-----L 163
+ L S N IP ++ V+ +D S N + D
Sbjct: 616 AFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675
Query: 164 QYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLS-------GAIPISLEKLLDLQHINV 216
+ L YN +Q + + ++ LSNN ++ + + L I++
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735
Query: 217 SFNKLEGEIPREGPFRNFS 235
FNKL + +
Sbjct: 736 RFNKLT-SLSDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 44/265 (16%), Positives = 86/265 (32%), Gaps = 28/265 (10%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYLGGNKLNG-SISIALGKLQKLQLLGLEDNQLEG---- 56
I IPE+ + + NKL + + + N++
Sbjct: 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
Query: 57 -SIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP--------L 107
S D + + L N++ F F + + + L +N +T IP
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722
Query: 108 TLWNLKYILYLNLSSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYL 166
N + ++L N T + L L +D+S N FS PT L+
Sbjct: 723 NYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAF 781
Query: 167 ------FLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220
E NR+ P I +L L + +N++ + + L ++++ N
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQLYILDIADNP 838
Query: 221 L-EGEIPREGPFRNFSIESFKGNEL 244
++ P+ + ++
Sbjct: 839 NISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-40
Identities = 41/238 (17%), Positives = 75/238 (31%), Gaps = 21/238 (8%)
Query: 8 GSIPEEINNLTNLIAIYLGGNKLNG-SISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLA 66
+ ++ + + Y+G N L S +L K+ KL LL N++ +
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV 595
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP--LTLWNLKYILYLNLSSNS 124
L L L N++ + L N+L YIP ++ + ++ S N
Sbjct: 596 KLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNK 655
Query: 125 FT-----IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ----- 174
I + + LS N + + L N +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 175 --GSIPDFIGGLINLKSLDLSNNNLSGAIP--ISLEKLLDLQHINVSFNKLEGEIPRE 228
L ++DL N L+ + L L +++VS+N P +
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQ 771
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 2e-34
Identities = 40/246 (16%), Positives = 83/246 (33%), Gaps = 21/246 (8%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD- 61
G +P+ I LT L + G + S + + + +++
Sbjct: 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391
Query: 62 LCRLAALFQLDLGDNKLSG---FVPSCFGNLTNLRKLYLG--SNQLTYIPLTLWNLKYIL 116
L L DL + ++ P + +L+ +G +N++T+I + L +
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQ 451
Query: 117 YLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
+ +++ FT + + + LKDL + L
Sbjct: 452 IIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 177 IPDFIGGLINLKSLDLSNNNLSG---------AIPISLEKLLDLQHINVSFNKLEGEIPR 227
+PDF+ L L+SL+++ N + + +Q + +N LE E P
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA 565
Query: 228 EGPFRN 233
+
Sbjct: 566 SASLQK 571
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 34/248 (13%), Positives = 80/248 (32%), Gaps = 13/248 (5%)
Query: 4 CNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC 63
+++N + + L G G + A+G+L +L++L + S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 64 RLAALFQLDLGDNKLSGFVPSCFGN-------LTNLRKLYLGSNQLTYIPLTLWNLKYIL 116
+ +++ F + L+ + ++ I
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 117 YLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
+ +N T + I L L I + + F+ D + +Y + +
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYEN 482
Query: 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSI 236
L +L ++L N +P L L +LQ +N++ N+ + + +
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 237 ESFKGNEL 244
+ G ++
Sbjct: 543 DEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 12/87 (13%), Positives = 31/87 (35%)
Query: 142 IDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI 201
+ ++ + + + L L +G +PD IG L LK L ++ + +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 202 PISLEKLLDLQHINVSFNKLEGEIPRE 228
+ ++ L +++ +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKM 390
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 54/255 (21%), Positives = 87/255 (34%), Gaps = 12/255 (4%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLN--GSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ G +L +L + L N L+ G S + L+ L L N + + +
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 63 CRLAALFQLDLGDNKLSGFVP-SCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNL 120
L L LD + L S F +L NL L + L + L +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 121 SSNSFTIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
+ NSF +I L L +DLS PT L LQ L + +N
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLLD-LQHINVSFNKLEGEIPREGPFRNF---- 234
L +L+ LD S N++ + L+ L +N++ N + F +
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ-SFLQWIKDQ 571
Query: 235 SIESFKGNELLCGMP 249
+ + C P
Sbjct: 572 RQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 47/243 (19%), Positives = 89/243 (36%), Gaps = 9/243 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD- 61
+ G + T+L + L N + +S L++L+ L + + L+ +
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY--IPLTLWNLKYILYLN 119
L L LD+ F L++L L + N +P L+ + +L+
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
LS P+ +L L +++S NNF L LQ L N + S
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 180 FIGGLI-NLKSLDLSNNNLSGAIPIS--LEKLLDLQHINVSFNKLEGEIPREGPFRNFSI 236
+ +L L+L+ N+ + L+ + D + + V ++E P + +
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP--SDKQGMPV 594
Query: 237 ESF 239
S
Sbjct: 595 LSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 43/229 (18%), Positives = 81/229 (35%), Gaps = 11/229 (4%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + L + L ++ A L L L L N ++
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL--TLWNLKYILYLNL 120
L++L +L + L+ G+L L++L + N + L NL + +L+L
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 121 SSNSFTIPLPSEIGNLE----VLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
SSN +++ L + + +DLS+N + P ++ L L L N +
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLN 215
Query: 177 IP-DFIGGLINLKSLDLSNNNLSGAIPI---SLEKLLDLQHINVSFNKL 221
+ I GL L+ L + L L ++ + +L
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 52/232 (22%), Positives = 84/232 (36%), Gaps = 10/232 (4%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
IP+ + + + L N L S + +LQ+L L +++ L+ L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKYILYLNLSSNSFT- 126
L L N + F L++L+KL L + +LK + LN++ N
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQY----LFLEYNRLQGSIPDFIG 182
LP NL L +DLS N T + L + L L N + I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197
Query: 183 GLINLKSLDLSNNNLSGAIP-ISLEKLLDLQHINVSFNKLEGEIPREGPFRN 233
I L L L NN S + ++ L L+ + + E E ++
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 40/241 (16%), Positives = 74/241 (30%), Gaps = 19/241 (7%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNG-SISIALGKLQKLQLLGLEDNQLEGSIP 59
N++ I +L L + + N + + L L+ L L N+++
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 60 YDLCRLAAL----FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY--IPLTLWNLK 113
DL L + LDL N ++ P F + L KL L +N + + + L
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLA 225
Query: 114 YILYLNLSSNSFT---IPLPSEIGNLEVLVQIDLSMNNFS------GAIPTTIGGLKDLQ 164
+ L F + LE L + + + I L ++
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 165 YLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGE 224
L ++ + L+L N + L+ L L + E
Sbjct: 286 SFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343
Query: 225 I 225
+
Sbjct: 344 V 344
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 30/139 (21%), Positives = 45/139 (32%), Gaps = 3/139 (2%)
Query: 85 CFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDL 144
C + N+ IP L L+LS N + L +DL
Sbjct: 3 CVEVVPNI-TYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 145 SMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPIS 204
S L L L L N +Q GL +L+ L NL+
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 205 LEKLLDLQHINVSFNKLEG 223
+ L L+ +NV+ N ++
Sbjct: 120 IGHLKTLKELNVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 28/148 (18%), Positives = 49/148 (33%), Gaps = 6/148 (4%)
Query: 3 NCNISGSI-PEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
+ + P+ L NL + L +L A L LQ+L + N +
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNL-TNLRKLYLGSNQLT---YIPLTLWNLKYILY 117
L +L LD N + + ++L L L N L +K
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLS 145
L + PS+ + VL ++++
Sbjct: 574 LLVEVERMECATPSDKQGMPVL-SLNIT 600
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-42
Identities = 50/239 (20%), Positives = 96/239 (40%), Gaps = 16/239 (6%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + P++ L++L + + L + + + L+ L L N L ++P +
Sbjct: 90 SVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASI 146
Query: 63 CRLAALFQLDL-GDNKL--------SGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLK 113
L L +L + +L S L NL+ L L + +P ++ NL+
Sbjct: 147 ASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQ 206
Query: 114 YILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFL-EYNR 172
+ L + ++ + L I +L L ++DL P GG L+ L L + +
Sbjct: 207 NLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN 265
Query: 173 LQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPF 231
L ++P I L L+ LDL +P + +L I V + L+ ++ + P
Sbjct: 266 LL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-36
Identities = 39/217 (17%), Positives = 78/217 (35%), Gaps = 15/217 (6%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+ + +P+ + L + L N L ++ ++ L +L+ L + +P
Sbjct: 111 IDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168
Query: 61 DLCRLAA---------LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWN 111
L A L L L + +P+ NL NL+ L + ++ L+ + + +
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHH 227
Query: 112 LKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYN 171
L + L+L + P G L ++ L + +P I L L+ L L
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
Query: 172 RLQGSIPDFIGGLINLKSLDLSNN---NLSGAIPISL 205
+P I L + + + L P++
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 48/238 (20%), Positives = 86/238 (36%), Gaps = 22/238 (9%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ ++ Y S Q+ L+ + L
Sbjct: 21 GSTALRPYHDVLSQWQRH---YNADRNRWHSAWR-QANSNNPQIETRTGRALK-ATADLL 75
Query: 63 --CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNL 120
L+L L F P L++L+ + + + L +P T+ + L L
Sbjct: 76 EDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTL 134
Query: 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG---------GLKDLQYLFLEYN 171
+ N LP+ I +L L ++ + +P + GL +LQ L LE+
Sbjct: 135 ARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 172 RLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVS-FNKLEGEIPRE 228
++ S+P I L NLKSL + N+ LS A+ ++ L L+ +++ L P
Sbjct: 194 GIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR-NYPPI 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 38/232 (16%), Positives = 76/232 (32%), Gaps = 20/232 (8%)
Query: 8 GSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAA 67
GS ++ + +Y G+ L + Q+ +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 68 LFQLDLGDNKLSGFVPSCFGNLT--NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSF 125
L + T L L S L P + L ++ ++ + +
Sbjct: 58 PQIETRTGRALKAT-ADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGL 116
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG--- 182
LP + L + L+ N A+P +I L L+ L + +P+ +
Sbjct: 117 ME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174
Query: 183 ------GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
GL+NL+SL L + ++P S+ L +L+ + + + L +
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPA 224
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 10/66 (15%), Positives = 25/66 (37%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+C+ ++P +I+ LT L + L G + + +L ++ + + +
Sbjct: 262 DCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRP 321
Query: 63 CRLAAL 68
A
Sbjct: 322 VARPAE 327
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 15/221 (6%)
Query: 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
N N+S ++N+T L + + +K+ + L L L L NQ+E P
Sbjct: 141 ANHNLS--DLSPLSNMTGLNYLTVTESKVKDVT--PIANLTDLYSLSLNYNQIEDISP-- 194
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLS 121
L L +L N+++ P N+T L L +G+N++T + L NL + +L +
Sbjct: 195 LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS-PLANLSQLTWLEIG 251
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
+N + + + +L L +++ N S + + L L LFL N+L + I
Sbjct: 252 TNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
GGL NL +L LS N+++ P++ L + + + ++
Sbjct: 308 GGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 14/224 (6%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
NIS P + NLT + ++ LG N +S L + L L + +++++ P +
Sbjct: 119 EDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--I 173
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
L L+ L L N++ P +LT+L NQ+T I + N+ + L + +
Sbjct: 174 ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT-PVANMTRLNSLKIGN 230
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N T S + NL L +++ N S + L L+ L + N++ S +
Sbjct: 231 NKITDL--SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLN 284
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
L L SL L+NN L + L +L + +S N + P
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 16/224 (7%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+++ + L ++ + + G K+ SI + L L+ L L NQ+ P L
Sbjct: 31 KASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--L 84
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
L L L +G NK++ S NLTNLR+LYL + ++ I L NL + LNL +
Sbjct: 85 SNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDIS-PLANLTKMYSLNLGA 141
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N S + N+ L + ++ + P I L DL L L YN+++ P +
Sbjct: 142 NHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LA 196
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
L +L N ++ P++ + L + + NK+ P
Sbjct: 197 SLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 14/212 (6%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
+ I LTNL + L GN++ L L KL L + N++ + L L L +L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLREL 115
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
L ++ +S S NLT + L LG+N L N+ + YL ++ + +
Sbjct: 116 YLNEDNISDI--SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD--VT 171
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
I NL L + L+ N P + L L Y N++ P + + L SL
Sbjct: 172 PIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223
+ NN ++ P L L L + + N++
Sbjct: 228 IGNNKITDLSP--LANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 14/220 (6%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
+ + NLTNL +YL + ++ L L K+ L L N + L + L
Sbjct: 101 TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGL 157
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIP 128
L + ++K+ P NLT+L L L NQ+ I L +L + Y N T
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDIS-PLASLTSLHYFTAYVNQITD- 213
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLK 188
+ + N+ L + + N + P + L L +L + N++ + + L LK
Sbjct: 214 -ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLK 268
Query: 189 SLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
L++ +N +S ++ L L + ++ N+L E
Sbjct: 269 MLNVGSNQISDISVLN--NLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 48/215 (22%), Positives = 93/215 (43%), Gaps = 14/215 (6%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
+L I L + ++ +L+ + L + ++ SI + L L L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYL 71
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
+L N+++ P NL L LY+G+N++T I L NL + L L+ ++ + S
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS-ALQNLTNLRELYLNEDNISD--IS 126
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
+ NL + ++L N+ + + + L YL + ++++ P I L +L SL
Sbjct: 127 PLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
L+ N + P++ L L + N++ P
Sbjct: 184 LNYNQIEDISPLA--SLTSLHYFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 6e-19
Identities = 30/157 (19%), Positives = 61/157 (38%), Gaps = 11/157 (7%)
Query: 70 QLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPL 129
L ++ P +L + L +T + T L+ I L ++
Sbjct: 4 TLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVV-TQEELESITKLVVAGEKVASI- 59
Query: 130 PSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKS 189
I L L ++L+ N + P + L L L++ N++ + + L NL+
Sbjct: 60 -QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRE 114
Query: 190 LDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
L L+ +N+S P++ L + +N+ N ++
Sbjct: 115 LYLNEDNISDISPLA--NLTKMYSLNLGANHNLSDLS 149
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 47/241 (19%), Positives = 98/241 (40%), Gaps = 10/241 (4%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALG-----KLQKLQLLGLEDNQLEGS 57
N N I + ++ GG + I L L ++D + +
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
Query: 58 IPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILY 117
+ LC ++ + ++L + + F + L++L L + L+ +P L L +
Sbjct: 247 VFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKK 305
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPT-TIGGLKDLQYLFLEYNRLQGS 176
L LS+N F N L + + N + T + L++L+ L L ++ ++ S
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365
Query: 177 --IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNF 234
+ L +L+SL+LS N + ++ L+ ++++F +L+ + PF+N
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNL 424
Query: 235 S 235
Sbjct: 425 H 425
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 50/232 (21%), Positives = 86/232 (37%), Gaps = 9/232 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSI-SIALGKLQKLQLLGLEDNQLEGS--IP 59
+N +L + + GN + + L L+ L+ L L + +E S
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL--TLWNLKYILY 117
L L+ L L+L N+ F L L L +L NL +
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAI---PTTIGGLKDLQYLFLEYNRLQ 174
LNLS + I L L ++L N+F ++ L L+ L L + L
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 175 GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
L + +DLS+N L+ + +L L + ++N++ N + +P
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-37
Identities = 52/241 (21%), Positives = 82/241 (34%), Gaps = 11/241 (4%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + L + L L+ + L L L+ L L N+ E
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 63 CRLAALFQLDLGDNKLSGFVPS-CFGNLTNLRKLYLGSNQLTYIPL---TLWNLKYILYL 118
+L L + N + + C NL NLR+L L + + L NL ++ L
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIP-TTIGGLKDLQYLFLEYNRLQGSI 177
NLS N L +DL+ + L L+ L L ++ L S
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441
Query: 178 PDFIGGLINLKSLDLSNNNLSGAIPI---SLEKLLDLQHINVSFNKLEGEIPREGPFRNF 234
GL L+ L+L N+ SL+ L L+ + +SF L F +
Sbjct: 442 EQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ--HAFTSL 499
Query: 235 S 235
Sbjct: 500 K 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 40/241 (16%), Positives = 76/241 (31%), Gaps = 9/241 (3%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+ + ++ L ++ ++ I L + L+ L L N +
Sbjct: 88 LTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP 147
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL--GSNQLTYIPLTLWNLKYILYL 118
L LD +N + +L L L N + I ++ L
Sbjct: 148 KGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSL 207
Query: 119 NLSSNSFTIPLPSEIGNLEV--LVQIDLSMNNFSGAIPTTIGGLKD--LQYLFLEYNRLQ 174
N + + + N + L + P GL + ++ + L+ +
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267
Query: 175 GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNF 234
+ L+ LDL+ +LS +P L L L+ + +S NK E NF
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS--ASNF 324
Query: 235 S 235
Sbjct: 325 P 325
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 41/233 (17%), Positives = 77/233 (33%), Gaps = 9/233 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
C I + + L + L N L AL + L+ L + L
Sbjct: 66 RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLK--YILYLN 119
L L LG N +S L+ L +N + Y+ + +L+ L LN
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGG--LKDLQYLFLEYNRLQGSI 177
L+ N + + V ++ I + ++ L E +
Sbjct: 186 LNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244
Query: 178 PDFIGGL--INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
P GL ++++S++L + + LQ ++++ L E+P
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 43/239 (17%), Positives = 76/239 (31%), Gaps = 8/239 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + L NL + L ++ +L L L N L L
Sbjct: 42 FNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL 101
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLS 121
AL L +S N L LYLGSN ++ I L + + + L+
Sbjct: 102 SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQ 161
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMN-NFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
+N+ ++ +L+ + L++N N I Q L + I
Sbjct: 162 NNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKG 221
Query: 181 IGG--LINLKSLDLSNNNLSGAIPISLEKL--LDLQHINVSFNKLEGEIPREGPFRNFS 235
+ + +L + + P E L + ++ IN+ + F FS
Sbjct: 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS--NTFHCFS 278
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 40/222 (18%), Positives = 62/222 (27%), Gaps = 6/222 (2%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
IP + + + N L + +L L L L Q+ L
Sbjct: 26 EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTI 127
L L N L + L+ L+ ++ I + L N K + L L SN +
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 128 PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ-GSIPDFIGGLIN 186
+ E L +D N + L+ L L N I
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 187 LKSLDLSNNNLSGAIPISLE--KLLDLQHINVSFNKLEGEIP 226
+SL+ I L+ + L E P
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 45/201 (22%), Positives = 70/201 (34%), Gaps = 10/201 (4%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSI--- 58
+ + NL L + L + L+ S L LQ L L+ N
Sbjct: 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468
Query: 59 PYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYL 118
L L L L L LS F +L + + L N+LT + + +YL
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL 528
Query: 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDL-QYLFLEYNRLQGSI 177
NL+SN +I LPS + L I+L N ++ +L+ +
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTE 583
Query: 178 PDFIGGLINLKSLDLSNNNLS 198
L+ + LS+ LS
Sbjct: 584 DTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 27/157 (17%), Positives = 52/157 (33%), Gaps = 4/157 (2%)
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTIPL 129
+ + L+ +P + L N L I T L + +L+L+
Sbjct: 17 YNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 130 PSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKS 189
+ L + L+ N T + G K L++LF + + L+S
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 190 LDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
L L +N++S L+ ++ N +
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 27/136 (19%), Positives = 39/136 (28%), Gaps = 2/136 (1%)
Query: 93 RKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGA 152
+ + L IP TL L S N + L L +DL+
Sbjct: 15 KTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 153 IPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQ 212
T L L L N L + G LK L +S I L L+
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 213 HINVSFNKLEGEIPRE 228
+ + N + +
Sbjct: 133 SLYLGSNHISSIKLPK 148
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 50/220 (22%), Positives = 75/220 (34%), Gaps = 6/220 (2%)
Query: 7 SGSIPEEINNLTNLIAIYLGGNKLNGSISIAL--GKLQKLQLLGLEDNQLEGSIPYDLCR 64
GSI + L +L + L N L+ S + L+ L L N + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 65 LAALFQLDLGDNKLSGFVP-SCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSS 122
L L LD + L S F +L L L + L + L ++
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 123 NSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
NSF L + N L +DLS L LQ L + +N L
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L +L +LD S N + + I L N++ N +
Sbjct: 518 NQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 46/246 (18%), Positives = 79/246 (32%), Gaps = 14/246 (5%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ +N + L + L ++ A L L L L N ++ P
Sbjct: 41 FNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL--TLWNLKYILYLNL 120
L +L L + KL+ G L L+KL + N + L NL +++++L
Sbjct: 101 SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDL 160
Query: 121 SSNSFTIPLPSEIGNLE----VLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
S N +++ L V + +D+S+N G+K L L L N +
Sbjct: 161 SYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSN 219
Query: 177 IP-DFIGGLINLKSLDLSNNNLSGAIPIS------LEKLLDLQHINVSFNKLEGEIPREG 229
I + L L L + +E L D+
Sbjct: 220 IMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV 279
Query: 230 PFRNFS 235
F +
Sbjct: 280 KFHCLA 285
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 54/222 (24%), Positives = 82/222 (36%), Gaps = 10/222 (4%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
+P++I ++ I L N L S + +LQ L L ++E L L
Sbjct: 25 KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFT- 126
L L N + F P F LT+L L +L + + L + LN++ N
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDL----QYLFLEYNRLQGSIPDFIG 182
LP+ NL LV +DLS N + L++ L + N + I D
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAF 201
Query: 183 GLINLKSLDLSNNNLSGAIP-ISLEKLLDLQHINVSFNKLEG 223
I L L L N S I L+ L L + + +
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 54/297 (18%), Positives = 93/297 (31%), Gaps = 51/297 (17%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSI-SIALGKLQKLQLLGLEDNQLEG--- 56
M I I ++ L + L GN + +I L L L + L + +
Sbjct: 188 MSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN 246
Query: 57 ------SIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP---- 106
SI LC + + L F L N+ + L + Y+
Sbjct: 247 LEIFEPSIMEGLCDVTID-EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK 305
Query: 107 ----------------LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS 150
+L ++ L L+ N +I L L +DLS N S
Sbjct: 306 HFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALS 363
Query: 151 --GAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPIS-LEK 207
G + G L++L L +N + GL L+ LD ++ L S
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422
Query: 208 LLDLQHINVSFNKLEGEIPREGPFRNFS-----------IESFKGNELLCGMPNLHV 253
L L ++++S+ + + G F + + + + NL
Sbjct: 423 LEKLLYLDISYTNTKIDFD--GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 34/156 (21%), Positives = 57/156 (36%), Gaps = 4/156 (2%)
Query: 80 GFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVL 139
G + C + N+ +L+ +P + ++LS N I N L
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSEL 58
Query: 140 VQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG 199
+DLS GL L L L N +Q P GL +L++L L+
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 200 AIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
+ +L+ L+ +NV+ N + F N +
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 37/210 (17%), Positives = 66/210 (31%), Gaps = 30/210 (14%)
Query: 56 GSIPYDLCRLAALFQLDLGDNKL---------------------SGFVPSCFGNLTNLRK 94
GS+ + + + D KL F N + L+
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQW 60
Query: 95 LYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAI 153
L L ++ I L ++ L L+ N P L L + +
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 154 PTTIGGLKDLQYLFLEYNRLQG-SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKL---- 208
IG L L+ L + +N + +P + L NL +DLS N + L+ L
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
Query: 209 LDLQHINVSFNKLEGEIPREGPFRNFSIES 238
+++S N ++ F+ +
Sbjct: 181 QVNLSLDMSLNPIDFIQD--QAFQGIKLHE 208
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 28/126 (22%), Positives = 43/126 (34%), Gaps = 2/126 (1%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSI-SIALGKLQKLQLLGLEDNQLEGSIPYD 61
N LT+L + + GN + S L L L QLE
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNL 120
L L L++ N L S + L +L L N++ + K + + NL
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552
Query: 121 SSNSFT 126
++NS
Sbjct: 553 TNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 24/113 (21%), Positives = 40/113 (35%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
N ++ N TNL + L +L L +LQLL + N L
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYI 115
+L +L LD N++ +L L +N + I L+++
Sbjct: 518 NQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWV 570
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 43/221 (19%), Positives = 83/221 (37%), Gaps = 13/221 (5%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
+I E N + + L +++ ++ L L N L DL L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIP 128
L+L N L + +L+ LR L L +N + + +++ L+ ++N+ +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-VGPSIE---TLHAANNNISR- 113
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG-SIPDFIGGLINL 187
+ G I L+ N + G +QYL L+ N + + + L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 188 KSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
+ L+L N + + L+ +++S NKL + E
Sbjct: 172 EHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPE 209
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 44/244 (18%), Positives = 91/244 (37%), Gaps = 16/244 (6%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+S ++ T L + L N L ++ + L L+ L L +N ++ +L
Sbjct: 43 GNPLSQISAADLAPFTKLELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYVQ-----EL 95
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLS 121
++ L +N +S S + +YL +N++T + L + YL+L
Sbjct: 96 LVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 122 SNSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
N + + + L ++L N + + L+ L L N+L +
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPE 209
Query: 181 IGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFK 240
+ + L NN L I +L +L+H ++ N R+ +N +++
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268
Query: 241 GNEL 244
+
Sbjct: 269 KQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 49/228 (21%), Positives = 93/228 (40%), Gaps = 16/228 (7%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ ++ ++ + N+ + L GN L+ + L KL+LL L N L DL
Sbjct: 19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DL 76
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLS 121
L+ L LDL +N + ++ L+ +N ++ + K + L+
Sbjct: 77 ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGKK---NIYLA 128
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSG-AIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
+N T+ + G + +DL +N L++L L+YN + +
Sbjct: 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ 187
Query: 181 IGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
+ LK+LDLS+N L+ + + + I++ NKL I +
Sbjct: 188 V-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 37/202 (18%), Positives = 77/202 (38%), Gaps = 11/202 (5%)
Query: 33 SISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNL 92
+I + ++ + D+ L+ ++ + +LDL N LS + T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 93 RKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGA 152
L L SN L L +L + L+L++N E+ + + + NN S
Sbjct: 61 ELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 153 IPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG-AIPISLEKLLDL 211
+ + + + ++L N++ G ++ LDL N + L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 212 QHINVSFNKLEGEIPREGPFRN 233
+H+N+ +N + ++ + F
Sbjct: 172 EHLNLQYNFIY-DVKGQVVFAK 192
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 27/148 (18%), Positives = 56/148 (37%), Gaps = 5/148 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNG-SISIALGKLQKLQLLGLEDNQLEGSIPYD 61
N I+ + + + + L N+++ + + L+ L L+ N + +
Sbjct: 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ 187
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLS 121
+ A L LDL NKL+ F+ F + + + L +N+L I L + + + +L
Sbjct: 188 VV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLR 245
Query: 122 SNSFT-IPLPSEIGNLEVLVQIDLSMNN 148
N F L + + +
Sbjct: 246 GNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 43/221 (19%), Positives = 84/221 (38%), Gaps = 13/221 (5%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
+I E N + + L +++ ++ L L N L DL L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIP 128
L+L N L + +L+ LR L L +N + + +++ L+ ++N+ +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-VGPSIE---TLHAANNNISR- 113
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG-SIPDFIGGLINL 187
+ G I L+ N + G +QYL L+ N + + + L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 188 KSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
+ L+L N + + + L+ +++S NKL + E
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPE 209
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 49/228 (21%), Positives = 93/228 (40%), Gaps = 16/228 (7%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ ++ ++ + N+ + L GN L+ + L KL+LL L N L DL
Sbjct: 19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DL 76
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLS 121
L+ L LDL +N + ++ L+ +N ++ + K + L+
Sbjct: 77 ESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRVSCSRGQGKK---NIYLA 128
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSG-AIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
+N T+ + G + +DL +N L++L L+YN + +
Sbjct: 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ 187
Query: 181 IGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
+ LK+LDLS+N L+ + + + I++ NKL I +
Sbjct: 188 V-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 30/222 (13%), Positives = 56/222 (25%), Gaps = 8/222 (3%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
+ E + L + L N + + KL+ L L N+L + + A +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIP 128
+ L +NKL + NL L N L + K ++ +
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS----IPDFIGGL 184
V L L+ QGS +
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335
Query: 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
+ +D I + + L+ ++
Sbjct: 336 ARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 16/175 (9%), Positives = 38/175 (21%), Gaps = 2/175 (1%)
Query: 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGD 75
+ G++ + + + + Q I R A L+
Sbjct: 311 KRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369
Query: 76 NKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPL-PSEIG 134
L V + L + + + L + +
Sbjct: 370 KALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSV 429
Query: 135 NLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKS 189
+ D+ + + K L ++ + + NL S
Sbjct: 430 QNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 50/225 (22%), Positives = 86/225 (38%), Gaps = 8/225 (3%)
Query: 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLE--GSIPYDLCRLAALFQLD 72
L +L + NK + S L L+ L L N L G +L LD
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 73 LGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP--LTLWNLKYILYLNLSSNSFTIPLP 130
L N + + S F L L L + L + +L+ ++YL++S +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 131 SEIGNLEVLVQIDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNRLQGSIPDFIGGLINLKS 189
L L + ++ N+F I L++L +L L +L+ P L +L+
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 190 LDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNF 234
L++++N L ++L LQ I + N + PR +
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 52/223 (23%), Positives = 82/223 (36%), Gaps = 12/223 (5%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAA 67
IP+ + + NL L N L S + +LQ+L L +++ L+
Sbjct: 21 KIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFT 126
L L L N + F L++L+KL L + + +LK + LN++ N
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 127 -IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLF----LEYNRLQGSIPDFI 181
LP NL L +DLS N T + L + L L N + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 182 GGLINLKSLDLSNNNLSGAIP-ISLEKLLDLQHINVSFNKLEG 223
I L L L NN S + ++ L L+ + +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 50/269 (18%), Positives = 93/269 (34%), Gaps = 21/269 (7%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + L + L ++ A L L L L N ++
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL--TLWNLKYILYLNL 120
L++L +L + L+ G+L L++L + N + L NL + +L+L
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 121 SSNSFTIPLPSEIGNLEVL----VQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
SSN +++ L + + +DLS+N + P ++ L L L N +
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLN 215
Query: 177 IPD-FIGGLINLKSLDL------SNNNLSGAIPISLEKL-------LDLQHINVSFNKLE 222
+ I GL L+ L + NL +LE L L +++ + +
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275
Query: 223 GEIPREGPFRNFSIESFKGNELLCGMPNL 251
+FS+ S + N
Sbjct: 276 DLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 44/233 (18%), Positives = 83/233 (35%), Gaps = 15/233 (6%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGS---ISIALGKLQKLQLLGLEDNQLEGSIP 59
N+ + L NL L+ I L + L +E +
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK 298
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLN 119
D L+L + K F L +L++L SN+ + +L + +L+
Sbjct: 299 -DFSYNFGWQHLELVNCKFGQF---PTLKLKSLKRLTFTSNKGGNAF-SEVDLPSLEFLD 353
Query: 120 LSSNSFTIP--LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI 177
LS N + L +DLS N + + GL+ L++L +++ L+ +
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QM 411
Query: 178 PD--FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
+ L NL LD+S+ + A L L+ + ++ N + +
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 42/237 (17%), Positives = 78/237 (32%), Gaps = 22/237 (9%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLN-GSISIALGKLQKLQLLGLEDNQLEGSIP 59
N++ I +L L + + N + + L L+ L L N+++
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 60 YDLCRLAAL----FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY--IPLTLWNLK 113
DL L + LDL N ++ P F + L KL L +N + + + L
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLA 225
Query: 114 YILYLNL------SSNSFTIPLPSEIGNLEVLVQIDLSMN---NFSGAIPTTIGGLKDLQ 164
+ L + + S + L L + + + I L ++
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 165 YLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L ++ + DF + L+L N KL L+ + + NK
Sbjct: 286 SFSLVSVTIE-RVKDFS-YNFGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKG 337
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 29/151 (19%), Positives = 47/151 (31%), Gaps = 4/151 (2%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNG-SISIALGKLQKLQLLGLEDNQLEGSIPYD 61
+ ++ L L + + L S L+ L L + +
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 62 LCRLAALFQLDLGDNKLSGFVPS-CFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLN 119
L++L L + N F L NL L L QL + +L + LN
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS 150
++SN L L +I L N +
Sbjct: 501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 33/152 (21%), Positives = 51/152 (33%), Gaps = 6/152 (3%)
Query: 85 CFGNLTNLRKLYLGSNQLTYIPLTL-WNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQID 143
C + N+ IP L ++ K L+LS N + L +D
Sbjct: 3 CVEVVPNI-TYQCMELNFYKIPDNLPFSTKN---LDLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 144 LSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPI 203
LS L L L L N +Q GL +L+ L NL+
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 204 SLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
+ L L+ +NV+ N ++ F N +
Sbjct: 119 PIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 54/235 (22%), Positives = 100/235 (42%), Gaps = 5/235 (2%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
I +E + +L + L N ++ A L L+ LGL N+L+ IP +
Sbjct: 41 KNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGV 99
Query: 63 CR-LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNL 120
L+ L +LD+ +NK+ + F +L NL+ L +G N L YI L + L L
Sbjct: 100 FTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTL 159
Query: 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
+ T + +L L+ + L N + + L L+ L + + ++
Sbjct: 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
Query: 181 IGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
+NL SL +++ NL+ +++ L+ L+ +N+S+N + I
Sbjct: 220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIE-GSMLHELL 272
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 52/243 (21%), Positives = 88/243 (36%), Gaps = 7/243 (2%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD-LCRLA 66
IP + L+NL + + NK+ + L L+ L + DN L I + L
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN 152
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSF 125
+L QL L L+ +L L L L + I + L + L +S +
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLI 185
+ L + ++ N + + L L++L L YN + + L+
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272
Query: 186 NLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE--GPFRNFSIESFKGNE 243
L+ + L L+ P + L L+ +NVS N+L + N N
Sbjct: 273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNP 331
Query: 244 LLC 246
L C
Sbjct: 332 LAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 46/227 (20%), Positives = 82/227 (36%), Gaps = 7/227 (3%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD-LCRLAA 67
++PE I T + LG N++ L+ L L +N + ++ L
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFT 126
L L L N+L F L+NL KL + N++ + +L + L + N
Sbjct: 82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLIN 186
L L Q+ L N + + L L L L + + L
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201
Query: 187 LKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRN 233
LK L++S+ + + L+L ++++ L +P R+
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP-YLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 4/197 (2%)
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
+LL L N+++ + L +L+L +N +S P F NL NLR L L SN+L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
Query: 104 YIP-LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD 162
IP L + L++S N I L +L L +++ N+ GL
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153
Query: 163 LQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L+ L LE L SIP L L L L + N++ S ++L L+ + +S
Sbjct: 154 LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
Query: 222 EGEIPREGPFRNFSIES 238
+ ++ S
Sbjct: 213 LDTMT-PNCLYGLNLTS 228
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 41/199 (20%), Positives = 73/199 (36%), Gaps = 25/199 (12%)
Query: 1 MFNCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP 59
+ CN++ SIP E ++L LI + L +N + +L +L++L + ++
Sbjct: 159 LEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLN 119
+ L L + L+ +L LR L L N ++ I
Sbjct: 218 PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIE------------- 264
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
+ L L +I L + P GL L+ L + N+L
Sbjct: 265 --GSMLH--------ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEES 314
Query: 180 FIGGLINLKSLDLSNNNLS 198
+ NL++L L +N L+
Sbjct: 315 VFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 142 IDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI 201
+ F A+P I + + L L NR++ D +L+ L+L+ N +S
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 202 PISLEKLLDLQHINVSFNKLEGEIPRE 228
P + L +L+ + + N+L+ IP
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLK-LIPLG 98
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 18/221 (8%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
N++ ++ +L + + + SI + L L + +NQL P L
Sbjct: 33 KTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--L 86
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
L L + + +N+++ P NLTNL L L +NQ+T I L NL + L LSS
Sbjct: 87 KNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSS 143
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N+ + S + L L Q+ N + P + L L+ L + N++ S +
Sbjct: 144 NTISDI--SALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKV--SDISVLA 196
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223
L NL+SL +NN +S P+ L +L ++++ N+L+
Sbjct: 197 KLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 47/220 (21%), Positives = 82/220 (37%), Gaps = 15/220 (6%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + +LTNL + L N+++ L L KL L L NQ+ P L
Sbjct: 230 GNQLKD--IGTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISP--L 283
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
L AL L+L +N+L P NL NL L L N ++ I + +L + L +
Sbjct: 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFYN 340
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N + S + NL + + N S P + L + L L + ++
Sbjct: 341 NKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
+ ++ L P ++ ++++N
Sbjct: 397 NVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 31/151 (20%), Positives = 53/151 (35%), Gaps = 11/151 (7%)
Query: 73 LGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSE 132
D ++ L K LG +T + +L + L
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTV-SQTDLDQVTTLQADRLGIKS--IDG 63
Query: 133 IGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDL 192
+ L L QI+ S N + P + L L + + N++ P + L NL L L
Sbjct: 64 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119
Query: 193 SNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223
NN ++ P+ L +L + +S N +
Sbjct: 120 FNNQITDIDPLK--NLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 36/178 (20%), Positives = 61/178 (34%), Gaps = 10/178 (5%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+ + P I+NL NL + L N ++ + L KLQ L +N++
Sbjct: 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFYNNKVSDVSS- 348
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNL 120
L L + L G N++S P NLT + +L L T P+ I
Sbjct: 349 -LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405
Query: 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178
+ I P+ I + + D++ N S + G++
Sbjct: 406 NVTGALIA-PATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 6/96 (6%)
Query: 131 SEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSL 190
L ++ L N + + L + L + + D + L NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 191 DLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
+ SNN L+ P+ L L I ++ N++ P
Sbjct: 74 NFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP 107
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 35/220 (15%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
S+P L L + GN+L S+ + L +L + L L
Sbjct: 75 SLPALPPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GL 123
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIP 128
+L + N+L+ L++L + NQL +P L L +N T
Sbjct: 124 CKLWIFGNQLTSLPVL----PPGLQELSVSDNQLASLPALPSELC---KLWAYNNQLTS- 175
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLK 188
LP L+ L +S N + ++PT L L+ NRL S+P LK
Sbjct: 176 LPMLPSGLQEL---SVSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPS---GLK 224
Query: 189 SLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
L +S N L+ ++P+ + L+ + VS N+L +P
Sbjct: 225 ELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPML 259
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 56/231 (24%), Positives = 83/231 (35%), Gaps = 45/231 (19%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
S+P L L L S L L + NQL S+P L
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLP---VLPPGL 143
Query: 69 FQLDLGDNKLSGFVPSCFGNLT-----------------NLRKLYLGSNQLTYIPLTLWN 111
+L + DN+L+ P+ L L++L + NQL +P
Sbjct: 144 QELSVSDNQLASL-PALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPTLPSE 202
Query: 112 LKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYN 171
L L +N T LP+ L+ L +S N ++P +L+ L + N
Sbjct: 203 LY---KLWAYNNRLT-SLPALPSGLKEL---IVS-GNRLTSLPVLPS---ELKELMVSGN 251
Query: 172 RLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
RL S+P L SL + N L+ +P SL L +N+ N L
Sbjct: 252 RLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 30/223 (13%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
S+P L L + N+L S+ +L KL +NQL S+P L
Sbjct: 135 SLPVLPPGLQEL---SVSDNQLA-SLPALPSELCKLWAY---NNQLT-SLPMLPSGLQ-- 184
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIP 128
+L + DN+L+ + L KL+ +N+LT +P LK L +S N T
Sbjct: 185 -ELSVSDNQLASLPTL----PSELYKLWAYNNRLTSLPALPSGLKE---LIVSGNRLTS- 235
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLK 188
LP L+ L +S N + ++P GL L + N+L +P+ + L +
Sbjct: 236 LPVLPSELKEL---MVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSET 287
Query: 189 SLDLSNNNLS---GAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
+++L N LS + + F+ PRE
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 9e-22
Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 27/186 (14%)
Query: 41 LQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSN 100
+L + ++ L ++P L A + L + DN L+ +P+ LR L + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA---LPPELRTLEVSGN 91
Query: 101 QLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160
QLT +P+ L + + LP+ L L + N + ++P G
Sbjct: 92 QLTSLPVLPPGLLELSIFSNPLTH----LPALPSGLCKL---WIFGNQLT-SLPVLPPG- 142
Query: 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220
LQ L + N+L S+P L L NN L+ ++P+ LQ ++VS N+
Sbjct: 143 --LQELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQ 192
Query: 221 LEGEIP 226
L +P
Sbjct: 193 LA-SLP 197
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 9e-20
Identities = 39/166 (23%), Positives = 67/166 (40%), Gaps = 23/166 (13%)
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
C L++G++ L+ +P C ++ L + N LT +P L+ L +S
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPALPPELR---TLEVSG 90
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N T LP L L + + +P G L L++ N+L S+P
Sbjct: 91 NQLTS-LPVLPPGLLELSIFSNPLTH----LPALPSG---LCKLWIFGNQLT-SLPVLPP 141
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
L+ L +S+N L+ ++P +L L N+L +P
Sbjct: 142 ---GLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPML 179
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 44/214 (20%), Positives = 70/214 (32%), Gaps = 36/214 (16%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
S+P + L L + N+L S+ +L KL +N+L S+P L
Sbjct: 175 SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAY---NNRLT-SLPALPSGLK-- 224
Query: 69 FQLDLGDNKLSGFVPSCFGNLT-----------------NLRKLYLGSNQLTYIPLTLWN 111
+L + N+L+ P L L L + NQLT +P +L +
Sbjct: 225 -ELIVSGNRLTSL-PVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLTRLPESLIH 282
Query: 112 LKYILYLNLSSNSFTIP---LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFL 168
L +NL N + EI + + + + P L +L
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL 342
Query: 169 EYNRLQGSIP----DFIGGLINLKSLDLSNNNLS 198
R P G N + L + LS
Sbjct: 343 VPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 52/250 (20%), Positives = 94/250 (37%), Gaps = 20/250 (8%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR 64
I+ + NL NL + L NK++ A L KL+ L L NQL+ +P +
Sbjct: 63 KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM-- 119
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL---TLWNLKYILYLNLS 121
L +L + +N+++ S F L + + LG+N L + +K + Y+ ++
Sbjct: 120 PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
+ T +L L L N + ++ GL +L L L +N + +
Sbjct: 180 DTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKG 241
+L+ L L+NN L +P L +Q + + N + F
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI----------SAIGSNDFCP 285
Query: 242 NELLCGMPNL 251
+
Sbjct: 286 PGYNTKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 53/243 (21%), Positives = 91/243 (37%), Gaps = 18/243 (7%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
N IS I L L +YL N+L + + LQ L + +N++
Sbjct: 85 NNKIS-KISPGAFAPLVKLERLYLSKNQLK---ELPEKMPKTLQELRVHENEITKVRKSV 140
Query: 62 LCRLAALFQLDLGDNKL--SGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYL 118
L + ++LG N L SG F + L + + +T IP +L L
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---EL 197
Query: 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178
+L N T + + L L ++ LS N+ S ++ L+ L L N+L +P
Sbjct: 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256
Query: 179 DFIGGLINLKSLDLSNNNLSG------AIPISLEKLLDLQHINVSFNKLEGEIPREGPFR 232
+ ++ + L NNN+S P K +++ N ++ + FR
Sbjct: 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
Query: 233 NFS 235
Sbjct: 317 CVY 319
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-23
Identities = 39/196 (19%), Positives = 67/196 (34%), Gaps = 24/196 (12%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
N S I + L I + + +I G L L L+ N++
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAAS 211
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLS 121
L L L +L L N +S N +LR+L+L +N+L +P L + KYI + L
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 271
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ-GSIPDF 180
+N+ + ++ + P + L N +Q I
Sbjct: 272 NNNIS------------------AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 181 I-GGLINLKSLDLSNN 195
+ ++ L N
Sbjct: 314 TFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 51/192 (26%), Positives = 81/192 (42%), Gaps = 9/192 (4%)
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
LL L++N++ D L L L L +NK+S P F L L +LYL NQL
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 104 YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAI--PTTIGGLK 161
+P + K + L + N T S L ++ ++L N + G+K
Sbjct: 114 ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171
Query: 162 DLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L Y+ + + +IP G +L L L N ++ SL+ L +L + +SFN +
Sbjct: 172 KLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
Query: 222 EGEIPREGPFRN 233
+ G N
Sbjct: 229 S-AVD-NGSLAN 238
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 31/143 (21%), Positives = 54/143 (37%), Gaps = 5/143 (3%)
Query: 91 NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS 150
+LR + L +P L L+L +N T + NL+ L + L N S
Sbjct: 32 HLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 151 GAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD 210
P L L+ L+L N+L+ +P+ L+ L + N ++ L
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 211 LQHINVSFNKLEGEIPREGPFRN 233
+ + + N L+ G F+
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQG 169
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 51/225 (22%), Positives = 81/225 (36%), Gaps = 7/225 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLN--GSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+ + + LT L + L N L+ G S + L+ L L N + ++
Sbjct: 37 SNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSS 95
Query: 61 DLCRLAALFQLDLGDNKLSGFVP-SCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYL 118
+ L L LD + L S F +L NL L + L + L
Sbjct: 96 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155
Query: 119 NLSSNSFTIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI 177
++ NSF +I L L +DLS PT L LQ L + +N
Sbjct: 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 215
Query: 178 PDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD-LQHINVSFNKL 221
L +L+ LD S N++ + L+ L +N++ N
Sbjct: 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 12/221 (5%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLE--GSIPYDLCRLA 66
S+P I ++ + L NKL KL +L L L N L G
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP--LTLWNLKYILYLNLSSNS 124
+L LDL N + + S F L L L + L + +L+ ++YL++S
Sbjct: 79 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 125 FTIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNRLQGSIPDFI- 181
+ + I L L + ++ N+F I L++L +L L +L+ +
Sbjct: 138 TRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF 195
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
L +L+ L++S+NN + L LQ ++ S N +
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 10/182 (5%)
Query: 57 SIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL---TLWNLK 113
S+P + ++ +L+L NKL F LT L KL L SN L++ + +
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 114 YILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNR 172
+ YL+LS N + S LE L +D +N ++ L++L YL + +
Sbjct: 79 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 173 LQGSIPDFIGGLINLKSLDLSNNNLSGAI-PISLEKLLDLQHINVSFNKLEGEIPREGPF 231
+ + GL +L+ L ++ N+ P +L +L +++S +LE ++ F
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS-PTAF 195
Query: 232 RN 233
+
Sbjct: 196 NS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 32/135 (23%), Positives = 54/135 (40%), Gaps = 6/135 (4%)
Query: 91 NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNN-- 148
+ ++ S LT +P + L L SN L L ++ LS N
Sbjct: 8 SGTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 149 FSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISL-EK 207
F G + G L+YL L +N + ++ GL L+ LD ++NL S+
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124
Query: 208 LLDLQHINVSFNKLE 222
L +L ++++S
Sbjct: 125 LRNLIYLDISHTHTR 139
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 57/245 (23%), Positives = 89/245 (36%), Gaps = 23/245 (9%)
Query: 11 PEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQ 70
++ L +L A+ L NK++ A L+KLQ L + N L IP +L ++L +
Sbjct: 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVE 127
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL---TLWNLKYILYLNLSSNSFTI 127
L + DN++ F L N+ + +G N L LK + YL +S T
Sbjct: 128 LRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTG 186
Query: 128 PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLIN 186
L L L N + L L L +N+++ I + L
Sbjct: 187 IPKDLPETLNEL---HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPT 242
Query: 187 LKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLC 246
L+ L L NN LS +P L L LQ + + N + + F
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI----------TKVGVNDFCPVGFGV 291
Query: 247 GMPNL 251
Sbjct: 292 KRAYY 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 19/243 (7%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
N IS I E+ + L L +Y+ N L I L L + DN++
Sbjct: 87 NNKIS-KIHEKAFSPLRKLQKLYISKNHLV---EIPPNLPSSLVELRIHDNRIRKVPKGV 142
Query: 62 LCRLAALFQLDLGDNKL--SGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLN 119
L + +++G N L SGF P F L L L + +LT IP L + + L+
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDL--PETLNELH 199
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
L N ++ L ++ L N ++ L L+ L L+ N+L +P
Sbjct: 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258
Query: 180 FIGGLINLKSLDLSNNNLSGAIPIS-------LEKLLDLQHINVSFNKLEGEIPREGPFR 232
+ L L+ + L NN++ + ++ K I++ N + + FR
Sbjct: 259 GLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
Query: 233 NFS 235
+
Sbjct: 318 CVT 320
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 37/196 (18%), Positives = 73/196 (37%), Gaps = 25/196 (12%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP-YD 61
N + + L + + KL I + L L L+ N+++ +I D
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQ-AIELED 212
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLS 121
L R + L++L LG N++ L LR+L+L +N+L+ +P L +LK + + L
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLH 272
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ-GSIPDF 180
+N+ T + +N+F + L N + +
Sbjct: 273 TNNIT----------------KVGVNDFCPVGFGV--KRAYYNGISLFNNPVPYWEVQPA 314
Query: 181 I-GGLINLKSLDLSNN 195
+ + ++ N
Sbjct: 315 TFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 46/208 (22%), Positives = 75/208 (36%), Gaps = 29/208 (13%)
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
LL L++N + D L L+ L L +NK+S F L L+KLY+ N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 104 YIP----------------------LTLWNLKYILYLNLSSNSFT-IPLPSEIGNLEVLV 140
IP L+ + + + N + L
Sbjct: 116 EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLN 175
Query: 141 QIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNLSG 199
+ +S + IP + L L L++N++Q +I L L L +N +
Sbjct: 176 YLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM 231
Query: 200 AIPISLEKLLDLQHINVSFNKLEGEIPR 227
SL L L+ +++ NKL +P
Sbjct: 232 IENGSLSFLPTLRELHLDNNKLS-RVPA 258
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 30/143 (20%), Positives = 50/143 (34%), Gaps = 5/143 (3%)
Query: 91 NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS 150
+LR + L +P + L+L +N + + L+ L + L N S
Sbjct: 34 HLRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 151 GAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD 210
L+ LQ L++ N L IP +L L + +N + L +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 211 LQHINVSFNKLEGEIPREGPFRN 233
+ I + N LE G F
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDG 171
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 35/163 (21%), Positives = 65/163 (39%), Gaps = 11/163 (6%)
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPL 129
+ D L VP + L L +N ++ + L+++ L L +N +
Sbjct: 38 VQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94
Query: 130 PSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINLK 188
L L ++ +S N+ IP L L + NR++ +P + GL N+
Sbjct: 95 EKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMN 150
Query: 189 SLDLSNNNL-SGAIPISLEKLLDLQHINVSFNKLEGEIPREGP 230
+++ N L + L L ++ +S KL IP++ P
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP 192
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 20/103 (19%), Positives = 42/103 (40%), Gaps = 12/103 (11%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD------ 61
I + L L ++L NKL+ + L L+ LQ++ L N + + +
Sbjct: 231 MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVG 288
Query: 62 -LCRLAALFQLDLGDNKLSGFV--PSCFGNLTNLRKLYLGSNQ 101
+ A + L +N + + P+ F +T+ + G+ +
Sbjct: 289 FGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 50/240 (20%), Positives = 92/240 (38%), Gaps = 19/240 (7%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAA 67
S+P I +N L + + N L LQ L L N+L + L + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPS 187
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFT 126
LF ++ N LS + +L N + + L L L N+ T
Sbjct: 188 LFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLT 239
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLIN 186
+ + N LV++DLS N + ++ L+ L++ NRL ++ + +
Sbjct: 240 DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296
Query: 187 LKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLC 246
LK LDLS+N+L + + + L+++ + N + + + N+ C
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDC 353
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 17/217 (7%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL-CRLA 66
I + +Y+G N + + L +L LE N L S+P +
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 141
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSF 125
L L + +N L F T+L+ L L SN+LT++ L + +L + N+S N
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFH---ANVSYNLL 198
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLI 185
+ + + ++D S N+ + + +L L L++N L
Sbjct: 199 S-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAWL-LNYP 248
Query: 186 NLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
L +DLS N L + K+ L+ + +S N+L
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 42/208 (20%), Positives = 84/208 (40%), Gaps = 14/208 (6%)
Query: 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGD 75
L N + + + + L ++++LL L D Q+E Y + +L +G
Sbjct: 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 76 NKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEI- 133
N + P F N+ L L L N L+ +P N + L++S+N+ + +
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTF 161
Query: 134 GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLS 193
L + LS N + + + + L + + YN L + I ++ LD S
Sbjct: 162 QATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 213
Query: 194 NNNLSGAIPISLEKLLDLQHINVSFNKL 221
+N+++ + ++L + + N L
Sbjct: 214 HNSINV---VRGPVNVELTILKLQHNNL 238
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 48/252 (19%), Positives = 89/252 (35%), Gaps = 18/252 (7%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
I + +++ + L +++ +++ + L +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTI 127
L+L D ++ F ++KLY+G N + Y+P N+ + L L N +
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 128 PLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLIN 186
LP I N L + +S NN T LQ L L NRL + + +
Sbjct: 132 -LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPS 187
Query: 187 LKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL-- 244
L ++S N LS +L + ++ ++ S N + + +I + N L
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHNNLTD 240
Query: 245 ---LCGMPNLHV 253
L P L
Sbjct: 241 TAWLLNYPGLVE 252
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 37/202 (18%), Positives = 74/202 (36%), Gaps = 11/202 (5%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR 64
N+S ++ + + + N +N + +L +L L+ N L L
Sbjct: 192 NVSYNLLSTLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLT-DTA-WLLN 246
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNS 124
L ++DL N+L + F + L +LY+ +N+L + L + + L+LS N
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNH 306
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
+ + L + L N+ + + L+ L L +N +
Sbjct: 307 LLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALF 360
Query: 185 INLKSLDLSNNNLSGAIPISLE 206
N+ + + + I LE
Sbjct: 361 RNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 14/128 (10%), Positives = 38/128 (29%), Gaps = 1/128 (0%)
Query: 101 QLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160
+ I L +++ + + E L + + +
Sbjct: 9 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 68
Query: 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220
+ ++ L L +++ ++ L + N + P + + L + + N
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 221 LEGEIPRE 228
L +PR
Sbjct: 129 LS-SLPRG 135
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 11/243 (4%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD-LCRLAA 67
+P+ I+ TN + L N++ + L+ L++L L N + +I LA
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILYLNLSSNSFT 126
L L+L DN+L+ F L+ L++L+L +N + IP + + + L+L
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 127 IPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLI 185
+ L L ++L+M N IP + L L L L N L P GL+
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLM 231
Query: 186 NLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE--GPFRNFSIESFKGNE 243
+L+ L + + + + + L L IN++ N L +P + P + N
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNP 290
Query: 244 LLC 246
C
Sbjct: 291 WNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 57/198 (28%), Positives = 85/198 (42%), Gaps = 6/198 (3%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
+I +I N L NL + L N+L + A L KL+ L L +N +E SIP
Sbjct: 97 RNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSY 154
Query: 62 L-CRLAALFQLDLGD-NKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLN 119
R+ +L +LDLG+ +LS F L+NLR L L L IP L L + L+
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-NLTPLIKLDELD 213
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
LS N + P L L ++ + + L+ L + L +N L D
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273
Query: 180 FIGGLINLKSLDLSNNNL 197
L +L+ + L +N
Sbjct: 274 LFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 38/155 (24%), Positives = 64/155 (41%), Gaps = 9/155 (5%)
Query: 71 LDLGDNKLSGFVPSCFGNL-TNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFTIP 128
+ L VP + TN R L L NQ+ I + +L+++ L LS N
Sbjct: 48 VICVRKNLR-EVPD---GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTI 103
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINL 187
L L ++L N + L L+ L+L N ++ SIP + + +L
Sbjct: 104 EIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSL 162
Query: 188 KSLDLSNNNLSGAIPI-SLEKLLDLQHINVSFNKL 221
+ LDL I + E L +L+++N++ L
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 36/138 (26%), Positives = 48/138 (34%), Gaps = 12/138 (8%)
Query: 84 SCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQID 143
SC K+ L +P + LNL N I + +L L +
Sbjct: 40 SCSNQF---SKVICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQ 94
Query: 144 LSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPI 203
LS N+ GL +L L L NRL L LK L L NN + +IP
Sbjct: 95 LSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPS 153
Query: 204 S----LEKL--LDLQHIN 215
+ L LDL +
Sbjct: 154 YAFNRIPSLRRLDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 22/94 (23%), Positives = 38/94 (40%), Gaps = 5/94 (5%)
Query: 142 IDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI 201
+ N +P I + + L L N++Q + L +L+ L LS N++
Sbjct: 48 VICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104
Query: 202 PISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
+ L +L + + N+L IP G F S
Sbjct: 105 IGAFNGLANLNTLELFDNRLT-TIP-NGAFVYLS 136
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 48/193 (24%), Positives = 77/193 (39%), Gaps = 8/193 (4%)
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
+ L L +N ++ L L L LG N + F L +L L L N LT
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136
Query: 104 YIPL-TLWNLKYILYLNLSSNSFTIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTI-GGL 160
IP L + L L +N +PS + L+++DL I GL
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195
Query: 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220
+L+YL L ++ +P+ L+ L+ L++S N+ P S L L+ + V ++
Sbjct: 196 FNLKYLNLGMCNIK-DMPNL-TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 221 LEGEIPREGPFRN 233
+ I F
Sbjct: 254 VS-LIE-RNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 58/243 (23%), Positives = 97/243 (39%), Gaps = 11/243 (4%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD-LCRLAA 67
+P+ I +N + L N + + L L++L L N + I LA+
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFT 126
L L+L DN L+ F L+ LR+L+L +N + IP + ++ L+L
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL 184
Query: 127 IPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLI 185
+ L L ++L M N +P + L L+ L + N P GL
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLS 242
Query: 186 NLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE--GPFRNFSIESFKGNE 243
+LK L + N+ +S + + L L +N++ N L +P + P R N
Sbjct: 243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNP 301
Query: 244 LLC 246
C
Sbjct: 302 WNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 59/198 (29%), Positives = 80/198 (40%), Gaps = 6/198 (3%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
+I I N L +L + L N L S A L KL+ L L +N +E SIP
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165
Query: 62 -LCRLAALFQLDLGD-NKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLN 119
R+ +L +LDLG+ KL F L NL+ L LG + +P L L + L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP-NLTPLVGLEELE 224
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
+S N F P L L ++ + + S GL L L L +N L D
Sbjct: 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD 284
Query: 180 FIGGLINLKSLDLSNNNL 197
L L L L +N
Sbjct: 285 LFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 37/155 (23%), Positives = 61/155 (39%), Gaps = 9/155 (5%)
Query: 71 LDLGDNKLSGFVPSCFGNL-TNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFTIP 128
+ LS VP + +N R L L N + I T +L ++ L L NS
Sbjct: 59 VVCTRRGLS-EVPQ---GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQI 114
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINL 187
L L ++L N + L L+ L+L N ++ SIP + + +L
Sbjct: 115 EVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSL 173
Query: 188 KSLDLSNNNLSGAIPI-SLEKLLDLQHINVSFNKL 221
LDL I + E L +L+++N+ +
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 35/139 (25%), Positives = 49/139 (35%), Gaps = 14/139 (10%)
Query: 84 SCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQID 143
SC K+ L+ +P + YLNL N+ + +L L +
Sbjct: 51 SCSNQF---SKVVCTRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQ 105
Query: 144 LSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP-DFIGGLINLKSLDLSNNNLSGAIP 202
L N+ GL L L L N L IP L L+ L L NN + +IP
Sbjct: 106 LGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIP 163
Query: 203 IS----LEKL--LDLQHIN 215
+ L LDL +
Sbjct: 164 SYAFNRVPSLMRLDLGELK 182
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 4/87 (4%)
Query: 142 IDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI 201
+ + S +P I + +YL L N +Q D L +L+ L L N++
Sbjct: 59 VVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115
Query: 202 PISLEKLLDLQHINVSFNKLEGEIPRE 228
+ L L + + N L IP
Sbjct: 116 VGAFNGLASLNTLELFDNWLT-VIPSG 141
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 23/242 (9%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + L +L + L NK+N A L LQ+L L N L +
Sbjct: 275 HGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNF 334
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP---------LTLWNLK 113
L + +DL N ++ F L L+ L L N LT I L+ L
Sbjct: 335 YGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV 394
Query: 114 YILYLNLSSNSF--------TIPLPSEIGNLEVLVQIDLSMNNFSG-AIPTTIGGLKDLQ 164
+ +NL++N + + + + L + L+ N FS + T L+
Sbjct: 395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454
Query: 165 YLFLEYNRLQGSI-----PDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
LFL N LQ + D GL +L+ L L++N L+ P L L+ ++++ N
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514
Query: 220 KL 221
+L
Sbjct: 515 RL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 62/245 (25%), Positives = 93/245 (37%), Gaps = 29/245 (11%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
CN++ +P+ +N L L N + + + L++LQLL L +I +
Sbjct: 13 FCNLT-QVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68
Query: 63 CR-LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL---TLWNLKYILYL 118
R L L LDLG +K+ P F L +L +L L L+ L NLK + L
Sbjct: 69 FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128
Query: 119 NLSSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL--KDLQYLFLEYNRLQG 175
+LS N + L G L L ID S N + L K L + L N L
Sbjct: 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS 188
Query: 176 SIPDFIGGLIN------LKSLDLSNNNLSGAIP------------ISLEKLLDLQHINVS 217
+ G +N L+ LD+S N + I SL +
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248
Query: 218 FNKLE 222
F+ ++
Sbjct: 249 FHNIK 253
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 9e-25
Identities = 62/333 (18%), Positives = 106/333 (31%), Gaps = 53/333 (15%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ L + I L N + L+KLQ L L DN L +
Sbjct: 323 YNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TI 377
Query: 63 CRLAALFQLDLGDNKLSGF---------------------VPSCFGNLTNLRKLYLGSNQ 101
+ ++ + L NKL + + +L+ L L N+
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNR 437
Query: 102 LTYIPL--TLWNLKYILYLNLSSNSFTIPLPSEI-----GNLEVLVQIDLSMNNFSGAIP 154
+ T + L L N + +E+ L L + L+ N + P
Sbjct: 438 FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPP 497
Query: 155 TTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHI 214
L L+ L L NRL + + NL+ LD+S N L + + + L +
Sbjct: 498 GVFSHLTALRGLSLNSNRLTVLSHNDLPA--NLEILDISRNQLLA---PNPDVFVSLSVL 552
Query: 215 NVSFNKLEGEIPREGPFRNFSIESFKG-----NELLCGMP---------NLHVPPCRTGI 260
+++ NK E F N+ + ++ C P +L C
Sbjct: 553 DITHNKFICECE-LSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEE 611
Query: 261 HHTSRKNDLLIGIVLPLSTIFMMVVILLILRYR 293
S K L I + L+ M ++ + R
Sbjct: 612 VLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 49/244 (20%), Positives = 83/244 (34%), Gaps = 23/244 (9%)
Query: 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQ--KLQLLGLEDNQLEGSIP 59
N S + L +L +I N++ L LQ L L N L +
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191
Query: 60 YDLCRLAALFQ------LDLGDNKLSGFVPSCFGN------------LTNLRKLYLGSNQ 101
D + F+ LD+ N + + F N ++ G +
Sbjct: 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251
Query: 102 LTYIPL-TLWNLK--YILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158
+ T L + +L+LS L+ L ++L+ N +
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311
Query: 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSF 218
GL +LQ L L YN L GL + +DL N+++ + + L LQ +++
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371
Query: 219 NKLE 222
N L
Sbjct: 372 NALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 34/146 (23%), Positives = 52/146 (35%), Gaps = 7/146 (4%)
Query: 93 RKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGA 152
R + LT +P L L LS N S LE L ++L
Sbjct: 7 RIAFYRFCNLTQVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 153 I-PTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI--PISLEKLL 209
I L +L+ L L +++ PD GL +L L L LS A+ L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 210 DLQHINVSFNKLEGEIPREGPFRNFS 235
L +++S N++ + F +
Sbjct: 124 ALTRLDLSKNQIR-SLYLHPSFGKLN 148
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 49/239 (20%), Positives = 93/239 (38%), Gaps = 17/239 (7%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAA 67
S+P I +N L + + N L LQ L L N+L + L + +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPS 193
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTI 127
LF ++ N LS + +L N + + + + L L N+ T
Sbjct: 194 LFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTD 246
Query: 128 PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINL 187
+ + N LV++DLS N + ++ L+ L++ NRL ++ + + L
Sbjct: 247 T--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303
Query: 188 KSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLC 246
K LDLS+N+L + + + L+++ + N + + + N+ C
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDC 359
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 17/217 (7%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL-CRLA 66
I + +Y+G N + + L +L LE N L S+P +
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 147
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSF 125
L L + +N L F T+L+ L L SN+LT++ L + +L + N+S N
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFH---ANVSYNLL 204
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLI 185
+ + + ++D S N+ + + + +L L L++N L
Sbjct: 205 S-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWL-LNYP 254
Query: 186 NLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
L +DLS N L + K+ L+ + +S N+L
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 48/252 (19%), Positives = 89/252 (35%), Gaps = 18/252 (7%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
I + +++ + L +++ +++ + L +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFTI 127
L+L D ++ F ++KLY+G N + Y+P N+ + L L N +
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137
Query: 128 PLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLIN 186
LP I N L + +S NN T LQ L L NRL + + +
Sbjct: 138 -LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPS 193
Query: 187 LKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL-- 244
L ++S N LS +L + ++ ++ S N + + +I + N L
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHNNLTD 246
Query: 245 ---LCGMPNLHV 253
L P L
Sbjct: 247 TAWLLNYPGLVE 258
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 50/234 (21%), Positives = 88/234 (37%), Gaps = 20/234 (8%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
N + +P + ++ + + L ++ + A +Q L + N + P+
Sbjct: 60 NSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV 118
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNL 120
+ L L L N LS F N L L + +N L I T + L L
Sbjct: 119 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 178
Query: 121 SSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
SSN T + L + L ++S N +T+ ++ L +N + +
Sbjct: 179 SSNRLTHVDL----SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG 228
Query: 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRN 233
+ L L L +NNL+ L L +++S+N+LE +I PF
Sbjct: 229 --PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIM-YHPFVK 276
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 38/205 (18%), Positives = 75/205 (36%), Gaps = 11/205 (5%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR 64
N+S ++ + + + N +N + +L +L L+ N L L
Sbjct: 198 NVSYNLLSTLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLT-DTA-WLLN 252
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNS 124
L ++DL N+L + F + L +LY+ +N+L + L + + L+LS N
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNH 312
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
+ + L + L N+ + + L+ L L +N +
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALF 366
Query: 185 INLKSLDLSNNNLSGAIPISLEKLL 209
N+ + + + I LE L
Sbjct: 367 RNVARPAVDDADQHCKIDYQLEHGL 391
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 14/128 (10%), Positives = 38/128 (29%), Gaps = 1/128 (0%)
Query: 101 QLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160
+ I L +++ + + E L + + +
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 74
Query: 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220
+ ++ L L +++ ++ L + N + P + + L + + N
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 221 LEGEIPRE 228
L +PR
Sbjct: 135 LS-SLPRG 141
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 49/228 (21%), Positives = 88/228 (38%), Gaps = 27/228 (11%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
S+P+ + + + + N L S+ L+ L DN+L ++P L
Sbjct: 73 SLPDNL--PPQITVLEITQNAL-ISLPELPASLEYLDAC---DNRLS-TLPELPASLK-- 123
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIP 128
LD+ +N+L+ +P L + +NQLT +P +L+ L++ +N T
Sbjct: 124 -HLDVDNNQLT-MLPEL---PALLEYINADNNQLTMLPELPTSLEV---LSVRNNQLTF- 174
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQ----YLFLEYNRLQGSIPDFIGGL 184
LP +LE L D+S N ++P + + NR+ IP+ I L
Sbjct: 175 LPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSL 229
Query: 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFR 232
++ L +N LS I SL + + ++
Sbjct: 230 DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 46/216 (21%), Positives = 73/216 (33%), Gaps = 46/216 (21%)
Query: 9 SIPEEINNLTNLI--AIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLA 66
SI INN +L + Y + A K +K L G N+ +
Sbjct: 2 SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK------- 54
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFT 126
+ +L L L+ +P L I L ++ N+
Sbjct: 55 -------------------ECLINQFSELQLNRLNLSSLPDNL--PPQITVLEITQNALI 93
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLIN 186
LP +LE L D N S +P LK L ++ N+L +P+
Sbjct: 94 S-LPELPASLEYL---DACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPA---L 141
Query: 187 LKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
L+ ++ NN L+ +P L L +V N+L
Sbjct: 142 LEYINADNNQLT-MLPELPTSLEVL---SVRNNQLT 173
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 33/231 (14%), Positives = 69/231 (29%), Gaps = 15/231 (6%)
Query: 8 GSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQ----LLGLEDNQLEGSIPYDLC 63
+PE +L L + N L S+ + + +N++ IP ++
Sbjct: 173 TFLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
Query: 64 RLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSN 123
L + L DN LS + + Y G + N + + +
Sbjct: 228 SLDPTCTIILEDNPLSSR-IRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286
Query: 124 SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGG 183
F S++ + + + N FS + L D + + + ++
Sbjct: 287 WFPENKQSDVSQIWHAFEHEEHANTFS----AFLDRLSDTVS-ARNTSGFREQVAAWLEK 341
Query: 184 LINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNF 234
L L + ++ S E + L N+ L + +
Sbjct: 342 LSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDT 392
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 46/225 (20%), Positives = 90/225 (40%), Gaps = 9/225 (4%)
Query: 4 CNISG----SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP 59
C+ SIP + + ++ L NK+ L LQ+L L+ +++
Sbjct: 10 CDGRSRSFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT--LWNLKYILY 117
L +L LDL DN LS S FG L++L+ L L N + +T NL +
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 118 LNLSS-NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
L + + +F+ + L L ++++ + ++ ++D+ +L L +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
+ F L +++ L+L + NL+ L + +
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 50/225 (22%), Positives = 85/225 (37%), Gaps = 16/225 (7%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD- 61
+ + + L + I + +K+ L+ L+ L L +N + +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 62 --LCRLAALFQLDLGDNKLS--GFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILY 117
+L L L N L L NL L + N +P + + + +
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRF 414
Query: 118 LNLSSNSFTIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
LNLSS + + + I LEVL D+S NN + L LQ L++ N+L+ +
Sbjct: 415 LNLSSTGIRV-VKTCIPQTLEVL---DVSNNNLD-SFSL---FLPRLQELYISRNKLK-T 465
Query: 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
+PD L + +S N L ++L LQ I + N
Sbjct: 466 LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 39/256 (15%), Positives = 82/256 (32%), Gaps = 23/256 (8%)
Query: 3 NCNISGSIPEE-INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
N I LT+L + + L S +L ++ + L L ++ +
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQ-----------LTYIPLTLW 110
L+++ L+L D L+ F S + + + L + +
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 111 NLKYILYLNLSSNSFTIPLPSEIGNLE--------VLVQIDLSMNNFSGAIPTTIGGLKD 162
L + + + + N PSE + + ++ + + T L+
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 163 LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI---PISLEKLLDLQHINVSFN 219
++ + +E +++ F L +L+ LDLS N + LQ + +S N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 220 KLEGEIPREGPFRNFS 235
L
Sbjct: 372 HLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 44/227 (19%), Positives = 87/227 (38%), Gaps = 15/227 (6%)
Query: 13 EINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLD 72
E ++ T ++ + + + ++ L + L + L + ++
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 73 LGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYIL----YLNLSSNSFTI- 127
+ ++K+ S +L +L L L N + L K L LS N
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376
Query: 128 -PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLIN 186
+ L+ L +D+S N F +P + + +++L L ++ +
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQT 432
Query: 187 LKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRN 233
L+ LD+SNNNL + + L +L Q + +S NKL+ +P F
Sbjct: 433 LEVLDVSNNNLD-SFSLFLPRL---QELYISRNKLK-TLPDASLFPV 474
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 44/223 (19%), Positives = 81/223 (36%), Gaps = 3/223 (1%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
I+ ++ NL + L +++N A L L+ L L DN L
Sbjct: 35 FNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWF 94
Query: 63 CRLAALFQLDLGDNKLSGF-VPSCFGNLTNLRKLYLGS-NQLTYIP-LTLWNLKYILYLN 119
L++L L+L N V S F NLTNL+ L +G+ + I + L + L
Sbjct: 95 GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
+ + S + ++ + + L ++ + + L ++YL L L
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214
Query: 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
+ + S S +LL L + +++E
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 39/252 (15%), Positives = 78/252 (30%), Gaps = 26/252 (10%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + + L+++ + L L L + + +
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 63 CRLAALFQL------------------DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY 104
L L + D ++ +R+L++ L Y
Sbjct: 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 105 IP-LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTT---IGGL 160
L+ + + + ++ + S +L+ L +DLS N G
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 161 KDLQYLFLEYNRLQ--GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSF 218
LQ L L N L+ + + L NL SLD+S N +P S + ++ +N+S
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS 419
Query: 219 NKLEGEIPREGP 230
+ + P
Sbjct: 420 TGIR-VVKTCIP 430
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 40/240 (16%), Positives = 82/240 (34%), Gaps = 21/240 (8%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQL-EGSIPYD 61
+ I+ + +L +L + L N L+ S G L L+ L L N +
Sbjct: 59 SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 62 LCRLAALFQLDLGD-NKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLN 119
L L L +G+ S F LT+L +L + + L +L +++ I +L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG---- 175
L + L L + ++L N + + + + + R
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 176 ------SIPDFIGGLINLKSLDLSNNNLSGAIPISLE--------KLLDLQHINVSFNKL 221
+ +I L ++ D + N L P + + + ++ +++ L
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 40/189 (21%), Positives = 62/189 (32%), Gaps = 13/189 (6%)
Query: 11 PEEINNLTNLIAIYLGGNKLN--GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
+L + L N L L L+ L L + N +P +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIP 128
L+L + V +C L L + +N L L L L+ L +S N
Sbjct: 413 RFLNLSSTGIR-VVKTC--IPQTLEVLDVSNNNLDSFSLFLPRLQE---LYISRNKLKT- 465
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP--DFIGGLIN 186
LP VL+ + +S N L LQ ++L N S P D++ +N
Sbjct: 466 LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 524
Query: 187 LKSLDLSNN 195
S +
Sbjct: 525 KNSQKEQGS 533
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 31/140 (22%), Positives = 49/140 (35%), Gaps = 4/140 (2%)
Query: 97 LGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTT 156
S T IP L + L+LS N T ++ L + L + +
Sbjct: 12 GRSRSFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 157 IGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG-AIPISLEKLLDLQHIN 215
L L++L L N L + G L +LK L+L N + L +LQ +
Sbjct: 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129
Query: 216 VSFNKLEGEIPREGPFRNFS 235
+ + EI F +
Sbjct: 130 IGNVETFSEIR-RIDFAGLT 148
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 6/117 (5%)
Query: 118 LNLSSNSFTIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
+ S SFT +PS + ++ L DLS N + + +LQ L L+ +R+
Sbjct: 10 CDGRSRSFTS-IPSGLTAAMKSL---DLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRN 233
D L +L+ LDLS+N+LS L L+++N+ N + + F N
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 56/219 (25%), Positives = 84/219 (38%), Gaps = 13/219 (5%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC-RLA 66
IP+ + + NL L N L S + +LQ+L L +++ +I L+
Sbjct: 21 KIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSF 125
L L L N + F L++L+KL L + + +LK + LN++ N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 126 T-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQY----LFLEYNRLQGSIPDF 180
LP NL L +DLS N T + L + L L N + I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG 195
Query: 181 IGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
I LK L L N L ++L LQ I + N
Sbjct: 196 AFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 11/199 (5%)
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
+ L L N L Y L LDL ++ + +L++L L L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 104 YIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNF-SGAIPTTIGGLK 161
+ L L + L + IG+L+ L +++++ N S +P L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 162 DLQYLFLEYNRLQGSIPDFI-GGLINLK----SLDLSNNNLSGAIPISLEKLLDLQHINV 216
+L++L L N++Q SI L + SLDLS N ++ I K + L+ + +
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELAL 207
Query: 217 SFNKLEGEIPREGPFRNFS 235
N+L+ +P G F +
Sbjct: 208 DTNQLK-SVPD-GIFDRLT 224
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 33/137 (24%), Positives = 61/137 (44%), Gaps = 8/137 (5%)
Query: 90 TNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEI-GNLEVLVQIDLSMN 147
+ + L L N L ++ ++ + L+LS + +L L + L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGN 86
Query: 148 NFSGAIPTTI-GGLKDLQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNL-SGAIPIS 204
++ GL LQ L L S+ +F G L LK L++++N + S +P
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 205 LEKLLDLQHINVSFNKL 221
L +L+H+++S NK+
Sbjct: 145 FSNLTNLEHLDLSSNKI 161
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 51/196 (26%), Positives = 72/196 (36%), Gaps = 4/196 (2%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD-LC 63
IS NL ++L N L + A L L+ L L DN S+
Sbjct: 43 RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
Query: 64 RLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILYLNLSS 122
L L L L L P F L L+ LYL N L +P + +L + +L L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI- 181
N + L L ++ L N + P L L L+L N L ++P
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEAL 221
Query: 182 GGLINLKSLDLSNNNL 197
L L+ L L++N
Sbjct: 222 APLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 55/217 (25%), Positives = 83/217 (38%), Gaps = 30/217 (13%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
++P I I+L GN+++ + + + L +L L N L LA L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 69 FQLDLGDN-KLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFT 126
QLDL DN +L P+ F L L L+L L + L + YL L N+
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLI 185
L + F L +L +LFL NR+ S+P+ GL
Sbjct: 143 ----------------ALPDDTFRD--------LGNLTHLFLHGNRIS-SVPERAFRGLH 177
Query: 186 NLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
+L L L N ++ P + L L + + N L
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 32/126 (25%), Positives = 53/126 (42%), Gaps = 5/126 (3%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISI-ALGKLQKLQLLGLEDNQLEGSIPY 60
C + + + L L +YL N L ++ L L L L N++
Sbjct: 114 RCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILYLN 119
L +L +L L N+++ P F +L L LYL +N L+ +P L+ + YL
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 120 LSSNSF 125
L+ N +
Sbjct: 232 LNDNPW 237
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 46/235 (19%), Positives = 86/235 (36%), Gaps = 40/235 (17%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + +P E N+ + Y ++ + G+ +++ + L D
Sbjct: 19 HSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD----------- 67
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
C +L+L + LS +P +L L N LT +P +LK +L N +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLTELPELPQSLKSLLVDNNNL 123
Query: 123 NSFTIPLPS---------------EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLF 167
+ + P E+ N L ID+ N+ +P L+++
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLP---DLPPSLEFIA 179
Query: 168 LEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
N+L+ +P+ L L ++ NN+L +P L+ I N LE
Sbjct: 180 AGNNQLE-ELPEL-QNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE 228
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 37/233 (15%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
+P+ +L + G N+L + L L L + ++N L+ +P L
Sbjct: 167 KLPDLPPSLEFI---AAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLE-- 218
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIP 128
+ G+N L NL L +Y +N L +P +L+ LN+ N T
Sbjct: 219 -SIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLE---ALNVRDNYLT-D 271
Query: 129 LPSEIGNLEVLVQIDLSMNNFSGAIP-------------TTIGGLKDLQYLFLEYNRLQG 175
LP +L L + + S P + L+ L + N+L
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI- 330
Query: 176 SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
+P L+ L S N+L+ +P + L+ ++V +N L E P
Sbjct: 331 ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDI 375
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 42/213 (19%), Positives = 77/213 (36%), Gaps = 29/213 (13%)
Query: 10 IPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALF 69
I + T L + L + + ++ ++ E + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 70 QLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPL 129
L D +L L + L+ +P +L+ L S NS T L
Sbjct: 62 VSRLRDCL-----------DRQAHELELNNLGLSSLPELPPHLE---SLVASCNSLTE-L 106
Query: 130 PSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKS 189
P +L+ L+ + ++ S P L+YL + N+L+ +P+ + LK
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLPE-LQNSSFLKI 157
Query: 190 LDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
+D+ NN+L +P L+ I N+LE
Sbjct: 158 IDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/237 (23%), Positives = 92/237 (38%), Gaps = 48/237 (20%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
+P+ +L ++ G N L L L L + ++N L+ ++P L
Sbjct: 209 KLPDLPLSLESI---VAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE-- 260
Query: 69 FQLDLGDNKLSGFVPSCFGNLT-----------------NLRKLYLGSNQLTYIPLTLWN 111
L++ DN L+ P +LT NL L SN++ + +
Sbjct: 261 -ALNVRDNYLTDL-PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPS 318
Query: 112 LKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYN 171
L+ LN+S+N LP+ LE L S N+ + +P LK L +EYN
Sbjct: 319 LEE---LNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVPELPQNLK---QLHVEYN 367
Query: 172 RLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
L+ PD + +L+ N+ +P + L + ++V N L E P
Sbjct: 368 PLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNL---KQLHVETNPLR-EFPDI 414
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 44/227 (19%), Positives = 79/227 (34%), Gaps = 39/227 (17%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL--- 65
++P+ +L L + N L + L L + + L +P +L L
Sbjct: 251 TLPDLPPSLEAL---NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNAS 305
Query: 66 -----------AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKY 114
+L +L++ +NKL L +L N L +P NLK
Sbjct: 306 SNEIRSLCDLPPSLEELNVSNNKLIELPAL----PPRLERLIASFNHLAEVPELPQNLKQ 361
Query: 115 ILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ 174
L++ N P ++E DL MN+ +P LK L +E N L+
Sbjct: 362 ---LHVEYNPLRE-FPDIPESVE-----DLRMNSHLAEVPELPQNLK---QLHVETNPLR 409
Query: 175 GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
PD +++ L +++ + + E L+ +
Sbjct: 410 -EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 25/136 (18%), Positives = 49/136 (36%), Gaps = 19/136 (13%)
Query: 104 YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD- 162
+I + ++ S++ T +P E N++ + + + + P G ++
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 163 ------------LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD 210
L L L S+P+ +L+SL S N+L+ +P + L
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKS 115
Query: 211 LQHINVSFNKLEGEIP 226
L N + L P
Sbjct: 116 LLVDNNNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 28/158 (17%), Positives = 53/158 (33%), Gaps = 31/158 (19%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
S+ + +L L + NKL + +L++L N L +P L
Sbjct: 311 SLCDLPPSLEEL---NVSNNKLI-ELPALPPRLERLIASF---NHLA-EVPELPQNLK-- 360
Query: 69 FQLDLGDNKLSGFVPSCFGNLT----------------NLRKLYLGSNQLTYIPLTLWNL 112
QL + N L F P ++ NL++L++ +N L P ++
Sbjct: 361 -QLHVEYNPLREF-PDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESV 418
Query: 113 KYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS 150
+ L ++S P + L ++
Sbjct: 419 E---DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 12/96 (12%), Positives = 28/96 (29%), Gaps = 12/96 (12%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
P+ ++ +L ++N ++ Q L+ L +E N L P +
Sbjct: 371 EFPDIPESVEDL--------RMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVE-- 419
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY 104
L + ++ L + +
Sbjct: 420 -DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHHH 454
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 42/209 (20%), Positives = 81/209 (38%), Gaps = 7/209 (3%)
Query: 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG 74
+L L + + S + + + +++ LD
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 75 DNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT---LWNLKYILYLNLSSNSFTIPLPS 131
+N L+ V G+LT L L L NQL + +K + L++S NS +
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 132 EI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSL 190
+ L+ +++S N + I + ++ L L N+++ SIP + L L+ L
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449
Query: 191 DLSNNNLSGAIPISLEKLLDLQHINVSFN 219
++++N L ++L LQ I + N
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 44/189 (23%), Positives = 76/189 (40%), Gaps = 11/189 (5%)
Query: 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG 74
+N+ + + K+ L +N L ++ + L L L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 75 DNKLS--GFVPSCFGNLTNLRKLYLGSNQLTYI--PLTLWNLKYILYLNLSSNSFT-IPL 129
N+L + + +L++L + N ++Y K +L LN+SSN T
Sbjct: 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 130 PSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINLK 188
++VL DL N +IP + L+ LQ L + N+L+ S+PD I L +L+
Sbjct: 417 RCLPPRIKVL---DLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ 471
Query: 189 SLDLSNNNL 197
+ L N
Sbjct: 472 KIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 44/246 (17%), Positives = 85/246 (34%), Gaps = 19/246 (7%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR 64
IS +I +L+ L + + N++ Q+L+ L L N+L I
Sbjct: 32 YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--P 88
Query: 65 LAALFQLDLGDNKLSGF-VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSN 123
L LDL N + FGN++ L+ L L + L + I + L
Sbjct: 89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 124 SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG-------- 175
+ L+ L + + I + LE + ++
Sbjct: 149 ETYGE-KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS 207
Query: 176 ---SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD---LQHINVSFNKLEGEIPREG 229
SI + L +L L+N + I + +L+ + + ++S KL+G++
Sbjct: 208 YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267
Query: 230 PFRNFS 235
+ +
Sbjct: 268 FDYSGT 273
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 35/180 (19%), Positives = 67/180 (37%), Gaps = 6/180 (3%)
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
+L + N + D+ L+ L L + N++ S F L L L N+L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 104 YIPLTLWNLKYILYLNLSSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD 162
I + +L+LS N+F +P+ E GN+ L + LS + + I L
Sbjct: 83 KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140
Query: 163 LQYLFLEYNRLQGSIP---DFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
+ L + +L + +N + +S++ + +L+ N+
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 35/150 (23%), Positives = 64/150 (42%), Gaps = 5/150 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLN--GSISIALGKLQKLQLLGLEDNQLEGSIPY 60
N ++ ++ E +LT L + L N+L I+ +++ LQ L + N +
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 61 DLC-RLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLN 119
C +L L++ N L+ + C ++ L L SN++ IP + L+ + LN
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELN 450
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNF 149
++SN L L +I L N +
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 38/219 (17%), Positives = 75/219 (34%), Gaps = 19/219 (8%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC-RLA 66
+P+++ T L + N ++ + + L KL++L + N+++ + +
Sbjct: 14 HVPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQ 69
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT-----LWNLKYILYLNLS 121
L LDL NKL + NL+ L L N +P+ + LK +L LS
Sbjct: 70 ELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLK---FLGLS 123
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
+ I +L + + + + GL+D L FI
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220
+ +L +N+ + + + N
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP 220
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 41/245 (16%), Positives = 82/245 (33%), Gaps = 43/245 (17%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQK---LQLLGLEDNQLEG--- 56
C+ SI ++ L + L + + I + +L + + + +L+G
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264
Query: 57 --SIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWN-LK 113
Y L AL + + + +N+ + + + + +
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 114 YILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173
L+L+ S+N T D N G L +L+ L L+ N+L
Sbjct: 325 PFLHLDFSNNLLT----------------DTVFENC--------GHLTELETLILQMNQL 360
Query: 174 QGSIPDFIG---GLINLKSLDLSNNNLSGAIP-ISLEKLLDLQHINVSFNKLEGEIPREG 229
+ + + +L+ LD+S N++S L +N+S N L +
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT-----DT 414
Query: 230 PFRNF 234
FR
Sbjct: 415 IFRCL 419
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 8e-12
Identities = 31/119 (26%), Positives = 54/119 (45%), Gaps = 9/119 (7%)
Query: 116 LYLNLSSNSFTIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ 174
++ S N +P ++ +L ++S N S + I L L+ L + +NR+Q
Sbjct: 3 FLVDRSKNGLIH-VPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQ 58
Query: 175 GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRN 233
L+ LDLS+N L IS ++L+H+++SFN + +P F N
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGN 113
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 31/256 (12%), Positives = 69/256 (26%), Gaps = 44/256 (17%)
Query: 10 IPEEINNLTNLIAIYLGGNKL----------------------NGSISIALGKLQKLQLL 47
I +E N++ L + L L LQ
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 48 GLEDNQLEGSIPYDLCRLAALFQLDL----------------GDNKLSGFVPSCFGNLTN 91
L + + ++ +L + L+ + +
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
Query: 92 LRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIG-----NLEVLVQIDLSM 146
L + N I +W+ + Y ++S+ L +L+ L +
Sbjct: 227 LNNIETTWNSFIRILQLVWHTT-VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 147 NNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLE 206
+ F ++ + + + LD SNN L+ + +
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 207 KLLDLQHINVSFNKLE 222
L +L+ + + N+L+
Sbjct: 346 HLTELETLILQMNQLK 361
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 38/184 (20%), Positives = 71/184 (38%), Gaps = 5/184 (2%)
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
++ L L +N++ DL R L L L N ++ F +L +L L L N L+
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 104 YIPL-TLWNLKYILYLNLSSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPT-TIGGL 160
+ L + +LNL N + + S +L L + + + I GL
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173
Query: 161 KDLQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
L+ L ++ + LQ S + N+ L L + I ++ ++ + +
Sbjct: 174 TFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 220 KLEG 223
L+
Sbjct: 233 DLDT 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 40/226 (17%), Positives = 80/226 (35%), Gaps = 15/226 (6%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISI-ALGKLQKLQLLGLEDNQLEGSIPYDL-CRL 65
+I E+ ++L +L + L N L ++S L L L L N + L L
Sbjct: 90 TIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL 148
Query: 66 AALFQLDLGDNKLSGFVPS-CFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSN 123
L L +G+ + F LT L +L + ++ L +L +++ + +L L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 124 SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI--------GGLKDLQYLFLEYNRLQG 175
+ L + + ++L + + + + + + L
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF- 267
Query: 176 SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
+ + + L L+ S N L ++L LQ I + N
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 42/226 (18%), Positives = 89/226 (39%), Gaps = 17/226 (7%)
Query: 16 NLTNLIAIYLGGNKLNGSISI-ALGKLQKLQLLGLEDNQLEGSIPYDLCR-LAALFQLDL 73
NL A+ L N +N +I + L L+ L L N L ++ + L++L L+L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 74 GDNKLSGFVP-SCFGNLTNLRKLYLGSN-QLTYIPL-TLWNLKYILYLNLSSNSFTIPLP 130
N S F +LT L+ L +G+ T I L ++ L + ++ P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 131 SEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG----SIP----DFIG 182
+ +++ + + L M + + ++ L L L + + +
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228
+++ +++ +L + L ++ L + S N+L+ +P
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDG 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 39/166 (23%), Positives = 63/166 (37%), Gaps = 14/166 (8%)
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLS 121
L+ +PS G ++ L L +N++TYI L + L L+
Sbjct: 28 LSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLT 84
Query: 122 SNSFT-IP--LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178
SN I S +G+LE L DLS N S + L L +L L N + ++
Sbjct: 85 SNGINTIEEDSFSSLGSLEHL---DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLG 140
Query: 179 D--FIGGLINLKSLDLSNNNLSGAIPI-SLEKLLDLQHINVSFNKL 221
+ L L+ L + N + I L L+ + + + L
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 21/136 (15%), Positives = 47/136 (34%), Gaps = 12/136 (8%)
Query: 1 MFNCNISGSIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEG--- 56
+ ++ S + ++ N+ + L + + I + ++ L L D L+
Sbjct: 181 IDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239
Query: 57 -SIPYD----LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLW 110
+ L + + + D L V ++ L +L NQL +P
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKSVPDGIFD 298
Query: 111 NLKYILYLNLSSNSFT 126
L + + L +N +
Sbjct: 299 RLTSLQKIWLHTNPWD 314
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 46/211 (21%), Positives = 76/211 (36%), Gaps = 22/211 (10%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
I LT L + N + ++ L + L L + N+L ++ + L L L
Sbjct: 58 TGIEKLTGLTKLICTSNNIT---TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
+ NKL+ L L N LT I ++ + + L+ N L
Sbjct: 112 NCDTNKLTKLD---VSQNPLLTYLNCARNTLTEIDVS--HNTQLTELDCHLNKKITKLD- 165
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
+ L +D S N + + K L L + N + + + I L LD
Sbjct: 166 -VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLD 218
Query: 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
S+N L+ I + L L + + S N L
Sbjct: 219 CSSNKLTE---IDVTPLTQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 42/220 (19%), Positives = 83/220 (37%), Gaps = 21/220 (9%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
+ + L L ++ + + ++ + KL L L N + DL
Sbjct: 27 AFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITT---LDL 81
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
+ L L NKL+ LT L L +N+LT + ++ + YLN +
Sbjct: 82 SQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCDTNKLTKLDVS--QNPLLTYLNCAR 136
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
N+ T ++ + L ++D +N + + L L +N++ + +
Sbjct: 137 NTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VS 188
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
L L+ NN++ + L + + L ++ S NKL
Sbjct: 189 QNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 38/226 (16%), Positives = 76/226 (33%), Gaps = 32/226 (14%)
Query: 13 EINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLD 72
++++ T L + NK + + +L L N++ D+ + L +L+
Sbjct: 143 DVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLN 197
Query: 73 LGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSE 132
N ++ L L SN+LT I +T L + Y + S N T S
Sbjct: 198 CDTNNITKLD---LNQNIQLTFLDCSSNKLTEIDVT--PLTQLTYFDCSVNPLTELDVST 252
Query: 133 IGNLEVL-------VQIDLS---------MNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
+ L L ++IDL+ + L L + +
Sbjct: 253 LSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-E 311
Query: 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
+ + L L L+N L+ + + L+ ++ ++
Sbjct: 312 LD--LSQNPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 37/204 (18%), Positives = 77/204 (37%), Gaps = 18/204 (8%)
Query: 19 NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKL 78
N + ++ + +I+ +L L L ++ + + + +L L +L N +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNI 76
Query: 79 SGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEV 138
+ TNL L SN+LT + +T L + YLN +N T ++ +
Sbjct: 77 TTLD---LSQNTNLTYLACDSNKLTNLDVT--PLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 139 LVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLS 198
L ++ + N + + L L N+ + + L +LD S N ++
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 199 GAIPISLEKLLDLQHINVSFNKLE 222
+ + + L +N N +
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 30/194 (15%), Positives = 62/194 (31%), Gaps = 19/194 (9%)
Query: 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDL 73
++ L+ L ++ L I L +L E + + D+ L+ LD
Sbjct: 250 VSTLSKLTTLHCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDC 304
Query: 74 GDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFT-IPLPSE 132
++ L LYL + +LT + ++ + + L+ +
Sbjct: 305 QAAGITELD---LSQNPKLVYLYLNNTELTELDVS--HNTKLKSLSCVNAHIQDFS---S 356
Query: 133 IGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLF----LEYNRLQGSIPDFIGGLINLK 188
+G + L + +P L L+ +I GG+ +
Sbjct: 357 VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQA 415
Query: 189 SLDLSNNNLSGAIP 202
+ ++ NLS P
Sbjct: 416 TNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 26/162 (16%), Positives = 53/162 (32%), Gaps = 16/162 (9%)
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNS 124
A+ L L L ++ +T + + L + L +SN+
Sbjct: 20 FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNN 75
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGL 184
T ++ L + N + + + L L YL + N+L + +
Sbjct: 76 ITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQN 126
Query: 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226
L L+ + N L+ I + L ++ NK ++
Sbjct: 127 PLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 17/145 (11%), Positives = 44/145 (30%), Gaps = 7/145 (4%)
Query: 13 EINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLD 72
+++ L+ +YL +L + + KL+ L + ++ + ++ AL
Sbjct: 313 DLSQNPKLVYLYLNNTELT---ELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNF 367
Query: 73 LGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSE 132
+ + N + + P+ + +Y ++ L ++
Sbjct: 368 EAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTD 427
Query: 133 IGNLEVLVQIDLSMNNFSGAIPTTI 157
N V G + T
Sbjct: 428 --NPAVTYTFTSENGAIVGTVTTPF 450
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-23
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 15/211 (7%)
Query: 11 PEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQ 70
+L + + G + +I + L L L L+DNQ+ + L L + +
Sbjct: 34 TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITE 89
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLP 130
L+L N L L +++ L L S Q+T + L L + L L N T
Sbjct: 90 LELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVT-PLAGLSNLQVLYLDLNQITN--I 144
Query: 131 SEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSL 190
S + L L + + S P + L L L + N++ I + L NL +
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIEV 200
Query: 191 DLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L NN +S P L +L + ++ +
Sbjct: 201 HLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-23
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGD 75
L N I I G + + +++ L + L + +I + L L L+L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 76 NKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGN 135
N+++ + NLT + +L L N L + + L+ I L+L+S T + +
Sbjct: 73 NQITDL--APLKNLTKITELELSGNPLKNVS-AIAGLQSIKTLDLTSTQITD--VTPLAG 127
Query: 136 LEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNN 195
L L + L +N + P + GL +LQYL + ++ P + L L +L +N
Sbjct: 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN 183
Query: 196 NLSGAIPISLEKLLDLQHINVSFNKLE 222
+S P L L +L +++ N++
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 13/210 (6%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
E + L NLI + L N++ ++ L L K+ L L N L+ ++ + L ++ L
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTL 112
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
DL +++ P L+NL+ LYL NQ+T I L L + YL++ + + +
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSD--LT 167
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
+ NL L + N S P + L +L + L+ N++ P + NL +
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L+N ++ L+ +
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 13/211 (6%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
+ NLT + + L GN L ++S A+ LQ ++ L L Q+ P L L+ L L
Sbjct: 79 APLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL 134
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
L N+++ P LTNL+ L +G+ Q++ + L NL + L N I S
Sbjct: 135 YLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNK--ISDIS 189
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
+ +L L+++ L N S P + +L + L + + L+
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NV 245
Query: 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
+ + + P ++ N+++N
Sbjct: 246 VKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-23
Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 11/190 (5%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
++P ++ + ++L N L L +L L L+ +L + D L L
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVL 79
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTI 127
LDL N+L +P L L L + N+LT +PL L L + L L N
Sbjct: 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 128 PLPSEI-GNLEVLVQIDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNRLQGSIPDFIGGLI 185
LP + L ++ L+ NN + +P + GL++L L L+ N L +IP G
Sbjct: 139 -LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 186 NLKSLDLSNN 195
L L N
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 11/196 (5%)
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
+ + L ++P DL L L +N L F + T L +L L +LT
Sbjct: 12 HLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 104 YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDL 163
+ L + L+LS N LP L L +D+S N + + GL +L
Sbjct: 69 KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126
Query: 164 QYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNLSGAIPISL-EKLLDLQHINVSFNKL 221
Q L+L+ N L+ ++P + L+ L L+NNNL+ +P L L +L + + N L
Sbjct: 127 QELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184
Query: 222 EGEIPREGPFRNFSIE 237
IP+ G F + +
Sbjct: 185 YT-IPK-GFFGSHLLP 198
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-22
Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 9/221 (4%)
Query: 19 NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKL 78
N+ + + + + L+ L + +++ S A + L +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 79 SGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILYLNLSSNSFT-IPLPSEI-GN 135
C + ++ L N T LK + L L N + + N
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN 401
Query: 136 LEVLVQIDLSMNNF-SGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSN 194
+ L +D+S+N+ S A T + + L L N L GS+ F +K LDL N
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV--FRCLPPKVKVLDLHN 459
Query: 195 NNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
N + +IP + L LQ +NV+ N+L+ +P G F +
Sbjct: 460 NRIM-SIPKDVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 43/190 (22%), Positives = 65/190 (34%), Gaps = 15/190 (7%)
Query: 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG 74
+ + L + + L N S+ L L L L
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385
Query: 75 DNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP------LTLWNLKYILYLNLSSNSFTIP 128
N L N+ L L + W IL LNLSSN T
Sbjct: 386 RNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES-ILVLNLSSNMLTGS 443
Query: 129 LPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD-FIGGLIN 186
+ + ++VL DL N +IP + L+ LQ L + N+L+ S+PD L +
Sbjct: 444 VFRCLPPKVKVL---DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTS 498
Query: 187 LKSLDLSNNN 196
L+ + L +N
Sbjct: 499 LQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 15/230 (6%)
Query: 11 PEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQ 70
+I+ L+ L + L N++ Q L+ L + N+L+ +I +A+L
Sbjct: 69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRH 125
Query: 71 LDLGDNKLSGF-VPSCFGNLTNLRKLYLGSNQLTYIPLT----LWNLKYILYLNLSSNSF 125
LDL N V FGNLT L L L + + + L L +L L
Sbjct: 126 LDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKG 185
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ-GSIPDFIGGL 184
+I N VL + + FS + ++ L LQ ++ N + F+ L
Sbjct: 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSEL 245
Query: 185 ---INLKSLDLSNNNLSGAIPISLEKLL---DLQHINVSFNKLEGEIPRE 228
L ++ L + + + L + ++++N+ + I RE
Sbjct: 246 TRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 47/204 (23%), Positives = 72/204 (35%), Gaps = 7/204 (3%)
Query: 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
+ L L N + D+ L+ L L L N++ F +L L + N+L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113
Query: 104 YIPLTLWNLKYILYLNLSSNSF-TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD 162
I + + +L+LS N F +P+ E GNL L + LS F + L
Sbjct: 114 NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH- 170
Query: 163 LQYLFLEYNRLQGS-IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L + L+ + N L L + S + L H+ +S KL
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230
Query: 222 EGEIPREGPFRNFSIESFKGNELL 245
E F E +G LL
Sbjct: 231 NDE--NCQRLMTFLSELTRGPTLL 252
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 34/150 (22%), Positives = 60/150 (40%), Gaps = 5/150 (3%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLN--GSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+ S+ + + L L + L N L +++ + L+ L + N L
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421
Query: 61 DLCRLAA-LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLN 119
C A + L+L N L+G V C ++ L L +N++ IP + +L+ + LN
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNF 149
++SN L L I L N +
Sbjct: 480 VASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 39/260 (15%), Positives = 73/260 (28%), Gaps = 50/260 (19%)
Query: 9 SIPE--EINNLTNLIAIYLGGNKLNGSISIALGKLQKLQL----LGLEDNQLEGSIPYDL 62
+P E NLT L + L K + L + L L L L ++G L
Sbjct: 135 VLPVCKEFGNLTKLTFLGLSAAKFR---QLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP---------------- 106
L L + S F ++ L L L + +L
Sbjct: 192 QIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250
Query: 107 -------------------LTLWNLKYILYLNLSSNSFTIPLPSEIGN-----LEVLVQI 142
+ + + YLN+ + + T + E L+ L+
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310
Query: 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIP 202
+ F + ++ L + + L+ + N + ++
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370
Query: 203 ISLEKLLDLQHINVSFNKLE 222
L LQ + + N L+
Sbjct: 371 QGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 36/197 (18%), Positives = 62/197 (31%), Gaps = 21/197 (10%)
Query: 82 VPSCFGNLTNLRKLYLGSNQLTYIPLT----LWNLKYILYLNLSSNSFTIPLPSEI-GNL 136
VP + L L N ++ + + L L+ L LS N L +
Sbjct: 46 VPK--DLPPRTKALSLSQNSISELRMPDISFLSELR---VLRLSHNRIRS-LDFHVFLFN 99
Query: 137 EVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD--FIGGLINLKSLDLSN 194
+ L +D+S N I + L++L L +N +P G L L L LS
Sbjct: 100 QDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSA 155
Query: 195 NNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMPNLHVP 254
+ L + L + + + I G + I + L+ +L
Sbjct: 156 AKFRQ---LDLLPVAHLHLSCILLDLVSYHIK-GGETESLQIPNTTVLHLVFHPNSLFSV 211
Query: 255 PCRTGIHHTSRKNDLLI 271
++ I
Sbjct: 212 QVNMSVNALGHLQLSNI 228
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.9 bits (243), Expect = 3e-22
Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 17/211 (8%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
+ I L + +++ +L + + ++ ++ S+ + L + +L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 70
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFT-IPLP 130
L NKL+ P NL NL L+L N++ + +L +LK + L+L N + I
Sbjct: 71 FLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLS-SLKDLKKLKSLSLEHNGISDI--- 124
Query: 131 SEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSL 190
+ + +L L + L N + T + L L L LE N++ I GL L++L
Sbjct: 125 NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVPL-AGLTKLQNL 180
Query: 191 DLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
LS N++S L L +L + + +
Sbjct: 181 YLSKNHISDLRA--LAGLKNLDVLELFSQEC 209
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 15/224 (6%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
N +I S+ + I L N+ ++L GNKL I L L+ L L L++N+++ + L
Sbjct: 52 NSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DLS-SL 105
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
L L L L N +S + +L L LYLG+N++T I L L + L+L
Sbjct: 106 KDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLED 162
Query: 123 NSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
N + I + L L + LS N+ S + GLK+L L L +
Sbjct: 163 NQISDI---VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQ 217
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225
L+ ++ ++ +L IS + + ++ + E+
Sbjct: 218 SNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.6 bits (224), Expect = 8e-20
Identities = 45/203 (22%), Positives = 82/203 (40%), Gaps = 15/203 (7%)
Query: 20 LIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLS 79
+ + I + L+ + ++ L ++ Q+ ++ +
Sbjct: 1 MGETITVSTPIK-QIF-PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 80 GFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVL 139
L N+ KL+L N+LT I L NLK + +L L N I S + +L+ L
Sbjct: 57 SV--QGIQYLPNVTKLFLNGNKLTDIK-PLTNLKNLGWLFLDENK--IKDLSSLKDLKKL 111
Query: 140 VQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG 199
+ L N S + L L+ L+L N++ + + L L +L L +N +S
Sbjct: 112 KSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD 167
Query: 200 AIPISLEKLLDLQHINVSFNKLE 222
+P L L LQ++ +S N +
Sbjct: 168 IVP--LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.8 bits (209), Expect = 7e-18
Identities = 52/264 (19%), Positives = 93/264 (35%), Gaps = 13/264 (4%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
+ + NL NL ++L NK+ +S +L L+KL+ L LE N + I L L L L
Sbjct: 81 KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESL 136
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
LG+NK++ + LT L L L NQ++ I L L + L LS N I
Sbjct: 137 YLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNH--ISDLR 191
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
+ L+ L ++L L + L P+ I + + +
Sbjct: 192 ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPN 249
Query: 192 LSNNNLSGAIPISLEKLLDLQH--INVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249
+ + +S + F+ + +E ++ ++ +
Sbjct: 250 VKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGT 309
Query: 250 NLHVPPCRTGIHHTSRKNDLLIGI 273
+ P T + +
Sbjct: 310 RITAPKPPTKQGYVFKGWYTEKNG 333
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 62/219 (28%), Positives = 90/219 (41%), Gaps = 41/219 (18%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC-RLA 66
+IP I + L L NKL+ S A +L KL+LL L DN+L+ ++P + L
Sbjct: 30 AIPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT----LWNLKYILYLNLSS 122
L L + DNKL F L NL +L L NQL +P L L Y L+L
Sbjct: 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY---LSLGY 142
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNRLQGSIPDFI 181
N ++P + L L+ L L N+L+ +P+
Sbjct: 143 NELQ-------------------------SLPKGVFDKLTSLKELRLYNNQLK-RVPEGA 176
Query: 182 -GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
L LK+L L NN L + + L L+ + + N
Sbjct: 177 FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 58/172 (33%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 70 QLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT----LWNLKYILYLNLSSNSF 125
+LDL NKLS F LT LR LYL N+L +P L NL+ L ++ N
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE---TLWVTDNKL 97
Query: 126 TIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNRLQGSIPDFI-G 182
LP + L L ++ L N ++P + L L YL L YN LQ S+P +
Sbjct: 98 QA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 183 GLINLKSLDLSNNNLSGAIPISL-EKLLDLQHINVSFNKLEGEIPREGPFRN 233
L +LK L L NN L +P +KL +L+ + + N+L+ +P G F +
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPE-GAFDS 203
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-21
Identities = 30/194 (15%), Positives = 64/194 (32%), Gaps = 9/194 (4%)
Query: 31 NGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLT 90
+++I + L + + +L + L + ++
Sbjct: 12 QDNVNIPDSTFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTG--IEYAH 66
Query: 91 NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS 150
N++ L + + T + L + L + T + L L +D+S +
Sbjct: 67 NIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 151 GAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD 210
+I T I L + + L YN I + L LKSL++ + + +E
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPK 182
Query: 211 LQHINVSFNKLEGE 224
L + + G+
Sbjct: 183 LNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 21/140 (15%), Positives = 45/140 (32%), Gaps = 4/140 (2%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
I N+ + + + + + L L+ L + + +L L +L L
Sbjct: 60 TGIEYAHNIKDLTINNIHAT-NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
D+ + + + L + + L N + L L + LN+ + +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDG--VHDYR 175
Query: 132 EIGNLEVLVQIDLSMNNFSG 151
I + L Q+ G
Sbjct: 176 GIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-10
Identities = 24/128 (18%), Positives = 48/128 (37%), Gaps = 9/128 (7%)
Query: 99 SNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158
S IP + K L L +S +++ +L + L+ N + I
Sbjct: 11 SQDNVNIPDS--TFKAYLNGLLGQSSTANITEAQMNSLTYI---TLANINVTDLTG--IE 63
Query: 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSF 218
+++ L + P I GL NL+ L + +++ +L L L +++S
Sbjct: 64 YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 219 NKLEGEIP 226
+ + I
Sbjct: 122 SAHDDSIL 129
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 50/251 (19%), Positives = 82/251 (32%), Gaps = 21/251 (8%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR-LAA 67
+PE ++ + L N + + +LQ LQ L +E I + R L++
Sbjct: 24 QVPELPAHVNYV---DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL---TLWNLKYILYLNLSSNS 124
L L L N+ F L NL L L L L L + L L N+
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 125 FT-IPLPSEIGNLEVLVQIDLSMNNFS----------GAIPTTIGGLKDLQYLFLEYNRL 173
I S N+ +DL+ N T+ L + + L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 174 QGSIPDFIGGLINLKSLDLSNNNLSGAIP---ISLEKLLDLQHINVSFNKLEGEIPREGP 230
++ +LDLS N ++ +Q + +S + G
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260
Query: 231 FRNFSIESFKG 241
F++ +FKG
Sbjct: 261 FKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 50/248 (20%), Positives = 89/248 (35%), Gaps = 36/248 (14%)
Query: 7 SGSIPEEI-NNLTNLIAIYLGGNKLNGSIS--IALGKLQKLQLLGLEDNQLEGSIPYD-- 61
+ LT+L + L N + I +++ +L L N+++ SI +
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVK-SICEEDL 174
Query: 62 ---------LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP------ 106
L RL+++ D+ + L T++ L L N
Sbjct: 175 LNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234
Query: 107 -------LTLW-NLKYILYLNLSSNSFTIPLPSEIGNLEV--LVQIDLSMNNFSGAIPTT 156
+L + Y + + +F P LE + DLS + A+ +
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKS 293
Query: 157 I-GGLKDLQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHI 214
+ DL+ L L N + I D GL +L L+LS N L E L L+ +
Sbjct: 294 VFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVL 352
Query: 215 NVSFNKLE 222
++S+N +
Sbjct: 353 DLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 51/236 (21%), Positives = 82/236 (34%), Gaps = 42/236 (17%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIA---LGKLQKLQLLGLEDNQLEG- 56
M + T++ + L GN S++ K+Q L L ++ G
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 57 --------SIPYDLCR---LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYI 105
+ + + DL +K+ + S F + T+L +L L N++ I
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI 314
Query: 106 PL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQ 164
W L ++L LNLS N + F L L+
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLG----------------SIDSRMFEN--------LDKLE 350
Query: 165 YLFLEYNRLQGSIP-DFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
L L YN ++ ++ GL NLK L L N L ++L LQ I + N
Sbjct: 351 VLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 31/193 (16%)
Query: 10 IPEEINNLTNLIAIYLGGNKLNGSISIALGKLQ--KLQLLGLEDNQLEGSIPYDLCR-LA 66
I I + + + G + L+ ++ L +++ ++ +
Sbjct: 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFT 299
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFT 126
L QL L N+++ + F LT+L KL L N L I S F
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSID---------------SRMFE 344
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPT-TIGGLKDLQYLFLEYNRLQGSIPDFI-GGL 184
NL+ L +DLS N+ A+ + GL +L+ L L+ N+L+ S+PD I L
Sbjct: 345 --------NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRL 394
Query: 185 INLKSLDLSNNNL 197
+L+ + L N
Sbjct: 395 TSLQKIWLHTNPW 407
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 6e-20
Identities = 45/217 (20%), Positives = 78/217 (35%), Gaps = 7/217 (3%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD-LCRLAA 67
IP ++ N I + KL A L+ + + N + I D L
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 68 LFQLDL-GDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSF 125
L ++ + N L P F NL NL+ L + + + ++P + + + L++ N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 126 --TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGG 183
TI S +G V + L+ N + G + + + N L+ D G
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200
Query: 184 LINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220
LD+S + LE L L+ + K
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 7e-17
Identities = 41/199 (20%), Positives = 73/199 (36%), Gaps = 11/199 (5%)
Query: 3 NCNISGSIPEEI-NNLTNLIAIYL-GGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP- 59
++ I ++ +NL L I + N L A L LQ L + + ++ +P
Sbjct: 63 QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD 121
Query: 60 YDLCRLAALFQLDLGDN-KLSGFVPSCFGNLT-NLRKLYLGSNQLTYIPLTLWNLKYILY 117
LD+ DN + + F L+ L+L N + I + +N +
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDE 181
Query: 118 LNLSSNSFTIPLPSEI-GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
LNLS N+ LP+++ V +D+S + LK L+ +
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---K 238
Query: 177 IPDFIGGLINLKSLDLSNN 195
+P L+ L L+
Sbjct: 239 LPTL-EKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 26/124 (20%), Positives = 45/124 (36%), Gaps = 6/124 (4%)
Query: 3 NCNISGSIPEE-INNLT-NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
N NI +I L+ + ++L N + + A Q +L ++N LE
Sbjct: 138 NINIH-TIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPND 196
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNL 120
+ LD+ ++ NL LR L +P TL L ++ +L
Sbjct: 197 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP-TLEKLVALMEASL 253
Query: 121 SSNS 124
+ S
Sbjct: 254 TYPS 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-20
Identities = 50/210 (23%), Positives = 81/210 (38%), Gaps = 13/210 (6%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
N L ++ I + + S+ + L + L L N+L I L L L L
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWL 95
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
L +NK+ +L L+ L L N ++ I L +L + L L +N I +
Sbjct: 96 FLDENKVKDLSS--LKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNK--ITDIT 150
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
+ L L + L N S +P + GL LQ L+L N + + + GL NL L+
Sbjct: 151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLE 206
Query: 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L + L+ + + L
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 47/210 (22%), Positives = 89/210 (42%), Gaps = 15/210 (7%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
+ I L + +++ +L + + ++ ++ S+ + L + +L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 73
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
L NKL+ P NL NL L+L N++ + +L +LK + L+L N + +
Sbjct: 74 FLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLEHNGISD--IN 128
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
+ +L L + L N + T + L L L LE N++ I GL L++L
Sbjct: 129 GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVPL-AGLTKLQNLY 184
Query: 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
LS N++S L L +L + + +
Sbjct: 185 LSKNHISDLRA--LAGLKNLDVLELFSQEC 212
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 11/214 (5%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
+ I L N+ ++L GNKL I L L+ L L L++N+++ + L L L L
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSL 117
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
L N +S + +L L LYLG+N++T I L L + L+L N +
Sbjct: 118 SLEHNGIS--DINGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDI--V 172
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
+ L L + LS N+ S + GLK+L L L + L+ ++
Sbjct: 173 PLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 230
Query: 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225
++ +L IS + + ++ + E+
Sbjct: 231 NTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 32/161 (19%), Positives = 66/161 (40%), Gaps = 11/161 (6%)
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLS 121
A + +L ++ V L ++ ++ ++ + + + L + L L+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLN 76
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI 181
N + + NL+ L + L N + LK L+ L LE+N + S + +
Sbjct: 77 GNK--LTDIKPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI--SDINGL 130
Query: 182 GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
L L+SL L NN ++ L +L L +++ N++
Sbjct: 131 VHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS 169
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 39/226 (17%), Positives = 66/226 (29%), Gaps = 20/226 (8%)
Query: 13 EINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL------CRLA 66
+ ++ L + L ++ G+ L + L L + +
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQL--------TYIPLTLWNLKYILYL 118
L L + F L L L N PL L+ +
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNRLQGSI 177
N + + + L +DLS N+ A L L L + L+ +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268
Query: 178 PDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223
P + L LDLS N L P E L + ++++ N
Sbjct: 269 PKGLPA--KLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 7e-17
Identities = 40/213 (18%), Positives = 63/213 (29%), Gaps = 20/213 (9%)
Query: 3 NCNISGSIPEEI--NNLTNLIAIYLGGNKLNGSISIALG----KLQKLQLLGLEDNQLEG 56
N ++G+ P + +L + L + L++L +
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 57 SIPYDLCRLAALFQLDLGDNKLSGFVP----SCFGNLTNLRKLYLGSNQLTYIPLT---- 108
+ AL LDL DN G C L+ L L + +
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223
Query: 109 LWNLKYILYLNLSSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLF 167
+ L+LS NS L ++LS +P + L L
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLD 280
Query: 168 LEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA 200
L YNRL P L + +L L N +
Sbjct: 281 LSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 8e-16
Identities = 44/246 (17%), Positives = 84/246 (34%), Gaps = 19/246 (7%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
FNC + + + + + + + K L+ L + ++ I +
Sbjct: 27 AFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILF 86
Query: 61 DLCRLAALFQ---LDLGDNKLSG--FVPSCFGNLTNLRKLYLGSNQLTYIP-----LTLW 110
R+ + L L + +++G P +L L L + L W
Sbjct: 87 GALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQW 146
Query: 111 NLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI----GGLKDLQYL 166
+ L+++ ++ L +DLS N G LQ L
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206
Query: 167 FLEYNRLQ---GSIPDFIGGLINLKSLDLSNNNLSGAIP-ISLEKLLDLQHINVSFNKLE 222
L ++ G + L+ LDLS+N+L A S + L +N+SF L+
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
Query: 223 GEIPRE 228
++P+
Sbjct: 267 -QVPKG 271
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 42/244 (17%), Positives = 77/244 (31%), Gaps = 28/244 (11%)
Query: 4 CNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC 63
CN S P+ + L A + + G LL D + + D+
Sbjct: 15 CNFSDPKPDWSSAFNCLGAA---------DVELYGGGRSLEYLLKRVDTEADLGQFTDII 65
Query: 64 RLAALFQLDLGDNKLSG---FVPSCFGNLTNLRKLYLGSNQLT---YIPLTLWNLKYILY 117
+ +L +L + ++ F ++ L++L L + ++T PL +
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 118 LNLSSNSFTIPLPSEIGNL-----EVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNR 172
LNL + S+ + + L L + ++ + + L L L N
Sbjct: 126 LNLRNVSWA-TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 173 LQGSIP----DFIGGLINLKSLDLSNNN---LSGAIPISLEKLLDLQHINVSFNKLEGEI 225
G L+ L L N SG + LQ +++S N L
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 226 PREG 229
Sbjct: 245 GAPS 248
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 7e-18
Identities = 41/139 (29%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 16 NLTNLIAIYLGGNKLNGSISI-ALGKLQKLQLLGLEDNQLEGSIPYD-LCRLAALFQLDL 73
LTNL ++ L N LN IS A + L+ L L N L ++ L AL L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 74 GDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP----LTLWNLKYILYLNLSSNSFTIPL 129
+N + + F ++ L+KLYL NQ++ P L ++ L+LSSN
Sbjct: 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP 179
Query: 130 PSEIGNLEVLVQIDLSMNN 148
+++ L V+ L ++N
Sbjct: 180 LTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 42/196 (21%), Positives = 63/196 (32%), Gaps = 33/196 (16%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSIS--IALGKLQKLQLLGLEDNQLEGSIPYD-LCR 64
++P+ + + L L N L + +L L L L N L I +
Sbjct: 32 NVPQSLPSYTALL---DLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVP 86
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSN 123
+ L LDL N L F +L L L L +N + + ++ + L LS N
Sbjct: 87 VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146
Query: 124 SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGG 183
+ P E+ L L L L N+L+ +
Sbjct: 147 QISR-FPVEL---------------IKD-----GNKLPKLMLLDLSSNKLKKLPLTDLQK 185
Query: 184 LINLK--SLDLSNNNL 197
L L L NN L
Sbjct: 186 LPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 43/183 (23%), Positives = 62/183 (33%), Gaps = 33/183 (18%)
Query: 44 LQLLGLEDNQLEGSIP--YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQ 101
LL L N L + + RL L L L N L+ F + NLR L L SN
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 102 LTYIP-LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160
L + +L+ + L L +N I ++ +
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNN--------HIVVVD----------------RNAFEDM 135
Query: 161 KDLQYLFLEYNRLQGSIPD--FIG--GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINV 216
LQ L+L N++ P L L LDLS+N L L+KL +
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 217 SFN 219
+
Sbjct: 195 YLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 32/121 (26%), Positives = 46/121 (38%), Gaps = 14/121 (11%)
Query: 118 LNLSSNSFT-IP--LPSEIGNLEVLVQIDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNRL 173
L+ S +P LPS L DLS NN S L +L L L +N L
Sbjct: 23 LSCSKQQLPNVPQSLPSYTALL------DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 174 QGSIPDFI-GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFR 232
I + NL+ LDLS+N+L L L+ + + N + + F
Sbjct: 77 N-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVD-RNAFE 133
Query: 233 N 233
+
Sbjct: 134 D 134
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 36/211 (17%), Positives = 77/211 (36%), Gaps = 16/211 (7%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
L N + LG + + + +L +Q +++ ++ S+ + L +L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKEL 68
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTIPLP 130
L N++S S +LT L +L + N+L + + L L L +N +
Sbjct: 69 HLSHNQISDL--SPLKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNE--LRDT 121
Query: 131 SEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSL 190
+ +L+ L + + N + +G L L+ L L N + + + L + +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWI 177
Query: 191 DLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
DL+ +L + +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 35/193 (18%), Positives = 71/193 (36%), Gaps = 12/193 (6%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
L+ + + + S++ + L+ L L NQ+ + L L L +L
Sbjct: 35 VSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEEL 90
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS 131
+ N+L L +L+L +N+L +L +LK + L++ +N +
Sbjct: 91 SVNRNRLKNLNG---IPSACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNK--LKSIV 144
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
+G L L +DL N + + LK + ++ L + + L ++
Sbjct: 145 MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVK 202
Query: 192 LSNNNLSGAIPIS 204
+ IS
Sbjct: 203 DPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 27/134 (20%), Positives = 50/134 (37%), Gaps = 9/134 (6%)
Query: 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGD 75
L ++L N+L +L L+ L++L + +N+L+ SI L L+ L LDL
Sbjct: 104 PSACLSRLFLDNNELR-DTD-SLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHG 159
Query: 76 NKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPL-PSEIG 134
N+++ L + + L + P+ + N + + P I
Sbjct: 160 NEITNTGG--LTRLKKVNWIDLTGQKCVNEPVK--YQPELYITNTVKDPDGRWISPYYIS 215
Query: 135 NLEVLVQIDLSMNN 148
N V +
Sbjct: 216 NGGSYVDGCVLWEL 229
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 33/144 (22%), Positives = 59/144 (40%), Gaps = 7/144 (4%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC-RLA 66
IP + +T + L N + A +KL+ + L +NQ+ + D L
Sbjct: 25 EIPTNLPETITEI---RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSF 125
+L L L NK++ S F L +L+ L L +N++ + + +L + L+L N
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNF 149
L + + L+ N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 34/151 (22%), Positives = 55/151 (36%), Gaps = 27/151 (17%)
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPL 129
+ L N + P F LR++ L +NQ++ + L+ + L L N T L
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 130 PSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINLK 188
P + F G L LQ L L N++ + L NL
Sbjct: 96 PKSL---------------FEG--------LFSLQLLLLNANKIN-CLRVDAFQDLHNLN 131
Query: 189 SLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
L L +N L + L +Q ++++ N
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 19/61 (31%), Positives = 31/61 (50%)
Query: 310 NQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDN 369
R ++L ATN F +IG G G +YK ++DG +VA+K + + + F+
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 370 E 370
E
Sbjct: 85 E 85
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 35/207 (16%), Positives = 75/207 (36%), Gaps = 9/207 (4%)
Query: 17 LTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL-CRLAALFQLDLGD 75
+ + L L S A L + + + + + L+ + +++ +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 76 NK-LSGFVPSCFGNLTNLRKLYLGSNQLTYIP--LTLWNLKYILYLNLSSNSF--TIPLP 130
+ L+ P L L+ L + + L P +++ L ++ N + +IP+
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 131 SEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD--FIGGLINLK 188
+ G + + L N F+ ++ L ++L N+ I F G
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 189 SLDLSNNNLSGAIPISLEKLLDLQHIN 215
LD+S +++ LE L +L N
Sbjct: 209 LLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 28/70 (40%), Positives = 39/70 (55%), Gaps = 3/70 (4%)
Query: 308 LANQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSF 367
L +RF+ EL A++ FS NI+GRGG G +YK R+ DG VAVK E +
Sbjct: 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK---EERTQGG 70
Query: 368 DNEFMTVVDA 377
+ +F T V+
Sbjct: 71 ELQFQTEVEM 80
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 41/238 (17%)
Query: 3 NCNISG--SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+ P++ I L + + ++ +L + + ++ ++
Sbjct: 4 TVSTPIKQIFPDDA--FAETIKANLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQGI 59
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWN-LKYILYLN 119
L + L LG NKL S LTNL L L NQL +P +++ L + L
Sbjct: 60 Q--YLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELV 115
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
L N LP + + L +L YL L +N+LQ S+P
Sbjct: 116 LVENQLQ-SLPDGVFD-----------------------KLTNLTYLNLAHNQLQ-SLPK 150
Query: 180 FI-GGLINLKSLDLSNNNLSGAIPISL-EKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
+ L NL LDLS N L ++P + +KL L+ + + N+L+ +P G F +
Sbjct: 151 GVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPD-GVFDRLT 205
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 45/123 (36%), Positives = 62/123 (50%), Gaps = 18/123 (14%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGSIP---YD 61
S+P + + LTNL + L N+L S+ G KL L L L NQL+ S+P +D
Sbjct: 99 SLPNGVFDKLTNLKELVLVENQLQ---SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFD 154
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL----TLWNLKYI-L 116
+L L +LDL N+L F LT L+ L L NQL +P L +L+YI L
Sbjct: 155 --KLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL 212
Query: 117 YLN 119
+ N
Sbjct: 213 HDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 15/101 (14%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGSIP---YD 61
S+P+ + + LTNL + L N+L S+ G KL L L L NQL+ S+P +D
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQ---SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD 178
Query: 62 LCRLAALFQLDLGDNKLSGFVPS-CFGNLTNLRKLYLGSNQ 101
+L L L L N+L VP F LT+L+ ++L N
Sbjct: 179 --KLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNP 216
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 49/179 (27%), Positives = 67/179 (37%), Gaps = 41/179 (22%)
Query: 45 QLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY 104
+ L L+ L L L L+L N+L F +LT L L L +NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 105 IP------LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI- 157
+P LT L L L N ++P+ +
Sbjct: 98 LPLGVFDHLT--QLDK---LYLGGNQLK-------------------------SLPSGVF 127
Query: 158 GGLKDLQYLFLEYNRLQGSIPD--FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHI 214
L L+ L L N+LQ SIP F L NL++L LS N L + ++L LQ I
Sbjct: 128 DRLTKLKELRLNTNQLQ-SIPAGAF-DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 37/100 (37%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGSIP---YD 61
S+P + ++LT L +YLGGN+L S+ G +L KL+ L L NQL+ SIP +D
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK---SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQ 101
+L L L L N+L F L L+ + L NQ
Sbjct: 153 --KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.5 bits (177), Expect = 7e-14
Identities = 38/217 (17%), Positives = 62/217 (28%), Gaps = 33/217 (15%)
Query: 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD 61
+ S + E+ + L + +I + + L L D
Sbjct: 356 LSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVD 415
Query: 62 LCRLAALFQ---------------------LDLGDNKLSGFVPSCFGNLTNLRKLYLGSN 100
R A L L L L+ V L + L L N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHN 473
Query: 101 QLTYIPLTLWNLKYILYLNLSSNSFT-IPLPSEIGNLEVLVQIDLSMNNFSG-AIPTTIG 158
+L +P L L+ + L S N+ + + NL L ++ L N A +
Sbjct: 474 RLRALPPALAALRCLEVLQASDNALENVD---GVANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 159 GLKDLQYLFLEYNRLQGSIPDFIGGLI----NLKSLD 191
L L L+ N L L ++ S+
Sbjct: 531 SCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 37/165 (22%), Positives = 65/165 (39%), Gaps = 8/165 (4%)
Query: 59 PYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSN-QLTYIPLTLWNLKYILY 117
D LF+ +L K + + S + L++L + L I L + L +LY
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI 177
+ F+ + +D + F D++ L L + L ++
Sbjct: 401 EKETLQYFSTLKAVDPMRAA---YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TV 455
Query: 178 PDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
+ L+ + LDLS+N L A+P +L L L+ + S N LE
Sbjct: 456 LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 42/150 (28%), Positives = 65/150 (43%), Gaps = 10/150 (6%)
Query: 3 NCNISG--SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP- 59
+C S+P I TN +YL N++ L L+ L L NQL ++P
Sbjct: 25 DCRSKRHASVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPV 81
Query: 60 --YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILY 117
+D L L LDLG N+L+ + F L +L++L++ N+LT +P + L ++ +
Sbjct: 82 GVFD--SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTH 139
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMN 147
L L N L L L N
Sbjct: 140 LALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 49/160 (30%), Positives = 63/160 (39%), Gaps = 42/160 (26%)
Query: 45 QLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY 104
Q+L L DNQ+ P L L +L LG N+L F +LT L L LG+NQLT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 105 IP------LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158
+P L +LK L + N T +P I
Sbjct: 103 LPSAVFDRLV--HLK---ELFMCCNKLT-------------------------ELPRGIE 132
Query: 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD---LSNN 195
L L +L L+ N+L+ SIP G L SL L N
Sbjct: 133 RLTHLTHLALDQNQLK-SIPH--GAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-12
Identities = 45/148 (30%), Positives = 65/148 (43%), Gaps = 32/148 (21%)
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL----TLWNLKYILYLNLSSNSFT 126
L L DN+++ P F +L NL++LYLGSNQL +P+ +L L L+L +N T
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV---LDLGTNQLT 101
Query: 127 IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLIN 186
LPS + LV L+ LF+ N+L +P I L +
Sbjct: 102 -VLPS--AVFDRLVH---------------------LKELFMCCNKLT-ELPRGIERLTH 136
Query: 187 LKSLDLSNNNLSGAIPISLEKLLDLQHI 214
L L L N L + ++L L H
Sbjct: 137 LTHLALDQNQLKSIPHGAFDRLSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 31/116 (26%), Positives = 51/116 (43%), Gaps = 18/116 (15%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGSIPYDLCR 64
++P + ++LT L + LG N+L + +L L+ L + N+L +P + R
Sbjct: 78 ALPVGVFDSLTQLTVLDLGTNQLT---VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIER 133
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWN--LKYILYL 118
L L L L N+L F L++L YL N W+ + I+YL
Sbjct: 134 LTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP--------WDCECRDIMYL 181
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 32/156 (20%)
Query: 82 VPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILYLNLSSNSFTIPLPSEIGNLEVLV 140
VP+ G TN + LYL NQ+T + ++ +L + L L SN LP +
Sbjct: 34 VPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGV------- 83
Query: 141 QIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNLSG 199
F L L L L N+L +P + L++LK L + N L+
Sbjct: 84 --------FDS--------LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT- 125
Query: 200 AIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
+P +E+L L H+ + N+L+ IP G F S
Sbjct: 126 ELPRGIERLTHLTHLALDQNQLKS-IPH-GAFDRLS 159
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-13
Identities = 35/191 (18%), Positives = 65/191 (34%), Gaps = 56/191 (29%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIAL-GKLQKLQLLGLEDNQLEGSIPYD-LCRL 65
IPE I L L N+ + + KL +L+ + +N++ I
Sbjct: 25 KIPEHIPQYTAEL---RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGA 80
Query: 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSF 125
+ + ++ L N+L F L +L+ L L SN++T + ++SF
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVG---------------NDSF 125
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGL 184
GL ++ L L N++ ++ L
Sbjct: 126 I--------------------------------GLSSVRLLSLYDNQIT-TVAPGAFDTL 152
Query: 185 INLKSLDLSNN 195
+L +L+L N
Sbjct: 153 HSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 32/155 (20%), Positives = 61/155 (39%), Gaps = 34/155 (21%)
Query: 71 LDLGDNKLSGFVPS-CFGNLTNLRKLYLGSNQLTYIP----LTLWNLKYILYLNLSSNSF 125
L L +N+ + + F L LRK+ +N++T I + + L+SN
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE---ILLTSNRL 93
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGL 184
+ ++ F G L+ L+ L L NR+ + + GL
Sbjct: 94 EN-VQHKM---------------FKG--------LESLKTLMLRSNRIT-CVGNDSFIGL 128
Query: 185 INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219
+++ L L +N ++ P + + L L +N+ N
Sbjct: 129 SSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-12
Identities = 30/118 (25%), Positives = 55/118 (46%), Gaps = 8/118 (6%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC-RLA 66
+P+ I ++T L YL GN+ + L + L L+ L +N++ ++ +
Sbjct: 24 VLPKGIPRDVTEL---YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMT 78
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILYLNLSSN 123
L L L N+L P F L +LR L L N ++ +P + +L + +L + +N
Sbjct: 79 QLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-10
Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 12/106 (11%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGSIP 59
+ N +P+E++N +L I L N+++ +++ + +L L L N+L IP
Sbjct: 39 DGNQFTLVPKELSNYKHLTLIDLSNNRIS---TLSNQSFSNMTQLLTLILSYNRLR-CIP 94
Query: 60 ---YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQL 102
+D L +L L L N +S F +L+ L L +G+N L
Sbjct: 95 PRTFD--GLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-10
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 10/111 (9%)
Query: 90 TNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEI-GNLEVLVQIDLSMNN 148
++ +LYL NQ T +P L N K++ ++LS+N + L ++ N+ L+ + LS N
Sbjct: 31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNR 89
Query: 149 FSGAIPTTI-GGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD---LSNN 195
IP GLK L+ L L N + +P+ G +L +L + N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPE--GAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-07
Identities = 23/93 (24%), Positives = 41/93 (44%), Gaps = 7/93 (7%)
Query: 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNLSGAI 201
L N F+ +P + K L + L NR+ ++ + + L +L LS N L I
Sbjct: 37 YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 202 PISL-EKLLDLQHINVSFNKLEGEIPREGPFRN 233
P + L L+ +++ N + +P G F +
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPE-GAFND 124
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 18/69 (26%), Positives = 32/69 (46%), Gaps = 7/69 (10%)
Query: 153 IPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQ 212
IP + L+L+ N+ +P + +L +DLSNN +S S + L
Sbjct: 29 IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 213 HINVSFNKL 221
+ +S+N+L
Sbjct: 82 TLILSYNRL 90
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-12
Identities = 39/130 (30%), Positives = 56/130 (43%), Gaps = 17/130 (13%)
Query: 3 NCNISG--SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP- 59
C G S+P I T + L N L + +L L L L N+L+ S+P
Sbjct: 13 ECYSQGRTSVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPN 69
Query: 60 --YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL----TLWNLK 113
++ +L +L L+L N+L F LT L++L L +NQL +P L LK
Sbjct: 70 GVFN--KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLK 127
Query: 114 YILYLNLSSN 123
L L N
Sbjct: 128 ---DLRLYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 50/160 (31%), Positives = 63/160 (39%), Gaps = 41/160 (25%)
Query: 45 QLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY 104
L LE N L+ L +L QL LG NKL F LT+L L L +NQL
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 105 IP------LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158
+P LT LK L L++N LP G + L Q
Sbjct: 91 LPNGVFDKLT--QLK---ELALNTNQLQ-SLPD--GVFDKLTQ----------------- 125
Query: 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD---LSNN 195
L+ L L N+L+ S+PD G L SL L +N
Sbjct: 126 ----LKDLRLYQNQLK-SVPD--GVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 50/153 (32%), Positives = 64/153 (41%), Gaps = 39/153 (25%)
Query: 70 QLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL----TLWNLKYILYLNLSSNSF 125
LDL N L F LT+L +LYLG N+L +P L +L Y LNLS+N
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY---LNLSTNQL 88
Query: 126 TIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGG-- 183
LP+ G + L Q L+ L L N+LQ S+PD G
Sbjct: 89 Q-SLPN--GVFDKLTQ---------------------LKELALNTNQLQ-SLPD---GVF 120
Query: 184 --LINLKSLDLSNNNLSGAIPISLEKLLDLQHI 214
L LK L L N L ++L LQ+I
Sbjct: 121 DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 13/100 (13%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGSIP---YD 61
S+P + N LT+L + L N+L S+ G KL +L+ L L NQL+ S+P +D
Sbjct: 66 SLPNGVFNKLTSLTYLNLSTNQLQ---SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFD 121
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQ 101
+L L L L N+L F LT+L+ ++L N
Sbjct: 122 --KLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 159
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-11
Identities = 39/120 (32%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 9 SIPEEI-NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP---YDLCR 64
S+P I ++ T L L NKL KL +L L L NQ++ S+P +D +
Sbjct: 21 SVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFD--K 74
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-NLKYILYLNLSSN 123
L L L L +NKL F LT L++L L +NQL +P ++ L + + L +N
Sbjct: 75 LTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 22/110 (20%)
Query: 17 LTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGSIP---YDLCRLAALFQ 70
LT L + L N++ S+ G KL KL +L L +N+L+ S+P +D +L L +
Sbjct: 51 LTQLTKLSLSQNQIQ---SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFD--KLTQLKE 104
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWN--LKYILYL 118
L L N+L F LT+L+K++L +N W+ I YL
Sbjct: 105 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNP--------WDCSCPRIDYL 146
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNLSGAI 201
+L N L L L L N++Q S+PD + L L L L N L ++
Sbjct: 34 ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SL 91
Query: 202 PISL-EKLLDLQHINVSFNKLEGEIPREGPFRNFS 235
P + +KL L+ + + N+L+ +P G F +
Sbjct: 92 PNGVFDKLTQLKELALDTNQLKS-VPD-GIFDRLT 124
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 5e-04
Identities = 22/76 (28%), Positives = 33/76 (43%), Gaps = 9/76 (11%)
Query: 153 IPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISL-EKLLDL 211
IP+ L LE N+LQ L L L LS N + ++P + +KL L
Sbjct: 26 IPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 212 QHINVSFNKLEGEIPR 227
+ + NKL+ +P
Sbjct: 79 TILYLHENKLQ-SLPN 93
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 36/246 (14%), Positives = 75/246 (30%), Gaps = 41/246 (16%)
Query: 10 IPEEINNLTNLIAIYLGGNKLNG----SISIALGKLQKLQLLGLEDNQLE---------- 55
+ + ++ I L GN + +S + + L++ D
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 56 GSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNL----TNLRKLYLGSNQLTYIPLTLWN 111
+ L + L + L DN + T L LYL +N L
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAK-- 141
Query: 112 LKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSG----AIPTTIGGLKDLQYLF 167
++ + + + N L I N T + L +
Sbjct: 142 --------IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVK 193
Query: 168 LEYNRL-----QGSIPDFIGGLINLKSLDLSNNNLS--GAIPIS--LEKLLDLQHINVSF 218
+ N + + + + + LK LDL +N + G+ ++ L+ +L+ + ++
Sbjct: 194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253
Query: 219 NKLEGE 224
L
Sbjct: 254 CLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 42/246 (17%), Positives = 80/246 (32%), Gaps = 44/246 (17%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNG----SISIALGKLQKLQLLGLEDNQL---------- 54
+ + + L + L N + L K L+ L L +N L
Sbjct: 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144
Query: 55 ---EGSIPYDLCRLAALFQLDLGDNKLSG----FVPSCFGNLTNLRKLYLGSNQLTY--- 104
E ++ L + G N+L F + L + + N +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 105 ---IPLTLWNLKYILYLNLSSNSFT----IPLPSEIGNLEVLVQIDLSMNNFS--GAIP- 154
+ L + + L+L N+FT L + + L ++ L+ S GA
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264
Query: 155 ---TTIGGLKDLQYLFLEYNRLQGSIPDFIGGLI-----NLKSLDLSNNNLS--GAIPIS 204
+ LQ L L+YN ++ + +I +L L+L+ N S +
Sbjct: 265 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDE 324
Query: 205 LEKLLD 210
+ ++
Sbjct: 325 IREVFS 330
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 19/75 (25%), Positives = 29/75 (38%), Gaps = 11/75 (14%)
Query: 310 NQRRFTYLELFHATNGFS------ANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREA 363
F++ EL + TN F N +G GG G +YK + + VAVK L
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK--LAAMVD 67
Query: 364 FKSF--DNEFMTVVD 376
+ +F +
Sbjct: 68 ITTEELKQQFDQEIK 82
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 34/148 (22%), Positives = 61/148 (41%), Gaps = 20/148 (13%)
Query: 94 KLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQI---DLSMNNFS 150
+L+ + + TL LK +L LS+N+ +I +L + + L N
Sbjct: 29 ELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLI- 82
Query: 151 GAIPTTIGGL----KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPIS-L 205
I L L+ L++ YN++ S+ I L+NL+ L +SNN ++ I L
Sbjct: 83 ----KKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKL 136
Query: 206 EKLLDLQHINVSFNKLEGEIPREGPFRN 233
L L+ + ++ N L +
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 39/156 (25%), Positives = 53/156 (33%), Gaps = 16/156 (10%)
Query: 47 LGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP 106
L +E + L L A L L N + S + NLR L LG N + I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKKIE 86
Query: 107 LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIP-TTIGGLKDLQY 165
+ L +S N I S I L L + +S N + + L L+
Sbjct: 87 NLDAVADTLEELWISYNQ--IASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLED 144
Query: 166 LFLEYNRLQGSIPDF----------IGGLINLKSLD 191
L L N L + + L NLK LD
Sbjct: 145 LLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 28/116 (24%), Positives = 51/116 (43%), Gaps = 7/116 (6%)
Query: 10 IPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALF 69
+ ++ L + L N + IS +L ++ L++L L N ++ I L
Sbjct: 40 MDATLSTLKACKHLALSTNNI-EKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 70 QLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP--LTLWNLKYILYLNLSSN 123
+L + N+++ S L NLR LY+ +N++T L L + L L+ N
Sbjct: 97 ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-09
Identities = 26/92 (28%), Positives = 42/92 (45%), Gaps = 12/92 (13%)
Query: 15 NNLTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGSIP---YDLCRLAAL 68
L +L+ + L N+L I +Q L L +N+++ I + L L
Sbjct: 51 GRLPHLVKLELKRNQLT---GIEPNAFEGASHIQELQLGENKIK-EISNKMFL--GLHQL 104
Query: 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSN 100
L+L DN++S +P F +L +L L L SN
Sbjct: 105 KTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 14/87 (16%)
Query: 45 QLLGLEDNQLEGSIPYD--LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQL 102
L L DN+L I D RL L +L+L N+L+G P+ F +++++L LG N++
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90
Query: 103 TYIP------LTLWNLKYILYLNLSSN 123
I L LK LNL N
Sbjct: 91 KEISNKMFLGLH--QLK---TLNLYDN 112
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-07
Identities = 33/134 (24%), Positives = 53/134 (39%), Gaps = 30/134 (22%)
Query: 90 TNLRKLYLGSNQLTYIPLT--LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMN 147
+ +L L N+L I L +++ L L N T +
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNA-------------- 73
Query: 148 NFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD--FIGGLINLKSLDLSNNNLSGAIPISL 205
F G +Q L L N+++ I + F GL LK+L+L +N +S +P S
Sbjct: 74 -FE--------GASHIQELQLGENKIK-EISNKMF-LGLHQLKTLNLYDNQISCVMPGSF 122
Query: 206 EKLLDLQHINVSFN 219
E L L +N++ N
Sbjct: 123 EHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 21/95 (22%), Positives = 38/95 (40%), Gaps = 7/95 (7%)
Query: 142 IDLSMNNFSGAIPTTI-GGLKDLQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNLSG 199
+ L+ N + G L L L L+ N+L I G +++ L L N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 200 AIPISL-EKLLDLQHINVSFNKLEGEIPREGPFRN 233
I + L L+ +N+ N++ + G F +
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISC-VMP-GSFEH 124
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 6e-09
Identities = 22/98 (22%), Positives = 41/98 (41%), Gaps = 5/98 (5%)
Query: 152 AIPTTIGGLKDLQYLFLEYNRLQGSIPDF-IGGLINLKSLDLSNNNLSGAIPISLEKLLD 210
+ G ++L L++E + + + GL L++L + + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 211 LQHINVSFNKLEGEIPREGPFRNFSIES--FKGNELLC 246
L +N+SFN LE + + S++ GN L C
Sbjct: 82 LSRLNLSFNALE-SLS-WKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 7e-09
Identities = 19/102 (18%), Positives = 39/102 (38%), Gaps = 4/102 (3%)
Query: 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPT-TIGGLKDLQYLFLEYNRLQGSIPDF 180
+ + + E L ++ + + + GL +L+ L + + L+ +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 181 I-GGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221
L L+LS N L ++ + L LQ + +S N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 9e-09
Identities = 22/91 (24%), Positives = 31/91 (34%), Gaps = 1/91 (1%)
Query: 37 ALGKLQKLQLLGLEDNQLEGSIP-YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKL 95
L + L L +E+ Q + DL L L L + + L P F L +L
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85
Query: 96 YLGSNQLTYIPLTLWNLKYILYLNLSSNSFT 126
L N L + + L LS N
Sbjct: 86 NLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 3e-08
Identities = 20/97 (20%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSI-SIALGKLQKLQLLGLEDNQLEGSIPYD-LCRLA 66
+ NL +Y+ + + L L +L+ L + + L + D
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT 103
L +L+L N L L +L++L L N L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 8e-07
Identities = 23/142 (16%), Positives = 35/142 (24%), Gaps = 49/142 (34%)
Query: 57 SIPYDLCRLAALFQLDL-GDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYI 115
+ L L +L + L L LR L + + L ++
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA--------- 72
Query: 116 LYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG 175
P L L L +N L+
Sbjct: 73 --------------------------------------PDAFHFTPRLSRLNLSFNALES 94
Query: 176 SIPDFIGGLINLKSLDLSNNNL 197
+ GL +L+ L LS N L
Sbjct: 95 LSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 40.5 bits (94), Expect = 6e-04
Identities = 9/59 (15%), Positives = 20/59 (33%), Gaps = 2/59 (3%)
Query: 171 NRLQGSIPDFIGGLINLKSLDLSNNNLSGAIP-ISLEKLLDLQHINVSFNKLEGEIPRE 228
+ G NL L + N + L L +L+++ + + L + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 40/247 (16%), Positives = 80/247 (32%), Gaps = 37/247 (14%)
Query: 15 NNLTNLIAIYLGGNKLN----GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL----- 65
+ L + L L+ ++ L + L + +N + + LC+
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198
Query: 66 AALFQLDLGDNKLS----GFVPSCFGNLTNLRKLYLGSNQLTY------IPLTLWNLKYI 115
L L L ++ + + +LR+L LGSN+L P L +
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 116 LYLNLSSNSFT----IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG-GLKD----LQYL 166
L + T L + E L ++ L+ N + L + L+ L
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318
Query: 167 FLEYNRLQG----SIPDFIGGLINLKSLDLSNNNL--SGAIPIS--LEKLL-DLQHINVS 217
+++ + L L +SNN L +G + L + L+ + ++
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 378
Query: 218 FNKLEGE 224
+
Sbjct: 379 DCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 49/248 (19%), Positives = 89/248 (35%), Gaps = 39/248 (15%)
Query: 15 NNLTNLIAIYLGGNKLN----GSISIALGKLQKLQLLGLEDNQLEGS-----IPYDLCRL 65
++ L A+ L + + + L+ L L N+L P L
Sbjct: 196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPS 255
Query: 66 AALFQLDLGDNKLS----GFVPSCFGNLTNLRKLYLGSNQLT-----YIPLTLWNLKYIL 116
+ L L + + ++ G + +L++L L N+L + TL L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315
Query: 117 -YLNLSSNSFT----IPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG-GLKD----LQYL 166
L + S SFT S + L+++ +S N A + GL L+ L
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375
Query: 167 FLEYNRLQ----GSIPDFIGGLINLKSLDLSNNNL--SGAIPISLEKLLD----LQHINV 216
+L + S+ + +L+ LDLSNN L +G + + E + L+ + +
Sbjct: 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV-ESVRQPGCLLEQLVL 434
Query: 217 SFNKLEGE 224
E
Sbjct: 435 YDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 47/247 (19%), Positives = 87/247 (35%), Gaps = 43/247 (17%)
Query: 3 NCNIS----GSIPEEINNLTNLIAIYLGGNKL--NGSISIALGKLQ---KLQLLGLEDNQ 53
+C ++ + + + +L + LG NKL G + G L +L+ L + +
Sbjct: 208 SCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267
Query: 54 LE----GSIPYDLCRLAALFQLDLGDNKLS-----GFVPSCFGNLTNLRKLYLGSNQLT- 103
+ G + L +L +L L N+L + L L++ S T
Sbjct: 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327
Query: 104 ----YIPLTLWNLKYILYLNLSSNSFTIP--------LPSEIGNLEVLVQIDLSMNNFS- 150
+ L +++L L +S+N L L VL L+ + S
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL---WLADCDVSD 384
Query: 151 ---GAIPTTIGGLKDLQYLFLEYNRLQGS-IPDFIGGLIN----LKSLDLSNNNLSGAIP 202
++ T+ L+ L L N L + I + + L+ L L + S +
Sbjct: 385 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 444
Query: 203 ISLEKLL 209
L+ L
Sbjct: 445 DRLQALE 451
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 47/230 (20%), Positives = 86/230 (37%), Gaps = 47/230 (20%)
Query: 18 TNLIAIYLGGNKLN-GSISIALGKLQKLQLLGLEDNQL--EG--SIPYDLCRLAALFQLD 72
++ ++ + +L+ + L LQ+ Q++ L+D L I L AL +L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 73 LGDNKL--SGFVPSCFG---NLTNLRKLYLGSNQLT-----YIPLTLWNLKYILYLNLSS 122
L N+L G G ++KL L + LT + TL L + L+LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAI--PTTIGGLKDLQYLFLEYNRLQGSIPDF 180
N D + + P L+ L LEY L + +
Sbjct: 123 NLLG----------------DAGLQLLCEGLLDPQCR-----LEKLQLEYCSLSAASCEP 161
Query: 181 IGGLI----NLKSLDLSNNNLSGAIPISLEKLLD-----LQHINVSFNKL 221
+ ++ + K L +SNN+++ A L + L L+ + + +
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-08
Identities = 31/83 (37%), Positives = 42/83 (50%), Gaps = 11/83 (13%)
Query: 45 QLLGLEDNQLEGSIP---YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQ 101
Q+L L DNQ+ + +D RL L +LDL +N+L+ F LT L +L L NQ
Sbjct: 33 QVLYLYDNQIT-KLEPGVFD--RLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89
Query: 102 LTYIPL----TLWNLKYI-LYLN 119
L IP L +L +I L N
Sbjct: 90 LKSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-05
Identities = 38/121 (31%), Positives = 48/121 (39%), Gaps = 39/121 (32%)
Query: 82 VPSCFGNLTNLRKLYLGSNQLTYIPL----TLWNLKYILYLNLSSNSFTIPLPSEIGNLE 137
VP+ G T + LYL NQ+T + L L L+L +N T LP+ G +
Sbjct: 24 VPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLT---RLDLDNNQLT-VLPA--GVFD 75
Query: 138 VLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD---LSN 194
L Q L L L N+L+ SIP G NLKSL L N
Sbjct: 76 KLTQ---------------------LTQLSLNDNQLK-SIPR--GAFDNLKSLTHIWLLN 111
Query: 195 N 195
N
Sbjct: 112 N 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-05
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 6/83 (7%)
Query: 152 AIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISL-EKLLD 210
++PT I Q L+L N++ P L L LDL NN L+ +P + +KL
Sbjct: 23 SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 211 LQHINVSFNKLEGEIPREGPFRN 233
L ++++ N+L+ IPR G F N
Sbjct: 80 LTQLSLNDNQLKS-IPR-GAFDN 100
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 27/87 (31%), Positives = 36/87 (41%), Gaps = 30/87 (34%)
Query: 17 LTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDL 73
LT L + L N+L + G KL +L L L DNQL+ SIP R A
Sbjct: 53 LTQLTRLDLDNNQLT---VLPAGVFDKLTQLTQLSLNDNQLK-SIP----RGA------- 97
Query: 74 GDNKLSGFVPSCFGNLTNLRKLYLGSN 100
F NL +L ++L +N
Sbjct: 98 ------------FDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-08
Identities = 29/83 (34%), Positives = 37/83 (44%), Gaps = 11/83 (13%)
Query: 45 QLLGLEDNQLEGSIP---YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQ 101
Q L L +NQ+ + +D L L QL NKL+ F LT L +L L N
Sbjct: 36 QRLWLNNNQIT-KLEPGVFD--HLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92
Query: 102 LTYIPL----TLWNLKYI-LYLN 119
L IP L +L +I LY N
Sbjct: 93 LKSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-06
Identities = 39/127 (30%), Positives = 57/127 (44%), Gaps = 28/127 (22%)
Query: 3 NCNISG--SIPEEINNLTNLIAIYLGGNKLNGSISIALG---KLQKLQLLGLEDNQLEGS 57
NC S+P I T+ ++L N++ + G L LQ L N+L +
Sbjct: 18 NCQNIRLASVPAGI--PTDKQRLWLNNNQIT---KLEPGVFDHLVNLQQLYFNSNKLT-A 71
Query: 58 IP---YDLCRLAALFQLDLGDNKLSGFVPS-CFGNLTNLRKLYLGSNQLTYIPLTLWN-- 111
IP +D +L L QLDL DN L +P F NL +L +YL +N W+
Sbjct: 72 IPTGVFD--KLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNNP--------WDCE 120
Query: 112 LKYILYL 118
+ I+YL
Sbjct: 121 CRDIMYL 127
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-05
Identities = 37/121 (30%), Positives = 51/121 (42%), Gaps = 39/121 (32%)
Query: 82 VPSCFGNLTNLRKLYLGSNQLTYIPL----TLWNLKYILYLNLSSNSFTIPLPSEIGNLE 137
VP+ G T+ ++L+L +NQ+T + L NL+ L +SN T +P+ G +
Sbjct: 27 VPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQ---QLYFNSNKLT-AIPT--GVFD 78
Query: 138 VLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD---LSN 194
L Q L L L N L+ SIP G NLKSL L N
Sbjct: 79 KLTQ---------------------LTQLDLNDNHLK-SIPR--GAFDNLKSLTHIYLYN 114
Query: 195 N 195
N
Sbjct: 115 N 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-05
Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 10/82 (12%)
Query: 153 IPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISL-EKLLDL 211
IPT D Q L+L N++ P L+NL+ L ++N L+ AIP + +KL L
Sbjct: 31 IPT------DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83
Query: 212 QHINVSFNKLEGEIPREGPFRN 233
++++ N L+ IPR G F N
Sbjct: 84 TQLDLNDNHLKS-IPR-GAFDN 103
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-08
Identities = 25/117 (21%), Positives = 44/117 (37%), Gaps = 5/117 (4%)
Query: 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQL 71
+ N + L G K+ I L + + DN++ + L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTL 69
Query: 72 DLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP--LTLWNLKYILYLNLSSNSFT 126
+ +N++ L +L +L L +N L + L +LK + YL + N T
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 24/133 (18%), Positives = 41/133 (30%), Gaps = 27/133 (20%)
Query: 88 NLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMN 147
N R+L L ++ I L ++ S N ++
Sbjct: 17 NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-----KLDGFP---------- 61
Query: 148 NFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG-AIPISLE 206
L+ L+ L + NR+ L +L L L+NN+L L
Sbjct: 62 -----------LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA 110
Query: 207 KLLDLQHINVSFN 219
L L ++ + N
Sbjct: 111 SLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI 177
+ L++ I ++ N ++DL I L + N ++ +
Sbjct: 2 VKLTAE--LIEQAAQYTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 178 PDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222
F L LK+L ++NN + + L DL + ++ N L
Sbjct: 58 DGF-PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-05
Identities = 22/120 (18%), Positives = 43/120 (35%), Gaps = 7/120 (5%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR 64
I L AI N++ + L++L+ L + +N++
Sbjct: 29 YKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQA 86
Query: 65 LAALFQLDLGDNKLSGFVP-SCFGNLTNLRKLYLGSNQLT----YIPLTLWNLKYILYLN 119
L L +L L +N L +L +L L + N +T Y ++ + + L+
Sbjct: 87 LPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 15/58 (25%), Positives = 27/58 (46%), Gaps = 4/58 (6%)
Query: 314 FTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEF 371
L+ + + RG G ++KA++ VAVK+F +Q +S+ NE+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEY 67
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-06
Identities = 27/114 (23%), Positives = 53/114 (46%), Gaps = 5/114 (4%)
Query: 16 NLTNLIAIYLGGNKLN-GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG 74
+++ + L ++ N G + + ++L+ L + L SI +L +L L +L+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 75 DNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP--LTLWNLKYILYLNLSSNSFT 126
DN++SG + NL L L N++ + L L+ + L+L + T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 3/100 (3%)
Query: 8 GSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAA 67
G + + L + L SI+ L KL KL+ L L DN++ G + +
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 68 LFQLDLGDNKLSGF-VPSCFGNLTNLRKLYLGSNQLTYIP 106
L L+L NK+ L NL+ L L + ++T +
Sbjct: 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-05
Identities = 26/138 (18%), Positives = 50/138 (36%), Gaps = 35/138 (25%)
Query: 88 NLTNLRKLYLGSNQLTYIPL-----TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQI 142
+++++L L +++ L L++ L+ + T I NL
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEF---LSTINVGLT-----SIANLP----- 61
Query: 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG-AI 201
L L+ L L NR+ G + NL L+LS N + +
Sbjct: 62 ----------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLST 105
Query: 202 PISLEKLLDLQHINVSFN 219
L+KL +L+ +++
Sbjct: 106 IEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 135 NLEVLVQIDLSMNNFS-GAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLS 193
+ ++ L + + G + ++L++L L SI + L LK L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANL-PKLNKLKKLELS 72
Query: 194 NNNLSGAIPISLEKLLDLQHINVSFNKLE 222
+N +SG + + EK +L H+N+S NK++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 17/54 (31%), Positives = 24/54 (44%), Gaps = 1/54 (1%)
Query: 314 FTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSF 367
E + +IGRG G++YK + D VAVKVF R+ F +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE 55
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 5/114 (4%)
Query: 16 NLTNLIAIYLGGNKLN-GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG 74
+ + L K N G I + L+ L L + L S+ +L +L L +L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 75 DNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP--LTLWNLKYILYLNLSSNSFT 126
+N++ G + L NL L L N+L I L L+ + L+L + T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-06
Identities = 33/119 (27%), Positives = 48/119 (40%), Gaps = 7/119 (5%)
Query: 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCR 64
+ G I NL + L L S+S L KL KL+ L L +N++ G + +
Sbjct: 36 SNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEK 93
Query: 65 LAALFQLDLGDNKLSGFVP-SCFGNLTNLRKLYLGSNQLT----YIPLTLWNLKYILYL 118
L L L+L NKL L L+ L L + ++T Y L + YL
Sbjct: 94 LPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 3/89 (3%)
Query: 135 NLEVLVQIDLSMNNFS-GAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLS 193
+ ++ L + G I +L++L L L S+ + L LK L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNL-PKLPKLKKLELS 79
Query: 194 NNNLSGAIPISLEKLLDLQHINVSFNKLE 222
N + G + + EKL +L H+N+S NKL+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 23/107 (21%), Positives = 38/107 (35%), Gaps = 10/107 (9%)
Query: 118 LNLSSNSFTIPLPSEIG-NLEVLVQIDLSMNNFSGAIPTTIGGL---KDLQYLFLEYNRL 173
L L + + L + L ++ L L+ L L NR+
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKLELSENRI 83
Query: 174 QGSIPDFIGGLINLKSLDLSNNNLSGAIPIS-LEKLLDLQHINVSFN 219
G + L NL L+LS N L + L+KL L+ +++
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 3e-06
Identities = 76/467 (16%), Positives = 145/467 (31%), Gaps = 145/467 (31%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
NCN ++ E + L I ++ + S +I L ++ + E +L S PY+
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNW-TSRSDHSSNIKL----RIHSIQAELRRLLKSKPYEN 245
Query: 63 CRLAALFQLD-LGDNK-LSGFVPSC-------FGNLTNLRKLYLGSNQLTYIP------- 106
C L L + + K + F SC F +T+ +L + T+I
Sbjct: 246 C----LLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD----FLSAATTTHISLDHHSMT 297
Query: 107 LTLWNLKYIL--YLNLSSNSFTIPLPSEI--GNLEVLVQIDLSMNNFSGAIPTTIGGLKD 162
LT +K +L YL+ LP E+ N L I S+ + T
Sbjct: 298 LTPDEVKSLLLKYLDCRPQD----LPREVLTTNPRRLSIIAESIRDG----LATWD---- 345
Query: 163 LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLL-DL----QHINVS 217
+ + ++L ++ S N L P K+ L ++
Sbjct: 346 -NWKHVNCDKLT-------------TIIESSLNVLE---PAEYRKMFDRLSVFPPSAHIP 388
Query: 218 FNKLE---GEIPREGP------FRNFSIESFKGNELLCGMPNLHV-----PPCRTGIHHT 263
L ++ + +S+ + E +P++++ +H
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH-- 446
Query: 264 SRKNDLLIGIVLPLSTIFMMVVILLILRYRKRGKPLLNDANMPPLANQRRFTYLELFHAT 323
R ++ Y K +D +PP +Q ++++ H
Sbjct: 447 -RS---------------------IVDHYNIP-KTFDSDDLIPPYLDQYFYSHIG-HHLK 482
Query: 324 N-----------------GFSANNIIGRG----GIGSI---------YKARIQD------ 347
N F I GSI YK I D
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE 542
Query: 348 GMEVAVKVFDLQYREAFKSFDNEFMTVVDANLLTREDKHFMTKEQRV 394
+ A+ F + E +++ ++ L+ ++ F ++V
Sbjct: 543 RLVNAILDFLPKIEE--NLICSKYTDLLRIALMAEDEAIFEEAHKQV 587
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 45/269 (16%), Positives = 86/269 (31%), Gaps = 39/269 (14%)
Query: 15 NNLTNLIAIYLGGNKLNGSISIALGKL-----QKLQLLGLEDNQLEGSIPYDLCRL---- 65
N+ ++ L GN L+ S L K + +L L N + +
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 66 -AALFQLDLGDNKLS-----GFVPSCFGNLTNLRKLYLGSNQLTYI-------PLTLWNL 112
A++ L+L N L + N+ L L N L L
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 113 KYILYLNLSSNSFTIPLPSEIG-----NLEVLVQIDLSMNNFSG----AIPTTIGGLKDL 163
+ L+LS+N + +E+ +V ++L +N G + LK L
Sbjct: 197 S-VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 164 QYLFLEYNRLQGSIPDFIGGLI-------NLKSLDLSNNNLSGAIPISLEKLLDLQHINV 216
Q ++L+Y+ ++ + L + +D + + + I + L+
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315
Query: 217 SFNKLEGEIPREGPFRNFSIESFKGNELL 245
L + +IE + L
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDEL 344
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 52/268 (19%), Positives = 86/268 (32%), Gaps = 50/268 (18%)
Query: 1 MFNCNISGS----IPEEINNLTNLIAIYLGGNKLNGSISIALGKL-----QKLQLLGLED 51
M + E + + ++ L N L ++ L + + L L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 52 NQLEGSIPYDLCRL-----AALFQLDLGDNKLS-----GFVPSCFGNLTNLRKLYLGSNQ 101
N L +L ++ A + L+L N LS V + + L LG N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 102 LT-----YIPLTLWNL-KYILYLNLSSNSFTIP--------LPSEIGNLEVLVQIDLSMN 147
+ NL I LNL N I L + N+ L +L N
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL---NLRGN 177
Query: 148 NFSGAIPTTIG-GLKD----LQYLFLEYNRLQGS-IPDFIGGL----INLKSLDLSNNNL 197
N + + L + L L N L + ++ SL+L N L
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237
Query: 198 SGAIPISLEKLLD----LQHINVSFNKL 221
G +L+ L D LQ + + ++ +
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIV 265
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 2e-05
Identities = 28/163 (17%), Positives = 59/163 (36%), Gaps = 24/163 (14%)
Query: 82 VPSCFGNLTNLRKLYLGSNQ-LTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIG-----N 135
+ + L L + L+ NLK L + S + +I N
Sbjct: 164 LSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKS---LEIISGGLPDSVVEDILGSDLPN 220
Query: 136 LEVLVQIDLSMNNFSGAIPTTI-------GGLKDLQYLFLEYNRLQGSIPDFIGG---LI 185
LE L + + + ++ + +L++L + Q + + L
Sbjct: 221 LEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 186 NLKSLDLSNNNLSG----AIPISLEKLLDLQHINVSFNKLEGE 224
L+++D+S L+ + ++K+ L+ IN+ +N L E
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 3e-05
Identities = 28/189 (14%), Positives = 55/189 (29%), Gaps = 28/189 (14%)
Query: 31 NGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFG--N 88
+S L + L L ++ ++ L L++ L V +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 89 LTNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMN 147
L NL KL L Y + + + L + +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLF---------------SKDRFPNLKWLGIVDA 262
Query: 148 NFSGAIPTTIGG---LKDLQYLFLEYNRLQGS----IPDFIGGLINLKSLDLSNNNLSGA 200
+ L L+ + + L + D + + +LK +++ N LS
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
Query: 201 IPISLEKLL 209
+ L+K L
Sbjct: 323 MKKELQKSL 331
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 411 | |||
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.96 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.96 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.96 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.96 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.95 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.95 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.94 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.94 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.94 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.92 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.92 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.92 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.91 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.91 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.87 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.85 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.85 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.85 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.85 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.8 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.66 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.66 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.62 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.62 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.61 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.49 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.4 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.38 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.37 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.36 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.24 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.16 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.13 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.11 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.09 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.08 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.06 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.06 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.04 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.02 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.01 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 98.99 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 98.99 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 98.96 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.86 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.83 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 98.82 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 98.8 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 98.8 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 98.79 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.79 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 98.77 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 98.77 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 98.74 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.74 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 98.74 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 98.71 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 98.7 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 98.7 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 98.69 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 98.69 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 98.68 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.67 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 98.66 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 98.66 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 98.66 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 98.66 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 98.65 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 98.64 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 98.64 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 98.64 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.64 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.63 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 98.63 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 98.63 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 98.63 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 98.62 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 98.62 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 98.62 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 98.62 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 98.61 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 98.6 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 98.6 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 98.6 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 98.6 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 98.59 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 98.59 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 98.59 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 98.59 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 98.58 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 98.58 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 98.57 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 98.57 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 98.57 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 98.56 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 98.56 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 98.56 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 98.56 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 98.56 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 98.56 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 98.55 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 98.55 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 98.55 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 98.55 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 98.55 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 98.55 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 98.54 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 98.54 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 98.54 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 98.53 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 98.53 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 98.53 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 98.53 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 98.52 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 98.52 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 98.51 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 98.51 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 98.51 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 98.51 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 98.51 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 98.5 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 98.5 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 98.5 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 98.5 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 98.49 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 98.49 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 98.49 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 98.49 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 98.49 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 98.49 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 98.49 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 98.49 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 98.49 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 98.49 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 98.48 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 98.48 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 98.48 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 98.48 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 98.47 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 98.47 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 98.47 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.47 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 98.47 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 98.47 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 98.47 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 98.46 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 98.46 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 98.46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 98.46 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 98.46 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 98.45 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 98.45 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 98.45 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 98.45 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 98.45 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 98.45 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 98.45 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 98.44 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 98.44 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 98.44 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 98.44 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 98.44 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 98.43 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 98.43 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 98.43 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 98.43 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 98.43 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 98.43 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 98.42 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 98.42 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 98.42 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 98.42 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 98.42 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 98.42 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 98.42 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 98.41 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 98.41 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 98.41 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 98.41 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 98.41 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 98.41 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 98.41 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 98.41 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 98.41 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 98.41 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 98.4 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 98.4 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 98.4 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 98.4 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 98.4 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 98.4 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 98.4 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 98.39 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 98.39 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 98.39 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 98.39 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 98.39 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 98.39 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 98.39 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 98.39 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 98.38 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 98.38 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 98.38 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 98.38 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 98.37 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 98.37 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 98.37 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 98.37 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 98.37 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 98.37 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 98.36 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 98.36 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 98.36 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 98.36 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 98.36 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 98.36 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 98.36 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 98.35 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 98.35 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 98.35 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 98.35 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 98.35 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 98.35 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 98.35 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 98.35 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 98.35 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 98.34 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 98.34 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 98.34 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 98.33 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 98.33 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 98.33 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 98.32 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 98.32 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 98.32 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 98.32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 98.32 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 98.32 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 98.32 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 98.31 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 98.31 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 98.31 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 98.31 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 98.31 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 98.31 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 98.3 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 98.3 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 98.3 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 98.3 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 98.3 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 98.3 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 98.29 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 98.29 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 98.29 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 98.29 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 98.29 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.28 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 98.28 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 98.27 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 98.27 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 98.27 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 98.27 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 98.27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 98.27 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 98.27 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 98.25 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 98.25 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 98.24 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 98.23 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 98.23 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 98.23 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 98.23 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 98.23 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 98.22 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 98.22 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 98.21 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 98.21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 98.2 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 98.2 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 98.2 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 98.2 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 98.15 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 98.14 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 98.14 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 98.13 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 98.08 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 98.04 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 98.03 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.9 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 97.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 97.82 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 97.81 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.66 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.48 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 97.35 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.06 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 95.34 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.53 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 91.74 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 88.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 85.85 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 84.15 |
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=278.69 Aligned_cols=247 Identities=34% Similarity=0.554 Sum_probs=234.5
Q ss_pred CCCCcccc--cCChhcccCCcCCceeecC-cccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCc
Q 015202 1 MFNCNISG--SIPEEINNLTNLIAIYLGG-NKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNK 77 (411)
Q Consensus 1 l~~n~~~~--~~p~~~~~~~~L~~L~l~~-n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 77 (411)
|++|.++| .+|+.|.++++|++|+|++ |++.+.+|..|.++++|++|++++|.+++.+|..|.++++|++|++++|.
T Consensus 57 L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 136 (313)
T 1ogq_A 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136 (313)
T ss_dssp EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred CCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence 46789999 9999999999999999995 99999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccccCCccCCeeecccccCC-ccCccccCCC-CCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCC
Q 015202 78 LSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLK-YILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPT 155 (411)
Q Consensus 78 l~~~~~~~~~~l~~L~~L~l~~n~l~-~~p~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 155 (411)
+.+.+|..+..+++|++|++++|.++ .+|..+..++ +|+.|++++|.+.+..|..+..+. |+.|++++|.+++..|.
T Consensus 137 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~ 215 (313)
T 1ogq_A 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215 (313)
T ss_dssp EESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGG
T ss_pred cCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCH
Confidence 99999999999999999999999998 8999999998 999999999999999999999987 99999999999999999
Q ss_pred CccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCcc
Q 015202 156 TIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235 (411)
Q Consensus 156 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~ 235 (411)
.+..+++|+.|++++|.+++..|. +..+++|++|++++|.+++.+|..+..+++|+.|++++|.+++.+|....++.+.
T Consensus 216 ~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~ 294 (313)
T 1ogq_A 216 LFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD 294 (313)
T ss_dssp GCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSC
T ss_pred HHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccC
Confidence 999999999999999999976665 7889999999999999999999999999999999999999999999988889999
Q ss_pred ccccCCCCcccCCC
Q 015202 236 IESFKGNELLCGMP 249 (411)
Q Consensus 236 ~~~~~~n~~~c~~~ 249 (411)
.+++.+|+.+|+.|
T Consensus 295 ~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 295 VSAYANNKCLCGSP 308 (313)
T ss_dssp GGGTCSSSEEESTT
T ss_pred hHHhcCCCCccCCC
Confidence 99999999999864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.46 Aligned_cols=257 Identities=36% Similarity=0.565 Sum_probs=209.8
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+++.+|..|.++++|+.|++++|.+++.+|..+.++++|++|++++|.+++.+|..+.++++|++|++++|++++
T Consensus 425 Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 504 (768)
T 3rgz_A 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG 504 (768)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred CcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCC
Confidence 45666666777667777777777777777766677777777777777777777777777777777777777777777777
Q ss_pred cCCccccCCccCCeeecccccCC-ccCccccCCCCCcEEEcCCCeeeecCCCC---------------------------
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNSFTIPLPSE--------------------------- 132 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~-~~p~~~~~~~~L~~L~l~~n~l~~~~~~~--------------------------- 132 (411)
.+|..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|.+++.+|..
T Consensus 505 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (768)
T 3rgz_A 505 EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK 584 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCC
T ss_pred cCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccc
Confidence 77777777777777777777776 67777777888888888888777665543
Q ss_pred -------------------------------------------ccCccCCCeEEccCCeecccCCCCccCCCccCeeecc
Q 015202 133 -------------------------------------------IGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLE 169 (411)
Q Consensus 133 -------------------------------------------~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~ 169 (411)
+..+++|+.|++++|.++|.+|..++.+++|+.|+|+
T Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls 664 (768)
T 3rgz_A 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664 (768)
T ss_dssp TTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCc
Confidence 3335678888999999999999999999999999999
Q ss_pred cccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCcccCCC
Q 015202 170 YNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 170 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 249 (411)
+|.+++.+|..+..+++|+.|++++|.++|.+|..+..+++|+.|++++|+++|.+|....+..+....+.+|+.+|+.+
T Consensus 665 ~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred CCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 99999999999999999999999999999999999999999999999999999999999899999999999999999965
Q ss_pred CCCCCCCCCCC
Q 015202 250 NLHVPPCRTGI 260 (411)
Q Consensus 250 ~~~~~~c~~~~ 260 (411)
.++|....
T Consensus 745 ---l~~C~~~~ 752 (768)
T 3rgz_A 745 ---LPRCDPSN 752 (768)
T ss_dssp ---SCCCCSCC
T ss_pred ---CcCCCCCc
Confidence 34787654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=279.81 Aligned_cols=244 Identities=36% Similarity=0.543 Sum_probs=221.5
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+++.+|..+.++++|+.|++++|.+++.+|..|.++++|++|++++|.+.+.+|..+..+++|++|++++|.+++
T Consensus 401 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 480 (768)
T 3rgz_A 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480 (768)
T ss_dssp CCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred CCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccC
Confidence 56888999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCccccCCccCCeeecccccCC-ccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCC---
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTT--- 156 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~-~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~--- 156 (411)
.+|..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|.+++.+|..++.+++|+.|++++|.++|.+|..
T Consensus 481 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~ 560 (768)
T 3rgz_A 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGT
T ss_pred cCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhc
Confidence 99999999999999999999998 88888999999999999999999999999999999999999999998766643
Q ss_pred -------------------------------------------------------------------ccCCCccCeeecc
Q 015202 157 -------------------------------------------------------------------IGGLKDLQYLFLE 169 (411)
Q Consensus 157 -------------------------------------------------------------------~~~~~~L~~L~l~ 169 (411)
+..+++|+.|+++
T Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs 640 (768)
T 3rgz_A 561 QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640 (768)
T ss_dssp TTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECC
T ss_pred ccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECc
Confidence 3345778999999
Q ss_pred cccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC-CCCCCccccccCCCCc
Q 015202 170 YNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE-GPFRNFSIESFKGNEL 244 (411)
Q Consensus 170 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~ 244 (411)
+|++++.+|..++.++.|+.|++++|.++|.+|..+..+++|+.||+++|.++|.+|.. ..+..+..+++++|+.
T Consensus 641 ~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp SSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred CCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 99999999999999999999999999999999999999999999999999999999865 4567788888888864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=248.14 Aligned_cols=221 Identities=29% Similarity=0.431 Sum_probs=206.9
Q ss_pred CCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccC
Q 015202 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFV 82 (411)
Q Consensus 3 ~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 82 (411)
.|.+.+.+|+.|.++++|++|+|++|.+++.+|..|.++++|++|++++|.+++.+|..+..+++|++|++++|.+++.+
T Consensus 86 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 165 (313)
T 1ogq_A 86 INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165 (313)
T ss_dssp ETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEEC
T ss_pred CCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcC
Confidence 38999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCc-cCCeeecccccCC-ccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCC
Q 015202 83 PSCFGNLT-NLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160 (411)
Q Consensus 83 ~~~~~~l~-~L~~L~l~~n~l~-~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 160 (411)
|..+..++ +|+.|++++|.++ .+|..+..+. |+.|++++|.+.+..|..+..+++|+.|++++|.+++..|. +..+
T Consensus 166 p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l 243 (313)
T 1ogq_A 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLS 243 (313)
T ss_dssp CGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCC
T ss_pred CHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-cccc
Confidence 99999998 9999999999998 7888888887 99999999999999999999999999999999999977766 7789
Q ss_pred CccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 161 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
++|+.|++++|.+++.+|..+..+++|+.|++++|.+++.+|.. ..+++|+.+++++|+..+..|
T Consensus 244 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTT
T ss_pred CCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCCC
Confidence 99999999999999999999999999999999999999988876 789999999999998554433
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=254.02 Aligned_cols=249 Identities=23% Similarity=0.216 Sum_probs=178.9
Q ss_pred CCCCcccccCC-hhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchh--hhccccCCeeeecCCc
Q 015202 1 MFNCNISGSIP-EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYD--LCRLAALFQLDLGDNK 77 (411)
Q Consensus 1 l~~n~~~~~~p-~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~--~~~l~~L~~L~l~~n~ 77 (411)
+++|.+.+.+| ..|.++++|++|+|++|.+++..|..|.++++|++|++++|.+++..+.. +..+++|++|++++|.
T Consensus 61 L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~ 140 (455)
T 3v47_A 61 VEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140 (455)
T ss_dssp CCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSB
T ss_pred CcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCc
Confidence 35666665554 45677777777777777777666667777777777777777766544433 6667777777777777
Q ss_pred ccccCCcc-ccCCccCCeeecccccCCccC-cccc----------------------------------CC---------
Q 015202 78 LSGFVPSC-FGNLTNLRKLYLGSNQLTYIP-LTLW----------------------------------NL--------- 112 (411)
Q Consensus 78 l~~~~~~~-~~~l~~L~~L~l~~n~l~~~p-~~~~----------------------------------~~--------- 112 (411)
+.+..|.. +..+++|+.|++++|.++.++ ..+. .+
T Consensus 141 l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls 220 (455)
T 3v47_A 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLS 220 (455)
T ss_dssp CCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECT
T ss_pred cCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecC
Confidence 76655554 566677777777766665332 1111 11
Q ss_pred ------------------------------------------------------CCCcEEEcCCCeeeecCCCCccCccC
Q 015202 113 ------------------------------------------------------KYILYLNLSSNSFTIPLPSEIGNLEV 138 (411)
Q Consensus 113 ------------------------------------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~ 138 (411)
++|+.|++++|.+.+..|..+..+++
T Consensus 221 ~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 300 (455)
T 3v47_A 221 GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTD 300 (455)
T ss_dssp TSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTT
T ss_pred CCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCC
Confidence 35566666666666666777888888
Q ss_pred CCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEccc
Q 015202 139 LVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSF 218 (411)
Q Consensus 139 L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~ 218 (411)
|+.|++++|.+++..|..|..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++
T Consensus 301 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 380 (455)
T 3v47_A 301 LEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380 (455)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCC
Confidence 88888888888888788888888888888888888877778888888888888888888877788888888888888888
Q ss_pred CcccccCCCC-CCCCCccccccCCCCcccCCC
Q 015202 219 NKLEGEIPRE-GPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 219 n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 249 (411)
|.+++..+.. ..++.++.+++.+|+..|.++
T Consensus 381 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 381 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 8888755543 456778888888888888765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=240.58 Aligned_cols=216 Identities=21% Similarity=0.255 Sum_probs=131.5
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
++|.++ .+|+.+.++++|++|+|++|.++ .+|..+.++++|++|+|++|.++ .+|..+.++++|++|++++|.+.+.
T Consensus 89 ~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~ 165 (328)
T 4fcg_A 89 RSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE 165 (328)
T ss_dssp ESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCC
T ss_pred cCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccc
Confidence 345554 55655666666666666666665 55555666666666666666665 4455566666666666666555555
Q ss_pred CCccccC---------CccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeeccc
Q 015202 82 VPSCFGN---------LTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGA 152 (411)
Q Consensus 82 ~~~~~~~---------l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 152 (411)
+|..+.. +++|+.|++++|.++.+|..+..+++|++|++++|.++ .+|..+..+++|+.|++++|.+.+.
T Consensus 166 ~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~ 244 (328)
T 4fcg_A 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN 244 (328)
T ss_dssp CCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCB
T ss_pred cChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhh
Confidence 5555433 56666666666666666666666666666666666665 3444566666666666666666666
Q ss_pred CCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcc
Q 015202 153 IPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221 (411)
Q Consensus 153 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l 221 (411)
.|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.+++..+.+
T Consensus 245 ~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp CCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred hHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 666666666666666666666556666666666666666666666666666666666666666655443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=234.01 Aligned_cols=239 Identities=26% Similarity=0.292 Sum_probs=205.6
Q ss_pred cCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCc-ccccCCcccc
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNK-LSGFVPSCFG 87 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~ 87 (411)
.+|..+ .++|+.|++++|.+++..+..|.++++|++|++++|.+++..+..|.++++|++|++++|. +....+..+.
T Consensus 25 ~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~ 102 (285)
T 1ozn_A 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102 (285)
T ss_dssp SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTT
T ss_pred cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhc
Confidence 456644 4789999999999998888889999999999999999998888899999999999999997 8877788999
Q ss_pred CCccCCeeecccccCCcc-CccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCee
Q 015202 88 NLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYL 166 (411)
Q Consensus 88 ~l~~L~~L~l~~n~l~~~-p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L 166 (411)
.+++|+.|++++|.++.+ |..+..+++|++|++++|.+....+..+..+++|+.|++++|.+++..+..+..+++|+.|
T Consensus 103 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 182 (285)
T 1ozn_A 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182 (285)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEE
Confidence 999999999999999977 4567789999999999999997777779999999999999999998878889999999999
Q ss_pred ecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCccc
Q 015202 167 FLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLC 246 (411)
Q Consensus 167 ~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c 246 (411)
++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.+++++|++.+.++.......+.......+...|
T Consensus 183 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c 262 (285)
T 1ozn_A 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262 (285)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBE
T ss_pred ECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCcccc
Confidence 99999999888999999999999999999999887788999999999999999999877643222222333334444455
Q ss_pred CCC
Q 015202 247 GMP 249 (411)
Q Consensus 247 ~~~ 249 (411)
..|
T Consensus 263 ~~p 265 (285)
T 1ozn_A 263 SLP 265 (285)
T ss_dssp EES
T ss_pred CCc
Confidence 443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=243.66 Aligned_cols=229 Identities=24% Similarity=0.280 Sum_probs=107.0
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeec
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 97 (411)
++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.++...+..|..+++|+.|++
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 34445555555554444444555555555555555554444444555555555555555554443344444555555555
Q ss_pred ccccCCccCc-cccCCCCCcEEEcCCC-eeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccc
Q 015202 98 GSNQLTYIPL-TLWNLKYILYLNLSSN-SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG 175 (411)
Q Consensus 98 ~~n~l~~~p~-~~~~~~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 175 (411)
++|.++.++. .+..+++|+.|++++| .+....+..|.++++|+.|++++|.++. +| .+..+++|+.|++++|.+++
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSA 221 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCc
Confidence 5555544433 2334455555555442 2222222344444555555555554442 22 23444445555555555544
Q ss_pred cCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC-CCCCCccccccCCCCcccCC
Q 015202 176 SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE-GPFRNFSIESFKGNELLCGM 248 (411)
Q Consensus 176 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~ 248 (411)
..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++..+.. ..+..+..+++.+||+.|+|
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC
Confidence 44444444555555555555554444444444455555555555444333322 22344444444555544443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=249.92 Aligned_cols=249 Identities=24% Similarity=0.273 Sum_probs=147.6
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.+.+
T Consensus 39 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~ 118 (477)
T 2id5_A 39 LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI 118 (477)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCE
T ss_pred CCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCcccc
Confidence 34555655555556666666666666665555555555555555555555555554444445555555555555555554
Q ss_pred cCCccccCCccCCeeeccccc------------------------CCccCc-cccCCCCCcEEEcCCCeeeecCCCCccC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQ------------------------LTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGN 135 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~------------------------l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 135 (411)
..+..|..+++|+.|++++|. ++.+|. .+..+++|+.|++++|.+.+..+..|..
T Consensus 119 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~ 198 (477)
T 2id5_A 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198 (477)
T ss_dssp ECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCS
T ss_pred CChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhccc
Confidence 444444445555555554444 444432 2334455555555555544444434444
Q ss_pred ccCCCeEE------------------------ccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEe
Q 015202 136 LEVLVQID------------------------LSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191 (411)
Q Consensus 136 l~~L~~L~------------------------l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 191 (411)
+++|+.|+ +++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|+
T Consensus 199 l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 278 (477)
T 2id5_A 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278 (477)
T ss_dssp CTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEE
T ss_pred CcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEE
Confidence 44333333 333444433223455667777777777777766667777777888888
Q ss_pred CCCCccccccchhhhcCCCCCEEEcccCcccccCCCC-CCCCCccccccCCCCcccCCC
Q 015202 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE-GPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 192 l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 249 (411)
+++|.+++..|..+..+++|+.|++++|.+++..+.. ..+..+..+++.+|++.|.+.
T Consensus 279 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp CCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred CCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 8888887777777778888888888888887655433 345667778888888887653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=244.91 Aligned_cols=229 Identities=24% Similarity=0.258 Sum_probs=122.6
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeec
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 97 (411)
++|+.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.++...+..|..+++|+.|++
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 45555555555555555555555555555555555555555555555555555555555555444444555555555555
Q ss_pred ccccCCccCc-cccCCCCCcEEEcCCC-eeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccc
Q 015202 98 GSNQLTYIPL-TLWNLKYILYLNLSSN-SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG 175 (411)
Q Consensus 98 ~~n~l~~~p~-~~~~~~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 175 (411)
++|.++.+|. .+..+++|+.|++++| .+....+..|.++++|+.|++++|.+++. | .+..+++|+.|++++|.+++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcc
Confidence 5555555543 3345555555555552 23322333455555555555555555532 2 24455555555555555555
Q ss_pred cCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC-CCCCCccccccCCCCcccCC
Q 015202 176 SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE-GPFRNFSIESFKGNELLCGM 248 (411)
Q Consensus 176 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~ 248 (411)
..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++..+.. ..+..+..+++.+||+.|++
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 55555555555555555555555555555555555555555555555433322 23444555555555555544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-29 Score=240.54 Aligned_cols=224 Identities=25% Similarity=0.308 Sum_probs=208.2
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|+|++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+..
T Consensus 71 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 150 (440)
T 3zyj_A 71 LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES 150 (440)
T ss_dssp CCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCE
T ss_pred ccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccc
Confidence 57899999999999999999999999999998888999999999999999999997777789999999999999999998
Q ss_pred cCCccccCCccCCeeeccc-ccCCccCc-cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCcc
Q 015202 81 FVPSCFGNLTNLRKLYLGS-NQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~-n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 158 (411)
..+..|..+++|+.|++++ +.+..++. .+..+++|+.|++++|.++ .+| .+..+++|+.|++++|.+++..|..|.
T Consensus 151 ~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 228 (440)
T 3zyj_A 151 IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQ 228 (440)
T ss_dssp ECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTT
T ss_pred cCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhc
Confidence 8888999999999999998 45677766 5678999999999999998 555 488899999999999999999999999
Q ss_pred CCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 159 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
.+++|+.|++++|.+++..+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|++.|.+.
T Consensus 229 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred cCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence 99999999999999999999999999999999999999998888888999999999999999998775
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-29 Score=241.52 Aligned_cols=225 Identities=25% Similarity=0.293 Sum_probs=208.6
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|.|++..|+.|.++++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.+..
T Consensus 82 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 161 (452)
T 3zyi_A 82 LMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES 161 (452)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCE
T ss_pred CcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcce
Confidence 57899999999999999999999999999999888999999999999999999998877789999999999999999998
Q ss_pred cCCccccCCccCCeeeccc-ccCCccCc-cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCcc
Q 015202 81 FVPSCFGNLTNLRKLYLGS-NQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~-n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 158 (411)
..+..|..+++|+.|++++ |.+..++. .+..+++|+.|++++|.+++ +| .+..+++|+.|++++|.+++..|..|.
T Consensus 162 ~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 239 (452)
T 3zyi_A 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFH 239 (452)
T ss_dssp ECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGT
T ss_pred eCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCccccc
Confidence 8788899999999999998 56777776 46789999999999999984 44 588899999999999999999999999
Q ss_pred CCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCC
Q 015202 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 159 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 227 (411)
.+++|+.|++++|.+++..+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|++.|.+..
T Consensus 240 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 999999999999999999899999999999999999999988888889999999999999999988753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=241.74 Aligned_cols=244 Identities=23% Similarity=0.238 Sum_probs=199.2
Q ss_pred CCCCcccccCChhcccCCcCCceeecCccccccc-chhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSI-SIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 79 (411)
|++|.+++..|..|.++++|++|+|++|.+.+.+ +..|.++++|++|+|++|.+++..|..|.++++|++|++++|.++
T Consensus 37 Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 116 (455)
T 3v47_A 37 LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116 (455)
T ss_dssp CCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCB
T ss_pred ecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCC
Confidence 5789999999999999999999999999997544 668999999999999999999888999999999999999999998
Q ss_pred ccCCcc--ccCCccCCeeecccccCCcc-Ccc-ccCCCCCcEEEcCCCeeeecCCCCccCc-------------------
Q 015202 80 GFVPSC--FGNLTNLRKLYLGSNQLTYI-PLT-LWNLKYILYLNLSSNSFTIPLPSEIGNL------------------- 136 (411)
Q Consensus 80 ~~~~~~--~~~l~~L~~L~l~~n~l~~~-p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l------------------- 136 (411)
+..+.. +..+++|++|++++|.++.+ |.. +..+++|++|++++|.+.+..+..+..+
T Consensus 117 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~ 196 (455)
T 3v47_A 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196 (455)
T ss_dssp THHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCS
T ss_pred ccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccc
Confidence 754444 89999999999999999977 544 7789999999999999987766555433
Q ss_pred ---------------cCC--------------------------------------------------------------
Q 015202 137 ---------------EVL-------------------------------------------------------------- 139 (411)
Q Consensus 137 ---------------~~L-------------------------------------------------------------- 139 (411)
++|
T Consensus 197 ~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (455)
T 3v47_A 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG 276 (455)
T ss_dssp TTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSC
T ss_pred hhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccC
Confidence 334
Q ss_pred -CeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEccc
Q 015202 140 -VQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSF 218 (411)
Q Consensus 140 -~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~ 218 (411)
+.|++++|.+++..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.|++++
T Consensus 277 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 356 (455)
T 3v47_A 277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356 (455)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCS
T ss_pred ceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCC
Confidence 4444444455555666777788888888888888877777888888888888888888877777888888888888888
Q ss_pred CcccccCCCC-CCCCCccccccCCCCc
Q 015202 219 NKLEGEIPRE-GPFRNFSIESFKGNEL 244 (411)
Q Consensus 219 n~l~~~~~~~-~~~~~~~~~~~~~n~~ 244 (411)
|.+++..|.. ..++.++.+++.+|..
T Consensus 357 N~l~~~~~~~~~~l~~L~~L~L~~N~l 383 (455)
T 3v47_A 357 NHIRALGDQSFLGLPNLKELALDTNQL 383 (455)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcccccChhhccccccccEEECCCCcc
Confidence 8887776643 4567777777777754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-29 Score=227.53 Aligned_cols=238 Identities=23% Similarity=0.314 Sum_probs=209.1
Q ss_pred cCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCccccc--CchhhhccccCCeeeecCCcccccCCccc
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGS--IPYDLCRLAALFQLDLGDNKLSGFVPSCF 86 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 86 (411)
.+|..+. ++|+.|+|++|+++...+..|.++++|++|++++|.++.. .+..+..+++|++|++++|.+.. +|..+
T Consensus 21 ~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~ 97 (306)
T 2z66_A 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 97 (306)
T ss_dssp SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEE
T ss_pred cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-Chhhc
Confidence 4666443 6899999999999966666789999999999999998743 36778889999999999999984 66778
Q ss_pred cCCccCCeeecccccCCccCc--cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecc-cCCCCccCCCcc
Q 015202 87 GNLTNLRKLYLGSNQLTYIPL--TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSG-AIPTTIGGLKDL 163 (411)
Q Consensus 87 ~~l~~L~~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~~~L 163 (411)
..+++|+.|++++|.++.++. .+..+++|++|++++|.+.+..+..+..+++|+.|++++|.+++ ..|..+..+++|
T Consensus 98 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 177 (306)
T 2z66_A 98 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177 (306)
T ss_dssp ETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred CCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCC
Confidence 999999999999999998764 67889999999999999998888889999999999999999987 678899999999
Q ss_pred CeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC-CCC-CCccccccCC
Q 015202 164 QYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE-GPF-RNFSIESFKG 241 (411)
Q Consensus 164 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~-~~~~~~~~~~ 241 (411)
+.|++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++..|.. ..+ ..+..+++.+
T Consensus 178 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~ 257 (306)
T 2z66_A 178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257 (306)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTT
T ss_pred CEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccC
Confidence 99999999999888999999999999999999999888888899999999999999999877754 334 3788899999
Q ss_pred CCcccCCC
Q 015202 242 NELLCGMP 249 (411)
Q Consensus 242 n~~~c~~~ 249 (411)
|+..|.+.
T Consensus 258 N~~~~~c~ 265 (306)
T 2z66_A 258 NDFACTCE 265 (306)
T ss_dssp CCEECSGG
T ss_pred CCeecccC
Confidence 99888753
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=227.48 Aligned_cols=225 Identities=23% Similarity=0.199 Sum_probs=200.8
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccc--cchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGS--ISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKL 78 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 78 (411)
+++|.++..-+..|.++++|+.|+|++|.++.. .+..+..+++|++|++++|.+.. +|..+..+++|++|++++|.+
T Consensus 35 L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l 113 (306)
T 2z66_A 35 LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 113 (306)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEE
T ss_pred CCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcc
Confidence 578888854445589999999999999999743 36788899999999999999984 566788999999999999999
Q ss_pred cccCC-ccccCCccCCeeecccccCCcc-CccccCCCCCcEEEcCCCeeee-cCCCCccCccCCCeEEccCCeecccCCC
Q 015202 79 SGFVP-SCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTI-PLPSEIGNLEVLVQIDLSMNNFSGAIPT 155 (411)
Q Consensus 79 ~~~~~-~~~~~l~~L~~L~l~~n~l~~~-p~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 155 (411)
++..+ ..+..+++|+.|++++|.++.+ +..+..+++|++|++++|.+.+ ..|..+..+++|+.|++++|.+++..|.
T Consensus 114 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 193 (306)
T 2z66_A 114 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 193 (306)
T ss_dssp ESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred cccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHH
Confidence 97655 5789999999999999999844 5567789999999999999986 5788999999999999999999988899
Q ss_pred CccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCC-CCCEEEcccCcccccCC
Q 015202 156 TIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLL-DLQHINVSFNKLEGEIP 226 (411)
Q Consensus 156 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~l~l~~n~l~~~~~ 226 (411)
.+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++..+..+..++ +|+.|++++|++++.++
T Consensus 194 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 194 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp TTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred HhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 999999999999999999988787899999999999999999999998898885 99999999999998765
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=227.17 Aligned_cols=216 Identities=24% Similarity=0.331 Sum_probs=115.2
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|++++|.++. +|..+. ++|++|++++|.+.+.
T Consensus 60 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~ 136 (330)
T 1xku_A 60 QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRVHENEITKV 136 (330)
T ss_dssp CSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEECCSSCCCBB
T ss_pred CCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--ccccEEECCCCccccc
Confidence 4455555444455555555555555555554445555555555555555555542 222221 4555555555555544
Q ss_pred CCccccCCccCCeeecccccCC---ccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCcc
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLT---YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~---~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 158 (411)
.+..+..+++|+.|++++|.++ ..+..+..+++|+.|++++|.+. .+|..+. ++|+.|++++|.+++..+..+.
T Consensus 137 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~ 213 (330)
T 1xku_A 137 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLK 213 (330)
T ss_dssp CHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGT
T ss_pred CHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhc
Confidence 4444555555555555555554 22334445555555555555555 2333332 4555566666655555555555
Q ss_pred CCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCccccc
Q 015202 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGE 224 (411)
Q Consensus 159 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~ 224 (411)
.+++|+.|++++|.+++..+..+..+++|+.|++++|.++ .+|..+..+++|+.|++++|.+++.
T Consensus 214 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~ 278 (330)
T 1xku_A 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 278 (330)
T ss_dssp TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred CCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCcc
Confidence 5566666666666665555555555566666666666655 4455555556666666666665543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=244.59 Aligned_cols=248 Identities=20% Similarity=0.157 Sum_probs=169.3
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
++|.+++..+..|.++++|++|+|++|.+.+..+..|.++++|++|++++|.+.+..+..|.++++|++|++++|.+++.
T Consensus 88 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 167 (477)
T 2id5_A 88 RSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167 (477)
T ss_dssp CSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred CCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence 45555544444455555555666655555555555555555555555555555555455555555555555555555543
Q ss_pred CCccccCCccCCeeecccccCC-------------------------ccCccccCCCCCcEEEcCCCeeeecCCCCccCc
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLT-------------------------YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNL 136 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~-------------------------~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 136 (411)
.+..+..+++|+.|++++|.+. .+|.......+|+.|++++|.++...+..+..+
T Consensus 168 ~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 247 (477)
T 2id5_A 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL 247 (477)
T ss_dssp CHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTC
T ss_pred ChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCc
Confidence 3334444444444444444444 444444444567777777777774433568889
Q ss_pred cCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEc
Q 015202 137 EVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINV 216 (411)
Q Consensus 137 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l 216 (411)
++|+.|++++|.+++..+..|..+++|+.|++++|.+++..|..|..+++|+.|++++|.+++..+..+..+++|+.|++
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 327 (477)
T 2id5_A 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL 327 (477)
T ss_dssp TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEEC
T ss_pred cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEc
Confidence 99999999999999888899999999999999999999998999999999999999999999888888899999999999
Q ss_pred ccCcccccCCCCCCCCCccccccCCCCcccCCC
Q 015202 217 SFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 217 ~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 249 (411)
++|++.|.++....+.......+.++...|..|
T Consensus 328 ~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 328 DSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp CSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred cCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 999999876532111122223445556666544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=236.61 Aligned_cols=239 Identities=20% Similarity=0.251 Sum_probs=181.9
Q ss_pred cCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccC
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGN 88 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 88 (411)
.+|..+. ++|++|++++|++++..+..|.++++|++|++++|.+++..+..|.++++|++|++++|.+++..+..+..
T Consensus 45 ~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 122 (353)
T 2z80_A 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKP 122 (353)
T ss_dssp SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTT
T ss_pred ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCC
Confidence 4566554 47888888888887666667888888888888888888777777888888888888888887655455777
Q ss_pred CccCCeeecccccCCccCc--cccCCCCCcEEEcCCC-eeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCe
Q 015202 89 LTNLRKLYLGSNQLTYIPL--TLWNLKYILYLNLSSN-SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQY 165 (411)
Q Consensus 89 l~~L~~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~ 165 (411)
+++|+.|++++|+++.+|. .+..+++|++|++++| .+....+..+.++++|+.|++++|.+++..|..+..+++|+.
T Consensus 123 l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 202 (353)
T 2z80_A 123 LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202 (353)
T ss_dssp CTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE
T ss_pred CccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCe
Confidence 8888888888888887776 5667888888888887 366556677788888888888888888777788888888888
Q ss_pred eecccccccccCCccccCCCCCCEEeCCCCccccc-------------------------------cchhhhcCCCCCEE
Q 015202 166 LFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA-------------------------------IPISLEKLLDLQHI 214 (411)
Q Consensus 166 L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~-------------------------------~~~~~~~l~~L~~l 214 (411)
|++++|.++...+..+..+++|+.|++++|.+++. +|..+..+++|+.|
T Consensus 203 L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L 282 (353)
T 2z80_A 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLEL 282 (353)
T ss_dssp EEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEE
T ss_pred ecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEE
Confidence 88888877644333344567777888777777653 35567788999999
Q ss_pred EcccCcccccCCCC-CCCCCccccccCCCCcccCCC
Q 015202 215 NVSFNKLEGEIPRE-GPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 215 ~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 249 (411)
++++|.++...+.. ..++.+..+++.+|+..|.++
T Consensus 283 ~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 283 EFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 99999998544443 567888999999999888654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=254.93 Aligned_cols=236 Identities=22% Similarity=0.361 Sum_probs=186.6
Q ss_pred CCcccccCChhcccCCcCCceeecCcccccc-----------------cchhhh--CCCCCCeeecccCcccccCchhhh
Q 015202 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGS-----------------ISIALG--KLQKLQLLGLEDNQLEGSIPYDLC 63 (411)
Q Consensus 3 ~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~-----------------~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~ 63 (411)
.|+++| +|+.|+++++|++|+|++|.+++. +|..+. ++++|++|++++|.+.+.+|+.+.
T Consensus 192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~ 270 (636)
T 4eco_A 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270 (636)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence 678888 899999999999999999999875 788887 999999999999998888898899
Q ss_pred ccccCCeeeecCCc-ccc-cCCccccCC------ccCCeeecccccCCccCc--cccCCCCCcEEEcCCCeeeecCCCCc
Q 015202 64 RLAALFQLDLGDNK-LSG-FVPSCFGNL------TNLRKLYLGSNQLTYIPL--TLWNLKYILYLNLSSNSFTIPLPSEI 133 (411)
Q Consensus 64 ~l~~L~~L~l~~n~-l~~-~~~~~~~~l------~~L~~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n~l~~~~~~~~ 133 (411)
++++|++|++++|. +++ .+|..+..+ ++|+.|++++|+++.+|. .+..+++|+.|++++|.+.+.+| .+
T Consensus 271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~ 349 (636)
T 4eco_A 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AF 349 (636)
T ss_dssp TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence 99999999999998 887 778777766 889999999999888888 78888999999999998888888 78
Q ss_pred cCccCCCeEEccCCeecccCCCCccCCCc-cCeeecccccccccCCccccCCC--CCCEEeCCCCccccccchhhh----
Q 015202 134 GNLEVLVQIDLSMNNFSGAIPTTIGGLKD-LQYLFLEYNRLQGSIPDFIGGLI--NLKSLDLSNNNLSGAIPISLE---- 206 (411)
Q Consensus 134 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~~~~~~~--~L~~L~l~~n~l~~~~~~~~~---- 206 (411)
..+++|+.|++++|.++ .+|..+..+++ |+.|++++|.++ .+|..+...+ +|+.|++++|.+++..|..+.
T Consensus 350 ~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~ 427 (636)
T 4eco_A 350 GSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427 (636)
T ss_dssp EEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCS
T ss_pred CCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccccc
Confidence 88888888888888887 66777888887 888888888887 5666665543 677777777777776666665
Q ss_pred ---cCCCCCEEEcccCcccccCCCC--CCCCCccccccCCCC
Q 015202 207 ---KLLDLQHINVSFNKLEGEIPRE--GPFRNFSIESFKGNE 243 (411)
Q Consensus 207 ---~l~~L~~l~l~~n~l~~~~~~~--~~~~~~~~~~~~~n~ 243 (411)
.+++|+.|++++|.++. +|.. ..++.+..+++.+|.
T Consensus 428 ~~~~~~~L~~L~Ls~N~l~~-lp~~~~~~l~~L~~L~Ls~N~ 468 (636)
T 4eco_A 428 TPFKGINVSSINLSNNQISK-FPKELFSTGSPLSSINLMGNM 468 (636)
T ss_dssp SCCCCCCEEEEECCSSCCCS-CCTHHHHTTCCCSEEECCSSC
T ss_pred ccccCCCCCEEECcCCccCc-CCHHHHccCCCCCEEECCCCC
Confidence 55667777777776663 3321 124455555555554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=248.19 Aligned_cols=246 Identities=20% Similarity=0.251 Sum_probs=129.2
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCch-hhhccccCCeeeecCCccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY-DLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~ 79 (411)
+++|.++ .+|+.+.++++|++|++++|.+.+..|..+.++++|++|++++|.+.+.++. .+..+++|++|++++|.+.
T Consensus 285 l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 363 (606)
T 3t6q_A 285 LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363 (606)
T ss_dssp CTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCC
T ss_pred ccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccc
Confidence 3456665 5666666666677777766666655555666666666666666655533332 3555555555555555555
Q ss_pred ccC--CccccCCccCCeeecccccCCcc-CccccCCCCCcEEEcCCCeeeecCCC-CccCccCCCeEEccCCeecccCCC
Q 015202 80 GFV--PSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTIPLPS-EIGNLEVLVQIDLSMNNFSGAIPT 155 (411)
Q Consensus 80 ~~~--~~~~~~l~~L~~L~l~~n~l~~~-p~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~~~~~~~ 155 (411)
+.. +..+..+++|+.|++++|.++.+ |..+..+++|+.|++++|.+.+..+. .+..+++|+.|++++|.+++..|.
T Consensus 364 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 443 (606)
T 3t6q_A 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443 (606)
T ss_dssp EEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTT
T ss_pred cccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHH
Confidence 433 44455555555555555555433 33344455555555555554433322 244444455555555544444444
Q ss_pred CccCC---------------------------CccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcC
Q 015202 156 TIGGL---------------------------KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKL 208 (411)
Q Consensus 156 ~~~~~---------------------------~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 208 (411)
.+..+ ++|+.|++++|.+++..|..+..+++|+.|++++|.+++..|..+..+
T Consensus 444 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 523 (606)
T 3t6q_A 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523 (606)
T ss_dssp TTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTC
T ss_pred HHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcc
Confidence 44444 445555555555544444445555555555555555555555555555
Q ss_pred CCCCEEEcccCcccccCCCC-CCCCCccccccCCCCcccCC
Q 015202 209 LDLQHINVSFNKLEGEIPRE-GPFRNFSIESFKGNELLCGM 248 (411)
Q Consensus 209 ~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~ 248 (411)
+.| .|++++|.+++..|.. ..+..++.+++.+|++.|.+
T Consensus 524 ~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 524 KGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp CSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred ccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 555 5555555555443322 22344555566666666654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=258.10 Aligned_cols=245 Identities=25% Similarity=0.272 Sum_probs=201.3
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+.+..|..|.++++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|++++|.+..
T Consensus 273 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 352 (844)
T 3j0a_A 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAI 352 (844)
T ss_dssp CTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCC
T ss_pred CCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCc
Confidence 46788888888889999999999999999998888889999999999999999988888889999999999999999988
Q ss_pred cCCccccCCccCCeeecccccCCccCc-----------------------------------------cccCCCCCcEEE
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPL-----------------------------------------TLWNLKYILYLN 119 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~-----------------------------------------~~~~~~~L~~L~ 119 (411)
..+..|..+++|+.|++++|.++.++. .+..+++|+.|+
T Consensus 353 ~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~ 432 (844)
T 3j0a_A 353 IQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILI 432 (844)
T ss_dssp CCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEE
T ss_pred cChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceee
Confidence 777788889999999998888775432 012466677777
Q ss_pred cCCCeeeecCCC-CccCccCCCeEEccCCeec-----ccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCC
Q 015202 120 LSSNSFTIPLPS-EIGNLEVLVQIDLSMNNFS-----GAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLS 193 (411)
Q Consensus 120 l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~~-----~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~ 193 (411)
+++|.+++..+. .+..+++|+.|++++|.++ +..+..|..+++|+.|+|++|.+++..|..|..+++|+.|+++
T Consensus 433 Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 512 (844)
T 3j0a_A 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLN 512 (844)
T ss_dssp EESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEE
T ss_pred CCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECC
Confidence 777776643322 3455677788888888776 3344667888999999999999998888889999999999999
Q ss_pred CCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCcccCCC
Q 015202 194 NNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 194 ~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 249 (411)
+|.+++..+..+. ++|+.|++++|.+++..|.. +..+..+++.+||+.|.|+
T Consensus 513 ~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 513 SNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp SCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred CCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence 9999987776665 78999999999999888754 5688889999999999775
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=243.60 Aligned_cols=240 Identities=22% Similarity=0.242 Sum_probs=170.3
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.+.+
T Consensus 82 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~ 161 (597)
T 3oja_B 82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 161 (597)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC
Confidence 35666666666666666666666666666666666666666667777776666665544455666667777777666666
Q ss_pred cCCccccCCccCCeeecccccCCccCccccCCC----------------------------------------CCcEEEc
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLK----------------------------------------YILYLNL 120 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~----------------------------------------~L~~L~l 120 (411)
..|..|..+++|+.|++++|.++.++. ..++ +|+.|++
T Consensus 162 ~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L 239 (597)
T 3oja_B 162 IEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKL 239 (597)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSBCCG--GGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEEC
T ss_pred CChhhhhcCCcCcEEECcCCCCCCcCh--hhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEEC
Confidence 666666666666666666666654431 1112 2333333
Q ss_pred CCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccc
Q 015202 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 121 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
++|.+++ +..+..+++|+.|++++|.+++..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.++ .
T Consensus 240 ~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~ 315 (597)
T 3oja_B 240 QHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-H 315 (597)
T ss_dssp CSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-C
T ss_pred CCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-c
Confidence 3333332 2446778888999999999988888888899999999999999985 4556677889999999999998 5
Q ss_pred cchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCcccCC
Q 015202 201 IPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGM 248 (411)
Q Consensus 201 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 248 (411)
+|..+..+++|+.|++++|.+++.. ...++.+..+++.+|++.|.+
T Consensus 316 i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 316 VERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp CGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred cCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCChh
Confidence 6777888999999999999987653 445778888999999988754
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-28 Score=224.50 Aligned_cols=224 Identities=21% Similarity=0.202 Sum_probs=126.0
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeec
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 97 (411)
++|+.|++++|.+++..+..|.++++|++|++++|.+++..|..|.++++|++|++++|.++ .+|..+. ++|+.|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 45555555555555444445555555555555555555444555555555555555555555 2333222 45555555
Q ss_pred ccccCCccCcc-ccCCCCCcEEEcCCCeeee--cCCCCccCc--------------------cCCCeEEccCCeecccCC
Q 015202 98 GSNQLTYIPLT-LWNLKYILYLNLSSNSFTI--PLPSEIGNL--------------------EVLVQIDLSMNNFSGAIP 154 (411)
Q Consensus 98 ~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~--~~~~~~~~l--------------------~~L~~L~l~~n~~~~~~~ 154 (411)
++|.++.+|.. +..+++|+.|++++|.+.. ..+..+..+ ++|+.|++++|.+++..+
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~ 210 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIEL 210 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCT
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCH
Confidence 55555544432 3445555555555555431 233333333 456666666666666666
Q ss_pred CCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCC-----
Q 015202 155 TTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREG----- 229 (411)
Q Consensus 155 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~----- 229 (411)
..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.++ .+|..+..+++|+.|++++|.+++..+...
T Consensus 211 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~ 289 (332)
T 2ft3_A 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF 289 (332)
T ss_dssp TSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC
T ss_pred HHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccc
Confidence 66667777777777777777666666667777777777777776 455566677777777777777765443221
Q ss_pred --CCCCccccccCCCCcc
Q 015202 230 --PFRNFSIESFKGNELL 245 (411)
Q Consensus 230 --~~~~~~~~~~~~n~~~ 245 (411)
....+..+++.+|+..
T Consensus 290 ~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 290 GVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp CSSSCCBSEEECCSSSSC
T ss_pred ccccccccceEeecCccc
Confidence 1233455566666554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-28 Score=228.88 Aligned_cols=238 Identities=22% Similarity=0.242 Sum_probs=134.0
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|++++|.++...+..|.++++|++|++++|.+.+.
T Consensus 77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~ 156 (390)
T 3o6n_A 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 156 (390)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCcc
Confidence 45555555555566666666666666666655555566666666666666666544333455566666666666666655
Q ss_pred CCccccCCccCCeeecccccCCccCccccCCC----------------------------------------CCcEEEcC
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLK----------------------------------------YILYLNLS 121 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~----------------------------------------~L~~L~l~ 121 (411)
.+..+..+++|+.|++++|.++.++. ..++ +|+.|+++
T Consensus 157 ~~~~~~~l~~L~~L~l~~n~l~~~~~--~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~ 234 (390)
T 3o6n_A 157 EDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQ 234 (390)
T ss_dssp CTTTTSSCTTCCEEECCSSCCSBCCG--GGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECC
T ss_pred ChhhccCCCCCCEEECCCCcCCcccc--ccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECC
Confidence 55556666666666666665554321 1112 22223333
Q ss_pred CCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCcccccc
Q 015202 122 SNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI 201 (411)
Q Consensus 122 ~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 201 (411)
+|.+++ ...+..+++|+.|++++|.+++..|..|..+++|+.|++++|.+++ +|..+..+++|+.|++++|.++ .+
T Consensus 235 ~n~l~~--~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~ 310 (390)
T 3o6n_A 235 HNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HV 310 (390)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CC
T ss_pred CCCCcc--cHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ec
Confidence 333221 1234455666666666666666666666666666666666666653 3334455666666666666666 34
Q ss_pred chhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCcccC
Q 015202 202 PISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCG 247 (411)
Q Consensus 202 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 247 (411)
|..+..+++|+.|++++|.++... ...++.+..+++.+|++.|.
T Consensus 311 ~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 311 ERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp GGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHH
T ss_pred CccccccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccch
Confidence 445556666666666666665432 33455566666666665553
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-28 Score=243.08 Aligned_cols=242 Identities=23% Similarity=0.281 Sum_probs=208.1
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCccccc--CchhhhccccCCeeeecCCccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGS--IPYDLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~ 79 (411)
++|.+ +.+| .+ .+++|+.|++++|...+.. .+..+++|++|++++|.+++. .+..+..+++|++|++++|.+.
T Consensus 315 ~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 389 (606)
T 3vq2_A 315 IRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389 (606)
T ss_dssp ESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE
T ss_pred ccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc
Confidence 45666 6777 35 7777888888777554333 567889999999999998866 3788899999999999999998
Q ss_pred ccCCccccCCccCCeeecccccCCccCc--cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecc-cCCCC
Q 015202 80 GFVPSCFGNLTNLRKLYLGSNQLTYIPL--TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSG-AIPTT 156 (411)
Q Consensus 80 ~~~~~~~~~l~~L~~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~ 156 (411)
+ +|..+..+++|+.|++++|.+..++. .+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+++ ..|..
T Consensus 390 ~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 468 (606)
T 3vq2_A 390 I-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468 (606)
T ss_dssp E-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred c-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHh
Confidence 5 56889999999999999999986653 67789999999999999998899999999999999999999987 47889
Q ss_pred ccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCC-Ccc
Q 015202 157 IGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFR-NFS 235 (411)
Q Consensus 157 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~-~~~ 235 (411)
+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.++...+....++ ++.
T Consensus 469 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~ 548 (606)
T 3vq2_A 469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548 (606)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCC
T ss_pred hccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCc
Confidence 9999999999999999999889999999999999999999999889999999999999999999985444434454 488
Q ss_pred ccccCCCCcccCCC
Q 015202 236 IESFKGNELLCGMP 249 (411)
Q Consensus 236 ~~~~~~n~~~c~~~ 249 (411)
.+++.+|++.|.++
T Consensus 549 ~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 549 FFNLTNNSVACICE 562 (606)
T ss_dssp EEECCSCCCCCSST
T ss_pred EEEccCCCcccCCc
Confidence 89999999999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=225.36 Aligned_cols=220 Identities=22% Similarity=0.271 Sum_probs=196.5
Q ss_pred cCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCee
Q 015202 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKL 95 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 95 (411)
..++++.|+|++|.++ .+|..+.++++|++|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..+..+++|+.|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3478999999999998 67778889999999999999999 78888999999999999999999 779999999999999
Q ss_pred ecccccC-CccCccccC---------CCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCe
Q 015202 96 YLGSNQL-TYIPLTLWN---------LKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQY 165 (411)
Q Consensus 96 ~l~~n~l-~~~p~~~~~---------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~ 165 (411)
++++|++ ..+|..+.. +++|++|++++|.++ .+|..+.++++|+.|++++|.+++ +|..+..+++|+.
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~ 233 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE 233 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCE
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCE
Confidence 9999765 578877654 999999999999998 888899999999999999999995 5667899999999
Q ss_pred eecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC-CCCCCccccccC
Q 015202 166 LFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE-GPFRNFSIESFK 240 (411)
Q Consensus 166 L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~ 240 (411)
|++++|.+.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++.+.+|.. ..++.+..+.+.
T Consensus 234 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~ 309 (328)
T 4fcg_A 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309 (328)
T ss_dssp EECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECC
T ss_pred EECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCC
Confidence 999999999999999999999999999999999999999999999999999999999988854 334444444433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=222.47 Aligned_cols=227 Identities=24% Similarity=0.258 Sum_probs=200.0
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCc-ccccCchhhhccccCCeeeecCCccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQ-LEGSIPYDLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~ 79 (411)
+++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|++++|. ++...+..|..+++|++|++++|.++
T Consensus 39 l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~ 118 (285)
T 1ozn_A 39 LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118 (285)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred eeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCC
Confidence 57899999888899999999999999999998889999999999999999997 88777888999999999999999999
Q ss_pred ccCCccccCCccCCeeecccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCcc
Q 015202 80 GFVPSCFGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158 (411)
Q Consensus 80 ~~~~~~~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 158 (411)
+..+..+..+++|+.|++++|.++.++.. +..+++|+.|++++|.++...+..+..+++|+.|++++|.+++..|..+.
T Consensus 119 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 198 (285)
T 1ozn_A 119 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198 (285)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred EECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHcc
Confidence 88888999999999999999999988765 67899999999999999977777899999999999999999999999999
Q ss_pred CCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC
Q 015202 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228 (411)
Q Consensus 159 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~ 228 (411)
.+++|+.|++++|.+++..+..+..+++|+.|++++|.+....+.. .....++.+..+.+.+.|..|..
T Consensus 199 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp TCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred CcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchH
Confidence 9999999999999999877777999999999999999998554321 11122344456778888877754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-28 Score=244.34 Aligned_cols=249 Identities=24% Similarity=0.289 Sum_probs=195.7
Q ss_pred CCCCcccccCChhcccCCcCCceeecCc----------------------------ccccccchhhhCCCCCCeeecccC
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGN----------------------------KLNGSISIALGKLQKLQLLGLEDN 52 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n----------------------------~~~~~~~~~~~~l~~L~~L~l~~n 52 (411)
+++|.+++..|..|.++++|++|++++| ++++..|..|.++++|++|++++|
T Consensus 336 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 415 (680)
T 1ziw_A 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415 (680)
T ss_dssp CCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCC
Confidence 4567777777777777776666666544 444555666777777777777777
Q ss_pred cccccCc-hhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCC---ccCccccCCCCCcEEEcCCCeeeec
Q 015202 53 QLEGSIP-YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT---YIPLTLWNLKYILYLNLSSNSFTIP 128 (411)
Q Consensus 53 ~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---~~p~~~~~~~~L~~L~l~~n~l~~~ 128 (411)
.+.+.+| ..|.++++|++|++++|.+.+..+..|..+++|+.|++++|.++ .+|..+..+++|+.|++++|.+++.
T Consensus 416 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i 495 (680)
T 1ziw_A 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495 (680)
T ss_dssp CCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCC
T ss_pred cCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcC
Confidence 7765444 56777777777777777777777777777788888888887764 5677788899999999999999877
Q ss_pred CCCCccCccCCCeEEccCCeecccCC--------CCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccc
Q 015202 129 LPSEIGNLEVLVQIDLSMNNFSGAIP--------TTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 129 ~~~~~~~l~~L~~L~l~~n~~~~~~~--------~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
.+..|.++++|+.|++++|.+++..+ ..+..+++|+.|++++|.++...+..|.++++|+.|++++|.+++.
T Consensus 496 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l 575 (680)
T 1ziw_A 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575 (680)
T ss_dssp CTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcC
Confidence 77778899999999999999886532 2367889999999999999866666789999999999999999987
Q ss_pred cchhhhcCCCCCEEEcccCcccccCCCCC--CCCCccccccCCCCcccCCC
Q 015202 201 IPISLEKLLDLQHINVSFNKLEGEIPREG--PFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 201 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~ 249 (411)
.+..+..+++|+.|++++|.+++..+... .++.+..+++.+||+.|+|.
T Consensus 576 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 77778889999999999999987665432 45678889999999999875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-29 Score=252.73 Aligned_cols=189 Identities=22% Similarity=0.318 Sum_probs=136.0
Q ss_pred cchhhhCCCCCCeeecccCcccc-----------------cCchhhh--ccccCCeeeecCCcccccCCccccCCccCCe
Q 015202 34 ISIALGKLQKLQLLGLEDNQLEG-----------------SIPYDLC--RLAALFQLDLGDNKLSGFVPSCFGNLTNLRK 94 (411)
Q Consensus 34 ~~~~~~~l~~L~~L~l~~n~l~~-----------------~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 94 (411)
+|..|.++++|++|+|++|.+++ .+|+.+. ++++|++|+|++|.+.+.+|..+..+++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 66677777778888887777776 2666655 7777788888777777777777777777777
Q ss_pred eeccccc-CCc--cCccccCCC-------CCcEEEcCCCeeeecCCC--CccCccCCCeEEccCCeecccCCCCccCCCc
Q 015202 95 LYLGSNQ-LTY--IPLTLWNLK-------YILYLNLSSNSFTIPLPS--EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD 162 (411)
Q Consensus 95 L~l~~n~-l~~--~p~~~~~~~-------~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~ 162 (411)
|++++|+ ++. +|..+..++ +|+.|++++|.+. .+|. .++++++|+.|++++|.++ .+| .|..+++
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~ 596 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK 596 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc
Confidence 7777776 663 666554443 7777777777777 6776 6777777777777777777 556 6777777
Q ss_pred cCeeecccccccccCCccccCCCC-CCEEeCCCCccccccchhhhcCCC--CCEEEcccCcccccCCC
Q 015202 163 LQYLFLEYNRLQGSIPDFIGGLIN-LKSLDLSNNNLSGAIPISLEKLLD--LQHINVSFNKLEGEIPR 227 (411)
Q Consensus 163 L~~L~l~~n~l~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~~~~~l~~--L~~l~l~~n~l~~~~~~ 227 (411)
|+.|++++|.++ .+|..+..+++ |+.|++++|.++ .+|..+..++. |+.|++++|.+++.+|.
T Consensus 597 L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~ 662 (876)
T 4ecn_A 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662 (876)
T ss_dssp ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSS
T ss_pred ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCcccc
Confidence 777777777777 66666777777 777777777777 55655555433 77777777777665553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=217.99 Aligned_cols=217 Identities=25% Similarity=0.260 Sum_probs=193.8
Q ss_pred cCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccC
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGN 88 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 88 (411)
.+|..+. ++|++|++++|++++..+..|.++++|++|++++|.+++..+..|.++++|++|++++|.+++..+..+..
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 4666554 57999999999999888889999999999999999999888888999999999999999999888889999
Q ss_pred CccCCeeecccccCCccCc-cccCCCCCcEEEcCCCeeeec-CCCCccCccCCCeEEccCCeecccCCCCccCCCccC--
Q 015202 89 LTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIP-LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQ-- 164 (411)
Q Consensus 89 l~~L~~L~l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~-- 164 (411)
+++|+.|++++|.++.++. .+..+++|++|++++|.+... +|..+..+++|+.|++++|.+++..+..+..+++|+
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l 178 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTC
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcccc
Confidence 9999999999999998765 678999999999999999863 588999999999999999999988888888777777
Q ss_pred --eeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC
Q 015202 165 --YLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228 (411)
Q Consensus 165 --~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~ 228 (411)
.|++++|.+++..+..+.. .+|+.|++++|.+++..+..+..+++|+.+++++|+++|.++..
T Consensus 179 ~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 179 NLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred ceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 8999999999776665544 58999999999999877777889999999999999999988754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=245.71 Aligned_cols=239 Identities=22% Similarity=0.249 Sum_probs=207.0
Q ss_pred CCCCccccc-----------------CChhcc--cCCcCCceeecCcccccccchhhhCCCCCCeeecccCc-ccc-cCc
Q 015202 1 MFNCNISGS-----------------IPEEIN--NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQ-LEG-SIP 59 (411)
Q Consensus 1 l~~n~~~~~-----------------~p~~~~--~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~-l~~-~~~ 59 (411)
|++|.|+|. +|+.++ ++++|++|+|++|.+.+.+|..|.++++|++|++++|. +++ .+|
T Consensus 213 Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp 292 (636)
T 4eco_A 213 MGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292 (636)
T ss_dssp EESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHH
T ss_pred CcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccch
Confidence 467888886 999998 99999999999999999999999999999999999998 988 788
Q ss_pred hhhhcc------ccCCeeeecCCcccccCCc--cccCCccCCeeecccccCC-ccCccccCCCCCcEEEcCCCeeeecCC
Q 015202 60 YDLCRL------AALFQLDLGDNKLSGFVPS--CFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNSFTIPLP 130 (411)
Q Consensus 60 ~~~~~l------~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~-~~p~~~~~~~~L~~L~l~~n~l~~~~~ 130 (411)
..+..+ ++|++|++++|.++ .+|. .+..+++|+.|++++|.++ .+| .+..+++|+.|++++|.+. .+|
T Consensus 293 ~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp 369 (636)
T 4eco_A 293 DDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIP 369 (636)
T ss_dssp HHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECC
T ss_pred HHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-ccc
Confidence 888876 99999999999999 7888 8999999999999999999 999 8889999999999999999 888
Q ss_pred CCccCccC-CCeEEccCCeecccCCCCccCCC--ccCeeecccccccccCCcccc-------CCCCCCEEeCCCCccccc
Q 015202 131 SEIGNLEV-LVQIDLSMNNFSGAIPTTIGGLK--DLQYLFLEYNRLQGSIPDFIG-------GLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 131 ~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~~--~L~~L~l~~n~l~~~~~~~~~-------~~~~L~~L~l~~n~l~~~ 200 (411)
..+..+++ |+.|++++|.++ .+|..+...+ +|+.|++++|.+++..|..+. .+++|+.|++++|.+++.
T Consensus 370 ~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~l 448 (636)
T 4eco_A 370 ANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448 (636)
T ss_dssp TTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSC
T ss_pred HhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcC
Confidence 88999999 999999999998 7787776654 899999999999988888887 778999999999999965
Q ss_pred cchhhhcCCCCCEEEcccCcccccCCCC-CCC--------CCccccccCCCCc
Q 015202 201 IPISLEKLLDLQHINVSFNKLEGEIPRE-GPF--------RNFSIESFKGNEL 244 (411)
Q Consensus 201 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~--------~~~~~~~~~~n~~ 244 (411)
.+..+..+++|+.|++++|.++ .+|.. ... ..++.+++.+|..
T Consensus 449 p~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 500 (636)
T 4eco_A 449 PKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKL 500 (636)
T ss_dssp CTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCC
T ss_pred CHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcC
Confidence 5555666899999999999998 44432 111 1677777777754
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-27 Score=236.70 Aligned_cols=126 Identities=20% Similarity=0.177 Sum_probs=104.0
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|+|++..|..|.++++|++|+|++|+++++.+.+|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++
T Consensus 59 Ls~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~ 138 (635)
T 4g8a_A 59 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 138 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC
T ss_pred eeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC
Confidence 57889988888889999999999999999988888889999999999999999987777788889999999999998887
Q ss_pred cCCccccCCccCCeeecccccCCc--cCccccCCCCCcEEEcCCCeee
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTY--IPLTLWNLKYILYLNLSSNSFT 126 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~--~p~~~~~~~~L~~L~l~~n~l~ 126 (411)
..+..|+++++|+.|++++|.++. +|..+..+++|++|++++|.++
T Consensus 139 l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 186 (635)
T 4g8a_A 139 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 186 (635)
T ss_dssp STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccc
Confidence 777778888888888888888763 4556666777777777666543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=218.62 Aligned_cols=217 Identities=22% Similarity=0.285 Sum_probs=195.6
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+++..|..|.++++|++|++++|.++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.+..
T Consensus 83 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 159 (330)
T 1xku_A 83 LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159 (330)
T ss_dssp CCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred CCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc
Confidence 5789999999999999999999999999998 4454433 799999999999998888889999999999999999964
Q ss_pred --cCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCcc
Q 015202 81 --FVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158 (411)
Q Consensus 81 --~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 158 (411)
..+..+..+++|+.|++++|.++.+|..+. ++|+.|++++|.+.+..+..+..+++|+.|++++|.+++..+..+.
T Consensus 160 ~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 237 (330)
T 1xku_A 160 SGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237 (330)
T ss_dssp GGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred cCcChhhccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence 677889999999999999999999998765 8999999999999988889999999999999999999988888999
Q ss_pred CCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhc------CCCCCEEEcccCcccc
Q 015202 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEK------LLDLQHINVSFNKLEG 223 (411)
Q Consensus 159 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~l~l~~n~l~~ 223 (411)
.+++|+.|++++|.++ .+|..+..+++|+.|++++|.+++..+..+.. .+.++.+++++|++..
T Consensus 238 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp GSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence 9999999999999998 77888999999999999999999877766643 3678999999999864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-29 Score=232.40 Aligned_cols=227 Identities=21% Similarity=0.223 Sum_probs=197.0
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+++..+..|.++++|++|++++|.+++..+..|.++++|++|++++|.+++..+..|.++++|++|++++|.++.
T Consensus 59 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 138 (353)
T 2z80_A 59 LSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT 138 (353)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS
T ss_pred CCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc
Confidence 57899998777789999999999999999998888899999999999999999997766669999999999999999996
Q ss_pred cCC-ccccCCccCCeeecccc-cCCccC-ccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCc
Q 015202 81 FVP-SCFGNLTNLRKLYLGSN-QLTYIP-LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI 157 (411)
Q Consensus 81 ~~~-~~~~~l~~L~~L~l~~n-~l~~~p-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 157 (411)
..+ ..+..+++|+.|++++| .++.++ ..+..+++|++|++++|.+.+..|..+..+++|+.|++++|.++...+..+
T Consensus 139 l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 218 (353)
T 2z80_A 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFV 218 (353)
T ss_dssp SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHH
T ss_pred cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhh
Confidence 544 47899999999999999 577664 567889999999999999998889999999999999999999875544445
Q ss_pred cCCCccCeeecccccccccC-------------------------------CccccCCCCCCEEeCCCCccccccchhhh
Q 015202 158 GGLKDLQYLFLEYNRLQGSI-------------------------------PDFIGGLINLKSLDLSNNNLSGAIPISLE 206 (411)
Q Consensus 158 ~~~~~L~~L~l~~n~l~~~~-------------------------------~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 206 (411)
..+++|+.|++++|.+++.. |..+..+++|+.|++++|.++...+..+.
T Consensus 219 ~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~ 298 (353)
T 2z80_A 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFD 298 (353)
T ss_dssp HHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred hhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHh
Confidence 56889999999999988643 23456788999999999999955444568
Q ss_pred cCCCCCEEEcccCcccccCCC
Q 015202 207 KLLDLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 207 ~l~~L~~l~l~~n~l~~~~~~ 227 (411)
.+++|+.|++++|++.|.+|.
T Consensus 299 ~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 299 RLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp TCTTCCEEECCSSCBCCCHHH
T ss_pred cCCCCCEEEeeCCCccCcCCC
Confidence 999999999999999988763
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-27 Score=234.38 Aligned_cols=243 Identities=22% Similarity=0.235 Sum_probs=216.2
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+++..|..|.++++|++|++++|.++ .+|..+.++++|++|++++|.+++..|..+..+++|++|++++|.+.+
T Consensus 261 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~ 339 (606)
T 3t6q_A 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339 (606)
T ss_dssp CTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCC
T ss_pred eecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCccc
Confidence 4678888888888999999999999999998 677789999999999999999998888899999999999999999986
Q ss_pred cCCc-cccCCccCCeeecccccCCcc---CccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCC-
Q 015202 81 FVPS-CFGNLTNLRKLYLGSNQLTYI---PLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPT- 155 (411)
Q Consensus 81 ~~~~-~~~~l~~L~~L~l~~n~l~~~---p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~- 155 (411)
.++. .+..+++|+.|++++|.++.+ +..+..+++|++|++++|.+.+..|..+..+++|+.|++++|.+++..+.
T Consensus 340 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 419 (606)
T 3t6q_A 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419 (606)
T ss_dssp BCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCC
T ss_pred ccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccch
Confidence 6655 489999999999999999865 66788999999999999999988899999999999999999999877654
Q ss_pred CccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccc---cchhhhcCCCCCEEEcccCcccccCCCC-CCC
Q 015202 156 TIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA---IPISLEKLLDLQHINVSFNKLEGEIPRE-GPF 231 (411)
Q Consensus 156 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~ 231 (411)
.+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++. .+..+..+++|+.|++++|.+++..|.. ..+
T Consensus 420 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 499 (606)
T 3t6q_A 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499 (606)
T ss_dssp TTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred hhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccc
Confidence 488999999999999999988899999999999999999999863 2357889999999999999999887654 557
Q ss_pred CCccccccCCCCc
Q 015202 232 RNFSIESFKGNEL 244 (411)
Q Consensus 232 ~~~~~~~~~~n~~ 244 (411)
+.++.+++.+|..
T Consensus 500 ~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 500 KMMNHVDLSHNRL 512 (606)
T ss_dssp TTCCEEECCSSCC
T ss_pred cCCCEEECCCCcc
Confidence 7888888888854
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-27 Score=237.76 Aligned_cols=227 Identities=21% Similarity=0.224 Sum_probs=206.0
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccc-hhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSIS-IALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 79 (411)
+++|++++..|..|.++++|+.|+|++|.+++.+| ..|.++++|++|++++|.+.+..+..|..+++|++|++++|.+.
T Consensus 388 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 467 (680)
T 1ziw_A 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467 (680)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCB
T ss_pred CCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccc
Confidence 46899999999999999999999999999987665 78999999999999999999888899999999999999999987
Q ss_pred --ccCCccccCCccCCeeecccccCCccCcc-ccCCCCCcEEEcCCCeeeecCC--------CCccCccCCCeEEccCCe
Q 015202 80 --GFVPSCFGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLP--------SEIGNLEVLVQIDLSMNN 148 (411)
Q Consensus 80 --~~~~~~~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~--------~~~~~l~~L~~L~l~~n~ 148 (411)
+..|..+..+++|+.|++++|+++.+|.. +..+++|+.|++++|.+++..+ ..+.++++|+.|++++|.
T Consensus 468 ~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~ 547 (680)
T 1ziw_A 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547 (680)
T ss_dssp CTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSC
T ss_pred ccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCC
Confidence 56788999999999999999999988765 6789999999999999985422 237889999999999999
Q ss_pred ecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhh-cCCCCCEEEcccCcccccCCC
Q 015202 149 FSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLE-KLLDLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 149 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~l~l~~n~l~~~~~~ 227 (411)
++...+..|..+++|+.|++++|++++..+..|..+++|+.|++++|.+++..+..+. .+++|+.+++++|++.|.++.
T Consensus 548 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 9976667899999999999999999988888889999999999999999988888787 789999999999999999875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=233.16 Aligned_cols=223 Identities=23% Similarity=0.251 Sum_probs=194.1
Q ss_pred ccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCe
Q 015202 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRK 94 (411)
Q Consensus 15 ~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 94 (411)
..+++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..| +..+++|++|+|++|.+++.. ..++|+.
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~ 103 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIET 103 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCE
Confidence 344589999999999998888999999999999999999987766 889999999999999998643 2389999
Q ss_pred eecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCcc-CCCccCeeecccccc
Q 015202 95 LYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG-GLKDLQYLFLEYNRL 173 (411)
Q Consensus 95 L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~-~~~~L~~L~l~~n~l 173 (411)
|++++|.++.++.. .+++|+.|++++|.+++..|..++.+++|+.|++++|.+++..|..+. .+++|+.|+|++|.+
T Consensus 104 L~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 104 LHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp EECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred EECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 99999999987654 468999999999999988888999999999999999999988888776 789999999999999
Q ss_pred cccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCcccCCC
Q 015202 174 QGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 174 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 249 (411)
++..+ ...+++|+.|++++|.+++..| .+..+++|+.|++++|.+++..+....++.+..+++.+|+..|+..
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~ 254 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTL 254 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHH
T ss_pred ccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcch
Confidence 97643 3468999999999999997544 5889999999999999999866665667888899999999887643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=222.15 Aligned_cols=232 Identities=20% Similarity=0.199 Sum_probs=123.7
Q ss_pred CCcccccCChhcccCCcCCceeecCcccc-cccchhhh-------CCCCCCeeecccCcccccCchhh--hccccCCeee
Q 015202 3 NCNISGSIPEEINNLTNLIAIYLGGNKLN-GSISIALG-------KLQKLQLLGLEDNQLEGSIPYDL--CRLAALFQLD 72 (411)
Q Consensus 3 ~n~~~~~~p~~~~~~~~L~~L~l~~n~~~-~~~~~~~~-------~l~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~ 72 (411)
+|.+ .+|..+... |+.|+|++|.+. ..+|..+. ++++|++|++++|.+++..|..+ ..+++|++|+
T Consensus 52 ~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~ 127 (312)
T 1wwl_A 52 VDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127 (312)
T ss_dssp CCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEE
T ss_pred cccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEE
Confidence 4444 555554433 556666666652 33444333 55666666666666655555543 5566666666
Q ss_pred ecCCcccccCCccccCC-----ccCCeeecccccCCccC-ccccCCCCCcEEEcCCCeeeec--CCCCc--cCccCCCeE
Q 015202 73 LGDNKLSGFVPSCFGNL-----TNLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFTIP--LPSEI--GNLEVLVQI 142 (411)
Q Consensus 73 l~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~l~~~p-~~~~~~~~L~~L~l~~n~l~~~--~~~~~--~~l~~L~~L 142 (411)
+++|.+++. |..+..+ ++|++|++++|+++.++ ..+..+++|++|++++|.+.+. .+..+ ..+++|++|
T Consensus 128 Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L 206 (312)
T 1wwl_A 128 LRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206 (312)
T ss_dssp EESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEE
T ss_pred ccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEE
Confidence 666666544 5555544 56666666666665544 4455566666666666654432 12222 555566666
Q ss_pred EccCCeecc---cCCCCccCCCccCeeecccccccccCC-ccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEccc
Q 015202 143 DLSMNNFSG---AIPTTIGGLKDLQYLFLEYNRLQGSIP-DFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSF 218 (411)
Q Consensus 143 ~l~~n~~~~---~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~ 218 (411)
++++|.+++ .....+..+++|+.|++++|.+++..| ..+..+++|+.|++++|.++ .+|..+. ++|+.|++++
T Consensus 207 ~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~ 283 (312)
T 1wwl_A 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSY 283 (312)
T ss_dssp ECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCS
T ss_pred ECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCC
Confidence 666665552 111223345566666666666655443 23344556666666666665 3444433 5566666666
Q ss_pred CcccccCCCCCCCCCccccccCCCC
Q 015202 219 NKLEGEIPREGPFRNFSIESFKGNE 243 (411)
Q Consensus 219 n~l~~~~~~~~~~~~~~~~~~~~n~ 243 (411)
|.+++. |....++.++.+++.+|+
T Consensus 284 N~l~~~-p~~~~l~~L~~L~L~~N~ 307 (312)
T 1wwl_A 284 NRLDRN-PSPDELPQVGNLSLKGNP 307 (312)
T ss_dssp SCCCSC-CCTTTSCEEEEEECTTCT
T ss_pred CCCCCC-hhHhhCCCCCEEeccCCC
Confidence 666554 334445555555555554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=219.46 Aligned_cols=235 Identities=22% Similarity=0.234 Sum_probs=200.9
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
+.+.+....+..+..+++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..+ +..+++|++|++++|.+++.
T Consensus 18 s~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l 95 (317)
T 3o53_A 18 TDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL 95 (317)
T ss_dssp CTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE
T ss_pred cccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc
Confidence 4566666666667788899999999999998888899999999999999999987655 88999999999999999854
Q ss_pred CCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCc-cCC
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTI-GGL 160 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~-~~~ 160 (411)
. ..++|+.|++++|.++.++.. .+++|++|++++|.+++..+..+..+++|+.|++++|.+++..+..+ ..+
T Consensus 96 ~-----~~~~L~~L~l~~n~l~~~~~~--~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 168 (317)
T 3o53_A 96 L-----VGPSIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168 (317)
T ss_dssp E-----ECTTCCEEECCSSCCSEEEEC--CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGT
T ss_pred c-----CCCCcCEEECCCCccCCcCcc--ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhcc
Confidence 3 348999999999999987654 36889999999999998778889999999999999999998777766 468
Q ss_pred CccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccC
Q 015202 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFK 240 (411)
Q Consensus 161 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~ 240 (411)
++|+.|++++|.+++..+ ...+++|+.|++++|.+++. |..+..+++|+.|++++|.++...+....++.+..+++.
T Consensus 169 ~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~ 245 (317)
T 3o53_A 169 DTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLR 245 (317)
T ss_dssp TTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECT
T ss_pred CcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEcc
Confidence 999999999999986633 34589999999999999965 445889999999999999999765555667888999999
Q ss_pred CCCcccCC
Q 015202 241 GNELLCGM 248 (411)
Q Consensus 241 ~n~~~c~~ 248 (411)
+|+..|+.
T Consensus 246 ~N~~~~~~ 253 (317)
T 3o53_A 246 GNGFHCGT 253 (317)
T ss_dssp TCCCBHHH
T ss_pred CCCccCcC
Confidence 99887753
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-27 Score=217.31 Aligned_cols=236 Identities=24% Similarity=0.246 Sum_probs=177.6
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+++..|..|.++++|++|++++|.+++..|..|.++++|++|++++|.++. +|..+. ++|++|++++|.+..
T Consensus 61 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~ 137 (332)
T 2ft3_A 61 LQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNLP--SSLVELRIHDNRIRK 137 (332)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCS-CCSSCC--TTCCEEECCSSCCCC
T ss_pred CCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCc-cCcccc--ccCCEEECCCCccCc
Confidence 56788888888888888899999999888888778888888888888888888773 333222 456666666666654
Q ss_pred cCCccccCCccCCeeecccccC-------------------------CccCccccCCCCCcEEEcCCCeeeecCCCCccC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQL-------------------------TYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGN 135 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l-------------------------~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 135 (411)
..+..+..+++|+.|++++|.+ +.+|..+. ++|++|++++|.+.+..+..+..
T Consensus 138 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~ 215 (332)
T 2ft3_A 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLR 215 (332)
T ss_dssp CCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTT
T ss_pred cCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcC
Confidence 4444455555555555555554 44443332 67888999999988777788999
Q ss_pred ccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhc------CC
Q 015202 136 LEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEK------LL 209 (411)
Q Consensus 136 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~------l~ 209 (411)
+++|+.|++++|.+++..+..+..+++|+.|++++|.++ .+|..+..+++|+.|++++|.+++..+..+.. .+
T Consensus 216 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 294 (332)
T 2ft3_A 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294 (332)
T ss_dssp CTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSC
T ss_pred CCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccc
Confidence 999999999999999888888999999999999999998 77888999999999999999999877766654 36
Q ss_pred CCCEEEcccCcccc--cCCCC-CCCCCccccccCCC
Q 015202 210 DLQHINVSFNKLEG--EIPRE-GPFRNFSIESFKGN 242 (411)
Q Consensus 210 ~L~~l~l~~n~l~~--~~~~~-~~~~~~~~~~~~~n 242 (411)
+|+.+++++|++.. ..|.. ..+..+..+++.+|
T Consensus 295 ~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp CBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred cccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 78999999999873 23221 23444555555444
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=224.88 Aligned_cols=233 Identities=21% Similarity=0.189 Sum_probs=137.3
Q ss_pred CCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccC
Q 015202 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFV 82 (411)
Q Consensus 3 ~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 82 (411)
+|.++..-+..|.++++|++|+|++|.+++..+..|.++++|++|++++|.+++..|..|.++++|++|++++|.++...
T Consensus 54 ~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~ 133 (390)
T 3o6n_A 54 NSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 133 (390)
T ss_dssp SCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCC
Confidence 34443333333566667777777777666655666666777777777777666666666666667777777777666444
Q ss_pred CccccCCccCCeeecccccCCccCc-cccCCCCCcEEEcCCCeeeecCCCCccCccC-------------------CCeE
Q 015202 83 PSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEV-------------------LVQI 142 (411)
Q Consensus 83 ~~~~~~l~~L~~L~l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-------------------L~~L 142 (411)
+..|..+++|+.|++++|.++.++. .+..+++|++|++++|.++... +..+++ |+.|
T Consensus 134 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~L~~L 210 (390)
T 3o6n_A 134 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEEL 210 (390)
T ss_dssp TTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEECCSSCSEE
T ss_pred HHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccccCCCCcceEE
Confidence 4445666677777777776665533 3556666777777766665321 122222 2233
Q ss_pred EccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCccc
Q 015202 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 143 ~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~ 222 (411)
++++|.+..... . ..++|+.|++++|.+++. ..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.++
T Consensus 211 ~l~~n~l~~~~~-~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 285 (390)
T 3o6n_A 211 DASHNSINVVRG-P--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285 (390)
T ss_dssp ECCSSCCCEEEC-C--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC
T ss_pred ECCCCeeeeccc-c--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc
Confidence 333333322111 1 123566666666666532 35666677777777777777666666777777777777777776
Q ss_pred ccCCCCCCCCCccccccCCCC
Q 015202 223 GEIPREGPFRNFSIESFKGNE 243 (411)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~n~ 243 (411)
+.......++.+..+++.+|.
T Consensus 286 ~~~~~~~~l~~L~~L~L~~n~ 306 (390)
T 3o6n_A 286 ALNLYGQPIPTLKVLDLSHNH 306 (390)
T ss_dssp EEECSSSCCTTCCEEECCSSC
T ss_pred ccCcccCCCCCCCEEECCCCc
Confidence 554444455566666666654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-27 Score=210.83 Aligned_cols=206 Identities=24% Similarity=0.226 Sum_probs=185.7
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
+.++++++.+++++++++. +|..+. +++++|+|++|.+++..+..|.++++|++|++++|.+++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 7889999999999999984 444442 6899999999999988888999999999999999999965443 7889999
Q ss_pred eeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccc
Q 015202 94 KLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173 (411)
Q Consensus 94 ~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l 173 (411)
.|++++|.++.+|..+..+++|+.|++++|.++...+..|.++++|+.|++++|.+++..+..|..+++|+.|++++|++
T Consensus 81 ~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 99999999999999899999999999999999977778899999999999999999988888899999999999999999
Q ss_pred cccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccC
Q 015202 174 QGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225 (411)
Q Consensus 174 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 225 (411)
++..+..+..+++|+.|++++|.++ .+|..+...++|+.+++++|++.|.+
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 9777778889999999999999999 56777778889999999999998765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=236.83 Aligned_cols=237 Identities=21% Similarity=0.175 Sum_probs=143.4
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
++|.+...-|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.++..
T Consensus 59 ~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l 138 (597)
T 3oja_B 59 KNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 138 (597)
T ss_dssp SSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred eCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCC
Confidence 44555554445567788888888888888777777788888888888888888777777777888888888888888765
Q ss_pred CCccccCCccCCeeecccccCCccCc-cccCCCCCcEEEcCCCeeeecCCCCccC----------------ccCCCeEEc
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGN----------------LEVLVQIDL 144 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~----------------l~~L~~L~l 144 (411)
.+..|..+++|+.|++++|.++.++. .+..+++|+.|++++|.+++.....+.+ ..+|+.|++
T Consensus 139 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~l 218 (597)
T 3oja_B 139 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDA 218 (597)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEEC
T ss_pred CHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeec
Confidence 55566778888888888888876544 5667788888888888776432221111 112222333
Q ss_pred cCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCccccc
Q 015202 145 SMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGE 224 (411)
Q Consensus 145 ~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~ 224 (411)
++|.++...+.. .++|+.|++++|.+++ +..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++.
T Consensus 219 s~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l 293 (597)
T 3oja_B 219 SHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 293 (597)
T ss_dssp CSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE
T ss_pred cCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC
Confidence 333322111111 1345555555555543 23445555555555555555555555555555555555555555554
Q ss_pred CCCCCCCCCccccccCCCC
Q 015202 225 IPREGPFRNFSIESFKGNE 243 (411)
Q Consensus 225 ~~~~~~~~~~~~~~~~~n~ 243 (411)
.+....++.+..+++.+|.
T Consensus 294 ~~~~~~l~~L~~L~Ls~N~ 312 (597)
T 3oja_B 294 NLYGQPIPTLKVLDLSHNH 312 (597)
T ss_dssp ECSSSCCTTCCEEECCSSC
T ss_pred CcccccCCCCcEEECCCCC
Confidence 3333334455555555443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-27 Score=240.84 Aligned_cols=231 Identities=19% Similarity=0.196 Sum_probs=195.7
Q ss_pred cCChhcc--cCCcCCceeecCcccccccchhhhCCCCCCeeecccCc-ccc-cCchhhhccc-------cCCeeeecCCc
Q 015202 9 SIPEEIN--NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQ-LEG-SIPYDLCRLA-------ALFQLDLGDNK 77 (411)
Q Consensus 9 ~~p~~~~--~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~-l~~-~~~~~~~~l~-------~L~~L~l~~n~ 77 (411)
.+|+.++ ++++|+.|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..+..++ +|++|+|++|.
T Consensus 480 ~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~ 559 (876)
T 4ecn_A 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559 (876)
T ss_dssp HTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSC
T ss_pred cCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCc
Confidence 5999987 99999999999999999999999999999999999998 888 7888887776 99999999999
Q ss_pred ccccCCc--cccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccC-CCeEEccCCeecccCC
Q 015202 78 LSGFVPS--CFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEV-LVQIDLSMNNFSGAIP 154 (411)
Q Consensus 78 l~~~~~~--~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~~~~~~~ 154 (411)
++ .+|. .+..+++|+.|++++|.++.+| .+..+++|+.|++++|.+. .+|..+..+++ |+.|++++|.++ .+|
T Consensus 560 L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp 635 (876)
T 4ecn_A 560 LE-EFPASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP 635 (876)
T ss_dssp CC-BCCCHHHHTTCTTCCEEECTTSCCCBCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCC
T ss_pred CC-ccCChhhhhcCCCCCEEECCCCCcccch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCc
Confidence 99 7888 8999999999999999999999 8889999999999999999 88888999999 999999999998 778
Q ss_pred CCccCCCc--cCeeecccccccccCCccc---c--CCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCC
Q 015202 155 TTIGGLKD--LQYLFLEYNRLQGSIPDFI---G--GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 155 ~~~~~~~~--L~~L~l~~n~l~~~~~~~~---~--~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 227 (411)
..+..++. |+.|++++|.+++.+|... . .+++|+.|++++|.++...+..+..+++|+.|++++|.++ .+|.
T Consensus 636 ~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~ 714 (876)
T 4ecn_A 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPE 714 (876)
T ss_dssp SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCT
T ss_pred hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccCh
Confidence 87776654 9999999999987665432 2 3458999999999998544444457889999999999988 4443
Q ss_pred -CCCC--------CCccccccCCCCc
Q 015202 228 -EGPF--------RNFSIESFKGNEL 244 (411)
Q Consensus 228 -~~~~--------~~~~~~~~~~n~~ 244 (411)
.... +.+..+++.+|..
T Consensus 715 ~~~~~~~~~l~nl~~L~~L~Ls~N~L 740 (876)
T 4ecn_A 715 NSLKPKDGNYKNTYLLTTIDLRFNKL 740 (876)
T ss_dssp TSSSCTTSCCTTGGGCCEEECCSSCC
T ss_pred HHhccccccccccCCccEEECCCCCC
Confidence 2221 1677777777743
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=205.11 Aligned_cols=207 Identities=25% Similarity=0.290 Sum_probs=184.0
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeec
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 97 (411)
.+.+.+++++++++. +|..+. ++|++|++++|.+++..+..|.++++|++|++++|.++...+..|..+++|+.|++
T Consensus 16 ~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 357899999999984 554443 68999999999999877778999999999999999999777777899999999999
Q ss_pred ccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccccccc
Q 015202 98 GSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176 (411)
Q Consensus 98 ~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 176 (411)
++|.++.+|.. +..+++|+.|++++|.++...+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|.+++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 99999988765 46899999999999999987788899999999999999999988777889999999999999999988
Q ss_pred CCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCC
Q 015202 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 177 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 227 (411)
.+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|++.+.++.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 778899999999999999999987777888999999999999999887753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-27 Score=229.29 Aligned_cols=86 Identities=19% Similarity=0.177 Sum_probs=54.4
Q ss_pred cCCCccCeeecccccccccCCccccCCCCCCEEeCCCCcccc--ccchhhhcCCCCCEEEcccCcccccCCC--CCCCCC
Q 015202 158 GGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG--AIPISLEKLLDLQHINVSFNKLEGEIPR--EGPFRN 233 (411)
Q Consensus 158 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~l~l~~n~l~~~~~~--~~~~~~ 233 (411)
..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++ .+|..+..+++|+.|++++|.+++.+|. ...+..
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 455667777777777766666666777777777777777765 3445666677777777777777664442 233455
Q ss_pred ccccccCCCC
Q 015202 234 FSIESFKGNE 243 (411)
Q Consensus 234 ~~~~~~~~n~ 243 (411)
++.+++.+|.
T Consensus 401 L~~L~Ls~N~ 410 (520)
T 2z7x_B 401 LLSLNMSSNI 410 (520)
T ss_dssp CCEEECCSSC
T ss_pred CCEEECcCCC
Confidence 5555555553
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=227.30 Aligned_cols=158 Identities=23% Similarity=0.216 Sum_probs=78.7
Q ss_pred CCccCCeeecccccCCc-cCccccCCCCCcEEEcCCCeeee--cCCCCccCccCCCeEEccCCeecccCC-CCccCCCcc
Q 015202 88 NLTNLRKLYLGSNQLTY-IPLTLWNLKYILYLNLSSNSFTI--PLPSEIGNLEVLVQIDLSMNNFSGAIP-TTIGGLKDL 163 (411)
Q Consensus 88 ~l~~L~~L~l~~n~l~~-~p~~~~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~~~~~~~-~~~~~~~~L 163 (411)
.+++|+.|++++|.++. +|..+..+++|+.|++++|.+.+ .+|..+..+++|+.|++++|.+++.+| ..+..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 33444444444444442 34444444555555555554443 223344445555555555555544222 234444555
Q ss_pred CeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCC-CCCCCCccccccCCC
Q 015202 164 QYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR-EGPFRNFSIESFKGN 242 (411)
Q Consensus 164 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~~~~~~~~~~~n 242 (411)
+.|++++|.+++..|..+. ++|+.|++++|.++ .+|..+..+++|+.|++++|.++...+. ...+..+..+++.+|
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N 478 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCC
Confidence 5555555555444433332 45566666666655 4455555666666666666666633222 234455566666666
Q ss_pred CcccCC
Q 015202 243 ELLCGM 248 (411)
Q Consensus 243 ~~~c~~ 248 (411)
+..|.+
T Consensus 479 ~~~c~c 484 (520)
T 2z7x_B 479 PWDCSC 484 (520)
T ss_dssp CBCCCH
T ss_pred CCcccC
Confidence 665543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-28 Score=223.18 Aligned_cols=217 Identities=20% Similarity=0.218 Sum_probs=155.9
Q ss_pred CCCCcc-cccCChhcc-------cCCcCCceeecCcccccccchhh--hCCCCCCeeecccCcccccCchhhhcc-----
Q 015202 1 MFNCNI-SGSIPEEIN-------NLTNLIAIYLGGNKLNGSISIAL--GKLQKLQLLGLEDNQLEGSIPYDLCRL----- 65 (411)
Q Consensus 1 l~~n~~-~~~~p~~~~-------~~~~L~~L~l~~n~~~~~~~~~~--~~l~~L~~L~l~~n~l~~~~~~~~~~l----- 65 (411)
|++|.+ .+.+|+.+. ++++|++|+|++|.+++..|..+ ..+++|++|++++|.+++. |..+..+
T Consensus 70 L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~ 148 (312)
T 1wwl_A 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLK 148 (312)
T ss_dssp CCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCC
T ss_pred cccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhc
Confidence 356666 456776655 67788888888888877777665 7788888888888887766 6666666
Q ss_pred ccCCeeeecCCcccccCCccccCCccCCeeecccccCCc---cCccc--cCCCCCcEEEcCCCeeee---cCCCCccCcc
Q 015202 66 AALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY---IPLTL--WNLKYILYLNLSSNSFTI---PLPSEIGNLE 137 (411)
Q Consensus 66 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---~p~~~--~~~~~L~~L~l~~n~l~~---~~~~~~~~l~ 137 (411)
++|++|++++|.+.+..+..+..+++|+.|++++|++.. ++..+ ..+++|++|++++|.+++ .....+..++
T Consensus 149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~ 228 (312)
T 1wwl_A 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228 (312)
T ss_dssp TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC
T ss_pred CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC
Confidence 778888888888877777778888888888888887653 33344 577788888888887762 1122344667
Q ss_pred CCCeEEccCCeecccCC-CCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEc
Q 015202 138 VLVQIDLSMNNFSGAIP-TTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINV 216 (411)
Q Consensus 138 ~L~~L~l~~n~~~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l 216 (411)
+|+.|++++|.+++..| ..+..+++|+.|++++|.++ .+|..+. ++|+.|++++|.+++. |. +..+++|+.|++
T Consensus 229 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L 303 (312)
T 1wwl_A 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSL 303 (312)
T ss_dssp CCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEEC
T ss_pred CCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEec
Confidence 78888888888876654 44556778888888888887 5555554 6788888888888765 44 777788888888
Q ss_pred ccCcccc
Q 015202 217 SFNKLEG 223 (411)
Q Consensus 217 ~~n~l~~ 223 (411)
++|++++
T Consensus 304 ~~N~l~~ 310 (312)
T 1wwl_A 304 KGNPFLD 310 (312)
T ss_dssp TTCTTTC
T ss_pred cCCCCCC
Confidence 8887764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=241.91 Aligned_cols=125 Identities=26% Similarity=0.217 Sum_probs=74.3
Q ss_pred CCCcccccCChhcccCCcCCceeecCccccccc-chhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSI-SIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
++|.|++..|..|.++++|++|+|++|...+.+ |..|.++++|++|+|++|.+.+..|+.|.++++|++|+|++|.+.+
T Consensus 32 s~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 111 (844)
T 3j0a_A 32 SFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD 111 (844)
T ss_dssp ESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSS
T ss_pred CCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCc
Confidence 566666666666666666666666666443333 5566666666666666666666666666666666666666666665
Q ss_pred cCCcc--ccCCccCCeeecccccCCccC--ccccCCCCCcEEEcCCCeee
Q 015202 81 FVPSC--FGNLTNLRKLYLGSNQLTYIP--LTLWNLKYILYLNLSSNSFT 126 (411)
Q Consensus 81 ~~~~~--~~~l~~L~~L~l~~n~l~~~p--~~~~~~~~L~~L~l~~n~l~ 126 (411)
..+.. +..+++|+.|++++|.++.++ ..+.++++|++|++++|.+.
T Consensus 112 ~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~ 161 (844)
T 3j0a_A 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161 (844)
T ss_dssp CCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred ccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence 44333 556666666666666655432 23455555555555555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=232.02 Aligned_cols=222 Identities=23% Similarity=0.143 Sum_probs=199.9
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccc--cchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGS--ISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 79 (411)
++|...+.+ .+..+++|++|++++|.+++. .+..+..+++|++|++++|.+++ +|..+..+++|++|++++|.+.
T Consensus 336 ~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~ 412 (606)
T 3vq2_A 336 TMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLK 412 (606)
T ss_dssp ESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEE
T ss_pred cCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccC
Confidence 455555555 567999999999999999876 38889999999999999999985 4578999999999999999999
Q ss_pred ccCC-ccccCCccCCeeecccccCCc-cCccccCCCCCcEEEcCCCeeee-cCCCCccCccCCCeEEccCCeecccCCCC
Q 015202 80 GFVP-SCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKYILYLNLSSNSFTI-PLPSEIGNLEVLVQIDLSMNNFSGAIPTT 156 (411)
Q Consensus 80 ~~~~-~~~~~l~~L~~L~l~~n~l~~-~p~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 156 (411)
+..| ..+..+++|+.|++++|.++. .|..+..+++|++|++++|.+.+ ..|..+..+++|+.|++++|.+++..|..
T Consensus 413 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 492 (606)
T 3vq2_A 413 RVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492 (606)
T ss_dssp STTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred CccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhh
Confidence 8877 689999999999999999984 67778899999999999999987 47889999999999999999999999999
Q ss_pred ccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCC-CCCEEEcccCcccccCCC
Q 015202 157 IGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLL-DLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 157 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~l~l~~n~l~~~~~~ 227 (411)
+..+++|+.|++++|++++..|..+..+++|+.|++++|.++ .+|..+..++ +|+.+++++|++.|.++.
T Consensus 493 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred hcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999999999999999888999999999999999999999 5666688887 599999999999998874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=228.37 Aligned_cols=158 Identities=24% Similarity=0.254 Sum_probs=81.5
Q ss_pred CCccCCeeecccccCCc-cCccccCCCCCcEEEcCCCeeee--cCCCCccCccCCCeEEccCCeecc-cCCCCccCCCcc
Q 015202 88 NLTNLRKLYLGSNQLTY-IPLTLWNLKYILYLNLSSNSFTI--PLPSEIGNLEVLVQIDLSMNNFSG-AIPTTIGGLKDL 163 (411)
Q Consensus 88 ~l~~L~~L~l~~n~l~~-~p~~~~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~~~L 163 (411)
.+++|+.|++++|.++. +|..+..+++|+.|++++|.+++ ..|..+.++++|+.|++++|.+++ ..+..+..+++|
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 34455555555555543 34444555555555555555543 122344555555555555555554 222234455555
Q ss_pred CeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCC-CCCCCCccccccCCC
Q 015202 164 QYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR-EGPFRNFSIESFKGN 242 (411)
Q Consensus 164 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~-~~~~~~~~~~~~~~n 242 (411)
+.|++++|.+++..|..+. ++|+.|++++|.++ .+|..+..+++|+.|++++|.++...+. ...++.+..+++.+|
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N 507 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSC
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCC
Confidence 5555555555444333322 45666666666665 3444444666666666666666643332 334555566666666
Q ss_pred CcccCC
Q 015202 243 ELLCGM 248 (411)
Q Consensus 243 ~~~c~~ 248 (411)
++.|.+
T Consensus 508 ~~~c~c 513 (562)
T 3a79_B 508 PWDCTC 513 (562)
T ss_dssp CBCCCH
T ss_pred CcCCCc
Confidence 666644
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=229.95 Aligned_cols=209 Identities=21% Similarity=0.234 Sum_probs=185.0
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|.+++..|..|.++++|++|+|++|.+++..| |..+++|++|+|++|.+++..+ .++|++|++++|.+++
T Consensus 41 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~ 113 (487)
T 3oja_A 41 LSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISR 113 (487)
T ss_dssp CCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCC
T ss_pred eeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCC
Confidence 57899999989999999999999999999997776 8999999999999999986543 3899999999999997
Q ss_pred cCCccccCCccCCeeecccccCCcc-CccccCCCCCcEEEcCCCeeeecCCCCcc-CccCCCeEEccCCeecccCCCCcc
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTIPLPSEIG-NLEVLVQIDLSMNNFSGAIPTTIG 158 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~-p~~~~~~~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~~~~~~~~~~~ 158 (411)
..+. .+++|+.|++++|.++.+ |..+..+++|+.|++++|.+++..|..+. .+++|+.|+|++|.+++..+. .
T Consensus 114 ~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~--~ 188 (487)
T 3oja_A 114 VSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ--V 188 (487)
T ss_dssp EEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC--C
T ss_pred CCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccccc--c
Confidence 6554 357899999999999976 55778899999999999999988888876 789999999999999977443 3
Q ss_pred CCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccc
Q 015202 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 159 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
.+++|+.|++++|.+++..|. +..+++|+.|++++|.+++ +|..+..+++|+.+++++|++.+
T Consensus 189 ~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 189 VFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred cCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 589999999999999976554 8899999999999999995 67778899999999999999984
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=229.08 Aligned_cols=243 Identities=23% Similarity=0.210 Sum_probs=193.7
Q ss_pred cccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhh-------------------hcc
Q 015202 5 NISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL-------------------CRL 65 (411)
Q Consensus 5 ~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-------------------~~l 65 (411)
.+.+.+|..+.++++|+.|++++|.+. .+|..+..+ +|++|++++|.+.......+ ..+
T Consensus 269 ~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~ 346 (570)
T 2z63_A 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346 (570)
T ss_dssp EEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBC
T ss_pred hhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCcccccccCEEeCcCCccccccccccC
Confidence 566777888888888888888888877 455556665 66666666666552211111 456
Q ss_pred ccCCeeeecCCcccccC--CccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCC-CCccCccCCCeE
Q 015202 66 AALFQLDLGDNKLSGFV--PSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLP-SEIGNLEVLVQI 142 (411)
Q Consensus 66 ~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L 142 (411)
++|++|++++|.+++.. +..+..+++|+.|++++|.++.++..+..+++|+.|++++|.+.+..+ ..+..+++|+.|
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 426 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence 77888888888777543 566778888888888888888887778888999999999998886655 467888999999
Q ss_pred EccCCeecccCCCCccCCCccCeeeccccccc-ccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcc
Q 015202 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ-GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221 (411)
Q Consensus 143 ~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l 221 (411)
++++|.+.+..|..+..+++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+
T Consensus 427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 506 (570)
T 2z63_A 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506 (570)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcC
Confidence 99999998888888889999999999999987 46788889999999999999999988888899999999999999999
Q ss_pred cccCCCC-CCCCCccccccCCCCcccCCC
Q 015202 222 EGEIPRE-GPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 222 ~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 249 (411)
++..+.. ..++.+..+++.+|+..|.++
T Consensus 507 ~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 507 KSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 8876653 467788888999999888765
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-26 Score=226.47 Aligned_cols=85 Identities=18% Similarity=0.223 Sum_probs=45.9
Q ss_pred cCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccc--cchhhhcCCCCCEEEcccCcccccCCCC--CCCCC
Q 015202 158 GGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA--IPISLEKLLDLQHINVSFNKLEGEIPRE--GPFRN 233 (411)
Q Consensus 158 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~l~l~~n~l~~~~~~~--~~~~~ 233 (411)
..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++. .|..+..+++|+.|++++|.+++.+|.. ..+..
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 3445566666666666655555566666666666666666542 2344555666666666666665533321 22344
Q ss_pred ccccccCCC
Q 015202 234 FSIESFKGN 242 (411)
Q Consensus 234 ~~~~~~~~n 242 (411)
+..+++.+|
T Consensus 430 L~~L~l~~n 438 (562)
T 3a79_B 430 ILVLNLSSN 438 (562)
T ss_dssp CCEEECCSS
T ss_pred CCEEECCCC
Confidence 444444444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-26 Score=205.35 Aligned_cols=201 Identities=20% Similarity=0.204 Sum_probs=182.5
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+++..|..|.++++|++|++++|.+++..+..|.++++|++|++++|.+++..+..|.++++|++|++++|.+.+
T Consensus 35 ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 114 (276)
T 2z62_A 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114 (276)
T ss_dssp CTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC
T ss_pred CCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccc
Confidence 57899999888899999999999999999998888899999999999999999998888899999999999999999998
Q ss_pred cCCccccCCccCCeeecccccCCc--cCccccCCCCCcEEEcCCCeeeecCCCCccCccCCC----eEEccCCeecccCC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTY--IPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLV----QIDLSMNNFSGAIP 154 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~--~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~----~L~l~~n~~~~~~~ 154 (411)
..+..+..+++|+.|++++|.++. +|..+..+++|+.|++++|.+++..+..+..+.+|+ .|++++|.+++..+
T Consensus 115 ~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~ 194 (276)
T 2z62_A 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194 (276)
T ss_dssp STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECT
T ss_pred cCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCc
Confidence 777789999999999999999986 688899999999999999999987777888877777 89999999997777
Q ss_pred CCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccc
Q 015202 155 TTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIP 202 (411)
Q Consensus 155 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 202 (411)
..+.. .+|+.|++++|.+++..+..+..+++|+.|++++|.+++..+
T Consensus 195 ~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 195 GAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp TSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 66654 589999999999998777778999999999999999986543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=228.27 Aligned_cols=135 Identities=24% Similarity=0.232 Sum_probs=116.1
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|++++|.+++..+..|.++++|++|++++|.+++
T Consensus 33 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 112 (549)
T 2z81_A 33 LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT 112 (549)
T ss_dssp CCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSS
T ss_pred CcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccc
Confidence 57899999989999999999999999999998888899999999999999999998887779999999999999999986
Q ss_pred c-CCccccCCccCCeeeccccc-CCccC-ccccCCCCCcEEEcCCCeeeecCCCCccC
Q 015202 81 F-VPSCFGNLTNLRKLYLGSNQ-LTYIP-LTLWNLKYILYLNLSSNSFTIPLPSEIGN 135 (411)
Q Consensus 81 ~-~~~~~~~l~~L~~L~l~~n~-l~~~p-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 135 (411)
. .|..+..+++|+.|++++|. +..+| ..+..+++|++|++++|.+.+..|..+..
T Consensus 113 ~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 170 (549)
T 2z81_A 113 LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170 (549)
T ss_dssp SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred cchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence 3 56778899999999999998 56776 46778888888888888888777766554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-25 Score=202.99 Aligned_cols=207 Identities=26% Similarity=0.279 Sum_probs=186.1
Q ss_pred hhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCc
Q 015202 37 ALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYIL 116 (411)
Q Consensus 37 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~ 116 (411)
.+.++++++++++++|.++. +|..+. +++++|++++|.+++..+..|..+++|+.|++++|.++.++.. ..+++|+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~ 80 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLG 80 (290)
T ss_dssp EEECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCC
T ss_pred cccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCC
Confidence 46789999999999999984 454443 6899999999999988888999999999999999999988765 7899999
Q ss_pred EEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCc
Q 015202 117 YLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNN 196 (411)
Q Consensus 117 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~ 196 (411)
.|++++|.+. .+|..+..+++|+.|++++|.+++..+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|.
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999998 788889999999999999999998888999999999999999999998888888999999999999999
Q ss_pred cccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCcccCC
Q 015202 197 LSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGM 248 (411)
Q Consensus 197 l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 248 (411)
+++..+..+..+++|+.|++++|.++...+.......+..+++.+||+.|.+
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 9987777788999999999999999966555566677888999999999976
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=199.14 Aligned_cols=204 Identities=18% Similarity=0.194 Sum_probs=166.2
Q ss_pred ccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCc-ccccCchhhhccccCCeeeecC-CcccccCCcc
Q 015202 8 GSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQ-LEGSIPYDLCRLAALFQLDLGD-NKLSGFVPSC 85 (411)
Q Consensus 8 ~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~ 85 (411)
..+|. +. ++|+.|++++|++++..+..|.++++|++|++++|. ++...+..|.++++|++|++++ |.++...+..
T Consensus 24 ~~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~ 100 (239)
T 2xwt_C 24 QRIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA 100 (239)
T ss_dssp SSCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTS
T ss_pred cccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHH
Confidence 45666 43 478899999999987777788899999999999996 8877777888899999999998 8888777778
Q ss_pred ccCCccCCeeecccccCCccCccccCCCCCc---EEEcCCC-eeeecCCCCccCccCCC-eEEccCCeecccCCCCccCC
Q 015202 86 FGNLTNLRKLYLGSNQLTYIPLTLWNLKYIL---YLNLSSN-SFTIPLPSEIGNLEVLV-QIDLSMNNFSGAIPTTIGGL 160 (411)
Q Consensus 86 ~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~---~L~l~~n-~l~~~~~~~~~~l~~L~-~L~l~~n~~~~~~~~~~~~~ 160 (411)
|..+++|+.|++++|.++.+|. +..+++|+ .|++++| .+....+..|.++++|+ .|++++|.++...+..|..
T Consensus 101 f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~- 178 (239)
T 2xwt_C 101 LKELPLLKFLGIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG- 178 (239)
T ss_dssp EECCTTCCEEEEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-
T ss_pred hCCCCCCCEEeCCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-
Confidence 8889999999999999988886 77778887 8999988 88876677788888998 9999999888555555655
Q ss_pred CccCeeeccccc-ccccCCccccCC-CCCCEEeCCCCccccccchhhhcCCCCCEEEcccC
Q 015202 161 KDLQYLFLEYNR-LQGSIPDFIGGL-INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219 (411)
Q Consensus 161 ~~L~~L~l~~n~-l~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n 219 (411)
++|+.|++++|. +++..+..|..+ ++|+.|++++|.+++..+. .+++|+.|+++++
T Consensus 179 ~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 179 TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 789999999984 887777788888 8899999999888854443 5677888888765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=203.44 Aligned_cols=204 Identities=25% Similarity=0.302 Sum_probs=132.8
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
+..+++|+.|++++|.++. + ..+..+++|++|++++|.+++. +.+..+++|++|++++|.+++..+..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 3456667777777776652 2 2466677777777777766642 3566667777777777777666555666677777
Q ss_pred eeecccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccc
Q 015202 94 KLYLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNR 172 (411)
Q Consensus 94 ~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~ 172 (411)
+|++++|+++.++.. +..+++|++|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 777777777665544 4566677777777776665555556666777777777777766666666666777777777777
Q ss_pred ccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC
Q 015202 173 LQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228 (411)
Q Consensus 173 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~ 228 (411)
+++..+..+..+++|+.|++++|.+.+. ++.|+.+++..|.++|.+|..
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 7666666666667777777777766543 345666666667666666643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-25 Score=198.87 Aligned_cols=196 Identities=29% Similarity=0.316 Sum_probs=175.9
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
++|.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|++++|.++...+..|.++++|++|++++|.+...
T Consensus 24 ~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~ 100 (270)
T 2o6q_A 24 SSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQAL 100 (270)
T ss_dssp TTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCC
T ss_pred cCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcC
Confidence 456666 4777664 6899999999999988888999999999999999999977777789999999999999999987
Q ss_pred CCccccCCccCCeeecccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCC
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 160 (411)
.+..|..+++|+.|++++|.++.++.. +..+++|++|++++|.+....+..|..+++|+.|++++|.+++..+..|..+
T Consensus 101 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 180 (270)
T 2o6q_A 101 PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKL 180 (270)
T ss_dssp CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred CHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccC
Confidence 778889999999999999999988754 5789999999999999997666778999999999999999998888889999
Q ss_pred CccCeeecccccccccCCccccCCCCCCEEeCCCCccccc
Q 015202 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 161 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
++|+.|++++|.+++..+..+..+++|+.|++++|.+...
T Consensus 181 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 9999999999999987777889999999999999998744
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=222.88 Aligned_cols=210 Identities=23% Similarity=0.299 Sum_probs=182.8
Q ss_pred cCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccC--chhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSI--PYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
.+++|+.|++++|.+.+..+. ..+++|++|++++|.+++.. +..+..+++|++|++++|.+.+..+. +..+++|+
T Consensus 323 ~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~ 399 (570)
T 2z63_A 323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLE 399 (570)
T ss_dssp BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCC
T ss_pred cccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCC
Confidence 344455555555544433332 67899999999999988654 77899999999999999999965544 99999999
Q ss_pred eeecccccCCccCc--cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeec-ccCCCCccCCCccCeeeccc
Q 015202 94 KLYLGSNQLTYIPL--TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS-GAIPTTIGGLKDLQYLFLEY 170 (411)
Q Consensus 94 ~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~L~l~~ 170 (411)
.|++++|.++..+. .+..+++|+.|++++|.+.+..|..+.++++|+.|++++|.++ +..|..+..+++|+.|++++
T Consensus 400 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~ 479 (570)
T 2z63_A 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479 (570)
T ss_dssp EEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred EEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCC
Confidence 99999999986643 5778999999999999999889999999999999999999997 57899999999999999999
Q ss_pred ccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC
Q 015202 171 NRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE 228 (411)
Q Consensus 171 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~ 228 (411)
|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.+++++|+++|.+|..
T Consensus 480 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 9999888999999999999999999999988888999999999999999999998864
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-26 Score=208.45 Aligned_cols=209 Identities=21% Similarity=0.212 Sum_probs=181.9
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|.+++..|..|.++++|++|+|++|.+++..+ +..+++|++|++++|.+++.. ..++|++|++++|.+++
T Consensus 41 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~ 113 (317)
T 3o53_A 41 LSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISR 113 (317)
T ss_dssp CTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSE
T ss_pred CcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCC
Confidence 57899999888999999999999999999987665 899999999999999998543 34899999999999997
Q ss_pred cCCccccCCccCCeeecccccCCccCc-cccCCCCCcEEEcCCCeeeecCCCCcc-CccCCCeEEccCCeecccCCCCcc
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIG-NLEVLVQIDLSMNNFSGAIPTTIG 158 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~~~~~~~~~~~ 158 (411)
..+.. +++|+.|++++|.++.++. .+..+++|+.|++++|.+.+..+..+. .+++|+.|++++|.+++..+. .
T Consensus 114 ~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~ 188 (317)
T 3o53_A 114 VSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ--V 188 (317)
T ss_dssp EEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC--C
T ss_pred cCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccc--c
Confidence 65544 5789999999999997754 677899999999999999987777664 789999999999999866333 3
Q ss_pred CCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccc
Q 015202 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 159 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
.+++|+.|++++|.+++..+ .+..+++|+.|++++|.++ .+|..+..+++|+.+++++|++.+
T Consensus 189 ~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 189 VFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp CCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred ccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 48999999999999996544 5889999999999999999 467788899999999999999984
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-25 Score=205.63 Aligned_cols=229 Identities=25% Similarity=0.348 Sum_probs=129.4
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+++ + +.+.++++|++|++++|.+++..+ +.++++|++|++++|.....++ .+..+++|++|++++|.+..
T Consensus 95 L~~n~i~~-~-~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~ 169 (347)
T 4fmz_A 95 IGTNKITD-I-SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD 169 (347)
T ss_dssp CCSSCCCC-C-GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCC
T ss_pred ccCCcccC-c-hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCC
Confidence 46777776 3 458888899999999888875443 7788888888888885443333 36777777777777777764
Q ss_pred cCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCC------
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIP------ 154 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~------ 154 (411)
..+ +..+++|+.|++++|.++.++. +..+++|+.|++++|.+....+ +..+++|+.|++++|.+++..+
T Consensus 170 ~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~ 244 (347)
T 4fmz_A 170 VTP--IANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQ 244 (347)
T ss_dssp CGG--GGGCTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTT
T ss_pred chh--hccCCCCCEEEccCCccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCC
Confidence 332 6667777777777777766554 4445555555555555442222 4444455555555554443322
Q ss_pred --------------CCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCc
Q 015202 155 --------------TTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220 (411)
Q Consensus 155 --------------~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~ 220 (411)
..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+..+..+++|+.|++++|+
T Consensus 245 L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 245 LTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp CCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred CCEEECCCCccCCChhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence 2334444444445444444432 224444455555555555544444444555555555555555
Q ss_pred ccccCCCCCCCCCccccccCCC
Q 015202 221 LEGEIPREGPFRNFSIESFKGN 242 (411)
Q Consensus 221 l~~~~~~~~~~~~~~~~~~~~n 242 (411)
+++..| ...++.+..+++.+|
T Consensus 323 l~~~~~-~~~l~~L~~L~l~~N 343 (347)
T 4fmz_A 323 ITDIRP-LASLSKMDSADFANQ 343 (347)
T ss_dssp CCCCGG-GGGCTTCSEESSSCC
T ss_pred cccccC-hhhhhccceeehhhh
Confidence 544333 233444444444444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-25 Score=197.29 Aligned_cols=206 Identities=24% Similarity=0.278 Sum_probs=183.4
Q ss_pred cCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCee
Q 015202 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKL 95 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 95 (411)
.+.++..+++..+.+.... ....+++|+.|++++|.++.. +.+..+++|++|++++|.+.+. ..+..+++|++|
T Consensus 17 ~~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 90 (272)
T 3rfs_A 17 AFAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYL 90 (272)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEE
T ss_pred hHHHHHHHHhcCccccccc--ccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEE
Confidence 4456778888888876544 467899999999999998843 3588999999999999999863 478899999999
Q ss_pred ecccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccccc
Q 015202 96 YLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ 174 (411)
Q Consensus 96 ~l~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~ 174 (411)
++++|.++.++.. +..+++|++|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.++
T Consensus 91 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 170 (272)
T 3rfs_A 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC
Confidence 9999999988765 578999999999999999777777899999999999999999888888899999999999999999
Q ss_pred ccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCC
Q 015202 175 GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 175 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 227 (411)
+..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++.|.+|.
T Consensus 171 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 171 SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 88888889999999999999999998888899999999999999999988774
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=216.71 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=199.2
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
|++|+|++..|++|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|.++.
T Consensus 83 Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~ 162 (635)
T 4g8a_A 83 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 162 (635)
T ss_dssp CTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcccc
Confidence 57889998888889999999999999999988778889999999999999999987777778889999999999998875
Q ss_pred c-CCccccCCccCCeeecccccCCccCcc---------------------------------------------------
Q 015202 81 F-VPSCFGNLTNLRKLYLGSNQLTYIPLT--------------------------------------------------- 108 (411)
Q Consensus 81 ~-~~~~~~~l~~L~~L~l~~n~l~~~p~~--------------------------------------------------- 108 (411)
. .|..+..+++|+.|++++|+++.++..
T Consensus 163 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~ 242 (635)
T 4g8a_A 163 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMK 242 (635)
T ss_dssp CCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHH
T ss_pred CCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccc
Confidence 3 466777888888888877765422100
Q ss_pred --------------------------------------------------------------------------------
Q 015202 109 -------------------------------------------------------------------------------- 108 (411)
Q Consensus 109 -------------------------------------------------------------------------------- 108 (411)
T Consensus 243 ~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~ 322 (635)
T 4g8a_A 243 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK 322 (635)
T ss_dssp HHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG
T ss_pred hhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------ccCCCCCcEEEcCCCee-------------------
Q 015202 109 --------------------------------------------LWNLKYILYLNLSSNSF------------------- 125 (411)
Q Consensus 109 --------------------------------------------~~~~~~L~~L~l~~n~l------------------- 125 (411)
...+++|+.|+++.|.+
T Consensus 323 ~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L 402 (635)
T 4g8a_A 323 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYL 402 (635)
T ss_dssp GGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEE
T ss_pred ccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhh
Confidence 00122334444433322
Q ss_pred -------------------------------------------------------eecCCCCccCccCCCeEEccCCee-
Q 015202 126 -------------------------------------------------------TIPLPSEIGNLEVLVQIDLSMNNF- 149 (411)
Q Consensus 126 -------------------------------------------------------~~~~~~~~~~l~~L~~L~l~~n~~- 149 (411)
.+..+..+..++.|+.|++++|.+
T Consensus 403 ~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~ 482 (635)
T 4g8a_A 403 DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 482 (635)
T ss_dssp ECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEG
T ss_pred hccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccc
Confidence 122233344566788999999975
Q ss_pred cccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCC
Q 015202 150 SGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREG 229 (411)
Q Consensus 150 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~ 229 (411)
.+..|..|..+++|+.|+|++|++++..|..|.++++|+.|++++|.+++..+..+..+++|+.|++++|.+++..|...
T Consensus 483 ~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 562 (635)
T 4g8a_A 483 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 562 (635)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCT
T ss_pred cccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHH
Confidence 44678899999999999999999999999999999999999999999999999999999999999999999999888653
Q ss_pred -CC-CCccccccCCCCcccCCC
Q 015202 230 -PF-RNFSIESFKGNELLCGMP 249 (411)
Q Consensus 230 -~~-~~~~~~~~~~n~~~c~~~ 249 (411)
.+ .+++.+++.+||+.|+|.
T Consensus 563 ~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 563 QHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TCCCTTCCEEECTTCCBCCSGG
T ss_pred HhhhCcCCEEEeeCCCCcccCC
Confidence 33 578899999999999875
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=198.10 Aligned_cols=195 Identities=26% Similarity=0.349 Sum_probs=171.2
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
+.++++|+.|++++|.++. ++ .+..+++|++|++++|.+++..+ +..+++|++|++++|.+++. ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 4578899999999999974 44 68899999999999999986544 89999999999999999864 4688999999
Q ss_pred eeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccc
Q 015202 94 KLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173 (411)
Q Consensus 94 ~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l 173 (411)
.|++++|.++.++. +..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+
T Consensus 111 ~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 111 TLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185 (308)
T ss_dssp EEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EEECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence 99999999998875 8899999999999999985433 8899999999999999986544 88999999999999999
Q ss_pred cccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccc
Q 015202 174 QGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 174 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++
T Consensus 186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 86544 7889999999999999997653 7899999999999999975
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-25 Score=218.33 Aligned_cols=163 Identities=22% Similarity=0.275 Sum_probs=140.1
Q ss_pred CCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccC
Q 015202 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFV 82 (411)
Q Consensus 3 ~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 82 (411)
+|.++ .+|+.+. ++|++|+|++|++++..|..|.++++|++|++++|.+++..|+.|.++++|++|++++|.+++..
T Consensus 14 ~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 90 (549)
T 2z81_A 14 SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90 (549)
T ss_dssp TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCC
T ss_pred CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccC
Confidence 44444 5777664 79999999999999888899999999999999999999888889999999999999999999877
Q ss_pred CccccCCccCCeeecccccCCc--cCccccCCCCCcEEEcCCCeeeecC-CCCccCccCCCeEEccCCeecccCCCCccC
Q 015202 83 PSCFGNLTNLRKLYLGSNQLTY--IPLTLWNLKYILYLNLSSNSFTIPL-PSEIGNLEVLVQIDLSMNNFSGAIPTTIGG 159 (411)
Q Consensus 83 ~~~~~~l~~L~~L~l~~n~l~~--~p~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 159 (411)
+..|..+++|++|++++|.++. +|..+..+++|++|++++|.+.+.+ +..+.++++|+.|++++|.+++..|..+..
T Consensus 91 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 170 (549)
T 2z81_A 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170 (549)
T ss_dssp HHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred HHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence 7779999999999999999984 4678889999999999999844344 468999999999999999999888887765
Q ss_pred CCccCeeec
Q 015202 160 LKDLQYLFL 168 (411)
Q Consensus 160 ~~~L~~L~l 168 (411)
+++|+.|++
T Consensus 171 l~~L~~L~l 179 (549)
T 2z81_A 171 IRDIHHLTL 179 (549)
T ss_dssp CSEEEEEEE
T ss_pred cccCceEec
Confidence 444433333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=200.64 Aligned_cols=196 Identities=27% Similarity=0.425 Sum_probs=153.9
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
+.++++|+.|++++|.+.+..+ +..+++|++|++++|.+.+..+ +..+++|++|++++|.+.+..+ +..+++|+
T Consensus 151 ~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~ 224 (347)
T 4fmz_A 151 LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLN 224 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCC
T ss_pred hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCC
Confidence 5555566666666665553332 5666666666666666664322 5666777777777777664433 77888999
Q ss_pred eeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccc
Q 015202 94 KLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173 (411)
Q Consensus 94 ~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l 173 (411)
.|++++|.++.++. +..+++|++|++++|.+... ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+
T Consensus 225 ~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 225 SLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp EEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred EEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcC
Confidence 99999999998876 88899999999999998843 4688899999999999999865 4578899999999999999
Q ss_pred cccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCccc
Q 015202 174 QGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 174 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~ 222 (411)
++..+..+..+++|+.|++++|.+++..| +..+++|+.+++++|+++
T Consensus 300 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 98888889999999999999999997766 889999999999999885
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-24 Score=206.26 Aligned_cols=206 Identities=30% Similarity=0.426 Sum_probs=90.1
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
++|.+++..| +.++++|++|++++|.+++..+ +.++++|++|++++|.+++..+ +..+++|++|++++|.+.+.
T Consensus 76 s~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 149 (466)
T 1o6v_A 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI 149 (466)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC
T ss_pred CCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC
Confidence 4444444322 5555555555555555543333 5555555555555555553322 45555555555555554432
Q ss_pred CC-------------------ccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeE
Q 015202 82 VP-------------------SCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQI 142 (411)
Q Consensus 82 ~~-------------------~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 142 (411)
.+ ..+..+++|+.|++++|.++.++ .+..+++|+.|++++|.+.+..+ ++.+++|+.|
T Consensus 150 ~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 226 (466)
T 1o6v_A 150 SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQISDITP--LGILTNLDEL 226 (466)
T ss_dssp GGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred hhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCCh-hhccCCCCCEEEecCCccccccc--ccccCCCCEE
Confidence 10 11333444455555555544443 23444555555555554443222 3334444444
Q ss_pred EccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCccc
Q 015202 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 143 ~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~ 222 (411)
++++|.+++. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.++
T Consensus 227 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~ 300 (466)
T 1o6v_A 227 SLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE 300 (466)
T ss_dssp ECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS
T ss_pred ECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc
Confidence 4444444322 123334444444444444433222 3334444444444444433222 333344444444444333
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-23 Score=200.99 Aligned_cols=201 Identities=24% Similarity=0.232 Sum_probs=145.8
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+++. | .+.++++|++|++++|++++. | +.++++|++|++++|.+++. + +.++++|++|++++|.+++
T Consensus 49 Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~ 120 (457)
T 3bz5_A 49 CHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK 120 (457)
T ss_dssp CCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC
T ss_pred ccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe
Confidence 456777764 5 577777777777777777754 3 67777777777777777754 2 6677777777777777775
Q ss_pred cCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 160 (411)
. + +..+++|+.|++++|+++.++ +..+++|++|++++|...+.+ .+..+++|+.|++++|.+++. | +..+
T Consensus 121 l-~--~~~l~~L~~L~l~~N~l~~l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l 190 (457)
T 3bz5_A 121 L-D--VSQNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQN 190 (457)
T ss_dssp C-C--CTTCTTCCEEECTTSCCSCCC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTC
T ss_pred e-c--CCCCCcCCEEECCCCccceec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccC
Confidence 3 3 677777777777777777764 566777777777777544344 366777888888888888753 3 6677
Q ss_pred CccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccC
Q 015202 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225 (411)
Q Consensus 161 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 225 (411)
++|+.|++++|.+++. .+..+++|+.|++++|.+++ +| +..+++|+.|++++|.+++..
T Consensus 191 ~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~ 249 (457)
T 3bz5_A 191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD 249 (457)
T ss_dssp TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC
T ss_pred CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC
Confidence 7888888888888754 26777888888888888886 44 667788888888888887654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.5e-24 Score=204.87 Aligned_cols=227 Identities=30% Similarity=0.410 Sum_probs=150.3
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCc-------------------hh
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP-------------------YD 61 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-------------------~~ 61 (411)
+++|.+++..| +.++++|++|++++|.+++..+ +.++++|++|++++|.+.+... ..
T Consensus 97 l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~ 172 (466)
T 1o6v_A 97 MNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKP 172 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGG
T ss_pred CCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchh
Confidence 45677776554 7788888888888888775443 7778888888888777664311 12
Q ss_pred hhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCe
Q 015202 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQ 141 (411)
Q Consensus 62 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 141 (411)
+.++++|++|++++|.+... ..+..+++|+.|++++|.++.++. +..+++|+.|++++|.+... ..+..+++|+.
T Consensus 173 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 247 (466)
T 1o6v_A 173 LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI--GTLASLTNLTD 247 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccc--hhhhcCCCCCE
Confidence 55667778888888877643 346777788888888887776654 55677777777777776632 34666777777
Q ss_pred EEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcc
Q 015202 142 IDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221 (411)
Q Consensus 142 L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l 221 (411)
|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+
T Consensus 248 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l 321 (466)
T 1o6v_A 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI 321 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCC
T ss_pred EECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcC
Confidence 7777777765544 5666777777777777764433 5666677777777777665433 55666677777777766
Q ss_pred cccCCCCCCCCCccccccCCCC
Q 015202 222 EGEIPREGPFRNFSIESFKGNE 243 (411)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~n~ 243 (411)
++..| ...++.++.+++.+|.
T Consensus 322 ~~~~~-~~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 322 SDISP-VSSLTKLQRLFFYNNK 342 (466)
T ss_dssp SCCGG-GGGCTTCCEEECCSSC
T ss_pred CCchh-hccCccCCEeECCCCc
Confidence 65544 3344555555555553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-25 Score=199.66 Aligned_cols=221 Identities=18% Similarity=0.163 Sum_probs=117.7
Q ss_pred CCceeecCcccccccc---hhhhCCCCCCeeecccCcccccCchhh--hccccCCeeeecCCcccccCC----ccccCCc
Q 015202 20 LIAIYLGGNKLNGSIS---IALGKLQKLQLLGLEDNQLEGSIPYDL--CRLAALFQLDLGDNKLSGFVP----SCFGNLT 90 (411)
Q Consensus 20 L~~L~l~~n~~~~~~~---~~~~~l~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~n~l~~~~~----~~~~~l~ 90 (411)
++.|.+.++.++...- ..+..+++|++|++++|.+.+..|..+ ..+++|++|++++|.+.+..+ ..+..++
T Consensus 66 l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~ 145 (310)
T 4glp_A 66 VRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKP 145 (310)
T ss_dssp CCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCS
T ss_pred eeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhcc
Confidence 4555555555432110 012234556666666666665555555 556666666666666654333 2233456
Q ss_pred cCCeeecccccCCccC-ccccCCCCCcEEEcCCCeeeec--C--CCCccCccCCCeEEccCCeecccCC--C-CccCCCc
Q 015202 91 NLRKLYLGSNQLTYIP-LTLWNLKYILYLNLSSNSFTIP--L--PSEIGNLEVLVQIDLSMNNFSGAIP--T-TIGGLKD 162 (411)
Q Consensus 91 ~L~~L~l~~n~l~~~p-~~~~~~~~L~~L~l~~n~l~~~--~--~~~~~~l~~L~~L~l~~n~~~~~~~--~-~~~~~~~ 162 (411)
+|+.|++++|.++.++ ..+..+++|++|++++|.+.+. + +..+..+++|++|++++|.++...+ . .+..+++
T Consensus 146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~ 225 (310)
T 4glp_A 146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQ 225 (310)
T ss_dssp CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCC
T ss_pred CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCC
Confidence 6666666666665444 3445566666666666654431 1 2223455666666666666642111 1 2344566
Q ss_pred cCeeecccccccccCCccccCC---CCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCcccccc
Q 015202 163 LQYLFLEYNRLQGSIPDFIGGL---INLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESF 239 (411)
Q Consensus 163 L~~L~l~~n~l~~~~~~~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~ 239 (411)
|+.|++++|.+++..|..+..+ ++|++|++++|.++ .+|..+. ++|+.|++++|.+++. |....++.++.+++
T Consensus 226 L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L 301 (310)
T 4glp_A 226 PHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTL 301 (310)
T ss_dssp CSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEEC
T ss_pred CCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEEC
Confidence 6666666666665545444444 46666666666666 3344432 5666666666666543 22344555555666
Q ss_pred CCCCc
Q 015202 240 KGNEL 244 (411)
Q Consensus 240 ~~n~~ 244 (411)
.+|+.
T Consensus 302 ~~N~l 306 (310)
T 4glp_A 302 DGNPF 306 (310)
T ss_dssp SSTTT
T ss_pred cCCCC
Confidence 65543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=187.28 Aligned_cols=217 Identities=15% Similarity=0.166 Sum_probs=180.3
Q ss_pred CCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCc-ccccCCccccCCccCCee
Q 015202 17 LTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNK-LSGFVPSCFGNLTNLRKL 95 (411)
Q Consensus 17 ~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L 95 (411)
|...+.+.++.++++ .+|. + .++|++|++++|.+++..+..|.++++|++|++++|. ++...+..|..+++|+.|
T Consensus 10 C~~~~~~~v~c~~l~-~ip~-~--~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L 85 (239)
T 2xwt_C 10 CHQEEDFRVTCKDIQ-RIPS-L--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHI 85 (239)
T ss_dssp EEECSTTEEEECSCS-SCCC-C--CTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEE
T ss_pred eCCCCcceeEccCcc-ccCC-C--CCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEE
Confidence 433344554444455 4554 3 3489999999999998888889999999999999997 887777789999999999
Q ss_pred eccc-ccCCccCc-cccCCCCCcEEEcCCCeeeecCCCCccCccCCC---eEEccCC-eecccCCCCccCCCccC-eeec
Q 015202 96 YLGS-NQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLV---QIDLSMN-NFSGAIPTTIGGLKDLQ-YLFL 168 (411)
Q Consensus 96 ~l~~-n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~---~L~l~~n-~~~~~~~~~~~~~~~L~-~L~l 168 (411)
++++ |.++.++. .+..+++|++|++++|.+++ +|. +..+++|+ .|++++| .+++..+..|..+++|+ .|++
T Consensus 86 ~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred ECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence 9998 99998875 56789999999999999985 665 88888888 9999999 99988888899999999 9999
Q ss_pred ccccccccCCccccCCCCCCEEeCCCCc-cccccchhhhcC-CCCCEEEcccCcccccCCCCCCCCCccccccCCC
Q 015202 169 EYNRLQGSIPDFIGGLINLKSLDLSNNN-LSGAIPISLEKL-LDLQHINVSFNKLEGEIPREGPFRNFSIESFKGN 242 (411)
Q Consensus 169 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l-~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n 242 (411)
++|.++...+..+.. ++|+.|++++|. +++..+..+..+ ++|+.|++++|.+++..+. .+..++.+.+.++
T Consensus 164 ~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 164 YNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred CCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 999999555555655 899999999995 987777888899 9999999999999854433 5667776666554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-23 Score=183.83 Aligned_cols=180 Identities=24% Similarity=0.268 Sum_probs=124.7
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeec
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 97 (411)
...+.++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|+.|++
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 45667888888777 3444333 57888888888887777777778888888888888887777777777778888888
Q ss_pred ccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccccccc
Q 015202 98 GSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176 (411)
Q Consensus 98 ~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 176 (411)
++|.++.+|.. +..+++|++|++++|.+++..+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|.+++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 88777766643 44667777777777777655555566666777777777766655555666666666666666666655
Q ss_pred CCccccCCCCCCEEeCCCCccccc
Q 015202 177 IPDFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 177 ~~~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
.+..+..+++|+.|++++|.+...
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CHHHHhCCCCCCEEEeeCCceeCC
Confidence 555666666666666666666543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-23 Score=198.34 Aligned_cols=216 Identities=21% Similarity=0.259 Sum_probs=187.4
Q ss_pred ccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCcc
Q 015202 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSC 85 (411)
Q Consensus 6 ~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 85 (411)
..+..|..++++++|++|++++|.+++. | .+..+++|++|++++|.+++. | +..+++|++|++++|.+++. +
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~-- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D-- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--
T ss_pred cCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--
Confidence 4455666788999999999999999965 4 689999999999999999975 3 88999999999999999975 3
Q ss_pred ccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCe
Q 015202 86 FGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQY 165 (411)
Q Consensus 86 ~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~ 165 (411)
+..+++|+.|++++|.++.+| +..+++|++|++++|.+++. .++.+++|+.|++++|...+.. .+..+++|+.
T Consensus 102 ~~~l~~L~~L~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~ 174 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTT 174 (457)
T ss_dssp CTTCTTCCEEECCSSCCSCCC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCE
T ss_pred cCCCCcCCEEECCCCcCCeec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCE
Confidence 889999999999999999886 88999999999999999863 3888999999999999655454 4778999999
Q ss_pred eecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCc
Q 015202 166 LFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244 (411)
Q Consensus 166 L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~ 244 (411)
|++++|.+++ +| +..+++|+.|++++|.+++. .+..+++|+.|++++|.+++ +| ...++.+..+++.+|..
T Consensus 175 L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l 245 (457)
T 3bz5_A 175 LDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPL 245 (457)
T ss_dssp EECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCC
T ss_pred EECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcC
Confidence 9999999996 44 78899999999999999975 37889999999999999998 45 55677788888777753
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-23 Score=183.00 Aligned_cols=182 Identities=25% Similarity=0.249 Sum_probs=159.8
Q ss_pred CCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCcc-ccCCCCCcEEEc
Q 015202 42 QKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNL 120 (411)
Q Consensus 42 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l 120 (411)
...++++++++.++ .+|..+. +++++|+|++|.+.+..+..|..+++|+.|++++|.++.++.. +..+++|++|++
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 45688999999988 4554443 5899999999999988888899999999999999999977654 678999999999
Q ss_pred CCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccc
Q 015202 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 121 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
++|.++...+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.+++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999977778889999999999999999988888888999999999999999977777899999999999999999988
Q ss_pred cchhhhcCCCCCEEEcccCcccccCC
Q 015202 201 IPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 201 ~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
.+..+..+++|+.|++++|++.+...
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 88889999999999999999988743
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.2e-24 Score=193.49 Aligned_cols=202 Identities=18% Similarity=0.174 Sum_probs=172.0
Q ss_pred cCCcCCceeecCcccccccchhh--hCCCCCCeeecccCcccccCc----hhhhccccCCeeeecCCcccccCCccccCC
Q 015202 16 NLTNLIAIYLGGNKLNGSISIAL--GKLQKLQLLGLEDNQLEGSIP----YDLCRLAALFQLDLGDNKLSGFVPSCFGNL 89 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~~~~--~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 89 (411)
.+++|++|++++|.+++..|..+ .++++|++|+|++|.+++..+ ..+..+++|++|++++|.+.+..+..+..+
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 45779999999999999998888 899999999999999987544 345679999999999999998888999999
Q ss_pred ccCCeeecccccCCc---cCc--cccCCCCCcEEEcCCCeeeecCCC----CccCccCCCeEEccCCeecccCCCCccCC
Q 015202 90 TNLRKLYLGSNQLTY---IPL--TLWNLKYILYLNLSSNSFTIPLPS----EIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160 (411)
Q Consensus 90 ~~L~~L~l~~n~l~~---~p~--~~~~~~~L~~L~l~~n~l~~~~~~----~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 160 (411)
++|+.|++++|++.. ++. .+..+++|++|++++|.++ .++. .+..+++|++|++++|.+++..|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 999999999999863 432 3358899999999999987 2332 25678999999999999998878777776
Q ss_pred ---CccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccc
Q 015202 161 ---KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 161 ---~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
++|+.|++++|.++ .+|..+. ++|+.|++++|.+++. |. +..+++|+.|++++|+++.
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 5666653 7999999999999965 33 6788999999999999864
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-25 Score=207.75 Aligned_cols=236 Identities=19% Similarity=0.253 Sum_probs=181.4
Q ss_pred cCChhcccCCcCCceeecCcccccccc----hhhhCCCCCCeeecccC---cccccCchhh-------hccccCCeeeec
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSIS----IALGKLQKLQLLGLEDN---QLEGSIPYDL-------CRLAALFQLDLG 74 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~----~~~~~l~~L~~L~l~~n---~l~~~~~~~~-------~~l~~L~~L~l~ 74 (411)
.++..+..+++|+.|+|++|.++...+ ..+.++++|++|+|++| .+++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 466778888999999999999886544 34678999999999986 4455556554 678999999999
Q ss_pred CCcccc----cCCccccCCccCCeeecccccCCc-----cCccccCC---------CCCcEEEcCCCeee-ecCC---CC
Q 015202 75 DNKLSG----FVPSCFGNLTNLRKLYLGSNQLTY-----IPLTLWNL---------KYILYLNLSSNSFT-IPLP---SE 132 (411)
Q Consensus 75 ~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~-----~p~~~~~~---------~~L~~L~l~~n~l~-~~~~---~~ 132 (411)
+|.+.. .+|..+..+++|+.|++++|.++. ++..+..+ ++|++|++++|.+. ..++ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 999886 466778888999999999998862 33334444 89999999999886 3333 45
Q ss_pred ccCccCCCeEEccCCeecc-----cCCCCccCCCccCeeeccccccc----ccCCccccCCCCCCEEeCCCCccccc---
Q 015202 133 IGNLEVLVQIDLSMNNFSG-----AIPTTIGGLKDLQYLFLEYNRLQ----GSIPDFIGGLINLKSLDLSNNNLSGA--- 200 (411)
Q Consensus 133 ~~~l~~L~~L~l~~n~~~~-----~~~~~~~~~~~L~~L~l~~n~l~----~~~~~~~~~~~~L~~L~l~~n~l~~~--- 200 (411)
+..+++|+.|++++|.++. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|+.|++++|.+++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 6678899999999998872 34447788899999999999986 45677788889999999999998865
Q ss_pred -cchhhhc--CCCCCEEEcccCcccc----cCCCC--CCCCCccccccCCCCc
Q 015202 201 -IPISLEK--LLDLQHINVSFNKLEG----EIPRE--GPFRNFSIESFKGNEL 244 (411)
Q Consensus 201 -~~~~~~~--l~~L~~l~l~~n~l~~----~~~~~--~~~~~~~~~~~~~n~~ 244 (411)
++..+.. +++|+.|++++|.+++ .+|.. ..++.+..+++.+|+.
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l 315 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence 4555543 8899999999999887 24432 2256777888887754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-24 Score=202.59 Aligned_cols=243 Identities=19% Similarity=0.159 Sum_probs=190.5
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccc----hhhhCCC-CCCeeecccCcccccCchhhhcc-----ccCCe
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSIS----IALGKLQ-KLQLLGLEDNQLEGSIPYDLCRL-----AALFQ 70 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~----~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~ 70 (411)
++.|.++|.+|..+...++|+.|+|++|.+++..+ ..|.+++ +|++|+|++|.+++..+..+..+ ++|++
T Consensus 5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~ 84 (362)
T 3goz_A 5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS 84 (362)
T ss_dssp CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence 57899999999987777789999999999997777 7888999 99999999999998878777775 99999
Q ss_pred eeecCCcccccCCcccc----CC-ccCCeeecccccCCccCcc-----ccC-CCCCcEEEcCCCeeeecC----CCCccC
Q 015202 71 LDLGDNKLSGFVPSCFG----NL-TNLRKLYLGSNQLTYIPLT-----LWN-LKYILYLNLSSNSFTIPL----PSEIGN 135 (411)
Q Consensus 71 L~l~~n~l~~~~~~~~~----~l-~~L~~L~l~~n~l~~~p~~-----~~~-~~~L~~L~l~~n~l~~~~----~~~~~~ 135 (411)
|+|++|.+++..+..+. .+ ++|+.|++++|.++..+.. +.. .++|++|++++|.+.... +..+..
T Consensus 85 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~ 164 (362)
T 3goz_A 85 LNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAA 164 (362)
T ss_dssp EECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHT
T ss_pred EECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhc
Confidence 99999999976666444 34 8999999999999866542 333 369999999999988433 333455
Q ss_pred cc-CCCeEEccCCeecccCCCCc----cCC-CccCeeeccccccccc----CCccccC-CCCCCEEeCCCCccccccc--
Q 015202 136 LE-VLVQIDLSMNNFSGAIPTTI----GGL-KDLQYLFLEYNRLQGS----IPDFIGG-LINLKSLDLSNNNLSGAIP-- 202 (411)
Q Consensus 136 l~-~L~~L~l~~n~~~~~~~~~~----~~~-~~L~~L~l~~n~l~~~----~~~~~~~-~~~L~~L~l~~n~l~~~~~-- 202 (411)
++ +|+.|++++|.+++..+..+ ..+ ++|+.|++++|.+++. ++..+.. .++|+.|++++|.+++..+
T Consensus 165 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~ 244 (362)
T 3goz_A 165 IPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLEN 244 (362)
T ss_dssp SCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHH
T ss_pred CCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHH
Confidence 55 99999999999987766444 344 5999999999999863 3444444 4699999999999987654
Q ss_pred --hhhhcCCCCCEEEcccCcccccCC--------CCCCCCCccccccCCCC
Q 015202 203 --ISLEKLLDLQHINVSFNKLEGEIP--------REGPFRNFSIESFKGNE 243 (411)
Q Consensus 203 --~~~~~l~~L~~l~l~~n~l~~~~~--------~~~~~~~~~~~~~~~n~ 243 (411)
..+..+++|+.|++++|.+....+ .......+..+++.+|.
T Consensus 245 l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~ 295 (362)
T 3goz_A 245 LKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE 295 (362)
T ss_dssp HHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCB
T ss_pred HHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCc
Confidence 334667899999999998543221 22345566777777775
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=185.27 Aligned_cols=184 Identities=26% Similarity=0.402 Sum_probs=161.5
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.+.. +| .+..+++|+.|++++|.+++..+ +.++++|++|++++|.+++. +.+..+++|++|++++|.+++
T Consensus 48 l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~ 121 (308)
T 1h6u_A 48 AFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD 121 (308)
T ss_dssp CTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC
T ss_pred eeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC
Confidence 45677765 45 58999999999999999986555 99999999999999999864 368999999999999999986
Q ss_pred cCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 160 (411)
. + .+..+++|+.|++++|.++.++. +..+++|+.|++++|.+++. +. +..+++|+.|++++|.+++..+ +..+
T Consensus 122 ~-~-~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l 194 (308)
T 1h6u_A 122 V-T-PLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP--LASL 194 (308)
T ss_dssp C-G-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGC
T ss_pred c-h-hhcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCC
Confidence 4 3 38999999999999999998876 88999999999999999854 33 8899999999999999986654 7889
Q ss_pred CccCeeecccccccccCCccccCCCCCCEEeCCCCcccc
Q 015202 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG 199 (411)
Q Consensus 161 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~ 199 (411)
++|+.|++++|.+++..+ +..+++|+.|++++|.+++
T Consensus 195 ~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp TTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 999999999999996553 7899999999999999985
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.1e-23 Score=196.68 Aligned_cols=221 Identities=24% Similarity=0.295 Sum_probs=122.7
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCC-------------CeeecccCcccccCchhhhcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKL-------------QLLGLEDNQLEGSIPYDLCRLAA 67 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L-------------~~L~l~~n~l~~~~~~~~~~l~~ 67 (411)
+++|.+ |.+|+.++++++|++|++++|.+.+..|..++++++| ++|++++|.+++. |.. .++
T Consensus 18 l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~~---~~~ 92 (454)
T 1jl5_A 18 RHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PEL---PPH 92 (454)
T ss_dssp -----------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CSC---CTT
T ss_pred cccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CCC---cCC
Confidence 467888 8999999999999999999999988888888777654 7777777776642 221 245
Q ss_pred CCeeeecCCcccccCCcccc----------------CC-ccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCC
Q 015202 68 LFQLDLGDNKLSGFVPSCFG----------------NL-TNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLP 130 (411)
Q Consensus 68 L~~L~l~~n~l~~~~~~~~~----------------~l-~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~ 130 (411)
|++|++++|.+++ +|..+. .+ ++|++|++++|.++.+| .+..+++|++|++++|.+++ +|
T Consensus 93 L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~-lp 169 (454)
T 1jl5_A 93 LESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKK-LP 169 (454)
T ss_dssp CSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSC-CC
T ss_pred CCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCCCc-ccCCCCCCCEEECCCCcCcc-cC
Confidence 6666666666654 333210 11 35555566655555555 35556666666666665553 33
Q ss_pred CCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCC
Q 015202 131 SEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD 210 (411)
Q Consensus 131 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 210 (411)
..+ .+|++|++++|.+++ +| .+..+++|+.|++++|.+++ +|.. .++|+.|++++|.++ .+| .+..+++
T Consensus 170 ~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~ 238 (454)
T 1jl5_A 170 DLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPF 238 (454)
T ss_dssp CCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTT
T ss_pred CCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCC
Confidence 322 356666666666654 33 35666666666666666663 3322 246667777777666 444 3667777
Q ss_pred CCEEEcccCcccccCCCCCCCCCccccccCCCC
Q 015202 211 LQHINVSFNKLEGEIPREGPFRNFSIESFKGNE 243 (411)
Q Consensus 211 L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~ 243 (411)
|+.|++++|.+++. |. ....++.+++.+|.
T Consensus 239 L~~L~l~~N~l~~l-~~--~~~~L~~L~l~~N~ 268 (454)
T 1jl5_A 239 LTTIYADNNLLKTL-PD--LPPSLEALNVRDNY 268 (454)
T ss_dssp CCEEECCSSCCSSC-CS--CCTTCCEEECCSSC
T ss_pred CCEEECCCCcCCcc-cc--cccccCEEECCCCc
Confidence 77888877777652 22 12455555555553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=4.5e-24 Score=197.55 Aligned_cols=208 Identities=20% Similarity=0.176 Sum_probs=137.1
Q ss_pred ChhcccC--CcCCceeecCcccccccchhhhCCCCCCeeecccCccccc-CchhhhccccCCeeeecCCcccccCCcccc
Q 015202 11 PEEINNL--TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGS-IPYDLCRLAALFQLDLGDNKLSGFVPSCFG 87 (411)
Q Consensus 11 p~~~~~~--~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 87 (411)
|..+..+ ++++.|++++|.+.+..+. +.++++|++|++++|.+++. ++..+..+++|++|++++|.+++..+..+.
T Consensus 61 ~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~ 139 (336)
T 2ast_B 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA 139 (336)
T ss_dssp HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHT
T ss_pred HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHh
Confidence 3445555 6777777777777655544 44677777777777776654 566667777777777777777666666677
Q ss_pred CCccCCeeecccc-cCC--ccCccccCCCCCcEEEcCCC-eeeec-CCCCccCcc-CCCeEEccCC--eec-ccCCCCcc
Q 015202 88 NLTNLRKLYLGSN-QLT--YIPLTLWNLKYILYLNLSSN-SFTIP-LPSEIGNLE-VLVQIDLSMN--NFS-GAIPTTIG 158 (411)
Q Consensus 88 ~l~~L~~L~l~~n-~l~--~~p~~~~~~~~L~~L~l~~n-~l~~~-~~~~~~~l~-~L~~L~l~~n--~~~-~~~~~~~~ 158 (411)
.+++|+.|++++| .++ .++..+..+++|++|++++| .+++. ++..+..++ +|+.|++++| .++ +.++..+.
T Consensus 140 ~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~ 219 (336)
T 2ast_B 140 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 219 (336)
T ss_dssp TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHH
T ss_pred cCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHh
Confidence 7777777777777 566 35555666777777777777 66643 455566677 7777777777 343 23445556
Q ss_pred CCCccCeeeccccc-ccccCCccccCCCCCCEEeCCCCc-cccccchhhhcCCCCCEEEcccC
Q 015202 159 GLKDLQYLFLEYNR-LQGSIPDFIGGLINLKSLDLSNNN-LSGAIPISLEKLLDLQHINVSFN 219 (411)
Q Consensus 159 ~~~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~l~l~~n 219 (411)
.+++|+.|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++|
T Consensus 220 ~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred hCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 67777777777777 555555566777777777777774 22222224666777777777776
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-24 Score=202.61 Aligned_cols=225 Identities=22% Similarity=0.242 Sum_probs=179.5
Q ss_pred CCCCcccccCCh----hcccCCcCCceeecCc---ccccccchhh-------hCCCCCCeeecccCcccc----cCchhh
Q 015202 1 MFNCNISGSIPE----EINNLTNLIAIYLGGN---KLNGSISIAL-------GKLQKLQLLGLEDNQLEG----SIPYDL 62 (411)
Q Consensus 1 l~~n~~~~~~p~----~~~~~~~L~~L~l~~n---~~~~~~~~~~-------~~l~~L~~L~l~~n~l~~----~~~~~~ 62 (411)
|++|.+++..+. .+.++++|+.|+|++| ++++.+|..+ .++++|++|+|++|.+++ .++..+
T Consensus 39 L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l 118 (386)
T 2ca6_A 39 LSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118 (386)
T ss_dssp CTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHH
Confidence 577888887554 4678999999999986 4445555554 789999999999999987 467788
Q ss_pred hccccCCeeeecCCcccccCCccc----cCC---------ccCCeeecccccCC--ccC---ccccCCCCCcEEEcCCCe
Q 015202 63 CRLAALFQLDLGDNKLSGFVPSCF----GNL---------TNLRKLYLGSNQLT--YIP---LTLWNLKYILYLNLSSNS 124 (411)
Q Consensus 63 ~~l~~L~~L~l~~n~l~~~~~~~~----~~l---------~~L~~L~l~~n~l~--~~p---~~~~~~~~L~~L~l~~n~ 124 (411)
..+++|++|+|++|.++...+..+ ..+ ++|+.|++++|+++ .++ ..+..+++|+.|++++|.
T Consensus 119 ~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~ 198 (386)
T 2ca6_A 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 198 (386)
T ss_dssp HHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSC
T ss_pred HhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCC
Confidence 889999999999999875433333 334 89999999999997 444 456678899999999998
Q ss_pred eee-----cCCCCccCccCCCeEEccCCeec----ccCCCCccCCCccCeeeccccccccc----CCcccc--CCCCCCE
Q 015202 125 FTI-----PLPSEIGNLEVLVQIDLSMNNFS----GAIPTTIGGLKDLQYLFLEYNRLQGS----IPDFIG--GLINLKS 189 (411)
Q Consensus 125 l~~-----~~~~~~~~l~~L~~L~l~~n~~~----~~~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~--~~~~L~~ 189 (411)
+.. ..+..+..+++|+.|++++|.++ +.+|..+..+++|+.|+|++|.+++. ++..+. .+++|+.
T Consensus 199 l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~ 278 (386)
T 2ca6_A 199 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 278 (386)
T ss_dssp CCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCE
T ss_pred CCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEE
Confidence 872 34447888999999999999996 56677888899999999999998864 455553 3889999
Q ss_pred EeCCCCcccc----ccchhh-hcCCCCCEEEcccCcccccC
Q 015202 190 LDLSNNNLSG----AIPISL-EKLLDLQHINVSFNKLEGEI 225 (411)
Q Consensus 190 L~l~~n~l~~----~~~~~~-~~l~~L~~l~l~~n~l~~~~ 225 (411)
|++++|.+++ .+|..+ ..+++|+.|++++|.+++..
T Consensus 279 L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 279 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp EECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred EECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 9999999987 477766 56899999999999987543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-21 Score=192.43 Aligned_cols=108 Identities=23% Similarity=0.381 Sum_probs=65.4
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.++ .+|..+. ++|+.|+|++|+++. +|. .+++|++|+|++|.+++ +|. .+++|++|++++|.+++
T Consensus 47 ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~ 115 (622)
T 3g06_A 47 VGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH 115 (622)
T ss_dssp CCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC
T ss_pred ecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC
Confidence 4566776 6777664 678888888888773 333 56778888888887774 333 56677777777777764
Q ss_pred cCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeee
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFT 126 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~ 126 (411)
. |. .+++|+.|++++|+++.+|.. +++|++|++++|.++
T Consensus 116 l-~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N~l~ 154 (622)
T 3g06_A 116 L-PA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLA 154 (622)
T ss_dssp C-CC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS
T ss_pred C-CC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCCcCC
Confidence 3 33 334555555555555555432 244444444444444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-23 Score=192.61 Aligned_cols=223 Identities=21% Similarity=0.202 Sum_probs=172.3
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccc-cchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCC-cc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGS-ISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDN-KL 78 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l 78 (411)
+++|.+.+..|. +.++++|+.|+|++|.+++. ++..+..+++|++|++++|.+++..+..+..+++|++|++++| .+
T Consensus 77 l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l 155 (336)
T 2ast_B 77 CPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 155 (336)
T ss_dssp CTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSC
T ss_pred cCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCC
Confidence 467888887776 55789999999999998765 7778889999999999999888778888888999999999998 56
Q ss_pred ccc-CCccccCCccCCeeecccc-cCCc--cCccccCCC-CCcEEEcCCC--eee-ecCCCCccCccCCCeEEccCCe-e
Q 015202 79 SGF-VPSCFGNLTNLRKLYLGSN-QLTY--IPLTLWNLK-YILYLNLSSN--SFT-IPLPSEIGNLEVLVQIDLSMNN-F 149 (411)
Q Consensus 79 ~~~-~~~~~~~l~~L~~L~l~~n-~l~~--~p~~~~~~~-~L~~L~l~~n--~l~-~~~~~~~~~l~~L~~L~l~~n~-~ 149 (411)
++. ++..+..+++|+.|++++| .++. ++..+..++ +|++|++++| .++ ..++..+..+++|+.|++++|. +
T Consensus 156 ~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l 235 (336)
T 2ast_B 156 SEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 235 (336)
T ss_dssp CHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTC
T ss_pred CHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcC
Confidence 652 5666778899999999999 8873 666777888 9999999998 444 3456667788899999999998 7
Q ss_pred cccCCCCccCCCccCeeeccccc-ccccCCccccCCCCCCEEeCCCCccccccchhhhcC-CCCCEEEcccCcccccCCC
Q 015202 150 SGAIPTTIGGLKDLQYLFLEYNR-LQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKL-LDLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 150 ~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~l~l~~n~l~~~~~~ 227 (411)
++..+..+..+++|+.|++++|. +.......+..+++|+.|++++| ++.. .+..+ ..+..|++++|.+++..|.
T Consensus 236 ~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 236 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp CGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred CHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCC
Confidence 76777788888999999999985 33222235778899999999988 4432 22222 2355666888888877765
Q ss_pred C
Q 015202 228 E 228 (411)
Q Consensus 228 ~ 228 (411)
.
T Consensus 312 ~ 312 (336)
T 2ast_B 312 T 312 (336)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-23 Score=196.63 Aligned_cols=224 Identities=20% Similarity=0.201 Sum_probs=178.2
Q ss_pred CCCCcccccCC----hhcccCC-cCCceeecCcccccccchhhhCC-----CCCCeeecccCcccccCchhhhc----c-
Q 015202 1 MFNCNISGSIP----EEINNLT-NLIAIYLGGNKLNGSISIALGKL-----QKLQLLGLEDNQLEGSIPYDLCR----L- 65 (411)
Q Consensus 1 l~~n~~~~~~p----~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~~~~----l- 65 (411)
|++|.+++..+ ..|.+++ +|++|+|++|.+++..+..+..+ ++|++|+|++|.+++..+..+.. +
T Consensus 29 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~ 108 (362)
T 3goz_A 29 LSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108 (362)
T ss_dssp CTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred ccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCC
Confidence 57899998888 7788898 99999999999998877777775 99999999999999877765544 4
Q ss_pred ccCCeeeecCCcccccCCcccc----C-CccCCeeecccccCC-----ccCccccCCC-CCcEEEcCCCeeeecCCCCcc
Q 015202 66 AALFQLDLGDNKLSGFVPSCFG----N-LTNLRKLYLGSNQLT-----YIPLTLWNLK-YILYLNLSSNSFTIPLPSEIG 134 (411)
Q Consensus 66 ~~L~~L~l~~n~l~~~~~~~~~----~-l~~L~~L~l~~n~l~-----~~p~~~~~~~-~L~~L~l~~n~l~~~~~~~~~ 134 (411)
++|++|++++|.++...+..+. . .++|+.|++++|.++ .++..+..++ +|++|++++|.++...+..+.
T Consensus 109 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 188 (362)
T 3goz_A 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELA 188 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred CCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHH
Confidence 8999999999999876555443 3 269999999999998 4455556665 999999999999866554443
Q ss_pred ----Cc-cCCCeEEccCCeeccc----CCCCccC-CCccCeeecccccccccCC----ccccCCCCCCEEeCCCCccccc
Q 015202 135 ----NL-EVLVQIDLSMNNFSGA----IPTTIGG-LKDLQYLFLEYNRLQGSIP----DFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 135 ----~l-~~L~~L~l~~n~~~~~----~~~~~~~-~~~L~~L~l~~n~l~~~~~----~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
.. ++|+.|++++|.+++. ++..+.. .++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+.
T Consensus 189 ~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i 268 (362)
T 3goz_A 189 KFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNM 268 (362)
T ss_dssp HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTC
T ss_pred HHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCcccc
Confidence 44 5999999999999863 3444444 4599999999999986443 3457789999999999995543
Q ss_pred c-------chhhhcCCCCCEEEcccCccccc
Q 015202 201 I-------PISLEKLLDLQHINVSFNKLEGE 224 (411)
Q Consensus 201 ~-------~~~~~~l~~L~~l~l~~n~l~~~ 224 (411)
. +..+..+++|+.+++++|.+...
T Consensus 269 ~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 269 SKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp CHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred CHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 3 33556778899999999998755
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.87 E-value=7e-21 Score=182.81 Aligned_cols=120 Identities=24% Similarity=0.324 Sum_probs=59.1
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeec
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 97 (411)
++|++|++++|.+++ +| .|.++++|++|++++|.+++ +|.. ..+|++|++++|.+++ +| .+..+++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 355555555555554 33 35555555555555555553 2322 1355555555555553 23 3555555555555
Q ss_pred ccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeec
Q 015202 98 GSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS 150 (411)
Q Consensus 98 ~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~ 150 (411)
++|.++.+|... ++|+.|++++|.+. .+| .++.+++|+.|++++|.++
T Consensus 203 ~~N~l~~l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 203 DNNSLKKLPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp CSSCCSSCCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred CCCcCCcCCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCC
Confidence 555555444321 34455555555444 333 2444444555555554444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.9e-21 Score=190.39 Aligned_cols=199 Identities=26% Similarity=0.279 Sum_probs=111.9
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.|+ .+|. .+++|++|+|++|++++ +|. .+++|++|++++|.+++. |. .+++|++|++++|.++.
T Consensus 68 L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~ 135 (622)
T 3g06_A 68 IPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS 135 (622)
T ss_dssp ECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC
T ss_pred ecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc
Confidence 3567776 4565 46778888888888774 333 667777777777777643 22 34555555555555553
Q ss_pred cCCccccCCccCCeeecccccCCccCcccc-----------------CCCCCcEEEcCCCeeeecCCCCcc---------
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLTLW-----------------NLKYILYLNLSSNSFTIPLPSEIG--------- 134 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~-----------------~~~~L~~L~l~~n~l~~~~~~~~~--------- 134 (411)
+|.. +++|+.|++++|.++.+|..+. .+++|+.|++++|.+++ +|..+.
T Consensus 136 -lp~~---l~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~ 210 (622)
T 3g06_A 136 -LPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYN 210 (622)
T ss_dssp -CCCC---CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCS
T ss_pred -CCCC---CCCCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccchhhEEECcC
Confidence 2322 2455555555555544433211 12556666666666552 222111
Q ss_pred --------CccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhh
Q 015202 135 --------NLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLE 206 (411)
Q Consensus 135 --------~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 206 (411)
.+++|+.|++++|.+++ +| ..+++|+.|++++|.++ .+|. .+++|+.|++++|.++ .+|..+.
T Consensus 211 N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~ 281 (622)
T 3g06_A 211 NRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLI 281 (622)
T ss_dssp SCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGG
T ss_pred CcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHh
Confidence 11445556666665553 23 23456666666666665 2333 3456666777776666 4566666
Q ss_pred cCCCCCEEEcccCcccccC
Q 015202 207 KLLDLQHINVSFNKLEGEI 225 (411)
Q Consensus 207 ~l~~L~~l~l~~n~l~~~~ 225 (411)
.+++|+.|++++|++++..
T Consensus 282 ~l~~L~~L~L~~N~l~~~~ 300 (622)
T 3g06_A 282 HLSSETTVNLEGNPLSERT 300 (622)
T ss_dssp GSCTTCEEECCSCCCCHHH
T ss_pred hccccCEEEecCCCCCCcC
Confidence 6677777777777666543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=168.10 Aligned_cols=179 Identities=24% Similarity=0.241 Sum_probs=119.0
Q ss_pred CceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccc
Q 015202 21 IAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSN 100 (411)
Q Consensus 21 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 100 (411)
+.++.+++.++. +|.. -.++|++|++++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~~-~p~~--~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTG--IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSC--CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCC--CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 455666666653 3322 2346777777777777555555667777777777777777555555667777777777777
Q ss_pred cCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCc
Q 015202 101 QLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179 (411)
Q Consensus 101 ~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 179 (411)
.++.+|.. +..+++|++|++++|.+.+..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 77766654 3567777777777777775555556777777777777777776666666777777777777776542
Q ss_pred cccCCCCCCEEeCCCCccccccchhhhcCC
Q 015202 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLL 209 (411)
Q Consensus 180 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 209 (411)
.+++|+.|++..|.++|.+|..++.++
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 345667777777777777776666554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-21 Score=180.16 Aligned_cols=236 Identities=18% Similarity=0.170 Sum_probs=181.0
Q ss_pred CCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCc-hhhhccccCCe-eeecCCcccc
Q 015202 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP-YDLCRLAALFQ-LDLGDNKLSG 80 (411)
Q Consensus 3 ~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~-L~l~~n~l~~ 80 (411)
+++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.+.+| ..|.+++++++ +.+..|++..
T Consensus 18 ~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~ 94 (350)
T 4ay9_X 18 ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 94 (350)
T ss_dssp STTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCE
T ss_pred CCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccc
Confidence 34454 6787663 689999999999997777789999999999999999865554 56888988776 5677799998
Q ss_pred cCCccccCCccCCeeecccccCCccCcc-ccCCCCCcEEEcCC-CeeeecCCCCccCcc-CCCeEEccCCeecccCCCCc
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSS-NSFTIPLPSEIGNLE-VLVQIDLSMNNFSGAIPTTI 157 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~ 157 (411)
..|..|..+++|+.|++++|+++.+|.. +.....+..|++.+ +.+....+..|..+. .++.|++++|.++.+.+..|
T Consensus 95 l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f 174 (350)
T 4ay9_X 95 INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF 174 (350)
T ss_dssp ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSS
T ss_pred cCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhc
Confidence 8889999999999999999999988754 34667788888855 567655666677764 68899999999986666655
Q ss_pred cCCCccCeeeccc-ccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccc
Q 015202 158 GGLKDLQYLFLEY-NRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSI 236 (411)
Q Consensus 158 ~~~~~L~~L~l~~-n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~ 236 (411)
...+|+.+++.+ |.++.+.+..|..+++|+.|++++|.++...+.. +.+|+.|.+.++.--...|....+..+..
T Consensus 175 -~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~---~~~L~~L~~l~~~~l~~lP~l~~l~~L~~ 250 (350)
T 4ay9_X 175 -NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG---LENLKKLRARSTYNLKKLPTLEKLVALME 250 (350)
T ss_dssp -TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS---CTTCCEEECTTCTTCCCCCCTTTCCSCCE
T ss_pred -cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh---hccchHhhhccCCCcCcCCCchhCcChhh
Confidence 457899999975 6677565678899999999999999999655544 45677777666554456666666667766
Q ss_pred cccCCCCccc
Q 015202 237 ESFKGNELLC 246 (411)
Q Consensus 237 ~~~~~n~~~c 246 (411)
.++. ++..|
T Consensus 251 l~l~-~~~~c 259 (350)
T 4ay9_X 251 ASLT-YPSHC 259 (350)
T ss_dssp EECS-CHHHH
T ss_pred CcCC-CCccc
Confidence 6654 33444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5.8e-22 Score=179.26 Aligned_cols=193 Identities=24% Similarity=0.336 Sum_probs=158.3
Q ss_pred cCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCee
Q 015202 16 NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKL 95 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 95 (411)
++.++..+.+..+.+++..+ +..+++|++|++++|.+... + .+..+++|++|++++|.+++..+ +..+++|+.|
T Consensus 22 ~l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L 95 (291)
T 1h6t_A 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWL 95 (291)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEE
Confidence 34455666777777765443 45788999999999988754 3 47888999999999999986544 8889999999
Q ss_pred ecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccc
Q 015202 96 YLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG 175 (411)
Q Consensus 96 ~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 175 (411)
++++|.++.++. +..+++|+.|++++|.+... ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++
T Consensus 96 ~l~~n~l~~~~~-l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~ 170 (291)
T 1h6t_A 96 FLDENKVKDLSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 170 (291)
T ss_dssp ECCSSCCCCGGG-GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred ECCCCcCCCChh-hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc
Confidence 999999988764 88899999999999988843 4688889999999999999865 567889999999999999986
Q ss_pred cCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccc
Q 015202 176 SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 176 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
..+ +..+++|+.|++++|.+++. + .+..+++|+.|++++|+++.
T Consensus 171 ~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 171 IVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred chh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 555 88899999999999999864 3 47889999999999998875
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=191.51 Aligned_cols=181 Identities=26% Similarity=0.332 Sum_probs=152.6
Q ss_pred cCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecc
Q 015202 19 NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLG 98 (411)
Q Consensus 19 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 98 (411)
+|+.|+|++|++++ +|..+ +++|++|+|++|.++ .+| ..+++|++|++++|.+++ +|. +.. +|+.|+++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 89999999999986 55544 378999999999998 555 457899999999999997 666 665 99999999
Q ss_pred cccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCC
Q 015202 99 SNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178 (411)
Q Consensus 99 ~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 178 (411)
+|.++.+|. .+++|+.|++++|.+++ +|. .+++|+.|++++|.+++ +|. |. ++|+.|++++|.++ .+|
T Consensus 129 ~N~l~~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp 196 (571)
T 3cvr_A 129 NNQLTMLPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP 196 (571)
T ss_dssp SSCCSCCCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred CCcCCCCCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence 999999987 68999999999999985 665 57899999999999986 555 65 89999999999998 556
Q ss_pred ccccCCCCC-------CEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 179 DFIGGLINL-------KSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 179 ~~~~~~~~L-------~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
. +.. +| +.|++++|.++ .+|..+..+++|+.|++++|++++.+|
T Consensus 197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p 247 (571)
T 3cvr_A 197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247 (571)
T ss_dssp C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence 5 544 77 99999999999 577778889999999999999987655
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=167.72 Aligned_cols=174 Identities=24% Similarity=0.300 Sum_probs=129.9
Q ss_pred CeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCcc-ccCCCCCcEEEcCCC
Q 015202 45 QLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSSN 123 (411)
Q Consensus 45 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~n 123 (411)
+.++.+++.++. +|..+ .++|++|++++|.+++..+..|..+++|+.|++++|+++.+|.. +..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 466777776663 33332 35788888888888866666677888888888888888877665 357788888888888
Q ss_pred eeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccch
Q 015202 124 SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPI 203 (411)
Q Consensus 124 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 203 (411)
.++...+..+..+++|+.|++++|.+++..+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 8876556667788888888888888887767677778888888888888886666667778888888888887764
Q ss_pred hhhcCCCCCEEEcccCcccccCCCC
Q 015202 204 SLEKLLDLQHINVSFNKLEGEIPRE 228 (411)
Q Consensus 204 ~~~~l~~L~~l~l~~n~l~~~~~~~ 228 (411)
.+++|+.|+++.|.++|.+|..
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~ 184 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNS 184 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCT
T ss_pred ---CCCCHHHHHHHHHhCCceeecc
Confidence 3456777788888888777753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.7e-21 Score=188.30 Aligned_cols=183 Identities=27% Similarity=0.350 Sum_probs=156.1
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
+++|.|++ +|..+. ++|+.|+|++|+++ .+| ..+++|++|++++|.+++ +|. +.+ +|++|+|++|.+++
T Consensus 66 Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~ 134 (571)
T 3cvr_A 66 LNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM 134 (571)
T ss_dssp CCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC
T ss_pred eCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC
Confidence 57889988 888664 89999999999998 556 568999999999999997 565 554 99999999999997
Q ss_pred cCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGL 160 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 160 (411)
+|. .+++|+.|++++|.++.+|. .+++|+.|++++|.+++ +|. |. ++|+.|++++|.++ .+|. +..
T Consensus 135 -lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~- 200 (571)
T 3cvr_A 135 -LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV- 200 (571)
T ss_dssp -CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--
T ss_pred -CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH-
Confidence 555 67999999999999999987 57899999999999995 666 65 89999999999998 5565 554
Q ss_pred Ccc-------CeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCC
Q 015202 161 KDL-------QYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD 210 (411)
Q Consensus 161 ~~L-------~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 210 (411)
+| +.|++++|.++ .+|..+..+++|+.|++++|.+++..|..+..+..
T Consensus 201 -~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 201 -RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp --------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred -hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 77 99999999999 57777777999999999999999999988877543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-21 Score=174.19 Aligned_cols=174 Identities=28% Similarity=0.355 Sum_probs=153.8
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
+..+++|+.|++++|.+... + .+..+++|++|++++|.+++..+ +..+++|++|++++|.+++. ..+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCC
Confidence 46788999999999999854 3 48899999999999999996654 89999999999999999863 3489999999
Q ss_pred eeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccc
Q 015202 94 KLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173 (411)
Q Consensus 94 ~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l 173 (411)
.|++++|.++.++ .+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+
T Consensus 116 ~L~L~~n~i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 116 SLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EEECCCCcCCCCh-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 9999999999885 688999999999999999854 578999999999999999987655 88999999999999999
Q ss_pred cccCCccccCCCCCCEEeCCCCccccc
Q 015202 174 QGSIPDFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 174 ~~~~~~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
++. + .+..+++|+.|++++|.++..
T Consensus 191 ~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 191 SDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred CCC-h-hhccCCCCCEEECcCCcccCC
Confidence 854 4 488999999999999999753
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=191.75 Aligned_cols=193 Identities=24% Similarity=0.351 Sum_probs=118.9
Q ss_pred CCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeee
Q 015202 17 LTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLY 96 (411)
Q Consensus 17 ~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 96 (411)
+.++..+.+..+.+....+ +..+++|+.|++++|.+... + .+..+++|+.|+|++|.+.+..+ +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 3445555555555554333 45666666666666666533 2 45666666666666666664433 66666666666
Q ss_pred cccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccccccc
Q 015202 97 LGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176 (411)
Q Consensus 97 l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 176 (411)
|++|.++.+| .+..+++|+.|+|++|.+.. + ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++.
T Consensus 94 Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 94 LDENKIKDLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CCSSCCCCCT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred CcCCCCCCCh-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 6666666655 45666666666666666663 2 3466666666666666666644 4556666677777777766654
Q ss_pred CCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCccccc
Q 015202 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGE 224 (411)
Q Consensus 177 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~ 224 (411)
.| +..+++|+.|+|++|.+++. ..+..+++|+.|++++|++.+.
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 44 56666677777777766643 2456666677777776666543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.85 E-value=4.6e-23 Score=199.18 Aligned_cols=222 Identities=17% Similarity=0.121 Sum_probs=125.3
Q ss_pred CCCCcccccCChhccc-----CCcCCceeecCcccccc----cchhhhCCCCCCeeecccCcccccCchhhhc-----cc
Q 015202 1 MFNCNISGSIPEEINN-----LTNLIAIYLGGNKLNGS----ISIALGKLQKLQLLGLEDNQLEGSIPYDLCR-----LA 66 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~-----~~~L~~L~l~~n~~~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----l~ 66 (411)
+++|.+++..+..+.. .++|++|++++|++++. ++..+..+++|++|++++|.+++..+..+.. ++
T Consensus 120 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~ 199 (461)
T 1z7x_W 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC 199 (461)
T ss_dssp CCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCC
T ss_pred CCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCC
Confidence 4566666554543322 34677777777776643 2445566677777777777666443333322 44
Q ss_pred cCCeeeecCCccccc----CCccccCCccCCeeecccccCCcc-----Cccc-cCCCCCcEEEcCCCeeeec----CCCC
Q 015202 67 ALFQLDLGDNKLSGF----VPSCFGNLTNLRKLYLGSNQLTYI-----PLTL-WNLKYILYLNLSSNSFTIP----LPSE 132 (411)
Q Consensus 67 ~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~-----p~~~-~~~~~L~~L~l~~n~l~~~----~~~~ 132 (411)
+|++|++++|.++.. ++..+..+++|+.|++++|.++.. ...+ ..+++|+.|++++|.++.. ++..
T Consensus 200 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 279 (461)
T 1z7x_W 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279 (461)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred CceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence 677777777766642 344555666777777777666532 1222 2456667777776666532 3444
Q ss_pred ccCccCCCeEEccCCeecccCCCCccC-----CCccCeeeccccccccc----CCccccCCCCCCEEeCCCCccccccch
Q 015202 133 IGNLEVLVQIDLSMNNFSGAIPTTIGG-----LKDLQYLFLEYNRLQGS----IPDFIGGLINLKSLDLSNNNLSGAIPI 203 (411)
Q Consensus 133 ~~~l~~L~~L~l~~n~~~~~~~~~~~~-----~~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~ 203 (411)
+..+++|+.|++++|.+++..+..+.. .++|+.|++++|.+++. ++..+..+++|+.|++++|.+++..+.
T Consensus 280 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 555666666666666665433222221 24666666666666543 233444556666666666666544333
Q ss_pred hhhc-----CCCCCEEEcccCccc
Q 015202 204 SLEK-----LLDLQHINVSFNKLE 222 (411)
Q Consensus 204 ~~~~-----l~~L~~l~l~~n~l~ 222 (411)
.+.. .++|+.|++++|.++
T Consensus 360 ~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 360 ELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HHHHHHcCCCCceEEEECCCCCCC
Confidence 3332 456666666666665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.85 E-value=6.3e-21 Score=188.62 Aligned_cols=185 Identities=26% Similarity=0.339 Sum_probs=160.3
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
..+.+.+.++ +..+++|+.|++++|.+... + .+..+++|+.|+|++|.+.+..+ +..+++|+.|+|++|.+.+.
T Consensus 29 ~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l 102 (605)
T 1m9s_A 29 KKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL 102 (605)
T ss_dssp TCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred cCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC
Confidence 3445555444 46889999999999999744 3 58999999999999999997655 89999999999999999853
Q ss_pred CCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCC
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLK 161 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~ 161 (411)
..+..+++|+.|+|++|.++.++ .+..+++|+.|+|++|.+.+. ..+..+++|+.|+|++|.+++..| +..++
T Consensus 103 --~~l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~ 175 (605)
T 1m9s_A 103 --SSLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLT 175 (605)
T ss_dssp --TTSTTCTTCCEEECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred --hhhccCCCCCEEEecCCCCCCCc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCC
Confidence 37899999999999999999875 588999999999999999854 678999999999999999997766 88999
Q ss_pred ccCeeecccccccccCCccccCCCCCCEEeCCCCcccccc
Q 015202 162 DLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI 201 (411)
Q Consensus 162 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 201 (411)
+|+.|+|++|.+++. ..+..+++|+.|+|++|.+.+..
T Consensus 176 ~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 176 KLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp TCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred CCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence 999999999999864 35889999999999999998653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.4e-21 Score=177.18 Aligned_cols=179 Identities=26% Similarity=0.233 Sum_probs=93.9
Q ss_pred CceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhh-ccccCCeeeecCCcccccCCccccCCccCCeeeccc
Q 015202 21 IAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLC-RLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGS 99 (411)
Q Consensus 21 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 99 (411)
+.+++++++++. +|..+. +.++.|+|++|.+++..+..|. ++++|++|+|++|.+++..+..|..+++|+.|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 355555555542 332221 2355555555555544444444 555555555555555544444455555555555555
Q ss_pred ccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCc
Q 015202 100 NQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179 (411)
Q Consensus 100 n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 179 (411)
|+++.+ .+..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|.+++..+.
T Consensus 98 N~l~~~-----------------------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 154 (361)
T 2xot_A 98 NHLHTL-----------------------DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154 (361)
T ss_dssp SCCCEE-----------------------CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred CcCCcC-----------------------CHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence 555444 344445555555555555555555555555555555555555555543333
Q ss_pred cc---cCCCCCCEEeCCCCccccccchhhhcCCC--CCEEEcccCcccccC
Q 015202 180 FI---GGLINLKSLDLSNNNLSGAIPISLEKLLD--LQHINVSFNKLEGEI 225 (411)
Q Consensus 180 ~~---~~~~~L~~L~l~~n~l~~~~~~~~~~l~~--L~~l~l~~n~l~~~~ 225 (411)
.+ ..+++|+.|++++|.+++..+..+..++. ++.|++++|++.|.+
T Consensus 155 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp GTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred HhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 33 34566666666666666555555555554 356666666666543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.84 E-value=3.6e-23 Score=199.91 Aligned_cols=223 Identities=20% Similarity=0.174 Sum_probs=114.7
Q ss_pred CCCCcccccCChhc-ccCC----cCCceeecCccccc----ccchhhhCCCCCCeeecccCcccccCchhhhc-----cc
Q 015202 1 MFNCNISGSIPEEI-NNLT----NLIAIYLGGNKLNG----SISIALGKLQKLQLLGLEDNQLEGSIPYDLCR-----LA 66 (411)
Q Consensus 1 l~~n~~~~~~p~~~-~~~~----~L~~L~l~~n~~~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----l~ 66 (411)
|++|.+++..+..+ ..++ +|++|+|++|.++. .++..+.++++|++|++++|.+++..+..+.. .+
T Consensus 63 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 142 (461)
T 1z7x_W 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 142 (461)
T ss_dssp CTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCC
Confidence 35566665544433 2333 57777777776663 34566666777777777777665443333222 34
Q ss_pred cCCeeeecCCcccccC----CccccCCccCCeeecccccCCcc-----Ccccc-CCCCCcEEEcCCCeeeec----CCCC
Q 015202 67 ALFQLDLGDNKLSGFV----PSCFGNLTNLRKLYLGSNQLTYI-----PLTLW-NLKYILYLNLSSNSFTIP----LPSE 132 (411)
Q Consensus 67 ~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~-----p~~~~-~~~~L~~L~l~~n~l~~~----~~~~ 132 (411)
+|++|++++|.+++.. +..+..+++|+.|++++|.++.. ...+. ..++|+.|++++|.++.. ++..
T Consensus 143 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred cceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 5666666666665422 33444556666666666665421 11111 234566666666655532 2444
Q ss_pred ccCccCCCeEEccCCeecccC-----CCCccCCCccCeeeccccccccc----CCccccCCCCCCEEeCCCCccccccch
Q 015202 133 IGNLEVLVQIDLSMNNFSGAI-----PTTIGGLKDLQYLFLEYNRLQGS----IPDFIGGLINLKSLDLSNNNLSGAIPI 203 (411)
Q Consensus 133 ~~~l~~L~~L~l~~n~~~~~~-----~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~ 203 (411)
+..+++|+.|++++|.+++.. +..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+.+..+.
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 445556666666666554321 11122345566666666655532 333444455555555555555433332
Q ss_pred hhhcC-----CCCCEEEcccCcccc
Q 015202 204 SLEKL-----LDLQHINVSFNKLEG 223 (411)
Q Consensus 204 ~~~~l-----~~L~~l~l~~n~l~~ 223 (411)
.+... ++|+.|++++|.+++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~ 327 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTA 327 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred HHHHHhccCCccceeeEcCCCCCch
Confidence 22221 355555555555543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.2e-20 Score=161.68 Aligned_cols=154 Identities=22% Similarity=0.276 Sum_probs=87.2
Q ss_pred eeeecCCcccccCCccccCCccCCeeecccccCCccCc--cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCC
Q 015202 70 QLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL--TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMN 147 (411)
Q Consensus 70 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 147 (411)
.+++++|.++. +|..+. +.++.|++++|.++.++. .+..+++|+.|++++|.+++..+..|.++++|+.|++++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 44555555442 333332 234455555555554421 2345555555555555555444555556666666666666
Q ss_pred eecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 148 NFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 148 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
.+++..+..|..+++|+.|++++|.+++..|..|..+++|+.|++++|.+++..|..+..+++|+.|++++|++.|.++
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 6665555556666666666666666665556666666666666666666665556666666666666666666665543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.4e-20 Score=160.53 Aligned_cols=153 Identities=22% Similarity=0.273 Sum_probs=85.4
Q ss_pred eeeecCCcccccCCccccCCccCCeeecccccCCccCc-cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCe
Q 015202 70 QLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNN 148 (411)
Q Consensus 70 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 148 (411)
.++++++.++ .+|..+. ++|+.|++++|.++.++. .+..+++|+.|++++|.+++..|..|.++++|+.|+|++|.
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 2333332 345555555555554443 34445555555555555555555555556666666666666
Q ss_pred ecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccC
Q 015202 149 FSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225 (411)
Q Consensus 149 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 225 (411)
++...+..|..+++|+.|+|++|.+++..|..|..+++|+.|++++|.+++..+..+..+++|+.+++++|++.+.+
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 65554455555666666666666666555556666666666666666666555555666666666666666665543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.3e-20 Score=159.89 Aligned_cols=150 Identities=24% Similarity=0.307 Sum_probs=87.9
Q ss_pred CceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccc
Q 015202 21 IAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSN 100 (411)
Q Consensus 21 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 100 (411)
+.++++++.++ .+|..+. ++|+.|++++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|+.|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46677777776 3343332 56777777777777666666777777777777777777666777777777777777777
Q ss_pred cCCccCccc-cCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccc
Q 015202 101 QLTYIPLTL-WNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173 (411)
Q Consensus 101 ~l~~~p~~~-~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l 173 (411)
.++.+|... ..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+++..+..|..+++|+.|++++|.+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 776666543 3455555555555555544444444444444444444444444433444444444444444433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.8e-20 Score=170.78 Aligned_cols=215 Identities=18% Similarity=0.106 Sum_probs=171.4
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccc-hhhhCCCCCCe-eecccCcccccCchhhhccccCCeeeecCCcc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSIS-IALGKLQKLQL-LGLEDNQLEGSIPYDLCRLAALFQLDLGDNKL 78 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~-~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 78 (411)
|++|+|+..-+.+|.++++|++|+|++|++.+.+| .+|.+++++++ +.+.+|+++...|+.|..+++|++|++++|.+
T Consensus 37 Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l 116 (350)
T 4ay9_X 37 FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 116 (350)
T ss_dssp EESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECC
T ss_pred ccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccccc
Confidence 46889987666789999999999999999866554 57899999876 56677999988888999999999999999999
Q ss_pred cccCCccccCCccCCeeeccc-ccCCccCcc-ccCC-CCCcEEEcCCCeeeecCCCCccCccCCCeEEccC-CeecccCC
Q 015202 79 SGFVPSCFGNLTNLRKLYLGS-NQLTYIPLT-LWNL-KYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSM-NNFSGAIP 154 (411)
Q Consensus 79 ~~~~~~~~~~l~~L~~L~l~~-n~l~~~p~~-~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~~~~~~~ 154 (411)
....+..+....++..|++.+ +.+..++.. +..+ ..++.|++++|.++. ++.......+|+.|++++ |.++.+.+
T Consensus 117 ~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~ 195 (350)
T 4ay9_X 117 KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPN 195 (350)
T ss_dssp SSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCT
T ss_pred ccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCH
Confidence 977777777778888999865 578888764 3344 468999999999984 555555667899999985 77776666
Q ss_pred CCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCc
Q 015202 155 TTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220 (411)
Q Consensus 155 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~ 220 (411)
..|..+++|+.|++++|+++...+.. +.+|+.|.+.++.--..+| .+..+++|+.++++++.
T Consensus 196 ~~f~~l~~L~~LdLs~N~l~~lp~~~---~~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 196 DVFHGASGPVILDISRTRIHSLPSYG---LENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp TTTTTEECCSEEECTTSCCCCCCSSS---CTTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred HHhccCcccchhhcCCCCcCccChhh---hccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCc
Confidence 78899999999999999999555544 4566677666554444566 47889999999997654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=9e-22 Score=193.50 Aligned_cols=180 Identities=25% Similarity=0.225 Sum_probs=94.7
Q ss_pred ccCCcCCceeecCcccccccchhhhCCCCCCeeecccCc-------------ccccCchhhhccccCCeee-ecCCcccc
Q 015202 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQ-------------LEGSIPYDLCRLAALFQLD-LGDNKLSG 80 (411)
Q Consensus 15 ~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~-------------l~~~~~~~~~~l~~L~~L~-l~~n~l~~ 80 (411)
..+++|+.|+|++|.++ .+|..+++|++|+.|++++|. +.+..|+.+..+++|+.|+ ++.|.+..
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~ 424 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence 44566777777777775 566677777777777776553 3445555666666666666 44443221
Q ss_pred cCCc------cccC--CccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeeccc
Q 015202 81 FVPS------CFGN--LTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGA 152 (411)
Q Consensus 81 ~~~~------~~~~--l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~ 152 (411)
. +. .+.. ...|+.|++++|.++.+|. +..+++|+.|++++|.++ .+|..++.+++|+.|+|++|.+++
T Consensus 425 L-~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~- 500 (567)
T 1dce_A 425 L-RSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN- 500 (567)
T ss_dssp H-HHHHHHHHHHHHHHHTTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-
T ss_pred h-hhhhhhcccccccCccCceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-
Confidence 0 00 0000 0134555555555555543 445555555555555554 444455555555555555555543
Q ss_pred CCCCccCCCccCeeecccccccccC-CccccCCCCCCEEeCCCCccccc
Q 015202 153 IPTTIGGLKDLQYLFLEYNRLQGSI-PDFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 153 ~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
+| .++.+++|+.|+|++|.+++.. |..+..+++|+.|++++|.+++.
T Consensus 501 lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 23 4445555555555555555443 44555555555555555555443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=174.50 Aligned_cols=170 Identities=23% Similarity=0.226 Sum_probs=129.5
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhh-CCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALG-KLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
++|.++. +|..+. +.++.|+|++|++++..+..|. ++++|++|+|++|.+++..+..|.++++|++|+|++|.++.
T Consensus 26 ~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~ 102 (361)
T 2xot_A 26 SKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT 102 (361)
T ss_dssp CSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCc
Confidence 4455554 677554 5689999999999988888887 99999999999999998888889999999999999999998
Q ss_pred cCCccccCCccCCeeecccccCCcc-CccccCCCCCcEEEcCCCeeeecCCCCc---cCccCCCeEEccCCeecccCCCC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLNLSSNSFTIPLPSEI---GNLEVLVQIDLSMNNFSGAIPTT 156 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~-p~~~~~~~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~~~~~~~~~ 156 (411)
..+..|..+++|+.|+|++|.++.+ |..+..+++|+.|++++|.++...+..| ..+++|+.|+|++|.+++..+..
T Consensus 103 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~ 182 (361)
T 2xot_A 103 LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182 (361)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHH
T ss_pred CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHH
Confidence 8888899999999999999999876 4566678888888888888774333333 44666666677666666444444
Q ss_pred ccCCCc--cCeeeccccccc
Q 015202 157 IGGLKD--LQYLFLEYNRLQ 174 (411)
Q Consensus 157 ~~~~~~--L~~L~l~~n~l~ 174 (411)
+..++. ++.|++++|.+.
T Consensus 183 ~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 183 LQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp HHHSCHHHHTTEECCSSCEE
T ss_pred hhhccHhhcceEEecCCCcc
Confidence 444444 255555555543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-19 Score=157.17 Aligned_cols=154 Identities=21% Similarity=0.257 Sum_probs=85.4
Q ss_pred CceeecCcccccccchhhhCCCCCCeeecccCcccccCc-hhhhccccCCeeeecCCcccccCCccccCCccCCeeeccc
Q 015202 21 IAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP-YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGS 99 (411)
Q Consensus 21 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 99 (411)
+.+++++|.++. +|..+ ...+++|+|++|.+++..+ ..|..+++|++|+|++|.+++..+..|..+++|+.|++++
T Consensus 14 ~~l~~s~n~l~~-iP~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 466666666653 33322 2234566666666665533 2355666666666666666655555555555555555555
Q ss_pred ccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCc
Q 015202 100 NQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179 (411)
Q Consensus 100 n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 179 (411)
|.++.++ +..|.++++|++|++++|.+++..|..|..+++|+.|+|++|.+++..|.
T Consensus 91 N~l~~~~-----------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 91 NRLENVQ-----------------------HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp SCCCCCC-----------------------GGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred CccCccC-----------------------HhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 5555444 33344455555555555555555555555555555555555555555555
Q ss_pred cccCCCCCCEEeCCCCccccc
Q 015202 180 FIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 180 ~~~~~~~L~~L~l~~n~l~~~ 200 (411)
.|..+++|+.|++++|.+...
T Consensus 148 ~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp TTTTCTTCCEEECCSCCEECS
T ss_pred HhcCCCCCCEEEecCcCCcCC
Confidence 555566666666666665533
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=9.5e-20 Score=158.77 Aligned_cols=153 Identities=27% Similarity=0.306 Sum_probs=124.2
Q ss_pred CCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeeccc
Q 015202 20 LIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGS 99 (411)
Q Consensus 20 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 99 (411)
-+.++.+++.++ .+|..+ .++|++|+|++|.+++..|..|.++++|++|+|++|.+....+..|..+++|+.|++++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 456788888876 444433 27888888888888887788888888888888888888866667778888888888888
Q ss_pred ccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccccccc
Q 015202 100 NQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176 (411)
Q Consensus 100 n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 176 (411)
|.++.++.. +..+++|+.|++++|.+. .+|..+..+++|+.|++++|.+++..+..|..+++|+.|++++|.+...
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 888887765 457888888999888888 7788888888899999999988877777788888999999999888743
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=167.50 Aligned_cols=177 Identities=20% Similarity=0.270 Sum_probs=112.4
Q ss_pred ccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCcc
Q 015202 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSC 85 (411)
Q Consensus 6 ~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 85 (411)
+....|+ .++.++..++++++.+++.. .+..+++|++|++++|.++.. + .+..+++|++|++++|.+++..+
T Consensus 9 i~~~~pd--~~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~-- 80 (263)
T 1xeu_A 9 INQVFPD--PGLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP-- 80 (263)
T ss_dssp HHHHCCS--HHHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--
T ss_pred HHHhCCC--HHHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--
Confidence 3444555 25677788888888887444 577888888888888887743 3 57778888888888888875543
Q ss_pred ccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCe
Q 015202 86 FGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQY 165 (411)
Q Consensus 86 ~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~ 165 (411)
+..+++|+.|++++|+++.+|.... ++|+.|++++|.+++ ++ .+..+++|+.|++++|.+++. + .+..+++|+.
T Consensus 81 l~~l~~L~~L~L~~N~l~~l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~ 154 (263)
T 1xeu_A 81 LKDLTKLEELSVNRNRLKNLNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEV 154 (263)
T ss_dssp GTTCSSCCEEECCSSCCSCCTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCE
T ss_pred hccCCCCCEEECCCCccCCcCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCE
Confidence 7778888888888888877764332 666777777666663 22 355556666666666655543 1 3445555555
Q ss_pred eecccccccccCCccccCCCCCCEEeCCCCccc
Q 015202 166 LFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLS 198 (411)
Q Consensus 166 L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 198 (411)
|++++|.+++. ..+..+++|+.|++++|.++
T Consensus 155 L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 155 LDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp EECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred EECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence 55555555433 33444444555555544444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.8e-19 Score=154.98 Aligned_cols=152 Identities=26% Similarity=0.349 Sum_probs=88.0
Q ss_pred CCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCcc-ccCCCCCcEEEcCC
Q 015202 44 LQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSS 122 (411)
Q Consensus 44 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~ 122 (411)
.+.++.+++.++ .+|..+. ++|++|+|++|.+.+..|..|..+++|+.|++++|+++.+|.. +..+++|+.|++++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 345666666665 3333222 5666677777766666666666666666666666666666543 34566666666666
Q ss_pred CeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCcccc
Q 015202 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG 199 (411)
Q Consensus 123 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~ 199 (411)
|.++...+..|..+++|+.|++++|.++ .+|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+..
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 6665444444555566666666666555 445555555555555555555554444445555555555555555543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.4e-21 Score=189.43 Aligned_cols=187 Identities=17% Similarity=0.114 Sum_probs=155.1
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcc-------------cccccchhhhCCCCCCeee-cccCcccccCch-----h
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNK-------------LNGSISIALGKLQKLQLLG-LEDNQLEGSIPY-----D 61 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~-------------~~~~~~~~~~~l~~L~~L~-l~~n~l~~~~~~-----~ 61 (411)
|++|+++ .+|+.++++++|+.|++++|. ..+..|..+.++++|+.|+ ++.|.+.....- .
T Consensus 356 Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~ 434 (567)
T 1dce_A 356 LSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENS 434 (567)
T ss_dssp CCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHH
T ss_pred CChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhhhhhhhccc
Confidence 4567775 789999999999999998775 5677888899999999999 676654422110 1
Q ss_pred hhc--cccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCC
Q 015202 62 LCR--LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVL 139 (411)
Q Consensus 62 ~~~--l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 139 (411)
+.. ...|++|+|++|.+++ +|. +..+++|+.|++++|.++.+|..+..+++|+.|++++|.+++ +| .++.+++|
T Consensus 435 i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L 510 (567)
T 1dce_A 435 VLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRL 510 (567)
T ss_dssp HHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSC
T ss_pred ccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCC
Confidence 111 2369999999999996 566 999999999999999999999999999999999999999995 66 89999999
Q ss_pred CeEEccCCeecccC-CCCccCCCccCeeecccccccccCCcc---ccCCCCCCEEeC
Q 015202 140 VQIDLSMNNFSGAI-PTTIGGLKDLQYLFLEYNRLQGSIPDF---IGGLINLKSLDL 192 (411)
Q Consensus 140 ~~L~l~~n~~~~~~-~~~~~~~~~L~~L~l~~n~l~~~~~~~---~~~~~~L~~L~l 192 (411)
+.|+|++|.+++.. |..+..+++|+.|++++|.+++.+|.. +..+++|+.|++
T Consensus 511 ~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 511 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred cEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999999999887 999999999999999999999765532 234677777754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-19 Score=152.59 Aligned_cols=153 Identities=18% Similarity=0.235 Sum_probs=108.8
Q ss_pred hccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeE
Q 015202 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQI 142 (411)
Q Consensus 63 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 142 (411)
..+++|++|++++|.+. .+| .+..+++|+.|++++|.++.++ .+..+++|++|++++|.+++..+..+..+++|+.|
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 45666777777777766 334 4666677777777777665554 56667777777777777776667777777888888
Q ss_pred EccCCeecccCCCCccCCCccCeeeccccc-ccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcc
Q 015202 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNR-LQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221 (411)
Q Consensus 143 ~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l 221 (411)
++++|.+++..+..+..+++|+.|++++|. ++ .+| .+..+++|+.|++++|.+++. + .+..+++|+.|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence 888888777667777778888888888887 55 344 577788888888888888753 3 677788888888888876
Q ss_pred c
Q 015202 222 E 222 (411)
Q Consensus 222 ~ 222 (411)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 5
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-19 Score=152.61 Aligned_cols=152 Identities=17% Similarity=0.247 Sum_probs=96.7
Q ss_pred hCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCc-cCccccCCCCCcE
Q 015202 39 GKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKYILY 117 (411)
Q Consensus 39 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~p~~~~~~~~L~~ 117 (411)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.+.. +..+..+++|+.|++++|.++. .+..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 55666667777766666 333 46666667777777665542 2356666677777777776663 4556666677777
Q ss_pred EEcCCCeeeecCCCCccCccCCCeEEccCCe-ecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCc
Q 015202 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMNN-FSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNN 196 (411)
Q Consensus 118 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~ 196 (411)
|++++|.+++..+..+..+++|+.|++++|. ++ .++ .+..+++|+.|++++|.+++. + .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 7777777665556666667777777777776 44 333 466677777777777777643 2 46667777777777777
Q ss_pred cc
Q 015202 197 LS 198 (411)
Q Consensus 197 l~ 198 (411)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 64
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.3e-19 Score=157.30 Aligned_cols=161 Identities=20% Similarity=0.291 Sum_probs=139.2
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
++|.+++.. .+..+++|+.|++++|.++. ++ .+..+++|++|++++|.+++..+ +..+++|++|++++|.+++.
T Consensus 27 ~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l 100 (263)
T 1xeu_A 27 GKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL 100 (263)
T ss_dssp TCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCC
T ss_pred cCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCc
Confidence 456666544 57899999999999999984 44 78999999999999999996654 89999999999999999964
Q ss_pred CCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCC
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLK 161 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~ 161 (411)
|. +.. ++|+.|++++|.++.++ .+..+++|+.|++++|.+++. + .+..+++|+.|++++|.+++. ..+..++
T Consensus 101 -~~-~~~-~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~ 172 (263)
T 1xeu_A 101 -NG-IPS-ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLK 172 (263)
T ss_dssp -TT-CCC-SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCC
T ss_pred -Cc-ccc-CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCC
Confidence 33 333 89999999999999886 588999999999999999854 4 688999999999999999876 6788999
Q ss_pred ccCeeeccccccccc
Q 015202 162 DLQYLFLEYNRLQGS 176 (411)
Q Consensus 162 ~L~~L~l~~n~l~~~ 176 (411)
+|+.|++++|.++..
T Consensus 173 ~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 173 KVNWIDLTGQKCVNE 187 (263)
T ss_dssp CCCEEEEEEEEEECC
T ss_pred CCCEEeCCCCcccCC
Confidence 999999999999854
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=8.5e-20 Score=184.91 Aligned_cols=182 Identities=24% Similarity=0.246 Sum_probs=105.3
Q ss_pred ccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCC
Q 015202 33 SISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNL 112 (411)
Q Consensus 33 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~ 112 (411)
..+..|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.++ .+|..|..+++|+.|+|++|.++.+|..+..+
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l 292 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSC 292 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCC
Confidence 44666778888888888888777 45555667788888888888887 66777788888888888888888888778888
Q ss_pred CCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCc-cCeeecccccccccCCccccCCCCCCEEe
Q 015202 113 KYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD-LQYLFLEYNRLQGSIPDFIGGLINLKSLD 191 (411)
Q Consensus 113 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 191 (411)
++|++|+|++|.+. .+|..|+++++|+.|+|++|.+++.+|..+..+.. +..+++++|.+++.+|. .|+.|+
T Consensus 293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~ 365 (727)
T 4b8c_D 293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIE 365 (727)
T ss_dssp TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C-----
T ss_pred CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeE
Confidence 88888888888776 66777888888888888888887777766644322 23466777877766664 344555
Q ss_pred CCCC--------ccccccchhhhcCCCCCEEEcccCcccc
Q 015202 192 LSNN--------NLSGAIPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 192 l~~n--------~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
++.| .+.+..+..+..+..+....+++|.+.+
T Consensus 366 l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 366 INTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ------------------------------------CCCG
T ss_pred eecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 6655 2333333344455556666777776653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=3.3e-19 Score=150.89 Aligned_cols=131 Identities=22% Similarity=0.241 Sum_probs=100.2
Q ss_pred CeeeecCCcccccCCccccCCccCCeeecccccCCccCcc--ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccC
Q 015202 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT--LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSM 146 (411)
Q Consensus 69 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~--~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 146 (411)
+++++++|.++ .+|..+.. +|+.|++++|.++.++.. +..+++|++|++++|.+++..|..|.++++|+.|++++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67788888886 45655543 788888888888877653 66788888888888888777777788888888888888
Q ss_pred CeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccc
Q 015202 147 NNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIP 202 (411)
Q Consensus 147 n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 202 (411)
|.+++..+..|..+++|+.|++++|++++..|..+..+++|+.|++++|.+.+..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 88887777777778888888888888887777777777888888888888775543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=4.9e-18 Score=143.66 Aligned_cols=132 Identities=26% Similarity=0.312 Sum_probs=71.0
Q ss_pred CeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCC-CccCccCCCeEEccCCeecccCCCCccCCCccCeeecccc
Q 015202 93 RKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPS-EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYN 171 (411)
Q Consensus 93 ~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n 171 (411)
+.+++++|+++.+|..+.. +|+.|++++|.+.+..+. .|..+++|+.|++++|.+++..|..|..+++|+.|++++|
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4455555555555544432 555555555555533332 2555555555555555555555555555555555555555
Q ss_pred cccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 172 RLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 172 ~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
.+++..+..|..+++|++|++++|.+++..|..+..+++|+.|++++|+++|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 5555555555555555555555555555555555555555555555555554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=3e-19 Score=180.87 Aligned_cols=181 Identities=23% Similarity=0.247 Sum_probs=126.1
Q ss_pred cCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccC
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGN 88 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 88 (411)
..|+.|.++++|+.|+|++|.+. .+|..+.++++|++|+|++|.++ .+|..|.++++|++|+|++|.++ .+|..|..
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 44778999999999999999998 66667779999999999999999 78889999999999999999999 67999999
Q ss_pred CccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccC-CCeEEccCCeecccCCCCccCCCccCeee
Q 015202 89 LTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEV-LVQIDLSMNNFSGAIPTTIGGLKDLQYLF 167 (411)
Q Consensus 89 l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~~~L~~L~ 167 (411)
+++|+.|+|++|.++.+|..+..+++|+.|+|++|.+++.+|..+..+.. +..+++++|.+++.+|.. |..|+
T Consensus 292 l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~ 365 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIE 365 (727)
T ss_dssp GTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----------
T ss_pred CCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeE
Confidence 99999999999999999999999999999999999999888887765432 234789999999887754 45566
Q ss_pred cccc--------cccccCCccccCCCCCCEEeCCCCccc
Q 015202 168 LEYN--------RLQGSIPDFIGGLINLKSLDLSNNNLS 198 (411)
Q Consensus 168 l~~n--------~l~~~~~~~~~~~~~L~~L~l~~n~l~ 198 (411)
++.| .+.+..+..+..+..+....++.|.+.
T Consensus 366 l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 366 INTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ------------------------------------CCC
T ss_pred eecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 6666 333334444455566666777777764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.1e-17 Score=152.20 Aligned_cols=82 Identities=12% Similarity=0.144 Sum_probs=58.2
Q ss_pred CCcCCceeecCcccc--------------------cccchhhhC--------CCCCCeeecccCcccccCchhhhccccC
Q 015202 17 LTNLIAIYLGGNKLN--------------------GSISIALGK--------LQKLQLLGLEDNQLEGSIPYDLCRLAAL 68 (411)
Q Consensus 17 ~~~L~~L~l~~n~~~--------------------~~~~~~~~~--------l~~L~~L~l~~n~l~~~~~~~~~~l~~L 68 (411)
+++|+.|+|++|++. .+.+.+|.+ |++|+.|+|++ .++.+.+.+|.+|++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 678999999999987 233445666 77777777777 6666666677777777
Q ss_pred CeeeecCCcccccCCccccCCccCCeeeccc
Q 015202 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGS 99 (411)
Q Consensus 69 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 99 (411)
++|++++|.+..+.+..|..+.++..+....
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence 7777777777666666777666666655544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-17 Score=139.45 Aligned_cols=129 Identities=29% Similarity=0.378 Sum_probs=69.0
Q ss_pred eeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccc
Q 015202 94 KLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173 (411)
Q Consensus 94 ~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l 173 (411)
.+++++|.++.+|..+. ++|+.|++++|.++ .+|..|.++++|+.|++++|.+++..+..|..+++|+.|+|++|.+
T Consensus 14 ~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 14 VVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 34444444444444332 34455555555544 3444455555555555555555555455555555555555555555
Q ss_pred cccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccC
Q 015202 174 QGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225 (411)
Q Consensus 174 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 225 (411)
++..+..|..+++|+.|++++|.+++..+..+..+++|+.+++++|++.|.+
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 5555555555556666666666665444445555666666666666665543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.73 E-value=4.2e-18 Score=140.88 Aligned_cols=131 Identities=24% Similarity=0.170 Sum_probs=81.6
Q ss_pred CCCCeeecccCccc-ccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCc-cCccccCCCCCcEEE
Q 015202 42 QKLQLLGLEDNQLE-GSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IPLTLWNLKYILYLN 119 (411)
Q Consensus 42 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~p~~~~~~~~L~~L~ 119 (411)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|+.|++++|.++. +|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 44555556666666666666666644 556666666666666666665 444444566666666
Q ss_pred cCCCeeeecC-CCCccCccCCCeEEccCCeecccCC---CCccCCCccCeeeccccccc
Q 015202 120 LSSNSFTIPL-PSEIGNLEVLVQIDLSMNNFSGAIP---TTIGGLKDLQYLFLEYNRLQ 174 (411)
Q Consensus 120 l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~~~~~~~---~~~~~~~~L~~L~l~~n~l~ 174 (411)
+++|.+++.. +..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666665321 1456666777777777777765444 35666777777777777765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.5e-17 Score=136.26 Aligned_cols=131 Identities=25% Similarity=0.222 Sum_probs=62.9
Q ss_pred CcCCceeecCcccc-cccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeee
Q 015202 18 TNLIAIYLGGNKLN-GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLY 96 (411)
Q Consensus 18 ~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 96 (411)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|.+.+.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555544 34444444555555555555554433 3444455555555555555444444444455555555
Q ss_pred cccccCCccC--ccccCCCCCcEEEcCCCeeeecCC---CCccCccCCCeEEccCCeec
Q 015202 97 LGSNQLTYIP--LTLWNLKYILYLNLSSNSFTIPLP---SEIGNLEVLVQIDLSMNNFS 150 (411)
Q Consensus 97 l~~n~l~~~p--~~~~~~~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l~~n~~~ 150 (411)
+++|.++.+| ..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555555443 344445555555555555442222 24444555555555555443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.70 E-value=8.3e-18 Score=136.18 Aligned_cols=125 Identities=22% Similarity=0.254 Sum_probs=69.5
Q ss_pred CcCCceeecCcccc-cccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeee
Q 015202 18 TNLIAIYLGGNKLN-GSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLY 96 (411)
Q Consensus 18 ~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 96 (411)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666665 45555556666666666666666544 4455566666666666666654555555556666666
Q ss_pred cccccCCccC--ccccCCCCCcEEEcCCCeeeecCC---CCccCccCCCeEEc
Q 015202 97 LGSNQLTYIP--LTLWNLKYILYLNLSSNSFTIPLP---SEIGNLEVLVQIDL 144 (411)
Q Consensus 97 l~~n~l~~~p--~~~~~~~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~l 144 (411)
+++|.++.++ ..+..+++|+.|++++|.+++..+ ..+..+++|+.|++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 6666655543 444455555555555555543222 23444444444444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-16 Score=133.33 Aligned_cols=132 Identities=25% Similarity=0.277 Sum_probs=73.8
Q ss_pred CeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccc
Q 015202 93 RKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNR 172 (411)
Q Consensus 93 ~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~ 172 (411)
+.+++++|+++.+|..+. ++|+.|++++|.+.+..+..+..+++|+.|++++|.+++..+..|..+++|+.|++++|.
T Consensus 10 ~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp TEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 444555555555543332 455555555555554444445555566666666666655555555556666666666666
Q ss_pred ccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 173 LQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 173 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
+++..+..+..+++|+.|++++|.+++..+..+..+++|+.+++++|++.+.+|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 665555555556666666666666665444445556666666666666655444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2e-16 Score=133.75 Aligned_cols=128 Identities=27% Similarity=0.350 Sum_probs=108.4
Q ss_pred CeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCe
Q 015202 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNN 148 (411)
Q Consensus 69 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 148 (411)
+++++++|.++ .+|..+. ++|+.|++++|.++.+|..+..+++|+.|++++|.++...+..|.++++|+.|+|++|.
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 56778888877 4555443 57888888888888888888888889999999998887777788899999999999999
Q ss_pred ecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCcccc
Q 015202 149 FSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSG 199 (411)
Q Consensus 149 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~ 199 (411)
+++..+..|..+++|+.|+|++|.++...+..|..+++|+.|++++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 998888889999999999999999997777778889999999999999874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-16 Score=146.71 Aligned_cols=207 Identities=15% Similarity=0.115 Sum_probs=148.9
Q ss_pred cCCcCCceeecCcccccccchhhhC-CCCCCeeecccCccc--------------------ccCchhhhc--------cc
Q 015202 16 NLTNLIAIYLGGNKLNGSISIALGK-LQKLQLLGLEDNQLE--------------------GSIPYDLCR--------LA 66 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~~~~~~-l~~L~~L~l~~n~l~--------------------~~~~~~~~~--------l~ 66 (411)
.+.+++.|.++++ +....-..+.. +++|++|||++|.+. .+.+..|.+ |+
T Consensus 23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~ 101 (329)
T 3sb4_A 23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQ 101 (329)
T ss_dssp HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECT
T ss_pred hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccC
Confidence 3668899999874 32222234444 899999999999988 233446777 89
Q ss_pred cCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccc-cCCCCCcEEEcCCCeee----ecCCCCc--------
Q 015202 67 ALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTL-WNLKYILYLNLSSNSFT----IPLPSEI-------- 133 (411)
Q Consensus 67 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~-~~~~~L~~L~l~~n~l~----~~~~~~~-------- 133 (411)
+|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+..++... ..+.++..+.+..+... ......|
T Consensus 102 ~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~ 180 (329)
T 3sb4_A 102 TLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLET 180 (329)
T ss_dssp TCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEE
T ss_pred CCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccce
Confidence 999999988 788777788999999999999999887776543 35555555554432110 0000000
Q ss_pred ------------------------------------------cCccCCCeEEccCCeecccCCCCccCCCccCeeecccc
Q 015202 134 ------------------------------------------GNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYN 171 (411)
Q Consensus 134 ------------------------------------------~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n 171 (411)
..+++|+.+++++|.++.+.+.+|..+++|+.+++.+|
T Consensus 181 ~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n 260 (329)
T 3sb4_A 181 TIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN 260 (329)
T ss_dssp EEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT
T ss_pred eEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc
Confidence 02678888888888888777788888888999988887
Q ss_pred cccccCCccccCCCCCC-EEeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 172 RLQGSIPDFIGGLINLK-SLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 172 ~l~~~~~~~~~~~~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
++.+.+.+|.++++|+ .+++.+ .++...+.+|..+++|+.+++++|.++...+
T Consensus 261 -i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~ 314 (329)
T 3sb4_A 261 -LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGD 314 (329)
T ss_dssp -CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECT
T ss_pred -cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccch
Confidence 7767778888888888 888887 6776777888888888888888887765444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=5.9e-17 Score=131.13 Aligned_cols=83 Identities=23% Similarity=0.178 Sum_probs=33.8
Q ss_pred ccCCeeeecCCccc-ccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEc
Q 015202 66 AALFQLDLGDNKLS-GFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDL 144 (411)
Q Consensus 66 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 144 (411)
++|++|++++|.++ +.+|..+..+++|+.|++++|.++.+ ..+..+++|+.|++++|.+++.+|..+..+++|+.|++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 34444444444444 33344444444444444444444433 23333444444444444433323333333333444444
Q ss_pred cCCee
Q 015202 145 SMNNF 149 (411)
Q Consensus 145 ~~n~~ 149 (411)
++|.+
T Consensus 96 s~N~i 100 (149)
T 2je0_A 96 SGNKI 100 (149)
T ss_dssp TTSCC
T ss_pred CCCcC
Confidence 44433
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.66 E-value=7.6e-17 Score=134.35 Aligned_cols=109 Identities=24% Similarity=0.248 Sum_probs=54.7
Q ss_pred cccCCcCCceeecCcccccccchhhhCCC-CCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQ-KLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNL 92 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 92 (411)
+.++.+|+.|++++|+++. ++. +..+. +|++|++++|.+++. +.+..+++|++|++++|.+++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4455555556665555552 232 22322 555555555555543 345555555555555555554333333555555
Q ss_pred CeeecccccCCccCc--cccCCCCCcEEEcCCCeee
Q 015202 93 RKLYLGSNQLTYIPL--TLWNLKYILYLNLSSNSFT 126 (411)
Q Consensus 93 ~~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n~l~ 126 (411)
+.|++++|.++.+|. .+..+++|+.|++++|.+.
T Consensus 91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence 555555555555544 3444444555555444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-18 Score=147.66 Aligned_cols=135 Identities=22% Similarity=0.262 Sum_probs=76.2
Q ss_pred cccCCcCCceeecCcccccccch------hhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCcccc
Q 015202 14 INNLTNLIAIYLGGNKLNGSISI------ALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFG 87 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 87 (411)
+...+.++.++++.+.+++..|. .+.++++|++|++++|.+++ +| .+..+++|++|++++|.++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44555666666666666665554 56666666666666666664 34 5666666666666666666 3455555
Q ss_pred CCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCC-CCccCccCCCeEEccCCeeccc
Q 015202 88 NLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLP-SEIGNLEVLVQIDLSMNNFSGA 152 (411)
Q Consensus 88 ~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~~~~~ 152 (411)
.+++|+.|++++|.++.+| .+..+++|+.|++++|.+....+ ..+..+++|+.|++++|.+++.
T Consensus 91 ~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 91 VADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred cCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 5566666666666666554 34455555555555555542111 2344444445555554444433
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.9e-18 Score=147.02 Aligned_cols=134 Identities=25% Similarity=0.250 Sum_probs=80.6
Q ss_pred hhCCCCCCeeecccCcccccCch------hhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccC
Q 015202 38 LGKLQKLQLLGLEDNQLEGSIPY------DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWN 111 (411)
Q Consensus 38 ~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~ 111 (411)
+.....++.++++.+.+.+..|. .+..+++|++|++++|.+++ +| .+..+++|+.|++++|.++.+|..+..
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~ 91 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAV 91 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhc
Confidence 55666777777777777766655 67777777777777777775 44 666677777777777777766655555
Q ss_pred CCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCC-CCccCCCccCeeecccccccc
Q 015202 112 LKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIP-TTIGGLKDLQYLFLEYNRLQG 175 (411)
Q Consensus 112 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~-~~~~~~~~L~~L~l~~n~l~~ 175 (411)
+++|+.|++++|.+++ +| .+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+++
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 5666666666666553 22 34455555555555555543211 233444444444444444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.2e-15 Score=124.59 Aligned_cols=132 Identities=22% Similarity=0.246 Sum_probs=88.6
Q ss_pred CCeeeecCCcccccCCccccCCccCCeeecccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccC
Q 015202 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSM 146 (411)
Q Consensus 68 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 146 (411)
.+.+++++|.++. +|..+. ++|+.|++++|+++.+|.. +..+++|++|++++|.+++..+..+..+++|+.|++++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 3455555555552 333222 4566666666666655543 34566666666666666654455567777777788888
Q ss_pred CeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccc
Q 015202 147 NNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIP 202 (411)
Q Consensus 147 n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 202 (411)
|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+.+..+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 87776666677778888888888888886666667778888888888888876554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=127.28 Aligned_cols=132 Identities=20% Similarity=0.141 Sum_probs=77.1
Q ss_pred cCCccCCeeecccccCCccCccccCC-CCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCe
Q 015202 87 GNLTNLRKLYLGSNQLTYIPLTLWNL-KYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQY 165 (411)
Q Consensus 87 ~~l~~L~~L~l~~n~l~~~p~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~ 165 (411)
..+.+|+.|++++|.++.+|. +..+ ++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+..+..+++|+.
T Consensus 16 ~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp ECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 334455555555555554432 2222 2555666666555533 34556666666666666666544444466666666
Q ss_pred eecccccccccCCc--cccCCCCCCEEeCCCCccccccch---hhhcCCCCCEEEcccCccc
Q 015202 166 LFLEYNRLQGSIPD--FIGGLINLKSLDLSNNNLSGAIPI---SLEKLLDLQHINVSFNKLE 222 (411)
Q Consensus 166 L~l~~n~l~~~~~~--~~~~~~~L~~L~l~~n~l~~~~~~---~~~~l~~L~~l~l~~n~l~ 222 (411)
|++++|.++ .+|. .+..+++|+.|++++|.++...+. .+..+++|+.|+++.|...
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 777666665 3333 566677777777777777633222 3667777777777777654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.62 E-value=6.7e-17 Score=160.88 Aligned_cols=178 Identities=13% Similarity=0.087 Sum_probs=102.7
Q ss_pred cccCCcCCceeecCcccccc----cchhhhCCCCCCeeecccCccc----ccCchhhhccccCCeeeecCCcccccCCcc
Q 015202 14 INNLTNLIAIYLGGNKLNGS----ISIALGKLQKLQLLGLEDNQLE----GSIPYDLCRLAALFQLDLGDNKLSGFVPSC 85 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~----~~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 85 (411)
..++++|++|+|++|.+++. ++..+.++++|++|++++|.++ +.++..+.++++|++|++++|.+.+ ++..
T Consensus 160 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~ 238 (592)
T 3ogk_B 160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGF 238 (592)
T ss_dssp HHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHH
T ss_pred HhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHH
Confidence 35778888888888887654 4445667888888888888776 2334445677888888888887774 4566
Q ss_pred ccCCccCCeeecccccCC----ccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCC-CCccCC
Q 015202 86 FGNLTNLRKLYLGSNQLT----YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIP-TTIGGL 160 (411)
Q Consensus 86 ~~~l~~L~~L~l~~n~l~----~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~-~~~~~~ 160 (411)
+..+++|+.|+++..... ..+..+..+++|+.|++.++... .+|..+..+++|+.|++++|.+++... ..+..+
T Consensus 239 ~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~ 317 (592)
T 3ogk_B 239 FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKC 317 (592)
T ss_dssp HHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTC
T ss_pred HhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhC
Confidence 666777777777643221 22334445556666665554222 344445555566666666665443222 223455
Q ss_pred CccCeeecccccccccCCccccCCCCCCEEeCC
Q 015202 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLS 193 (411)
Q Consensus 161 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~ 193 (411)
++|+.|+++++-..+.++..+..+++|++|+++
T Consensus 318 ~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 318 PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp TTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred cCCCEEeccCccCHHHHHHHHHhCCCCCEEEee
Confidence 555555555221111222222344555555555
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.62 E-value=4.1e-17 Score=162.46 Aligned_cols=201 Identities=14% Similarity=0.068 Sum_probs=116.8
Q ss_pred cCCcCCceeecCcccccccchhhhC-CCC-CCeeecccCc-ccc-cCchhhhccccCCeeeecCCccccc----CCcccc
Q 015202 16 NLTNLIAIYLGGNKLNGSISIALGK-LQK-LQLLGLEDNQ-LEG-SIPYDLCRLAALFQLDLGDNKLSGF----VPSCFG 87 (411)
Q Consensus 16 ~~~~L~~L~l~~n~~~~~~~~~~~~-l~~-L~~L~l~~n~-l~~-~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~ 87 (411)
++++|++|+|++|.+++..+..+.. +++ |++|+|++|. ++. .++.....+++|++|+|++|.+.+. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 6788888888888777665555555 333 8888887775 221 1222234677888888888876644 222345
Q ss_pred CCccCCeeecccccCC-----ccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCee-------------
Q 015202 88 NLTNLRKLYLGSNQLT-----YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNF------------- 149 (411)
Q Consensus 88 ~l~~L~~L~l~~n~l~-----~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~------------- 149 (411)
.+++|+.|++++|.++ .++..+.++++|+.|++++|.+.+ ++..+.++++|+.|+++....
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 5677777777777775 233334467777777777776653 444455555555555553211
Q ss_pred -------------cccCCCCccCCCccCeeecccccccccCC-ccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEE
Q 015202 150 -------------SGAIPTTIGGLKDLQYLFLEYNRLQGSIP-DFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHIN 215 (411)
Q Consensus 150 -------------~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~ 215 (411)
.+.+|..+..+++|+.|++++|.+++... ..+..+++|+.|+++++...+.++.....+++|+.|+
T Consensus 269 ~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 269 PRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp CTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEE
T ss_pred cccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEE
Confidence 12334444555666666666666543222 2345566666666663222222333345566666666
Q ss_pred cc
Q 015202 216 VS 217 (411)
Q Consensus 216 l~ 217 (411)
++
T Consensus 349 L~ 350 (592)
T 3ogk_B 349 IE 350 (592)
T ss_dssp EE
T ss_pred ee
Confidence 66
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.1e-14 Score=135.16 Aligned_cols=226 Identities=12% Similarity=0.066 Sum_probs=150.2
Q ss_pred ccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCcc
Q 015202 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSC 85 (411)
Q Consensus 6 ~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 85 (411)
++..-+.+|.++ +|+.+.|.++ ++.+...+|.++ +|+.+.+.. .++.+....|.+|++|+.+++.+|.++......
T Consensus 124 i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~a 199 (401)
T 4fdw_A 124 VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPAST 199 (401)
T ss_dssp CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTT
T ss_pred cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhh
Confidence 333344567665 6888888765 665666777774 688888875 566566677888888888888888887665566
Q ss_pred ccCCccCCeeecccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccC
Q 015202 86 FGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQ 164 (411)
Q Consensus 86 ~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~ 164 (411)
|. ..+|+.+.+.+ .++.++.. +.++++|+.+.+..+ +.......|.+ .+|+.+.+. +.++.+...+|..+++|+
T Consensus 200 F~-~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~ 274 (401)
T 4fdw_A 200 FV-YAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELA 274 (401)
T ss_dssp TT-TCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCC
T ss_pred Ee-ecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCC
Confidence 66 47888888874 36666554 446778888888765 44345556666 677877774 345556677777888888
Q ss_pred eeeccccccc-----ccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCcccccc
Q 015202 165 YLFLEYNRLQ-----GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESF 239 (411)
Q Consensus 165 ~L~l~~n~l~-----~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~ 239 (411)
.+.+.+|.+. .+.+.+|.++++|+.+++.+ .++.....+|..+.+|+.+.+..| ++..-.....-..+..+.+
T Consensus 275 ~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l 352 (401)
T 4fdw_A 275 EVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKV 352 (401)
T ss_dssp EEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEE
T ss_pred EEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEE
Confidence 8888777654 35566777888888888873 466566667777788888877554 3332222221114555555
Q ss_pred CCC
Q 015202 240 KGN 242 (411)
Q Consensus 240 ~~n 242 (411)
.+|
T Consensus 353 ~~n 355 (401)
T 4fdw_A 353 EGT 355 (401)
T ss_dssp CCS
T ss_pred cCC
Confidence 554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3e-14 Score=134.00 Aligned_cols=209 Identities=12% Similarity=0.079 Sum_probs=173.3
Q ss_pred ccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCcc
Q 015202 6 ISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSC 85 (411)
Q Consensus 6 ~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 85 (411)
++..-..+|.++ +|+.+.|.+ .+..+.+.+|.+|++|+.+++++|.++.+....|. +.+|+.+.+.++ +..+...+
T Consensus 146 i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~a 221 (401)
T 4fdw_A 146 LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQA 221 (401)
T ss_dssp CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTT
T ss_pred ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhH
Confidence 444445678775 699999986 77767788999999999999999999877666777 689999999854 77777889
Q ss_pred ccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeec-----ccCCCCccCC
Q 015202 86 FGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFS-----GAIPTTIGGL 160 (411)
Q Consensus 86 ~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~-----~~~~~~~~~~ 160 (411)
|.++++|+.+++.++ ++.++...+.-.+|+.+.+.+ .+.......|.++++|+.+++.+|.+. .+.+..|.++
T Consensus 222 F~~~~~L~~l~l~~~-l~~I~~~aF~~~~L~~i~lp~-~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c 299 (401)
T 4fdw_A 222 FLKTSQLKTIEIPEN-VSTIGQEAFRESGITTVKLPN-GVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGC 299 (401)
T ss_dssp TTTCTTCCCEECCTT-CCEECTTTTTTCCCSEEEEET-TCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTC
T ss_pred hhCCCCCCEEecCCC-ccCccccccccCCccEEEeCC-CccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCC
Confidence 999999999999974 778877666558999999954 466566788999999999999988775 4677899999
Q ss_pred CccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccc
Q 015202 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 161 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
++|+.+.+. +.++.+...+|.++++|+.+.+.++ ++.....+|..+ +|+.+++.+|.+..
T Consensus 300 ~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 300 PKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ 359 (401)
T ss_dssp TTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred ccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence 999999999 4577677889999999999999655 666777889999 99999999987654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=3.5e-14 Score=117.29 Aligned_cols=108 Identities=22% Similarity=0.184 Sum_probs=75.2
Q ss_pred cCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccc
Q 015202 91 NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEY 170 (411)
Q Consensus 91 ~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~ 170 (411)
..+.+++++|.++.+|..+. ++|+.|++++|.+++..|..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++
T Consensus 10 ~~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 10 SGTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp ETTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 35677888888887776653 6677777777777766666677777777777777777766666666677777777777
Q ss_pred ccccccCCccccCCCCCCEEeCCCCccccc
Q 015202 171 NRLQGSIPDFIGGLINLKSLDLSNNNLSGA 200 (411)
Q Consensus 171 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 200 (411)
|++++..+..|..+++|+.|++++|.++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 777665555666667777777777766543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=4.3e-14 Score=116.76 Aligned_cols=109 Identities=22% Similarity=0.221 Sum_probs=78.9
Q ss_pred CcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCC
Q 015202 115 ILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSN 194 (411)
Q Consensus 115 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 194 (411)
.+.+++++|.++ .+|..+. ++|+.|++++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|++++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 466777777776 4555443 6677777777777777777777777777777777777766666677777777777777
Q ss_pred CccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 195 NNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 195 n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
|.+++..+..+..+++|+.|++++|++++.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 77776666667777777777777777776654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=9.9e-14 Score=114.99 Aligned_cols=105 Identities=21% Similarity=0.155 Sum_probs=73.9
Q ss_pred CeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccc
Q 015202 93 RKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNR 172 (411)
Q Consensus 93 ~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~ 172 (411)
+.+++++|.++.+|..+. ++|+.|++++|.+.+..|..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 566777777777776553 667777777777776666677777777777777777776666666677777777777777
Q ss_pred ccccCCccccCCCCCCEEeCCCCcccc
Q 015202 173 LQGSIPDFIGGLINLKSLDLSNNNLSG 199 (411)
Q Consensus 173 l~~~~~~~~~~~~~L~~L~l~~n~l~~ 199 (411)
+++..+..|..+++|+.|++++|.+..
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred cceeCHHHhccccCCCEEEeCCCCccc
Confidence 775555556777777777777777763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-15 Score=151.52 Aligned_cols=110 Identities=14% Similarity=0.117 Sum_probs=73.6
Q ss_pred cccCCcCCceeecCcccccccchhhh-CCCCCCeeecccC-ccccc-CchhhhccccCCeeeecCCcccccCCccc----
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALG-KLQKLQLLGLEDN-QLEGS-IPYDLCRLAALFQLDLGDNKLSGFVPSCF---- 86 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~-~l~~L~~L~l~~n-~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---- 86 (411)
+..+++|+.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|++++|.+++..+..+
T Consensus 101 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~ 180 (594)
T 2p1m_B 101 SSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP 180 (594)
T ss_dssp HHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC
T ss_pred HHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh
Confidence 35677888888888888766666665 6888888888887 45432 33444578888888888888765433333
Q ss_pred cCCccCCeeeccccc--CC--ccCccccCCCCCcEEEcCCC
Q 015202 87 GNLTNLRKLYLGSNQ--LT--YIPLTLWNLKYILYLNLSSN 123 (411)
Q Consensus 87 ~~l~~L~~L~l~~n~--l~--~~p~~~~~~~~L~~L~l~~n 123 (411)
..+++|+.|++++|. ++ .++.-+..+++|+.|++++|
T Consensus 181 ~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 181 DTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp TTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred hcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 356688888888776 22 12222234677777777776
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1e-13 Score=114.94 Aligned_cols=109 Identities=23% Similarity=0.283 Sum_probs=98.4
Q ss_pred CcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCC
Q 015202 115 ILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSN 194 (411)
Q Consensus 115 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 194 (411)
-+.+++++|.+. .+|..+. ++|+.|++++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|++++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999987 6777664 7899999999999998899999999999999999999987777789999999999999
Q ss_pred CccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 195 NNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 195 n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
|.+++..+..+..+++|+.|++++|++.+.++
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 99998777779999999999999999987765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.49 E-value=2.6e-15 Score=149.48 Aligned_cols=156 Identities=13% Similarity=0.092 Sum_probs=102.8
Q ss_pred hcccCCcCCceeecCccccc---cc------------chhhhCCCCCCeeecccCcccccCchhhh-ccccCCeeeecCC
Q 015202 13 EINNLTNLIAIYLGGNKLNG---SI------------SIALGKLQKLQLLGLEDNQLEGSIPYDLC-RLAALFQLDLGDN 76 (411)
Q Consensus 13 ~~~~~~~L~~L~l~~n~~~~---~~------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n 76 (411)
.+..+++|+.|+++++.... .. +..+..+++|++|+|++|.+++..+..+. .+++|++|++++|
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~ 140 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence 45778889999999875321 11 22345788999999999988776666665 6889999999988
Q ss_pred -ccccc-CCccccCCccCCeeecccccCCc-----cCccccCCCCCcEEEcCCCe--eee-cCCCCccCccCCCeEEccC
Q 015202 77 -KLSGF-VPSCFGNLTNLRKLYLGSNQLTY-----IPLTLWNLKYILYLNLSSNS--FTI-PLPSEIGNLEVLVQIDLSM 146 (411)
Q Consensus 77 -~l~~~-~~~~~~~l~~L~~L~l~~n~l~~-----~p~~~~~~~~L~~L~l~~n~--l~~-~~~~~~~~l~~L~~L~l~~ 146 (411)
.++.. ++..+..+++|+.|++++|.++. ++.....+++|+.|++++|. +.. .++..+..+++|+.|++++
T Consensus 141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~ 220 (594)
T 2p1m_B 141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR 220 (594)
T ss_dssp EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCC
Confidence 44432 33444578899999999888653 22223367789999998886 211 1112224468888888888
Q ss_pred C-eecccCCCCccCCCccCeeecc
Q 015202 147 N-NFSGAIPTTIGGLKDLQYLFLE 169 (411)
Q Consensus 147 n-~~~~~~~~~~~~~~~L~~L~l~ 169 (411)
| .+.+ ++..+..+++|+.|++.
T Consensus 221 ~~~~~~-l~~~~~~~~~L~~L~l~ 243 (594)
T 2p1m_B 221 AVPLEK-LATLLQRAPQLEELGTG 243 (594)
T ss_dssp TSCHHH-HHHHHHHCTTCSEEECS
T ss_pred CCcHHH-HHHHHhcCCcceEcccc
Confidence 7 3332 44444555566666543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=8.8e-15 Score=136.36 Aligned_cols=169 Identities=21% Similarity=0.149 Sum_probs=118.7
Q ss_pred CCCCCCeeecccCcccccCchhhhcc-----ccCCeeeecCCcccccCCccc-cCCccCCeeecccccCCcc-----Ccc
Q 015202 40 KLQKLQLLGLEDNQLEGSIPYDLCRL-----AALFQLDLGDNKLSGFVPSCF-GNLTNLRKLYLGSNQLTYI-----PLT 108 (411)
Q Consensus 40 ~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~-----p~~ 108 (411)
-+++|+.|+|++|.++......+..+ ++|++|+|++|.++......+ ..+++|+.|+|++|.++.. ...
T Consensus 70 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~ 149 (372)
T 3un9_A 70 VLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL 149 (372)
T ss_dssp HHTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHH
T ss_pred HHhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHH
Confidence 34678888888888875544444433 688888888888764332333 3457888889998888732 222
Q ss_pred c-cCCCCCcEEEcCCCeeeec----CCCCccCccCCCeEEccCCeecccC----CCCccCCCccCeeeccccccccc---
Q 015202 109 L-WNLKYILYLNLSSNSFTIP----LPSEIGNLEVLVQIDLSMNNFSGAI----PTTIGGLKDLQYLFLEYNRLQGS--- 176 (411)
Q Consensus 109 ~-~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~~~~~~----~~~~~~~~~L~~L~l~~n~l~~~--- 176 (411)
+ ...++|++|++++|.++.. ++..+...++|++|+|++|.++... ...+...++|+.|+|++|.+++.
T Consensus 150 L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~ 229 (372)
T 3un9_A 150 LLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL 229 (372)
T ss_dssp HHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH
T ss_pred HHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH
Confidence 2 2467899999999988642 3344567788999999999887532 44556678999999999998753
Q ss_pred -CCccccCCCCCCEEeCCCCccccccchhhhcC
Q 015202 177 -IPDFIGGLINLKSLDLSNNNLSGAIPISLEKL 208 (411)
Q Consensus 177 -~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 208 (411)
+...+...++|++|++++|.+++.....+..+
T Consensus 230 ~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 230 ALARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp HHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred HHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 23344567899999999999986655555443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.2e-13 Score=124.46 Aligned_cols=83 Identities=19% Similarity=0.150 Sum_probs=66.6
Q ss_pred cCCeeeccCCceEEEEEec------CCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------
Q 015202 328 ANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------- 376 (411)
-.++||+|+||.||+|++. +++.||||+++..+....++|.+|+++|++
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3478999999999999974 467899999977666667899999999998
Q ss_pred -------cccCCCC------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------ANLLTRE------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------~~l~~~~------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ...+++|.++++|+.|||+||+|||+.
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 177 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 3333211 123599999999999999999999964
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-14 Score=135.45 Aligned_cols=159 Identities=19% Similarity=0.192 Sum_probs=117.2
Q ss_pred cccCCeeeecCCcccccCCccccC-----CccCCeeecccccCCcc-Cccc-cCCCCCcEEEcCCCeeeecCCCCc----
Q 015202 65 LAALFQLDLGDNKLSGFVPSCFGN-----LTNLRKLYLGSNQLTYI-PLTL-WNLKYILYLNLSSNSFTIPLPSEI---- 133 (411)
Q Consensus 65 l~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~L~l~~n~l~~~-p~~~-~~~~~L~~L~l~~n~l~~~~~~~~---- 133 (411)
+++|++|+|++|.++......+.. .++|+.|+|++|.++.. ...+ ..+++|+.|++++|.++......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 568999999999987543333333 26899999999998732 1122 245679999999999875433333
Q ss_pred -cCccCCCeEEccCCeeccc----CCCCccCCCccCeeeccccccccc----CCccccCCCCCCEEeCCCCccccc----
Q 015202 134 -GNLEVLVQIDLSMNNFSGA----IPTTIGGLKDLQYLFLEYNRLQGS----IPDFIGGLINLKSLDLSNNNLSGA---- 200 (411)
Q Consensus 134 -~~l~~L~~L~l~~n~~~~~----~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~---- 200 (411)
...++|+.|+|++|.++.. ++..+..+++|++|+|++|.+++. ++..+...++|+.|++++|.+++.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 2457899999999998753 334446788999999999998752 245566778999999999999753
Q ss_pred cchhhhcCCCCCEEEcccCcccc
Q 015202 201 IPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 201 ~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
+...+...++|+.|++++|.++.
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHHhCCCCCEEeccCCCCCH
Confidence 34455667899999999998864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.38 E-value=7.1e-14 Score=126.43 Aligned_cols=81 Identities=21% Similarity=0.241 Sum_probs=62.7
Q ss_pred CeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH--------------------------
Q 015202 330 NIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-------------------------- 376 (411)
+.||+|+||.||+|++. +++.||||+++... ....++|.+|+.++++
T Consensus 32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~ 111 (308)
T 4gt4_A 32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC 111 (308)
T ss_dssp EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence 68999999999999983 45789999996443 3345789999999998
Q ss_pred ------cccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++|+.+. ....++|.++++||.|||+||+|||+.
T Consensus 112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 164 (308)
T 4gt4_A 112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 164 (308)
T ss_dssp SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3443221 013499999999999999999999974
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.37 E-value=1e-12 Score=121.64 Aligned_cols=102 Identities=20% Similarity=0.170 Sum_probs=61.2
Q ss_pred eecccc-cCCccCccccCCCCCcEEEcCC-CeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccc
Q 015202 95 LYLGSN-QLTYIPLTLWNLKYILYLNLSS-NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNR 172 (411)
Q Consensus 95 L~l~~n-~l~~~p~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~ 172 (411)
++.+++ +++.+|. +..+++|+.|+|++ |.+.+..+..|.++++|+.|+|++|.+++..|..|..+++|+.|+|++|+
T Consensus 13 v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 13 LRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp EECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 455554 5555665 55555666666654 66655555556666666666666666666666666666666666666666
Q ss_pred ccccCCccccCCCCCCEEeCCCCccc
Q 015202 173 LQGSIPDFIGGLINLKSLDLSNNNLS 198 (411)
Q Consensus 173 l~~~~~~~~~~~~~L~~L~l~~n~l~ 198 (411)
+++..+..+..++ |+.|++.+|.+.
T Consensus 92 l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred cceeCHHHcccCC-ceEEEeeCCCcc
Confidence 6655444444444 666666666665
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.5e-13 Score=122.29 Aligned_cols=82 Identities=21% Similarity=0.242 Sum_probs=64.1
Q ss_pred CCeeeccCCceEEEEEec------CCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------------
Q 015202 329 NNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------- 376 (411)
.+.||+|+||.||+|++. +|..||||+++..+....++|.+|++++++
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 478999999999999873 467899999977666667899999999998
Q ss_pred ------cccCCC----------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTR----------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~----------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++|+.. .....++|.++++||.|||+||+|||++
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 223221 1124599999999999999999999974
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=120.71 Aligned_cols=103 Identities=22% Similarity=0.199 Sum_probs=79.9
Q ss_pred ceeecCc-ccccccchhhhCCCCCCeeeccc-CcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeeccc
Q 015202 22 AIYLGGN-KLNGSISIALGKLQKLQLLGLED-NQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGS 99 (411)
Q Consensus 22 ~L~l~~n-~~~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 99 (411)
.++.+++ +++. +|. +..+++|++|+|++ |.+++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 5677776 6763 555 77888888888885 888877777788888888888888888877777788888888888888
Q ss_pred ccCCccCccccCCCCCcEEEcCCCeee
Q 015202 100 NQLTYIPLTLWNLKYILYLNLSSNSFT 126 (411)
Q Consensus 100 n~l~~~p~~~~~~~~L~~L~l~~n~l~ 126 (411)
|+++.+|..++....|+.|++.+|.+.
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCcc
Confidence 888888776665445888888888776
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=6.4e-12 Score=113.23 Aligned_cols=83 Identities=20% Similarity=0.277 Sum_probs=64.0
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------------------~~l~~ 381 (411)
+.-.+.||+|+||.||+|++.+ .||||.++.. .....++|.+|++++++ +|..+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~g 115 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEG 115 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCSS
T ss_pred eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCCC
Confidence 3344789999999999999853 6999998543 23446789999999998 33322
Q ss_pred CC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+ ...+++|.++++||.|||+||+|||+.
T Consensus 116 GsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 151 (307)
T 3omv_A 116 SSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK 151 (307)
T ss_dssp CBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21 124599999999999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2.3e-11 Score=110.00 Aligned_cols=78 Identities=22% Similarity=0.284 Sum_probs=57.0
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHH--HHHHHHHH---------------------------ccc
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFD--NEFMTVVD---------------------------ANL 379 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~--~e~~~~~~---------------------------~~l 379 (411)
.+.||+|+||.||+|++ +|+.||||+++... .++|. .|+..+.+ +|.
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 37899999999999999 68999999995432 33444 44544443 222
Q ss_pred CCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.+ ...+++|.++++|+.|+|+||+|||++
T Consensus 84 ~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~ 119 (303)
T 3hmm_A 84 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 119 (303)
T ss_dssp TTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 2211 123599999999999999999999974
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=9.5e-11 Score=106.32 Aligned_cols=100 Identities=24% Similarity=0.352 Sum_probs=80.2
Q ss_pred ccccccHHHHHHHhcCCCcC------CeeeccCCceEEEEEecCCCEEEEEEEeccc----chhhHhHHHHHHHHHH---
Q 015202 310 NQRRFTYLELFHATNGFSAN------NIIGRGGIGSIYKARIQDGMEVAVKVFDLQY----REAFKSFDNEFMTVVD--- 376 (411)
Q Consensus 310 ~~~~~~~~~l~~at~~f~~~------~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~----~~~~~~f~~e~~~~~~--- 376 (411)
....|++.++..+|++|+.. +.||+|+||.||+|.. ++..||||++.... ....+.|.+|+.++.+
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45689999999999999987 8999999999999997 67899999985422 2335779999999987
Q ss_pred --------------------ccc---------CCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------------ANL---------LTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------------~~l---------~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. .......+++|..+.+|+.++|+||+|||+.
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 152 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 222 1111234599999999999999999999964
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=2.3e-11 Score=111.93 Aligned_cols=94 Identities=18% Similarity=0.286 Sum_probs=68.8
Q ss_pred HHHHHHhcCCCcCCeeeccCCceEEEEEecC------CCEEEEEEEecccc-hhhHhHHHHHHHHHH-------------
Q 015202 317 LELFHATNGFSANNIIGRGGIGSIYKARIQD------GMEVAVKVFDLQYR-EAFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 317 ~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~------~~~vavk~l~~~~~-~~~~~f~~e~~~~~~------------- 376 (411)
.+++...++|.-.+.||+|+||.||+|.+.+ ++.||||++..... ...++|.+|++++.+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3333344555556889999999999998732 35799999965443 345789999999987
Q ss_pred ---------------------cccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------------------ANLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------------------~~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++|+... ....++|.+++.||.|||+||+|||+.
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~ 204 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 204 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC
Confidence 2332111 123489999999999999999999964
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=3.9e-11 Score=109.72 Aligned_cols=98 Identities=27% Similarity=0.370 Sum_probs=77.8
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------- 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------- 376 (411)
.+.+.++..++++|...+.||+|+||.||+|+..+|..||||++........+.|.+|++++.+
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3444556678889999999999999999999998899999999876665667889999999886
Q ss_pred ----------------cccCCCC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------------ANLLTRE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------------~~l~~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.... ....++|.++.+|+.++++||+|||+.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 158 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC
Confidence 2222221 123499999999999999999999963
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.9e-09 Score=100.16 Aligned_cols=198 Identities=11% Similarity=0.083 Sum_probs=99.3
Q ss_pred hhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCcc
Q 015202 12 EEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTN 91 (411)
Q Consensus 12 ~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 91 (411)
.+|.++.+|+.+.+.++- ..+....|.++.+|+.+++..+ ++.+....|.++..|+.+.+..+... +...+....+
T Consensus 156 ~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~ 231 (394)
T 4fs7_A 156 EAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTG 231 (394)
T ss_dssp TTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCC
T ss_pred hhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCC
Confidence 345666666666665443 2244456666666666666655 33344445566666666555443221 1111122233
Q ss_pred CCeeecccccCCccCc-cccCCCCCcEEEcCCCeeeecCC---------------------CCccCccCCCeEEccCCee
Q 015202 92 LRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLP---------------------SEIGNLEVLVQIDLSMNNF 149 (411)
Q Consensus 92 L~~L~l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~---------------------~~~~~l~~L~~L~l~~n~~ 149 (411)
|+.+.+... ++.+.. .+..+..|+.+.+..+... ... ..|..+.+|+.+.+..+ +
T Consensus 232 l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i 308 (394)
T 4fs7_A 232 VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-V 308 (394)
T ss_dssp CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-C
T ss_pred CceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccccccccccccccccc-c
Confidence 444443321 222221 2334555555555444322 222 33445555665555543 3
Q ss_pred cccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEccc
Q 015202 150 SGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSF 218 (411)
Q Consensus 150 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~ 218 (411)
+.+...+|..+.+|+.+++.++ ++.+-..+|.++.+|+.+++..+ ++.....+|..+.+|+.+++..
T Consensus 309 ~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 309 KFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp CEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred ceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 3344555666666666666533 44344556666666666666544 4444455566666666666543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.7e-10 Score=103.07 Aligned_cols=81 Identities=16% Similarity=0.126 Sum_probs=63.3
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH---------------------------ccc
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD---------------------------ANL 379 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~---------------------------~~l 379 (411)
.+||+|+||.||+|.. ..+..||||++.... ....+.|.+|++++++ +|.
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 5799999999999987 457899999995432 3345779999999997 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.+ ...++++.....|+.|||+||+|||++
T Consensus 112 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~ 148 (290)
T 3fpq_A 112 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148 (290)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222 123589999999999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=7.5e-11 Score=107.99 Aligned_cols=101 Identities=29% Similarity=0.394 Sum_probs=80.8
Q ss_pred ccccccHHHHHHHhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccc-hhhHhHHHHHHHHHH------------
Q 015202 310 NQRRFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD------------ 376 (411)
Q Consensus 310 ~~~~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~------------ 376 (411)
....+++.++..++++|...+.||+|+||.||+|...+|+.||||++..... .....|.+|++++..
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4567899999999999999999999999999999988899999999854432 233479999999886
Q ss_pred -----------cc---------cCCCC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----------AN---------LLTRE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----------~~---------l~~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++ ++... ...+++|..+..|+.++|+||+|||+.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 150 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDH 150 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 22 22222 223599999999999999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=3e-10 Score=103.76 Aligned_cols=100 Identities=21% Similarity=0.182 Sum_probs=78.3
Q ss_pred cccccHHHHHHHhcC----------CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH---
Q 015202 311 QRRFTYLELFHATNG----------FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD--- 376 (411)
Q Consensus 311 ~~~~~~~~l~~at~~----------f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~--- 376 (411)
...+++++++.+++. |...+.||+|+||.||+|... +|+.||||++........+.|.+|+.++.+
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 357899999999976 334468999999999999985 689999999976666666789999999987
Q ss_pred --------------------cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------------ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------------~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....++|..+..|+.++++||+|||+.
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~ 160 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332221 223589999999999999999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=1.2e-10 Score=106.45 Aligned_cols=85 Identities=24% Similarity=0.243 Sum_probs=67.6
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
|...+.||+|+||.||+|+. .+|+.||||+++.......+.|.+|++++.+ +|..+
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 44557899999999999987 4689999999976555556789999999998 33332
Q ss_pred CC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.+...|+.+|++||+|||++
T Consensus 156 g~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~ 189 (346)
T 4fih_A 156 GALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ 189 (346)
T ss_dssp EEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21 123489999999999999999999974
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.02 E-value=3e-11 Score=111.58 Aligned_cols=180 Identities=17% Similarity=0.141 Sum_probs=109.3
Q ss_pred hhhhCCCCCCeeecccCccc---------ccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCc-c
Q 015202 36 IALGKLQKLQLLGLEDNQLE---------GSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-I 105 (411)
Q Consensus 36 ~~~~~l~~L~~L~l~~n~l~---------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~ 105 (411)
.+...+++|+.|.+..+... +.+...+..+|+|+.|+|++|.-. .++. +. +++|+.|++..+.++. .
T Consensus 133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHH
T ss_pred HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHH
Confidence 34556677777777544221 123344566778888888776311 1222 33 6788888888777652 1
Q ss_pred Ccccc--CCCCCcEEEcCC--Ceeeec-----CCCCc--cCccCCCeEEccCCeecccCCCCc---cCCCccCeeecccc
Q 015202 106 PLTLW--NLKYILYLNLSS--NSFTIP-----LPSEI--GNLEVLVQIDLSMNNFSGAIPTTI---GGLKDLQYLFLEYN 171 (411)
Q Consensus 106 p~~~~--~~~~L~~L~l~~--n~l~~~-----~~~~~--~~l~~L~~L~l~~n~~~~~~~~~~---~~~~~L~~L~l~~n 171 (411)
...+. .+++|+.|+|+. |...+. +...+ ..+++|+.|++.+|.+.+..+..+ ..+++|+.|+|+.|
T Consensus 210 l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n 289 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAG 289 (362)
T ss_dssp HHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSS
T ss_pred HHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCC
Confidence 12232 578888887742 211111 11112 246789999998888764332222 24789999999999
Q ss_pred ccccc----CCccccCCCCCCEEeCCCCccccccchhhhc-CCCCCEEEcccCc
Q 015202 172 RLQGS----IPDFIGGLINLKSLDLSNNNLSGAIPISLEK-LLDLQHINVSFNK 220 (411)
Q Consensus 172 ~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~l~l~~n~ 220 (411)
.+++. ++..+..+++|+.|++++|.++...-..+.. + ...++++.+.
T Consensus 290 ~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 290 VLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp CCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 88753 2333456789999999999887554444443 2 3567888776
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.5e-08 Score=95.26 Aligned_cols=38 Identities=16% Similarity=0.127 Sum_probs=17.2
Q ss_pred hcccCC-cCCceeecCcccccccchhhhCCCCCCeeeccc
Q 015202 13 EINNLT-NLIAIYLGGNKLNGSISIALGKLQKLQLLGLED 51 (411)
Q Consensus 13 ~~~~~~-~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~ 51 (411)
+|.++. .|+.+.|..+ ++.+-..+|.+|++|+.+.+..
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~ 96 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQD 96 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGG
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecC
Confidence 344442 3555555432 3333344455555555555443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.8e-10 Score=106.35 Aligned_cols=180 Identities=17% Similarity=0.201 Sum_probs=119.5
Q ss_pred CCCCeeecccCcccc-c-------CchhhhccccCCeeeecCCccc---------ccCCccccCCccCCeeecccccCCc
Q 015202 42 QKLQLLGLEDNQLEG-S-------IPYDLCRLAALFQLDLGDNKLS---------GFVPSCFGNLTNLRKLYLGSNQLTY 104 (411)
Q Consensus 42 ~~L~~L~l~~n~l~~-~-------~~~~~~~l~~L~~L~l~~n~l~---------~~~~~~~~~l~~L~~L~l~~n~l~~ 104 (411)
..++.|.+......+ . +..+...+++|+.|.+.++... +.++..+..+|+|+.|++++|.-..
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 456777777554431 1 1233456889999998765321 1233445778999999999874234
Q ss_pred cCccccCCCCCcEEEcCCCeeeecCCCCcc--CccCCCeEEccC--Ceeccc-----CCCCc--cCCCccCeeecccccc
Q 015202 105 IPLTLWNLKYILYLNLSSNSFTIPLPSEIG--NLEVLVQIDLSM--NNFSGA-----IPTTI--GGLKDLQYLFLEYNRL 173 (411)
Q Consensus 105 ~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~--n~~~~~-----~~~~~--~~~~~L~~L~l~~n~l 173 (411)
++. + .+++|+.|++..|.+.......+. .+++|+.|+|+. |...+. +...+ ..+++|+.|++.+|.+
T Consensus 187 l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i 264 (362)
T 2ra8_A 187 IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEE 264 (362)
T ss_dssp CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTT
T ss_pred ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCC
Confidence 554 3 388999999998877643333343 688999999863 221111 01112 3578999999999988
Q ss_pred cccCCccc---cCCCCCCEEeCCCCccccc----cchhhhcCCCCCEEEcccCcccc
Q 015202 174 QGSIPDFI---GGLINLKSLDLSNNNLSGA----IPISLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 174 ~~~~~~~~---~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~l~l~~n~l~~ 223 (411)
.+..+..+ ..+++|++|+++.|.+.+. ++..+..+++|+.|++++|.++.
T Consensus 265 ~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 265 QNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp HHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred chHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 75332222 2578999999999999764 33444678999999999998763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=2e-10 Score=103.45 Aligned_cols=86 Identities=17% Similarity=0.235 Sum_probs=61.6
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH--------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-------------------------- 376 (411)
+|...+.||+|+||.||+|+. .+|+.||||++..... ...+.|.+|++++++
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 455668999999999999986 4689999999964433 335679999999997
Q ss_pred ---------cccCCCC---------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------ANLLTRE---------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------~~l~~~~---------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. .....+|.....|+.||++||+|||++
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~ 137 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK 137 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC
Confidence 1111111 112256777789999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=2.8e-10 Score=106.65 Aligned_cols=86 Identities=23% Similarity=0.225 Sum_probs=68.5
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|...+.||+|+||.||+|.. .+|+.||||++........+.|.+|+++|.+ +|+.
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 355567899999999999987 4689999999976655556789999999998 3333
Q ss_pred CCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.+...|+.+|++||+|||++
T Consensus 232 gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~ 266 (423)
T 4fie_A 232 GGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ 266 (423)
T ss_dssp TEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 221 123489999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=6.4e-10 Score=101.73 Aligned_cols=86 Identities=10% Similarity=0.204 Sum_probs=60.4
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+|.-.+.||+|+||.||+|+. .+|+.||||++.... ....+.|.+|++++++ +|
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 344557899999999999986 568999999995432 3345789999999998 43
Q ss_pred cCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.+ ++..+++.+...|+.||++||+|||++
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~ 144 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 33222 123478888899999999999999974
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.5e-08 Score=93.76 Aligned_cols=195 Identities=17% Similarity=0.176 Sum_probs=128.4
Q ss_pred ChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCc
Q 015202 11 PEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLT 90 (411)
Q Consensus 11 p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 90 (411)
...|.++.+|+.+.+..+ ++.+...+|.++..|+.+.+..+... +.+.+....+|+.+.+..+ ++......+..+.
T Consensus 178 ~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~ 253 (394)
T 4fs7_A 178 NGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCT 253 (394)
T ss_dssp TTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCS
T ss_pred cccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccc
Confidence 346788899999999776 55566678888888888887765322 1122222344555544322 2222233344444
Q ss_pred cCCeeecccccCC--------------------ccCc-cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCee
Q 015202 91 NLRKLYLGSNQLT--------------------YIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNF 149 (411)
Q Consensus 91 ~L~~L~l~~n~l~--------------------~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~ 149 (411)
.|+.+.+..+... .++. .+..+.+|+.+.+..+ +.......|.++.+|+.+++..+ +
T Consensus 254 ~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v 331 (394)
T 4fs7_A 254 DLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V 331 (394)
T ss_dssp SCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C
T ss_pred cceeEEcCCCcceeeccccccccccceeccCceeeccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-c
Confidence 4444444332111 1222 3457888999988765 55456678999999999999865 6
Q ss_pred cccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEE
Q 015202 150 SGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHI 214 (411)
Q Consensus 150 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l 214 (411)
+.+...+|.++.+|+.+.+..+ ++.+-..+|.++++|+.+++..+ +. .....|..+++|+.+
T Consensus 332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 6677889999999999999877 76677889999999999999754 33 234566666666543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.83 E-value=2.4e-07 Score=86.96 Aligned_cols=204 Identities=13% Similarity=0.142 Sum_probs=109.0
Q ss_pred ChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccc----
Q 015202 11 PEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCF---- 86 (411)
Q Consensus 11 p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---- 86 (411)
..+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ +..+....|..+.+|+.+.+.++ +..+....|
T Consensus 107 ~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~ 183 (394)
T 4gt6_A 107 RQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTGTA 183 (394)
T ss_dssp TTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCC
T ss_pred hhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccccc
Confidence 345777777777776654 44355566777777777777654 23244445666666666666543 222222233
Q ss_pred ------------------cCCccCCeeecccccCC-----------------------------ccCc--------cccC
Q 015202 87 ------------------GNLTNLRKLYLGSNQLT-----------------------------YIPL--------TLWN 111 (411)
Q Consensus 87 ------------------~~l~~L~~L~l~~n~l~-----------------------------~~p~--------~~~~ 111 (411)
..+.++.......+... .+|. .+..
T Consensus 184 l~~i~ip~~~~~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~ 263 (394)
T 4gt6_A 184 LTQIHIPAKVTRIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDS 263 (394)
T ss_dssp CSEEEECTTCCEECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTT
T ss_pred eeEEEECCcccccccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeee
Confidence 33333333322211111 1111 2234
Q ss_pred CCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEe
Q 015202 112 LKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191 (411)
Q Consensus 112 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 191 (411)
+..|+.+.+..+... .....|.++..|+.+.+.. .++.+...+|.++.+|+.+.+..+ ++.+-..+|.++.+|+.+.
T Consensus 264 c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ 340 (394)
T 4gt6_A 264 CAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIA 340 (394)
T ss_dssp CSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred cccccEEecccccce-ecCcccccccccccccCCC-cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEE
Confidence 555555555544322 3344555666666666643 333355566666666777666543 4434455666666777776
Q ss_pred CCCCccccccchhhhcCCCCCEEEcccCcc
Q 015202 192 LSNNNLSGAIPISLEKLLDLQHINVSFNKL 221 (411)
Q Consensus 192 l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l 221 (411)
+..+ ++.....+|..+.+|+.+++.++..
T Consensus 341 ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 341 IPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp ECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred ECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 6543 4445555666667777776665543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=98.82 E-value=2.4e-09 Score=94.80 Aligned_cols=86 Identities=14% Similarity=0.208 Sum_probs=62.3
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||+|.. .+|+.||||++.... ......|.+|++++.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4566668999999999999986 468999999995432 2224679999999997
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|.. .. ...+++..+...++.||+.||+|||++
T Consensus 93 Ey~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~ 131 (275)
T 3hyh_A 93 EYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131 (275)
T ss_dssp ECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3321 11 123589999999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.80 E-value=5.3e-09 Score=94.87 Aligned_cols=86 Identities=17% Similarity=0.158 Sum_probs=68.2
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
+|...+.||+|+||.||+|+. .+|..||||++........+.|.+|++++.+ +|..
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 344558999999999999997 4588999999966555667889999999987 3332
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....++|.++.+|+.++|+||+|||+.
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 127 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 211 134599999999999999999999964
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.80 E-value=4e-09 Score=98.75 Aligned_cols=86 Identities=19% Similarity=0.210 Sum_probs=65.1
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------- 376 (411)
+|.-.+.||+|+||.||+|.. ..|+.||||++.... ....+.+.+|+++|.+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 344557999999999999986 568999999995432 2335679999999997
Q ss_pred ----cccCCC-----CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTR-----EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~-----~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+. ....++++.+...|+.||++||+|||++
T Consensus 135 ~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~ 177 (398)
T 4b99_A 135 YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA 177 (398)
T ss_dssp EEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111100 0134599999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=2.3e-09 Score=97.62 Aligned_cols=81 Identities=15% Similarity=0.183 Sum_probs=62.2
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|...+.||+|+||.||+|+. ..|+.||||+++... .+.+|+.++++ +|+.
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 344456899999999999987 468999999996432 23579998887 4443
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.+ ...++++.+...|+.||++||+|||++
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~ 169 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 169 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 322 123599999999999999999999985
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.79 E-value=1.5e-09 Score=90.65 Aligned_cols=115 Identities=10% Similarity=0.074 Sum_probs=59.6
Q ss_pred hhhhCCCCCCeeecccC-ccccc----CchhhhccccCCeeeecCCccccc----CCccccCCccCCeeecccccCCc--
Q 015202 36 IALGKLQKLQLLGLEDN-QLEGS----IPYDLCRLAALFQLDLGDNKLSGF----VPSCFGNLTNLRKLYLGSNQLTY-- 104 (411)
Q Consensus 36 ~~~~~l~~L~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~-- 104 (411)
..+...++|++|+|++| .+... +...+...++|++|+|++|.+... +...+...++|+.|+|++|.++.
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34455555666666655 55422 222333445566666666655421 22233334556666666666652
Q ss_pred ---cCccccCCCCCcEEEc--CCCeeeec----CCCCccCccCCCeEEccCCeec
Q 015202 105 ---IPLTLWNLKYILYLNL--SSNSFTIP----LPSEIGNLEVLVQIDLSMNNFS 150 (411)
Q Consensus 105 ---~p~~~~~~~~L~~L~l--~~n~l~~~----~~~~~~~l~~L~~L~l~~n~~~ 150 (411)
+...+...++|++|++ ++|.+... +...+...++|+.|++++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3444555566666666 55665532 2223334466777777777654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=98.77 E-value=5.3e-09 Score=97.52 Aligned_cols=87 Identities=18% Similarity=0.274 Sum_probs=66.1
Q ss_pred cCCCcCCeeeccCCceEEEEEec----CCCEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
++|...+.||+|+||.||+|+.. ++..||||++.... ....++|.+|+.++.+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 34566789999999999999874 46789999996543 3345789999999987
Q ss_pred -cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. .+..++|.++.+|+.+||+||+|||+.
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 123599999999999999999999964
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.1e-08 Score=93.47 Aligned_cols=98 Identities=21% Similarity=0.238 Sum_probs=63.9
Q ss_pred cccHHHHHHHhcCCCc---------CCeeeccCCceEEEEEec----CCCEEEEEEEeccc-chhhHhHHHHHHHHHH--
Q 015202 313 RFTYLELFHATNGFSA---------NNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-- 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~---------~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-- 376 (411)
..++.+...++..|.. .+.||+|+||.||+|... .+..||||++.... ....+.|.+|++++.+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 108 (325)
T 3kul_A 29 PHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108 (325)
T ss_dssp --------------CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC
T ss_pred cccccCccccchhhccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC
Confidence 3445555555555543 378999999999999983 34569999996543 3345789999999987
Q ss_pred ---------------------cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------------------ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------------------~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++|.++..|+.++++||+|||+.
T Consensus 109 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 170 (325)
T 3kul_A 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170 (325)
T ss_dssp CTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 123599999999999999999999964
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=98.74 E-value=3.2e-09 Score=95.49 Aligned_cols=86 Identities=13% Similarity=0.130 Sum_probs=65.6
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|++++.+ +
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 455568999999999999986 568999999995432 2335679999999997 3
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.+ ....++..+-..++.||+.||+|||++
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~ 151 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 332211 123588888889999999999999974
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.74 E-value=3.2e-07 Score=85.64 Aligned_cols=106 Identities=13% Similarity=0.101 Sum_probs=73.6
Q ss_pred CCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEE
Q 015202 111 NLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSL 190 (411)
Q Consensus 111 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 190 (411)
.+.+|+.+.+..+ +.......|.++..|+.+.+..+ ++.+....|..+.+|+.+.+..+ ++.....+|.++++|+.+
T Consensus 215 ~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i 291 (379)
T 4h09_A 215 YGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKV 291 (379)
T ss_dssp TCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEE
T ss_pred cccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccc
Confidence 4566777777654 33345566777788888888766 44456677777788888877654 444555677788888888
Q ss_pred eCCCCccccccchhhhcCCCCCEEEcccC
Q 015202 191 DLSNNNLSGAIPISLEKLLDLQHINVSFN 219 (411)
Q Consensus 191 ~l~~n~l~~~~~~~~~~l~~L~~l~l~~n 219 (411)
.+.++.++.....+|..+.+|+.+.+..+
T Consensus 292 ~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 292 VMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp EECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred cccccccceehhhhhcCCCCCCEEEcCcc
Confidence 88777777666677778888888877543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=3.8e-09 Score=95.85 Aligned_cols=86 Identities=21% Similarity=0.303 Sum_probs=65.5
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
++|.-.+.||+|+||.||+|.. +|..||||++.... ....++|.+|++++.+ +|
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 3455558999999999999988 67899999985433 2335689999999997 22
Q ss_pred cCCCC------CC---CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DK---HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~---~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. .. ..+++..+..|+.++++||+|||+.
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 156 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Confidence 22211 11 1389999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=98.71 E-value=1.1e-08 Score=91.98 Aligned_cols=84 Identities=18% Similarity=0.244 Sum_probs=65.5
Q ss_pred CcCCeeeccCCceEEEEEe-----cCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------
Q 015202 327 SANNIIGRGGIGSIYKARI-----QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l-----~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------- 376 (411)
.-.+.||+|+||.||+|++ .+|+.||||++........+.|.+|++++.+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 92 (295)
T 3ugc_A 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 92 (295)
T ss_dssp EEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEE
T ss_pred hhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEE
Confidence 3447899999999999986 3578899999976655566789999999987
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....++|.++.+|+.++++||+|||+.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (295)
T 3ugc_A 93 EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133 (295)
T ss_dssp ECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 2222211 122489999999999999999999963
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=8.9e-09 Score=91.27 Aligned_cols=84 Identities=15% Similarity=0.235 Sum_probs=64.2
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-------------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-------------------------~~ 378 (411)
|.-.+.||+|+||.||+|+. +|..||||++.... ....+.|.+|+.++.+ ++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 44458999999999999998 57899999995432 3345679999998886 12
Q ss_pred cCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ...+++|.++..|+.++++||+|||+.
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 130 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 21111 122489999999999999999999973
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.70 E-value=2.5e-09 Score=97.13 Aligned_cols=87 Identities=15% Similarity=0.083 Sum_probs=63.2
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------ 376 (411)
++|...++||+|+||.||+|... +|+.||||++.... ......+..|+..+.+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 35666789999999999999985 68999999985432 2334556667766654
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. .+..++|..+.+|+.++|+||+|||+.
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 176 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2221100 123599999999999999999999964
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.69 E-value=2.6e-08 Score=89.53 Aligned_cols=85 Identities=13% Similarity=0.109 Sum_probs=63.6
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------------- 376 (411)
+....+||+|+||.||+|.. .++..||||.+........+.|.+|+.++..
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 34446999999999999986 5678999999976555556789999999986
Q ss_pred ----cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++........+++.....|+.++++||+|||+.
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 141 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC
Confidence 2222211223477888999999999999999963
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=98.69 E-value=4.2e-09 Score=100.99 Aligned_cols=86 Identities=14% Similarity=0.171 Sum_probs=66.5
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCC
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLT 381 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~ 381 (411)
++|.-.+.||+|+||.||+|.+.++..||||++.... ...++|.+|++++.+ ++..+
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 266 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecCC
Confidence 4444558999999999999999888899999996543 346789999999987 22211
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. .+..+++..+++|+.+||+||+|||+.
T Consensus 267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 303 (454)
T 1qcf_A 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303 (454)
T ss_dssp CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 012478889999999999999999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2e-08 Score=93.24 Aligned_cols=98 Identities=15% Similarity=0.211 Sum_probs=75.5
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccch-----------hhHhHHHHHHHHHH-----
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYRE-----------AFKSFDNEFMTVVD----- 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~-----------~~~~f~~e~~~~~~----- 376 (411)
+....++....++|.-.+.||+|+||.||+|...+|..||||++...... ..+.|.+|++++.+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 34567888889999999999999999999999888999999998432211 13679999999987
Q ss_pred -----------------------cccCCC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----------------------ANLLTR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----------------------~~l~~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+. .....+++..+..|+.++++||+|||+.
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 153 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA 153 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111100 0123589999999999999999999964
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.67 E-value=3e-09 Score=88.70 Aligned_cols=114 Identities=18% Similarity=0.100 Sum_probs=67.0
Q ss_pred hcccCCcCCceeecCc-cccc----ccchhhhCCCCCCeeecccCccccc----CchhhhccccCCeeeecCCccccc--
Q 015202 13 EINNLTNLIAIYLGGN-KLNG----SISIALGKLQKLQLLGLEDNQLEGS----IPYDLCRLAALFQLDLGDNKLSGF-- 81 (411)
Q Consensus 13 ~~~~~~~L~~L~l~~n-~~~~----~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~-- 81 (411)
.+...+.|++|+|++| .+.. .+...+...++|++|+|++|.++.. +.+.+...++|++|+|++|.|...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3455666777777776 6642 1334455566677777777766532 223344456677777777766532
Q ss_pred --CCccccCCccCCeeec--ccccCCc-----cCccccCCCCCcEEEcCCCeee
Q 015202 82 --VPSCFGNLTNLRKLYL--GSNQLTY-----IPLTLWNLKYILYLNLSSNSFT 126 (411)
Q Consensus 82 --~~~~~~~l~~L~~L~l--~~n~l~~-----~p~~~~~~~~L~~L~l~~n~l~ 126 (411)
+...+...++|+.|++ ++|.++. +...+...++|++|++++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3444555566777777 6666662 3344445566777777776654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=98.66 E-value=7.2e-09 Score=99.25 Aligned_cols=85 Identities=13% Similarity=0.161 Sum_probs=65.7
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTR 382 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~ 382 (411)
+|.-.+.||+|+||.||+|.+.++..||||++.... ...++|.+|++++.+ ++..+.
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~g 263 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG 263 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTC
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcCC
Confidence 344457899999999999999877889999996543 235689999999997 222211
Q ss_pred C--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. .+..+++.++++|+.+||+||+|||+.
T Consensus 264 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 299 (452)
T 1fmk_A 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299 (452)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 113489999999999999999999964
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=2.7e-09 Score=95.88 Aligned_cols=86 Identities=16% Similarity=0.176 Sum_probs=58.9
Q ss_pred CCCcCCeeeccCCceEEEEEe----cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI----QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l----~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~---------------------- 376 (411)
+|.-.+.||+|+||.||+|+- ..++.||||.++... ......|.+|++++.+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 344558999999999999975 246789999995432 2234568999998887
Q ss_pred -cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.+ ...++++.+...++.||++||+|||++
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~ 145 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4443322 123589999999999999999999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=2.9e-08 Score=89.45 Aligned_cols=87 Identities=21% Similarity=0.268 Sum_probs=68.2
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+.|...+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++.+ +|+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 3466668999999999999985 5788999999976555556789999999987 333
Q ss_pred CCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++.+...|+.++++||+|||+.
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 135 (297)
T 3fxz_A 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135 (297)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222 122488999999999999999999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=98.66 E-value=8.2e-09 Score=101.00 Aligned_cols=86 Identities=13% Similarity=0.163 Sum_probs=66.0
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCC
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLT 381 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~ 381 (411)
++|.-.+.||+|+||.||+|.+.++..||||++.... ...++|.+|+++|.+ +|+.+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~ 345 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 345 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcC
Confidence 3444558899999999999999877889999996543 235689999999997 22211
Q ss_pred CC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. .+..++|.++++|+.+||+||+|||+.
T Consensus 346 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 382 (535)
T 2h8h_A 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382 (535)
T ss_dssp EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 10 113489999999999999999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=98.65 E-value=2.4e-08 Score=98.12 Aligned_cols=86 Identities=14% Similarity=0.200 Sum_probs=67.5
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
+|.-.+.||+|+||.||+|.. ..|+.||||.+........+.+.+|+++|.. +|+.
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 455557899999999999987 4689999999966555556789999999987 3333
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.+...++.||++||+|||++
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~ 274 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 211 123589999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.1e-08 Score=87.80 Aligned_cols=84 Identities=12% Similarity=0.103 Sum_probs=65.4
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
|.-.+.||+|+||.||+|...++..||||++.... ...++|.+|++++.+ ++..+.
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 34457899999999999999888899999996443 234679999999987 222221
Q ss_pred C-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++..+.+|+.++++||+|||+.
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 125 (269)
T 4hcu_A 91 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125 (269)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 123489999999999999999999964
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.64 E-value=1.7e-08 Score=91.96 Aligned_cols=85 Identities=14% Similarity=0.176 Sum_probs=64.3
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-------------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-------------------------~~ 378 (411)
|.-.++||+|+||.||+|... +|+.||||++.... ....+.+.+|++++.+ +|
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 334579999999999999984 48899999996433 2335778999999987 22
Q ss_pred cCCCC---------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE---------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~---------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++.++..|+.++++||+|||+.
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 131 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21111 112389999999999999999999964
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=9.4e-09 Score=95.24 Aligned_cols=64 Identities=16% Similarity=0.267 Sum_probs=48.8
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~ 376 (411)
.+...++....++|.-.+.||+|+||.||+|.+ .+++.||||++.... ....+.|.+|++++.+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 81 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHH
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHh
Confidence 345555566677787789999999999999974 245689999996543 3345779999999886
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.64 E-value=1.4e-08 Score=89.10 Aligned_cols=104 Identities=21% Similarity=0.249 Sum_probs=77.3
Q ss_pred cccCCcCCc--eeecCccc---ccccchhhhCCCCCCeeecccCcccc--cCchhhhccccCCeeeecCCcccccCCccc
Q 015202 14 INNLTNLIA--IYLGGNKL---NGSISIALGKLQKLQLLGLEDNQLEG--SIPYDLCRLAALFQLDLGDNKLSGFVPSCF 86 (411)
Q Consensus 14 ~~~~~~L~~--L~l~~n~~---~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 86 (411)
|...+.|.. ++++.|.. .+..+....++++|+.|+|++|.+++ .++..+..+++|+.|+|++|.+.+. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 555666666 77777743 33333344688999999999999987 4456778899999999999999865 334
Q ss_pred cCCc--cCCeeecccccCC-ccCc-------cccCCCCCcEEE
Q 015202 87 GNLT--NLRKLYLGSNQLT-YIPL-------TLWNLKYILYLN 119 (411)
Q Consensus 87 ~~l~--~L~~L~l~~n~l~-~~p~-------~~~~~~~L~~L~ 119 (411)
..+. +|+.|+|++|.++ .+|. .+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 8999999999997 4552 355789999876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.63 E-value=1e-08 Score=89.96 Aligned_cols=105 Identities=22% Similarity=0.205 Sum_probs=76.4
Q ss_pred hhCCCCCCe--eecccCccc---ccCchhhhccccCCeeeecCCcccc--cCCccccCCccCCeeecccccCCccCcccc
Q 015202 38 LGKLQKLQL--LGLEDNQLE---GSIPYDLCRLAALFQLDLGDNKLSG--FVPSCFGNLTNLRKLYLGSNQLTYIPLTLW 110 (411)
Q Consensus 38 ~~~l~~L~~--L~l~~n~l~---~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~ 110 (411)
|...+.|.. ++++.|... ..++....++++|++|+|++|.+++ .+|..+..+++|+.|+|++|.++.+. .+.
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~-~l~ 215 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSER-ELD 215 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGG-GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCch-hhh
Confidence 444455555 677777433 2222233568999999999999997 34566778999999999999999763 344
Q ss_pred CCC--CCcEEEcCCCeeeecCCC-------CccCccCCCeEE
Q 015202 111 NLK--YILYLNLSSNSFTIPLPS-------EIGNLEVLVQID 143 (411)
Q Consensus 111 ~~~--~L~~L~l~~n~l~~~~~~-------~~~~l~~L~~L~ 143 (411)
.+. +|++|++++|.+.+.+|. .+..+++|+.||
T Consensus 216 ~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 216 KIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 444 999999999999876552 356778888776
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=1e-08 Score=95.82 Aligned_cols=86 Identities=17% Similarity=0.206 Sum_probs=65.7
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|.-.+.||+|+||.||+|... +++.||||.+.... .....+|.+|++++.+ ++.
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 3444589999999999999985 68899999986443 2335679999999987 222
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. .+..+++.++.+|+.+||+||+|||+.
T Consensus 195 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 232 (377)
T 3cbl_A 195 QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232 (377)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2211 122489999999999999999999964
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=98.63 E-value=1.3e-08 Score=98.66 Aligned_cols=85 Identities=12% Similarity=0.187 Sum_probs=65.7
Q ss_pred CCCcCCeeeccCCceEEEEEecC-CCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
+|...+.||+|+||.||+|.+.+ +..||||.+.... ...++|.+|++++.+ ++..
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence 34455899999999999999854 7889999996443 235789999999997 2222
Q ss_pred CCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ....++|..++.|+.+||+||+|||+.
T Consensus 300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 337 (495)
T 1opk_A 300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337 (495)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 123589999999999999999999964
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.63 E-value=1.2e-08 Score=94.89 Aligned_cols=85 Identities=12% Similarity=0.113 Sum_probs=62.7
Q ss_pred hcCCCcCCeeeccCCceEEEEE------ecCCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKAR------IQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~------l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------- 376 (411)
.+.|...+.||+|+||.||+|+ ...++.||||++.... ..+|..|++++.+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3455566899999999999994 4567899999996443 4567777777765
Q ss_pred ------cccCCCC-----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTRE-----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~-----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++|..+..|+.+||+||+|||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~ 191 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 2222111 134599999999999999999999984
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.62 E-value=2.2e-08 Score=93.33 Aligned_cols=82 Identities=16% Similarity=0.217 Sum_probs=60.6
Q ss_pred CCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC-
Q 015202 329 NNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE- 383 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~- 383 (411)
.+.||+|+||.||+|.. .+|..||||++........++|.+|++++.+ +|..+..
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999987 4688999999976655567789999999987 3332211
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|..+..|+.+|++||+|||+.
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 206 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123489999999999999999999964
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.5e-08 Score=91.03 Aligned_cols=84 Identities=17% Similarity=0.163 Sum_probs=62.0
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH---------------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------------~ 377 (411)
+|...+.||+|+||.||+|+. .++.||||++.... .....+..|+.++.+ +
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 344558999999999999998 47899999995432 334456678887766 1
Q ss_pred ccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....++|..+.+|+.++|+||+|||+.
T Consensus 103 ~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~ 140 (322)
T 3soc_A 103 FHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHED 140 (322)
T ss_dssp CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhh
Confidence 111111 123489999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=98.62 E-value=3e-08 Score=94.88 Aligned_cols=83 Identities=16% Similarity=0.228 Sum_probs=64.0
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~l~ 380 (411)
+|.-.+.||+|+||.||+|.+ .|+.||||.++... ..++|.+|++++.+ +|..
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 344458999999999999998 57899999996433 45789999999987 2221
Q ss_pred CCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. +...+++.++.+|+.+||+||+|||+.
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 308 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 122378999999999999999999964
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.62 E-value=2.2e-08 Score=90.66 Aligned_cols=81 Identities=19% Similarity=0.292 Sum_probs=62.3
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH---------------------cccCC---
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------------ANLLT--- 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------~~l~~--- 381 (411)
|.-.+.||+|+||.||+|.. .++.||||++... ...+.|.+|++++.+ +|..+
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L 86 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBH
T ss_pred eeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCH
Confidence 33458899999999999998 5789999998532 345789999999987 22221
Q ss_pred ------CCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 382 ------REDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 382 ------~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
......+++...++++.++|+||+|||+
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 120 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHh
Confidence 1111237889999999999999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.61 E-value=3e-08 Score=93.20 Aligned_cols=85 Identities=15% Similarity=0.201 Sum_probs=64.4
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------------c-
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-------------------------A- 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-------------------------~- 377 (411)
|.-.++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++.+ +
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 334579999999999999984 48899999996433 2335678899999987 1
Q ss_pred --------ccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 --------NLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 --------~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++........+++..+..|+.++++||+|||+.
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 131 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 122111122389999999999999999999964
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=3.4e-08 Score=89.60 Aligned_cols=86 Identities=19% Similarity=0.220 Sum_probs=64.2
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|...+.||+|+||.||+|...+|+.||||++.... ......+.+|++++.+ ++.
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 344558999999999999999889999999985432 2234679999999987 222
Q ss_pred CCC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+. .....+++.....|+.++++||+|||+.
T Consensus 102 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 138 (311)
T 3niz_A 102 EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138 (311)
T ss_dssp SEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 110 0123489999999999999999999964
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=4.9e-08 Score=87.34 Aligned_cols=87 Identities=22% Similarity=0.378 Sum_probs=65.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchh-------hHhHHHHHHHHHH-------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREA-------FKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~-------~~~f~~e~~~~~~------------------- 376 (411)
++|.-.+.||+|+||.||+|.. .+++.||||++....... .+.|.+|++++.+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~l 98 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM 98 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEE
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeE
Confidence 3444558899999999999987 468899999984432211 1679999999987
Q ss_pred --cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ...+++|..+..|+.++++||+|||+.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 141 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC
Confidence 2222111 234599999999999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.60 E-value=5e-08 Score=87.88 Aligned_cols=87 Identities=15% Similarity=0.138 Sum_probs=61.6
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc--------------------------hhhHhHHHHHHHHHH
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR--------------------------EAFKSFDNEFMTVVD 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~--------------------------~~~~~f~~e~~~~~~ 376 (411)
++|.-.+.||+|+||.||+|.. .+|+.||||++..... ...+.|.+|++++.+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 3455568999999999999986 4678899999854321 113568999999987
Q ss_pred -------------------------cccCC-----CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------------------------ANLLT-----REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------------------------~~l~~-----~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+ .....++++.+...++.++++||+|||+.
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22211 11234589999999999999999999964
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=2.3e-08 Score=95.06 Aligned_cols=96 Identities=13% Similarity=0.189 Sum_probs=72.5
Q ss_pred cHHHHHHHhcCCCcCCeeeccCCceEEEEEecC-CCEEEEEEEecccc---hhhHhHHHHHHHHHH--------------
Q 015202 315 TYLELFHATNGFSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-------------- 376 (411)
Q Consensus 315 ~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-------------- 376 (411)
.+.++...+++|...++||+|+||.||+|...+ ++.||||++..... .....|.+|+.++..
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 455666677888888999999999999999854 67899999954321 223459999999886
Q ss_pred ---------cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....+++.....++.+++.||+|||+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~ 194 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3332211 124589999999999999999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.59 E-value=2.3e-08 Score=92.11 Aligned_cols=82 Identities=20% Similarity=0.251 Sum_probs=64.6
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------c-
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-------------------------A- 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-------------------------~- 377 (411)
|.-.+.||+|+||.||++...+++.||||++.... ....+.|.+|++++.+ +
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~ 90 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC
Confidence 44558999999999999998889999999985432 3345789999998886 1
Q ss_pred -------ccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 -------NLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 -------~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. ....+++..+..|+.++++||+|||+.
T Consensus 91 ~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~ 127 (343)
T 3dbq_A 91 GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 127 (343)
T ss_dssp CSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 123589999999999999999999964
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.59 E-value=2.5e-08 Score=91.41 Aligned_cols=86 Identities=13% Similarity=0.154 Sum_probs=65.9
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH---------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------------------- 376 (411)
+|.-.+.||+|+||.||+|.. .+|+.||||++........+.|.+|+.++.+
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 344558999999999999997 4688999999865555556789999988875
Q ss_pred -----cccC--------CCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLL--------TREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~--------~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.. ......+++|..+.+|+.++++||+|||+.
T Consensus 109 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 155 (337)
T 3ll6_A 109 FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155 (337)
T ss_dssp EEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred EEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0110 000123589999999999999999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=3.3e-08 Score=91.40 Aligned_cols=88 Identities=17% Similarity=0.137 Sum_probs=65.4
Q ss_pred HHhcCCCcCCeeeccCCceEEEEEec----CCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------
Q 015202 321 HATNGFSANNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------- 376 (411)
...+.|.-.+.||+|+||.||+|+-. .++.||||++.... ....+.+|++++..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34566777789999999999999742 35689999985432 24568899998875
Q ss_pred ----cccCCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. .-..+++.+...++.|+++||+|||++
T Consensus 96 ~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~ 136 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF 136 (361)
T ss_dssp EEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3433222 012488888999999999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=7.9e-08 Score=86.57 Aligned_cols=81 Identities=17% Similarity=0.200 Sum_probs=60.7
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH---------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------------------- 376 (411)
++|.-.+.||+|+||.||+|.. +|+.||||++... ....+..|.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 3455668999999999999998 7899999998533 34556667766654
Q ss_pred --cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccC
Q 015202 377 --ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVES 408 (411)
Q Consensus 377 --~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh 408 (411)
+|..... ....++|..+.+|+.++|+||+|||
T Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH 122 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLH 122 (301)
T ss_dssp EECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred ehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHH
Confidence 1111111 2335899999999999999999999
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=98.58 E-value=3.6e-08 Score=88.07 Aligned_cols=85 Identities=12% Similarity=0.154 Sum_probs=62.7
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
+|...+.||+|+||.||+|...++..||||++..... ..++|.+|++++.+ ++..+
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 3444589999999999999998888999999965432 34679999999987 22221
Q ss_pred CC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ....+++.++.+|+.++++||+|||+.
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 139 (283)
T 3gen_A 104 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139 (283)
T ss_dssp CBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 023489999999999999999999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.58 E-value=6.7e-08 Score=90.41 Aligned_cols=87 Identities=13% Similarity=0.163 Sum_probs=67.9
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------ccc
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+.|.-.+.||+|+||.||+|... +|+.||+|.+..........+.+|++++.+ +|+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 34556689999999999999874 688999999976555556789999999987 333
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++.....|+.+|++||+|||+.
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 168 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2211 123589999999999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=3.5e-08 Score=92.54 Aligned_cols=82 Identities=20% Similarity=0.251 Sum_probs=64.7
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------c-
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-------------------------A- 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-------------------------~- 377 (411)
|...+.||+|+||.||++...+|+.||||++.... ......|.+|+.++.+ +
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~ 137 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec
Confidence 55568999999999999998789999999985432 3345789999998876 1
Q ss_pred -------ccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 -------NLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 -------~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. ....+++..+..|+.+|++||+|||+.
T Consensus 138 ~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~ 174 (390)
T 2zmd_A 138 GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 174 (390)
T ss_dssp CSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111 123588889999999999999999974
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=3.7e-08 Score=87.19 Aligned_cols=85 Identities=13% Similarity=0.153 Sum_probs=65.3
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
+|.-.+.||+|+||.||+|...++..||||++..... ..++|.+|++++.+ ++..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 3444588999999999999998888899999964432 34679999999987 22221
Q ss_pred CC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. .+..+++.++..|+.++++||+|||+.
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 123 (268)
T 3sxs_A 88 GCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123 (268)
T ss_dssp CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 122489999999999999999999964
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.57 E-value=2.8e-08 Score=93.69 Aligned_cols=97 Identities=16% Similarity=0.211 Sum_probs=72.9
Q ss_pred ccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-------------
Q 015202 314 FTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 314 ~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------- 376 (411)
+.+.+....+++|...++||+|+||.||++.. .+|+.||||++.... ......|.+|..++..
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34555566678888889999999999999998 468999999995432 2234568999998886
Q ss_pred ----------cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. .+..+++.....++.+|++||+|||+.
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 181 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332221 123588999999999999999999964
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=98.56 E-value=2.9e-08 Score=92.39 Aligned_cols=86 Identities=19% Similarity=0.218 Sum_probs=63.3
Q ss_pred CCCcCCeeeccCCceEEEEEec--------CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ--------DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~--------~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~------------------- 376 (411)
+|.-.+.||+|+||.||+|+.. ++..||||.+..... ...++|.+|++++.+
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 4445578999999999999862 345799999965433 345789999999886
Q ss_pred -----cccCC---------CC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLT---------RE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~---------~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+ .. ....++|..+.+|+.+||+||+|||+.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 222 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 222 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 22111 10 112489999999999999999999964
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=98.56 E-value=2.6e-08 Score=88.82 Aligned_cols=85 Identities=13% Similarity=0.109 Sum_probs=65.2
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTR 382 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~ 382 (411)
+|.-.+.||+|+||.||+|...++..||||++.... ...+.|.+|++++.+ ++..+.
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENG 92 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTC
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCCC
Confidence 344558999999999999999888899999995433 235689999999987 222111
Q ss_pred C-----C---CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-----D---KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-----~---~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. . +..+++..+.+|+.++++||+|||+.
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (279)
T 1qpc_A 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128 (279)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1 1 11489999999999999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=98.56 E-value=4.1e-08 Score=87.96 Aligned_cols=85 Identities=19% Similarity=0.174 Sum_probs=64.5
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|.-.+.||+|+||.||+|...+|+.||||++..... .....+.+|++++.+ ++..
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 444578999999999999987799999999954332 224678999999987 1111
Q ss_pred CC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+. .....+++.....++.++++||+|||+.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (288)
T 1ob3_A 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119 (288)
T ss_dssp EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 10 0123589999999999999999999964
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=98.56 E-value=4.7e-08 Score=86.64 Aligned_cols=85 Identities=20% Similarity=0.212 Sum_probs=62.4
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccc----hhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYR----EAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~----~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|.. .|..||||++..... ...+.|.+|++++.. +
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 445568999999999999998 578999999854322 224679999999887 2
Q ss_pred ccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++....+|+.++++||+|||+.
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~ 124 (271)
T 3dtc_A 87 FARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDE 124 (271)
T ss_dssp CCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred cCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 221111 234589999999999999999999963
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=6.9e-08 Score=85.31 Aligned_cols=84 Identities=12% Similarity=0.104 Sum_probs=65.0
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
|.-.+.||+|+||.||+|...++..||||++..... ..++|.+|++++.+ ++..+.
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 344578999999999999998888999999965432 34679999999987 222211
Q ss_pred C-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++..+.+++.++++||+|||+.
T Consensus 89 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 123 (267)
T 3t9t_A 89 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123 (267)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 123489999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=98.56 E-value=7.6e-08 Score=87.38 Aligned_cols=81 Identities=12% Similarity=0.119 Sum_probs=63.3
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cccCCCC-
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ANLLTRE- 383 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~l~~~~- 383 (411)
++||+|+||.||+|.. .+|+.||||++..........+.+|++++.+ ++..+..
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 6799999999999985 4688999999966555556789999998875 2222111
Q ss_pred -----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.....|+.++++||+|||+.
T Consensus 99 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 130 (316)
T 2ac3_A 99 LSHIHKRRHFNELEASVVVQDVASALDFLHNK 130 (316)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123588999999999999999999964
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.55 E-value=5.6e-08 Score=96.55 Aligned_cols=78 Identities=14% Similarity=0.215 Sum_probs=62.1
Q ss_pred eeeccCCceEEEEEec---CCCEEEEEEEeccc-chhhHhHHHHHHHHHH------------------------------
Q 015202 331 IIGRGGIGSIYKARIQ---DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------------ 376 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------------ 376 (411)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|++++.+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 7999999999999874 45679999996543 3346789999999987
Q ss_pred -cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++. ....++|.++..|+.+||+||+|||+.
T Consensus 423 ~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~ 455 (613)
T 2ozo_A 423 HKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK 455 (613)
T ss_dssp HHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22222 134599999999999999999999964
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.55 E-value=2.5e-08 Score=90.63 Aligned_cols=86 Identities=13% Similarity=0.088 Sum_probs=65.3
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH---------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------------------- 376 (411)
+|.-.+.||+|+||.||++.. .+|+.||||++........+.|.+|++++..
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 444568999999999999986 5789999999866555566789999999887
Q ss_pred cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ...++++.++.+|+.++++||+|||+.
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 153 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 124589999999999999999999964
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.55 E-value=7e-08 Score=88.13 Aligned_cols=84 Identities=18% Similarity=0.244 Sum_probs=65.3
Q ss_pred CcCCeeeccCCceEEEEEe-----cCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------
Q 015202 327 SANNIIGRGGIGSIYKARI-----QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 327 ~~~~~lg~g~~g~vy~g~l-----~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------- 376 (411)
.-.+.||+|+||.||++.+ .+|+.||||++........+.|.+|++++.+
T Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 123 (326)
T 2w1i_A 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123 (326)
T ss_dssp EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence 3447899999999999985 3578999999976655666789999999987
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....++|.++.+|+.++++||+|||+.
T Consensus 124 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 164 (326)
T 2w1i_A 124 EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164 (326)
T ss_dssp CCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 123489999999999999999999963
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.55 E-value=6.2e-08 Score=90.06 Aligned_cols=86 Identities=15% Similarity=0.232 Sum_probs=64.0
Q ss_pred CCCcCCeeeccCCceEEEEEec------CCCEEEEEEEecc-cchhhHhHHHHHHHHHH---------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQ-YREAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~-~~~~~~~f~~e~~~~~~--------------------- 376 (411)
+|.-.+.||+|+||.||+|.+. .+..||||++... ......+|.+|+.++.+
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 3444578999999999999963 3568999999543 33445679999999987
Q ss_pred --ccc---------CCCC----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANL---------LTRE----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l---------~~~~----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. .... ....++|.++.+|+.+||+||+|||+.
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 200 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 222 1110 113489999999999999999999964
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=98.55 E-value=6.3e-08 Score=86.92 Aligned_cols=86 Identities=20% Similarity=0.138 Sum_probs=65.0
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+|...+.||+|+||.||+|... +|+.||||++.... ......+.+|++++.+ ++
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 3445578999999999999874 58899999995433 2334778999999987 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++.....|+.++++||+|||+.
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 120 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 21100 124589999999999999999999964
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.55 E-value=3.8e-08 Score=90.49 Aligned_cols=90 Identities=17% Similarity=0.199 Sum_probs=67.3
Q ss_pred HHhcCCCcCCeeeccCCceEEEEEecC------CCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------
Q 015202 321 HATNGFSANNIIGRGGIGSIYKARIQD------GMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------------- 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~l~~------~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------- 376 (411)
...++|.-.+.||+|+||.||+|...+ +..||||.+.... ....+.|.+|++++.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 345666677899999999999999842 3789999996543 3335789999999987
Q ss_pred ------cccCCCC------------------------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTRE------------------------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~------------------------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ...+++|.++..|+.+|++||+|||+.
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2211100 014599999999999999999999964
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=98.54 E-value=7.4e-08 Score=88.06 Aligned_cols=87 Identities=17% Similarity=0.167 Sum_probs=66.5
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------c
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
++|.-.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++.. +
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4555668999999999999987 578999999995432 2345678999999987 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.++++||+|||+.
T Consensus 95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~ 133 (328)
T 3fe3_A 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133 (328)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123488889999999999999999964
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=8.3e-08 Score=87.53 Aligned_cols=86 Identities=16% Similarity=0.137 Sum_probs=63.0
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|.-.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++.. +|.
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4555689999999999999874 688999999854332 334679999999887 222
Q ss_pred CC-----CC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LT-----RE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~-----~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+ .. ....+++....+|+.++++||+|||+.
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 124 (323)
T 3tki_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124 (323)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 11 223599999999999999999999964
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=4.6e-08 Score=87.04 Aligned_cols=86 Identities=16% Similarity=0.180 Sum_probs=66.8
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|.-.+.||+|+||.||+|... ++..||+|++........+.|.+|++++.+ ++..
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 3455689999999999999874 467899999976555556789999999987 2222
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++....+|+.++++||+|||+.
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 125 (277)
T 3f3z_A 90 GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125 (277)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 211 123489999999999999999999964
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=5.6e-08 Score=87.06 Aligned_cols=85 Identities=21% Similarity=0.232 Sum_probs=64.8
Q ss_pred CCcCCeeeccCCceEEEEEecC-C-------CEEEEEEEecccchhhHhHHHHHHHHHH---------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQD-G-------MEVAVKVFDLQYREAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~-~-------~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------------- 376 (411)
|.-.+.||+|+||.||+|+..+ + ..||+|.+........+.|.+|++++.+
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 3445789999999999998732 2 4699999976655667889999999987
Q ss_pred --cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++..+.+|+.++++||+|||+.
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 132 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN 132 (289)
T ss_dssp EEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 2222211 122389999999999999999999964
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=98.53 E-value=5.4e-08 Score=88.93 Aligned_cols=86 Identities=17% Similarity=0.230 Sum_probs=59.0
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCE----EEEEEEecc-cchhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGME----VAVKVFDLQ-YREAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~----vavk~l~~~-~~~~~~~f~~e~~~~~~---------------------- 376 (411)
+|...+.||+|+||.||+|... +|.. ||+|.+... .....++|.+|+.++.+
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v~ 95 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT 95 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3555689999999999999863 4443 588887433 23446789999999987
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.... ....++|..+..|+.++|+||+|||+.
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 136 (327)
T 3poz_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136 (327)
T ss_dssp ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 1111111 124589999999999999999999964
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=98.53 E-value=1.2e-07 Score=89.72 Aligned_cols=89 Identities=10% Similarity=0.182 Sum_probs=66.2
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--------chhhHhHHHHHHHHHH----------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--------REAFKSFDNEFMTVVD---------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--------~~~~~~f~~e~~~~~~---------------- 376 (411)
..++|.-.+.||+|+||.||+|.. .+++.||||.+.... ......|.+|++++.+
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 355676778999999999999987 457899999985432 1123468999999987
Q ss_pred ------cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.....|+.++++||+|||+.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 258 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 234589999999999999999999964
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.53 E-value=1.3e-07 Score=84.52 Aligned_cols=79 Identities=14% Similarity=0.201 Sum_probs=62.4
Q ss_pred CeeeccCCceEEEEEec---CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------------
Q 015202 330 NIIGRGGIGSIYKARIQ---DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------------------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------------- 376 (411)
..||+|+||.||+|+.. ++..||||.+.... ....+.|.+|++++.+
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCC
Confidence 48999999999999863 56789999996543 3346789999999987
Q ss_pred --cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.. ....+++.++.+|+.++++||+|||+.
T Consensus 96 L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~ 129 (287)
T 1u59_A 96 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK 129 (287)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22221 124599999999999999999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=4.9e-08 Score=90.05 Aligned_cols=85 Identities=19% Similarity=0.221 Sum_probs=65.2
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||+|.. .+|+.||||++..... ...++|.+|++++.+ +|
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 55668899999999999986 5788999999964322 234679999999987 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ...+++|..+..|+.++++||+|||+.
T Consensus 136 ~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 173 (348)
T 1u5q_A 136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173 (348)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 21100 124589999999999999999999964
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=4.6e-08 Score=89.39 Aligned_cols=85 Identities=15% Similarity=0.201 Sum_probs=65.6
Q ss_pred CCcCCeeeccCCceEEEEEe-----cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-----QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-----~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------ 376 (411)
|.-.+.||+|+||.||++++ .++..||||++........+.|.+|++++.+
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 33447999999999999985 4578899999976655556789999999987
Q ss_pred -cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++|.++..|+.++++||+|||+.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 146 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146 (327)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2221111 012489999999999999999999964
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.51 E-value=1.1e-07 Score=87.11 Aligned_cols=82 Identities=18% Similarity=0.233 Sum_probs=61.5
Q ss_pred CCeeeccCCceEEEEEecC-----CCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 329 NNIIGRGGIGSIYKARIQD-----GMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~-----~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
.+.||+|+||.||+|.... +..||||.+.... .....+|.+|++++.+ ++.
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4789999999999998742 2359999996543 2345679999999987 222
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|.++.+|+.++++||+|||+.
T Consensus 129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (333)
T 1mqb_A 129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166 (333)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111 123589999999999999999999963
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.51 E-value=8.3e-08 Score=88.56 Aligned_cols=86 Identities=16% Similarity=0.232 Sum_probs=59.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cc
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
.+.|...+.||+|+||.||+|... +++.||||++.... ..+.|.+|++++.+ +|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 345666689999999999999985 47889999996432 34578899999987 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++.+...|+.++++||+|||+.
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 167 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22111 123489999999999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=1.4e-07 Score=85.76 Aligned_cols=83 Identities=14% Similarity=0.130 Sum_probs=63.1
Q ss_pred cCCeeeccCCceEEEEEec-----CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------------
Q 015202 328 ANNIIGRGGIGSIYKARIQ-----DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~-----~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------- 376 (411)
..+.||+|+||.||++.+. +|+.||||++.... ....+.|.+|++++.+
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence 4478999999999999763 57789999996543 3445779999999987
Q ss_pred cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....++|.++..|+.++++||+|||+.
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~ 153 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 153 (318)
T ss_dssp CCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 123489999999999999999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=8.7e-08 Score=86.36 Aligned_cols=86 Identities=16% Similarity=0.169 Sum_probs=64.5
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|.-.+.||+|+||.||+|... +|..||+|.+........+.|.+|++++.+ ++..
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 3445578999999999999985 588999999966555556789999999987 2221
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++..+..|+.++++||.|||+.
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 111 123589999999999999999999964
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=9.6e-08 Score=95.22 Aligned_cols=81 Identities=15% Similarity=0.150 Sum_probs=61.9
Q ss_pred CeeeccCCceEEEEEec---CCCEEEEEEEecccc--hhhHhHHHHHHHHHH----------------------cccCCC
Q 015202 330 NIIGRGGIGSIYKARIQ---DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD----------------------ANLLTR 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~----------------------~~l~~~ 382 (411)
+.||+|+||.||+|.+. .+..||||+++.... ...++|.+|++++.+ +|..+.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 57999999999999773 356799999965432 335789999999997 222111
Q ss_pred C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....++|.++..|+.+||+||+|||+.
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 488 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 488 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1 123589999999999999999999964
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=98.50 E-value=7.7e-08 Score=88.18 Aligned_cols=87 Identities=20% Similarity=0.269 Sum_probs=62.3
Q ss_pred cCCCcCCeeeccCCceEEEEEe--------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI--------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------ 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l--------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------ 376 (411)
++|.-.+.||+|+||.||+|.. .++..||||++.... ....+.|.+|++++.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 3444558999999999999986 246789999996443 3345779999998876
Q ss_pred ---------------cccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------------ANLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------------~~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.... ....++|..+.+|+.++++||+|||+.
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 176 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1121111 012389999999999999999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=2.2e-07 Score=84.90 Aligned_cols=81 Identities=12% Similarity=0.139 Sum_probs=62.1
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH------------------------cccCCC
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------ANLLTR 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------~~l~~~ 382 (411)
+.||+|+||.||+|... +|+.||||.+.... .....++.+|+.++.. ++..+.
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999874 58899999985433 2335789999998876 222110
Q ss_pred --------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 --------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 --------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.....+++.++..|+.++++||+|||+.
T Consensus 115 ~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~ 150 (327)
T 3lm5_A 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150 (327)
T ss_dssp EGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1124599999999999999999999963
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=6.5e-08 Score=87.77 Aligned_cols=88 Identities=17% Similarity=0.224 Sum_probs=65.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH------------cc--------c-
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------AN--------L- 379 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------~~--------l- 379 (411)
.+.|.-.+.||+|+||.||++...+|+.||||.+.... ......|.+|++++.+ ++ +
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 34455568999999999999998889999999995432 3345789999988876 00 0
Q ss_pred CCCC---------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE---------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~---------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++..+..|+.++++||+|||+.
T Consensus 107 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 146 (313)
T 3cek_A 107 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146 (313)
T ss_dssp ECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0000 123588999999999999999999964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=98.49 E-value=2.1e-08 Score=91.34 Aligned_cols=94 Identities=15% Similarity=0.114 Sum_probs=68.3
Q ss_pred HHHHHHhcCCCcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------
Q 015202 317 LELFHATNGFSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 317 ~~l~~at~~f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------- 376 (411)
+++....++|...+.||+|+||.||+|+.. .+..||||.+.... ......|.+|++++.+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344445566667789999999999999863 36789999996433 3345679999999987
Q ss_pred ----------cccCCCC----------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTRE----------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~~----------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ...+++|..+.+|+.++++||+|||+.
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 157 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN 157 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 1211110 013468999999999999999999964
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.2e-07 Score=86.77 Aligned_cols=84 Identities=13% Similarity=0.122 Sum_probs=63.8
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cc
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------AN 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~ 378 (411)
++|.-.+.||+|+||.||+|.. .+|+.||||.+.... ....|..|++++.+ ++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 3455668999999999999985 578899999985432 23468899988876 33
Q ss_pred cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. +.. ....++|..+..|+.++++||+|||+.
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 124 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3 211 134699999999999999999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.49 E-value=9.7e-08 Score=86.71 Aligned_cols=86 Identities=17% Similarity=0.172 Sum_probs=60.9
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH----------cccCC------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------ANLLT------------ 381 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------~~l~~------------ 381 (411)
.|...+.||+|+||.||+|... +|+.||||++........++|.+|++++.+ ++...
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3445588999999999999985 488999999976655666889999999986 11100
Q ss_pred --------------CC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 --------------RE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 --------------~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ...++++.....|+.++++||+|||+.
T Consensus 92 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 139 (320)
T 2i6l_A 92 TELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA 139 (320)
T ss_dssp CSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC
Confidence 00 123478899999999999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=98.49 E-value=8.9e-08 Score=88.21 Aligned_cols=85 Identities=14% Similarity=0.208 Sum_probs=65.4
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchh-----------------hHhHHHHHHHHHH----------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREA-----------------FKSFDNEFMTVVD---------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~-----------------~~~f~~e~~~~~~---------- 376 (411)
++|.-.+.||+|+||.||+|.. +|..||||++....... .+.|.+|+.++.+
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3455568999999999999998 88999999985432211 1789999999987
Q ss_pred -------------cccCC------------CC--CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 -------------ANLLT------------RE--DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 -------------~~l~~------------~~--~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|..+ .. ....++|..+..|+.++++||+|||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 169 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN 169 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc
Confidence 22111 11 13569999999999999999999996
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=98.49 E-value=9.2e-08 Score=85.72 Aligned_cols=82 Identities=18% Similarity=0.311 Sum_probs=61.8
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH--------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-------------------------- 376 (411)
.|.-.+.||+|+||.||+|... ..||||.+.... ....+.|.+|++++.+
T Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~ 102 (289)
T 3og7_A 25 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCE 102 (289)
T ss_dssp SCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCC
T ss_pred ceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecC
Confidence 4445589999999999999874 369999985433 3445789999999987
Q ss_pred -----cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++. ....++|.++.+|+.++++||+|||+.
T Consensus 103 ~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~ 139 (289)
T 3og7_A 103 GSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAK 139 (289)
T ss_dssp EEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 12221 123589999999999999999999963
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.1e-07 Score=86.01 Aligned_cols=86 Identities=16% Similarity=0.102 Sum_probs=64.9
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++.+ ++
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 4455689999999999999984 488999999844332 235678999999987 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++.....|+.++++||+|||+.
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~ 121 (311)
T 4agu_A 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121 (311)
T ss_dssp CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21110 134589999999999999999999963
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=98.49 E-value=2.1e-07 Score=84.96 Aligned_cols=79 Identities=14% Similarity=0.118 Sum_probs=61.0
Q ss_pred CCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cccCCCC
Q 015202 329 NNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ANLLTRE 383 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~l~~~~ 383 (411)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.++.. ++..+..
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999984 5889999999532 34567888888775 2222211
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.+...|+.++++||+|||+.
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 125 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 123589999999999999999999964
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.8e-07 Score=89.99 Aligned_cols=84 Identities=18% Similarity=0.164 Sum_probs=64.5
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cc
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------AN 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~ 378 (411)
++|...++||+|+||.||+|+. .+|..||||.+..... ..++..|++++.. ++
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4566678999999999999986 5689999998854332 3468888888876 22
Q ss_pred cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ +.. ....++|.+++.|+.+|++||+|||+.
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 122 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2 111 134599999999999999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.7e-07 Score=85.52 Aligned_cols=85 Identities=15% Similarity=0.247 Sum_probs=64.9
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccch------hhHhHHHHHHHHHH----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYRE------AFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~------~~~~f~~e~~~~~~---------------------- 376 (411)
|...+.||+|+||.||++... +|..||||.+...... ....|.+|+.++.+
T Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 445589999999999999874 5889999998543221 24679999999987
Q ss_pred -cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.....|+.++++||+|||+.
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~ 133 (326)
T 2y0a_A 93 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133 (326)
T ss_dssp EECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 123589999999999999999999963
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.4e-07 Score=87.38 Aligned_cols=86 Identities=16% Similarity=0.227 Sum_probs=65.3
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccch------hhHhHHHHHHHHHH---------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYRE------AFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~------~~~~f~~e~~~~~~--------------------- 376 (411)
.|.-.+.||+|+||.||++... +|..||||.+...... ....|.+|+.++.+
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4445589999999999999874 5889999999543321 24679999999987
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.....++.+|++||.|||+.
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 134 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134 (361)
T ss_dssp EEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 123589999999999999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.6e-07 Score=84.70 Aligned_cols=86 Identities=16% Similarity=0.246 Sum_probs=65.9
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
.|...+.||+|+||.||+|.. .+|+.||||.+.... ....+.|.+|+.++.+ +|.
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 355568899999999999986 468899999996543 3345789999999987 222
Q ss_pred CCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ...++++..+..++.++++||.|||+.
T Consensus 103 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 138 (303)
T 3a7i_A 103 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSE 138 (303)
T ss_dssp TTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2111 224589999999999999999999963
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.2e-07 Score=84.63 Aligned_cols=87 Identities=13% Similarity=0.273 Sum_probs=65.6
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------c
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
++|.-.+.||+|+||.||+|.. .+|..||||++.... ....+.+.+|++++.+ +
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4455568999999999999987 458899999995433 2345678999999987 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++.....++.++++||+|||+.
T Consensus 86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 124 (284)
T 3kk8_A 86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124 (284)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123488999999999999999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=98.48 E-value=1.3e-07 Score=87.74 Aligned_cols=87 Identities=13% Similarity=0.273 Sum_probs=66.5
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------c
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
++|.-.+.||+|+||.||+|.. .+|..||||.+.... ....+.|.+|++++.+ +
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4455668999999999999987 458899999996432 2345679999999987 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++.....++.+|++||+|||+.
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~ 147 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123589999999999999999999964
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.48 E-value=8e-08 Score=88.38 Aligned_cols=88 Identities=16% Similarity=0.284 Sum_probs=62.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------- 376 (411)
.++|.-.+.||+|+||.||+|.. ..+..||||.+.... ....+.|.+|+.++.+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 34555668999999999999986 235579999995432 3345779999998886
Q ss_pred -----cc---------cCCCCC--------------------CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----AN---------LLTRED--------------------KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~---------l~~~~~--------------------~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++ +..... ...++|..+..|+.++++||+|||+.
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 191 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 191 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 111110 12389999999999999999999963
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=98.47 E-value=1.7e-07 Score=84.22 Aligned_cols=84 Identities=17% Similarity=0.145 Sum_probs=64.9
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cc
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------AN 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~ 378 (411)
++|.-.+.||+|+||.||+|+. .+|+.||||++..... ..+|.+|++++.. ++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4555668999999999999986 5788999999854332 3468899988876 22
Q ss_pred cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. +.. ....+++..+.+|+.++++||+|||+.
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 124 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2 111 134599999999999999999999964
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.47 E-value=4.1e-08 Score=92.80 Aligned_cols=53 Identities=17% Similarity=0.199 Sum_probs=39.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---hhhHhHHHHHHHHHH
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~ 376 (411)
..|...++||+|+||.||+|+. .+|+.||||++..... ...+.|.+|+.++..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~ 134 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGG
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHh
Confidence 3455568999999999999995 5689999999863322 224678888877664
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=2.3e-07 Score=83.40 Aligned_cols=83 Identities=13% Similarity=0.119 Sum_probs=63.2
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~l 379 (411)
+|...+.||+|+||.||+|.. .+|+.||||.+.... ....+.+|++++.. ++.
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 455568999999999999985 578899999985332 23567888887775 222
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .+.++++..+.+|+.++++||+|||+.
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 125 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 134599999999999999999999974
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.47 E-value=3.2e-06 Score=78.74 Aligned_cols=200 Identities=13% Similarity=0.088 Sum_probs=132.1
Q ss_pred hcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCccccc------------CchhhhccccCCeeeecCCcccc
Q 015202 13 EINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGS------------IPYDLCRLAALFQLDLGDNKLSG 80 (411)
Q Consensus 13 ~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~------------~~~~~~~l~~L~~L~l~~n~l~~ 80 (411)
.|.++ .|+.+.+..+ ++......|.++.+++.+.+..+..... ....+.....+..+.+.... ..
T Consensus 131 ~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 207 (379)
T 4h09_A 131 IFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTV-KT 207 (379)
T ss_dssp TTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTC-CE
T ss_pred ccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccce-eE
Confidence 34443 4555555443 4445566788889998888775432211 11123334455555544332 22
Q ss_pred cCCccccCCccCCeeecccccCCccCc-cccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccC
Q 015202 81 FVPSCFGNLTNLRKLYLGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGG 159 (411)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 159 (411)
.....+....+|+.+.+..+ +..++. .+..+..|+.+.+..+ ++......|.++..|+.+.+..+ +.......|..
T Consensus 208 i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~ 284 (379)
T 4h09_A 208 VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSG 284 (379)
T ss_dssp ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTT
T ss_pred Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccc
Confidence 44556677778888887654 444433 4557788888888765 44455667888888888888654 44466678888
Q ss_pred CCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccC
Q 015202 160 LKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFN 219 (411)
Q Consensus 160 ~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n 219 (411)
+++|+.+.+.++.++.+...+|.++.+|+.+.+..+ ++.....+|..+.+|+.+.+..+
T Consensus 285 c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 285 CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 889999998888887677788888889999988754 55566677888888888877543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.47 E-value=1.5e-07 Score=87.91 Aligned_cols=86 Identities=14% Similarity=0.166 Sum_probs=63.3
Q ss_pred CCCcCCeeeccCCceEEEEEec--------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ--------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~--------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------- 376 (411)
+|.-.+.||+|+||.||+|+.. ++..||||++.... .....+|.+|++++.+
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 149 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence 3444588999999999999862 23579999996543 3345789999998876
Q ss_pred -----cccCCCC----------------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTRE----------------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~----------------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....++|.++.+|+.++++||+|||+.
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 210 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 210 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 2221100 113499999999999999999999964
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.47 E-value=1.5e-07 Score=84.54 Aligned_cols=82 Identities=17% Similarity=0.261 Sum_probs=61.2
Q ss_pred CCeeeccCCceEEEEEecC-CC---EEEEEEEeccc-chhhHhHHHHHHHHHH------------------------ccc
Q 015202 329 NNIIGRGGIGSIYKARIQD-GM---EVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------ANL 379 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~-~~---~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------~~l 379 (411)
.++||+|+||.||+|...+ +. .||||.+.... ....+.|.+|+.++.+ ++.
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 3789999999999998632 22 69999995433 3445789999999987 111
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|.++..|+.++++||+|||+.
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 143 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111 134589999999999999999999964
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=98.47 E-value=9.1e-08 Score=87.77 Aligned_cols=87 Identities=15% Similarity=0.201 Sum_probs=65.3
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||++... +|+.||||.+.... ......+.+|++++..
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 34556689999999999999874 68899999995432 2335678999999886
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.+...++.+|++||+|||+.
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 124 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3322211 123488889999999999999999964
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=98.46 E-value=6.7e-08 Score=87.68 Aligned_cols=97 Identities=18% Similarity=0.312 Sum_probs=69.5
Q ss_pred ccHHHHHHHhcCCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH----------
Q 015202 314 FTYLELFHATNGFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD---------- 376 (411)
Q Consensus 314 ~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~---------- 376 (411)
+...+.....++|.-.+.||+|+||.||+|.. .+++.||||.+..... ...+.|.+|++++.+
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34444444556676778999999999999985 3457899999965433 345679999998876
Q ss_pred ------------------------cccCCCCC-------------CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------------------------ANLLTRED-------------KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------------------------~~l~~~~~-------------~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++..... ...+++..+..++.++++||+|||+.
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 167 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 167 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 11111110 11278999999999999999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.46 E-value=1.5e-07 Score=85.13 Aligned_cols=88 Identities=19% Similarity=0.148 Sum_probs=62.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc-----hhhHhHHHHHHHHHH--------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR-----EAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~-----~~~~~f~~e~~~~~~-------------------- 376 (411)
+++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 55677778999999999999985 5688999999853221 113467777776654
Q ss_pred -----------cccCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----------ANLLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----------~~l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+. .....+++.++..|+.++++||+|||+.
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 139 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 139 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111110 0122389999999999999999999964
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.46 E-value=1.1e-07 Score=87.72 Aligned_cols=88 Identities=14% Similarity=0.174 Sum_probs=65.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~---------------------- 376 (411)
.++|.-.+.||+|+||.||+|+.. +|+.||||++.... ......+..|.+++..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 356666789999999999999874 58899999995432 2234568888888875
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.+...++.+|+.||+|||+.
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 143 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332211 123588999999999999999999964
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.46 E-value=8.5e-08 Score=87.60 Aligned_cols=52 Identities=25% Similarity=0.421 Sum_probs=41.0
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~ 376 (411)
+|...+.||+|+||.||+|+.. +|+.||||++.... ....+.|.+|++++.+
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 60 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK 60 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTS
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHh
Confidence 4555689999999999999985 78999999996433 3345789999999886
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.2e-07 Score=87.34 Aligned_cols=90 Identities=11% Similarity=0.165 Sum_probs=65.9
Q ss_pred HHhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH--------------------
Q 015202 321 HATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-------------------- 376 (411)
...++|.-.+.||+|+||.||+|... +|+.||||++.... ......+..|.+++..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34566777789999999999999984 57899999995432 2234567888888764
Q ss_pred ----cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.+...++.+|++||+|||+.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 137 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332221 123588999999999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=98.45 E-value=4.9e-08 Score=90.45 Aligned_cols=98 Identities=14% Similarity=0.093 Sum_probs=71.5
Q ss_pred cccccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------
Q 015202 311 QRRFTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 311 ~~~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------- 376 (411)
...+++.+.....++|.-.+.||+|+||.||+|+. .+|..||||++... ....+.+..|++++..
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 33445555555567777789999999999999987 56789999999532 2334667778887765
Q ss_pred ---------------cccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------------ANLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------------~~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. +.. ....+++.....|+.++++||+|||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 156 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222 111 123489999999999999999999964
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=98.45 E-value=3.1e-08 Score=88.66 Aligned_cols=86 Identities=12% Similarity=0.190 Sum_probs=65.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEecC-CCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cc
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~-~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
.++|...+.||+|+||.||+|+..+ +..||||.+... ....+.|.+|++++.+ ++
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3445556899999999999999854 778999999543 3345789999999987 22
Q ss_pred cCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 379 LLTRE--------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 379 l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
..+.. ....+++..+..|+.++++||+|||+
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 129 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH
Confidence 21111 12358999999999999999999996
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=9.7e-08 Score=86.49 Aligned_cols=87 Identities=21% Similarity=0.292 Sum_probs=64.1
Q ss_pred cCCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH--------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-------------------- 376 (411)
++|.-.+.||+|+||.||+|+. .++..||||++..... ...+.|.+|++++.+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 3444558999999999999985 3457899999965433 345779999998876
Q ss_pred -------------cccCCCC---------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------------ANLLTRE---------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------------~~l~~~~---------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.... ...+++|..+.+++.++++||+|||+.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 164 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111110 012489999999999999999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=5.4e-08 Score=86.92 Aligned_cols=87 Identities=14% Similarity=0.093 Sum_probs=65.8
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecc--cchhhHhHHHHHHHHHH------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------------ 376 (411)
++|...+.||+|+||.||+|... +|+.||||++... ......++.+|+..+.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 44556689999999999999984 6899999998643 23345778899988875
Q ss_pred cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++....+|+.++++||+|||+.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 134 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222211 013489999999999999999999964
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=4.8e-08 Score=92.02 Aligned_cols=95 Identities=13% Similarity=0.100 Sum_probs=69.8
Q ss_pred HHHHHHHhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH---------------
Q 015202 316 YLELFHATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD--------------- 376 (411)
Q Consensus 316 ~~~l~~at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~--------------- 376 (411)
+.+++...++|.-.+.||+|+||.||+|... +|+.||||++.... ......|.+|+.++..
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556677877899999999999999984 57899999995422 2223568899999887
Q ss_pred --------cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.+|+.||+|||+.
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~ 187 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM 187 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222111 112478888999999999999999964
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.45 E-value=1.5e-07 Score=84.18 Aligned_cols=85 Identities=11% Similarity=0.169 Sum_probs=65.2
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|.-.+.||+|+||.||++.. .+|..||||++.... ....+.|.+|++++.+ ++..
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 44558999999999999987 467899999996543 2345789999999987 2222
Q ss_pred CCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .+..+++....+|+.++++||+|||+.
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 143 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 211 124589999999999999999999963
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=98.45 E-value=2.3e-07 Score=83.29 Aligned_cols=85 Identities=16% Similarity=0.127 Sum_probs=62.5
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------c
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------A 377 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~ 377 (411)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ...++..|++++.. +
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 45677778999999999999986 578899999874332 23468888888876 2
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+. +.. ....+++..+..|+.++++||+|||+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 124 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22 111 134599999999999999999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=98.44 E-value=1.7e-07 Score=85.43 Aligned_cols=85 Identities=16% Similarity=0.252 Sum_probs=64.6
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccch------hhHhHHHHHHHHHH----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYRE------AFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~------~~~~f~~e~~~~~~---------------------- 376 (411)
|.-.+.||+|+||.||+|... +|..||||.+...... ...+|.+|+.++.+
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 445589999999999999874 6889999998543321 25679999999987
Q ss_pred -cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++..+..|+.++++||+|||+.
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~ 134 (321)
T 2a2a_A 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134 (321)
T ss_dssp ECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222211 123588999999999999999999964
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=98.44 E-value=1.6e-07 Score=84.46 Aligned_cols=85 Identities=15% Similarity=0.242 Sum_probs=64.2
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|.-.+.||+|+||.||+|+. ..+..||||.+.... ....+.|.+|+.++.+ +|
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 44458999999999999986 468899999984332 2334679999999887 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ...++++.....++.++++||+|||+.
T Consensus 93 ~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 130 (294)
T 4eqm_A 93 IEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130 (294)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22211 123589999999999999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.44 E-value=2.8e-07 Score=83.91 Aligned_cols=85 Identities=11% Similarity=0.114 Sum_probs=64.6
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|.-.+.||+|+||.||++... +|..||+|.+... ......+.+|+.++.. +|..
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4445588999999999999874 5778999998543 2345678999999987 2222
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.....|+.++++||+|||+.
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 121 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 211 123589999999999999999999964
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.44 E-value=1.4e-07 Score=83.85 Aligned_cols=87 Identities=18% Similarity=0.334 Sum_probs=65.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||+|+. .+|+.||||.+..... ...+.|.+|++++.+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 3455568999999999999987 5789999999954321 224679999999886
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ...++++..+..|+.++++||+|||+.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 131 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2221111 124589999999999999999999964
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.4e-07 Score=89.56 Aligned_cols=83 Identities=14% Similarity=0.148 Sum_probs=61.8
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------------- 376 (411)
|...+.||+|+||.||+|... .++.||||++... ....+++..|++++..
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 445589999999999999874 5789999999543 2334678888887775
Q ss_pred -cccCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 -ANLLTR-------EDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 -~~l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+++... .....++|..+.+|+.+|++||+|||+
T Consensus 178 ~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 218 (429)
T 3kvw_A 178 FELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218 (429)
T ss_dssp ECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 111110 012348999999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=9.9e-08 Score=84.94 Aligned_cols=85 Identities=15% Similarity=0.198 Sum_probs=64.7
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------- 376 (411)
+|.-.+.||+|+||.||++... +|+.||||.+.... ....+.|.+|++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4445588999999999999874 68899999996433 3345779999999987
Q ss_pred cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|..+.. ....++|..+.+|+.++++||+|||+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 129 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 2211110 12348999999999999999999996
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.4e-07 Score=84.90 Aligned_cols=85 Identities=15% Similarity=0.240 Sum_probs=62.4
Q ss_pred CCcCCeeeccCCceEEEEEe-----cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-----QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-----~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------- 376 (411)
|...+.||+|+||.||+|++ .+|+.||||++.... ......|.+|++++.+
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 33457899999999999985 357899999996433 3345789999999987
Q ss_pred --cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.++..|+.++++||+|||+.
T Consensus 103 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 145 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145 (302)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence 2221111 123489999999999999999999964
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=98.43 E-value=2.8e-07 Score=82.56 Aligned_cols=81 Identities=16% Similarity=0.126 Sum_probs=61.7
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH---------------------------ccc
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD---------------------------ANL 379 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~---------------------------~~l 379 (411)
..||+|+||.||+|.. .++..||+|.+.... ....+.|.+|+.++.+ ++.
T Consensus 32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 111 (290)
T 1t4h_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence 5799999999999987 457789999985432 3345779999999987 111
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++.....|+.++++||+|||+.
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 148 (290)
T 1t4h_A 112 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148 (290)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred CCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC
Confidence 1111 113488999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=98.43 E-value=1.4e-07 Score=85.24 Aligned_cols=86 Identities=14% Similarity=0.180 Sum_probs=62.6
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|.-.+.||+|+||.||++... +|+.||||.+..........|.+|+.++.+ ++..
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 3445589999999999999874 688999999975544445679999999987 2222
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.....++.++++||+|||+.
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 125 (304)
T 2jam_A 90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125 (304)
T ss_dssp SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111 122478899999999999999999963
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=9.6e-08 Score=86.88 Aligned_cols=87 Identities=17% Similarity=0.172 Sum_probs=54.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------cc
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++.+ ++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 4566668999999999999987 4588999999965432 234678999999987 22
Q ss_pred cCC--------C---CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLT--------R---EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~--------~---~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+ . .....+++.....++.++++||+|||+.
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~ 127 (317)
T 2pmi_A 85 MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127 (317)
T ss_dssp CCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 211 0 0113488999999999999999999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.42 E-value=6.5e-08 Score=88.18 Aligned_cols=89 Identities=18% Similarity=0.329 Sum_probs=60.8
Q ss_pred HhcCCCcCCeeeccCCceEEEEEecCC----CEEEEEEEecc--cchhhHhHHHHHHHHHH-------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQDG----MEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~~~----~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------- 376 (411)
..++|.-.+.||+|+||.||+|..... ..||||.+... .....++|.+|++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 345566678999999999999987432 27999998543 33446789999999986
Q ss_pred ----------cccCCCC------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTRE------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~~------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.++.+|+.++++||+|||+.
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 156 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR 156 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC
Confidence 1111100 011488999999999999999999963
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=98.42 E-value=1.6e-07 Score=83.73 Aligned_cols=85 Identities=15% Similarity=0.226 Sum_probs=64.4
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccch------hhHhHHHHHHHHHH----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYRE------AFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~------~~~~f~~e~~~~~~---------------------- 376 (411)
|.-.+.||+|+||.||++... +|+.||||.+...... ..+.|.+|+.++.+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEE
Confidence 445588999999999999985 5889999998543211 25679999999987
Q ss_pred -cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++..+..|+.++++||+|||+.
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 127 (283)
T 3bhy_A 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127 (283)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222111 123589999999999999999999963
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.42 E-value=2e-07 Score=85.37 Aligned_cols=82 Identities=22% Similarity=0.246 Sum_probs=58.4
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------------- 376 (411)
+|.-.+.||+|+||.||+|.. +++.||||++.... ...+..|.++...
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 444558999999999999988 77999999995432 3455555555432
Q ss_pred --cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. .....+|..+.+|+.++++||+|||+.
T Consensus 90 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~ 130 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130 (336)
T ss_dssp EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred EEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhh
Confidence 1111111 112468899999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=98.42 E-value=1.8e-07 Score=86.93 Aligned_cols=87 Identities=16% Similarity=0.133 Sum_probs=60.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------cc------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------AN------------ 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------~~------------ 378 (411)
+.|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++.. ++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 4455668999999999999985 56889999998543 22345778999999987 10
Q ss_pred -----------cCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 -----------LLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 -----------l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|+.......+++.....++.+|++||+|||+.
T Consensus 109 ~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 151 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151 (367)
T ss_dssp CEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 01111123589999999999999999999963
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=98.42 E-value=2.5e-07 Score=82.11 Aligned_cols=86 Identities=16% Similarity=0.131 Sum_probs=65.4
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|.-.+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.++.. ++.
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 3455588999999999999874 68899999996443 2345779999999886 222
Q ss_pred CC-----CC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LT-----RE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~-----~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+ .. ....+++.....++.++++||+|||+.
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 124 (276)
T 2yex_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124 (276)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 11 123589999999999999999999964
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=2.3e-07 Score=82.72 Aligned_cols=87 Identities=17% Similarity=0.221 Sum_probs=64.1
Q ss_pred cCCCcCCeeeccCCceEEEEEecC----CCEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQD----GMEVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~----~~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
++|.-.+.||+|+||.||+|+..+ +..||||.+.... ....+.|.+|++++.+
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~ 91 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM 91 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEE
Confidence 445556899999999999998743 2359999986543 3345789999999987
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.....++.++++||+|||+.
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 132 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2221111 123489999999999999999999964
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=7.8e-08 Score=87.16 Aligned_cols=86 Identities=17% Similarity=0.252 Sum_probs=63.2
Q ss_pred CCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH---------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~--------------------- 376 (411)
+|.-.+.||+|+||.||+|+. .++..||||.+.... ....+.|.+|++++.+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 344557899999999999986 234789999996433 3345789999999986
Q ss_pred --ccc---------CCCC---------------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANL---------LTRE---------------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l---------~~~~---------------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. .... ....+++.++.+|+.++++||+|||+.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 111 1110 012389999999999999999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.41 E-value=2.5e-07 Score=83.47 Aligned_cols=87 Identities=10% Similarity=0.094 Sum_probs=65.9
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc----chhhHhHHHHHHHHHH----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY----REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~----~~~~~~f~~e~~~~~~---------------------- 376 (411)
++|.-.+.||+|+||.||++.. .++..||||.+.... ......|.+|+.++.+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 4566678999999999999987 467899999995432 2335779999999987
Q ss_pred ---cccCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... .....+++..+.+|+.++++||+|||+.
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 128 (305)
T 2wtk_C 85 MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128 (305)
T ss_dssp EEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 111100 0123589999999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=98.41 E-value=2.6e-07 Score=85.79 Aligned_cols=90 Identities=18% Similarity=0.245 Sum_probs=66.6
Q ss_pred HHhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--------hhhHhHHHHHHHHHH---------------
Q 015202 321 HATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--------EAFKSFDNEFMTVVD--------------- 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--------~~~~~f~~e~~~~~~--------------- 376 (411)
...++|...+.||+|+||.||+|... +|+.||||++..... ...+.|.+|+.++.+
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34455666789999999999999984 689999999865431 113568888888775
Q ss_pred ---------cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....|+.+|++||.|||+.
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 219 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3332211 113589999999999999999999964
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.41 E-value=1.8e-07 Score=87.13 Aligned_cols=82 Identities=23% Similarity=0.370 Sum_probs=60.7
Q ss_pred CCeeeccCCceEEEEEec--CC--CEEEEEEEeccc-chhhHhHHHHHHHHHH------------------------ccc
Q 015202 329 NNIIGRGGIGSIYKARIQ--DG--MEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------ANL 379 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~--~~--~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------~~l 379 (411)
.+.||+|+||.||+|.+. ++ ..||||.+.... ....++|.+|+.++.+ +|.
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 368999999999999873 22 358999985433 3446789999998887 222
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....++|..+..|+.+||+||+|||+.
T Consensus 174 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 211 (373)
T 3c1x_A 174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211 (373)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111 123488999999999999999999964
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.1e-07 Score=86.00 Aligned_cols=86 Identities=19% Similarity=0.246 Sum_probs=63.4
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc---cchhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ---YREAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~---~~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|.. .+|..||||++... ......+|.+|++++.+ +
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 455568999999999999986 57899999999642 23345779999999987 2
Q ss_pred ccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..... ....+++....+|+.++++||.|||+.
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 155 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 222111 123488999999999999999999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.6e-07 Score=86.68 Aligned_cols=87 Identities=14% Similarity=0.171 Sum_probs=65.0
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH----------cccCCC-----C---
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------ANLLTR-----E--- 383 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------~~l~~~-----~--- 383 (411)
++|.-.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++.+ ++.... .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 45556689999999999999974 58899999996433 2335678999999987 100000 0
Q ss_pred --------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 --------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 --------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.....++.++++||+|||+.
T Consensus 91 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 131 (353)
T 2b9h_A 91 IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131 (353)
T ss_dssp EEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 012488999999999999999999964
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.41 E-value=2.7e-07 Score=83.95 Aligned_cols=87 Identities=13% Similarity=0.175 Sum_probs=64.9
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||++... +|+.||||.+.... ....+.+.+|+.++..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 34555689999999999999874 68899999995432 2234668889988886
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.+|++||+|||+.
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 125 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 125 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 123588899999999999999999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2e-07 Score=83.06 Aligned_cols=86 Identities=15% Similarity=0.174 Sum_probs=63.2
Q ss_pred CCCcCCeeeccCCceEEEEEecC----CCEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD----GMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~----~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------~ 377 (411)
.|.-.+.||+|+||.||+|.... +..||||++.... ....+.|.+|+.++.+ +
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e 95 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIME 95 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEEe
Confidence 34445889999999999998732 4469999985433 3345679999999986 2
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..... ....++|..+..++.++++||+|||+.
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 135 (281)
T 1mp8_A 96 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135 (281)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 221111 123589999999999999999999964
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=98.41 E-value=4e-07 Score=81.85 Aligned_cols=82 Identities=22% Similarity=0.348 Sum_probs=60.5
Q ss_pred CCeeeccCCceEEEEEecCC----CEEEEEEEecccc-hhhHhHHHHHHHHHH------------------------ccc
Q 015202 329 NNIIGRGGIGSIYKARIQDG----MEVAVKVFDLQYR-EAFKSFDNEFMTVVD------------------------ANL 379 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~----~~vavk~l~~~~~-~~~~~f~~e~~~~~~------------------------~~l 379 (411)
.+.||+|+||.||+|+..+. ..||||.+..... ...+.|.+|++++.+ ++.
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 47899999999999987332 2589999865333 345789999999987 222
Q ss_pred CCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++..+.+|+.++++||+|||+.
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~ 147 (298)
T 3f66_A 110 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147 (298)
T ss_dssp TTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111 123488999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2e-07 Score=85.75 Aligned_cols=86 Identities=14% Similarity=0.193 Sum_probs=63.8
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------ 376 (411)
+|...+.||+|+||.||++... +|+.||||++.... ....+.+..|..++.+
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 4555689999999999999984 57889999996432 2234568889988865
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.+|++||+|||+.
T Consensus 90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 129 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129 (345)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 113488999999999999999999964
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.40 E-value=1.5e-07 Score=86.66 Aligned_cols=89 Identities=16% Similarity=0.231 Sum_probs=61.1
Q ss_pred HhcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccch-----hhHhHHHHHHHHHH-------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYRE-----AFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~-----~~~~f~~e~~~~~~------------------- 376 (411)
..+.|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3456777789999999999999874 5889999998543211 13578899999987
Q ss_pred ----cccCC------CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLT------REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~------~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+ ......+++.....++.++++||+|||+.
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 131 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11111 00123588899999999999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.8e-07 Score=87.70 Aligned_cols=85 Identities=14% Similarity=0.109 Sum_probs=65.1
Q ss_pred CCcCCeeecc--CCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------c
Q 015202 326 FSANNIIGRG--GIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g--~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
|.-.+.||+| +||.||+|... +|+.||||++.... ....+.|.+|++++.+ +
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 4455899999 99999999984 68999999996433 3335678899999987 2
Q ss_pred ccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++.....|+.++++||+|||+.
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 147 (389)
T 3gni_B 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 147 (389)
T ss_dssp CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 222111 124589999999999999999999964
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.40 E-value=1.9e-07 Score=89.46 Aligned_cols=87 Identities=15% Similarity=0.235 Sum_probs=56.7
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------cccCCC--------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------ANLLTR-------- 382 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~~l~~~-------- 382 (411)
++|.-.+.||+|+||.||+|.. .+|+.||||++.... ....+.|.+|++++.+ ++....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 4455668999999999999986 468899999995432 2345779999999987 111000
Q ss_pred ---------C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 ---------E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ---------~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++.....|+.+|++||+|||+.
T Consensus 133 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 175 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA 175 (458)
T ss_dssp EEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0 123489999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.40 E-value=1.9e-07 Score=87.18 Aligned_cols=86 Identities=19% Similarity=0.241 Sum_probs=64.7
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||++... +|+.||||.+.... ....+.+.+|++++.. +
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 3445589999999999999874 57889999995432 2335678999999987 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.+++.||.|||+.
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 134 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222111 123589999999999999999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.3e-07 Score=90.74 Aligned_cols=87 Identities=15% Similarity=0.205 Sum_probs=66.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|...++||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++.+
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 4466668999999999999988 468999999995432 2234668999999987
Q ss_pred cccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. +...+++.+...++.+|++||+|||+.
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~ 305 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332211 123489999999999999999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.1e-07 Score=83.59 Aligned_cols=85 Identities=12% Similarity=0.191 Sum_probs=64.0
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||++... +++.||+|.+.... ....+.|.+|+.++.. ++
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 444589999999999999984 47889999985432 2345679999999886 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++.++..|+.++++||+|||+.
T Consensus 97 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 134 (294)
T 2rku_A 97 CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134 (294)
T ss_dssp CTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22111 113589999999999999999999964
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.7e-07 Score=83.61 Aligned_cols=87 Identities=20% Similarity=0.326 Sum_probs=61.2
Q ss_pred cCCCcCCeeeccCCceEEEEEec----CCCEEEEEEEecc--cchhhHhHHHHHHHHHH---------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~--------------------- 376 (411)
++|.-.+.||+|+||.||+|... .+..||||++... .....+.|.+|+.++.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 34445578999999999999873 2347999998543 23345779999999886
Q ss_pred -------cccCCC------------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------ANLLTR------------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------~~l~~~------------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... .....+++..+.+|+.++++||.|||+.
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR 166 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111110 1124589999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2e-07 Score=85.21 Aligned_cols=85 Identities=15% Similarity=0.122 Sum_probs=63.8
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|...+.||+|+||.||+|... +|..||||++..... ...+.+.+|++++.+ ++.
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 344579999999999999984 488999999854332 234668899999987 221
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++....+|+.++++||+|||+.
T Consensus 107 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 143 (331)
T 4aaa_A 107 DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143 (331)
T ss_dssp SEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1100 123589999999999999999999964
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.2e-07 Score=88.32 Aligned_cols=87 Identities=20% Similarity=0.316 Sum_probs=65.1
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------cccCCC--------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------ANLLTR-------- 382 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~~l~~~-------- 382 (411)
++|.-.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++.+ ++....
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 3455568999999999999987 457889999995432 2345789999999987 110000
Q ss_pred ---------C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 ---------E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ---------~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++.....|+.+|++||+|||+.
T Consensus 106 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~ 148 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148 (432)
T ss_dssp EEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0 123489999999999999999999964
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.7e-07 Score=87.74 Aligned_cols=87 Identities=13% Similarity=0.192 Sum_probs=63.6
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.++||+|+||.||+++.. +++.||||++.... ......+..|..++.+
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 34556689999999999999984 56789999996432 2223568888888764
Q ss_pred -cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.+|+.||+|||+.
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 172 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332221 123589999999999999999999964
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=3.3e-07 Score=83.64 Aligned_cols=87 Identities=16% Similarity=0.239 Sum_probs=62.2
Q ss_pred cCCCcCCeeeccCCceEEEEEe------cCCCEEEEEEEecc-cchhhHhHHHHHHHHHH--------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQ-YREAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~-~~~~~~~f~~e~~~~~~-------------------- 376 (411)
++|.-.+.||+|+||.||+|.. .++..||||++... ......+|.+|+.++.+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 3455568999999999999985 34678999999543 33445789999999887
Q ss_pred ------------cccCCCC----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------------ANLLTRE----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------------~~l~~~~----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.... ....++|..+.+|+.++++||.|||+.
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 159 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 159 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 2222111 113489999999999999999999964
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=98.39 E-value=1.6e-07 Score=84.42 Aligned_cols=86 Identities=22% Similarity=0.225 Sum_probs=62.5
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
+|...+.||+|+||.||+|... +|+.||||++.... ......+.+|++++.+ ++
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (299)
T 2r3i_A 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 83 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEEc
Confidence 4555689999999999999874 68899999985432 2234678999999987 22
Q ss_pred cCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+. .....+++....+|+.++++||+|||+.
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (299)
T 2r3i_A 84 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122 (299)
T ss_dssp CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2110 0123488999999999999999999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=98.39 E-value=1.8e-07 Score=83.74 Aligned_cols=85 Identities=11% Similarity=-0.014 Sum_probs=61.7
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.|.-.+.||+|+||.||+|+.. .|+.||||.+..... ...+.|.+|+..+.+ +
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 3555589999999999999984 478999999964432 234789999999886 2
Q ss_pred ccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|+.+.. .. .....+..+|+.++++||+|||+.
T Consensus 112 ~~~g~~L~~~l~~-~~~~~~~~~i~~ql~~aL~~lH~~ 148 (286)
T 3uqc_A 112 WIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRA 148 (286)
T ss_dssp CCCEEEHHHHHTT-CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCCCHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHC
Confidence 222111 11 134456789999999999999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=98.39 E-value=2e-07 Score=86.45 Aligned_cols=87 Identities=11% Similarity=0.167 Sum_probs=64.8
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH----------cccCCC---------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD----------ANLLTR--------- 382 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~----------~~l~~~--------- 382 (411)
+.|...+.||+|+||.||+|.. .++..||||++..... ...+.|.+|++++.+ ++....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 3455668999999999999986 4677899999964333 334789999999987 110000
Q ss_pred --------C-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 --------E-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 --------~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++.++..|+.++++||+|||+.
T Consensus 107 iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~ 147 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147 (364)
T ss_dssp EEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0 112488999999999999999999964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=98.38 E-value=5.1e-07 Score=83.30 Aligned_cols=85 Identities=12% Similarity=0.155 Sum_probs=64.0
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-----chhhHhHHHHHHHHHH-----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-----REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-----~~~~~~f~~e~~~~~~----------------------- 376 (411)
|.-.+.||+|+||.||+|.. .+|+.||||.+.... ....+.|.+|+.++..
T Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 105 (351)
T 3c0i_A 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105 (351)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 44558999999999999987 468899999985322 1135679999999987
Q ss_pred cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. .+..+++.....|+.+|++||+|||+.
T Consensus 106 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 149 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149 (351)
T ss_dssp ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332211 122478889999999999999999964
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=98.38 E-value=1.5e-07 Score=87.44 Aligned_cols=83 Identities=14% Similarity=0.203 Sum_probs=56.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEecC------CCEEEEEEEecccchhhHhHHHHHHHHHH--------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQD------GMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~------~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------- 376 (411)
.++|.-.+.||+|+||.||+|...+ +..||||++.... ..+..|++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN----GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC----HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc----hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 3456666899999999999998854 4689999985433 233344433332
Q ss_pred ----------------------cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------------------ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------------------~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. +.. ....++|.++.+|+.+||+||+|||+.
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~ 171 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH 171 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111 000 124599999999999999999999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.4e-07 Score=84.91 Aligned_cols=86 Identities=12% Similarity=0.185 Sum_probs=64.5
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.|...+.||+|+||.||++... +++.||+|.+.... ....+.|.+|+.++.+ +
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 3445589999999999999874 47789999985432 2345679999999886 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.++..|+.++++||+|||+.
T Consensus 122 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (335)
T 2owb_A 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160 (335)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222111 113589999999999999999999964
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.1e-07 Score=82.50 Aligned_cols=87 Identities=16% Similarity=0.154 Sum_probs=64.4
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---------chhhHhHHHHHHHHHH-----------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---------REAFKSFDNEFMTVVD----------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---------~~~~~~f~~e~~~~~~----------------- 376 (411)
++|...+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|++++.+
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 44555689999999999999984 57899999995432 1124568899998875
Q ss_pred -------cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.....|+.++++||+|||+.
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 143 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222111 123588999999999999999999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3.1e-07 Score=84.71 Aligned_cols=86 Identities=13% Similarity=0.122 Sum_probs=62.9
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CC-CEEEEEEEecccchhhHhHHHHHHHHHH-------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DG-MEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~-~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------- 376 (411)
++|.-.+.||+|+||.||+|... ++ ..||||++... ......+..|++++.+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 34555689999999999999863 33 68999999543 2335678888888776
Q ss_pred ----cccCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... ....++++.+..+|+.+|++||+|||+.
T Consensus 98 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~ 142 (355)
T 2eu9_A 98 CIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN 142 (355)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111110 0123589999999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.37 E-value=2.9e-07 Score=84.05 Aligned_cols=87 Identities=17% Similarity=0.236 Sum_probs=63.1
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCE----EEEEEEecc-cchhhHhHHHHHHHHHH---------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGME----VAVKVFDLQ-YREAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~----vavk~l~~~-~~~~~~~f~~e~~~~~~--------------------- 376 (411)
++|...+.||+|+||.||+|.. .++.. ||+|.+... .....+.|.+|+.++.+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence 3455568999999999999986 34443 577777433 33456789999999987
Q ss_pred -cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....+++..+.+|+.++++||+|||+.
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 136 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 1111111 123589999999999999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.37 E-value=1.1e-07 Score=87.93 Aligned_cols=87 Identities=15% Similarity=0.195 Sum_probs=63.5
Q ss_pred cCCCcCCeeeccCCceEEEEEe----cCCCEEEEEEEeccc----chhhHhHHHHHHHHHH-------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI----QDGMEVAVKVFDLQY----REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l----~~~~~vavk~l~~~~----~~~~~~f~~e~~~~~~------------------- 376 (411)
++|...+.||+|+||.||++.. .+|+.||||++.... ......+.+|++++.+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 3455668999999999999987 468899999985322 2234567788887765
Q ss_pred -----cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.+|++||+|||+.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 178 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 113488899999999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=98.37 E-value=1.6e-07 Score=83.58 Aligned_cols=87 Identities=15% Similarity=0.195 Sum_probs=64.1
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||+|... ++..||||++.... ......+.+|++++.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 44555689999999999999874 56789999985432 1224678999999886
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....+++..+..|+.++++||+|||+.
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 128 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2211111 113478899999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=98.37 E-value=2.8e-07 Score=85.39 Aligned_cols=85 Identities=15% Similarity=0.091 Sum_probs=64.5
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|.-.+.||+|+||.||++... +|+.||||++.... .....+.+|+.++.+ +|..
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 3445589999999999999874 68899999996432 234678899998887 3332
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.....|+.++++||+|||+.
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~ 135 (361)
T 3uc3_A 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135 (361)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 211 123488999999999999999999963
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=98.36 E-value=3.5e-07 Score=83.55 Aligned_cols=82 Identities=12% Similarity=0.181 Sum_probs=61.6
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD--------------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------------------~~ 378 (411)
|.-.+.||+|+||.||+|.. .+|+.||||.+... ..+.+.+|++++.+ ++
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 44458999999999999986 57889999999643 24678999998886 11
Q ss_pred cCCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. .-..+++.....|+.++++||+|||+.
T Consensus 115 ~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 149 (330)
T 3nsz_A 115 VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 149 (330)
T ss_dssp CCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11111 001378889999999999999999964
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=98.36 E-value=2.6e-07 Score=89.96 Aligned_cols=87 Identities=14% Similarity=0.244 Sum_probs=65.8
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|...++||+|+||.||++... +|+.||||++.... ......+..|++++.+
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34555688999999999999984 68999999995432 2234678999999987
Q ss_pred cccCC---------CC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLT---------RE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~---------~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+ .. ....+++.....++.+|+.||+|||+.
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~ 308 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc
Confidence 22221 11 123589999999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.7e-07 Score=85.58 Aligned_cols=87 Identities=16% Similarity=0.267 Sum_probs=58.8
Q ss_pred cCCCcCCeeeccCCceEEEEEe----cCCCEEEEEEEeccc----chhhHhHHHHHHHHHH-------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI----QDGMEVAVKVFDLQY----REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l----~~~~~vavk~l~~~~----~~~~~~f~~e~~~~~~------------------- 376 (411)
++|...+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.++.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 3455568999999999999987 478899999995432 2234568899999887
Q ss_pred ----cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.++++||+|||+.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~ 140 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222111 112478888999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.7e-07 Score=86.55 Aligned_cols=88 Identities=11% Similarity=0.123 Sum_probs=65.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~---------------------- 376 (411)
.++|.-.+.||+|+||.||+|... +|+.||||++.... ......+..|.+++..
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 355666789999999999999985 46789999995432 2234668889988864
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.+...++.+|+.||+|||+.
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 140 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332211 113488999999999999999999964
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.36 E-value=5.9e-08 Score=88.54 Aligned_cols=97 Identities=15% Similarity=0.183 Sum_probs=69.2
Q ss_pred cccHHHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH---------------
Q 015202 313 RFTYLELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD--------------- 376 (411)
Q Consensus 313 ~~~~~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------- 376 (411)
.+++.++....+.|.-.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.++.+
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 344444455667777779999999999999997 568899999986432 335678899988875
Q ss_pred ---------------cccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------------ANLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------------~~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.....|+.++++||+|||+.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 148 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111100 013478888999999999999999963
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.8e-07 Score=86.37 Aligned_cols=86 Identities=10% Similarity=0.030 Sum_probs=63.3
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------- 376 (411)
+.|.-.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++.+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 3455568999999999999986 46788999999543 2335678889887765
Q ss_pred ---------cccCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------ANLLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------~~l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... .....+++.....|+.+|++||+|||+.
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~ 165 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK 165 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 111000 0123589999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=98.36 E-value=2.3e-07 Score=84.54 Aligned_cols=89 Identities=20% Similarity=0.178 Sum_probs=63.6
Q ss_pred HhcCCCcCCeeeccCCceEEEEEe--cCCCEEEEEEEecccc--hhhHhHHHHHHHHHH---------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARI--QDGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l--~~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~--------------------- 376 (411)
+.++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 345666678999999999999997 4678899999854332 223467778776653
Q ss_pred ----------cccCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+. .....+++..+..|+.++++||+|||+.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 139 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 139 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111110 0122489999999999999999999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.3e-07 Score=86.39 Aligned_cols=88 Identities=16% Similarity=0.142 Sum_probs=62.9
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~----------------------- 376 (411)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 34566668999999999999985 4678999999854332 234678899999987
Q ss_pred cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....|+.++++||+|||+.
T Consensus 113 e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~ 151 (329)
T 3gbz_A 113 EYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151 (329)
T ss_dssp ECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2221100 123489999999999999999999964
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.6e-07 Score=81.90 Aligned_cols=80 Identities=15% Similarity=0.143 Sum_probs=59.1
Q ss_pred eeeccCCceEEEEEec---CCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------------------cccCCCC
Q 015202 331 IIGRGGIGSIYKARIQ---DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------------------ANLLTRE 383 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------------------~~l~~~~ 383 (411)
.||+|+||.||+|.+. .+..||||.+.... ....++|.+|++++.. ++..+..
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 103 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGP 103 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEEEEeCCCCC
Confidence 8999999999999762 35689999985432 2335789999999987 1111111
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....+++.....|+.++++||+|||+.
T Consensus 104 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 136 (291)
T 1xbb_A 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136 (291)
T ss_dssp HHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 123489999999999999999999964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.35 E-value=3.5e-07 Score=86.21 Aligned_cols=80 Identities=18% Similarity=0.180 Sum_probs=53.9
Q ss_pred CCeeeccCCceEEEEEec---CCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------cccC
Q 015202 329 NNIIGRGGIGSIYKARIQ---DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------ANLL 380 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------~~l~ 380 (411)
.++||+|+||.||+|... ++..||||++.... ....+.+|++++.+ +|..
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 368999999999999975 46789999995332 23578899999987 1110
Q ss_pred C--------------CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 T--------------REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~--------------~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ ......+++.....|+.++++||+|||+.
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 147 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0 00112388999999999999999999964
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=98.35 E-value=2.3e-07 Score=85.57 Aligned_cols=86 Identities=14% Similarity=0.160 Sum_probs=64.8
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|...+.||+|+||.||++... +|..||||.+.... ....+.+.+|++++.. +
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 4555689999999999999874 68899999995432 2334678999999886 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.+...++.+|++||+|||+.
T Consensus 122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 160 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 322211 113488899999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.4e-07 Score=82.83 Aligned_cols=87 Identities=14% Similarity=0.189 Sum_probs=65.9
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------c
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+.|.-.+.||+|+||.||+|... +++.||||++.... ......|.+|++++.+ +
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 34556689999999999999874 68899999995433 2345789999999987 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++..+.+|+.++++||+|||+.
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 140 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 221111 123488999999999999999999964
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3e-07 Score=84.13 Aligned_cols=84 Identities=13% Similarity=0.171 Sum_probs=62.8
Q ss_pred CCCcCCeeeccCCceEEEEEe--cCCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI--QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l--~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------- 376 (411)
.|.-.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++..
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 344558899999999999986 36789999999543 2335678888888775
Q ss_pred ---cccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. +.. ...++++....+|+.++++||+|||+.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 137 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN 137 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence 222 111 123588999999999999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.35 E-value=5.1e-07 Score=86.68 Aligned_cols=85 Identities=13% Similarity=0.193 Sum_probs=64.4
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|.-.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++.. +|
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 444578999999999999874 689999999954321 224678999999886 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++.....|+.+|++||+|||+.
T Consensus 98 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 135 (476)
T 2y94_A 98 VSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135 (476)
T ss_dssp CSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 21111 123589999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=4.3e-07 Score=84.87 Aligned_cols=86 Identities=14% Similarity=0.169 Sum_probs=62.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------- 376 (411)
.++|...+.||+|+||.||+|... +|+.||||++... .....++..|++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 456666789999999999999874 5788999999633 2334567777777654
Q ss_pred ----cccCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ----ANLLTR-------EDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ----~~l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
++.... .....++|..+..|+.++++||+|||.
T Consensus 132 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 175 (382)
T 2vx3_A 132 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175 (382)
T ss_dssp EEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS
T ss_pred EEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc
Confidence 111110 012348999999999999999999994
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3e-07 Score=88.18 Aligned_cols=87 Identities=13% Similarity=0.060 Sum_probs=64.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH----------ccc-----------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------ANL----------- 379 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------~~l----------- 379 (411)
++|...+.||+|+||.||+|.- ..|+.||||++... .....+.+.+|++++.. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 4455668999999999999986 45789999999643 23345779999999987 110
Q ss_pred --------CCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 --------LTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 --------~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. -...+++.++..|+.++++||+|||+.
T Consensus 142 ~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~ 183 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 183 (464)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0000 012388999999999999999999963
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.7e-07 Score=85.17 Aligned_cols=86 Identities=17% Similarity=0.067 Sum_probs=64.1
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------- 376 (411)
+|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++.+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 444568999999999999997 568899999984332 2234678899999987
Q ss_pred ------cccCCC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+. .....+++.+...|+.++++||+|||+.
T Consensus 98 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 143 (351)
T 3mi9_A 98 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 143 (351)
T ss_dssp EEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111100 0123489999999999999999999964
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.34 E-value=4.8e-07 Score=83.53 Aligned_cols=86 Identities=15% Similarity=0.170 Sum_probs=64.2
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------c-------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------A------------- 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~------------- 377 (411)
++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.|.+|+.++.+ +
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 3444558899999999999987 468899999995432 2335679999999987 0
Q ss_pred ------ccC----CCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 ------NLL----TREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ------~l~----~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .. ....+++.+...|+.++++||+|||+.
T Consensus 104 ~~lv~e~~~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~ 145 (353)
T 3coi_A 104 FYLVMPFMQTDLQKI-MGLKFSEEKIQYLVYQMLKGLKYIHSA 145 (353)
T ss_dssp CEEEEECCSEEGGGT-TTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeccccCCHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 000 00 122489999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.3e-07 Score=81.32 Aligned_cols=85 Identities=14% Similarity=0.166 Sum_probs=64.0
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|+.. +|+.||||.+.... ....+.|.+|+.++.. +
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3445589999999999999984 68999999995432 2234678999998886 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+..+.. ....+++....+++.++++||+|||+
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~ 129 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 222211 11247899999999999999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=98.33 E-value=1.3e-07 Score=89.60 Aligned_cols=81 Identities=16% Similarity=0.241 Sum_probs=59.9
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------------- 376 (411)
|...+.||+|+||.||+|... +|+.||||++.... +.+.+|++++.+
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 444589999999999999984 58999999985432 234578888876
Q ss_pred -cccCCC---------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTR---------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~---------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+. .....++|.....++.+|++||+|||+.
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 175 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111100 0124588999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=98.33 E-value=3.8e-07 Score=84.87 Aligned_cols=87 Identities=15% Similarity=0.187 Sum_probs=64.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------cccCCC--------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------ANLLTR-------- 382 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~~l~~~-------- 382 (411)
+.|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.. ++....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 3455568899999999999986 468899999995432 2335789999999987 100000
Q ss_pred ----------C----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 ----------E----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ----------~----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++.....|+.++++||+|||+.
T Consensus 122 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 163 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA 163 (371)
T ss_dssp CEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0 122489999999999999999999964
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=98.33 E-value=2.8e-07 Score=83.42 Aligned_cols=87 Identities=16% Similarity=0.216 Sum_probs=65.2
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||+|... +++.||||.+..... ...+.|.+|+.++.+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 45556689999999999999874 678899999854322 224679999999886
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ...++++..+..|+.++++||+|||+.
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 153 (309)
T 2h34_A 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153 (309)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2221111 113589999999999999999999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.6e-07 Score=83.72 Aligned_cols=83 Identities=16% Similarity=0.247 Sum_probs=62.7
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH----------c---------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------A--------------- 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------~--------------- 377 (411)
++|...+.||+|+||.||+|... +|+.||||++.... ..+.+|++++.+ +
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 34556689999999999999985 68999999995432 467788988876 1
Q ss_pred --------------ccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 --------------NLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 --------------~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....++|..+.+|+.++++||.|||+.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 141 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK 141 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 001101 113588999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=98.32 E-value=2e-07 Score=83.42 Aligned_cols=86 Identities=14% Similarity=0.130 Sum_probs=58.6
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHH-HHH-----------------------c
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMT-VVD-----------------------A 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~-~~~-----------------------~ 377 (411)
++|...+.||+|+||.||+|.. .+|+.||||++.... .....++..|... +.. +
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 3455568999999999999987 578899999995432 2223344444443 332 2
Q ss_pred ccCCC---------CCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 378 NLLTR---------EDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 378 ~l~~~---------~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+..+. .....++|..+.+|+.++++||+|||+
T Consensus 87 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 127 (290)
T 3fme_A 87 LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127 (290)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 22110 013469999999999999999999996
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=98.32 E-value=3.1e-07 Score=84.44 Aligned_cols=83 Identities=17% Similarity=0.295 Sum_probs=61.1
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cc
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------AN 378 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~ 378 (411)
++|.-.+.||+|+||.||++... +|+.||||.+.... ..+.+|++++.+ +|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 34555689999999999999874 57899999995432 234567776655 33
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++.....++.+|++||+|||+.
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~ 135 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 32211 223589999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.32 E-value=1.7e-07 Score=86.48 Aligned_cols=80 Identities=16% Similarity=0.155 Sum_probs=58.3
Q ss_pred CCCcCCeeeccCCceEEEEEecC---------CCEEEEEEEecccchhhHhHHHHHHHHHH-------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD---------GMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~---------~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------- 376 (411)
+|.-.+.||+|+||.||+|.... ++.||||.+... +.|.+|++++.+
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 44455899999999999998753 788999998543 357777776664
Q ss_pred --------------------cccCCCC------C--CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------------ANLLTRE------D--KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------------~~l~~~~------~--~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. +.. . ...++|..+.+|+.++++||+|||+.
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 178 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN 178 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 100 0 14589999999999999999999964
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.4e-07 Score=85.45 Aligned_cols=86 Identities=20% Similarity=0.268 Sum_probs=63.4
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---hhhHhHHHHHHHHHH------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~------------------------ 376 (411)
.|.-.+.||+|+||.||+|.. .+|+.||||++..... .....|.+|++++.+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 344558999999999999986 5788999999954322 224578899988775
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ...++++....+|+.++++||+|||+.
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 135 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111101 123589999999999999999999964
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=98.32 E-value=3.3e-07 Score=84.83 Aligned_cols=85 Identities=13% Similarity=0.154 Sum_probs=64.8
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|...+.||+|+||.||+|... +|..||+|++.... ....+.|.+|++++.+ +|.
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 3445579999999999999984 68899999996543 3345789999999886 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.+.. ....+++....+|+.++++||+|||+
T Consensus 114 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~ 149 (360)
T 3eqc_A 114 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149 (360)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 2211 11248889999999999999999996
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-07 Score=90.81 Aligned_cols=86 Identities=12% Similarity=0.169 Sum_probs=56.5
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc---cchhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ---YREAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~---~~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|...+.||+|+||.||+|.. .+|+.||||++... .......+.+|++++.+
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 4455668999999999999986 46889999999543 22334668888888775
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|+.+.. ....+++.....|+.++++||+|||+
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 266 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3332221 12358999999999999999999996
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.31 E-value=1.9e-07 Score=85.58 Aligned_cols=87 Identities=13% Similarity=0.111 Sum_probs=65.3
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc--------hhhHhHHHHHHHHHH------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR--------EAFKSFDNEFMTVVD------------------ 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~--------~~~~~f~~e~~~~~~------------------ 376 (411)
++|...+.||+|+||.||+|+. .+|..||||++..... .....|.+|++++.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 4455668999999999999985 5678999999954321 134568889999987
Q ss_pred -----cccCCC-C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTR-E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~-~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... . ....+++..+..|+.++++||+|||+.
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 149 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 222111 1 223589999999999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.5e-07 Score=87.56 Aligned_cols=85 Identities=16% Similarity=0.254 Sum_probs=65.0
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||++... +|+.||||++.... ......+.+|+.++.+ ++
T Consensus 28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 107 (484)
T 3nyv_A 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107 (484)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 444588999999999999874 68899999995432 2345779999999987 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++....+|+.++++||+|||+.
T Consensus 108 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 145 (484)
T 3nyv_A 108 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145 (484)
T ss_dssp CCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 22111 123589999999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=98.31 E-value=5.4e-07 Score=84.67 Aligned_cols=76 Identities=12% Similarity=0.055 Sum_probs=56.1
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------------cccC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------------ANLL 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------------~~l~ 380 (411)
++||+|+||.||++.. .+|..||||+++.. ..+.+|++++.+ +|+.
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 6899999999999987 45889999999532 356677776643 2221
Q ss_pred CCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....++|.....|+.+|++||+|||+.
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 180 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111 123589999999999999999999963
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.31 E-value=3.9e-07 Score=86.77 Aligned_cols=87 Identities=8% Similarity=0.114 Sum_probs=64.1
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------c
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
++|.-.+.||+|+||.||++.- .+|+.+|+|.+.... ....+.|.+|++++.+ +
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 3455568999999999999976 468899999985433 2345679999999987 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++.....|+.++++||+|||+.
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~ 129 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 222211 123588999999999999999999964
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=1.8e-07 Score=85.42 Aligned_cols=85 Identities=14% Similarity=0.259 Sum_probs=61.2
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCE----EEEEEEeccc-chhhHhHHHHHHHHHH----------------------c
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGME----VAVKVFDLQY-REAFKSFDNEFMTVVD----------------------A 377 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~----vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------~ 377 (411)
|...+.||+|+||.||+|... +|.. ||+|.+.... ....+.|.+|+.++.+ +
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e 94 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQ 94 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEEEE
Confidence 344578999999999999873 4443 7888874332 3345678899998876 2
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.+.. ....++|..+..|+.++++||+|||+.
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 134 (325)
T 3kex_A 95 YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134 (325)
T ss_dssp CCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 222111 123588999999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=98.31 E-value=4.9e-07 Score=87.78 Aligned_cols=87 Identities=13% Similarity=0.132 Sum_probs=62.8
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc-------------hhhHhHHHHHHHHHH-------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-------------EAFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-------------~~~~~f~~e~~~~~~------------- 376 (411)
+.|...+.||+|+||.||+|... .+..||||++..... ...+.+.+|+.++.+
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 44555689999999999999874 578999999854321 224679999999987
Q ss_pred ----------cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....|+.++++||+|||+.
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 165 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH 165 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2222211 123489999999999999999999964
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=5.7e-07 Score=82.48 Aligned_cols=83 Identities=19% Similarity=0.242 Sum_probs=62.8
Q ss_pred HhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------
Q 015202 322 ATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 322 at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------- 376 (411)
..++|.-.+.||+|+||.||+|.. +|+.||||.+... ....+..|++++..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 345576778999999999999998 6899999999532 34678888888764
Q ss_pred ----cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccC
Q 015202 377 ----ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVES 408 (411)
Q Consensus 377 ----~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh 408 (411)
++..... ....++|.++.+|+.++|+||+|||
T Consensus 116 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH 156 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 156 (342)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHH
Confidence 1111101 1124889999999999999999999
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.30 E-value=4.4e-07 Score=83.08 Aligned_cols=84 Identities=15% Similarity=0.146 Sum_probs=60.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------- 376 (411)
.++|.-.+.||+|+||.||+|.. .|..||||++.... ...+..|.+++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 34566778999999999999998 48999999985332 3345555555443
Q ss_pred ---cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++|..+.+|+.++|+||+|||+.
T Consensus 112 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~ 153 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153 (337)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSC
T ss_pred EEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 1111111 123488999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=4.5e-07 Score=82.56 Aligned_cols=86 Identities=12% Similarity=0.188 Sum_probs=62.0
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--------chhhHhHHHHHHHHHH-------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--------REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--------~~~~~~f~~e~~~~~~------------------- 376 (411)
+|.-.+.||+|+||.||+|... +|+.||||.+.... ......|.+|++++.+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY 90 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSEE
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCceE
Confidence 4555689999999999999874 57889999985322 1123568999999987
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.....++.++++||.|||+.
T Consensus 91 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (322)
T 2ycf_A 91 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133 (322)
T ss_dssp EEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2221111 124589999999999999999999964
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=98.30 E-value=4.7e-07 Score=81.41 Aligned_cols=86 Identities=16% Similarity=0.211 Sum_probs=63.8
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------c---------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------A--------------- 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------~--------------- 377 (411)
++|...+.||+|+||.||+|.. .+|+.||||++... ....+.|.+|++++.+ +
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 3455668999999999999987 47889999999542 3345779999999886 0
Q ss_pred -----------ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 -----------NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 -----------~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++....+|+.++++||+|||+.
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 135 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC
Confidence 111101 112367788899999999999999964
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=98.30 E-value=4.7e-07 Score=89.25 Aligned_cols=87 Identities=22% Similarity=0.294 Sum_probs=60.2
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHH---HHHHH--------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEF---MTVVD-------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~---~~~~~-------------------- 376 (411)
++|.-.++||+|+||.||++.. ..|+.||||++.... ......+.+|. .++..
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 4465668999999999999987 468999999995432 12223344443 44432
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++...-..++.+|+.||+|||++
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~ 311 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3333322 123488888889999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=8.5e-08 Score=85.36 Aligned_cols=83 Identities=17% Similarity=0.226 Sum_probs=60.6
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------ccc-CCC---------CC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------ANL-LTR---------ED 384 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------~~l-~~~---------~~ 384 (411)
+|.-.+.||+|+||.||+|.. .|..||||.+.... ..+.|.+|++++.+ ++. ... ..
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 344558999999999999998 57899999985432 35679999999987 111 000 00
Q ss_pred C------------CCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 385 K------------HFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 385 ~------------~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+ ..+++..+.+++.++++||+|||+.
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 0 1267888999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=98.29 E-value=5.3e-07 Score=82.59 Aligned_cols=49 Identities=20% Similarity=0.396 Sum_probs=37.1
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--------chhhHhHHHHHHHHH
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--------REAFKSFDNEFMTVV 375 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--------~~~~~~f~~e~~~~~ 375 (411)
|...+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++.
T Consensus 22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 78 (336)
T 2vuw_A 22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78 (336)
T ss_dssp HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHH
T ss_pred chheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHH
Confidence 33458999999999999998 78999999995432 112367888887765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=98.29 E-value=3.4e-07 Score=91.87 Aligned_cols=88 Identities=11% Similarity=0.123 Sum_probs=65.6
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~---------------------- 376 (411)
.++|.-.++||+|+||.||+|... +++.||||++.... ......+..|.+++..
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 355666789999999999999974 57889999996432 2334668888888875
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....+++.+...|+.+|+.||+|||+.
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 461 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3332211 113589999999999999999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.29 E-value=3.4e-07 Score=85.01 Aligned_cols=87 Identities=13% Similarity=0.149 Sum_probs=58.1
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------cccCCC--------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------ANLLTR-------- 382 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~~l~~~-------- 382 (411)
+.|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++.+ ++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 3455568899999999999987 468999999984322 2335679999999987 111000
Q ss_pred ----------C-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 ----------E-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ----------~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....+++.....++.++++||+|||+.
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~ 147 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147 (367)
T ss_dssp CEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 0 012478888999999999999999964
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.29 E-value=5e-07 Score=81.84 Aligned_cols=86 Identities=16% Similarity=0.176 Sum_probs=61.0
Q ss_pred hcCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cc
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
.+.|...+.||+|+||.||+|... +|..||||.+.... ..++|.+|++++.+ ++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 344666689999999999999884 48899999996432 34679999999987 22
Q ss_pred cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ....+++.....|+.++++||.|||+.
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 144 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 21111 123589999999999999999999964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.29 E-value=1.2e-07 Score=86.44 Aligned_cols=86 Identities=19% Similarity=0.172 Sum_probs=61.5
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccch-hhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYRE-AFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~-~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|...+.||+|+||.||+|... +|+.||||++...... ....+.+|++++.+ +++
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 3445578999999999999974 6889999999543322 23456788888876 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. .+..+++.....|+.++++||+|||+.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 119 (324)
T 3mtl_A 83 DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119 (324)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1100 134589999999999999999999963
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.28 E-value=3.9e-07 Score=74.14 Aligned_cols=83 Identities=14% Similarity=0.126 Sum_probs=43.9
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCc-ccccCchhhhcc----ccCCeeeecCCc-ccccCCccccCCcc
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQ-LEGSIPYDLCRL----AALFQLDLGDNK-LSGFVPSCFGNLTN 91 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l----~~L~~L~l~~n~-l~~~~~~~~~~l~~ 91 (411)
.+|+.|++++|.++..--..+.+|++|+.|+|++|. +++.--..+..+ ++|++|+|++|. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666654433445666666666666663 443333334432 356666666653 44221123444556
Q ss_pred CCeeecccc
Q 015202 92 LRKLYLGSN 100 (411)
Q Consensus 92 L~~L~l~~n 100 (411)
|+.|+++++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 666666555
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=98.28 E-value=4.2e-07 Score=81.06 Aligned_cols=86 Identities=17% Similarity=0.207 Sum_probs=63.4
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|... ++..||||.+.... ....+.|.+|++++.+ +
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 3445589999999999999874 56789999985432 1224679999999886 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++.....++.++++||.|||+.
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 221111 112478999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=98.27 E-value=1e-07 Score=88.90 Aligned_cols=51 Identities=16% Similarity=0.197 Sum_probs=38.3
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc---cchhhHhHHHHHHHHH
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ---YREAFKSFDNEFMTVV 375 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~---~~~~~~~f~~e~~~~~ 375 (411)
+|...+.||+|+||.||+|+. .+|+.||||++... .....+.|.+|++++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~ 128 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGG
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHH
Confidence 344458899999999999996 56899999999532 2334577999995443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=4.5e-07 Score=82.75 Aligned_cols=86 Identities=21% Similarity=0.368 Sum_probs=60.8
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCE--EEEEEEecc-cchhhHhHHHHHHHHHH------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGME--VAVKVFDLQ-YREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~--vavk~l~~~-~~~~~~~f~~e~~~~~~------------------------ 376 (411)
+|.-.+.||+|+||.||+|... +|.. ||||++... .....+.|.+|++++.+
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 3445589999999999999874 4554 499998643 23345679999999876
Q ss_pred cccCCCC----------------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE----------------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~----------------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.++.+|+.++++||+|||+.
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 161 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 161 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2221111 113589999999999999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=98.27 E-value=3.6e-07 Score=92.07 Aligned_cols=87 Identities=15% Similarity=0.164 Sum_probs=65.2
Q ss_pred cCCCcCCeeeccCCceEEEEEec--CCCEEEEEEEeccc-chhhHhHHHHHHHHHH------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ--DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~--~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------ 376 (411)
+.|.-.+.||+|+||.||+|... +|+.||||++.... ......|.+|++++.+
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 44555689999999999999974 57899999985433 3345679999999987
Q ss_pred ----cccCCCC----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTRE----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....++|.++++|+.+|++||.|||+.
T Consensus 160 ~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 201 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI 201 (681)
T ss_dssp EEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111111 122589999999999999999999964
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=7.4e-07 Score=89.16 Aligned_cols=85 Identities=16% Similarity=0.194 Sum_probs=63.1
Q ss_pred CCcCCeeeccCCceEEEEEecC----CCEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARIQD----GMEVAVKVFDLQY-REAFKSFDNEFMTVVD----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~----~~~vavk~l~~~~-~~~~~~f~~e~~~~~~----------------------~~ 378 (411)
|.-.+.||+|+||.||+|.... +..||||++.... ....+.|.+|+.++.+ +|
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~E~ 471 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMEL 471 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEEEc
Confidence 3334789999999999998732 4579999985433 3335789999999987 22
Q ss_pred cCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..... ....++|..+..|+.++|+||+|||+.
T Consensus 472 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 510 (656)
T 2j0j_A 472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510 (656)
T ss_dssp CTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 22111 123589999999999999999999964
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=98.27 E-value=2.4e-07 Score=84.88 Aligned_cols=85 Identities=15% Similarity=0.163 Sum_probs=63.5
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|++++.. +
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 344458999999999999997 578899999995432 1224579999999986 2
Q ss_pred ccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 378 NLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 378 ~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
|..+.. ....+++.....|+.++++||.|||+
T Consensus 90 ~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~ 126 (336)
T 3h4j_B 90 YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126 (336)
T ss_dssp CCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 221100 12358999999999999999999996
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=7.9e-07 Score=85.87 Aligned_cols=85 Identities=14% Similarity=0.193 Sum_probs=64.6
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|.-.+.||+|+||.||++... +|+.||||++.... ......+.+|++++.+ ++.
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 103 (486)
T 3mwu_A 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103 (486)
T ss_dssp EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcC
Confidence 445589999999999999874 68899999995432 2345789999999997 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++.....|+.++++||.|||+.
T Consensus 104 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 140 (486)
T 3mwu_A 104 TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140 (486)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2111 123488999999999999999999964
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=4.4e-07 Score=80.89 Aligned_cols=84 Identities=15% Similarity=0.111 Sum_probs=58.2
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccc------------------hhhHhHHHHHHHHHH-----------
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYR------------------EAFKSFDNEFMTVVD----------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~------------------~~~~~f~~e~~~~~~----------- 376 (411)
+.-.+.||+|+||.||+|...+|+.||||.+..... .....|.+|++++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~~ 171 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 171 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEEe
Confidence 334489999999999999997789999999854321 124568999999875
Q ss_pred --------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+..-.. +.......|+.++++||+|||+.
T Consensus 172 ~~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~ 212 (282)
T 1zar_A 172 WEGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFYHR 212 (282)
T ss_dssp EETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHHT
T ss_pred ccceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHHC
Confidence 2221111000 22234568999999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=98.25 E-value=2.8e-07 Score=84.75 Aligned_cols=57 Identities=16% Similarity=0.231 Sum_probs=44.1
Q ss_pred HHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc-----cchhhHhHHHHHHHHHH
Q 015202 320 FHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ-----YREAFKSFDNEFMTVVD 376 (411)
Q Consensus 320 ~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~-----~~~~~~~f~~e~~~~~~ 376 (411)
....++|.-.+.||+|+||.||+|.. .++..||||++... .....+.|.+|++++.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~ 84 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHH
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHh
Confidence 34455676778999999999999987 46788999998543 23345789999999997
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=98.25 E-value=6.5e-07 Score=83.81 Aligned_cols=88 Identities=16% Similarity=0.163 Sum_probs=57.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-----------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~----------------------- 376 (411)
.++|.-.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++.+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 35566668999999999999986 46889999998432 23345678899998886
Q ss_pred ---cccCCCC----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....+++..+..|+.++++||+|||+.
T Consensus 88 lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 128 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG 128 (388)
T ss_dssp EEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111000 112488889999999999999999963
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=4.1e-07 Score=83.21 Aligned_cols=88 Identities=14% Similarity=0.194 Sum_probs=63.8
Q ss_pred hcCCCcCCeeeccCCceEEEEEecC------CCEEEEEEEecccc-hhhHhHHHHHHHHHH-------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQD------GMEVAVKVFDLQYR-EAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~------~~~vavk~l~~~~~-~~~~~f~~e~~~~~~------------------- 376 (411)
.++|.-.+.||+|+||.||+|.... +..||||.+..... ...+.|.+|++++.+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4556666899999999999998732 24799999965432 345779999998875
Q ss_pred -----cccCCCC--------------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTRE--------------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~--------------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++..+.+|+.++|+||+|||+.
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 183 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK 183 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 1111100 022478999999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=98.23 E-value=7.9e-07 Score=82.60 Aligned_cols=84 Identities=11% Similarity=0.080 Sum_probs=61.8
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH---------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------------------- 376 (411)
+|.-.+.||+|+||.||+|.. .+|+.||||.+... ......+.+|++++.+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 444558999999999999986 56889999999532 2334667888877664
Q ss_pred -----------ccc--------CCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----------ANL--------LTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----------~~l--------~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. ... ....+++....+|+.+|++||+|||+.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~ 150 (373)
T 1q8y_A 99 GPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRR 150 (373)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCceEEEEEecCCCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 111 000 123489999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=98.23 E-value=4.6e-07 Score=81.04 Aligned_cols=86 Identities=15% Similarity=0.169 Sum_probs=56.1
Q ss_pred CCCcCCeeeccCCceEEEEEec--CCC--EEEEEEEecc---cchhhHhHHHHHHHHHH---------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ--DGM--EVAVKVFDLQ---YREAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~--~~~--~vavk~l~~~---~~~~~~~f~~e~~~~~~--------------------- 376 (411)
+|.-.+.||+|+||.||+|++. ++. .||||.+... .....+.|.+|++++.+
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 98 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMV 98 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCceee
Confidence 3445588999999999999863 333 6899988543 23345789999999987
Q ss_pred -cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....+++....+++.++++||.|||+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 140 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 013488999999999999999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=1e-06 Score=80.66 Aligned_cols=86 Identities=12% Similarity=0.205 Sum_probs=58.3
Q ss_pred cCCCc-CCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------c
Q 015202 324 NGFSA-NNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------A 377 (411)
Q Consensus 324 ~~f~~-~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~ 377 (411)
++|.- .++||+|+||.||+|... +|+.||||++... ....+++..+...+.. +
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 34443 257999999999999884 6899999999543 2223444444444332 2
Q ss_pred ccCCCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.++.+|+.++++||+|||+.
T Consensus 107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~ 147 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147 (336)
T ss_dssp CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 221111 123599999999999999999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.7e-07 Score=83.07 Aligned_cols=88 Identities=13% Similarity=0.182 Sum_probs=51.4
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------c
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.++|.-.+.||+|+||.||+|.. .+|..||||++.... ....++|.+|+.++.+ +
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 45566678999999999999986 467899999985432 2335678899988775 2
Q ss_pred ccCCCC--------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE--------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~--------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++..+..|+.++++||+|||+.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 140 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 221110 123489999999999999999999963
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=98.23 E-value=5.3e-07 Score=84.28 Aligned_cols=52 Identities=15% Similarity=0.210 Sum_probs=37.2
Q ss_pred HHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH
Q 015202 321 HATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~ 376 (411)
...++|...+.||+|+||.||+|.. .+|+.||||++.... +.+.+|++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~ 56 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKV 56 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTT
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHH
Confidence 3455666778999999999999986 578999999985432 223467777765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=7.8e-07 Score=86.11 Aligned_cols=85 Identities=12% Similarity=0.119 Sum_probs=60.6
Q ss_pred CCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 326 FSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
|...+.||+|+||.||+|... .+..||||++.... ......+.+|++++.. +|.
T Consensus 39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 445589999999999999874 67899999985432 3335779999999987 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++.....|+.+|++||+|||+.
T Consensus 119 ~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 155 (494)
T 3lij_A 119 KGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155 (494)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2211 113488899999999999999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=98.22 E-value=6.7e-07 Score=83.18 Aligned_cols=87 Identities=14% Similarity=0.140 Sum_probs=63.8
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH----------cccCCCC-------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------ANLLTRE------- 383 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------~~l~~~~------- 383 (411)
++|...+.||+|+||.||+|.- .+|..||||++.... ....+.+.+|+.++.. ++.....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 4455668999999999999986 467889999996432 2335678999999986 1110000
Q ss_pred --------C-------CCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 --------D-------KHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 --------~-------~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ...+++.....|+.++++||+|||+.
T Consensus 105 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 146 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146 (371)
T ss_dssp EEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC
Confidence 0 12378889999999999999999964
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2.2e-06 Score=77.03 Aligned_cols=76 Identities=12% Similarity=0.062 Sum_probs=57.8
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------------cccC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------------ANLL 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------------~~l~ 380 (411)
++||+|+||.||++.. .+|+.||||++.. ...+.+|++++.+ +|..
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 6799999999999987 5688999999953 2356778877644 2222
Q ss_pred CCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ...++++.....|+.++++||+|||+.
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 136 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 211 123589999999999999999999964
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.21 E-value=3.1e-07 Score=83.16 Aligned_cols=89 Identities=15% Similarity=0.228 Sum_probs=59.8
Q ss_pred HHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc------hhhHhHHHHHHHHHH-----------------
Q 015202 321 HATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR------EAFKSFDNEFMTVVD----------------- 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~------~~~~~f~~e~~~~~~----------------- 376 (411)
...++|.-.+.||+|+||.||+|.. .+|+.||||++..... .....+..|+.++.+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3445677779999999999999986 5688999999854322 123446677776653
Q ss_pred ----------cc-cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ----------AN-LLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ----------~~-l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
++ ..+.. ....++|..+.+|+.++++||+|||+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~ 157 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 11 11000 12248999999999999999999996
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=98.20 E-value=2.9e-07 Score=83.82 Aligned_cols=87 Identities=16% Similarity=0.257 Sum_probs=62.7
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccch------hhHhHHHHHHHHHH--------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYRE------AFKSFDNEFMTVVD-------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~------~~~~f~~e~~~~~~-------------------- 376 (411)
++|.-.+.||+|+||.||+|.. .+|+.||||.+...... ....|..|+.++.+
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 4455568999999999999986 56789999999544321 23567788888775
Q ss_pred -----cccCC-CC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLT-RE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~-~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++... .. ....+++.....|+.++++||+|||+.
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 168 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11111 00 123488999999999999999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=2.4e-07 Score=91.70 Aligned_cols=87 Identities=13% Similarity=0.118 Sum_probs=64.2
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc-cchhhHhHHHHHHHHHH-------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ-YREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~-~~~~~~~f~~e~~~~~~------------------------- 376 (411)
++|.-.+.||+|+||.||+|.. .+|..||||++... .......|.+|++++.+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5577779999999999999987 46889999998543 33445779999999987
Q ss_pred ----cccCC---------CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLT---------REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~---------~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+ ......+++..+..|+.++++||+|||+.
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~ 140 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11111 11112478888999999999999999964
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=1.2e-06 Score=79.91 Aligned_cols=86 Identities=17% Similarity=0.122 Sum_probs=61.2
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH------------------------c
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD------------------------A 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~------------------------~ 377 (411)
++|...+.||+|+||.||+|.. .+|+.||||++.... .....++..|+..+.+ +
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 3444558999999999999998 468899999996543 2334567777764433 1
Q ss_pred ccCCC----------CCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 378 NLLTR----------EDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 378 ~l~~~----------~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+..+. .....+++..+.+|+.++++||.|||+
T Consensus 102 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 143 (327)
T 3aln_A 102 LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143 (327)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc
Confidence 11110 013458999999999999999999996
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=98.20 E-value=3e-06 Score=78.27 Aligned_cols=91 Identities=13% Similarity=0.081 Sum_probs=56.2
Q ss_pred HHHHHHhcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------
Q 015202 317 LELFHATNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 317 ~~l~~at~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------- 376 (411)
.+.....++|.-.+.||+|+||.||+|.. .+|..||||++.... .....+..|++.+..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 44566778888889999999999999997 468899999985432 223456666666654
Q ss_pred -----------cccCCC---------CCCCCCCHHHHHHHHHHHhhhhcccC
Q 015202 377 -----------ANLLTR---------EDKHFMTKEQRVSFVFNLAMECTVES 408 (411)
Q Consensus 377 -----------~~l~~~---------~~~~~l~w~~r~~ia~~ia~gl~ylh 408 (411)
+|..+. .....+++.....|+.++++||.|||
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 146 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 111110 01235788889999999999999999
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.15 E-value=7.9e-07 Score=81.80 Aligned_cols=86 Identities=19% Similarity=0.139 Sum_probs=53.1
Q ss_pred CCCcCCeeeccCCceEEEEEec----CCCEEEEEEEecccch-----------hhHhHHHHHHHHHH-------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ----DGMEVAVKVFDLQYRE-----------AFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~----~~~~vavk~l~~~~~~-----------~~~~f~~e~~~~~~------------- 376 (411)
+|.-.+.||+|+||.||+|... .+..||||+....... ....+.+|+..+..
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 3445589999999999999984 5678999998543321 12235666666654
Q ss_pred --------------ccc----CCCC-CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------------ANL----LTRE-DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------------~~l----~~~~-~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. .+.. ....++|.++.+|+.++|+||+|||+.
T Consensus 118 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 170 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN 170 (345)
T ss_dssp EEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111 0000 112589999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.3e-06 Score=83.06 Aligned_cols=79 Identities=15% Similarity=0.113 Sum_probs=53.4
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cc------
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------AN------ 378 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~------ 378 (411)
.++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.+ ++
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHH
Confidence 4789999999997665568899999998543 23567889988875 11
Q ss_pred --cCCCCC-CCC---CCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 --LLTRED-KHF---MTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 --l~~~~~-~~~---l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..... ... .++....+|+.+||+||+|||+.
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 134 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC
Confidence 111110 011 13334578999999999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=6.9e-07 Score=83.05 Aligned_cols=87 Identities=17% Similarity=0.204 Sum_probs=54.6
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||++... ++..||||++.... ......+..|..++.+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 34555689999999999999984 57889999995433 2233556777765322
Q ss_pred -cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.+|++||+|||+.
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 158 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3332211 113478888889999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.13 E-value=4.3e-07 Score=82.45 Aligned_cols=86 Identities=19% Similarity=0.351 Sum_probs=62.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------c
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.++|.-.+.||+|+||.||+|...+ .||||.+.... ....+.|.+|+.++.+ +
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3445556899999999999999843 49999885432 2334668888888876 2
Q ss_pred ccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. .+..+++..+.+|+.++|+||+|||+.
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 149 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 211100 123589999999999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.1e-06 Score=79.53 Aligned_cols=86 Identities=15% Similarity=0.114 Sum_probs=53.0
Q ss_pred cCCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccc-hhhHhHHHHHH-HHHH-----------------------c
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYR-EAFKSFDNEFM-TVVD-----------------------A 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~-~~~~~f~~e~~-~~~~-----------------------~ 377 (411)
++|...+.||+|+||.||+|... +|+.||||++..... ....++..|.. ++.. +
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 34445578999999999999984 688999999965432 22334444444 3333 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+..... ....+++....+|+.++++||+|||+
T Consensus 105 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 142 (318)
T 2dyl_A 105 LMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142 (318)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 211000 12358899999999999999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=98.04 E-value=7.7e-07 Score=83.48 Aligned_cols=81 Identities=16% Similarity=0.213 Sum_probs=58.4
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------------- 376 (411)
|...++||+|+||.||+|...++..||||++.... ....+|++++..
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 44558999999999999999777779999984322 223368888876
Q ss_pred cccCCC---------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTR---------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~---------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+. .....+++.....++.++++||+|||+.
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 160 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 111100 0123588888999999999999999963
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.03 E-value=8e-07 Score=84.36 Aligned_cols=83 Identities=16% Similarity=0.178 Sum_probs=57.2
Q ss_pred hcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------------
Q 015202 323 TNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------- 376 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------- 376 (411)
..+|...++||+|+||.||.....+|+.||||++.... ...+.+|++++.+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34466668999999998554444588999999995432 2346788888875
Q ss_pred ------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++... .....+.....|+.+|++||+|||+.
T Consensus 100 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~ 137 (432)
T 3p23_A 100 CAATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSL 137 (432)
T ss_dssp CSEEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHC
Confidence 112111 11244445678999999999999964
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.90 E-value=3.2e-06 Score=68.73 Aligned_cols=34 Identities=12% Similarity=0.064 Sum_probs=16.3
Q ss_pred CCcEEEcCCCeeeecCCCCccCccCCCeEEccCC
Q 015202 114 YILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMN 147 (411)
Q Consensus 114 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 147 (411)
.|+.|++++|.++..--..+.++++|+.|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4555555555544332333444455555555554
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=7.3e-06 Score=76.11 Aligned_cols=47 Identities=13% Similarity=0.208 Sum_probs=35.3
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---hhhHhHHHHHH
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---EAFKSFDNEFM 372 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~~~~~f~~e~~ 372 (411)
|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+..|++
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~ 114 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHH
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHH
Confidence 44558999999999999997 4688999999965432 23456777743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=5.3e-06 Score=72.87 Aligned_cols=82 Identities=16% Similarity=0.188 Sum_probs=55.1
Q ss_pred CCeeeccCCceEEEEEe-cCCCE--EEEEEEecccch------------------------hhHhHHHHHHHHHH-----
Q 015202 329 NNIIGRGGIGSIYKARI-QDGME--VAVKVFDLQYRE------------------------AFKSFDNEFMTVVD----- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l-~~~~~--vavk~l~~~~~~------------------------~~~~f~~e~~~~~~----- 376 (411)
...||+|+||.||+|.. .+|+. ||||.+...... ....+.+|++.+.+
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 36899999999999998 78888 999987432111 11357889888876
Q ss_pred ----------------cccCCCC-CCCC-------CCHHHHHHHHHHHhhhhcccC-CC
Q 015202 377 ----------------ANLLTRE-DKHF-------MTKEQRVSFVFNLAMECTVES-PN 410 (411)
Q Consensus 377 ----------------~~l~~~~-~~~~-------l~w~~r~~ia~~ia~gl~ylh-~~ 410 (411)
+|+.... .... .++.....++.++++||.||| ++
T Consensus 132 i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 132 VSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp CCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred CCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHC
Confidence 3331000 0001 113356889999999999999 53
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=3e-05 Score=75.62 Aligned_cols=82 Identities=11% Similarity=0.053 Sum_probs=47.2
Q ss_pred cCCeeeccCCceEEEEEecCCCEEEEEEEecccc--h------hhHhHHHHHHHHHH-cc--cC--------CCC-----
Q 015202 328 ANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYR--E------AFKSFDNEFMTVVD-AN--LL--------TRE----- 383 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~--~------~~~~f~~e~~~~~~-~~--l~--------~~~----- 383 (411)
..++||+|+||.||+|.. .+..+++|+...... . ..+.|.+|++++.+ .+ +- ...
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 347899999999999976 668899998733211 1 13458999999987 00 00 000
Q ss_pred -CCCCCCHHH----HHHHHHHHhhhhcccCCC
Q 015202 384 -DKHFMTKEQ----RVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -~~~~l~w~~----r~~ia~~ia~gl~ylh~~ 410 (411)
.-..-+..+ +.+|+.++++||+|||+.
T Consensus 419 E~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~ 450 (540)
T 3en9_A 419 SYINGKLAKDVIEDNLDIAYKIGEIVGKLHKN 450 (540)
T ss_dssp ECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHT
T ss_pred ECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHC
Confidence 000011111 568999999999999964
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.66 E-value=2.7e-05 Score=64.52 Aligned_cols=113 Identities=14% Similarity=0.169 Sum_probs=61.4
Q ss_pred hhhCCCCCCeeecccC-ccccc----CchhhhccccCCeeeecCCccccc----CCccccCCccCCeeecccccCC----
Q 015202 37 ALGKLQKLQLLGLEDN-QLEGS----IPYDLCRLAALFQLDLGDNKLSGF----VPSCFGNLTNLRKLYLGSNQLT---- 103 (411)
Q Consensus 37 ~~~~l~~L~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~---- 103 (411)
.+.+-+.|+.|+|++| .+... +.+.+..-..|+.|+|++|.+... +...+..-+.|+.|+|++|.|+
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3445566666776664 55421 233344455677777777766532 2223334456777777777766
Q ss_pred -ccCccccCCCCCcEEEcCCCe---eee----cCCCCccCccCCCeEEccCCee
Q 015202 104 -YIPLTLWNLKYILYLNLSSNS---FTI----PLPSEIGNLEVLVQIDLSMNNF 149 (411)
Q Consensus 104 -~~p~~~~~~~~L~~L~l~~n~---l~~----~~~~~~~~l~~L~~L~l~~n~~ 149 (411)
.+-..+..-+.|++|+|++|. +.. .+...+..-++|+.|+++.|.+
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 333445555667777776542 221 1222333445677777776654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.48 E-value=2.8e-05 Score=64.37 Aligned_cols=109 Identities=12% Similarity=0.072 Sum_probs=51.4
Q ss_pred cCCcCCceeecCc-cccc----ccchhhhCCCCCCeeecccCcccccC----chhhhccccCCeeeecCCccccc----C
Q 015202 16 NLTNLIAIYLGGN-KLNG----SISIALGKLQKLQLLGLEDNQLEGSI----PYDLCRLAALFQLDLGDNKLSGF----V 82 (411)
Q Consensus 16 ~~~~L~~L~l~~n-~~~~----~~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~----~ 82 (411)
+-+.|+.|+|++| .+.. .+..++..-+.|+.|+|++|.+.+.- .+.+..-+.|++|+|+.|.|... +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3445666666553 4431 12334445555666666666555322 22233345566666666665422 2
Q ss_pred CccccCCccCCeeecccccC---C-----ccCccccCCCCCcEEEcCCCe
Q 015202 83 PSCFGNLTNLRKLYLGSNQL---T-----YIPLTLWNLKYILYLNLSSNS 124 (411)
Q Consensus 83 ~~~~~~l~~L~~L~l~~n~l---~-----~~p~~~~~~~~L~~L~l~~n~ 124 (411)
...+..-+.|+.|+|++|.. . .+...+..-+.|+.|+++.|.
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 22333344566666654322 2 122233344555566655443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0001 Score=67.98 Aligned_cols=31 Identities=23% Similarity=0.302 Sum_probs=27.3
Q ss_pred cCCeeeccCCceEEEEEecCCCEEEEEEEec
Q 015202 328 ANNIIGRGGIGSIYKARIQDGMEVAVKVFDL 358 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~ 358 (411)
-...||+|++|.||+|.-++|+.||||.++.
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~ 129 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRL 129 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECT
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEec
Confidence 3478999999999999988999999998743
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0011 Score=51.01 Aligned_cols=39 Identities=26% Similarity=0.308 Sum_probs=19.6
Q ss_pred CCCEEeCCCCccccccchhhhcCCCCCEEEcccCccccc
Q 015202 186 NLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGE 224 (411)
Q Consensus 186 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~ 224 (411)
+|+.|+|++|.|+...+..|..+++|+.|+|++|++.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd 70 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD 70 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence 345555555555544444445555555555555555443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0007 Score=52.24 Aligned_cols=37 Identities=32% Similarity=0.222 Sum_probs=21.6
Q ss_pred CCCeeecccCcccccCchhhhccccCCeeeecCCccc
Q 015202 43 KLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 43 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 79 (411)
+|++|+|++|.|+.+.+..|..+++|++|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4566666666666555555555666666666666543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=95.34 E-value=0.0066 Score=59.43 Aligned_cols=76 Identities=14% Similarity=0.060 Sum_probs=44.1
Q ss_pred eeccCCceEEEEE-ecCCCEEEEEEEeccc----------chhhHhHHHHHHHHHH------------------------
Q 015202 332 IGRGGIGSIYKAR-IQDGMEVAVKVFDLQY----------REAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 332 lg~g~~g~vy~g~-l~~~~~vavk~l~~~~----------~~~~~~f~~e~~~~~~------------------------ 376 (411)
.+.|++|.++++. +--|+.+|||.+.... ....++|.+|++++.+
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455555544432 2246889999984321 1224679999999987
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ...+++.. +|+.||++||+|+|++
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~ 358 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ 358 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC
Confidence 4444322 23346643 5899999999999974
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=91.74 E-value=0.087 Score=45.57 Aligned_cols=84 Identities=8% Similarity=-0.002 Sum_probs=55.2
Q ss_pred HHhcCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------
Q 015202 321 HATNGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 321 ~at~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------ 376 (411)
....++.-....+.|+.+.||+... +|..+++|+...........+.+|++++..
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3344554445677788889999886 468999999854322334568899988875
Q ss_pred cccCCCCCCCCC-----CHHHHHHHHHHHhhhhcccCC
Q 015202 377 ANLLTREDKHFM-----TKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ~~l~~~~~~~~l-----~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+++. +..+ +..+..+++.+++++|+.||+
T Consensus 90 e~i~----G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 90 SEAD----GVLCSEEYEDEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp ECCS----SEEHHHHCCTTTCHHHHHHHHHHHHHHHHH
T ss_pred EecC----CeehhhccCCcccHHHHHHHHHHHHHHHhC
Confidence 2221 1111 112345788999999999996
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.08 E-value=0.18 Score=29.94 Aligned_cols=24 Identities=13% Similarity=0.155 Sum_probs=10.3
Q ss_pred ehhHHHHHHHHHHHHhhhhhhcCC
Q 015202 273 IVLPLSTIFMMVVILLILRYRKRG 296 (411)
Q Consensus 273 i~~~~~~~~~~~~~~~~~~~~~~~ 296 (411)
++.+++++++++..+++++||++.
T Consensus 17 VVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 17 MVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred hhHHHHHHHHHHHHHHHHhhhhHh
Confidence 333344333444444455544443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=88.90 E-value=0.19 Score=43.16 Aligned_cols=71 Identities=10% Similarity=-0.077 Sum_probs=47.8
Q ss_pred eccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-------------------------cccCCCCCCCC
Q 015202 333 GRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-------------------------ANLLTREDKHF 387 (411)
Q Consensus 333 g~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-------------------------~~l~~~~~~~~ 387 (411)
+.|..+.||+....+|..++||..... ....+..|++++.. +++. +.+
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~----G~~ 101 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP----GQD 101 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS----SEE
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC----Ccc
Confidence 345569999998877888999987443 23467788877765 2222 222
Q ss_pred CCHH--HHHHHHHHHhhhhcccCCC
Q 015202 388 MTKE--QRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 388 l~w~--~r~~ia~~ia~gl~ylh~~ 410 (411)
++|. .+..++.++|+.|..||+.
T Consensus 102 l~~~~~~~~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 102 LLSSHLAPAEKVSIMADAMRRLHTL 126 (264)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHTTS
T ss_pred cCcCcCCHhHHHHHHHHHHHHHhCC
Confidence 3332 2347889999999999973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=85.85 E-value=0.93 Score=39.64 Aligned_cols=51 Identities=18% Similarity=0.118 Sum_probs=39.5
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~ 376 (411)
+.....+|.|..+.||+.++.||+.+.||+-..........|..|.+.+..
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~ 67 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDW 67 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHH
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHH
Confidence 344567899999999999999999999998644333334578899988774
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.08 E-value=0.44 Score=28.18 Aligned_cols=19 Identities=16% Similarity=0.235 Sum_probs=8.1
Q ss_pred HHHHHHHHHHHhhhhhhcC
Q 015202 277 LSTIFMMVVILLILRYRKR 295 (411)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~ 295 (411)
++++++++..+++++||++
T Consensus 20 v~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 20 LFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhhhhh
Confidence 3333334444444444443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=84.15 E-value=1.6 Score=39.46 Aligned_cols=80 Identities=8% Similarity=-0.010 Sum_probs=52.0
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEe--cccc-hhhHhHHHHHHHHHH----------------------------c
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFD--LQYR-EAFKSFDNEFMTVVD----------------------------A 377 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~--~~~~-~~~~~f~~e~~~~~~----------------------------~ 377 (411)
...++.|.++.||+....+ ..+++|+.. .... .....+..|++++.. +
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4578899999999988754 677788764 3221 224578888888876 2
Q ss_pred ccCCCCC----CCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 378 NLLTRED----KHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 378 ~l~~~~~----~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
++.+..- -..++..++..++.+++++|+.||+
T Consensus 122 ~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 122 FVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp CCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 2222210 0125677899999999999999996
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 411 | ||||
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-14 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-09 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 9e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-06 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-05 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-05 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-05 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-05 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-05 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-04 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-04 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-04 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-04 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-04 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-04 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-04 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-04 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-04 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 0.001 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 0.001 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 0.001 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 0.001 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 0.001 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 0.002 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 0.002 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 0.002 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 0.002 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 0.002 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 0.002 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 0.003 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 0.003 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 0.004 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 0.004 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 0.004 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 92.1 bits (227), Expect = 2e-21
Identities = 68/257 (26%), Positives = 108/257 (42%), Gaps = 6/257 (2%)
Query: 3 NCNISG--SIPEEINNLTNLIAIYLGGN-KLNGSISIALGKLQKLQLLGLEDNQLEGSIP 59
N+ IP + NL L +Y+GG L G I A+ KL +L L + + G+IP
Sbjct: 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLN 119
L ++ L LD N LSG +P +L NL + N+++ + L+ +
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
++ + + + + N + + G
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESF 239
+G NL LDL NN + G +P L +L L +NVSFN L GEIP+ G + F + ++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 240 KGNELLCGMPNLHVPPC 256
N+ LCG P +P C
Sbjct: 299 ANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 1e-09
Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 1/63 (1%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+ N I G++P+ + L L ++ + N L G I G LQ+ + +N+ P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309
Query: 61 DLC 63
C
Sbjct: 310 PAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 7e-05
Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 5/153 (3%)
Query: 115 ILYLNLSSNSFT--IPLPSEIGNLEVLVQIDLSMN-NFSGAIPTTIGGLKDLQYLFLEYN 171
+ L+LS + P+PS + NL L + + N G IP I L L YL++ +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 172 RLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE--G 229
+ G+IPDF+ + L +LD S N LSG +P S+ L +L I N++ G IP
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 230 PFRNFSIESFKGNELLCGMPNLHVPPCRTGIHH 262
+ F+ + N L +P +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.1 bits (92), Expect = 3e-04
Identities = 41/137 (29%), Positives = 57/137 (41%), Gaps = 4/137 (2%)
Query: 87 GNLTNLRKLYLGSNQLT---YIPLTLWNLKYILYLNLSSN-SFTIPLPSEIGNLEVLVQI 142
+ L L L IP +L NL Y+ +L + + P+P I L L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIP 202
++ N SGAIP + +K L L YN L G++P I L NL + N +SGAIP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 203 ISLEKLLDLQHINVSFN 219
S L
Sbjct: 167 DSYGSFSKLFTSMTISR 183
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 4e-20
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG 74
LTNL ++ N+++ + + L L L NQL+ L L L LDL
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 75 DNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIG 134
+N++S P LT L +L LG+NQ++ I L L + L L+ N S I
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLEDI--SPIS 304
Query: 135 NLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSN 194
NL+ L + L NN S P + L LQ LF N++ + L N+ L +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 195 NNLSGAIPISLEKLLDLQHINVSFN 219
N +S P++ L + + ++
Sbjct: 361 NQISDLTPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.9 bits (193), Expect = 9e-17
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 13/188 (6%)
Query: 39 GKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLG 98
KL L+ L +NQ+ P + L +L L N+L +LTNL L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 99 SNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIG 158
+NQ++ + L L + L L +N + P + L L ++L+ N + I
Sbjct: 250 NNQISNLA-PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISPIS 304
Query: 159 GLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSF 218
LK+L YL L +N + P + L L+ L +NN +S SL L ++ ++
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 219 NKLEGEIP 226
N++ P
Sbjct: 361 NQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.4 bits (171), Expect = 6e-14
Identities = 38/167 (22%), Positives = 66/167 (39%), Gaps = 29/167 (17%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP- 59
+ + + +LTNL + L N+++ L L KL L L NQ+ P
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 281
Query: 60 -------------------YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSN 100
+ L L L L N +S P +LT L++L+ +N
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 339
Query: 101 QLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMN 147
+++ + +L NL I +L+ N + P + NL + Q+ L+
Sbjct: 340 KVSDVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 3e-06
Identities = 24/97 (24%), Positives = 41/97 (42%), Gaps = 11/97 (11%)
Query: 124 SFTIPLPSEIG------NLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSI 177
S TI + I L ++ L N + + + L + L + ++ SI
Sbjct: 3 SATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI 59
Query: 178 PDFIGGLINLKSLDLSNNNLSGAIPIS-LEKLLDLQH 213
D + L NL ++ SNN L+ P+ L KL+D+
Sbjct: 60 -DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILM 95
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 65 LAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNS 124
LA + LG ++ V +L + L + I + L + +N S+N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQ 77
Query: 125 FTIPLPSEIGNLEVLVQIDLSMNNF 149
T P + NL LV I ++ N
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQI 100
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 20/107 (18%), Positives = 36/107 (33%), Gaps = 31/107 (28%)
Query: 16 NLTNLIAIYLGGNKLNGSISIA-LGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG 74
L + LG + ++S L ++ LQ L ++G
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG------------------ 61
Query: 75 DNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLS 121
L NL ++ +NQLT I L NL ++ + ++
Sbjct: 62 -----------VEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMN 96
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.6 bits (213), Expect = 1e-19
Identities = 53/269 (19%), Positives = 93/269 (34%), Gaps = 7/269 (2%)
Query: 3 NCNISG--SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
C+ G +P+++ + + L NK+ L+ L L L +N++ P
Sbjct: 16 QCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNL 120
L L +L L N+L L LR ++ N ++ L
Sbjct: 74 AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 133
Query: 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
+ + ++ L I ++ N + IP G L L L+ N++
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAAS 190
Query: 181 IGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFK 240
+ GL NL L LS N++S SL L+ ++++ NKL + +
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
Query: 241 GNELLCGMPNLHVPPCRTGIHHTSRKNDL 269
N + N PP + L
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSL 279
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.5 bits (205), Expect = 1e-18
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 10/238 (4%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+ N IS P L L +YL N+L LQ+L++ E ++ S+
Sbjct: 62 LINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN 121
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNL 120
L + +L K SG F + L + + +T IP L + L+L
Sbjct: 122 GLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHL 178
Query: 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
N T + + L L ++ LS N+ S ++ L+ L L N+L +P
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237
Query: 181 IGGLINLKSLDLSNNNLSG------AIPISLEKLLDLQHINVSFNKLEGEIPREGPFR 232
+ ++ + L NNN+S P K +++ N ++ + FR
Sbjct: 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.1 bits (152), Expect = 1e-11
Identities = 39/194 (20%), Positives = 66/194 (34%), Gaps = 23/194 (11%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
SG + L I + + +I G L L L+ N++
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAA 189
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNL 120
L L L +L L N +S N +LR+L+L +N+L +P L + KYI + L
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYL 249
Query: 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS--IP 178
+N+ + + N+F P + L N +Q P
Sbjct: 250 HNNNIS----------------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQP 291
Query: 179 DFIGGLINLKSLDL 192
+ ++ L
Sbjct: 292 STFRCVYVRAAVQL 305
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.1 bits (180), Expect = 2e-15
Identities = 55/247 (22%), Positives = 83/247 (33%), Gaps = 30/247 (12%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSI-------------------------SIA 37
IS NL ++L N L
Sbjct: 41 GNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPAT 100
Query: 38 LGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97
L +L L L+ L+ P LAAL L L DN L F +L NL L+L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160
Query: 98 GSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTT 156
N+++ +P L + L L N P +L L+ + L NN S
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 157 IGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINV 216
+ L+ LQYL L N L+ S++ + ++P ++L +
Sbjct: 221 LAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRL 276
Query: 217 SFNKLEG 223
+ N L+G
Sbjct: 277 AANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (178), Expect = 3e-15
Identities = 44/200 (22%), Positives = 74/200 (37%), Gaps = 5/200 (2%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
N + P + L L ++L L L LQ L L+DN L+
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYI-PLTLWNLKYILYLN 119
L L L L N++S F L +L +L L N++ ++ P +L ++ L
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 120 LSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
L +N+ + + L L + L+ N + LQ + + S+P
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQ 266
Query: 180 FIGGLINLKSLDLSNNNLSG 199
+ G L+ N+L G
Sbjct: 267 RLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (174), Expect = 1e-14
Identities = 63/251 (25%), Positives = 93/251 (37%), Gaps = 6/251 (2%)
Query: 3 NCNISG--SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+C G ++P I I+L GN+++ + + + L +L L N L
Sbjct: 17 SCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74
Query: 61 DLCRLAALFQLDLGDNKLSGFV-PSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYL- 118
LA L QLDL DN V P+ F L L L+L L + L+ L
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134
Query: 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIP 178
L N+ +L L + L N S GL L L L NR+ P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 179 DFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIES 238
L L +L L NNLS +L L LQ++ ++ N + +
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254
Query: 239 FKGNELLCGMP 249
+E+ C +P
Sbjct: 255 GSSSEVPCSLP 265
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (156), Expect = 2e-12
Identities = 40/197 (20%), Positives = 66/197 (33%), Gaps = 7/197 (3%)
Query: 3 NCNISG--SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
NC+ ++P ++ + ++L N L L +L L L+ + +
Sbjct: 16 NCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQ 71
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNL 120
L L LDL N+L + + L L + L L
Sbjct: 72 VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131
Query: 121 SSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDF 180
N P + L ++ L+ NN + + GL++L L L+ N L +IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 181 IGGLINLKSLDLSNNNL 197
G L L N
Sbjct: 191 FFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 8e-07
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 3/65 (4%)
Query: 132 EIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLD 191
E+ + ++++ N + A+P + KD L L N L + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 192 LSNNN 196
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 2e-04
Identities = 14/68 (20%), Positives = 24/68 (35%), Gaps = 3/68 (4%)
Query: 83 PSC-FGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQ 141
P C + + ++ LT +P L K L+LS N + + L Q
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 142 IDLSMNNF 149
++L
Sbjct: 60 LNLDRAEL 67
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.1 bits (141), Expect = 3e-10
Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 8/89 (8%)
Query: 76 NKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGN 135
N S + S +L +L + +N+L +P L+ L S N +P N
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAE-VPELPQN 325
Query: 136 LEVLVQIDLSMNNFSGAIPTTIGGLKDLQ 164
L+ L + N P ++DL+
Sbjct: 326 LKQL---HVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 2e-09
Identities = 23/100 (23%), Positives = 35/100 (35%), Gaps = 13/100 (13%)
Query: 49 LEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLT 108
N I +L +L++ +NKL L +L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL----PPRLERLIASFNHLAEVPEL 322
Query: 109 LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNN 148
NLK L++ N P ++E DL MN+
Sbjct: 323 PQNLK---QLHVEYNPLRE-FPDIPESVE-----DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 1e-07
Identities = 27/103 (26%), Positives = 39/103 (37%), Gaps = 13/103 (12%)
Query: 110 WNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLE 169
+ YLN SSN +LE L ++S N +P L + L
Sbjct: 261 ELPPNLYYLNASSNEIRSL-CDLPPSLEEL---NVSNNKLI-ELPALPPRL---ERLIAS 312
Query: 170 YNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQ 212
+N L +P+ NLK L + N L P E + DL+
Sbjct: 313 FNHLA-EVPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 3e-06
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPY 60
+ S I + +L + + NKL + +L++L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321
Query: 61 DLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93
L QL + N L F P ++ +LR
Sbjct: 322 LPQNLK---QLHVEYNPLREF-PDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 2e-04
Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 4/69 (5%)
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
C +L+L + LS +L L N LT +P +LK +L N +
Sbjct: 35 CLDRQAHELELNNLGLSSLPEL----PPHLESLVASCNSLTELPELPQSLKSLLVDNNNL 90
Query: 123 NSFTIPLPS 131
+ + P
Sbjct: 91 KALSDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.1 bits (84), Expect = 0.003
Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 8/63 (12%)
Query: 161 KDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220
+ L L L S+P+ +L+SL S N+L+ +P E L+ + V N
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELP---ELPQSLKSLLVDNNN 89
Query: 221 LEG 223
L+
Sbjct: 90 LKA 92
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 7e-09
Identities = 40/215 (18%), Positives = 79/215 (36%), Gaps = 21/215 (9%)
Query: 9 SIPEEIN------NLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDL 62
++P I I L + +++ +L + + ++ ++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGI 64
Query: 63 CRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
L + +L L NKL+ L NL+ L + +LS
Sbjct: 65 QYLPNVTKLFLNGNKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119
Query: 123 NSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIG 182
I + + +L L + L N + + L L L LE N++ +P +
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LA 175
Query: 183 GLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVS 217
GL L++L LS N++S + +L L +L + +
Sbjct: 176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 13/37 (35%), Positives = 18/37 (48%), Gaps = 1/37 (2%)
Query: 86 FGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSS 122
LT L+ LYL N ++ + L LK + L L S
Sbjct: 174 LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFS 209
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 8e-09
Identities = 24/118 (20%), Positives = 36/118 (30%), Gaps = 6/118 (5%)
Query: 71 LDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLP 130
L L L+ V L + L L N+L +P L L+ + L S N+
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 131 SEIGNLEVLVQIDLSMNNF-SGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINL 187
++ L N A + L L L+ N L L +
Sbjct: 61 VANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 9e-09
Identities = 29/108 (26%), Positives = 41/108 (37%), Gaps = 5/108 (4%)
Query: 93 RKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGA 152
R L+L LT + L L + +L+LS N P+ + L L + S N
Sbjct: 1 RVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 153 IPTTIGGLKDLQYLFLEYNRLQG-SIPDFIGGLINLKSLDLSNNNLSG 199
LQ L L NRLQ + + L L+L N+L
Sbjct: 59 DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 6e-07
Identities = 25/109 (22%), Positives = 39/109 (35%), Gaps = 4/109 (3%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAAL 68
++ + L + + L N+L AL L+ L++L DN LE L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLP--RL 67
Query: 69 FQLDLGDNKLSGF-VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYIL 116
+L L +N+L + L L L N L L +L
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 3e-06
Identities = 27/109 (24%), Positives = 42/109 (38%), Gaps = 6/109 (5%)
Query: 117 YLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176
L+L+ T+ + L ++ +DLS N P + L+ L+ L N L+
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 177 IPDFIGGLINLKSLDLSNNNLSGAIPI-SLEKLLDLQHINVSFNKLEGE 224
L+ L L NN L + I L L +N+ N L E
Sbjct: 59 DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.0 bits (123), Expect = 2e-08
Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 25/218 (11%)
Query: 16 NLTNLIAIYLGGNKLNGSISIA-LGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG 74
L N I I G + + +++ A L + L G +EG + L L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELK 71
Query: 75 DNKLSGF-VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEI 133
DN+++ +T L ++ I L ++ + S +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 134 GNL--------------EVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
L + LS+ N + T + L L L + N++ P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVS 217
+ L NL + L NN +S P L +L + ++
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 2e-07
Identities = 16/94 (17%), Positives = 31/94 (32%), Gaps = 8/94 (8%)
Query: 135 NLEVLVQIDLSMNNFSGA-IPTTIGGLKDLQYLFLEYNRLQG----SIPDFIGGLINLKS 189
+++ L D+ S A + L+ Q + L+ L I + L
Sbjct: 3 DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 190 LDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEG 223
L+L +N L + + L + L+
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 2e-06
Identities = 13/72 (18%), Positives = 27/72 (37%), Gaps = 5/72 (6%)
Query: 162 DLQYLFLEYNRLQGS-IPDFIGGLINLKSLDLSNNNLSG----AIPISLEKLLDLQHINV 216
D+Q L ++ L + + + L + + L + L+ I +L L +N+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 217 SFNKLEGEIPRE 228
N+L
Sbjct: 63 RSNELGDVGVHC 74
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 3e-06
Identities = 15/80 (18%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 139 LVQIDLSMNNFSG----AIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLI-----NLKS 189
L + L+ + S ++ T+ L+ L L N L + + + L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 190 LDLSNNNLSGAIPISLEKLL 209
L L + S + L+ L
Sbjct: 431 LVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 1e-05
Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 9/75 (12%)
Query: 163 LQYLFLEYNRLQG----SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLD-----LQH 213
L+ L+L + S+ + +L+ LDLSNN L A + L + + L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 214 INVSFNKLEGEIPRE 228
+ + E+
Sbjct: 431 LVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 6e-05
Identities = 12/91 (13%), Positives = 28/91 (30%), Gaps = 6/91 (6%)
Query: 91 NLRKLYLGSNQLTYIPLT--LWNLKYILYLNLSSNSFT----IPLPSEIGNLEVLVQIDL 144
+++ L + +L+ L L+ + L T + S + L +++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 145 SMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG 175
N + ++ LQ
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 1e-04
Identities = 16/90 (17%), Positives = 25/90 (27%), Gaps = 11/90 (12%)
Query: 71 LDLGDNKLSGF-VPSCFGNLTNLRKLYLGSNQLT-----YIPLTLWNLKYILYLNLSSNS 124
LD+ +LS L + + L LT I L + LNL SN
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 125 FTIPLPSEIG-----NLEVLVQIDLSMNNF 149
+ + ++ L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 1e-04
Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 10/93 (10%)
Query: 19 NLIAIYLGGNKLNGS-ISIALGKLQKLQLLGLEDNQLEG----SIPYDLCRLAALFQLDL 73
++ ++ + +L+ + + L LQ+ Q++ L+D L I L AL +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 74 GDNKLSGFVPSCFG-----NLTNLRKLYLGSNQ 101
N+L C ++KL L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 1e-04
Identities = 15/89 (16%), Positives = 31/89 (34%), Gaps = 10/89 (11%)
Query: 83 PSCFGNLTNLRKLYLGSNQLT-----YIPLTLWNLKYILYLNLSSNSFTIPLPSEIG--- 134
+ LR L+L ++ + TL + L+LS+N ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 135 --NLEVLVQIDLSMNNFSGAIPTTIGGLK 161
+L Q+ L +S + + L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 5e-07
Identities = 23/99 (23%), Positives = 46/99 (46%), Gaps = 3/99 (3%)
Query: 51 DNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLW 110
+N+++ L L L+L DN++S +P F +L +L L L SN W
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146
Query: 111 NLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNF 149
+++ +L+ + PS++ ++++ DL + F
Sbjct: 147 FAEWLRKKSLNGGAARCGAPSKVRDVQIK---DLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 6e-07
Identities = 41/167 (24%), Positives = 63/167 (37%), Gaps = 8/167 (4%)
Query: 84 SCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEI-GNLEVLVQI 142
C G + L IP + + L L+ N + G L LV++
Sbjct: 7 HCEG-----TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKL 59
Query: 143 DLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIP 202
+L N +G P G +Q L L N+++ GL LK+L+L +N +S +P
Sbjct: 60 ELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMP 119
Query: 203 ISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249
S E L L +N++ N +S G CG P
Sbjct: 120 GSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 9e-06
Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 6/172 (3%)
Query: 9 SIPEEINNLTNLIAIYLGGNKLNGSISIAL-GKLQKLQLLGLEDNQLEGSIPYDLCRLAA 67
IP +I + + L N+L S L G+L L L L+ NQL G P +
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTI 127
+ +L LG+NK+ F L L+ L L NQ++ + + L +++
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 128 PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179
E L + L+ P+ ++D+Q L ++ + S +
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSEN 188
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 9e-07
Identities = 15/99 (15%), Positives = 39/99 (39%), Gaps = 3/99 (3%)
Query: 118 LNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQG-S 176
L+L+ + + + + V+ + + + +Q++ L + ++ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHIN 215
+ + L++L L LS I +L K +L +N
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 1e-06
Identities = 37/260 (14%), Positives = 81/260 (31%), Gaps = 41/260 (15%)
Query: 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEG-SIPYD 61
N+ + + + +IA + ++ ++ ++Q + L ++ +E ++
Sbjct: 9 GKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGI 66
Query: 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKL------YLGSNQLTYIPLTLWNLKYI 115
L + + L L L +LS + + +NL +L L + + L +
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126
Query: 116 LY---------------------------LNLSSNSFTIPLPSEIGNLEVLVQIDLSMN- 147
N L + + LV +DLS +
Sbjct: 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186
Query: 148 NFSGAIPTTIGGLKDLQYLFLEY-NRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLE 206
L LQ+L L + +G + LK+L + G + + E
Sbjct: 187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE 246
Query: 207 KLLDLQHINVSFNKLEGEIP 226
L H+ ++ +
Sbjct: 247 A---LPHLQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 9e-06
Identities = 17/99 (17%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 71 LDLGDNKLSGFVPSCFGNLT--NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTI- 127
LDL L P G L + + + ++ + +++LS++ +
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 128 PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYL 166
L + L + L S I T+ +L L
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 1e-06
Identities = 42/200 (21%), Positives = 77/200 (38%), Gaps = 17/200 (8%)
Query: 16 NLTNLIAIYLGGNKLNGSISIA-LGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG 74
L + LG + ++S L ++ LQ L ++G + L L Q++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 75 DNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIG 134
+N+L+ NLT L + + +NQ+ I ++ I +
Sbjct: 71 NNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128
Query: 135 NLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSN 194
NL L ++++ S T Q L N++ P + L L+ LD+S+
Sbjct: 129 NLNRLELSSNTISDISALSGLTSL-----QQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 195 NNLSGAIPISLEKLLDLQHI 214
N +S L KL +L+ +
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 46.7 bits (110), Expect = 2e-06
Identities = 15/71 (21%), Positives = 26/71 (36%), Gaps = 14/71 (19%)
Query: 314 FTYLELFHATNGFSAN---------NIIGRGGIGSIYKARI----QDGMEVAVKVFDLQY 360
FT+ + A F+ +IG G G + + + + VA+K Y
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 361 RE-AFKSFDNE 370
E + F +E
Sbjct: 67 TEKQRRDFLSE 77
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 2e-06
Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 5/155 (3%)
Query: 97 LGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTT 156
L Q+ + L + L ++ + V ++ ++ + +
Sbjct: 4 LKPEQVEQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRII 60
Query: 157 IGGLKDLQYLFLEYNRLQG--SIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHI 214
+ +L L L NRL + + NLK L+LS N L + K L L+ +
Sbjct: 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120
Query: 215 NVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249
+ N L + + + E F L G
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.3 bits (83), Expect = 0.002
Identities = 27/146 (18%), Positives = 50/146 (34%), Gaps = 6/146 (4%)
Query: 33 SISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNL 92
+ + + K L+ L S P DL L+ + ++ + N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL-RSDP-DLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67
Query: 93 RKLYLGSNQLTY---IPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNF 149
L L +N+L + + + LNLS N + L ++ L N+
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 150 SGAIPTTIGGLKDLQYLFLEYNRLQG 175
S + ++ F + RL G
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (104), Expect = 3e-06
Identities = 25/134 (18%), Positives = 43/134 (32%), Gaps = 6/134 (4%)
Query: 86 FGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLS 145
+ N R+L L ++ I L ++ S N I L L + ++
Sbjct: 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNE--IRKLDGFPLLRRLKTLLVN 71
Query: 146 MNNFSGAIPTTIGGLKDLQYLFLEYNRLQG-SIPDFIGGLINLKSLDLSNNN---LSGAI 201
N L DL L L N L D + L +L L + N
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131
Query: 202 PISLEKLLDLQHIN 215
+ K+ ++ ++
Sbjct: 132 LYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 9e-04
Identities = 21/130 (16%), Positives = 44/130 (33%), Gaps = 6/130 (4%)
Query: 68 LFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTI 127
+LDL K+ + + L + N++ + L+ + L +++N
Sbjct: 20 DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICR 77
Query: 128 PLPSEIGNLEVLVQIDLSMNNFSG-AIPTTIGGLKDLQYLFLE---YNRLQGSIPDFIGG 183
L L ++ L+ N+ + LK L YL + + I
Sbjct: 78 IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYK 137
Query: 184 LINLKSLDLS 193
+ ++ LD
Sbjct: 138 VPQVRVLDFQ 147
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 2e-05
Identities = 22/132 (16%), Positives = 43/132 (32%), Gaps = 2/132 (1%)
Query: 139 LVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFI-GGLINLKSLDLSNNNL 197
+ + + + G ++L L++E + + GL L++L + + L
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 198 SGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMPNLHVPPCR 257
P + L +N+SFN LE + + GN L C +
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128
Query: 258 TGIHHTSRKNDL 269
+ L
Sbjct: 129 EEGLGGVPEQKL 140
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 5e-05
Identities = 39/226 (17%), Positives = 66/226 (29%), Gaps = 9/226 (3%)
Query: 2 FNCNISG--SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIP 59
F C S IP ++ N I + KL A L+ + + N + I
Sbjct: 13 FLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 70
Query: 60 YDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLT-----YIPLTLWNLKY 114
D+ + + + YL + + K
Sbjct: 71 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 130
Query: 115 ILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ 174
+L + + N TI S +G V + L+ N G + + + N L+
Sbjct: 131 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE 190
Query: 175 GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220
D G LD+S + LE L L+ + K
Sbjct: 191 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 9e-05
Identities = 12/57 (21%), Positives = 18/57 (31%), Gaps = 3/57 (5%)
Query: 51 DNQLEGSIPYD-LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIP 106
DN +P D + LD+ ++ NL LR L +P
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP 239
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (98), Expect = 7e-05
Identities = 9/41 (21%), Positives = 14/41 (34%), Gaps = 1/41 (2%)
Query: 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNE 370
+G G G ++ +VAVK +F E
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAE 58
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (98), Expect = 8e-05
Identities = 8/45 (17%), Positives = 15/45 (33%), Gaps = 1/45 (2%)
Query: 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNE 370
+G+G G ++ VA+K ++F E
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQE 62
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (98), Expect = 8e-05
Identities = 14/40 (35%), Positives = 23/40 (57%), Gaps = 1/40 (2%)
Query: 332 IGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNE 370
IG+G G++Y A + G EVA++ +LQ + + NE
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 40.9 bits (95), Expect = 8e-05
Identities = 6/43 (13%), Positives = 15/43 (34%)
Query: 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFM 372
++G G +++ + E VK + + K +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDY 48
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (98), Expect = 9e-05
Identities = 13/56 (23%), Positives = 26/56 (46%), Gaps = 4/56 (7%)
Query: 317 LELFHATNGFSANNIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKS-FDNE 370
+EL + F + +G G G ++K G+ +A K+ L+ + A ++ E
Sbjct: 1 MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 54
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.5 bits (94), Expect = 3e-04
Identities = 19/64 (29%), Positives = 25/64 (39%), Gaps = 2/64 (3%)
Query: 324 NGFSANNIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNEFMTVVDANLLTR 382
N FS + IIGRGG G +Y R G A+K D + R K + + L
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLVS 62
Query: 383 EDKH 386
Sbjct: 63 TGDC 66
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (93), Expect = 3e-04
Identities = 9/41 (21%), Positives = 15/41 (36%), Gaps = 1/41 (2%)
Query: 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNE 370
IG G G ++ + +VA+K + F E
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEE 50
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (92), Expect = 3e-04
Identities = 8/41 (19%), Positives = 15/41 (36%), Gaps = 1/41 (2%)
Query: 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNE 370
+G G G + + + +VA+K+ F E
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEE 49
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 3e-04
Identities = 13/51 (25%), Positives = 20/51 (39%), Gaps = 6/51 (11%)
Query: 326 FSANNIIGRGGIGSIYKARIQDG-----MEVAVKVFDLQYREAF-KSFDNE 370
+ +IG G G +YK ++ + VA+K Y E F E
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 4e-04
Identities = 12/40 (30%), Positives = 20/40 (50%), Gaps = 1/40 (2%)
Query: 332 IGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNE 370
+G G G +YKA+ + + A KV D + E + + E
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (91), Expect = 5e-04
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 1/58 (1%)
Query: 331 IIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNEFMTVVDANLLTREDKHF 387
++G GG GS+Y + D + VA+K + + N ++ LL + F
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 5e-04
Identities = 10/55 (18%), Positives = 22/55 (40%), Gaps = 2/55 (3%)
Query: 318 ELFHATNGFSANNIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAF-KSFDNE 370
++F ++ + IG G G + A + + VA+K + + + E
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE 56
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.2 bits (91), Expect = 6e-04
Identities = 15/49 (30%), Positives = 23/49 (46%), Gaps = 4/49 (8%)
Query: 326 FSANNIIGRGGIGSIYKAR-IQDGMEVAVKVFDL---QYREAFKSFDNE 370
FS IG G G++Y AR +++ VA+K Q E ++ E
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 38.9 bits (90), Expect = 7e-04
Identities = 8/40 (20%), Positives = 14/40 (35%), Gaps = 1/40 (2%)
Query: 332 IGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNE 370
+G G G +++ G K + Y + NE
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNE 76
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (89), Expect = 0.001
Identities = 13/44 (29%), Positives = 19/44 (43%), Gaps = 1/44 (2%)
Query: 330 NIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNEFM 372
+ +G G ++YKAR VA+K L +R K N
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA 47
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 38.3 bits (88), Expect = 0.001
Identities = 12/43 (27%), Positives = 17/43 (39%), Gaps = 2/43 (4%)
Query: 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDL--QYREAFKSFDNE 370
IG G G +YKA+ G A+K L + + E
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE 50
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 38.5 bits (89), Expect = 0.001
Identities = 7/41 (17%), Positives = 14/41 (34%), Gaps = 1/41 (2%)
Query: 331 IIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNE 370
+G G G +++ G A K + ++ E
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE 73
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 13/44 (29%), Positives = 23/44 (52%), Gaps = 2/44 (4%)
Query: 332 IGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVV 375
IG+G G +++ + G EVAVK+F + ++ + E V
Sbjct: 11 IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTV 52
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 38.2 bits (88), Expect = 0.001
Identities = 11/46 (23%), Positives = 19/46 (41%), Gaps = 2/46 (4%)
Query: 326 FSANNIIGRGGIGSIYKARIQD-GMEVAVKVFDLQYREAFKSFDNE 370
+ + +G G G +Y+ + + VAVK E + F E
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 37.9 bits (87), Expect = 0.002
Identities = 9/37 (24%), Positives = 18/37 (48%), Gaps = 1/37 (2%)
Query: 330 NIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFK 365
+GRG +++A I + +V VK+ ++ K
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK 77
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 10/67 (14%)
Query: 324 NGFSANNIIGRGGIGSIYKARIQDG---MEVAVKVFDLQY-REAFKSFDNEFMTVVDANL 379
N ++IG G G + KARI+ M+ A+K ++ + F E +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE------LEV 63
Query: 380 LTREDKH 386
L + H
Sbjct: 64 LCKLGHH 70
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 10/33 (30%), Positives = 17/33 (51%), Gaps = 1/33 (3%)
Query: 326 FSANNIIGRGGIGSIYKAR-IQDGMEVAVKVFD 357
++ +IG G G +Y+A+ G VA+K
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 54
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (86), Expect = 0.002
Identities = 13/43 (30%), Positives = 23/43 (53%), Gaps = 4/43 (9%)
Query: 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNE 370
IG G G++YK + +VAVK+ ++ + ++F NE
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNE 54
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.002
Identities = 11/79 (13%), Positives = 22/79 (27%), Gaps = 11/79 (13%)
Query: 49 LEDNQLEGSIPYDL------CRLAALFQLDLGDNKLSG-----FVPSCFGNLTNLRKLYL 97
L D L + L L L N++ + +L L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 98 GSNQLTYIPLTLWNLKYIL 116
N+ + + ++ +
Sbjct: 310 NGNRFSEEDDVVDEIREVF 328
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 37.0 bits (85), Expect = 0.002
Identities = 14/54 (25%), Positives = 25/54 (46%), Gaps = 4/54 (7%)
Query: 321 HATNGFSANNIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQY---REAFKSFDNE 370
H ++ + I+G GG+ ++ AR ++ +VAVKV + F E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRRE 57
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (85), Expect = 0.002
Identities = 13/58 (22%), Positives = 25/58 (43%), Gaps = 5/58 (8%)
Query: 318 ELFHATNGFSANNI-IGRGGIGSIYKARIQ---DGMEVAVKVFDLQYREAF-KSFDNE 370
+LF + +I +G G GS+ + + ++VA+KV +A + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 59
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.3 bits (86), Expect = 0.002
Identities = 10/43 (23%), Positives = 18/43 (41%), Gaps = 2/43 (4%)
Query: 330 NIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAF-KSFDNE 370
+++G G + A + VA+K + E S +NE
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 57
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.1 bits (85), Expect = 0.003
Identities = 10/44 (22%), Positives = 19/44 (43%), Gaps = 3/44 (6%)
Query: 332 IGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNEFMTV 374
IG G G I++ + + +VA+K + +E+ T
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTY 54
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 37.0 bits (85), Expect = 0.003
Identities = 10/44 (22%), Positives = 20/44 (45%), Gaps = 1/44 (2%)
Query: 330 NIIGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNEFM 372
I+GRG + + E AVK+ D+ +F + + + +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 52
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 12/42 (28%), Positives = 18/42 (42%), Gaps = 3/42 (7%)
Query: 332 IGRGGIGSIYKAR-IQDGMEVAVKVFDLQYR--EAFKSFDNE 370
+G G GS+ A + G+ VAVK ++ K E
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 36.7 bits (84), Expect = 0.004
Identities = 10/44 (22%), Positives = 18/44 (40%), Gaps = 4/44 (9%)
Query: 331 IIGRGGIGSIYKAR-IQDGMEVAVKVFDLQY---REAFKSFDNE 370
+G G G + + + G A+K+ D Q + + NE
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.4 bits (83), Expect = 0.004
Identities = 13/40 (32%), Positives = 17/40 (42%), Gaps = 3/40 (7%)
Query: 332 IGRGGIGSIYKAR-IQDGMEVAVKVFDLQYREAFKSFDNE 370
IG G G IY I G EVA+K+ + + E
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIE 52
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 411 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.88 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.82 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.64 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.57 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.47 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.47 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.3 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.28 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.26 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.25 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.22 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.21 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.19 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.18 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.17 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.17 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.17 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.17 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.11 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.1 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.07 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.05 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.04 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.04 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.04 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.02 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.01 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 98.99 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 98.98 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 98.98 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 98.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 98.94 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 98.94 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 98.94 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 98.93 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 98.92 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 98.92 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 98.91 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 98.91 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 98.91 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 98.91 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 98.89 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 98.87 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 98.85 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 98.85 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 98.83 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 98.82 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 98.82 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 98.81 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 98.81 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 98.8 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 98.79 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 98.78 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 98.78 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 98.78 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 98.77 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 98.76 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 98.74 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 98.73 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 98.7 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 98.67 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 98.67 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 98.66 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 98.64 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 98.64 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 98.64 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 98.62 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.57 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.57 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 98.46 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 98.41 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 98.36 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.11 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.96 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.78 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.51 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=9.1e-33 Score=251.32 Aligned_cols=252 Identities=34% Similarity=0.561 Sum_probs=230.2
Q ss_pred CCCCcccc--cCChhcccCCcCCceeecC-cccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCc
Q 015202 1 MFNCNISG--SIPEEINNLTNLIAIYLGG-NKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNK 77 (411)
Q Consensus 1 l~~n~~~~--~~p~~~~~~~~L~~L~l~~-n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 77 (411)
|++|.++| .+|+.++++++|++|+|++ |+++|.+|..|.++++|++|+|++|.+.+..+..+..+.+|+++++++|.
T Consensus 57 L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~ 136 (313)
T d1ogqa_ 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136 (313)
T ss_dssp EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred CCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccc
Confidence 35788887 6899999999999999996 78999999999999999999999999999999889999999999999999
Q ss_pred ccccCCccccCCccCCeeecccccCC-ccCccccCCCCC-cEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCC
Q 015202 78 LSGFVPSCFGNLTNLRKLYLGSNQLT-YIPLTLWNLKYI-LYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPT 155 (411)
Q Consensus 78 l~~~~~~~~~~l~~L~~L~l~~n~l~-~~p~~~~~~~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 155 (411)
+.+.+|..+..++.|+.+++++|.++ .+|..+..+..+ +.++++.|.+++..|..+..+..+ .++++.+...+..|.
T Consensus 137 ~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~ 215 (313)
T d1ogqa_ 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASV 215 (313)
T ss_dssp EESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGG
T ss_pred ccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc
Confidence 99999999999999999999999998 889888888776 889999999999999888877654 799999999999999
Q ss_pred CccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCcc
Q 015202 156 TIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFS 235 (411)
Q Consensus 156 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~ 235 (411)
.+..+++++.+++++|.+.+.+| .+..+++|+.|++++|++++.+|..+..+++|+.|++++|.++|.+|....+..+.
T Consensus 216 ~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~ 294 (313)
T d1ogqa_ 216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD 294 (313)
T ss_dssp GCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSC
T ss_pred ccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCC
Confidence 99999999999999999987655 57888999999999999999999999999999999999999999999887888999
Q ss_pred ccccCCCCcccCCCCCCCCCCC
Q 015202 236 IESFKGNELLCGMPNLHVPPCR 257 (411)
Q Consensus 236 ~~~~~~n~~~c~~~~~~~~~c~ 257 (411)
.+++.+|+.+|+.| .|+|+
T Consensus 295 ~l~l~~N~~l~g~p---lp~c~ 313 (313)
T d1ogqa_ 295 VSAYANNKCLCGSP---LPACT 313 (313)
T ss_dssp GGGTCSSSEEESTT---SSCCC
T ss_pred HHHhCCCccccCCC---CCCCC
Confidence 99999999999865 45674
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=5.3e-28 Score=219.53 Aligned_cols=219 Identities=29% Similarity=0.430 Sum_probs=198.6
Q ss_pred CcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCC
Q 015202 4 CNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVP 83 (411)
Q Consensus 4 n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 83 (411)
|+++|.+|+.|+++++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|..+..+++++++++++|.+.+.+|
T Consensus 87 N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip 166 (313)
T d1ogqa_ 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166 (313)
T ss_dssp TTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred cccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccC-CeeecccccCC-ccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCC
Q 015202 84 SCFGNLTNL-RKLYLGSNQLT-YIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLK 161 (411)
Q Consensus 84 ~~~~~l~~L-~~L~l~~n~l~-~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~ 161 (411)
..+..+..+ +.+++++|+++ ..|..+..+. ...+++..+...+.+|..+..+++++.+++++|.+.+.++ .+..++
T Consensus 167 ~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~-~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~ 244 (313)
T d1ogqa_ 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSK 244 (313)
T ss_dssp GGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCT
T ss_pred cccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc-cccccc
Confidence 999888776 88999999998 4455555554 4579999999999999999999999999999999987665 577889
Q ss_pred ccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccC
Q 015202 162 DLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEI 225 (411)
Q Consensus 162 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~ 225 (411)
+|+.|++++|++++.+|..+..+++|++|+|++|+++|.+|. +..+++|+.+++++|+..+..
T Consensus 245 ~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred ccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 999999999999999999999999999999999999998884 577889999999999855433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.4e-27 Score=212.00 Aligned_cols=221 Identities=26% Similarity=0.282 Sum_probs=197.8
Q ss_pred CcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeec-CCcccccC
Q 015202 4 CNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLG-DNKLSGFV 82 (411)
Q Consensus 4 n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~-~n~l~~~~ 82 (411)
++++ .+|..+. +++++|+|++|+++...+..|.++++|++|++++|.+....+..+.++..++.+... .+.+....
T Consensus 21 ~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~ 97 (284)
T d1ozna_ 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97 (284)
T ss_dssp SCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCC
T ss_pred CCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccccccc
Confidence 3444 6777664 578999999999998888889999999999999999998888888889999998764 56777777
Q ss_pred CccccCCccCCeeecccccCCccCcc-ccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCC
Q 015202 83 PSCFGNLTNLRKLYLGSNQLTYIPLT-LWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLK 161 (411)
Q Consensus 83 ~~~~~~l~~L~~L~l~~n~l~~~p~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~ 161 (411)
+..|.++++|+.|++++|.+..++.. +....+|+.+++++|.++...+..|..++.|+.|++++|.+++..+..|..++
T Consensus 98 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~ 177 (284)
T d1ozna_ 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177 (284)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred chhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhcccc
Confidence 88899999999999999999877654 55789999999999999977778899999999999999999988899999999
Q ss_pred ccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCC
Q 015202 162 DLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPR 227 (411)
Q Consensus 162 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~ 227 (411)
+|+.+++++|++++..|..|..+++|+.|++++|.+.+..+..+..+++|+.+++++|++.|.++.
T Consensus 178 ~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred ccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 999999999999999999999999999999999999998889999999999999999999987763
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-25 Score=198.92 Aligned_cols=207 Identities=24% Similarity=0.221 Sum_probs=180.1
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
+.+...+.+.+-++++++. +|..+. ++|++|+|++|.+++..+.+|.++++|++|+|++|.++.. + .+..+++|+
T Consensus 6 ~~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~ 80 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLG 80 (266)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCC
T ss_pred EcccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccc
Confidence 3455667778888899984 565442 5799999999999977778899999999999999999854 2 357789999
Q ss_pred eeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccc
Q 015202 94 KLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRL 173 (411)
Q Consensus 94 ~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l 173 (411)
+|++++|+++.++..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.+++++|++
T Consensus 81 ~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 99999999999888888999999999999999877788888899999999999999988888888899999999999999
Q ss_pred cccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 174 QGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 174 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
++..+..|..+++|++|+|++|.++ .+|..+..+++|+.|++++|++.|.+.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 9888888999999999999999999 677788889999999999999987653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.7e-24 Score=191.39 Aligned_cols=206 Identities=26% Similarity=0.271 Sum_probs=182.4
Q ss_pred hCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEE
Q 015202 39 GKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYL 118 (411)
Q Consensus 39 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L 118 (411)
.+...+.+++-++++++ .+|+.+. +++++|+|++|.+++..+..|.++++|+.|+|++|+++.+|. +..+++|+.|
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L 82 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTL 82 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-cccccccccc
Confidence 35667777899999998 4565543 579999999999998777889999999999999999998874 5689999999
Q ss_pred EcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccc
Q 015202 119 NLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLS 198 (411)
Q Consensus 119 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 198 (411)
++++|.++ ..+..+..+++|+.|++++|.+....+..+..+.++..|++++|.++...+..+..+++++.+++++|.++
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 99999998 56778899999999999999999888888899999999999999999888888899999999999999999
Q ss_pred cccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCcccCCC
Q 015202 199 GAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 199 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 249 (411)
+..+..+..+++|+.|++++|.++...+.......++.+++.+||+.|+|.
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 888888999999999999999999544455667888999999999999864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.8e-24 Score=191.92 Aligned_cols=225 Identities=22% Similarity=0.236 Sum_probs=197.1
Q ss_pred ceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecc-cc
Q 015202 22 AIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLG-SN 100 (411)
Q Consensus 22 ~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~-~n 100 (411)
.++.++++++ .+|..+. +++++|+|++|+++...+.+|.++++|++|++++|.+....+..+..+..++.++.. .+
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 4566777777 5555442 578999999999998877889999999999999999998888888989999998875 55
Q ss_pred cCCcc-CccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecccccccccCCc
Q 015202 101 QLTYI-PLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPD 179 (411)
Q Consensus 101 ~l~~~-p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 179 (411)
.++.+ +..+.++++|++|++++|.+....+..+....+|+.+++++|.++++.+..|..+++|+.|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 67777 45577899999999999999877777888899999999999999988888999999999999999999988899
Q ss_pred cccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCC-CCCCCccccccCCCCcccCCC
Q 015202 180 FIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPRE-GPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 180 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 249 (411)
+|.++++|+.+++++|.+++..|..|..+++|+.|++++|.+.+..+.. .....+..+++.+|++.|.+.
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 9999999999999999999999999999999999999999998766543 456778899999999999764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=3.5e-23 Score=186.74 Aligned_cols=230 Identities=20% Similarity=0.286 Sum_probs=183.2
Q ss_pred cCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccC
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGN 88 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 88 (411)
.+|+.+. +++++|+|++|+++...+..|.++++|++|++++|.+....|..|.++++|++|++++|+++. +|..+.
T Consensus 24 ~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~~- 99 (305)
T d1xkua_ 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP- 99 (305)
T ss_dssp SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC-
T ss_pred ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccchh-
Confidence 6787664 689999999999987666789999999999999999998878889999999999999999884 444332
Q ss_pred CccCCeeecccccCCccC---------------------------ccccCCCCCcEEEcCCCeeeecCCCCccCccCCCe
Q 015202 89 LTNLRKLYLGSNQLTYIP---------------------------LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQ 141 (411)
Q Consensus 89 l~~L~~L~l~~n~l~~~p---------------------------~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 141 (411)
..++.|++.+|.+..++ ..+..+++|+.+++++|.+. .+|..+ .++|+.
T Consensus 100 -~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~ 175 (305)
T d1xkua_ 100 -KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTE 175 (305)
T ss_dssp -TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSE
T ss_pred -hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCE
Confidence 46677777766665433 23445778889999998877 455443 578999
Q ss_pred EEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcc
Q 015202 142 IDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKL 221 (411)
Q Consensus 142 L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l 221 (411)
|++++|..++..+..|..++.++.|++++|.+++..+..+.++++|++|++++|.++ .+|..+..+++|+.|++++|++
T Consensus 176 L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred EECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCcc
Confidence 999999998888888999999999999999999888888999999999999999998 4577888999999999999998
Q ss_pred cccCCCC-------CCCCCccccccCCCCcccC
Q 015202 222 EGEIPRE-------GPFRNFSIESFKGNELLCG 247 (411)
Q Consensus 222 ~~~~~~~-------~~~~~~~~~~~~~n~~~c~ 247 (411)
+...... ....++..+++.+|++.+.
T Consensus 255 ~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred CccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 8543221 2345567777888887554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.88 E-value=1.7e-21 Score=175.56 Aligned_cols=217 Identities=25% Similarity=0.279 Sum_probs=177.8
Q ss_pred cCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecc
Q 015202 19 NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLG 98 (411)
Q Consensus 19 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 98 (411)
..+.++=++++++ .+|..+. +++++|+|++|+++...+.+|.++++|++|++++|.+....|..|..+++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 5667776777787 4555542 689999999999997777789999999999999999998888999999999999999
Q ss_pred cccCCccCccccCCCCCcEEEcCCCeeeec--------------------------CCCCccCccCCCeEEccCCeeccc
Q 015202 99 SNQLTYIPLTLWNLKYILYLNLSSNSFTIP--------------------------LPSEIGNLEVLVQIDLSMNNFSGA 152 (411)
Q Consensus 99 ~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~--------------------------~~~~~~~l~~L~~L~l~~n~~~~~ 152 (411)
+|+++.+|..+. ..+..|.+..|.+... .+..+..+++|+.+++++|.++.
T Consensus 88 ~n~l~~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~- 164 (305)
T d1xkua_ 88 KNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT- 164 (305)
T ss_dssp SSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-
T ss_pred CCccCcCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-
Confidence 999999986543 4567777666655421 22345667788999999998874
Q ss_pred CCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCC
Q 015202 153 IPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFR 232 (411)
Q Consensus 153 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~ 232 (411)
+|.. .+++|+.|++++|..++..+..+..++.++.|++++|.+++..+..+..+++|++|++++|.++...+....++
T Consensus 165 l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~ 242 (305)
T d1xkua_ 165 IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242 (305)
T ss_dssp CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCS
T ss_pred cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccccccccccc
Confidence 4443 35789999999999998888899999999999999999998888999999999999999999986544456678
Q ss_pred CccccccCCCC
Q 015202 233 NFSIESFKGNE 243 (411)
Q Consensus 233 ~~~~~~~~~n~ 243 (411)
.++.+++.+|.
T Consensus 243 ~L~~L~Ls~N~ 253 (305)
T d1xkua_ 243 YIQVVYLHNNN 253 (305)
T ss_dssp SCCEEECCSSC
T ss_pred CCCEEECCCCc
Confidence 88888888875
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=4.9e-21 Score=178.01 Aligned_cols=72 Identities=28% Similarity=0.357 Sum_probs=51.9
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLS 79 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 79 (411)
++|.|+. + +.+..+++|++|+|++|++++.. .+.++++|++|++++|.+.+.. .+.++++|+.|+++++.++
T Consensus 52 ~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~ 123 (384)
T d2omza2 52 DRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQIT 123 (384)
T ss_dssp CSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred CCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccccccccccccccc
Confidence 4566654 3 35778888888888888887544 3788888888888888887543 3677778888877765543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.84 E-value=1.9e-20 Score=161.05 Aligned_cols=188 Identities=25% Similarity=0.317 Sum_probs=115.6
Q ss_pred ccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCe
Q 015202 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRK 94 (411)
Q Consensus 15 ~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 94 (411)
+.+.+|+.|++.+|+++.. ..+.++++|++|++++|.+++..| +..+++|+++++++|.++.. ..+..+++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccc
Confidence 4556667777777776632 246677777777777776664432 56667777777777666532 34566677777
Q ss_pred eecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccccc
Q 015202 95 LYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQ 174 (411)
Q Consensus 95 L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~ 174 (411)
++++++....++ .+...+.+..+.++++.+.. ...+.++++|+.|++++|.+.... .+..+++|+.|++++|.++
T Consensus 112 l~l~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 112 LDLTSTQITDVT-PLAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp EECTTSCCCCCG-GGTTCTTCCEEECCSSCCCC--CGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccccc-hhccccchhhhhchhhhhch--hhhhccccccccccccccccccch--hhcccccceecccCCCccC
Confidence 777666665443 24455666666666665542 223555666777777777665332 2556667777777777666
Q ss_pred ccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcc
Q 015202 175 GSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVS 217 (411)
Q Consensus 175 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~ 217 (411)
+. + .+.++++|++|++++|++++..| +..+++|+.|+++
T Consensus 187 ~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 187 DI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 43 2 25666677777777777664432 5666677777665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=3e-20 Score=161.42 Aligned_cols=205 Identities=20% Similarity=0.229 Sum_probs=150.7
Q ss_pred cCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccC-chhhhccccCCeeeecC-CcccccCCccc
Q 015202 9 SIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSI-PYDLCRLAALFQLDLGD-NKLSGFVPSCF 86 (411)
Q Consensus 9 ~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~-n~l~~~~~~~~ 86 (411)
.+|+.+. +++++|+|++|.++...+.+|.++++|++|++++|.+...+ +..|.++++++++++.. |.+....+..|
T Consensus 22 ~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~ 99 (242)
T d1xwdc1 22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF 99 (242)
T ss_dssp SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSE
T ss_pred CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccc
Confidence 6776553 57889999999998766778899999999999999876543 45688888999988764 67777777888
Q ss_pred cCCccCCeeecccccCCccCc--cccCCCCCcEEEcCCCeeeecCCCCccCcc-CCCeEEccCCeecccCCCCccCCCcc
Q 015202 87 GNLTNLRKLYLGSNQLTYIPL--TLWNLKYILYLNLSSNSFTIPLPSEIGNLE-VLVQIDLSMNNFSGAIPTTIGGLKDL 163 (411)
Q Consensus 87 ~~l~~L~~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~~~L 163 (411)
.++++|+.|++++|.+...+. .+..+..+..+...++.+....+..|.+++ .++.|++++|.++...+..+.. +++
T Consensus 100 ~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~-~~l 178 (242)
T d1xwdc1 100 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNG-TQL 178 (242)
T ss_dssp ECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTT-CCE
T ss_pred cccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccc-hhh
Confidence 899999999999998886653 223455566666677777756666666654 7888899999888666655544 444
Q ss_pred C-eeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEc
Q 015202 164 Q-YLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINV 216 (411)
Q Consensus 164 ~-~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l 216 (411)
. .+.+.+|.++...+..|.++++|+.|++++|.++...+..+..+++|+.+++
T Consensus 179 ~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp EEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred hccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 4 4456777888666667888899999999999988665555666555555444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=6.5e-20 Score=154.12 Aligned_cols=195 Identities=26% Similarity=0.357 Sum_probs=153.7
Q ss_pred CCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccC
Q 015202 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFV 82 (411)
Q Consensus 3 ~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 82 (411)
++.+...+|+ .+++++..+.+..+.+++.++ ...+.+|++|++++|.++.. +.+..+++|++|++++|++++..
T Consensus 5 ~~pi~~if~d--~~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~ 78 (199)
T d2omxa2 5 DTPINQIFTD--TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT 78 (199)
T ss_dssp CEEHHHHSCS--HHHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG
T ss_pred CCCcCccccC--HHHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCcc
Confidence 3455556666 355566677788888876554 35788999999999998854 35788999999999999998643
Q ss_pred CccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCc
Q 015202 83 PSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD 162 (411)
Q Consensus 83 ~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~ 162 (411)
.+.++++|+.|++++|.+..++ .+.+++.|+.|++++|.... ...+..+++|+.|++++|.+... ..+..+++
T Consensus 79 --~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~~~~~~--~~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~ 151 (199)
T d2omxa2 79 --PLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDI--SALSGLTS 151 (199)
T ss_dssp --GGTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTT
T ss_pred --cccCCccccccccccccccccc-cccccccccccccccccccc--ccccchhhhhHHhhhhhhhhccc--cccccccc
Confidence 3888999999999999998887 47789999999999888763 23477889999999999988643 35778899
Q ss_pred cCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEE
Q 015202 163 LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHI 214 (411)
Q Consensus 163 L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l 214 (411)
|+.|++.+|.+++.. .+.++++|+.|++++|++++. + .+..+++|+.|
T Consensus 152 L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 152 LQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp CSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred ccccccccccccCCc--cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 999999999998543 378899999999999998853 3 47788888765
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=4.9e-19 Score=164.27 Aligned_cols=195 Identities=31% Similarity=0.441 Sum_probs=146.8
Q ss_pred ChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCc
Q 015202 11 PEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLT 90 (411)
Q Consensus 11 p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 90 (411)
+..+..+++++.+++++|.+++..| +..+++|++|++++|.++.. +.+..+++|+.|++++|.+++.. .+..++
T Consensus 190 ~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~ 263 (384)
T d2omza2 190 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLT 263 (384)
T ss_dssp CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCT
T ss_pred ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccc
Confidence 4456777888888888888876544 45677888888888887743 35777888888888888887543 367778
Q ss_pred cCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccc
Q 015202 91 NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEY 170 (411)
Q Consensus 91 ~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~ 170 (411)
+|+.|+++++.++.++ .+..++.++.+.+..|.+.+ ...+..+++++.|++++|++++..+ +..+++|+.|++++
T Consensus 264 ~L~~L~l~~~~l~~~~-~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~ 338 (384)
T d2omza2 264 KLTELKLGANQISNIS-PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN 338 (384)
T ss_dssp TCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCS
T ss_pred cCCEeeccCcccCCCC-cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCC
Confidence 8888888888888766 36677788888888887763 2346777888888888888876532 67788888888888
Q ss_pred ccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCc
Q 015202 171 NRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNK 220 (411)
Q Consensus 171 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~ 220 (411)
|++++ ++ .+..+++|++|++++|++++..| +..+++|+.|++++|.
T Consensus 339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 339 NKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp SCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred CCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence 88874 33 57788888888888888886554 6778888888888773
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=1.7e-19 Score=152.89 Aligned_cols=187 Identities=24% Similarity=0.327 Sum_probs=150.3
Q ss_pred CCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeee
Q 015202 17 LTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLY 96 (411)
Q Consensus 17 ~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 96 (411)
++++...++..+.+++.++. ..+.+|++|++++|.++... .+..+++|++|++++|.+++.. .+..+++|+.|+
T Consensus 23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~ 96 (210)
T d1h6ta2 23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLF 96 (210)
T ss_dssp HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccc
Confidence 34455567777777765553 46778999999999988543 3778999999999999998643 467889999999
Q ss_pred cccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccccccccc
Q 015202 97 LGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGS 176 (411)
Q Consensus 97 l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 176 (411)
+++|+++.+| .+..+++|+.|++++|.+. . ...+..++.++.+++++|.+++. ..+..+++|+.+++++|.+++.
T Consensus 97 l~~n~i~~l~-~l~~l~~L~~L~l~~~~~~-~-~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i 171 (210)
T d1h6ta2 97 LDENKVKDLS-SLKDLKKLKSLSLEHNGIS-D-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 171 (210)
T ss_dssp CCSSCCCCGG-GGTTCTTCCEEECTTSCCC-C-CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred cccccccccc-ccccccccccccccccccc-c-ccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 9999999887 5788999999999999876 2 34578889999999999998743 3567789999999999999854
Q ss_pred CCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEccc
Q 015202 177 IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSF 218 (411)
Q Consensus 177 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~ 218 (411)
. .+.++++|+.|++++|.+++ ++ .+..+++|+.|++++
T Consensus 172 ~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 172 V--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred c--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 3 37889999999999999985 44 588899999999874
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=1e-19 Score=154.16 Aligned_cols=177 Identities=25% Similarity=0.347 Sum_probs=131.2
Q ss_pred CCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccC
Q 015202 3 NCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFV 82 (411)
Q Consensus 3 ~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 82 (411)
.+.+++.++. ..+.+|+.|++++|.++... .+.++++|++|++++|.+++.. .+..+++|++|++++|+++..
T Consensus 33 ~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l- 105 (210)
T d1h6ta2 33 KKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL- 105 (210)
T ss_dssp CSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG-
T ss_pred cCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccccc-
Confidence 4455555553 34567888888888887433 4778888888888888887543 357788888888888888743
Q ss_pred CccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCc
Q 015202 83 PSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKD 162 (411)
Q Consensus 83 ~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~ 162 (411)
+ .+..+++|+.|++++|.+..++ .+..++.++.+++++|.++. +..+..+++|+.+++++|.+++.. .+..+++
T Consensus 106 ~-~l~~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~ 179 (210)
T d1h6ta2 106 S-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTK 179 (210)
T ss_dssp G-GGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTT
T ss_pred c-cccccccccccccccccccccc-cccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCC
Confidence 3 4777888888888888887765 56678888888888888763 334667788888888888887543 3677888
Q ss_pred cCeeecccccccccCCccccCCCCCCEEeCCC
Q 015202 163 LQYLFLEYNRLQGSIPDFIGGLINLKSLDLSN 194 (411)
Q Consensus 163 L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 194 (411)
|+.|++++|.+++ ++ .+.++++|+.|++++
T Consensus 180 L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 180 LQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred CCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 8888888888874 33 478888888888763
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=5.9e-19 Score=148.17 Aligned_cols=174 Identities=26% Similarity=0.373 Sum_probs=145.1
Q ss_pred CCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc
Q 015202 2 FNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF 81 (411)
Q Consensus 2 ~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 81 (411)
+.+.+++.++. ..+++++.|++++|.++.. +.+..+++|++|++++|.+++..+ +.++++|++|++++|.+...
T Consensus 26 ~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~ 99 (199)
T d2omxa2 26 GKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI 99 (199)
T ss_dssp TCSSTTSEECH--HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCccCH--HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc
Confidence 45666666543 5678999999999999743 358899999999999999986543 89999999999999998753
Q ss_pred CCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCC
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLK 161 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~ 161 (411)
..+.++++|+.|++++|.+..++ .+..+++|+.|++++|.+. .+ ..+..+++|+.|++.+|.+++.. .+++++
T Consensus 100 --~~l~~l~~L~~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~-~~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~ 172 (199)
T d2omxa2 100 --TPLANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSSNTIS-DI-SALSGLTSLQQLNFSSNQVTDLK--PLANLT 172 (199)
T ss_dssp --GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCC-CC-GGGTTCTTCSEEECCSSCCCCCG--GGTTCT
T ss_pred --ccccccccccccccccccccccc-ccchhhhhHHhhhhhhhhc-cc-ccccccccccccccccccccCCc--cccCCC
Confidence 34889999999999999988765 4778999999999999987 33 35888999999999999998653 478999
Q ss_pred ccCeeecccccccccCCccccCCCCCCEE
Q 015202 162 DLQYLFLEYNRLQGSIPDFIGGLINLKSL 190 (411)
Q Consensus 162 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 190 (411)
+|+.|++++|++++. + .+.++++|+.|
T Consensus 173 ~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 173 TLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp TCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred CCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 999999999999853 3 47888888876
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=1.9e-19 Score=154.66 Aligned_cols=215 Identities=22% Similarity=0.326 Sum_probs=171.0
Q ss_pred cccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccc
Q 015202 7 SGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCF 86 (411)
Q Consensus 7 ~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 86 (411)
....|+ ..++++..+++..+.+++.. .+..+.+|+.|++.+|+++.. +.+..+++|++|++++|.+++.. .+
T Consensus 10 ~~~~pd--~~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l 81 (227)
T d1h6ua2 10 NVIFPD--PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PL 81 (227)
T ss_dssp HHHCCS--HHHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GG
T ss_pred cccCCC--HHHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--cc
Confidence 344454 44556667888888887655 467889999999999999854 35889999999999999998653 38
Q ss_pred cCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCee
Q 015202 87 GNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYL 166 (411)
Q Consensus 87 ~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L 166 (411)
..+++|+.+++++|.++.++ .+..+++|+.+.++++...+ ...+...+.+..+.++.+.+... ..+..+++|+.|
T Consensus 82 ~~l~~l~~l~~~~n~~~~i~-~l~~l~~L~~l~l~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L 156 (227)
T d1h6ua2 82 KNLTKITELELSGNPLKNVS-AIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYL 156 (227)
T ss_dssp TTCCSCCEEECCSCCCSCCG-GGTTCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEE
T ss_pred cccccccccccccccccccc-cccccccccccccccccccc--cchhccccchhhhhchhhhhchh--hhhccccccccc
Confidence 89999999999999999876 57889999999999988763 23466778899999999988644 336678999999
Q ss_pred ecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCcccccc
Q 015202 167 FLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESF 239 (411)
Q Consensus 167 ~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~ 239 (411)
++++|.+.+. ..+.++++|+.|++++|.+++. + .+..+++|+.|++++|+++... ....+..+..+++
T Consensus 157 ~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~-~l~~l~~L~~L~l 224 (227)
T d1h6ua2 157 SIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTL 224 (227)
T ss_dssp ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG-GGTTCTTCCEEEE
T ss_pred cccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc-ccccCCCCCEEEe
Confidence 9999998743 3378999999999999999864 3 3789999999999999998543 3344555554443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=1.6e-18 Score=144.66 Aligned_cols=175 Identities=19% Similarity=0.210 Sum_probs=120.5
Q ss_pred CeeeecCCcccccCCccccCCccCCeeecccccCCc-cC-ccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccC
Q 015202 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTY-IP-LTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSM 146 (411)
Q Consensus 69 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~p-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 146 (411)
++++.++++++ .+|..+. +++++|+|++|+++. ++ ..+..+++|+.|++++|.+....+..+..+++|+.|++++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 45666666666 3455443 467777777777763 32 3345677777777777777767777777788888888888
Q ss_pred CeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 147 NNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 147 n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
|+++...+..|.++++|+.|+|++|.+++..+.+|..+++|++|++++|.+........ -...++.+.+..+.+++..|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCC
Confidence 88887777788888888888888888887778888888888888888888764432211 11124445566777777666
Q ss_pred CCCCCCCccccccCCCCcccCCC
Q 015202 227 REGPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 227 ~~~~~~~~~~~~~~~n~~~c~~~ 249 (411)
. .+..+...++..+...|..+
T Consensus 167 ~--~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 167 S--KVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp T--TTTTSBGGGSCTTTCCCCCC
T ss_pred h--hhcCCEeeecCHhhCcCCCC
Confidence 4 35556666777777777544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=6.9e-19 Score=146.88 Aligned_cols=157 Identities=25% Similarity=0.301 Sum_probs=131.9
Q ss_pred cCCeeecccccCCccCccccCCCCCcEEEcCCCeeee-cCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeecc
Q 015202 91 NLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTI-PLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLE 169 (411)
Q Consensus 91 ~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~ 169 (411)
..+.++.++++++++|..+. +++++|+|++|.++. ..+..|.++++|+.|++++|.+....+..|..+++|+.|+++
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 34678999999999998874 789999999999975 446678899999999999999999999999999999999999
Q ss_pred cccccccCCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCcccCCC
Q 015202 170 YNRLQGSIPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNELLCGMP 249 (411)
Q Consensus 170 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 249 (411)
+|+++...+.+|.++++|++|+|++|.+++..+..|..+++|+.+++++|++.+.+........+....+..+...|..|
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 99999888999999999999999999999988999999999999999999998766432211123333444555556543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=7.8e-17 Score=139.46 Aligned_cols=202 Identities=18% Similarity=0.153 Sum_probs=155.7
Q ss_pred CceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCccccc-CCccccCCccCCeeeccc
Q 015202 21 IAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGF-VPSCFGNLTNLRKLYLGS 99 (411)
Q Consensus 21 ~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~ 99 (411)
+.++.++.+++ .+|..+. +++++|++++|.++...+..|.++++|++|++++|.+... .+..|..+++++.+.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67888888887 5554442 5899999999999977777899999999999999998754 456788999999998864
Q ss_pred -ccCCccC-ccccCCCCCcEEEcCCCeeeecCCC-CccCccCCCeEEccCCeecccCCCCccCCC-ccCeeecccccccc
Q 015202 100 -NQLTYIP-LTLWNLKYILYLNLSSNSFTIPLPS-EIGNLEVLVQIDLSMNNFSGAIPTTIGGLK-DLQYLFLEYNRLQG 175 (411)
Q Consensus 100 -n~l~~~p-~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~L~~L~l~~n~l~~ 175 (411)
|++..++ ..+..+++|+.|++++|.+....+. .+..+..+..+...++.+....+..|..++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 6777555 4567899999999999988743222 234456666667777788777777777664 79999999999996
Q ss_pred cCCccccCCCCCCE-EeCCCCccccccchhhhcCCCCCEEEcccCcccccCC
Q 015202 176 SIPDFIGGLINLKS-LDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIP 226 (411)
Q Consensus 176 ~~~~~~~~~~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~ 226 (411)
..+..+.. +++.. +.+.+|.++...+..|..+++|+.|++++|.++...+
T Consensus 168 i~~~~~~~-~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 218 (242)
T d1xwdc1 168 IHNCAFNG-TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218 (242)
T ss_dssp ECTTTTTT-CCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred cccccccc-hhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence 66655544 45444 4678888986666678999999999999999985433
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.2e-16 Score=128.63 Aligned_cols=110 Identities=22% Similarity=0.206 Sum_probs=58.9
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
|.++.+++.|+|++|+|+.+ +..+..+++|+.|+|++|.++.. +.|..+++|++|++++|.++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 45555666666666666532 34445556666666666665533 2355555666666666665544333444555666
Q ss_pred eeecccccCCccCc--cccCCCCCcEEEcCCCeee
Q 015202 94 KLYLGSNQLTYIPL--TLWNLKYILYLNLSSNSFT 126 (411)
Q Consensus 94 ~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n~l~ 126 (411)
.|++++|+++.++. .+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCccc
Confidence 66666665554442 3334455555555555443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.5e-15 Score=122.22 Aligned_cols=129 Identities=15% Similarity=0.087 Sum_probs=64.5
Q ss_pred hhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCe
Q 015202 62 LCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQ 141 (411)
Q Consensus 62 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 141 (411)
|.++.++++|+|++|.|+.. +..+..+++|+.|++++|.++.++ .+..+++|++|++++|.++...+..+..+++|+.
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCccC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 44455566666666666532 444455556666666666665553 3445555555555555555333333334444555
Q ss_pred EEccCCeecccCCCCccCCCccCeeecccccccccCCccccCCCCCCEEeCCCCcccccc---chhhhcCCCCCEEE
Q 015202 142 IDLSMNNFSGAIPTTIGGLKDLQYLFLEYNRLQGSIPDFIGGLINLKSLDLSNNNLSGAI---PISLEKLLDLQHIN 215 (411)
Q Consensus 142 L~l~~n~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~---~~~~~~l~~L~~l~ 215 (411)
|++++|.++.... ...+..+++|++|++++|.++... +..+..+|+|+.||
T Consensus 92 L~L~~N~i~~~~~-----------------------l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 92 LILTNNSLVELGD-----------------------LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSCCCCCGGG-----------------------GGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ceecccccccccc-----------------------ccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 5555544432111 123445555555555555554322 12455566666654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.59 E-value=4.9e-14 Score=128.29 Aligned_cols=221 Identities=26% Similarity=0.320 Sum_probs=123.8
Q ss_pred CCCCcccccCChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhcc-ccCCeeeecCCccc
Q 015202 1 MFNCNISGSIPEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRL-AALFQLDLGDNKLS 79 (411)
Q Consensus 1 l~~n~~~~~~p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~ 79 (411)
|++|.++ .+|+. .++|++|++++|+++ .+|.. +.+|+.|++++|+++.. + .+ +.|++|++++|.+.
T Consensus 45 Ls~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~----~lp~~L~~L~L~~n~l~ 111 (353)
T d1jl5a_ 45 LNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-S----DLPPLLEYLGVSNNQLE 111 (353)
T ss_dssp CTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-C----SCCTTCCEEECCSSCCS
T ss_pred eCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-h----hhccccccccccccccc
Confidence 3556665 46652 356777777777776 44533 35677777777766522 2 12 34777777777776
Q ss_pred ccCCccccCCccCCeeecccccCCccCc-------------------cccCCCCCcEEEcCCCeeeec------------
Q 015202 80 GFVPSCFGNLTNLRKLYLGSNQLTYIPL-------------------TLWNLKYILYLNLSSNSFTIP------------ 128 (411)
Q Consensus 80 ~~~~~~~~~l~~L~~L~l~~n~l~~~p~-------------------~~~~~~~L~~L~l~~n~l~~~------------ 128 (411)
. +|. +..+++|+.|+++++.+...+. .+..++.++.+.+..|.....
T Consensus 112 ~-lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~ 189 (353)
T d1jl5a_ 112 K-LPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA 189 (353)
T ss_dssp S-CCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEEC
T ss_pred c-ccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccc
Confidence 3 343 4567777777777776653332 123345556666655543311
Q ss_pred ------CCCCccCccCCCeEEccCCeecccCCCCccC-----------------CCccCeeeccccccccc---------
Q 015202 129 ------LPSEIGNLEVLVQIDLSMNNFSGAIPTTIGG-----------------LKDLQYLFLEYNRLQGS--------- 176 (411)
Q Consensus 129 ------~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~-----------------~~~L~~L~l~~n~l~~~--------- 176 (411)
....+..++.|+.+++++|.... .+..... ...+...++..+.+.+.
T Consensus 190 ~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~ 268 (353)
T d1jl5a_ 190 GNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYY 268 (353)
T ss_dssp CSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCE
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccchhcc
Confidence 01123445566666666665542 1211110 11122222222221110
Q ss_pred -------CCccccCCCCCCEEeCCCCccccccchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCCc
Q 015202 177 -------IPDFIGGLINLKSLDLSNNNLSGAIPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNEL 244 (411)
Q Consensus 177 -------~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~~ 244 (411)
++.....+++|++|++++|.++. +|. .+++|+.|++++|.++ .+|.. ..+++.+++.+|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~--~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNPL 336 (353)
T ss_dssp EECCSSCCSEECCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSCC
T ss_pred cccccCccccccccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-ccccc--cCCCCEEECcCCcC
Confidence 01111234689999999999984 553 3678999999999987 45542 45678888888864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=2.7e-15 Score=114.84 Aligned_cols=76 Identities=28% Similarity=0.322 Sum_probs=32.3
Q ss_pred eeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCee
Q 015202 46 LLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSF 125 (411)
Q Consensus 46 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l 125 (411)
+|+|++|+++.. + .+..+++|++|++++|.++ .+|..+..+++|+.|++++|.++.+| .+..+++|+.|++++|.+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCcc
Confidence 444444444422 2 2444444444444444444 23334444444444444444444443 233344444444444433
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=5.7e-16 Score=137.12 Aligned_cols=58 Identities=26% Similarity=0.287 Sum_probs=26.5
Q ss_pred CcCCceeecCcccccc-cchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecC
Q 015202 18 TNLIAIYLGGNKLNGS-ISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGD 75 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 75 (411)
.+|++|++++|.++.. +...+.++++|++|++++|.+++..+..+..+++|++|++++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 3445555554444322 223344445555555555544444444444444555555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=9.4e-15 Score=111.76 Aligned_cols=102 Identities=24% Similarity=0.233 Sum_probs=54.6
Q ss_pred CeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCCCcEEEcCCCeeeecCCCCccCccCCCeEEccCCe
Q 015202 69 FQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLPSEIGNLEVLVQIDLSMNN 148 (411)
Q Consensus 69 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 148 (411)
++|+|++|.++. ++ .+..+++|++|++++|.++.+|..+..+++|+.|++++|.++. +| .+..+++|+.|++++|.
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 356666666662 22 3566666666666666666666556666666666666666552 22 24555555555555555
Q ss_pred ecccC-CCCccCCCccCeeeccccccc
Q 015202 149 FSGAI-PTTIGGLKDLQYLFLEYNRLQ 174 (411)
Q Consensus 149 ~~~~~-~~~~~~~~~L~~L~l~~n~l~ 174 (411)
++... ...+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 54322 123344444444444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.52 E-value=4e-13 Score=122.07 Aligned_cols=209 Identities=24% Similarity=0.224 Sum_probs=138.8
Q ss_pred CcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeec
Q 015202 18 TNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYL 97 (411)
Q Consensus 18 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 97 (411)
.+++.|+|+++.++ .+|+ ..++|++|++++|+++ .+|+. ..+|+.|++++|+++. ++. +. +.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~---~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~~-lp--~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LSD-LP--PLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCS---CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCS-CC--TTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCC---CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccch-hhh-hc--cccccccc
Confidence 36899999999998 4664 3578999999999999 55654 4589999999999884 333 21 46999999
Q ss_pred ccccCCccCccccCCCCCcEEEcCCCeeeecCC------------------CCccCccCCCeEEccCCeecccC------
Q 015202 98 GSNQLTYIPLTLWNLKYILYLNLSSNSFTIPLP------------------SEIGNLEVLVQIDLSMNNFSGAI------ 153 (411)
Q Consensus 98 ~~n~l~~~p~~~~~~~~L~~L~l~~n~l~~~~~------------------~~~~~l~~L~~L~l~~n~~~~~~------ 153 (411)
++|.+..+|. +..+++|+.|++++|.+..... ..+..++.++.+++..|......
T Consensus 106 ~~n~l~~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 106 SNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp CSSCCSSCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred cccccccccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccc
Confidence 9999999985 6789999999999887653211 23445566777887777654321
Q ss_pred ------------CCCccCCCccCeeecccccccccCCcccc-----------------CCCCCCEEeCCCCccccc----
Q 015202 154 ------------PTTIGGLKDLQYLFLEYNRLQGSIPDFIG-----------------GLINLKSLDLSNNNLSGA---- 200 (411)
Q Consensus 154 ------------~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-----------------~~~~L~~L~l~~n~l~~~---- 200 (411)
...+..++.|+.+++++|.... .+.... ..+.+...++..+.+.+.
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~ 263 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCC
T ss_pred cccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1223456778888888876652 222111 112233334333322211
Q ss_pred ------------cchhhhcCCCCCEEEcccCcccccCCCCCCCCCccccccCCCC
Q 015202 201 ------------IPISLEKLLDLQHINVSFNKLEGEIPREGPFRNFSIESFKGNE 243 (411)
Q Consensus 201 ------------~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~~~~~n~ 243 (411)
++.....+++|++|++++|.++. +|. .+++++.+++.+|.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~-lp~--~~~~L~~L~L~~N~ 315 (353)
T d1jl5a_ 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA--LPPRLERLIASFNH 315 (353)
T ss_dssp TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSC
T ss_pred chhcccccccCccccccccCCCCCEEECCCCccCc-ccc--ccCCCCEEECCCCc
Confidence 01111235789999999999984 443 35677777777664
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=2e-15 Score=133.58 Aligned_cols=199 Identities=21% Similarity=0.163 Sum_probs=144.6
Q ss_pred CCceeecCcccccccchhhhCCCCCCeeecccCccccc-CchhhhccccCCeeeecCCcccccCCccccCCccCCeeecc
Q 015202 20 LIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGS-IPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLG 98 (411)
Q Consensus 20 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 98 (411)
+..+.+....+.... .......+|++|++++|.+++. +...+..+++|++|++++|.+....+..++.+++|+.|+++
T Consensus 25 ~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 445555555544222 2334667899999999988644 34457889999999999999887777788889999999999
Q ss_pred cc-cCCc--cCccccCCCCCcEEEcCCCe-eeec-CCCCccC-ccCCCeEEccCC--eeccc-CCCCccCCCccCeeecc
Q 015202 99 SN-QLTY--IPLTLWNLKYILYLNLSSNS-FTIP-LPSEIGN-LEVLVQIDLSMN--NFSGA-IPTTIGGLKDLQYLFLE 169 (411)
Q Consensus 99 ~n-~l~~--~p~~~~~~~~L~~L~l~~n~-l~~~-~~~~~~~-l~~L~~L~l~~n--~~~~~-~~~~~~~~~~L~~L~l~ 169 (411)
++ .++. +..-...+++|++|++++|. ++.. +...+.. .+.|+.|+++++ .++.. +...+..+++|+.|+++
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~ 183 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccc
Confidence 85 5662 33233468999999999864 3321 1222322 468999999875 33322 22233568999999999
Q ss_pred cc-cccccCCccccCCCCCCEEeCCCC-ccccccchhhhcCCCCCEEEcccC
Q 015202 170 YN-RLQGSIPDFIGGLINLKSLDLSNN-NLSGAIPISLEKLLDLQHINVSFN 219 (411)
Q Consensus 170 ~n-~l~~~~~~~~~~~~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~l~l~~n 219 (411)
+| .+++.....+..+++|++|++++| .+++.....+..+++|+.|+++++
T Consensus 184 ~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 86 477666677888999999999995 677666667888999999999887
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=2.6e-15 Score=136.80 Aligned_cols=235 Identities=17% Similarity=0.204 Sum_probs=154.1
Q ss_pred CChhcccCCcCCceeecCcccccc----cchhhhCCCCCCeeecccCcccc---c-------CchhhhccccCCeeeecC
Q 015202 10 IPEEINNLTNLIAIYLGGNKLNGS----ISIALGKLQKLQLLGLEDNQLEG---S-------IPYDLCRLAALFQLDLGD 75 (411)
Q Consensus 10 ~p~~~~~~~~L~~L~l~~n~~~~~----~~~~~~~l~~L~~L~l~~n~l~~---~-------~~~~~~~l~~L~~L~l~~ 75 (411)
+...+.+...|+.|+|++|.+... +...+..+++|+.|+++++.... . +...+..+++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 445577788899999999987632 33456677889999998765431 1 122345578899999999
Q ss_pred Cccccc----CCccccCCccCCeeecccccCCc-----cCcc---------ccCCCCCcEEEcCCCeeeec----CCCCc
Q 015202 76 NKLSGF----VPSCFGNLTNLRKLYLGSNQLTY-----IPLT---------LWNLKYILYLNLSSNSFTIP----LPSEI 133 (411)
Q Consensus 76 n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~-----~p~~---------~~~~~~L~~L~l~~n~l~~~----~~~~~ 133 (411)
|.+... +...+...++|+.|++++|.++. +... ....+.|+.+.+++|.+... +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 987653 23344567889999999888751 1111 12467788888888876522 22334
Q ss_pred cCccCCCeEEccCCeeccc-----CCCCccCCCccCeeeccccccccc----CCccccCCCCCCEEeCCCCccccccchh
Q 015202 134 GNLEVLVQIDLSMNNFSGA-----IPTTIGGLKDLQYLFLEYNRLQGS----IPDFIGGLINLKSLDLSNNNLSGAIPIS 204 (411)
Q Consensus 134 ~~l~~L~~L~l~~n~~~~~-----~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 204 (411)
...+.|+.|++++|.++.. +...+..+++|+.|++++|.++.. +...+..+++|++|++++|.+++.....
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~ 262 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence 5567888899988887642 334566778889999998887642 2345667888899999998887543222
Q ss_pred ----hhc--CCCCCEEEcccCcccccC----CC-C-CCCCCccccccCCCCc
Q 015202 205 ----LEK--LLDLQHINVSFNKLEGEI----PR-E-GPFRNFSIESFKGNEL 244 (411)
Q Consensus 205 ----~~~--l~~L~~l~l~~n~l~~~~----~~-~-~~~~~~~~~~~~~n~~ 244 (411)
+.. .+.|+.|++++|.++... .. . ...+.+..+++.+|..
T Consensus 263 l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 222 356888999988875321 00 0 0133456667777654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=5.2e-14 Score=112.25 Aligned_cols=111 Identities=20% Similarity=0.101 Sum_probs=94.8
Q ss_pred ccCCcCCceeecCcccccccchhhhCCCCCCeeecccC-cccccCchhhhccccCCeeeecCCcccccCCccccCCccCC
Q 015202 15 NNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDN-QLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLR 93 (411)
Q Consensus 15 ~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 93 (411)
..+...+.++.+++++. ..|..+..+++|++|++++| .++.+.+++|.++++|+.|+|++|+|+.+.+..|..+++|+
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 34455677888888886 55677888999999999766 48877778899999999999999999988888899999999
Q ss_pred eeecccccCCccCccccCCCCCcEEEcCCCeee
Q 015202 94 KLYLGSNQLTYIPLTLWNLKYILYLNLSSNSFT 126 (411)
Q Consensus 94 ~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n~l~ 126 (411)
+|+|++|+++.+|.......+|+.|++++|.+.
T Consensus 84 ~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 84 RLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EEECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred ceeccCCCCcccChhhhccccccccccCCCccc
Confidence 999999999999988877778999999998775
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.47 E-value=8e-16 Score=128.21 Aligned_cols=111 Identities=23% Similarity=0.270 Sum_probs=52.0
Q ss_pred chhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCccCCeeecccccCCccCccccCCCC
Q 015202 35 SIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTNLRKLYLGSNQLTYIPLTLWNLKY 114 (411)
Q Consensus 35 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~p~~~~~~~~ 114 (411)
+.++..+++|++|+|++|.++.. + .+..+++|++|++++|.++. ++..+..+++|+.|++++|.++.++ .+..+++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l~-~~~~l~~ 116 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLS-GIEKLVN 116 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCHH-HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-ccccccccccccccccccccccccc-ccccccc
Confidence 34455555555555555555532 2 35555555555555555542 2333333345555555555555443 2344444
Q ss_pred CcEEEcCCCeeeecCC-CCccCccCCCeEEccCCee
Q 015202 115 ILYLNLSSNSFTIPLP-SEIGNLEVLVQIDLSMNNF 149 (411)
Q Consensus 115 L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~~ 149 (411)
|+.|++++|.++.... ..+..+++|+.|++++|.+
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred ccccccccchhccccccccccCCCccceeecCCCcc
Confidence 5555555444432110 1233444444444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.46 E-value=1.2e-15 Score=127.05 Aligned_cols=115 Identities=23% Similarity=0.264 Sum_probs=97.7
Q ss_pred ChhcccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccCCccccCCc
Q 015202 11 PEEINNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFVPSCFGNLT 90 (411)
Q Consensus 11 p~~~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 90 (411)
|..+.++++|+.|+|++|+|+.. + .+.++++|++|+|++|.++. ++..+..+++|++|++++|.++.. +.+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccc
Confidence 35688999999999999999844 3 58999999999999999984 455556678899999999999854 4588899
Q ss_pred cCCeeecccccCCccCc--cccCCCCCcEEEcCCCeeeecCC
Q 015202 91 NLRKLYLGSNQLTYIPL--TLWNLKYILYLNLSSNSFTIPLP 130 (411)
Q Consensus 91 ~L~~L~l~~n~l~~~p~--~~~~~~~L~~L~l~~n~l~~~~~ 130 (411)
+|+.|++++|+++.++. .+..+++|+.|++++|.+....+
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 99999999999998863 57889999999999998875444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=1.6e-14 Score=131.43 Aligned_cols=222 Identities=21% Similarity=0.205 Sum_probs=125.5
Q ss_pred CCCCcccccCC----hhcccCCcCCceeecCcccccc----------cchhhhCCCCCCeeecccCccccc----Cchhh
Q 015202 1 MFNCNISGSIP----EEINNLTNLIAIYLGGNKLNGS----------ISIALGKLQKLQLLGLEDNQLEGS----IPYDL 62 (411)
Q Consensus 1 l~~n~~~~~~p----~~~~~~~~L~~L~l~~n~~~~~----------~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~ 62 (411)
|++|.|...-. ..+...++|+.|+++++..... +...+..+++|+.|+|++|.++.. +...+
T Consensus 38 Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l 117 (344)
T d2ca6a1 38 LSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 117 (344)
T ss_dssp CTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHH
T ss_pred CcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhh
Confidence 34555544322 2345566777777776543211 223345667777777777766543 22334
Q ss_pred hccccCCeeeecCCcccccCCc----c---------ccCCccCCeeecccccCC-----ccCccccCCCCCcEEEcCCCe
Q 015202 63 CRLAALFQLDLGDNKLSGFVPS----C---------FGNLTNLRKLYLGSNQLT-----YIPLTLWNLKYILYLNLSSNS 124 (411)
Q Consensus 63 ~~l~~L~~L~l~~n~l~~~~~~----~---------~~~l~~L~~L~l~~n~l~-----~~p~~~~~~~~L~~L~l~~n~ 124 (411)
..+++|++|++++|.+...-.. . ....+.|+.+++++|.++ .+...+..++.|+.|++++|.
T Consensus 118 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~ 197 (344)
T d2ca6a1 118 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNG 197 (344)
T ss_dssp HHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSC
T ss_pred cccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccc
Confidence 4566777777777765421100 0 123456777777777665 223334456677777777777
Q ss_pred eeec-----CCCCccCccCCCeEEccCCeeccc----CCCCccCCCccCeeecccccccccCC----cccc--CCCCCCE
Q 015202 125 FTIP-----LPSEIGNLEVLVQIDLSMNNFSGA----IPTTIGGLKDLQYLFLEYNRLQGSIP----DFIG--GLINLKS 189 (411)
Q Consensus 125 l~~~-----~~~~~~~l~~L~~L~l~~n~~~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~----~~~~--~~~~L~~ 189 (411)
+... +...+...++|+.|++++|.++.. +...+..+++|+.|++++|.+++.-. ..+. ..+.|++
T Consensus 198 i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~ 277 (344)
T d2ca6a1 198 IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 277 (344)
T ss_dssp CCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCE
T ss_pred ccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCE
Confidence 6531 233455667777777777776532 23344566777777777777654211 1122 2356777
Q ss_pred EeCCCCccccc----cchhhh-cCCCCCEEEcccCccc
Q 015202 190 LDLSNNNLSGA----IPISLE-KLLDLQHINVSFNKLE 222 (411)
Q Consensus 190 L~l~~n~l~~~----~~~~~~-~l~~L~~l~l~~n~l~ 222 (411)
|++++|.++.. +...+. ..++|+.|++++|.+.
T Consensus 278 L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 278 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp EECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred EECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 77777776532 222332 4567777777777764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.36 E-value=1.3e-13 Score=122.36 Aligned_cols=100 Identities=18% Similarity=0.216 Sum_probs=76.7
Q ss_pred cccccHHHHHHHhcCCCcC---------CeeeccCCceEEEEEecC-C---CEEEEEEEecc-cchhhHhHHHHHHHHHH
Q 015202 311 QRRFTYLELFHATNGFSAN---------NIIGRGGIGSIYKARIQD-G---MEVAVKVFDLQ-YREAFKSFDNEFMTVVD 376 (411)
Q Consensus 311 ~~~~~~~~l~~at~~f~~~---------~~lg~g~~g~vy~g~l~~-~---~~vavk~l~~~-~~~~~~~f~~e~~~~~~ 376 (411)
.+.++|+|+..|+.+|+.+ ++||+|+||.||+|.... | ..||||++... .....++|.+|++++++
T Consensus 4 ~d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 83 (299)
T d1jpaa_ 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83 (299)
T ss_dssp CCGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTT
T ss_pred cCCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh
Confidence 4567889999999888653 689999999999999842 2 25899998543 33446789999999998
Q ss_pred -----------------------cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----------------------ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----------------------~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++|.++++|+.|||+||+|||+.
T Consensus 84 l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T d1jpaa_ 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 147 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 2222211 133599999999999999999999974
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.7e-12 Score=103.29 Aligned_cols=105 Identities=17% Similarity=0.114 Sum_probs=53.6
Q ss_pred CCeeecccccCCccCccccCCCCCcEEEcCCC-eeeecCCCCccCccCCCeEEccCCeecccCCCCccCCCccCeeeccc
Q 015202 92 LRKLYLGSNQLTYIPLTLWNLKYILYLNLSSN-SFTIPLPSEIGNLEVLVQIDLSMNNFSGAIPTTIGGLKDLQYLFLEY 170 (411)
Q Consensus 92 L~~L~l~~n~l~~~p~~~~~~~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~L~l~~ 170 (411)
.+.++.+++++.++|..+..+++|++|++.+| .++...+..|.++++|+.|++++|+++.+.+..|..+++|+.|+|++
T Consensus 10 ~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34455555555555555555555555555433 24433344455555555555555555555555555555555555555
Q ss_pred ccccccCCccccCCCCCCEEeCCCCcc
Q 015202 171 NRLQGSIPDFIGGLINLKSLDLSNNNL 197 (411)
Q Consensus 171 n~l~~~~~~~~~~~~~L~~L~l~~n~l 197 (411)
|+++...+..+.. .+|+.|++++|.+
T Consensus 90 N~l~~l~~~~~~~-~~l~~L~L~~Np~ 115 (156)
T d2ifga3 90 NALESLSWKTVQG-LSLQELVLSGNPL 115 (156)
T ss_dssp SCCSCCCSTTTCS-CCCCEEECCSSCC
T ss_pred CCCcccChhhhcc-ccccccccCCCcc
Confidence 5555333333322 2355555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=1.5e-13 Score=129.61 Aligned_cols=39 Identities=15% Similarity=0.037 Sum_probs=22.7
Q ss_pred CCCCcEEEcCCCeeeecC----CCCccCccCCCeEEccCCeec
Q 015202 112 LKYILYLNLSSNSFTIPL----PSEIGNLEVLVQIDLSMNNFS 150 (411)
Q Consensus 112 ~~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~~~ 150 (411)
...++.+++++|.+.... ...+...+.++.+++++|.++
T Consensus 254 ~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~ 296 (460)
T d1z7xw1 254 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 296 (460)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc
Confidence 456888888888765321 122334455666666666554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=1.6e-12 Score=112.57 Aligned_cols=86 Identities=12% Similarity=0.154 Sum_probs=68.3
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
++|.-.+.||+|+||.||+|++++++.||||+++... ...++|.+|++++.+ +|..
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 3555668999999999999999888899999996543 335789999999998 2222
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ....++|..+.+|+.|+|+||+|||+.
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~ 119 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc
Confidence 111 123589999999999999999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=2.1e-12 Score=112.34 Aligned_cols=84 Identities=12% Similarity=0.103 Sum_probs=66.7
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTR 382 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~ 382 (411)
|.-.+.||+|+||.||+|.+.+++.||||++.... ...++|.+|++++.+ +|....
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 33447899999999999999888899999996433 345789999999998 332221
Q ss_pred C-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....++|.++++|+.|||+||+|||++
T Consensus 86 ~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~ 120 (263)
T d1sm2a_ 86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120 (263)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc
Confidence 1 234589999999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=9.5e-13 Score=115.16 Aligned_cols=84 Identities=13% Similarity=0.114 Sum_probs=66.1
Q ss_pred CCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCCC
Q 015202 326 FSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTRE 383 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~~ 383 (411)
|.-.+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++.+ +|.....
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCB
T ss_pred eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCCCc
Confidence 33447899999999999999888899999996543 335689999999998 2222211
Q ss_pred --------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 --------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 --------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.+++|.++++|+.|||+||+|||++
T Consensus 94 L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~ 128 (272)
T d1qpca_ 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128 (272)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 122489999999999999999999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=4.1e-12 Score=111.74 Aligned_cols=87 Identities=17% Similarity=0.222 Sum_probs=65.8
Q ss_pred cCCCcCCeeeccCCceEEEEEecCC-----CEEEEEEEecccc-hhhHhHHHHHHHHHH---------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDG-----MEVAVKVFDLQYR-EAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~-----~~vavk~l~~~~~-~~~~~f~~e~~~~~~--------------------- 376 (411)
..|...++||+|+||.||+|.+.+. ..||||++..... ....+|.+|++++.+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3455678999999999999998542 3699999965433 335679999999997
Q ss_pred --cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....++|.++++|+.|||+||+|||++
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~ 129 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 129 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc
Confidence 2222111 234599999999999999999999964
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=5.4e-13 Score=125.61 Aligned_cols=222 Identities=21% Similarity=0.120 Sum_probs=129.6
Q ss_pred CCCcccccC-ChhcccCCcCCceeecCccccc----ccchhhhCCCCCCeeecccCcccccCchhhh-----ccccCCee
Q 015202 2 FNCNISGSI-PEEINNLTNLIAIYLGGNKLNG----SISIALGKLQKLQLLGLEDNQLEGSIPYDLC-----RLAALFQL 71 (411)
Q Consensus 2 ~~n~~~~~~-p~~~~~~~~L~~L~l~~n~~~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L 71 (411)
+.|++++.. ..-+..++++++|+|++|+++. .+...+..+++|++|+|++|.++......+. ...+|++|
T Consensus 10 ~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L 89 (460)
T d1z7xw1 10 QCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKL 89 (460)
T ss_dssp ESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEE
T ss_pred eCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEE
Confidence 455665532 3335667788888888887763 3345567788888888888877632212221 12468888
Q ss_pred eecCCccccc----CCccccCCccCCeeecccccCCcc-----Cc-----------------------------ccc---
Q 015202 72 DLGDNKLSGF----VPSCFGNLTNLRKLYLGSNQLTYI-----PL-----------------------------TLW--- 110 (411)
Q Consensus 72 ~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~-----p~-----------------------------~~~--- 110 (411)
+|++|.++.. ++..+..+++|+.|++++|.++.. .. .+.
T Consensus 90 ~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (460)
T d1z7xw1 90 SLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 169 (460)
T ss_dssp ECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCT
T ss_pred ECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccc
Confidence 8888887643 344566777888888887765310 00 000
Q ss_pred ------------------------------------------------------CCCCCcEEEcCCCeeee-----cCCC
Q 015202 111 ------------------------------------------------------NLKYILYLNLSSNSFTI-----PLPS 131 (411)
Q Consensus 111 ------------------------------------------------------~~~~L~~L~l~~n~l~~-----~~~~ 131 (411)
..+.++.+++.+|.+.. ....
T Consensus 170 ~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~ 249 (460)
T d1z7xw1 170 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPG 249 (460)
T ss_dssp TCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcc
Confidence 11222333333332210 0111
Q ss_pred CccCccCCCeEEccCCeecccC----CCCccCCCccCeeecccccccccCCcc-----ccCCCCCCEEeCCCCccccccc
Q 015202 132 EIGNLEVLVQIDLSMNNFSGAI----PTTIGGLKDLQYLFLEYNRLQGSIPDF-----IGGLINLKSLDLSNNNLSGAIP 202 (411)
Q Consensus 132 ~~~~l~~L~~L~l~~n~~~~~~----~~~~~~~~~L~~L~l~~n~l~~~~~~~-----~~~~~~L~~L~l~~n~l~~~~~ 202 (411)
.......++.+++++|.+.... ...+...+.++.+++++|.+++..... ......|+.+++++|.++....
T Consensus 250 ~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~ 329 (460)
T d1z7xw1 250 LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACC 329 (460)
T ss_dssp HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhh
Confidence 1223456889999999876432 223345678888899888876321111 1234578888888888765432
Q ss_pred h----hhhcCCCCCEEEcccCcccc
Q 015202 203 I----SLEKLLDLQHINVSFNKLEG 223 (411)
Q Consensus 203 ~----~~~~l~~L~~l~l~~n~l~~ 223 (411)
. .+...++|+.|++++|.++.
T Consensus 330 ~~l~~~~~~~~~L~~L~Ls~N~i~~ 354 (460)
T d1z7xw1 330 SHFSSVLAQNRFLLELQISNNRLED 354 (460)
T ss_dssp HHHHHHHHHCSSCCEEECCSSBCHH
T ss_pred hhcccccccccchhhhheeeecccC
Confidence 2 33455678888888888753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.19 E-value=3.3e-12 Score=113.49 Aligned_cols=94 Identities=19% Similarity=0.193 Sum_probs=69.9
Q ss_pred HHHHHHhcCCCcCCeeeccCCceEEEEEec------CCCEEEEEEEecccch-hhHhHHHHHHHHHH-------------
Q 015202 317 LELFHATNGFSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQYRE-AFKSFDNEFMTVVD------------- 376 (411)
Q Consensus 317 ~~l~~at~~f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~~~-~~~~f~~e~~~~~~------------- 376 (411)
.+++..+++|.-.+.||+|+||.||+|++. +++.||||++...... ..++|.+|++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344445667777789999999999999873 3468999999654433 45789999999998
Q ss_pred -------------------cccCC---------------------CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------------------ANLLT---------------------REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------------------~~l~~---------------------~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++. ......++|.+++.||.|+|+||+|||+.
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 159 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence 11110 00123489999999999999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=5.6e-12 Score=110.70 Aligned_cols=85 Identities=13% Similarity=0.168 Sum_probs=66.8
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------cccCCC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------ANLLTR 382 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------~~l~~~ 382 (411)
++.-.+.||+|+||.||+|.+.++..||||++... ....++|.+|+.++.+ +|....
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g 96 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKG 96 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCC
Confidence 34445789999999999999988888999999543 3345789999999998 222221
Q ss_pred C--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ....++|.++++||.|||+||+|||++
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~ 132 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh
Confidence 1 112499999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=1e-11 Score=108.65 Aligned_cols=83 Identities=18% Similarity=0.295 Sum_probs=65.1
Q ss_pred cCCCcCCeeeccCCceEEEEEecCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-------------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------------- 376 (411)
++|.-.+.||+|+||.||+|++.+ .||||+++.. .....++|.+|++++.+
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence 344455899999999999999743 6999998543 34456789999999997
Q ss_pred ------cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++.. ..+++|.++++|+.|||+||+|||+.
T Consensus 86 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~ 123 (276)
T d1uwha_ 86 EGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK 123 (276)
T ss_dssp CEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 333222 23599999999999999999999964
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.17 E-value=3.7e-12 Score=112.20 Aligned_cols=85 Identities=12% Similarity=0.174 Sum_probs=66.1
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
+|.-.+.||+|+||.||+|+.. +|+.||||++.... ...++|.+|++++++ +|..
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 3444578999999999999985 57889999996433 345689999999998 2222
Q ss_pred CCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ....++|..+..|+.|||+||+|||++
T Consensus 97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~ 134 (287)
T d1opja_ 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134 (287)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC
Confidence 111 234699999999999999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=9.3e-12 Score=108.95 Aligned_cols=81 Identities=15% Similarity=0.144 Sum_probs=61.4
Q ss_pred CeeeccCCceEEEEEecC---CCEEEEEEEeccc--chhhHhHHHHHHHHHH----------------------cccCCC
Q 015202 330 NIIGRGGIGSIYKARIQD---GMEVAVKVFDLQY--REAFKSFDNEFMTVVD----------------------ANLLTR 382 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~---~~~vavk~l~~~~--~~~~~~f~~e~~~~~~----------------------~~l~~~ 382 (411)
++||+|+||.||+|.+++ ++.||||++.... ....++|.+|++++.+ +|..+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 679999999999999853 3579999995432 2335789999999997 222221
Q ss_pred C------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 383 E------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 383 ~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
. ...+++|..+++|+.|||+||+|||+.
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 126 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC
Confidence 1 234599999999999999999999964
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=1.7e-11 Score=107.60 Aligned_cols=80 Identities=13% Similarity=0.152 Sum_probs=62.1
Q ss_pred eeeccCCceEEEEEec---CCCEEEEEEEecccc-hhhHhHHHHHHHHHH----------------------cccCCCC-
Q 015202 331 IIGRGGIGSIYKARIQ---DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD----------------------ANLLTRE- 383 (411)
Q Consensus 331 ~lg~g~~g~vy~g~l~---~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~----------------------~~l~~~~- 383 (411)
+||+|+||.||+|++. ++..||||+++.... ...++|.+|++++.+ +|..+..
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L 95 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 95 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEH
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcH
Confidence 4999999999999873 345799999965443 345789999999998 2222111
Q ss_pred ------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 ------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 ------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
....++|.++.+|+.|||+||+|||++
T Consensus 96 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~ 128 (285)
T d1u59a_ 96 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 128 (285)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 134599999999999999999999974
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.11 E-value=3.2e-11 Score=107.74 Aligned_cols=86 Identities=17% Similarity=0.224 Sum_probs=63.3
Q ss_pred CCCcCCeeeccCCceEEEEEec-CCC----EEEEEEEecc-cchhhHhHHHHHHHHHH----------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ-DGM----EVAVKVFDLQ-YREAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~-~~~----~vavk~l~~~-~~~~~~~f~~e~~~~~~---------------------- 376 (411)
+|...++||+|+||.||+|.+. +|+ .||||++... +.+..++|.+|++++.+
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~ 89 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT 89 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEE
Confidence 4566689999999999999873 444 5899998543 34456789999999998
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....++|..+++|+.|||+||+|||++
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~ 130 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 1121111 234699999999999999999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=3.5e-12 Score=110.65 Aligned_cols=79 Identities=16% Similarity=0.249 Sum_probs=60.9
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cccCCCC-
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ANLLTRE- 383 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~l~~~~- 383 (411)
.+.||+|+||.||+|.+ .|..||||+++.. ...++|.+|++++++ +|.....
T Consensus 12 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 47899999999999999 6789999999543 335689999999998 1111110
Q ss_pred -------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
...+++|..+++||.|||+||+|||+.
T Consensus 89 ~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~ 122 (262)
T d1byga_ 89 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122 (262)
T ss_dssp HHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC
Confidence 012389999999999999999999964
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.07 E-value=8.3e-11 Score=104.56 Aligned_cols=81 Identities=21% Similarity=0.330 Sum_probs=61.5
Q ss_pred CeeeccCCceEEEEEecCC----CEEEEEEEecc-cchhhHhHHHHHHHHHH------------------------cccC
Q 015202 330 NIIGRGGIGSIYKARIQDG----MEVAVKVFDLQ-YREAFKSFDNEFMTVVD------------------------ANLL 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~----~~vavk~l~~~-~~~~~~~f~~e~~~~~~------------------------~~l~ 380 (411)
++||+|+||.||+|++.++ ..||||+++.. .....++|.+|++++++ +|..
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 6899999999999998442 25899999643 34456789999999998 2222
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ....++|..+++|+.|+|+||.|||+.
T Consensus 113 ~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~ 149 (311)
T d1r0pa_ 113 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149 (311)
T ss_dssp TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc
Confidence 111 123478999999999999999999963
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=1e-10 Score=102.88 Aligned_cols=86 Identities=21% Similarity=0.268 Sum_probs=68.6
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
.|...+.||+|+||.||+|.. .+|+.||||++........+.|.+|++++.+ +|..
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 455668899999999999986 5689999999975555556789999999997 4433
Q ss_pred CCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....++..+...|+.||++||+|||++
T Consensus 101 gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~ 135 (293)
T d1yhwa1 101 GGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135 (293)
T ss_dssp TCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 322 123589999999999999999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=2.7e-11 Score=107.73 Aligned_cols=85 Identities=14% Similarity=0.145 Sum_probs=63.6
Q ss_pred CCcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~---------------------- 376 (411)
|.-.+.||+|+||.||+|++. +++.||||+++... .+....|.+|+.++.+
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 101 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 101 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence 334478999999999999873 25689999996433 3445679999999998
Q ss_pred -cccCCCC----------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE----------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~----------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ....++|.++.+|+.++|+||.|||++
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~ 152 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN 152 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 2221110 112479999999999999999999964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=6.9e-11 Score=103.82 Aligned_cols=85 Identities=18% Similarity=0.169 Sum_probs=68.0
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLT 381 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~ 381 (411)
|.-.+.||+|+||.||+|.. .+|+.||||+++.......+.|.+|++++.+ +|..+
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 33347899999999999987 4688999999976666667889999999997 33322
Q ss_pred CC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 382 RE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 382 ~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.. ...++++.+...|+.||++||+|||++
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~ 129 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 11 134599999999999999999999964
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=3.8e-11 Score=106.83 Aligned_cols=86 Identities=21% Similarity=0.375 Sum_probs=62.0
Q ss_pred CCCcCCeeeccCCceEEEEEecC-CC--EEEEEEEecc-cchhhHhHHHHHHHHHH------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD-GM--EVAVKVFDLQ-YREAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~-~~--~vavk~l~~~-~~~~~~~f~~e~~~~~~------------------------ 376 (411)
+|.-.++||+|+||.||+|++.+ |. .||||++... .....++|.+|++++.+
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 34445889999999999999843 33 4788988543 33456789999999986
Q ss_pred ---------cccCCC-------------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---------ANLLTR-------------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---------~~l~~~-------------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++.. .....++|.++.+++.|||+||.|||+.
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~ 146 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 146 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC
Confidence 222221 1124599999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=1.5e-10 Score=100.55 Aligned_cols=81 Identities=16% Similarity=0.119 Sum_probs=62.8
Q ss_pred CeeeccCCceEEEEEec-CCCEEEEEEEeccc--chhhHhHHHHHHHHHH---------------------------ccc
Q 015202 330 NIIGRGGIGSIYKARIQ-DGMEVAVKVFDLQY--REAFKSFDNEFMTVVD---------------------------ANL 379 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~-~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~---------------------------~~l 379 (411)
.+||+|+||.||+|+.. +++.||||++.... ....+.|.+|++++.+ +|.
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 57999999999999874 57899999985432 3345779999999997 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.. ....+++.....|+.||++||+|||++
T Consensus 95 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~ 131 (270)
T d1t4ha_ 95 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 131 (270)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred CCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 2211 123589999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.01 E-value=5.8e-11 Score=105.38 Aligned_cols=85 Identities=19% Similarity=0.221 Sum_probs=66.1
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---hhhHhHHHHHHHHHH-----------------------cc
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---EAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
|...+.||+|+||.||+|+. .+|+.||||++..... ...+.|.+|++++.+ +|
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 56668899999999999986 5688899999964432 234679999999998 22
Q ss_pred cCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+.. ...+++|.+...|+.||++||.|||++
T Consensus 97 ~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~ 134 (309)
T d1u5ra_ 97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134 (309)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 22111 234699999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=1.5e-10 Score=100.55 Aligned_cols=86 Identities=16% Similarity=0.122 Sum_probs=63.7
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|.-.+.||+|+||.||+|+. .+|+.||||++.... ....+.|.+|++++.+ +|.
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 344558999999999999987 468999999995433 2335679999999987 222
Q ss_pred CCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.+ ....+++.+...|+.|+++||+|||++
T Consensus 86 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~ 122 (271)
T d1nvra_ 86 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122 (271)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 2111 234699999999999999999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=7.5e-11 Score=102.81 Aligned_cols=85 Identities=15% Similarity=0.170 Sum_probs=56.4
Q ss_pred CCcCCeeeccCCceEEEEEec--CCC--EEEEEEEecc---cchhhHhHHHHHHHHHH----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARIQ--DGM--EVAVKVFDLQ---YREAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l~--~~~--~vavk~l~~~---~~~~~~~f~~e~~~~~~---------------------- 376 (411)
|.-.+.||+|+||.||+|++. +++ .||||+++.. .....++|.+|++++.+
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~lv~ 89 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT 89 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchheee
Confidence 333478999999999999873 233 6899998543 23345789999999998
Q ss_pred cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..... ...+++|..+++++.|||+||.|||++
T Consensus 90 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 130 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130 (273)
T ss_dssp ECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC
Confidence 2222111 123599999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=98.98 E-value=2.4e-10 Score=103.07 Aligned_cols=86 Identities=14% Similarity=0.200 Sum_probs=68.3
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
+|.-.+.||+|+||.||+|+. .+|+.||||++........+.|.+|+.++.+ +|..
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 454558899999999999987 4688999999966555556789999999987 3332
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ...++++.....|+.||++||+|||++
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~ 143 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 221 123599999999999999999999974
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.96 E-value=3.2e-10 Score=100.31 Aligned_cols=77 Identities=21% Similarity=0.247 Sum_probs=56.5
Q ss_pred CCeeeccCCceEEEEEecCCCEEEEEEEecccchhhHhHHHHHHHHH--H---------------------------ccc
Q 015202 329 NNIIGRGGIGSIYKARIQDGMEVAVKVFDLQYREAFKSFDNEFMTVV--D---------------------------ANL 379 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~~~~~f~~e~~~~~--~---------------------------~~l 379 (411)
.+.||+|+||.||+|++ +|+.||||+++.. ..+++..|.+++. . +|.
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 36799999999999998 6799999999533 2345555555443 2 222
Q ss_pred CCCC-----CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 380 LTRE-----DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 380 ~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
.... ....++|.++++++.++|+||+|||+
T Consensus 84 ~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~ 118 (303)
T d1vjya_ 84 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 118 (303)
T ss_dssp TTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHC
T ss_pred cCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 2211 12359999999999999999999996
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=98.94 E-value=2.2e-10 Score=100.73 Aligned_cols=86 Identities=19% Similarity=0.168 Sum_probs=66.2
Q ss_pred CCCcCCeeeccCCceEEEEEecCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------ccc
Q 015202 325 GFSANNIIGRGGIGSIYKARIQDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------ANL 379 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~l 379 (411)
+|...+.||+|+||.||+|+..+|+.||||++.... ....+.|.+|+.++.+ ++.
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 344457899999999999999889999999995433 2235789999999998 111
Q ss_pred CCC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 380 LTR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 380 ~~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+. .....++..+...|+.||++||+|||+.
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 119 (286)
T d1ob3a_ 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119 (286)
T ss_dssp SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC
Confidence 100 0134599999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=2.2e-10 Score=101.27 Aligned_cols=87 Identities=22% Similarity=0.213 Sum_probs=65.5
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------c
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
++|...+.||+|+||.||+|+. .+|+.||||++.... ......|.+|++++.+ +
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 3566668999999999999986 568999999995432 2235789999999998 2
Q ss_pred ccCC-------CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLT-------REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~-------~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+ ......++|.....++.|+++||+|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~ 121 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC
Confidence 2111 01234599999999999999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=1.1e-10 Score=103.39 Aligned_cols=86 Identities=20% Similarity=0.327 Sum_probs=60.8
Q ss_pred CCCcCCeeeccCCceEEEEEec------CCCEEEEEEEeccc-chhhHhHHHHHHHHHH---------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQ------DGMEVAVKVFDLQY-REAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~------~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~--------------------- 376 (411)
+|.-.+.||+|+||.||+|+.. .++.||||+++... ....+.|..|++.+.+
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 3444589999999999999863 23579999996433 3445778999988876
Q ss_pred -------------cccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -------------ANLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -------------~~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ....++|.++..|+.|||+||+|||++
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2221110 123489999999999999999999964
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=2.8e-10 Score=101.83 Aligned_cols=86 Identities=17% Similarity=0.301 Sum_probs=60.2
Q ss_pred CCCcCCeeeccCCceEEEEEecC-C-----CEEEEEEEecc-cchhhHhHHHHHHHHHH---------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARIQD-G-----MEVAVKVFDLQ-YREAFKSFDNEFMTVVD--------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l~~-~-----~~vavk~l~~~-~~~~~~~f~~e~~~~~~--------------------- 376 (411)
+|.-.++||+|+||.||+|+..+ + ..||||++... .......|.+|+.++.+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 34445799999999999998733 1 26899998543 33445789999999876
Q ss_pred ------------cccCCCC--------------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------------ANLLTRE--------------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------------~~l~~~~--------------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ...+++|..++.|+.|||+||+|||++
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222211 113489999999999999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=2.2e-10 Score=101.83 Aligned_cols=82 Identities=20% Similarity=0.291 Sum_probs=62.1
Q ss_pred CCeeeccCCceEEEEEe------cCCCEEEEEEEecccc-hhhHhHHHHHHHHHH-------------------------
Q 015202 329 NNIIGRGGIGSIYKARI------QDGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l------~~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~------------------------- 376 (411)
.+.||+|+||.||+|++ ..++.||||+++.... ....+|.+|++++.+
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 47899999999999986 3456899999965443 345679999998887
Q ss_pred --------cccCCCC---------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------ANLLTRE---------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------~~l~~~~---------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ....++|..+.+|+.|||+||+|||++
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2221110 123599999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=1.1e-10 Score=101.48 Aligned_cols=85 Identities=15% Similarity=0.192 Sum_probs=65.2
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------- 376 (411)
+|.-.+.||+|+||.||+|.. .+|+.||||.+.... ....+.|.+|++++.+
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 454558999999999999986 568999999995443 3345679999999987
Q ss_pred cccCCCC----------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 377 ANLLTRE----------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 377 ~~l~~~~----------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+|..+.+ ....+++.....|+.|+|+||.|||+
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~ 127 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 2221111 12358999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=3e-10 Score=98.30 Aligned_cols=86 Identities=16% Similarity=0.198 Sum_probs=66.2
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|+. .+|+.||||++.... ....+.|.+|++++.+ +
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 344457899999999999997 468899999985432 2235679999999997 4
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ...++++.....|+.||++||+|||+.
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~ 125 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 433322 123589999999999999999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=98.91 E-value=6.6e-10 Score=100.26 Aligned_cols=86 Identities=13% Similarity=0.150 Sum_probs=68.2
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccC
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
+|.-.+.||+|+||.||+|.- .+|+.||||++..........+.+|++++.+ +|..
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 355558999999999999986 5689999999976555556789999999998 3333
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .+.++++.....|+.+|++||+|||++
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~ 146 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 221 233599999999999999999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=3.9e-10 Score=98.30 Aligned_cols=83 Identities=16% Similarity=0.180 Sum_probs=62.6
Q ss_pred cCCeeeccCCceEEEEEecC----CCEEEEEEEecccc-hhhHhHHHHHHHHHH----------------------cccC
Q 015202 328 ANNIIGRGGIGSIYKARIQD----GMEVAVKVFDLQYR-EAFKSFDNEFMTVVD----------------------ANLL 380 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l~~----~~~vavk~l~~~~~-~~~~~f~~e~~~~~~----------------------~~l~ 380 (411)
-.+.||+|+||.||+|++.. +..||||+++.... ...+.|.+|+.++.+ ++..
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~E~~~ 90 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCT 90 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEEEecc
Confidence 34789999999999998743 34688999854433 335779999999998 2221
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
... ...+++|.++..++.|||+||+|||++
T Consensus 91 ~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 127 (273)
T d1mp8a_ 91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 127 (273)
T ss_dssp TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc
Confidence 111 234589999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=5.7e-10 Score=98.31 Aligned_cols=85 Identities=15% Similarity=0.230 Sum_probs=65.6
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc------hhhHhHHHHHHHHHH----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR------EAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~------~~~~~f~~e~~~~~~---------------------- 376 (411)
|.-.+.||+|+||.||+|.. .+|+.||||++..... ...+.|.+|+.++.+
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 44457899999999999997 4689999999854321 125679999999997
Q ss_pred -cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....|+.++++||+|||+.
T Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~ 132 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132 (293)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc
Confidence 3333222 123599999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=2.4e-10 Score=102.15 Aligned_cols=87 Identities=13% Similarity=0.152 Sum_probs=67.3
Q ss_pred hcCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------c
Q 015202 323 TNGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 323 t~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
.++|...+.||+|+||.||+|+. .+|+.||||+++... ......|.+|+.++.+ +
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34566668999999999999987 568899999996543 3345789999999987 3
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
|..+.. ....+++.....++.|+++||.|||+
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~ 122 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 332211 12358999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.87 E-value=5.7e-10 Score=98.80 Aligned_cols=85 Identities=16% Similarity=0.223 Sum_probs=61.5
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH-----------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
|.-.+.||+|+||.||+|.. .+|+.||||++.... ......|.+|++++.+ +|..
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 44457899999999999987 468899999995433 2234678999999987 3333
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.+ ....+++.....|+.++++||+|||++
T Consensus 91 gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~ 126 (307)
T d1a06a_ 91 GGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126 (307)
T ss_dssp SCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc
Confidence 222 234599999999999999999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=98.85 E-value=1.1e-09 Score=95.51 Aligned_cols=86 Identities=16% Similarity=0.136 Sum_probs=65.1
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc---------hhhHhHHHHHHHHHH------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR---------EAFKSFDNEFMTVVD------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~---------~~~~~f~~e~~~~~~------------------ 376 (411)
+|.-.+.||+|+||.||+|.- .+|+.||||++..... ...+.|.+|++++.+
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 344458999999999999986 5788999999854321 113468999999987
Q ss_pred ------cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.+ ...+++|.+...++.||++||+|||++
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~ 129 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 3333222 123599999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.85 E-value=5.6e-10 Score=97.52 Aligned_cols=85 Identities=19% Similarity=0.240 Sum_probs=64.9
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------- 376 (411)
|.-.+.||+|+||.||+|+- .+|+.||||.+.... ......|.+|++++.+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 44457899999999999986 568899999995432 2234679999999987
Q ss_pred --cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ...+++|.+...|+.||++||+|||++
T Consensus 89 vmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~ 130 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 130 (277)
T ss_dssp EEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 2222111 123599999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.83 E-value=7.9e-10 Score=99.75 Aligned_cols=85 Identities=13% Similarity=0.220 Sum_probs=62.2
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc-chhhHhHHHHHHHHHH---------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY-REAFKSFDNEFMTVVD--------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~-~~~~~~f~~e~~~~~~--------------------------- 376 (411)
|...+.||+|+||.||+|+- .+|+.||||+++... ....+.|.+|++++.+
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 44558999999999999985 578999999996433 3335689999999998
Q ss_pred cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.+.+ ....+++.....|+.|+++||+|||++
T Consensus 90 ~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~ 128 (345)
T d1pmea_ 90 THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 128 (345)
T ss_dssp EECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1111111 123589999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.82 E-value=1.5e-09 Score=95.91 Aligned_cols=83 Identities=16% Similarity=0.101 Sum_probs=63.6
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~l~ 380 (411)
|.-.+.||+|+||.||+|.. .+|+.||||.+.... ...++..|++++.. ++..
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 44457899999999999986 568899999885432 23568899999887 2221
Q ss_pred CCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. ....+++.....+|.++++||+|||++
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence 110 234699999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=1.5e-09 Score=95.54 Aligned_cols=86 Identities=20% Similarity=0.151 Sum_probs=64.9
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-----------------------cc
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD-----------------------AN 378 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~-----------------------~~ 378 (411)
.|...+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+.++.+ ++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 344557999999999999986 578899999995433 2335789999999997 11
Q ss_pred cCCC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 379 LLTR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 379 l~~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
..+. .....+++.....++.|+++||+|||++
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~ 120 (292)
T d1unla_ 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccchhHHHHHHHHHHHHHHHhhcC
Confidence 1000 0133588899999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=8.6e-10 Score=96.62 Aligned_cols=86 Identities=13% Similarity=0.130 Sum_probs=65.8
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|.. .+|+.||||++.... ....+.|.+|++++.+ +
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 344558999999999999987 468999999995432 2234679999999997 3
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.++++||+|||++
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~ 127 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc
Confidence 332221 123589999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=98.81 E-value=2.2e-09 Score=96.07 Aligned_cols=83 Identities=12% Similarity=0.172 Sum_probs=63.3
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH--------------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD--------------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~--------------------------~ 377 (411)
+|.-.+.||+|+||+||+|+- .+|+.||||+++... .+++.+|+.++.+ +
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 344557899999999999986 568899999995432 4678999998876 2
Q ss_pred ccCCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++.... ....++......|+.||++||+|||++
T Consensus 113 ~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~ 148 (328)
T d3bqca1 113 HVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 148 (328)
T ss_dssp CCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 222111 123588899999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.80 E-value=4.9e-10 Score=101.34 Aligned_cols=81 Identities=16% Similarity=0.255 Sum_probs=60.8
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------------- 376 (411)
|...++||+|+||.||+|+. .+|+.||||++.... ..+.+|++++.+
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 34557899999999999997 468999999995432 234578998887
Q ss_pred -cccCCC---------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -ANLLTR---------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -~~l~~~---------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+. .....++|.+...|+.||++||+|||++
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~ 141 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 111100 0233589999999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.79 E-value=3.2e-09 Score=94.50 Aligned_cols=82 Identities=11% Similarity=0.097 Sum_probs=63.7
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH-----------------------cccCCCC
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD-----------------------ANLLTRE 383 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~-----------------------~~l~~~~ 383 (411)
-.+.||+|+||.||+|.. .+|+.||||.+.... .....+.+|++++.+ +|..+..
T Consensus 9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 347899999999999987 467889999995432 334568999999987 3333221
Q ss_pred -------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 384 -------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 384 -------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
.+.++++.+...|+.+|++||+|||+.
T Consensus 88 L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~ 121 (321)
T d1tkia_ 88 IFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121 (321)
T ss_dssp HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 123589999999999999999999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=1.7e-09 Score=95.36 Aligned_cols=82 Identities=17% Similarity=0.223 Sum_probs=56.0
Q ss_pred CCeeeccCCceEEEEEec--------CCCEEEEEEEecccc-hhhHhHHHHHHHHHH-----------------------
Q 015202 329 NNIIGRGGIGSIYKARIQ--------DGMEVAVKVFDLQYR-EAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 329 ~~~lg~g~~g~vy~g~l~--------~~~~vavk~l~~~~~-~~~~~f~~e~~~~~~----------------------- 376 (411)
.+.||+|+||.||+|+.. ++..||||++..... ....+|.+|+..+.+
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 378999999999999862 234799999965443 345789999888876
Q ss_pred ----------cccCCCC-------------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----------ANLLTRE-------------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----------~~l~~~~-------------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++++... ....++|.++++++.|+|+||+|||++
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~ 154 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 154 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC
Confidence 2222111 123489999999999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=1.2e-09 Score=96.39 Aligned_cols=81 Identities=17% Similarity=0.231 Sum_probs=59.2
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccch-----hhHhHHHHHHHHHH-----------------------cccC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYRE-----AFKSFDNEFMTVVD-----------------------ANLL 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~-----~~~~f~~e~~~~~~-----------------------~~l~ 380 (411)
++||+|+||.||+|.. .+|+.||||+++..... ..+.|.+|+.++.+ +|..
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6899999999999987 46899999998543221 13569999999987 2221
Q ss_pred CC------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TR------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+. .....+++.....++.||++||+|||++
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~ 119 (299)
T d1ua2a_ 84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119 (299)
T ss_dssp EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc
Confidence 10 0234588888999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=1.4e-09 Score=98.21 Aligned_cols=86 Identities=16% Similarity=0.216 Sum_probs=64.9
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------- 376 (411)
.|...+.||+|+||+||+|.- .+|+.||||++.... ....+.+.+|+.++.+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 344557899999999999985 578999999995432 2345679999999997
Q ss_pred ---cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.+.. ....+++.....|+.+|+.||+|||++
T Consensus 99 ~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~ 140 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 140 (348)
T ss_dssp EEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 1111111 133589999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.77 E-value=2.5e-09 Score=94.92 Aligned_cols=86 Identities=13% Similarity=0.173 Sum_probs=65.7
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|+. .+|+.||||++.... ....+.|.+|+.++.+ +
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 344558899999999999997 568999999995432 2335679999999987 3
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
|..+.. ....+++.....++.+|+.||+|||+.
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 123 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccC
Confidence 333222 123478888889999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=2.1e-09 Score=95.76 Aligned_cols=86 Identities=17% Similarity=0.064 Sum_probs=62.5
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------------- 376 (411)
+|.-.+.||+|+||.||+|+. .+|+.||||++... .....+++.+|+.++.+
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 344558999999999999997 57899999998433 22335779999999987
Q ss_pred ------cccCC------CCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ------ANLLT------REDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ------~~l~~------~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++... ......++......|+.|+++||.|||++
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~ 136 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC
Confidence 11110 00123477778889999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.74 E-value=2.9e-09 Score=94.70 Aligned_cols=86 Identities=12% Similarity=0.180 Sum_probs=63.4
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD------------------------ 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~------------------------ 376 (411)
+|.-.+.||+|+||.||+|.. .+|+.||||++.... ....+.+..|+.++.+
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 344458999999999999987 468899999995432 2334567888877664
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++..+...++.+||.||+|||+.
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~ 122 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4333322 123488888999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.73 E-value=2.4e-09 Score=96.52 Aligned_cols=86 Identities=14% Similarity=0.161 Sum_probs=64.8
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------c
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD-----------------------A 377 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~-----------------------~ 377 (411)
+|.-.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++.. +
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 344558999999999999987 468999999995322 2234679999999987 2
Q ss_pred ccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 378 NLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 378 ~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+..+.. ....+++.....|+.+|++||.|||++
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~ 160 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 222211 123588899999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.70 E-value=2.9e-09 Score=96.01 Aligned_cols=85 Identities=13% Similarity=0.129 Sum_probs=58.6
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecc--cchhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQ--YREAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~--~~~~~~~f~~e~~~~~~------------------------- 376 (411)
.|...+.||+|+||.||+|.- .+|+.||||++... .....+.+.+|+.++.+
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 444557899999999999986 56899999999543 22335679999999997
Q ss_pred ----cccCCCC-----CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTRE-----DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~-----~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++. +.. ....+++.....|+.|++.||.|||++
T Consensus 99 ~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 140 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 140 (346)
T ss_dssp EEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC
Confidence 011 000 123589999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=2.3e-09 Score=93.25 Aligned_cols=85 Identities=16% Similarity=0.243 Sum_probs=62.4
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccc------hhhHhHHHHHHHHHH----------------------
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYR------EAFKSFDNEFMTVVD---------------------- 376 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~------~~~~~f~~e~~~~~~---------------------- 376 (411)
|.-.++||+|+||.||+|+. .+|+.||||++..... .....+.+|+.++.+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 44457899999999999986 5789999999854321 123457889998875
Q ss_pred ---cccCCCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+++.....++.|+++||+|||++
T Consensus 86 lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~ 129 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2221110 123589999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=7.3e-09 Score=91.62 Aligned_cols=87 Identities=20% Similarity=0.176 Sum_probs=61.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe-c-CCCEEEEEEEecccc--hhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-Q-DGMEVAVKVFDLQYR--EAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~-~~~~vavk~l~~~~~--~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||+|.. . +++.||||++..... .....+.+|+.++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 3455567999999999999986 3 356799999854322 224567788877654
Q ss_pred --------cccCCC-------CCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 --------ANLLTR-------EDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 --------~~l~~~-------~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+++.+. .....+++.....|+.|+++||+|||++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~ 135 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 135 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111111 0233488999999999999999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.66 E-value=1.3e-08 Score=89.41 Aligned_cols=82 Identities=13% Similarity=0.126 Sum_probs=60.1
Q ss_pred CCcCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH------------------------cccC
Q 015202 326 FSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD------------------------ANLL 380 (411)
Q Consensus 326 f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~------------------------~~l~ 380 (411)
|.-.+.||+|+||.||+|+. .+|+.||||.+.... ....+..|++.+.. ++.
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 44457899999999999996 468899999885432 22346666666654 222
Q ss_pred CCC-------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE-------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~-------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.. .+..+++.+..+|+.+++.||+|||++
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~ 120 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC
Confidence 111 234699999999999999999999984
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=1.2e-08 Score=91.16 Aligned_cols=76 Identities=12% Similarity=0.062 Sum_probs=58.4
Q ss_pred CeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH----------------------------cccC
Q 015202 330 NIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD----------------------------ANLL 380 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~----------------------------~~l~ 380 (411)
++||+|+||.||+|.. .+|+.||||+++. ...+.+|++++.+ +|..
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 4699999999999986 5689999999953 2356778877665 2222
Q ss_pred CCC--------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 381 TRE--------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 381 ~~~--------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+.+ +..++++.+...|+.+|++||+|||++
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~ 130 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc
Confidence 111 234699999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.64 E-value=8.5e-09 Score=93.32 Aligned_cols=87 Identities=22% Similarity=0.294 Sum_probs=60.9
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHH---HHHHH--------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEF---MTVVD-------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~---~~~~~-------------------- 376 (411)
++|.-.++||+|+||.||+|+. .+|+.||||++.... ......+.+|. +++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 3565668999999999999987 468999999995322 12234455554 44442
Q ss_pred ---cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ---ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ---~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....+++.....++.+|++||+|||+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~ 126 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC
Confidence 3333222 123478888999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=7.7e-09 Score=92.46 Aligned_cols=87 Identities=15% Similarity=0.194 Sum_probs=65.2
Q ss_pred cCCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc---chhhHhHHHHHHHHHH-----------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY---REAFKSFDNEFMTVVD----------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~---~~~~~~f~~e~~~~~~----------------------- 376 (411)
++|.-.+.||+|+||.||+|.- .+|+.||||++.... ....+.+.+|+.++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 3455668999999999999986 578999999995432 2335679999999987
Q ss_pred cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|..+.. ....++...-..++.+++.||+|||++
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~ 124 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc
Confidence 3332221 123477777788899999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=8e-09 Score=93.37 Aligned_cols=86 Identities=13% Similarity=0.084 Sum_probs=62.3
Q ss_pred CCCcCCeeeccCCceEEEEEe-cCCCEEEEEEEeccc--chhhHhHHHHHHHHHH-------------------------
Q 015202 325 GFSANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQY--REAFKSFDNEFMTVVD------------------------- 376 (411)
Q Consensus 325 ~f~~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~--~~~~~~f~~e~~~~~~------------------------- 376 (411)
.|...++||+|+||+||+|+. .+|+.||||++.... ......+.+|+.++.+
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 355567999999999999986 468999999995432 2334679999999987
Q ss_pred ----cccCCCC---CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTRE---DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~---~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
+|+.+.. ....+++.+...++.+|+.||+|||++
T Consensus 98 ~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~ 138 (355)
T d2b1pa1 98 YLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138 (355)
T ss_dssp EEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 1111000 012488899999999999999999974
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=6.2e-09 Score=82.77 Aligned_cols=120 Identities=19% Similarity=0.137 Sum_probs=73.0
Q ss_pred cCCceeecCcccccccchhhhCCCCCCeeecccCcccccCchhhhccccCCeeeecCCcccccC--CccccCCccCCeee
Q 015202 19 NLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSIPYDLCRLAALFQLDLGDNKLSGFV--PSCFGNLTNLRKLY 96 (411)
Q Consensus 19 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~ 96 (411)
..+.|++++.... ..+..+..+..+....+... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666554432 22444445555555544333 33444566788888888888887542 34456778888888
Q ss_pred cccccCCccCc-cccCCCCCcEEEcCCCeeeecCCC-------CccCccCCCeEE
Q 015202 97 LGSNQLTYIPL-TLWNLKYILYLNLSSNSFTIPLPS-------EIGNLEVLVQID 143 (411)
Q Consensus 97 l~~n~l~~~p~-~~~~~~~L~~L~l~~n~l~~~~~~-------~~~~l~~L~~L~ 143 (411)
+++|.++.++. .......|+.|++++|.+...... .+..+++|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 88888887765 222445678888888877643332 245567777665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=6.4e-09 Score=82.69 Aligned_cols=105 Identities=17% Similarity=0.082 Sum_probs=75.3
Q ss_pred cccCCcCCceeecCcccccccchhhhCCCCCCeeecccCcccccC--chhhhccccCCeeeecCCcccccCCccccCCcc
Q 015202 14 INNLTNLIAIYLGGNKLNGSISIALGKLQKLQLLGLEDNQLEGSI--PYDLCRLAALFQLDLGDNKLSGFVPSCFGNLTN 91 (411)
Q Consensus 14 ~~~~~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 91 (411)
+..+..+..+...++.. ..++..+.++++|++|+|++|+++... +..+..+++|+.|+|++|.++...+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 33444444555444443 345566778999999999999998653 355778999999999999998654434444567
Q ss_pred CCeeecccccCCccCc--------cccCCCCCcEEE
Q 015202 92 LRKLYLGSNQLTYIPL--------TLWNLKYILYLN 119 (411)
Q Consensus 92 L~~L~l~~n~l~~~p~--------~~~~~~~L~~L~ 119 (411)
|+.|++++|+++.... .+..+|+|+.||
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 9999999999974432 244689999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=98.46 E-value=3.1e-08 Score=81.01 Aligned_cols=80 Identities=16% Similarity=0.137 Sum_probs=53.2
Q ss_pred CeeeccCCceEEEEEecCCCEEEEEEEecccch------------------hhHhHHHHHHHHHH---------------
Q 015202 330 NIIGRGGIGSIYKARIQDGMEVAVKVFDLQYRE------------------AFKSFDNEFMTVVD--------------- 376 (411)
Q Consensus 330 ~~lg~g~~g~vy~g~l~~~~~vavk~l~~~~~~------------------~~~~f~~e~~~~~~--------------- 376 (411)
+.||+|+||.||+|+..+|+.||||.++..... ....+..|+..+.+
T Consensus 6 ~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~~ 85 (191)
T d1zara2 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN 85 (191)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEETT
T ss_pred CEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecCC
Confidence 789999999999999888999999987432110 01233455655554
Q ss_pred ----cccCCCCCCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 ----ANLLTREDKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 ----~~l~~~~~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..... ...+++....+++.++++||+|||++
T Consensus 86 ~lvme~~~~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~ 122 (191)
T d1zara2 86 AVLMELIDAKE-LYRVRVENPDEVLDMILEEVAKFYHR 122 (191)
T ss_dssp EEEEECCCCEE-GGGCCCSCHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEeecccc-ccchhhHHHHHHHHHHHHHHHHHhhC
Confidence 1111111 11255556678999999999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=4.1e-08 Score=87.18 Aligned_cols=87 Identities=15% Similarity=0.195 Sum_probs=61.4
Q ss_pred cCCCcCCeeeccCCceEEEEEe----cCCCEEEEEEEeccc----chhhHhHHHHHHHHHH-------------------
Q 015202 324 NGFSANNIIGRGGIGSIYKARI----QDGMEVAVKVFDLQY----REAFKSFDNEFMTVVD------------------- 376 (411)
Q Consensus 324 ~~f~~~~~lg~g~~g~vy~g~l----~~~~~vavk~l~~~~----~~~~~~f~~e~~~~~~------------------- 376 (411)
++|.-.+.||+|+||.||+|.- .+|+.||||.++... ....+.|.+|++++.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 3455568999999999999975 247899999984322 2235679999999987
Q ss_pred -----cccCCCC------CCCCCCHHHHHHHHHHHhhhhcccCCC
Q 015202 377 -----ANLLTRE------DKHFMTKEQRVSFVFNLAMECTVESPN 410 (411)
Q Consensus 377 -----~~l~~~~------~~~~l~w~~r~~ia~~ia~gl~ylh~~ 410 (411)
++..+.. ....+.-.....++.|++.||+|+|++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~ 148 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC
Confidence 2222211 112345556777889999999999973
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.36 E-value=1.3e-07 Score=85.39 Aligned_cols=81 Identities=10% Similarity=0.084 Sum_probs=59.1
Q ss_pred cCCeeeccCCceEEEEEe-cCCCEEEEEEEecccchhhHhHHHHHHHHHH---------------------cc-------
Q 015202 328 ANNIIGRGGIGSIYKARI-QDGMEVAVKVFDLQYREAFKSFDNEFMTVVD---------------------AN------- 378 (411)
Q Consensus 328 ~~~~lg~g~~g~vy~g~l-~~~~~vavk~l~~~~~~~~~~f~~e~~~~~~---------------------~~------- 378 (411)
-.++||+|+||.||+|+- .+|+.||||+++... ...+.+.+|+.++.+ ++
T Consensus 17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~ 95 (362)
T d1q8ya_ 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 95 (362)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence 358999999999999986 578999999995432 224567888877654 00
Q ss_pred -----cC------------CCCCCCCCCHHHHHHHHHHHhhhhcccCC
Q 015202 379 -----LL------------TREDKHFMTKEQRVSFVFNLAMECTVESP 409 (411)
Q Consensus 379 -----l~------------~~~~~~~l~w~~r~~ia~~ia~gl~ylh~ 409 (411)
+. .......+++.....++.+|++||+|||+
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~ 143 (362)
T d1q8ya_ 96 GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 143 (362)
T ss_dssp EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh
Confidence 00 00022347888889999999999999996
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.11 E-value=9.8e-07 Score=69.99 Aligned_cols=109 Identities=10% Similarity=0.078 Sum_probs=65.3
Q ss_pred ccCCcCCceeecCc-ccccc----cchhhhCCCCCCeeecccCcccccC----chhhhccccCCeeeecCCccccc----
Q 015202 15 NNLTNLIAIYLGGN-KLNGS----ISIALGKLQKLQLLGLEDNQLEGSI----PYDLCRLAALFQLDLGDNKLSGF---- 81 (411)
Q Consensus 15 ~~~~~L~~L~l~~n-~~~~~----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~---- 81 (411)
.+.++|+.|+|+++ .++.. +-..+...+.|++|+|++|.++... .+.+...+.|++|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45678888888864 45422 2335667778888888888776322 23344567788888888877642
Q ss_pred CCccccCCccCCeeecccccCCccC--------ccccCCCCCcEEEcCCC
Q 015202 82 VPSCFGNLTNLRKLYLGSNQLTYIP--------LTLWNLKYILYLNLSSN 123 (411)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~n~l~~~p--------~~~~~~~~L~~L~l~~n 123 (411)
+...+...++|+.|++++|.+..+. ..+...++|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 2234555566777777776655432 22333455555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.96 E-value=1.2e-06 Score=69.46 Aligned_cols=89 Identities=13% Similarity=0.137 Sum_probs=60.3
Q ss_pred hhCCCCCCeeecccC-ccccc----CchhhhccccCCeeeecCCccccc----CCccccCCccCCeeecccccCCc----
Q 015202 38 LGKLQKLQLLGLEDN-QLEGS----IPYDLCRLAALFQLDLGDNKLSGF----VPSCFGNLTNLRKLYLGSNQLTY---- 104 (411)
Q Consensus 38 ~~~l~~L~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~---- 104 (411)
..+.++|+.|+|+++ .++.. +...+...++|++|+|++|.+... +...+...+.|+.|++++|.++.
T Consensus 11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 11 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 346788999999874 45532 223455677899999999988643 22344556788888888888872
Q ss_pred -cCccccCCCCCcEEEcCCCeee
Q 015202 105 -IPLTLWNLKYILYLNLSSNSFT 126 (411)
Q Consensus 105 -~p~~~~~~~~L~~L~l~~n~l~ 126 (411)
+-..+...++|++|++++|...
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHHhCCcCCEEECCCCcCC
Confidence 3345556677888888776543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.78 E-value=3e-06 Score=67.07 Aligned_cols=112 Identities=18% Similarity=0.111 Sum_probs=64.7
Q ss_pred hhcccCCcCCceeecC-cccccc----cchhhhCCCCCCeeecccCcccccCc----hhhhccccCCeeeecCCccccc-
Q 015202 12 EEINNLTNLIAIYLGG-NKLNGS----ISIALGKLQKLQLLGLEDNQLEGSIP----YDLCRLAALFQLDLGDNKLSGF- 81 (411)
Q Consensus 12 ~~~~~~~~L~~L~l~~-n~~~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~l~~~- 81 (411)
....+.+.|+.|+|++ +.++.. +-.++..+++|++|+|++|.++.... +.+...++++.+++++|.+...
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g 90 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 90 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchh
Confidence 3345667888888886 445421 33345577788888888887764322 2344566777788777776532
Q ss_pred ---CCccccCCccCCeeec--ccccCC-----ccCccccCCCCCcEEEcCCC
Q 015202 82 ---VPSCFGNLTNLRKLYL--GSNQLT-----YIPLTLWNLKYILYLNLSSN 123 (411)
Q Consensus 82 ---~~~~~~~l~~L~~L~l--~~n~l~-----~~p~~~~~~~~L~~L~l~~n 123 (411)
+...+...++|+.++| ++|.+. .+...+...++|+.|+++.+
T Consensus 91 ~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 91 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 2234555566665444 344454 23333445556666665544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.51 E-value=5.7e-06 Score=65.36 Aligned_cols=114 Identities=10% Similarity=0.097 Sum_probs=68.4
Q ss_pred cchhhhCCCCCCeeeccc-Cccccc----CchhhhccccCCeeeecCCccccc----CCccccCCccCCeeecccccCC-
Q 015202 34 ISIALGKLQKLQLLGLED-NQLEGS----IPYDLCRLAALFQLDLGDNKLSGF----VPSCFGNLTNLRKLYLGSNQLT- 103 (411)
Q Consensus 34 ~~~~~~~l~~L~~L~l~~-n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~- 103 (411)
+.....+.++|++|+|++ +.++.. +...+...++|++|++++|.++.. +...+...++++.+++++|.++
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 344456778999999987 456532 223445678899999999887643 2234555677888888887776
Q ss_pred ----ccCccccCCCCCcEEEcC--CCeeee----cCCCCccCccCCCeEEccCC
Q 015202 104 ----YIPLTLWNLKYILYLNLS--SNSFTI----PLPSEIGNLEVLVQIDLSMN 147 (411)
Q Consensus 104 ----~~p~~~~~~~~L~~L~l~--~n~l~~----~~~~~~~~l~~L~~L~l~~n 147 (411)
.+...+...++|+.++++ .|.+.. .+...+...++|+.|++..+
T Consensus 89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 89 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred hhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 233455566677765554 344432 12223334455555555544
|